Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7674137766852791,-2.7989471051089425,0.0,0.0,0.0,72/91,15.71%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;SRPRA;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;SSR1;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;ARL6IP1;RPL17;RPL23;SEC62;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SRP14;RPL31;RPSA;RPS26;RPL36
prerank,protein targeting to ER (GO:0045047),-0.7491251284639877,-2.7880195170269526,0.0,0.0,0.0,78/99,18.41%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;SRPRA;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;SEC62;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SGTB;SRP14;RPL31;RPSA;SPCS1;RPS26;RPL36;SRPRB;RPL13A;ZFAND2B;CHMP4B;CHMP4A;RPL35
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7681996319064364,-2.770543835954735,0.0,0.0,0.0,69/87,15.71%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;SEC61B;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SRP14;RPL31;RPSA;RPS26;RPL36
prerank,cytoplasmic translation (GO:0002181),-0.7316353382493803,-2.663401970451912,0.0,0.0,0.0,68/91,15.71%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;EIF3M;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;EIF2B3;RPS5;RPL36A;RPL6;RPL31;RPSA;RPS26;RPL36
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.663269390726374,-2.4820727443645976,0.0,0.0,0.0,80/110,20.81%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;PPP2R1A;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SMG5;RPL31;RPSA;RPS26;RPL36;RNPS1;PABPC1;RPL13A;PNRC2;RPL35;RPL24;RPS13;HELZ2;RPL11;DHX34;EIF4A3
prerank,peptide biosynthetic process (GO:0043043),-0.5864015040084822,-2.331111774705917,0.0,0.0,0.0,70/153,15.07%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;PCSK5;RPS7;RPL39;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;RPL31;HBS1L;RPSA;RPS26
prerank,translation (GO:0006412),-0.5294054399055546,-2.1927538105829707,0.0,0.00015091649646743782,0.001,106/208,25.37%,RPS24;RPS12;LARS2;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;WARS2;EEF2K;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;RPL12;RPL9;RPS25;GARS1;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;DARS2;RPL36A;RPL6;RPL31;HBS1L;RPSA;RPS26;ABCE1;RPL36;APEH;EEFSEC;RPL13A;RPL35;MRPL16;EEF2;COPS5;RPL24;RPS13;MRPL34;RPL11;CARS1;EEF1D;RSL24D1;IARS1;MRPS2;MRPS16;RPL22L1;MRPS21;MRPL10;MRPL13;TUFM;EEF1G;RPS27A;MRPS33;NDUFA7;EIF4EBP2;MRPL35;EEF1A2;GTPBP2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.636251534716978,-2.1559669892719397,0.0,0.0002641038688180162,0.002,18/56,8.32%,NRP1;NLGN1;CNTNAP2;NRXN1;GRID2;PTPRD;IL1RAPL1;PTPRJ;TEK;CAV1;CLSTN2;CLDN5;EPHB1;IL1RAP;SYNDIG1;KDR;EPHB2;MYOC
prerank,action potential (GO:0001508),-0.662611586290645,-2.1429337124694543,0.0,0.00035213849175735494,0.003,18/44,15.36%,KCND2;ANK3;AKAP6;KCNJ2;SCN1A;SCN2A;KCNMB2;CACNA1G;SCN7A;KCNQ1;SCN3A;SCN9A;KCNB1;GPER1;GNA14;SCN8A;KCNE4;CACNA1H
prerank,glutamate receptor signaling pathway (GO:0007215),-0.6902189006928505,-2.140721444504421,0.0,0.00031692464258161943,0.003,22/37,15.43%,GRID2;GRIK2;GRIA4;GRM7;GRM5;GRM3;GRIK1;GRIN2B;GRIA2;GRM8;PTK2B;GRIA3;GRIK4;GRIN3A;APP;GRIN2A;GRM1;KCNB1;HOMER1;CDK5R1;GRIN1;GRIK3
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5033826400017261,-2.0182623771088446,0.0,0.005762266228756717,0.054,90/168,21.59%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;PPP2R1A;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;CNOT2;RPL7A;RPS2;RPS9;RPS11;DCP1B;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;TNKS1BP1;RPL36A;RPL6;SMG5;RPL31;RPSA;RPS26;NBAS;RPL36;RNPS1;PABPC1;RPL13A;PNRC2;XRN2;RPL35;ERI1;RPL24;RPS13;HELZ2;RPL11;DHX34;LSM1;EIF4A3;DCP2;CNOT7;CNOT6L
prerank,regulation of synapse assembly (GO:0051963),-0.6365679345417755,-2.016238800806608,0.0,0.005282077376360324,0.054,18/46,10.87%,NLGN1;NRXN1;GRID2;MEF2C;PTPRD;ROBO2;IL1RAPL1;CLSTN2;GPC6;EPHB1;LRFN5;IL1RAP;IL1RAPL2;SYNDIG1;APP;EPHB2;SLITRK1;GPC4
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.6969132163745854,-1.975016954579435,0.0,0.011945621143461038,0.131,9/25,7.01%,PDE4D;SPTBN1;PDE4B;RUNX1;ANXA1;PTPRC;RPS3;PLCG2;MAP3K7
prerank,neuron development (GO:0048666),-0.4967728082939967,-1.9525265686149547,0.0,0.01697810585258675,0.191,41/141,9.93%,FRY;NLGN1;CNTNAP2;TENM2;MEF2C;PTPRM;CNTN4;EPHA5;TENM3;TGFB2;PLP1;TENM4;PBX3;RUNX1;ATP8A2;SH3GL2;UGCG;NTRK2;MYT1L;TMEM108;GPM6B;LYN;GSK3B;STX3;APOE;APP;STMN2;VSX1;B4GALT5;DCX;SRRM4;ULK1;LGI1;MYOC;GPRIN3;RASGRF1;ETV1;PPT1;RP1;PBX1;UHMK1
prerank,dendrite self-avoidance (GO:0070593),-0.7675669660828868,-1.9421662538624545,0.0,0.01943804474500599,0.219,7/16,8.05%,BSG;CNTN4;NPTN;DSCAML1;CNTN6;ROBO4;EMB
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.8135087481956129,-1.9383855896692208,0.0,0.019939842095760222,0.241,8/13,10.44%,PDE4D;SLC8A1;CAV1;ANK3;CAMK2D;CALM1;CALM2;CALM3
prerank,positive regulation of synapse assembly (GO:0051965),-0.6659492720458222,-1.929968849380103,0.0,0.021439019939344845,0.27,11/27,7.96%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;CLSTN2;EPHB1;IL1RAP;SYNDIG1;SEMA4D;EPHB2
prerank,regulation of fatty acid oxidation (GO:0046320),0.854961097859156,1.9296032891822048,0.0,0.4856105544198309,0.333,4/16,1.76%,PRKAG2;APPL2;PPARGC1A;PPARA
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.8235641113042514,-1.9293655319467695,0.0,0.02048272227055281,0.274,7/12,10.44%,PDE4D;CAV1;CAMK2D;GJD3;CALM1;CALM2;CALM3
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.5355474257939719,-1.9293350595449263,0.0,0.019404684256313188,0.274,30/88,13.77%,NRP1;PTPRM;TEK;CDH13;CAV1;BMPR2;VEGFC;THBS1;NRP2;SEMA5A;TIE1;PPP1R16B;CAV2;F3;ACVRL1;AKT3;KDR;APOE;ECM1;BMP2;PROX1;ATOH8;XDH;FGF2;FLT4;ITGB3;BMP4;HIF1A;PRKD1;VEGFA
prerank,positive regulation of nervous system development (GO:0051962),-0.5992575499349828,-1.9150741748360887,0.0,0.023293961229749027,0.328,14/42,11.24%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;CLSTN2;EPHB1;IL1RAP;SYNDIG1;SERPINF1;EPHB2;MME;NAP1L1;GPER1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.7427831040881119,-1.9106008756648114,0.0,0.024247250432435006,0.35,11/17,10.04%,SERPINE2;TENM4;NOTCH1;HES1;TNFRSF1B;PTPRZ1;BIN1;BMP2;TGFB1;PTN;ID2
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.46723837199492596,-1.9088404346777943,0.0,0.02367331042314218,0.356,72/224,13.31%,NLGN1;DLG2;NRXN1;GRIK2;KCND2;SYT1;GRIA4;CACNB2;GRM7;GRM5;SLC12A7;CACNA1E;GRM3;SNAP25;CHRM3;GABRG3;GRIK1;HTR2C;GABRB3;GRIN2B;GRIA1;GRIA2;GABRB1;RIT2;GABRA3;PLP1;KCNQ3;GLRB;GRIA3;SLC1A2;DLGAP1;GABRA2;UNC13B;GRIK4;SLC1A1;APBA2;SYN2;PDE7B;GABRB2;MBP;GLRA3;MINK1;CALM1;PTCHD1;HTR2A;GRIN2A;CACNA1B;AMPH;SYPL1;CHRM2;GRM1;CAMK4;GLRA1;GABRG2;HTR1F;GABBR2;HTR7;CAMKK2;RPS6KA3;RPS6KA2;GABRA4;SLC12A4;GABRG1;NRXN2;HCRTR2;PRKAR1B;PRKAR2B;HOMER1;HTR4;SLC12A6;SNCA;GLRA2
prerank,chemical synaptic transmission (GO:0007268),-0.44690682795415854,-1.9042277892623656,0.0,0.024481280361739587,0.376,99/284,17.14%,NLGN1;DLG2;NRXN1;GRID2;GRIK2;KCND2;SYT1;GRIA4;CACNB2;GRM7;GRM5;SLC12A7;CDH8;CACNA1E;GRM3;SNAP25;CHRM3;RIMS1;GABRG3;GRIK1;HTR2C;GABRB3;GRIN2B;GRIA1;GRIA2;LIN7A;GABRB1;RIT2;GABRA3;PLP1;KCNQ3;GLRB;GRIA3;SLC1A2;DLGAP1;PTPRN2;GABRA2;UNC13B;GRIK4;SLC1A1;APBA2;SYN2;PDE7B;SHISA6;GABRB2;MBP;GLRA3;DLGAP2;MINK1;CALM1;APOE;HSPA8;PTCHD1;HTR2A;GRIN2A;CACNA1B;AMPH;SYPL1;SLC1A4;CHRM2;GRM1;CAMK4;GLRA1;GABRG2;HTR1F;GABBR2;GRID1;HTR7;CAMKK2;RPS6KA3;RPS6KA2;GABRA4;SLC17A6;SLC12A4;ERC1;GABRG1;NRXN2;HCRTR2;PRKAR1B;PRKAR2B;HOMER1;HTR4;SLC12A6;SNCA;GLRA2;RPS6KA1;HTR1B;GRIN1;HRH1;SLC1A6;GRIK3;SLC12A5;SCN2B;NAPB;CHRNA7;CHRFAM7A;GABRA5;GABRE;STXBP3
prerank,angiogenesis involved in wound healing (GO:0060055),-0.8338840956049313,-1.8954325048255998,0.0,0.027246715799725336,0.419,8/11,13.77%,ADIPOR2;CD34;NDNF;KDR;GATA2;MCAM;ITGB3;VEGFA
prerank,neuronal action potential (GO:0019228),-0.6790918262030081,-1.8926264136130586,0.0,0.02729777588103015,0.432,11/22,15.36%,ANK3;SCN1A;SCN2A;KCNMB2;CACNA1G;SCN7A;SCN3A;SCN9A;GPER1;SCN8A;CACNA1H
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.6804894625050074,-1.8919320603335845,0.0,0.026369755517368077,0.433,10/25,13.16%,NRP1;ITGA6;THBS1;AR;APP;PSEN1;BTBD10;PTH1R;ILK;SNCA
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8389413484812815,1.8813312636602653,0.0,0.6361017460370656,0.637,4/14,1.93%,ACTN2;ATP1B3;ANK2;LRRC38
prerank,axon development (GO:0061564),-0.5208722617315332,-1.870471815972739,0.0,0.03611375865467096,0.537,28/78,14.09%,CTNNA2;GRM7;MAP1B;ANK3;KLF7;ACTB;CNTN4;RTN4;DCC;SEMA5A;PAK3;PLP1;NTNG1;S100A6;DSCAML1;SHTN1;APP;NRCAM;EPHB2;GAP43;S100B;SLITRK1;PLPPR4;MARK2;MAPT;RTN4RL1;ADGRB1;CDK5R1
prerank,regulation of T cell migration (GO:2000404),-0.7021990018083659,-1.867416375881712,0.0,0.03663497951747053,0.561,6/18,9.22%,LRCH1;CD200;CXCL12;APP;APOD;DOCK8
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.6077852730825155,-1.8619034666796321,0.0,0.038795947626370654,0.599,19/34,21.60%,GRID2;MEF2C;GABRG3;GRIN2B;GABRA3;GABRA2;GSK3B;GRIN2A;GLRA1;GABRG2;GABRA4;GABRG1;GRIN1;INSYN2A;GABRA5;GABRE;ARRB2;GABRA1;DRD2
prerank,smooth muscle cell differentiation (GO:0051145),-0.7938808856754412,-1.8594191379955893,0.002173913043478261,0.038805661791660506,0.612,11/12,19.50%,MEF2C;MRTFB;TBX18;MRTFA;TMEM204;HEY2;BMP4;MYOCD;EDNRB;APLNR;GATA6
prerank,regulation of interleukin-2 production (GO:0032663),-0.5916732235668268,-1.8559889405066525,0.002680965147453083,0.03959854136342385,0.63,12/43,7.01%,PDE4D;SPTBN1;PDE4B;NAV3;CD34;RUNX1;HDAC7;ANXA1;PTPRC;RPS3;PLCG2;MAP3K7
prerank,negative regulation of vascular permeability (GO:0043116),-0.8025254370334457,-1.854951347597073,0.002136752136752137,0.03895532065065739,0.634,8/12,9.51%,SLIT2;PTPRJ;PDE3A;CLDN5;SH3GL2;RAMP2;CEACAM1;PDE2A
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.5968788225355915,-1.8439169858093263,0.0,0.04452951291222552,0.695,17/39,8.46%,ACTN4;GCNT2;THBS1;EFNA5;CASK;ACER2;NEXMIF;JAG1;NOTCH1;SEMA3E;AJAP1;FZD4;CORO2B;ADAM15;CORO1C;MYOC;SPOCK1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.745802003022041,-1.840046810528804,0.0,0.0458297890007734,0.716,7/14,9.20%,GHR;PIK3R1;STAT3;LYN;SOCS2;PTK2;STAT5B
prerank,epithelial tube morphogenesis (GO:0060562),-0.6110817932741254,-1.8379896999755767,0.0,0.04572769842963365,0.723,17/32,13.46%,SLIT2;MEF2C;COL4A1;PODXL;RYR2;ACVRL1;RASIP1;PAK1;SOX17;HES1;MET;RHOB;PKD1;BMP4;CTNNB1;MTSS1;ACVR1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4681892645876855,-1.8372219926132403,0.0,0.044868312824749644,0.726,46/159,8.05%,NLGN1;ADGRL3;CDH11;GRID2;TENM2;LRRC4C;CADM1;PTPRM;PTPRD;ROBO2;HMCN1;IL1RAPL1;CDH8;CDH2;CDH13;PECAM1;KIRREL3;BSG;CLDN5;GPC6;CNTN4;UNC5D;LRFN5;NPTN;TENM3;PTPRT;TGFB2;ATP2C1;VCAM1;CDH10;TENM4;CDH12;CLDN11;NTNG1;DSCAML1;IGSF11;CNTN6;ICAM1;CDH6;PTPRF;ITGB1;CDH20;CDH19;CDH7;ROBO4;EMB
prerank,rRNA metabolic process (GO:0016072),-0.45891469874046337,-1.832766818590187,0.0,0.04693910922560201,0.75,66/160,18.85%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPL36A;RPL6;MAPT;EMG1;MDN1;RPL31;NOP53;TRIR;DDX10;NOL11;RPL36;TEX10;RPL13A;FBL;XRN2;RPL35;UTP15
prerank,positive regulation of developmental growth (GO:0048639),-0.5622734481303365,-1.8326512198714238,0.0,0.0457594703236268,0.75,20/49,21.68%,GHR;SYT1;RIMS2;RIMS1;SEMA7A;CDKL5;NGF;NEDD4L;NTN1;SHTN1;SEMA4D;PPIB;AGRN;MAPT;SMURF1;BDNF;CPNE9;SYT2;L1CAM;TWF2
prerank,limb development (GO:0060173),0.7290053853449795,1.8315734143851736,0.0,1.0,0.892,7/28,8.24%,SMOC1;RSPO2;LRP4;GLI3;COMP;CHD7;IFT122
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.604904720794548,-1.8191652921483439,0.0,0.053714663781141134,0.814,17/33,16.47%,NLGN1;NRG3;GRID2;GRIK2;LRRC4C;GRIK1;ABR;NGF;GRIK4;CACNA1B;RELN;GRID1;LRP8;FABP5;GRIK3;BDNF;CX3CR1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.6616795081269552,-1.8191196475363016,0.0023148148148148147,0.05245102834725801,0.815,12/24,14.99%,NRP1;SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;VEGFA;SEMA4C
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.7538224371258344,-1.814162079739892,0.0022371364653243847,0.05495937094525156,0.841,7/13,13.39%,NOS3;CALM1;GCH1;HSP90AA1;PRKG2;MTHFD1L;QDPR
prerank,synaptic membrane adhesion (GO:0099560),-0.7329606630120039,-1.813657732490053,0.002136752136752137,0.054078411234165215,0.841,8/14,10.87%,LRRC4C;PTPRD;GPC6;LRFN5;NTNG1;PTPRF;SLITRK1;GPC4
prerank,axonogenesis (GO:0007409),-0.43290217527729,-1.8132456360237388,0.0,0.053238426393361966,0.845,71/237,10.34%,NRP1;NRXN1;NRXN3;SPTBN1;SLIT2;CTNNA2;ROBO2;RPS6KA5;SEMA3C;UNC5C;LAMA1;SEMA6A;PIK3R1;SEMA6D;MAP1B;BSG;ANK3;SHANK3;KLF7;ACTB;ENAH;SH3KBP1;EPHB1;CNTN4;UNC5D;NOTCH3;DCC;NPTN;EPHA5;DAB1;EFNA5;NRP2;CXCL12;EPHA6;SEMA5A;PAK3;SEMA7A;LAMA2;EVL;GAB1;NTNG1;S100A6;DSCAML1;NOTCH1;HSP90AB1;SEMA3E;SHTN1;NTN4;CNTN6;APP;NRCAM;B4GALT5;EPHA7;SEMA4D;KIF5C;LAMA3;ULK1;LGI1;ROBO4;FEZ1;RELN;EPHB2;EMB;ULK2;PTK2;SLC9A6;TNR;S100B;SLITRK1;PLPPR4;HSP90AA1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.6431421361598929,-1.810399354174144,0.0,0.05438138753389152,0.86,9/23,15.16%,SLIT2;BMP5;THBS1;LYN;STK10;PTK2;MSN;CMKLR1;RARRES2
prerank,neural crest cell migration (GO:0001755),-0.5960604215560041,-1.8095715750979855,0.0,0.053736333842172364,0.862,12/36,7.53%,NRP1;SEMA3C;ERBB4;SEMA6A;SEMA6D;FN1;SEMA5A;SEMA7A;SEMA3E;TBX1;SEMA4D;CORO1C
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.6247162190419825,-1.804988875277523,0.0024449877750611247,0.05619671017371179,0.88,11/29,12.57%,GRIK2;SLC4A10;MCTP1;SHISA6;SHISA9;APOE;APP;EPHB2;NETO1;ZDHHC2;NCDN
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7394474576234669,1.8040925810686597,0.0,0.9548738228492911,0.967,6/21,8.43%,EYA1;EYA2;EYA4;MAP2K5;TERT;GDNF
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7394474576234669,1.8040925810686597,0.0,0.9548738228492911,0.967,6/21,8.43%,EYA1;EYA2;EYA4;MAP2K5;TERT;GDNF
prerank,chloride transmembrane transport (GO:1902476),-0.5568641922706388,-1.8038671103976909,0.002777777777777778,0.0558551586393847,0.881,29/48,17.12%,SLC12A7;ANO4;GABRG3;GABRB3;ANO1;GABRB1;GABRA3;GLRB;SLC12A2;GABRA2;SLC1A1;ANO3;GABRB2;GLRA3;GLRA1;GABRG2;SLC12A8;GABRA4;SLC12A4;GABRG1;SLC12A6;GLRA2;CLCN1;ANO5;ANO2;CLCN3;SLC12A5;GABRA5;GABRE
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6518078516923863,1.8031435503197057,0.0,0.8063058413485706,0.967,16/50,9.30%,RORA;TULP3;FGFR2;DCDC2;FBXL17;TTC23;GLI3;SUFU;GAS1;SMO;RAB34;MGRN1;BTRC;IFT122;ZIC1;GLI1
prerank,carnitine shuttle (GO:0006853),0.850301561246864,1.8005757269816716,0.0,0.7150220468897367,0.969,5/11,8.40%,PRKAG2;PRKAA2;CPT1A;SLC25A20;CPT2
prerank,basement membrane organization (GO:0071711),-0.7394979521459423,-1.8003601684521735,0.0022727272727272726,0.057596652058062366,0.892,6/14,11.63%,FLRT2;COL4A1;NTNG1;RAMP2;NTN4;CTSS
prerank,endoderm formation (GO:0001706),-0.5849977563499269,-1.7993783484865327,0.0,0.05724047116014963,0.893,20/35,22.93%,COL8A1;COL12A1;FN1;COL6A1;COL4A2;SOX17;LAMA3;ITGA4;DUSP1;SOX7;SETD2;MMP15;ITGA5;COL11A1;ITGB2;INHBA;VTN;ITGA7;COL7A1;LHX1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.6209437258726518,-1.7857594717483953,0.0024330900243309003,0.06818105477405906,0.931,9/27,7.16%,CTNNA2;IL1RAPL1;MARK1;NTNG1;CCDC88A;MBOAT1;GSK3B;DISC1;PSEN1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7829736810543761,-1.7814003433387968,0.0,0.07063483864074001,0.941,6/11,13.39%,NOS3;CALM1;GCH1;HSP90AA1;PRKG2;QDPR
prerank,positive regulation of chemotaxis (GO:0050921),-0.5634409538356526,-1.7805697150963549,0.0,0.06998752523677429,0.942,19/43,15.16%,NRP1;NTRK3;CDH13;TMSB4X;THBS1;SEMA5A;F3;KDR;STX3;MET;TGFB1;PTN;FGF2;P2RY12;EDN3;PRKD1;VEGFA;PPM1F;RARRES2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.70702374318352,1.7786137928027999,0.0,0.8591941195527106,0.991,8/26,8.43%,EYA1;EYA2;EYA4;FGFR1;MAP2K5;TERT;PPP2R1B;GDNF
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5744247081495261,-1.7763579273916297,0.0,0.0728129383239406,0.95,11/37,6.02%,NLGN1;GRID2;TENM2;CADM1;PTPRD;HMCN1;IL1RAPL1;TENM3;VCAM1;TENM4;ICAM1
prerank,regulation of osteoblast differentiation (GO:0045667),0.5814211685765621,1.765480361122158,0.001392757660167131,0.909785230117681,0.994,13/82,4.77%,RANBP3L;SMOC1;TMEM64;BMP6;BMP7;WNT4;DDX5;IGF1;FGFR2;NPNT;BMPR1A;SUFU;SMAD6
prerank,cellular response to copper ion (GO:0071280),-0.6983002045603985,-1.765360134624026,0.006521739130434782,0.08206783182900577,0.964,10/16,14.18%,MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;SNCA;MT3
prerank,regulation of lipid biosynthetic process (GO:0046890),0.6667518587449279,1.7644650968542455,0.0034482758620689655,0.8288073997117865,0.994,6/32,2.21%,PRKAG2;SORBS1;PRKAA2;PPARA;AVIL;ZBTB20
prerank,histone H3-K4 methylation (GO:0051568),0.7044445384415761,1.7632387253814827,0.0016778523489932886,0.7654376263726442,0.996,14/26,20.70%,KMT2A;CXXC1;CTR9;TET2;ASH2L;KMT2C;WDR82;KMT2D;BEND3;OGT;SETD1B;TET3;SETD1A;KDM6A
prerank,regulation of dendrite development (GO:0050773),-0.5773926648591827,-1.7604152853554969,0.0048543689320388345,0.08583855925437922,0.972,18/37,13.06%,CSMD3;ADGRB3;HECW2;BMP5;MARK1;HECW1;DCC;CDKL5;NEDD4L;GSK3B;DAB2IP;SEMA4D;LZTS1;PTN;RAP2A;MFSD2A;VLDLR;LRP8
prerank,aspartate family amino acid catabolic process (GO:0009068),0.7654024177865114,1.7588294762965182,0.0035026269702276708,0.7458849901880835,0.997,9/19,13.24%,DDO;ALDH7A1;ASPA;PIPOX;GOT2;OGDH;DLD;AASS;GCDH
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4712548023045207,-1.75473299011064,0.003663003663003663,0.09030465857370311,0.978,32/107,8.65%,NLGN1;NRG3;GRID2;GRIK2;MEF2C;LRRC4C;SYT1;GRM7;GRM5;RIMS2;CDH2;CLSTN2;GRM3;MCTP1;RIMS1;DGKI;GRIK1;ABR;GRM8;SLC12A2;DLGAP1;NGF;GRIK4;TMEM108;DLGAP2;APP;CACNA1B;ITGB1;CNTNAP4;LGI1;RELN;GRM1
prerank,mesenchymal cell differentiation (GO:0048762),0.6243819169052013,1.754635123514253,0.0015082956259426848,0.728674725299277,0.997,12/51,4.57%,RANBP3L;TGFBR3;BMP7;ROCK2;WNT4;DDX5;FGFR2;FBXL17;FGFR1;TGFBR1;FOXC1;LOXL3
prerank,cellular response to zinc ion (GO:0071294),-0.716032949395037,-1.7544461569766463,0.004347826086956522,0.08903543760012281,0.978,13/15,22.95%,GLRA1;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;GLRA2;MT3;MT2A;HVCN1
prerank,regulation of cation channel activity (GO:2001257),-0.4812719162558617,-1.7541168648885603,0.0035842293906810036,0.0877735547471738,0.978,40/89,15.27%,PDE4D;NLGN1;DLG2;FGF14;MEF2C;GRIA4;CACNB2;AHNAK;FGF12;ANK3;CAMK2D;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;KCNAB1;SHISA6;SHISA9;MINK1;CALM1;APP;CALM2;GRIN2A;ITGB1;RELN;NETO1;FGF13;FKBP1A;JPH2;CTSS;DAPK1;HOMER1;NOS1;SHANK1;SELENON;CACNG8;STAC;GRIN1
prerank,platelet aggregation (GO:0070527),-0.5861457816756689,-1.751030981593741,0.004914004914004914,0.08963416727477892,0.98,17/33,17.82%,ACTB;GNAS;ACTN1;UBASH3B;FN1;ACTG1;MYH9;PPIA;FLNA;MYL12A;P2RY12;ITGB3;ILK;MYL9;TYRO3;STXBP3;HSPB1
prerank,glycerolipid catabolic process (GO:0046503),-0.6674437307670864,-1.748567314400986,0.0045871559633027525,0.09078130317504608,0.982,6/19,7.94%,ABHD2;PLA2G4A;GPCPD1;MGLL;ENPP6;GDPD1
prerank,substantia nigra development (GO:0021762),-0.5570708909739404,-1.7484015477486612,0.002631578947368421,0.08946626795500798,0.982,18/37,20.13%,ACTB;PLP1;GNB4;YWHAE;MBP;CALM1;CALM2;BASP1;DYNLL1;HSPA5;GLUD1;CALM3;FGF9;SUDS3;NDRG2;SIRT2;YWHAQ;PADI2
prerank,chloride transport (GO:0006821),-0.49672107062503573,-1.7478083657284706,0.0030120481927710845,0.08868778304501769,0.983,34/74,17.12%,SLC4A10;SLC12A7;SLC26A7;CLIC4;ANO4;GABRG3;GABRB3;ANO1;GABRB1;GABRA3;GLRB;SLC12A2;GABRA2;SLC1A1;ANO3;GABRB2;GLRA3;GLRA1;GABRG2;SLC12A8;GABRA4;SLC12A4;CLIC5;GABRG1;SLC12A6;GLRA2;CLCN1;TTYH1;ANO5;ANO2;CLCN3;SLC12A5;GABRA5;GABRE
prerank,vasoconstriction (GO:0042310),-0.7613982131322083,-1.7467855955383156,0.006134969325153374,0.0883196874326661,0.983,7/11,16.55%,SLC8A1;EDNRA;ACTA2;EDN1;EDN3;EDNRB;PIK3C2A
prerank,positive regulation of tissue remodeling (GO:0034105),0.8272511784935123,1.7462795293827797,0.001937984496124031,0.7563023783192019,0.998,4/10,8.46%,ROCK2;IL18;IL12B;HRG
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5878781946615211,-1.7424988144156162,0.0024449877750611247,0.09187513336506738,0.987,18/35,18.06%,NRP1;SEMA3C;SEMA6A;SEMA6D;NRP2;SEMA5A;SEMA7A;SEMA3E;FLNA;MET;SEMA4D;PLXNA4;SEMA3D;SEMA3G;SEMA4C;PLXND1;ARHGDIA;SEMA4A
prerank,long-chain fatty acid transport (GO:0015909),0.6657835299060091,1.7410800919243317,0.008431703204047217,0.7522956905764641,0.999,8/30,9.66%,PRKAG2;ACSL1;PRKAA2;CPT1A;SLC25A20;SLC27A1;CPT2;SPX
prerank,regulation of gluconeogenesis (GO:0006111),0.6760070737748098,1.734511564089255,0.008503401360544218,0.7647164225789514,0.999,15/27,24.28%,C1QTNF3;PPARGC1A;SIK1;GCK;SIRT1;USP7;OGT;CLK2;CRY1;GNMT;EP300;PDK2;SELENOS;ARPP19;DGKQ
prerank,regulation of membrane repolarization (GO:0060306),-0.7272496257350839,-1.7328113732959494,0.006550218340611353,0.10092830925291571,0.988,7/13,8.00%,CAV1;AKAP6;CACNA2D1;KCNJ2;NEDD4L;YWHAE;KCNQ1
prerank,adherens junction organization (GO:0034332),-0.5401348758592505,-1.7323141526536459,0.002890173410404624,0.10005535054432843,0.988,18/48,12.06%,CDH11;CADM2;CADM1;CDH8;CDH2;CDH13;ACTB;CDH10;CDH12;RAMP2;CDH6;CDH20;CDH19;CDH7;SMAD7;PVR;CDH1;CTNNB1
prerank,cation transmembrane transport (GO:0098655),0.6333392536036578,1.7278067734654705,0.009216589861751152,0.7825768224109914,1.0,10/44,7.03%,TRPM3;ATP1A2;TRPM6;SLC7A2;SFXN2;SLC25A20;SLC6A9;P2RX3;SLC22A5;TRPM5
prerank,endothelial cell migration (GO:0043542),-0.5646314067126421,-1.7255524666498916,0.0,0.10680833476855174,0.992,18/37,15.97%,NRP1;CDH13;NOS3;FAP;ID1;CCN3;CYP1B1;MYH9;PLEKHG5;STARD13;SOX18;EMP2;LPXN;VEGFA;SCG2;PTP4A3;PLXND1;NR4A1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.7181644974162972,1.7251778718308772,0.010810810810810811,0.7625528111978731,1.0,4/20,7.26%,C1QTNF3;WNT4;SIK1;GCK
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.6246369892851423,-1.7251174742102506,0.011494252873563218,0.10585904483093897,0.992,11/22,16.33%,NTRK3;SH3GL2;NGF;NTRK2;TMEM108;RAP1A;STMN2;MAPT;BDNF;ACAP2;WASF1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.705846976528321,-1.7246499728942064,0.006521739130434782,0.10334761678090142,0.993,3/14,4.06%,ABCG2;SLCO2B1;HMOX2
prerank,heme catabolic process (GO:0042167),-0.705846976528321,-1.7246499728942064,0.006521739130434782,0.10334761678090142,0.993,3/14,4.06%,ABCG2;SLCO2B1;HMOX2
prerank,neuron cell-cell adhesion (GO:0007158),-0.7031091971107386,-1.723350487593672,0.0022172949002217295,0.1032906511174461,0.993,7/14,3.27%,NLGN1;NRXN1;NRXN3;ASTN2;NCAM2;CNTN4;ASTN1
prerank,maturation of 5.8S rRNA (GO:0000460),0.7539811483016612,1.722788378872468,0.008849557522123894,0.7444341474686078,1.0,2/17,0.31%,NSA2;MPHOSPH6
prerank,lipid phosphorylation (GO:0046834),-0.7468955386717097,-1.7170759955504538,0.002008032128514056,0.1102780376686783,0.998,6/10,13.00%,DGKH;DGKB;DGKI;DGKK;DGKG;DGKZ
prerank,regulation of glucose import (GO:0046324),0.659225931503875,1.7170558359508155,0.010033444816053512,0.7593795145056246,1.0,8/30,6.42%,PRKAG2;APPL2;OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;CREBL2
prerank,regulation of dendritic spine development (GO:0060998),-0.6535220106364048,-1.7161187396511888,0.0,0.11009875254616258,0.998,8/19,7.16%,NLGN1;MEF2C;PPFIA2;SHANK3;TANC2;GRIN3A;APOE;PSEN1
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.6215208444825187,-1.7156257780580735,0.004819277108433735,0.10918196695784799,0.998,9/23,16.01%,SLC12A7;SLC12A2;ATP6V0A4;SLC9A7;SLC12A8;SLC12A4;SLC12A6;CLCN3;SLC12A5
prerank,cellular glucan metabolic process (GO:0006073),0.8186480177205637,1.715606817913365,0.0076481835564053535,0.7361773581713928,1.0,3/11,3.00%,PRKAG2;PYGM;PHKB
prerank,positive regulation of vasoconstriction (GO:0045907),-0.7131124369831746,-1.7121865173452195,0.00437636761487965,0.11181101390279534,0.999,2/13,2.36%,CAV1;ADRA1B
prerank,alpha-amino acid catabolic process (GO:1901606),0.6698374503104363,1.70898783301363,0.010238907849829351,0.7639078001435989,1.0,7/29,12.38%,DDO;PRODH;ACADSB;ALDH4A1;GOT2;FAH;MTRR
prerank,positive regulation of behavior (GO:0048520),-0.7588445238735269,-1.7075029564745932,0.012121212121212121,0.11672000981394115,0.999,4/10,7.68%,NLGN1;MEF2C;SGIP1;STRA6
prerank,cellular response to glucose starvation (GO:0042149),0.6182710283102544,1.7065562811278585,0.009708737864077669,0.7521423912193506,1.0,14/41,11.45%,PRKAG2;PRKAA2;MTMR3;CPEB4;PRKAG3;SESN1;SESN2;NUAK2;TP53;SIK1;PICK1;BRSK1;BECN1;IMPACT
prerank,ribosome biogenesis (GO:0042254),-0.4161238719210055,-1.704919498741827,0.0,0.11852432845292685,0.999,70/187,19.06%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;XPO1;RPS17;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPL36A;RPL6;EMG1;MDN1;MALSU1;RPL31;NOP53;DDX10;LTV1;ABCE1;NOL11;RPL36;TEX10;RPL13A;FBL;XRN2;RBIS;RPL35;UTP15;RAN
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.7883999748917204,-1.7041482123854665,0.004048582995951417,0.11792576337428036,0.999,10/10,21.22%,GABRG3;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE;GABRA1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.6970010679644202,-1.7031724868958398,0.006122448979591836,0.11790399044903538,0.999,6/15,5.30%,NTRK3;CDH13;VEGFC;CXCL12;F3;KDR
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.6652296669492076,-1.7012976217507212,0.011312217194570135,0.11879392019434366,0.999,6/16,6.28%,KCNC2;NOS3;NDNF;GUCY1B1;APOE;GUCY1A1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.7670740497122497,1.69901169480034,0.024714828897338403,0.7835478549698196,1.0,9/13,18.12%,ADHFE1;GPT2;GOT2;OGDH;IDH1;D2HGDH;GOT1;IDH2;PHYH
prerank,ganglion development (GO:0061548),-0.7497420644980148,-1.6940146880170261,0.0020920502092050207,0.12739588101799418,0.999,3/11,2.99%,NRP1;UNC5C;NRP2
prerank,endocardial cushion development (GO:0003197),-0.6138136340627345,-1.692381763857782,0.00702576112412178,0.1281869997433786,0.999,10/21,13.46%,BMPR2;ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2;BMP4;ACVR1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.6361470491647007,-1.6921215557092388,0.004405286343612335,0.12698623128661915,0.999,10/20,14.99%,SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;SEMA4C
prerank,regulation of presynapse assembly (GO:1905606),-0.6518093166019223,-1.6881334078294952,0.0044444444444444444,0.12923068366916388,0.999,9/18,13.16%,PTPRD;IL1RAPL1;GPC6;LRFN5;IL1RAPL2;APP;SLITRK1;GPC4;SNCA
prerank,regulation of presynapse organization (GO:0099174),-0.6518093166019223,-1.6881334078294952,0.0044444444444444444,0.12923068366916388,0.999,9/18,13.16%,PTPRD;IL1RAPL1;GPC6;LRFN5;IL1RAPL2;APP;SLITRK1;GPC4;SNCA
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.48515544847577097,-1.6874286981825446,0.0,0.12878441677618985,0.999,21/64,8.55%,UTRN;LIMCH1;CDH13;THBS1;EFNA5;PEAK1;CASK;ACER2;NEXMIF;PTK2B;ACTG1;JAG1;SEMA3E;GPM6B;GSK3B;AJAP1;MINK1;ADAM15;CORO1C;MYOC;PTK2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.6018679053394658,-1.685240069422364,0.011160714285714286,0.13019410029732273,0.999,11/24,15.93%,PDE4D;PDE3A;PDE3B;PDE11A;PEX5L;GNAI1;PDE2A;PRKAR1B;PRKAR2B;UBE2B;APLNR
prerank,fatty acid transmembrane transport (GO:1902001),0.7033519056618088,1.6848371862122664,0.010869565217391304,0.8821380162427248,1.0,6/19,8.40%,PRKAG2;PRKAA2;CPT1A;SLC25A20;SLC27A1;CPT2
prerank,mesonephros development (GO:0001823),0.8109237632037608,1.681776891501145,0.013282732447817837,0.876798889080802,1.0,3/11,1.09%,FGF1;BMP7;OSR1
prerank,cellular response to sterol (GO:0036315),0.7662845773810685,1.681146339463247,0.02185792349726776,0.8503794065186873,1.0,5/13,7.02%,RORA;GRAMD1B;INSIG2;SMO;RORC
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6056897216289961,-1.6807438424129149,0.004889975550122249,0.13519717139220447,0.999,12/24,16.20%,NRP1;PTPRJ;TEK;PIK3R1;KDR;IQSEC1;MYOC;DUSP3;VEGFA;PPM1F;LIMS1;ARF6
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6449173903923066,-1.6789342380816634,0.011312217194570135,0.13611141859488501,1.0,6/18,11.72%,SLIT2;MTUS1;PTK2B;LYN;PTN;EDN3
prerank,negative regulation of cell adhesion (GO:0007162),-0.47536561431921504,-1.6760957740425488,0.003134796238244514,0.13855475855679392,1.0,30/72,13.12%,SEMA6A;CDH13;GCNT2;PODXL;PDE3B;SEMA5A;ACER2;NEXMIF;ACVRL1;CYP1B1;JAG1;NOTCH1;PTPRC;FZD4;CORO2B;SEMA4D;TGFBI;PLXNC1;EPHB2;ARHGDIB;TGFB1;SPOCK1;PTK2;PLXNA4;ADAM22;DUSP1;CDH1;RASA1;LPXN;DMTN
prerank,axon guidance (GO:0007411),-0.41312130951469495,-1.6759708401047428,0.0,0.1371947042501677,1.0,60/201,9.70%,NRP1;NRXN1;NRXN3;SPTBN1;SLIT2;PTPRM;ROBO2;RPS6KA5;SEMA3C;UNC5C;LAMA1;SEMA6A;PIK3R1;SEMA6D;BSG;SHANK3;KLF7;ENAH;SH3KBP1;EPHB1;CNTN4;UNC5D;NOTCH3;DCC;NPTN;EPHA5;DAB1;EFNA5;NRP2;CXCL12;EPHA6;SEMA5A;SEMA7A;TMEFF1;LAMA2;EVL;CHN1;GAB1;DSCAML1;NOTCH1;NTN1;SEMA3E;NTN4;CNTN6;EPHA7;SEMA4D;KIF5C;LAMA3;LGI1;ROBO4;FEZ1;PLXNC1;RELN;EPHB2;EMB;PTK2;PLXNA4;TNR;GAP43;RHOH
prerank,dendritic spine morphogenesis (GO:0060997),-0.6653726307231584,-1.6745591161784366,0.00909090909090909,0.1377703573077634,1.0,8/15,13.89%,CTNND2;DOCK10;SHANK3;EPHB1;PAK3;EPHB2;DIP2A;SHANK1
prerank,regulation of macrophage migration (GO:1905521),-0.7265488223481716,-1.6727715160873,0.015717092337917484,0.1391515007750838,1.0,5/10,16.47%,MTUS1;CD200;PTK2B;P2RY12;CX3CR1
prerank,negative regulation of axon extension (GO:0030517),-0.5683699529219453,-1.671928894146975,0.004705882352941176,0.13899730423579676,1.0,13/30,14.99%,SEMA3C;SEMA6A;SEMA6D;RTN4;SEMA5A;SEMA7A;SEMA3E;DIP2B;SEMA4D;SEMA3D;SEMA3G;MT3;SEMA4C
prerank,sodium ion export across plasma membrane (GO:0036376),0.7513315857136831,1.671678694572943,0.021235521235521235,0.9043208712152041,1.0,3/13,6.16%,ATP1A2;ATP1B3;ATP4A
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.764246260814379,1.6715154211790406,0.023076923076923078,0.8746958562677172,1.0,2/11,0.35%,DAB2;WNT5B
prerank,regulation of sequestering of triglyceride (GO:0010889),0.7404762363830011,1.6710864485646202,0.0186219739292365,0.848872891927418,1.0,3/15,5.38%,OSBPL8;PPARA;OSBPL11
prerank,positive regulation of protein secretion (GO:0050714),0.5657635432754317,1.6703272757288703,0.004484304932735426,0.8285623455195211,1.0,17/69,9.99%,NNAT;BMP6;C1QTNF3;FRMD4A;WLS;IGF1;NLGN2;MCU;MYO18A;EZR;TLR4;PTPN23;GCK;RBP4;DNM1L;GOLPH3L;TCF7L2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.7008409841833909,-1.668213507894845,0.004166666666666667,0.14262720932462636,1.0,4/13,5.75%,GRIK2;SLC4A10;SHISA6;SHISA9
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5530516536763629,-1.6678909083785287,0.013054830287206266,0.14172473860446794,1.0,14/32,7.96%,NLGN1;DLG2;MEF2C;GRIA4;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;APP;GRIN2A;RELN;EPHB2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.5602486446410484,-1.6672309224338038,0.007211538461538462,0.14137452870625436,1.0,16/32,13.12%,THBS1;CLASP2;CASK;ACER2;NEXMIF;ACVRL1;JAG1;SEMA3E;AJAP1;ADAM15;CORO1C;MYOC;APOD;FAM107A;RASA1;DMTN
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.7322597982621862,-1.666876250874798,0.010548523206751054,0.14062183545840903,1.0,6/11,14.65%,CACNB2;CAMK2D;CACNA2D1;BIN1;NOS1;SESTD1
prerank,metal ion homeostasis (GO:0055065),-0.531152472517226,-1.6626035056799435,0.008379888268156424,0.1451024003308034,1.0,15/40,16.01%,SLC8A1;TMTC2;SLC12A7;CAV1;ANK3;SLC12A2;SLC12A8;SLC12A4;JPH2;SLC12A6;SNCA;MT3;SELENON;GRIN1;SLC12A5
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.49585888689953733,-1.655870396356659,0.0,0.15451132741329218,1.0,19/54,9.40%,KCNIP4;DPP10;CAV1;AKAP6;KCNJ3;KCNMA1;DPP6;KCNJ2;KCNN2;KCNIP1;KCNAB1;KCNMB2;GNG2;NEDD4L;YWHAE;FLNA;KCNQ1;BIN1;GABBR2
prerank,carboxylic acid transport (GO:0046942),0.5673796661238645,1.6546237580701584,0.01228878648233487,0.9398487438140242,1.0,7/55,1.78%,SLC16A6;SLC13A3;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC38A3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6559724983490063,1.6534279688921905,0.013628620102214651,0.9218878553963509,1.0,7/26,5.21%,CACNA1D;ACTN2;ATP1B3;ANK2;DLG1;NEDD4;KCNS1
prerank,negative regulation of viral life cycle (GO:1903901),-0.6649011773091995,-1.6467092082076042,0.02631578947368421,0.16737386569607507,1.0,5/15,11.73%,GSN;LY6E;MID2;PPIA;IFITM3
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5736578375074107,-1.6402005451954675,0.014218009478672985,0.17689780703575358,1.0,11/22,21.68%,SLIT2;GSN;TMSB4X;KANK3;KANK4;PFN2;KANK1;HIP1R;MYADM;SSH2;TWF2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5470967646719331,-1.6374085145513968,0.013856812933025405,0.18014447968619948,1.0,14/30,7.16%,PECAM1;ACTB;CLDN5;ESAM;LAMA2;F11R;SLC12A2;ACTG1;SLC1A1;LSR;MBP;OCLN;JAM2;ITGB1
prerank,modified amino acid transport (GO:0072337),0.7155536353968874,1.6339997063895453,0.02099236641221374,1.0,1.0,5/15,8.49%,SLC6A13;SLC16A12;PDPN;SLC19A1;CTNS
prerank,protein ADP-ribosylation (GO:0006471),0.6329823053755758,1.6334294173604464,0.021922428330522766,1.0,1.0,16/28,13.19%,ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;PARP12;TNKS2;SIRT3;PARP9;SIRT1;ZC3HAV1;PARP11;PARP6;SIRT4;ART4
prerank,histone H3-K4 trimethylation (GO:0080182),0.7623644043614621,1.6333964285810443,0.026871401151631478,1.0,1.0,10/11,19.69%,KMT2A;CTR9;TET2;WDR82;KMT2D;BEND3;OGT;SETD1B;TET3;SETD1A
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.6391504621489982,-1.6325320616874952,0.021551724137931036,0.18754422038411664,1.0,9/18,12.00%,DAAM2;TENM4;NOTCH1;HES1;TNFRSF1B;PTPRZ1;TNFRSF21;PTN;OPALIN
prerank,cellular response to purine-containing compound (GO:0071415),-0.7364291437618371,-1.6323398297601652,0.005988023952095809,0.18621083444128927,1.0,7/10,21.42%,SLC8A1;RYR2;RYR3;P2RY1;TRPM2;CASQ2;GSTM2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6913257736489427,-1.6290840081647116,0.017391304347826087,0.1901846841001586,1.0,7/13,13.77%,NRP1;COL4A1;ENG;SEMA3E;KDR;CTNNB1;VEGFA
prerank,intracellular lipid transport (GO:0032365),0.6727094497082122,1.6287699581309338,0.016100178890876567,1.0,1.0,7/21,11.10%,PRKAG2;PRKAA2;CPT1A;SLC25A20;CPT2;PLEKHA8;ARV1
prerank,thyroid hormone generation (GO:0006590),0.79751292158738,1.6275270552112404,0.02330097087378641,1.0,1.0,2/10,1.23%,SLC5A5;CPQ
prerank,positive regulation of locomotion (GO:0040017),-0.5649390362344326,-1.625931413825575,0.018957345971563982,0.19412374836261062,1.0,10/27,15.16%,SPOCK2;THBS1;CAVIN1;NTN1;STX3;TGFB1;P2RY12;TWIST1;PPM1F;RARRES2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6758426933866901,1.6250419441506507,0.02664298401420959,1.0,1.0,4/21,1.91%,CACNA1D;ANK2;KCNA5;SNTA1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.630936699970641,1.6244677464289174,0.0192,1.0,1.0,4/31,4.77%,RANBP3L;TMEM64;SUFU;SMAD6
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5245200618455195,-1.622391083606331,0.013966480446927373,0.19880174184656893,1.0,12/36,10.43%,SLIT2;MEF2C;PTPRM;DCN;THBS1;ACVRL1;NOTCH1;DAB2IP;APOE;TGFB1;FGF2;ATP2B4
prerank,acylglycerol metabolic process (GO:0006639),-0.5273974329774013,-1.6217732131036156,0.008152173913043478,0.19809243944115348,1.0,11/37,13.92%,DGKH;DGKB;ABHD2;CAV1;DGKI;MGLL;APOE;DGKK;DGKG;DGKZ;PNPLA3
prerank,detection of calcium ion (GO:0005513),-0.6809299500282009,-1.6214109601402518,0.019148936170212766,0.19694465592185664,1.0,6/13,10.44%,SYT1;RYR2;KCNMB2;CALM1;CALM2;CALM3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.7401231542219683,1.6210251670981348,0.021505376344086023,1.0,1.0,4/13,3.46%,DAB2;BMP6;BMPR1A;TGFBR1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5105427592559815,-1.6190516763196492,0.00554016620498615,0.19959590403068234,1.0,16/39,15.49%,RPS24;RPS6;RPS19;RPS28;RPS15;RPS16;RPS7;RPS17;WDR3;RPS25;RPS27;RPS5;EMG1;RPSA;LTV1;NOL11
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.4689591978551356,-1.6189628483209406,0.0,0.19802130792733685,1.0,28/75,15.97%,NRP1;TEK;CDH13;BMPR2;VEGFC;NRP2;SEMA5A;PPP1R16B;F3;AKT3;KDR;ECM1;ITGA4;BMP2;GATA2;AGTR1;PROX1;FGF2;FLT4;JCAD;ITGB3;BMP4;HIF1A;PRKD1;VEGFA;SCG2;APLNR;NR4A1
prerank,regulation of neuron projection development (GO:0010975),-0.40619717369032693,-1.6153766117915918,0.0,0.20311223553770688,1.0,56/163,14.41%,CSMD3;CTNNA2;LRRC4C;IL1RAPL1;PPFIA2;MARK1;NTRK3;CDH2;ITGA6;SHANK3;ROR1;DCC;LRRC7;NPTN;TANC2;TENM3;RIT2;PAK3;CHN1;PTK2B;TOX;FUT9;NDNF;SERPINI1;CDKL5;NTNG1;CCDC88A;NTRK2;MBOAT1;LYN;GSK3B;ROR2;DAB2IP;PAK1;RAP1A;APOE;STMN2;DISC1;PRAG1;PSEN1;RELN;SPOCK1;PTN;SCARF1;TRPV4;PLPPR5;MFSD2A;MARK2;ABI3;PRKD1;CFL1;RET;RTN4RL1;CDK5R1;MT3;FES
prerank,membrane repolarization (GO:0086009),0.7171837664430614,1.6138656351220837,0.034482758620689655,1.0,1.0,3/15,1.34%,ATP1A2;ATP1B3;KCND3
prerank,endothelial cell differentiation (GO:0045446),-0.6867087283882533,-1.6137665912402217,0.029288702928870293,0.20462026411826723,1.0,7/12,12.21%,BMPR2;TIE1;ACVRL1;JAG1;KDR;PROX1;SOX18
prerank,extracellular matrix assembly (GO:0085029),-0.5845735491213624,-1.6120283582574968,0.0125,0.20615718344396242,1.0,9/23,11.27%,GAS6;NTNG1;GPM6B;RAMP2;NTN4;TGFB1;MYH11;TNXB;MFAP4
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6202142976368729,-1.6102694039548646,0.009478672985781991,0.20806831347880056,1.0,10/18,10.63%,GRID2;GRIK2;CDH8;GRIK1;GRIA2;UNC13B;GRIK4;SLC1A4;GRID1;SLC17A6
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.696225494503006,1.6091193766854497,0.02181818181818182,1.0,1.0,3/17,1.15%,ATP1A2;BMP7;TFPI
prerank,regulation of dendrite extension (GO:1903859),-0.6191285655514752,-1.6087494468021424,0.02320185614849188,0.20917026410386882,1.0,4/18,4.88%,SYT1;RIMS2;RIMS1;NEDD4L
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.7373687175915933,1.6086274313466877,0.031192660550458717,1.0,1.0,6/13,12.27%,SORBS1;PRKCZ;ECHDC3;GKAP1;SIRT1;PTPN11
prerank,lipid modification (GO:0030258),-0.5282000825990273,-1.6083774843603817,0.015665796344647518,0.20813175397563527,1.0,11/37,13.00%,DGKH;DGKB;DGKI;PLPP1;MBOAT1;PLPPR1;PLPPR5;PLPPR4;DGKK;DGKG;DGKZ
prerank,cyclooxygenase pathway (GO:0019371),0.7748688353883427,1.6073929781147174,0.03428571428571429,1.0,1.0,2/10,1.04%,PTGDS;PTGS1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.7559245973504178,1.6070927701264095,0.035849056603773584,1.0,1.0,3/11,7.26%,C1QTNF3;SIK1;GCK
prerank,epithelial cell development (GO:0002064),0.6620004560188171,1.6069260108761396,0.03213610586011342,0.9981665101529508,1.0,5/20,8.51%,WNT5B;PKHD1;RILPL1;DACT2;LRTOMT
prerank,triglyceride homeostasis (GO:0070328),0.6340642988893518,1.6056068117701852,0.025167785234899327,0.9891911033658413,1.0,7/26,12.36%,RORA;C1QTNF3;IL18;ANGPTL8;SIRT1;PLA2G12B;MLXIPL
prerank,dendritic spine organization (GO:0097061),-0.5559503510555438,-1.6022512391817074,0.012195121951219513,0.21856259664872463,1.0,9/26,13.89%,CTNND2;DOCK10;SHANK3;EPHB1;PAK3;EPHB2;MTMR2;DIP2A;SHANK1
prerank,negative regulation of TOR signaling (GO:0032007),0.598441274001278,1.6021645241224534,0.020338983050847456,0.9994805227966048,1.0,20/36,19.83%,RNF152;PRKAA2;FNIP1;NPRL3;SESN1;DEPTOR;SESN2;ATM;NPRL2;UBR2;SIRT1;DEPDC5;FLCN;KPTN;TSC1;TMEM127;UBR1;TBC1D7;ITFG2;TSC2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.546521977876729,-1.6002516194691738,0.01909307875894988,0.2204122854532224,1.0,11/27,14.43%,PPP1R16B;PPP2R5A;PPIA;CALM1;CALM2;CAMTA1;BMP2;TGFB1;CALM3;MTMR9;SPPL3
prerank,regulation of cardiac conduction (GO:1903779),0.5557233634202668,1.5996964065266126,0.014150943396226415,1.0,1.0,11/54,6.24%,ATP1A2;ATP1B3;ANK2;CORIN;ITPR2;ITPR1;NPR1;SLC8A3;DMPK;NPR2;AHCYL1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4672279537233075,-1.599282610083776,0.005649717514124294,0.22059002808449577,1.0,19/57,14.61%,RPS24;RPS6;RPL26;RPL38;RPL7;RPS19;RPS28;RPL35A;RPS15;RPS16;RPL5;RPS7;RPL14;XPO1;RPS17;RPS25;EMG1;MALSU1;LTV1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.7130909586866817,1.5987580372308845,0.044061302681992334,0.9892464899316966,1.0,5/15,12.91%,MOXD1;SMOX;SAT1;PAOX;ASMT
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5870348535410039,-1.5981847682062782,0.02132701421800948,0.22093803976694043,1.0,6/21,15.16%,MTUS1;THBS1;PTK2B;PTK2;CMKLR1;RARRES2
prerank,synaptic vesicle cycle (GO:0099504),-0.5412475648128257,-1.598003065756678,0.01937046004842615,0.2195798214699643,1.0,8/30,14.55%,NLGN1;SNAP25;RIMS1;PCLO;SYNDIG1;SLC17A6;SNCA;SYT7
prerank,bicarbonate transport (GO:0015701),-0.5843567730826982,-1.5979746577794294,0.014319809069212411,0.21789421125450262,1.0,4/25,6.93%,SLC4A10;SLC26A7;CA4;CA2
prerank,response to ethanol (GO:0045471),-0.6503563427807119,-1.5961306306424943,0.03171247357293869,0.21986118871362212,1.0,8/14,15.27%,GRIN2B;ADCY7;GRIN3A;GRIN2A;GLRA1;GLRA2;SDF4;GRIN1
prerank,nuclear migration (GO:0007097),0.7369546107799364,1.5958481492365755,0.01727447216890595,0.9954461593457538,1.0,5/13,9.79%,SYNE2;SYNE3;CLMN;FBXW11;DOCK7
prerank,retinoic acid metabolic process (GO:0042573),0.687105288433266,1.5926026173239816,0.041353383458646614,1.0,1.0,3/14,7.47%,ALDH1A2;CYP26B1;SCPEP1
prerank,response to copper ion (GO:0046688),-0.6003303984316348,-1.5924727835630146,0.020361990950226245,0.22498295923373476,1.0,10/20,14.18%,MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;SNCA;MT3
prerank,anion transport (GO:0006820),0.606297610098567,1.5923623137960747,0.03135313531353135,0.9881560423656338,1.0,6/33,5.93%,SLC22A6;SLC13A4;SLC13A3;VDAC2;SLC26A3;SLC19A1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5787335967709735,-1.592049758177283,0.016055045871559634,0.22415971832780787,1.0,14/24,25.60%,PECAM1;VCAM1;F11R;ICAM1;SEMA4D;ITGB1;ITGA4;MSN;NT5E;SYK;ITGB2;CERCAM;FERMT3;SELP
prerank,inhibitory synapse assembly (GO:1904862),-0.6895035799101253,-1.5916519777902651,0.025590551181102362,0.2233245808233344,1.0,6/11,10.88%,GABRB3;GABRA2;GABRB2;GABRG2;FGF13;LGI2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.6266680718475408,1.590825103979168,0.03590664272890485,0.982742885810415,1.0,9/26,16.00%,LGR4;APPL2;TLR3;GPS2;FLOT2;IRF1;LRRC14;TLR5;BIRC3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4675235174140944,-1.5883168299280397,0.00906344410876133,0.22815298558976532,1.0,32/63,17.12%,SLC12A7;ANO4;GABRG3;GABRB3;ANO1;SLC26A2;GABRB1;GABRA3;GLRB;SLC12A2;GABRA2;SLC1A1;ANO3;GABRB2;SLC5A6;GLRA3;XPR1;GLRA1;GABRG2;SLC12A8;GABRA4;SLC12A4;GABRG1;SLC12A6;GLRA2;CLCN1;ANO5;ANO2;CLCN3;SLC12A5;GABRA5;GABRE
prerank,mesenchyme morphogenesis (GO:0072132),-0.612571538805374,-1.588062463070899,0.02517162471395881,0.22686116017823252,1.0,7/17,8.22%,ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2
prerank,energy reserve metabolic process (GO:0006112),0.6830097963728504,1.5871549388697135,0.031423290203327174,0.9958622384574997,1.0,4/19,3.00%,PRKAG2;LEPR;PYGM;PHKB
prerank,neurotransmitter secretion (GO:0007269),-0.5068168344137738,-1.5870103918698433,0.007633587786259542,0.22722609806672492,1.0,10/44,6.77%,NRXN1;SYT1;RIMS2;SNAP25;RIMS1;LIN7A;PCLO;PTPRN2;SYN2;HSPA8
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5283304213171397,-1.5869113549364489,0.017632241813602016,0.22573677951154436,1.0,11/35,7.33%,NLGN1;CDH11;CDH8;CDH13;ATP2C1;CDH10;CDH12;CDH6;CDH20;CDH19;CDH7
prerank,vascular transport (GO:0010232),0.5191743089480864,1.58689029564767,0.01327433628318584,0.9806178459878934,1.0,20/81,9.62%,ATP1A2;SLC22A8;SLC13A3;SLC6A13;SLC6A1;SLC24A3;LEPR;SLC16A12;SLC5A5;SLC38A3;SLC7A2;SLC5A3;SLC6A9;SLC19A1;SLC22A5;SLC27A1;SLC38A1;SLC1A3;LRP1;LRP3
prerank,positive regulation of histone methylation (GO:0031062),0.6304408808067717,1.5868535592486988,0.04522613065326633,0.964058809095402,1.0,9/24,16.98%,AUTS2;KMT2A;JARID2;CTR9;SIRT1;PHF1;OGT;TET1;SMAD4
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.6412800408490172,-1.586698177882969,0.019736842105263157,0.22448431700856458,1.0,5/15,9.15%,TGFB2;TGFB3;TGFB1;IRAK3;SMAD7
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5357395176497637,-1.5859657505961908,0.018421052631578946,0.2243858004268172,1.0,16/32,14.16%,RHOJ;THBS1;MEOX2;HDAC7;HDAC9;NOTCH1;AKT3;KDR;ANXA1;GATA2;PTGS2;FGF2;JCAD;STARD13;VEGFA;SRPX2
prerank,regulation of glycolytic process (GO:0006110),0.5266771474061928,1.5854938584455067,0.017543859649122806,0.9585409607833224,1.0,14/68,13.91%,PRKAG2;IGF1;PRKAA2;PPARA;ZBTB20;NUPR1;GCK;HDAC4;NUP42;NUP98;MLXIPL;NUP43;NCOR1;OGT
prerank,myelination (GO:0042552),-0.5024525390482406,-1.585492372318096,0.005319148936170213,0.22361576756573723,1.0,25/46,23.24%,ADGRG6;ACER3;MAL;PLP1;EPB41L3;NFASC;SCN2A;MBP;B4GALT5;PLLP;MYOC;MARVELD1;TNFRSF21;ABCD2;SCN8A;GAL3ST1;MAL2;CMTM8;MALL;TPPP;SIRT2;LGI4;MPZ;CXCR4;SOX10
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.7048853756893388,1.584632781915978,0.027184466019417475,0.949328567013342,1.0,4/16,7.62%,AUTS2;KMT2A;CTR9;BCOR
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.6665843918195229,-1.5840798702123025,0.023554603854389723,0.224729089081589,1.0,6/12,10.34%,EPHB1;HSP90AB1;B4GALT5;MYCBP2;EPHB2;HSP90AA1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.7205109878588725,1.582364887228279,0.04798464491362764,0.9503810779049753,1.0,3/14,3.17%,AUTS2;KMT2A;CTR9
prerank,transport across blood-brain barrier (GO:0150104),0.5142343725720898,1.5823268903436747,0.013119533527696793,0.9353315265040665,1.0,20/83,9.62%,ATP1A2;SLC22A8;SLC13A3;SLC6A13;SLC6A1;SLC24A3;LEPR;SLC16A12;SLC5A5;SLC38A3;SLC7A2;SLC5A3;SLC6A9;SLC19A1;SLC22A5;SLC27A1;SLC38A1;SLC1A3;LRP1;LRP3
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.597260664942193,-1.5807011875268189,0.0228310502283105,0.22992073157800844,1.0,12/19,23.88%,NRP1;PTPRJ;TEK;KDR;MYOC;VEGFA;PPM1F;LIMS1;S100A10;SFRP1;THY1;MAP4K4
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5810099154333205,-1.5802247970871435,0.024774774774774775,0.22918857184181413,1.0,10/21,15.00%,PDE4D;CAV1;RASSF2;NCK2;SMAD7;CNKSR3;DDIT4;DMTN;PPM1F;NCK1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.6996126116215656,1.5787790807789523,0.04144144144144144,0.9477152074155994,1.0,2/15,5.49%,CPEB2;DDX3X
prerank,regulation of exocytosis (GO:0017157),-0.5008291741816768,-1.5781514843069957,0.011111111111111112,0.23166659364923076,1.0,10/46,6.67%,STXBP6;SYT1;IL1RAPL1;RIMS2;CADPS;CLASP2;STXBP5L;RAB3C;ANXA1;RAB27A
prerank,bone development (GO:0060348),0.5875734714371834,1.578149122119462,0.025196850393700787,0.9374898064054873,1.0,8/39,6.69%,RANBP3L;DYM;FGFR2;AKAP13;SULF2;CYP26B1;TP53;SH3PXD2B
prerank,positive regulation of dendrite extension (GO:1903861),-0.6256161485382472,-1.5780926999870404,0.02511415525114155,0.23007974468943232,1.0,4/17,4.88%,SYT1;RIMS2;RIMS1;NEDD4L
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3661871597692176,-1.5777827406874914,0.0,0.22906234273399176,1.0,133/306,25.78%,ST3GAL4;POLA1;RPS24;RPS12;RPL8;FUT9;EXT1;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;PTMA;APOE;RPL35A;RPLP0;RPS15;RPL30;RPS3;EEF2K;RPL19;RPS21;RPL4;B4GALT5;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;POLD3;RPL12;RPL9;RPS25;EXT2;RPL7A;RPS2;RPS9;RPS11;NAP1L1;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;TAF1B;DUT;POLR2J;RPL31;HBS1L;RNASEH2A;RPSA;RPS26;TIPIN;RPL36;BCL3;RPA1;ORC5;GCNT1;RNPS1;ORC2;EEFSEC;BARD1;RPL13A;CDC45;BRIP1;RPL35;DNA2;PAX8;INHBA;EEF2;RFC4;COPS5;RPL24;RPS13;MRPL34;RPL11;POLD1;EEF1D;RSL24D1;MRPS16;RFC2;POLR2C;POLR2L;BLM;MRPS21;RECQL5;MLF1;MRPL10;MRPL13;TUFM;EEF1G;RPS27A;MRPS33;HOXD3;EIF4EBP2;MRPL35;EEF1A2;SET;GTPBP2;MCM6;RFC5
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6996547483782117,-1.5770343799576063,0.016985138004246284,0.22900409267482183,1.0,7/10,15.93%,PDE4D;PDE3A;PDE3B;PDE11A;PDE2A;UBE2B;APLNR
prerank,positive chemotaxis (GO:0050918),-0.6242497046144492,-1.5762503792501454,0.04121475054229935,0.22894665730179414,1.0,8/17,17.18%,NRP1;PTPRJ;SEMA5A;MET;FGF7;VEGFA;SCG2;SCRIB
prerank,positive regulation of cell projection organization (GO:0031346),-0.4186006179963483,-1.5760624698741454,0.007575757575757576,0.22779692307411722,1.0,37/115,9.95%,SLIT2;PTPRD;ROBO2;IL1RAPL1;NTRK3;ITGA6;ROR1;LRRC7;NPTN;TENM3;GRIP1;RIT2;CARMIL1;PTK2B;TOX;FUT9;NDNF;SERPINI1;CDKL5;NGF;NTRK2;LYN;ROR2;DAB2IP;TIAM1;FZD4;RAP1A;APOE;STMN2;PLXNC1;RELN;PTN;PLXNA4;SCARF1;MAP6;PLPPR5;SLITRK1
prerank,endodermal cell differentiation (GO:0035987),-0.5357468797632765,-1.575760727155203,0.021844660194174758,0.22685975909670036,1.0,16/31,20.11%,COL8A1;COL12A1;FN1;COL6A1;COL4A2;LAMA3;ITGA4;SETD2;MMP15;CDC73;ITGA5;COL11A1;ITGB2;INHBA;VTN;ITGA7
prerank,regulation of small molecule metabolic process (GO:0062012),0.6278639440395103,1.5750001022286266,0.04035087719298246,0.9463377287167629,1.0,9/28,11.93%,RORA;PPARA;PRKN;NCOR2;RORC;SIRT1;MLYCD;ARV1;TTC39B
prerank,cGMP-mediated signaling (GO:0019934),-0.6571844447421801,-1.5744783629219061,0.025974025974025976,0.22780224936979734,1.0,6/13,9.51%,PDE3A;KCNC2;HTR2C;GUCY1B1;APOE;PDE2A
prerank,response to sterol (GO:0036314),0.7347924692788094,1.5731656808924135,0.04364326375711575,0.9453743304555999,1.0,4/11,7.33%,RORA;TGFBR1;RORC;TGFBR2
prerank,glycogen metabolic process (GO:0005977),0.6182611197014911,1.5729847631503833,0.03035413153456998,0.9323119847660054,1.0,5/27,8.85%,PRKAG2;PYGM;PHKB;GYS1;PHKG1
prerank,phosphate ion homeostasis (GO:0055062),-0.7039423430665419,-1.5717113152315265,0.031315240083507306,0.2316640085773488,1.0,3/10,7.03%,SFRP4;XPR1;ENPP1
prerank,sphingolipid metabolic process (GO:0006665),-0.4206385998396205,-1.5715375478375884,0.0035460992907801418,0.2304199186301184,1.0,30/108,13.22%,ST6GALNAC3;ELOVL7;CERT1;SGMS1;ESYT2;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;PPM1L;PLPP1;UGCG;SPTLC2;DEGS2;SPNS2;PSAP;PPP2R1A;GLTP;HEXB;B3GALNT1;PPT1;ELOVL6;ESYT3;CERS4;ENPP2;SERINC1;ASAH2;GAL3ST1;PRKD1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.6734782514652096,1.5711691441498197,0.05860805860805861,0.931399346427133,1.0,7/16,9.59%,BMP7;NAPEPLD;METRNL;RREB1;FNDC5;SIRT1;SOX13
prerank,regulation of MAP kinase activity (GO:0043405),0.5084446949712361,1.5709459769926484,0.01,0.9197543337651192,1.0,14/92,6.37%,FGF1;ROBO1;BMP7;TPD52L1;KSR1;KIT;CD300A;PPEF2;FGFR1;ADRA2A;LRRK2;FLT1;TRIB2;PDGFRB
prerank,sodium ion transport (GO:0006814),0.5082407482082771,1.570143399017676,0.008620689655172414,0.9122197699080302,1.0,8/85,1.99%,ATP1A2;SLC6A13;SLC6A1;SLC24A3;SLC6A12;ATP1B3;SLC5A5;SLC8A3
prerank,positive regulation of heart rate (GO:0010460),-0.6106619983724711,-1.5698728106924464,0.02654867256637168,0.23219161342070369,1.0,6/17,11.72%,PDE4D;RYR2;ADRA1B;KCNQ1;EDN1;EDN3
prerank,regulation of cytoplasmic translation (GO:2000765),0.6979581508386563,1.568393473681323,0.03910614525139665,0.9124142192206153,1.0,4/14,8.31%,CPEB2;CPEB4;ZCCHC13;CPEB3
prerank,linoleic acid metabolic process (GO:0043651),0.6791769574032139,1.5675570184589738,0.03962264150943396,0.9057384754975157,1.0,2/17,2.35%,ACSL1;ALOX12
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.7314852456377591,1.5667330114143252,0.03592814371257485,0.8988241033577307,1.0,3/11,1.42%,ACTN2;LEPROT;PICALM
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7018026547118363,-1.5634668687680602,0.026804123711340205,0.2435178525898812,1.0,3/11,3.67%,MECOM;CD34;RUNX1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5973592932421818,-1.5624476298354701,0.025974025974025976,0.24399699414297038,1.0,7/18,7.73%,NLGN1;RIMS2;RIMS1;GSK3B;RAP1B;RAP1A;PREPL
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.43486422614422743,-1.5620282789942652,0.0,0.2432396631813929,1.0,32/86,16.20%,NAV3;SEMA5A;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;PAK1;APOE;APP;RPS3;MET;STMN2;OCLN;PSEN1;BIN1;PROX1;TRPV4;CDK5RAP2;WDR1;EDN1;SYNPO2;MAPT;PFN2;CLIP1;CDK5R1;FES;CDC42EP2;CLU;NCK1;GPX1;ARF6
prerank,neural crest cell development (GO:0014032),-0.49590353164215956,-1.559695381552182,0.012953367875647668,0.24653837228800224,1.0,17/44,18.48%,SEMA3C;ERBB4;SEMA6A;SEMA6D;CDH2;SEMA5A;SEMA7A;SEMA3E;TBX1;SEMA4D;CORO1C;SEMA3D;SEMA3G;SEMA4C;KLHL12;SEMA4A;SOX8
prerank,excitatory postsynaptic potential (GO:0060079),-0.5808980755007945,-1.557753276031351,0.02466367713004484,0.24910825694175165,1.0,5/19,7.11%,GRID2;MEF2C;GRIN2B;GSK3B;GRIN2A
prerank,prostanoid biosynthetic process (GO:0046457),0.6568462032376097,1.5575424400021278,0.0539568345323741,0.9511573492457569,1.0,2/15,1.04%,PTGDS;PTGS1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.6238066776367956,1.5571783580222338,0.030685920577617327,0.9412831380259242,1.0,3/23,2.32%,PRKAG2;BMP7;SPHK1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6489797106264603,-1.5570347267698166,0.03571428571428571,0.24882333013698416,1.0,7/14,19.76%,DAB2IP;HSPA5;DDRGK1;BFAR;PTPN1;BCL2L11;COPS5
prerank,cellular response to drug (GO:0035690),-0.5646533337078593,-1.5553512421053755,0.030162412993039442,0.25089190348304313,1.0,10/25,14.49%,MEF2C;PDE4B;ACER2;GAS6;TFRC;KCNQ1;RAP2A;AIM2;HTR1B;PPM1F
prerank,endothelial cell proliferation (GO:0001935),-0.6067617707552482,-1.554867423298683,0.03056768558951965,0.2503166375515674,1.0,6/17,4.30%,TEK;BMPER;BMPR2;SEMA5A;CD34;ACVRL1
prerank,positive regulation of glucose import (GO:0046326),0.6397951784963851,1.554660270187638,0.03677758318739054,0.9470164973074798,1.0,6/21,6.42%,OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;CREBL2
prerank,negative regulation of calcium ion transport (GO:0051926),0.6892021209191981,1.554161418771164,0.043478260869565216,0.9382767693113214,1.0,2/15,3.64%,ATP1A2;ADRA2A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.4611185291062827,-1.5540722223203738,0.014619883040935672,0.2502300579877027,1.0,19/57,8.44%,NLGN1;DLG2;MEF2C;GRIA4;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;DLGAP1;SHISA6;SHISA9;DLGAP2;MINK1;APP;GRIN2A;RELN;NETO1
prerank,ganglioside biosynthetic process (GO:0001574),-0.6138708397477922,-1.5533517058609068,0.0467706013363029,0.25021765282230163,1.0,6/15,8.77%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST6GALNAC5;B4GALT5;ST8SIA6
prerank,regulation of cellular biosynthetic process (GO:0031326),0.605758403192761,1.5525892483253037,0.035175879396984924,0.937404664290954,1.0,7/28,9.34%,PRKAG2;PRKAA2;AVIL;MITF;SIRT5;CTNS;SIRT1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7012718801061844,-1.550491512472751,0.030634573304157548,0.25491965677986966,1.0,3/10,4.12%,CAV1;ANK3;KCNAB1
prerank,eye development (GO:0001654),0.542487380938399,1.55026456159764,0.0196078431372549,0.9422999237963853,1.0,10/54,7.53%,SMOC1;COL5A1;SHROOM2;FOXC1;CACNA1C;MEIS1;SH3PXD2B;FBN1;NIPBL;RBP4
prerank,peptidyl-lysine trimethylation (GO:0018023),0.6137322019142342,1.5499708112871546,0.038394415357766144,0.932756906509378,1.0,13/26,19.69%,KMT2A;CTR9;KMT5C;TET2;KMT5B;WDR82;KMT2D;BEND3;OGT;SETD1B;TET3;SETD3;SETD1A
prerank,leukocyte tethering or rolling (GO:0050901),-0.5982049692807553,-1.5495087745025569,0.04017857142857143,0.2553179040888901,1.0,9/17,26.09%,VCAM1;JAM2;ITGB1;ITGA4;ADD2;CX3CR1;GCNT1;SELP;ITGB7
prerank,regulation of receptor binding (GO:1900120),-0.7004739085560105,-1.549439779232619,0.038539553752535496,0.253911415806595,1.0,7/10,21.32%,GREM2;B2M;PTPRF;ADAM15;ATP2A3;BDNF;ATP2A2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6719838102075198,-1.5491037579941447,0.0440251572327044,0.25324806562120206,1.0,4/10,8.44%,SHANK3;NPTN;APP;NETO1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6157328950376384,1.5481096312191718,0.046511627906976744,0.9333861048808302,1.0,5/25,4.87%,WNK4;ACTN2;ATP1B3;ANK2;SLC6A9
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.6145922408607064,1.547114265507532,0.026936026936026935,0.9294264694783414,1.0,3/26,1.62%,PRKAG2;LPGAT1;PRKAA2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5549414074615968,-1.5465896298940869,0.019138755980861243,0.25683135008885666,1.0,14/24,24.01%,PDE4D;AKAP6;CAMK2D;CALM1;CALM2;CALM3;FKBP1A;JPH2;NOS1;SELENON;CASQ2;GSTM2;JPH3;DMD
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.55012871057397,-1.5459586540535062,0.020930232558139535,0.256542495022281,1.0,8/24,8.32%,TEK;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;GATA2
prerank,detection of visible light (GO:0009584),0.6985651491857491,1.5455303697320648,0.03512014787430684,0.929721478494157,1.0,5/16,11.74%,ABCA4;CEP250;GNAT2;RHO;CACNA2D4
prerank,carbohydrate derivative transport (GO:1901264),-0.5939742402905186,-1.5455113887679783,0.0350109409190372,0.256015290088674,1.0,9/18,15.36%,SCARB1;PLTP;ABCG1;SLC10A7;NPC2;MFSD2A;VLDLR;LBP;SLC29A1
prerank,cellular response to starvation (GO:0009267),0.4688882205344611,1.5455013219470815,0.005610098176718092,0.9188021854853853,1.0,32/147,11.45%,PRKAG2;RNF152;PRKAA2;PPARA;FNIP1;MTMR3;CPEB4;PRKAG3;NPRL3;SESN1;ATP6V0E1;LRRK2;LAMP2;SESN2;ATG5;NPRL2;NUAK2;ATP6V0B;TP53;SIK1;EIF2AK2;WIPI1;NUPR2;SIRT1;PICK1;BRSK1;BECN1;ATG7;ATP6V1D;ATP6V1E1;ATF2;IMPACT
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6179887601580804,-1.5450921742452457,0.0321285140562249,0.2553425787985443,1.0,7/15,15.43%,GRM7;GRM5;GRM3;GRM8;GRM1;HOMER1;GRIK3
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.6863079561529474,1.5450839813197503,0.045871559633027525,0.9108775631838579,1.0,12/15,25.05%,SPHK1;SIRT3;SAMD8;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A;ORMDL3;ORMDL1;PRKCD
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6177655925649554,1.5448071160170458,0.05660377358490566,0.9020526333701459,1.0,12/23,22.23%,C1QTNF3;PPARA;NUPR1;SIK1;GCK;HDAC4;NCOR1;CLK2;CRY1;PLEK;GSK3A;EP300
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5933453128765764,-1.5446696893183667,0.04576659038901602,0.2546652996014485,1.0,9/18,26.09%,VCAM1;JAM2;ITGB1;ITGA4;ADD2;CX3CR1;GCNT1;SELP;ITGB7
prerank,B cell receptor signaling pathway (GO:0050853),-0.5249644002535868,-1.5444311746726407,0.023752969121140142,0.25359597287758817,1.0,13/32,18.36%,MEF2C;RFTN1;CD38;PTPRC;BMX;PLCG2;PLEKHA1;TEC;BCAR1;SH2B2;BLNK;SYK;BTK
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.6270464611771223,1.5442190507286528,0.03804347826086957,0.8957406382323323,1.0,4/22,10.48%,ALDH1A2;RBP1;CYP2R1;GC
prerank,response to interleukin-6 (GO:0070741),-0.6809891363924561,-1.5437125296318124,0.04149377593360996,0.2535956419433982,1.0,5/10,11.88%,PID1;PTPRT;PTGIS;ST3GAL6;SBNO2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.6448564943943149,1.5437070624800018,0.056218057921635436,0.8892552049534522,1.0,5/21,6.90%,DAB2;BMP6;BMPR1A;TGFBR1;WWTR1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6508476407098673,-1.543674261062436,0.03131115459882583,0.2521682273079248,1.0,10/13,28.30%,CDH13;CD9;LDLR;ITGB1;SREBF2;SYK;ITGB2;CD81;ABCA1;CD36
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5484189490133294,-1.542157842595041,0.018779342723004695,0.2537731081819254,1.0,12/26,14.41%,NAV3;PAK1;RPS3;MET;STMN2;OCLN;TRPV4;CDK5RAP2;MAPT;CLIP1;CDK5R1;FES
prerank,prostaglandin biosynthetic process (GO:0001516),0.6423284803348498,1.5411402908855107,0.04945054945054945,0.8965832690369653,1.0,2/18,1.04%,PTGDS;PTGS1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5889966460578202,-1.5405954360748626,0.049145299145299144,0.2557441417333488,1.0,13/18,16.55%,RHOJ;HDAC7;HDAC9;AKT3;KDR;ANXA1;GATA2;PTGS2;FGF2;JCAD;VEGFA;SRPX2;PIK3C2A
prerank,regulation of ruffle assembly (GO:1900027),-0.5617859017581934,-1.5404075174196468,0.02962962962962963,0.2545961295405676,1.0,8/23,12.78%,NLGN1;CAV1;EVL;RDX;P2RY12;EPS8;ABI3;PFN2
prerank,cardiac ventricle development (GO:0003231),-0.5799145371845038,-1.540095325045287,0.03579952267303103,0.25387173035752386,1.0,7/20,9.51%,ENG;NOTCH1;HES1;STRA6;HEYL;HEY2;PDE2A
prerank,regulation of DNA repair (GO:0006282),0.5644402334972597,1.5400392487544432,0.023183925811437404,0.8943247576810364,1.0,14/44,14.03%,EYA1;EYA2;EYA4;BABAM2;RNF8;TRIP12;SIRT1;UBR5;AXIN2;UIMC1;KAT7;BABAM1;PML;SMCHD1
prerank,substrate-dependent cell migration (GO:0006929),-0.6287294136717008,-1.5393784890347764,0.048879837067209775,0.25396588167179734,1.0,7/14,10.23%,NRP1;VEGFC;NTN1;SHTN1;PTPRC;CD2AP;P2RY12
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5438206824228854,1.5392736943377159,0.022151898734177215,0.8898228257214819,1.0,13/53,14.03%,EYA1;EYA2;DDX5;EYA4;BABAM2;NACC2;ATM;RNF8;FBH1;SIRT1;UIMC1;BABAM1;SMCHD1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6359053897225014,1.5392083299776596,0.04713804713804714,0.8806629977011896,1.0,3/23,0.48%,UACA;BMP7;C1QTNF3
prerank,regulation of actomyosin structure organization (GO:0110020),0.7126300254871112,1.5388598723683158,0.0425531914893617,0.8736026856675629,1.0,7/13,14.57%,ROCK2;FHOD1;AKAP13;ASAP3;CDC42;TSC1;ALMS1
prerank,rRNA processing (GO:0006364),-0.3796572814113321,-1.5369265209253196,0.0,0.25758035404698587,1.0,79/172,24.15%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;SART1;RPL36A;RPL6;EMG1;MDN1;RPL31;NOP53;DDX10;NOL11;RPL36;TEX10;RPL13A;FBL;XRN2;RPL35;ERI1;UTP15;NHP2;RPL24;NOP56;RPL11;TFB1M;MTREX;EXOSC10;RRP15;NOP58;IMP4;EXOSC4;EXOSC1;POP4
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.679705616636755,1.5363519794639873,0.06653992395437262,0.8807688543172235,1.0,5/16,10.66%,RORA;PRKN;RORC;SIRT1;MLYCD
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4833822307296857,-1.5358032658885372,0.016666666666666666,0.2583707376432251,1.0,12/44,13.46%,MEF2C;ENG;RYR2;MICAL2;TBX3;NOTCH1;SOX17;HES1;VANGL2;SOX18;AHI1;ACVR1
prerank,endothelial tube morphogenesis (GO:0061154),-0.7008961087750039,-1.5357782867236867,0.02553191489361702,0.2570099503751278,1.0,5/10,12.06%,ACVRL1;RHOB;STARD13;BMP4;CTNNB1
prerank,gliogenesis (GO:0042063),-0.619386387507473,-1.5356522712617033,0.047311827956989246,0.2558168763119931,1.0,7/15,15.42%,CDH2;CD9;TGFB2;ANXA1;RELN;PAX2;METTL3
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.47974900988788777,-1.5350952414344408,0.011363636363636364,0.25546577542905125,1.0,15/46,12.85%,NRP1;TMEFF2;TEK;PIK3R1;PARVB;PEAK1;FN1;LAMC3;NTNG1;NTN4;ITGA4;ITGA8;ITGB3;ILK;LPXN
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.4972265634107382,-1.5348014608596081,0.024456521739130436,0.25478767740146857,1.0,18/39,15.30%,NRP1;SLIT2;COL4A1;ENG;TIE1;RASIP1;SEMA3E;KDR;PAK1;MET;BMP2;SIX1;FGF2;PKD1;BMP4;CTNNB1;VEGFA;PAX2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.5333950576497464,-1.5344335068990889,0.02617801047120419,0.25409967199481137,1.0,10/29,22.40%,MEF2C;TFRC;CD38;PTPRC;EPHB2;TIRAP;CD74;IRS2;CD320;CD81
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6818288270883468,-1.5334584191344116,0.05434782608695652,0.2548143023017651,1.0,7/10,24.83%,GHR;STAT3;LYN;STAT5B;PTPN1;PRLR;JAK2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.6170305441614552,-1.533440718132299,0.043912175648702596,0.25347118981825084,1.0,5/15,10.00%,CDH13;PTPN12;CEACAM1;ERBB2;MVB12B
prerank,positive regulation of interferon-beta production (GO:0032728),0.5817255241274987,1.5333993138772513,0.05414551607445008,0.8908208038108609,1.0,14/33,13.35%,OAS2;TLR3;TLR4;RNF135;DDX3X;TRIM56;RIPK2;MAVS;TOMM70;DHX58;PTPN11;IRF1;POLR3A;OAS3
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.7014994730090862,1.5330780372562822,0.05273833671399594,0.8836649649414824,1.0,2/12,0.43%,NOTCH2;DOCK11
prerank,cAMP-mediated signaling (GO:0019933),-0.5466706614414492,-1.5315117776830542,0.029339853300733496,0.256044441079247,1.0,9/24,5.44%,PDE4D;PDE3A;RIMS2;ADGRG6;AKAP6;ADCY2;EPHA5;PDE7B;CAP2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5697179330930435,1.531438133762142,0.03668261562998405,0.885013711039624,1.0,12/38,13.76%,BMP6;SASH1;IFNK;ANKRD17;PLSCR1;DDX60;LY96;DHX58;NMI;PRKCA;IFI35;ACOD1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7315178642269304,1.53138267104796,0.0690978886756238,0.8763067646710817,1.0,2/11,1.47%,NECAB1;BACE2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7046345956633622,1.5309508317987466,0.04950495049504951,0.8700777404393477,1.0,5/13,9.47%,RHOQ;LRRK2;OPA1;AK4;AK3
prerank,prostaglandin metabolic process (GO:0006693),0.5922861735146168,1.530603714797784,0.03361344537815126,0.863579038618363,1.0,2/26,1.04%,PTGDS;PTGS1
prerank,neuron projection development (GO:0031175),-0.3785383069959213,-1.5296236623274164,0.0,0.258533678130218,1.0,54/168,16.18%,FRY;NLGN1;CNTNAP2;CTNND2;PTPRM;DCLK1;GRM7;DOCK10;SHANK3;EPHB1;CNTN4;NYAP2;PAK3;PLP1;EPB41L3;SH3GL2;NGF;TRIO;NRK;TMEM108;GPM6B;SHTN1;LYN;GSK3B;DAB2IP;STX3;MINK1;PAK1;APOE;APP;STMN2;ULK1;LGI1;EPHB2;MYOC;GPRIN3;SLC9A6;RASGRF1;UHMK1;MARK2;DIP2A;NCDN;MAP4;MAPT;ERCC6;GPM6A;SHANK1;CDK5R1;UBB;MYO16;STMN1;BDNF;BICDL1;PACSIN1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5226571741074888,1.5294907812436465,0.024539877300613498,0.8617409448307678,1.0,7/62,3.04%,NOTCH2;ROBO1;AUTS2;LPAR1;IGF1;ALS2;AKAP13
prerank,diacylglycerol metabolic process (GO:0046339),-0.5565810325604407,-1.529162427129211,0.027149321266968326,0.2580744336852134,1.0,8/23,13.46%,DGKH;DGKB;PLCE1;DGKI;DGKK;DGKG;DGKZ;LIPE
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.4346907769131621,-1.5291506958791012,0.006211180124223602,0.2567313184905884,1.0,29/71,22.70%,PIK3R1;MYO10;ACTB;ACTG1;HSP90AB1;DOCK1;LYN;ACTR2;PAK1;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;VAV1;WASF2;SYK;NCKAP1;WIPF1;YES1;ARPC3;FYN
prerank,membrane lipid biosynthetic process (GO:0046467),-0.45244571337160366,-1.5289424760265964,0.0028089887640449437,0.2557859869706109,1.0,17/58,10.65%,ST3GAL4;ELOVL7;CERT1;SGMS1;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;PPM1L;PLPP1;SPTLC2;DEGS2;SPNS2;ST8SIA6;ELOVL6;CERS4
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4377271106795484,-1.5287498245197981,0.0030581039755351682,0.25475652770173457,1.0,29/70,22.70%,PIK3R1;MYO10;ACTB;ACTG1;HSP90AB1;DOCK1;LYN;ACTR2;PAK1;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;VAV1;WASF2;SYK;NCKAP1;WIPF1;YES1;ARPC3;FYN
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.41855049990713417,-1.5278967633479235,0.006711409395973154,0.2554214541306239,1.0,33/93,15.00%,PDE4D;NTRK3;CAV1;RASSF2;NCK2;BCAR3;GAS6;NGF;TFRC;HSP90AB1;PAK1;APP;TGFB1;SMAD7;CNKSR3;FNIP2;CD44;DDIT4;HSP90AA1;ATP2B4;TNKS1BP1;NOS1;PFN2;AXIN1;DMTN;SNCA;PRKD1;VEGFA;TXN;PINK1;TERF2IP;PPM1F;NCK1
prerank,phospholipid transport (GO:0015914),-0.45654319872523474,-1.5276979985019383,0.016304347826086956,0.254546866642757,1.0,21/52,14.29%,ATP10A;ATP8A1;ATP8B1;PITPNC1;ATP11A;ATP8A2;SCARB1;PLTP;APOE;ABCG1;LDLR;NPC2;ATP11C;PITPNB;TNFAIP8L3;MTTP;MFSD2A;PITPNA;TMEM30A;ATP8B2;ABCB4
prerank,cellular response to decreased oxygen levels (GO:0036294),0.5245784925312182,1.5273605175940534,0.023494860499265784,0.8664721499936369,1.0,13/65,9.71%,EPAS1;CPEB2;RORA;BMP7;SLC8A3;CPEB4;FAM162A;TP53;TERT;SIRT1;AK4;PICK1;NPEPPS
prerank,positive regulation of lipid metabolic process (GO:0045834),0.611837549710895,1.5268058249161098,0.051418439716312055,0.8614674285982019,1.0,7/22,12.56%,SORBS1;PPARA;ZBTB20;F2;CREBL2;MLXIPL;SIRT4
prerank,photoreceptor cell development (GO:0042461),-0.6326683020268073,-1.5266273591103487,0.041666666666666664,0.2553367094613769,1.0,6/14,13.77%,RORB;DCX;RP1;MFSD2A;AHI1;VEGFA
prerank,protein mono-ADP-ribosylation (GO:0140289),0.7226368247507678,1.526354796248562,0.05128205128205128,0.8560966417208248,1.0,8/11,10.70%,PARP10;PARP14;TIPARP;PARP4;PARP12;PARP9;PARP11;PARP6
prerank,ameboidal-type cell migration (GO:0001667),-0.46705683681634547,-1.5260818148987283,0.014044943820224719,0.25518663870366837,1.0,22/51,18.48%,SEMA3C;ERBB4;SEMA6A;SEMA6D;SEMA5A;SEMA7A;CCN3;SEMA3E;TBX1;SEMA4D;CORO1C;ITGA4;PDLIM1;AMOT;SEMA3D;SEMA3G;PKN3;FAT2;SEMA4C;AMOTL1;SEMA4A;SOX8
prerank,sprouting angiogenesis (GO:0002040),-0.4698523044788689,-1.525955540973537,0.008928571428571428,0.25420805854965134,1.0,16/51,5.33%,NRP1;SLIT2;TEK;BMPER;CDH13;RSPO3;ENG;CCBE1;VEGFC;THBS1;SEMA5A;PTK2B;ACVRL1;SEMA3E;KDR;RAMP2
prerank,negative regulation of cellular protein localization (GO:1903828),0.5649572775420207,1.5259154505988475,0.027586206896551724,0.8506999415381064,1.0,4/34,1.42%,ROCK2;ACTN2;LEPROT;PICALM
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.5693396901649228,-1.525127768513445,0.03424657534246575,0.2545478669046415,1.0,11/21,22.70%,GRIN2B;NGF;EPHA7;AIM2;MT3;USP50;GRIN1;PSMB9;SOX2;PYCARD;FYN
prerank,regulation of focal adhesion assembly (GO:0051893),-0.45880285130820253,-1.5249469269178062,0.03812316715542522,0.2537371250379474,1.0,22/54,14.56%,NRP1;LIMCH1;PTPRJ;TEK;THBS1;CLASP2;EFNA5;PEAK1;ACTG1;ACVRL1;GPM6B;KDR;CORO1C;MYOC;APOD;PTK2;DUSP3;FAM107A;DMTN;VEGFA;PPM1F;LIMS1
prerank,positive regulation of neuron migration (GO:2001224),-0.6488264672448709,-1.5245865670473653,0.04430379746835443,0.25329551752327284,1.0,4/11,5.82%,SEMA6A;SHTN1;ARHGEF2;DAB2IP
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.7100251771933566,1.524210326081941,0.052336448598130844,0.8534154174573355,1.0,5/12,12.27%,SORBS1;PRKCZ;GKAP1;SIRT1;PTPN11
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.6110380606240505,1.5242016775497,0.04325259515570934,0.8454575463606924,1.0,7/26,6.42%,OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;BRAF;CREBL2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5310888637758434,-1.5192770157388,0.046341463414634146,0.26262488715263527,1.0,6/25,8.94%,GRID2;MEF2C;GRIN2B;GSK3B;GRIN2A;GLRA1
prerank,positive regulation of axon extension (GO:0045773),-0.5747521290427242,-1.518664567471717,0.04597701149425287,0.2626164778752202,1.0,6/22,5.18%,NRP1;SEMA5A;SEMA7A;CDKL5;NTN1;SHTN1
prerank,mononuclear cell differentiation (GO:1903131),-0.534345945409606,-1.5182823375293493,0.026845637583892617,0.2619648889695693,1.0,11/24,15.38%,GAS6;MYH9;LYN;IKZF1;MT1G;BMP4;THOC5;VEGFA;TRPM2;RELB;IL31RA
prerank,positive regulation of MAP kinase activity (GO:0043406),0.5184267889576816,1.5170757855122776,0.023148148148148147,0.8810884421291383,1.0,10/66,6.37%,FGF1;ROBO1;TPD52L1;KIT;SASH1;FGFR1;ADRA2A;LRRK2;FLT1;PDGFRB
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.6018757862713091,-1.5166225053302615,0.0397489539748954,0.2639009121503531,1.0,6/15,13.79%,ACTR2;ACTR3;TRIM27;ARPC1B;ARPC5;ARPC4
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.6915661560294523,1.516200131115235,0.07088122605363985,0.8784394538149846,1.0,3/13,7.26%,SORBS1;IGF1;GCK
prerank,regulation of stem cell proliferation (GO:0072091),0.6611843056943494,1.5160130004601766,0.0595903165735568,0.8718173714083765,1.0,4/17,8.38%,ACE;FBLN1;EIF2AK2;TERT
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.6937935095415074,1.5156890305649744,0.060263653483992465,0.8659816651666244,1.0,6/13,9.59%,BMP7;NAPEPLD;METRNL;RREB1;FNDC5;SOX13
prerank,carbohydrate derivative catabolic process (GO:1901136),0.6485671469035745,1.515084189319848,0.04927007299270073,0.8618041904251227,1.0,6/18,8.42%,NGLY1;NEU2;ADAMTS9;DERA;SAMHD1;MANBA
prerank,cell-cell junction assembly (GO:0007043),-0.44350286241070747,-1.5147938197317405,0.024242424242424242,0.2665740167675494,1.0,22/63,10.63%,CDH11;CTNND2;CDH8;CDH2;ACTB;CLDN5;CD9;CDH10;EPB41L3;CDH12;ACTG1;CLDN11;GJC1;GJD3;RAMP2;CDH6;CDH20;CDH19;CDH7;SMAD7;TRPV4;WDR1
prerank,histone H3-K36 demethylation (GO:0070544),0.7428889602294396,1.5140926266379415,0.060362173038229376,0.8601514697213294,1.0,4/10,11.82%,KDM7A;KDM2B;KDM2A;RIOX2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5210751722729183,1.5140720541329944,0.030165912518853696,0.8527412435038803,1.0,16/61,14.03%,EYA1;EYA2;SMOC2;EYA4;BABAM2;USP9X;ATRX;PDGFRB;RNF8;SIRT1;UIMC1;RAD50;USP7;BABAM1;PML;SMCHD1
prerank,arachidonic acid metabolic process (GO:0019369),0.560019959448732,1.5130041861310386,0.04786324786324787,0.8513800332314824,1.0,5/35,6.61%,PTGDS;PTGS1;ALOX12;EPHX1;DAGLA
prerank,cellular protein metabolic process (GO:0044267),-0.3435468973181399,-1.5127719184080979,0.0,0.26933441373216815,1.0,119/396,15.79%,LTBP1;CDH2;MSRB3;ST8SIA4;CHRM3;CST3;FN1;RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;GAS6;RPL18A;RPS20;MGAT4A;ST3GAL1;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;IGFBP4;DAB2IP;RPL7;RPS19;RPL22;RPS28;APOE;RPL35A;RPLP0;APP;RPS15;MSLN;RPL30;RPS3;SFTPA1;SFTPA2;RPL19;RPS21;RPL4;PSEN1;IGFBP6;RPL32;UBE2G1;VCAN;RPL21;RPS16;RPL18;RPL5;PCSK5;RPS7;RPL39;ABCF1;RPL14;CKAP4;RPS17;CCN1;SIAH2;ST3GAL6;RPL28;RPL34;EEF1A1;SHISA5;RPL12;RPL9;FBXL2;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;PAPPA;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;SPARCL1;ZDHHC2;BMP4;RPS4X;RPS5;LCMT1;LOX;RPL36A;RPL6;LMCD1;UBE2D3;TMEM208;MMP15;CSNK1G3;RPL31;MFGE8;HBS1L;QPCT;SPPL3;RPSA;DUSP12;SPCS1;RPN1;SCG2;RPS26;MSRB2;PHEX;RPL36;GOLM1
prerank,fat cell differentiation (GO:0045444),0.5273229742031164,1.5120465090955877,0.04643962848297214,0.850141768487049,1.0,19/57,17.32%,WNT5B;C1QTNF3;OSBPL8;PPARGC1A;ADIG;METRNL;SMAD6;OSBPL11;SIRT1;CBY1;TCF7L2;MKKS;FAM120B;ERAP1;PER2;BBS2;CLIP3;CTBP2;MED1
prerank,cardiac cell development (GO:0055006),-0.6613315630462938,-1.5119733284011407,0.04536082474226804,0.26963722948703833,1.0,5/11,13.77%,SLC8A1;JAG1;NOTCH1;MYH11;VEGFA
prerank,peripheral nervous system development (GO:0007422),-0.5410342064249147,-1.5110302953885226,0.03636363636363636,0.2700289817010638,1.0,14/23,30.20%,ADGRG6;SERPINI1;NGF;NFASC;SCN8A;ADGRB1;BDNF;SOX8;SOX10;ERBB3;NF1;ADGRB2;NTF3;GPC1
prerank,sodium ion transmembrane transport (GO:0035725),0.49024900771066315,1.5096300898870822,0.023222060957910014,0.8574804900258166,1.0,7/84,1.99%,ATP1A2;SLC6A13;SLC6A1;SLC24A3;SLC6A12;ATP1B3;SLC8A3
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.7301156231549082,1.5094892777974607,0.04678362573099415,0.8438205596927602,1.0,3/10,11.74%,CEP250;GNAT2;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.7301156231549082,1.5094892777974607,0.04678362573099415,0.8438205596927602,1.0,3/10,11.74%,CEP250;GNAT2;CACNA2D4
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6771435083206037,1.50947262397416,0.060077519379844964,0.8368928955766316,1.0,8/14,20.03%,AMACR;ACOXL;CRAT;ACOT8;ACOX3;EHHADH;ECI2;CROT
prerank,cardiac myofibril assembly (GO:0055003),0.6640208749390882,1.5092758357741785,0.0521415270018622,0.8311605506022818,1.0,6/15,10.73%,NEBL;CSRP3;OBSL1;PDGFRB;MEF2A;MYLK3
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.504691832756395,-1.509223979487409,0.045,0.2726110607462888,1.0,11/34,12.67%,PDE4D;SLC8A1;PDE4B;RYR2;ATP1B1;CALM1;CALM2;KCNQ1;SMAD7;CALM3;NOS1
prerank,odontogenesis (GO:0042476),0.5749392758353349,1.5078792364423537,0.04376012965964344,0.8321036557393532,1.0,11/35,11.86%,OSR1;FGFR2;WNT6;GLI2;TUFT1;FOXC1;EDA;BCOR;COL1A2;HDAC1;AXIN2
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.4310467113286981,-1.5073927514888599,0.012084592145015106,0.27505217465265397,1.0,21/70,12.85%,NRP1;TMEFF2;MEF2C;TEK;PIK3R1;PARVB;ACTN1;PEAK1;FN1;LAMC3;NTNG1;NTN4;ITGA4;RELN;PROX1;ARL13B;ITGA8;ITGB3;ATF4;ILK;LPXN
prerank,stem cell differentiation (GO:0048863),0.5586824406215384,1.5067110911398203,0.04809286898839138,0.8316554706282342,1.0,7/39,2.45%,ACE;OSR1;KIT;FGFR2;HOXB4;JARID2;FBXL17
prerank,negative regulation of ion transport (GO:0043271),0.6235264193291803,1.5058532972033736,0.058823529411764705,0.8298806750348735,1.0,5/24,3.86%,WNK4;ACTN2;SYT11;ADRA2A;NEDD4
prerank,metal ion export (GO:0070839),0.5855447021382509,1.505622890044969,0.05517241379310345,0.8245494125138242,1.0,4/31,1.80%,ATP1A2;ATP1B3;KCND3;KCNA5
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7059207911134155,1.505572267298042,0.07495069033530571,0.818310641004431,1.0,3/12,7.26%,SORBS1;IGF1;GCK
prerank,lamellipodium organization (GO:0097581),-0.5118957618682851,-1.5053365749758578,0.029339853300733496,0.2782145612377216,1.0,14/29,13.12%,CDH13;ABLIM1;PARVB;CARMIL1;SPATA13;CCDC88A;ARHGEF7;ABLIM3;ITGB1;S1PR1;P2RY12;ABLIM2;SPEF1;DMTN
prerank,histone modification (GO:0016570),0.47047403155049583,1.5040474819377434,0.022284122562674095,0.8202718297734147,1.0,29/109,17.45%,EYA1;EYA2;BRD8;CCNA2;EYA4;PADI6;USP3;CPA4;NSD1;BAZ1B;TBL1X;HUWE1;TBL1XR1;KAT6B;HDAC4;SIRT1;NSD3;HDAC1;AURKB;PRDM5;HLCS;SIN3A;MIER3;MTA2;EHMT2;CREBBP;EHMT1;SGF29;PADI4
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6297948358738129,1.502281540399941,0.06569343065693431,0.8237123954109276,1.0,3/18,5.99%,PRKAG2;PRKCB;BRAF
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6714906521870808,-1.5022270193706677,0.06868686868686869,0.2834948505039342,1.0,5/10,19.59%,FN1;HSP90AB1;LAPTM4B;GATA6;TYROBP
prerank,secretion (GO:0046903),0.6771868303500297,1.5019791306301173,0.06502636203866433,0.8191607864878293,1.0,2/14,1.93%,SLC22A6;NPR1
prerank,histone lysine demethylation (GO:0070076),0.6033454758642691,1.4996257028789146,0.05073649754500818,0.8261666842825729,1.0,11/25,21.00%,KDM7A;KDM2B;KDM2A;HR;RIOX2;KDM3B;PHF2;KDM6B;KDM1A;KDM6A;RIOX1
prerank,dicarboxylic acid transport (GO:0006835),0.59777652023504,1.49958324855846,0.051457975986277875,0.820021559297833,1.0,7/28,9.87%,SLC22A6;SLC13A3;PDPN;SLC19A1;SLC26A1;SLC1A3;SLC25A12
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6949364197868586,1.4991859651322619,0.06261859582542695,0.8160603047804361,1.0,7/13,16.21%,DDO;ASPA;GOT2;GLUL;ACOT8;QPRT;GOT1
prerank,peptide hormone secretion (GO:0030072),-0.5296212348143771,-1.4990689655902083,0.04739336492890995,0.28900936195674154,1.0,5/26,11.72%,RIMS2;LTBP4;ANXA1;EDN1;EDN3
prerank,ERBB signaling pathway (GO:0038127),-0.43343384553722536,-1.4987698847093065,0.012345679012345678,0.28839150535513963,1.0,17/64,10.35%,RPS6KA5;ERBB4;PIK3R1;REPS2;PLCE1;PTPN12;IQGAP1;NCK2;GAB1;PTK2B;NRG2;TGFB1;PTK2;ERBIN;ERBB2;HSP90AA1;BCAR1
prerank,response to zinc ion (GO:0010043),-0.5356040785918388,-1.4984506337228358,0.05048076923076923,0.28759677184053845,1.0,13/25,14.18%,PAM;GLRA1;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;CRIP1;GLRA2;MT3
prerank,kidney development (GO:0001822),0.5146557905978832,1.4979716897916777,0.018518518518518517,0.8166557484229694,1.0,12/65,4.94%,BMP7;ACE;LRP4;WNT4;OSR1;GREB1L;GLI2;KANK2;TGFBR1;FOXC1;SULF2;CTSH
prerank,regulation of amyloid fibril formation (GO:1905906),-0.6037235472052404,-1.496801039412071,0.07234042553191489,0.2898656657336043,1.0,7/15,16.77%,APOE;APP;LDLR;PSEN1;CLU;IAPP;CHRNA7
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.49393248941046747,-1.4966463064508595,0.04477611940298507,0.28889050598782556,1.0,11/32,9.64%,ADGRB3;HECW2;PTPRD;IL1RAPL1;HECW1;CDKL5;NEDD4L;GSK3B;SEMA4D;LZTS1;RAP2A
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5828949509254471,-1.4965266950062417,0.057649667405764965,0.2878026270374835,1.0,6/17,9.92%,MAML2;NOTCH3;NOTCH1;HEYL;WWC1;PBX1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7260295740616877,1.49651163285515,0.07984031936127745,0.8187636501630058,1.0,4/10,12.63%,ACE;HOXB4;TP53;LMBR1L
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.540551340031815,1.4964859023924226,0.05263157894736842,0.8127913332414824,1.0,7/41,13.91%,PRKAG2;LACC1;GCK;NUP42;NUP98;NUP43;OGT
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6613154888645845,-1.4955072219345171,0.04462474645030426,0.2887261028999307,1.0,5/11,11.29%,SEMA6A;THBS1;EPN2;KLF2;CREB3L1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6525016933454124,1.495050846410931,0.06433823529411764,0.8144441312166143,1.0,3/17,1.76%,PRKAG2;PRKAA2;PPARA
prerank,endocardial cushion morphogenesis (GO:0003203),-0.5764711344874107,-1.4942595353179402,0.03827751196172249,0.2901524695781493,1.0,9/18,13.46%,ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2;BMP4;ACVR1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5690563954824766,-1.4941014297056743,0.05476190476190476,0.28908329291967655,1.0,5/17,9.06%,SLIT2;CASK;SFRP4;TMEM204;PCSK6
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6648433302074728,-1.494013666856457,0.046610169491525424,0.28802379206806783,1.0,6/11,22.96%,NRP1;PAK1;BCAR1;STMN1;SIRT2;HGF
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4844483073615813,1.4939611783604099,0.025936599423631124,0.8141917047277811,1.0,11/85,4.41%,FGF1;TGFBR3;BMP6;OSR1;IGF1;FGFR2;MCC;LAMC1;PKHD1;NUPR1;FUT1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6606300413377174,-1.493047055327724,0.056910569105691054,0.2886536320474242,1.0,5/10,20.71%,PTPRC;CEACAM1;CX3CR1;ARRB2;LGALS9
prerank,base conversion or substitution editing (GO:0016553),-0.6492902686953124,-1.4927081379303908,0.0625,0.28805560264301866,1.0,4/11,15.42%,ADARB1;ADARB2;APOBEC1;METTL3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5363699051763097,1.4924024176919743,0.03508771929824561,0.8168416880738223,1.0,9/47,6.42%,TMEM64;BMP7;MEDAG;NAPEPLD;ADIG;METRNL;RREB1;FNDC5;CREBL2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.425660611871079,-1.4920190936153606,0.0031847133757961785,0.2881797661450871,1.0,29/73,22.70%,PIK3R1;MYO10;ACTB;ACTG1;HSP90AB1;DOCK1;LYN;ACTR2;PAK1;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;VAV1;WASF2;SYK;NCKAP1;WIPF1;YES1;ARPC3;FYN
prerank,organic acid transport (GO:0015849),0.4755787731522851,1.4919041171399423,0.028106508875739646,0.813649321703534,1.0,18/94,8.69%,SLC22A6;SLC13A3;SLC6A13;ACSL1;SLC6A12;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN;SLC25A48;SLC10A4;SLC19A1;SLC27A1;GOT2;SLC26A1;SLC38A1;SLC51A
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6439768330768152,-1.4914923494052754,0.05063291139240506,0.28799294409883514,1.0,4/12,11.73%,GSN;LY6E;MID2;IFITM3
prerank,glycerolipid metabolic process (GO:0046486),-0.6441153561010498,-1.4913434006290858,0.06438631790744467,0.28699910332192136,1.0,6/11,19.38%,DGKB;DGKG;GAL3ST1;DGKZ;PNPLA3;PLA2G15
prerank,central nervous system development (GO:0007417),-0.35375746286758597,-1.4906798564694292,0.0,0.2872752020840057,1.0,61/250,10.92%,CNTNAP2;ADGRL3;ROBO2;ADGRL2;DCLK1;ZFHX3;CDH2;SLC2A1;GSN;COL4A1;WWP1;CNTN4;GRIK1;GRIN2B;ADAM23;TBX3;MAL;VIT;IL1RAPL2;SHROOM4;STAT3;PBX3;DNER;SERPINI1;SH3GL2;DSCAML1;ZBTB16;LSR;MBP;SNTG2;CNTN6;PDGFC;MARCKS;NRCAM;PTCH1;EPHA7;DCX;GRIN2A;MOG;HSPG2;VCAN;MEIS2;RELN;PTPRZ1;PCDH18;APOD;SPOCK1;PROX1;TUBGCP2;ADAM22;PPT1;S100B;ECRG4;RAB18;PBX1;DDIT4;UFM1;CDK5RAP2;RPS6KA3;PKD1;MFSD2A
prerank,histone lysine methylation (GO:0034968),0.5711297733292958,1.4906733771072525,0.047285464098073555,0.8149122066199715,1.0,14/33,21.15%,KMT2A;CXXC1;SMYD3;ASH2L;PRDM5;WDR82;KMT2D;DOT1L;SETD1B;SETDB2;EHMT2;SETD3;KDM6A;N6AMT1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.4315278271392659,-1.49059597178121,0.0061162079510703364,0.28620519257699756,1.0,21/72,11.24%,NLGN1;NRXN1;GRIK2;SYT1;RIMS2;CLSTN2;SHANK3;SLC24A2;RIMS1;NPTN;GRIN2B;PTK2B;PLK2;APP;GRIN2A;LGI1;RELN;EPHB2;ZDHHC2;SHANK2;GPER1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5861209336344703,-1.4902401943153996,0.03953488372093023,0.28579037165318644,1.0,8/18,17.63%,HEG1;RASIP1;MET;KCTD10;MYOC;CUL3;STMN1;KANK1
prerank,positive regulation of protein processing (GO:0010954),-0.5642288942201352,-1.4899554040724132,0.05555555555555555,0.28521839899117135,1.0,6/19,16.71%,GSN;CCBE1;MYH9;NKD2;RHBDD1;CLEC3B
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.4752436598715942,-1.4897295133156139,0.028328611898016998,0.2844593029324576,1.0,15/42,16.19%,UTRN;NRP1;PTPRJ;TEK;CDH13;PTK2B;KDR;GSK3B;MYOC;EMP2;VEGFA;PPM1F;LIMS1;RRAS;SKAP1
prerank,regulation of cell junction assembly (GO:1901888),-0.5147590168721043,-1.4893922236696073,0.03424657534246575,0.2839389800692451,1.0,8/27,6.59%,MEF2C;PRKCH;CLDN5;RUNX1;F11R;RAP1B;RAP1A;OCLN
prerank,lung development (GO:0030324),0.5660844255581245,1.4890245138510059,0.05132450331125828,0.8180940281797577,1.0,7/33,7.53%,FGF1;ERRFI1;FGFR2;GLI2;PDPN;LOXL3;RBP4
prerank,sensory perception of sound (GO:0007605),0.47937517111301664,1.48858909736871,0.025899280575539568,0.8146826403419791,1.0,15/88,8.93%,EYA1;CACNA1D;KIT;GSDME;WHRN;ALDH7A1;DCDC2;EML2;HOXA1;COL4A3;TBL1X;CDC14A;NIPBL;LRTOMT;EPS8L2
prerank,blood vessel morphogenesis (GO:0048514),-0.4540955205263596,-1.4876528076283413,0.020348837209302327,0.286125370806842,1.0,26/54,12.50%,NRP1;LAMA1;CDH2;CAV1;COL4A1;ENG;CCBE1;ID1;CYP1B1;RASIP1;SLC1A1;KDR;RAMP2;TBX1;ITGB8;SOX17;HES1;STRA6;TGFB1;PROX1;SMAD7;HEY2;FLT4;RASA1;SOX18;LOX
prerank,activation of protein kinase B activity (GO:0032148),0.5753868551659436,1.4872209489758768,0.05140961857379768,0.8162816532641258,1.0,8/29,8.74%,FGF1;OSBPL8;IGF1;IL18;ADRA2A;RICTOR;NRG1;PDPK1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.6384846219544001,1.4860475336124068,0.0718132854578097,0.8168834969893988,1.0,1/16,0.01%,RANBP3L
prerank,monosaccharide transmembrane transport (GO:0015749),0.6366607817418237,1.48478432698522,0.07129455909943715,0.8179081037583692,1.0,3/16,9.52%,SLC2A12;SLC5A3;SLC45A3
prerank,ncRNA processing (GO:0034470),-0.3631641369169557,-1.484707477400535,0.0,0.2909070255560087,1.0,69/200,19.20%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;SMAD1;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;DROSHA;RPL36A;RPL6;EMG1;MDN1;RPL31;NOP53;DDX10;METTL3;NOL11;RPL36;LIN28B;TEX10;RPL13A;FBL;XRN2;RPL35;UTP15;ADAT1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5448620379785402,1.4841641618555603,0.03697478991596639,0.8157506471947397,1.0,4/37,2.95%,PRKAG2;BMP7;SPHK1;PPEF2
prerank,transepithelial transport (GO:0070633),-0.5984497470130814,-1.4828076110094368,0.051224944320712694,0.29346322826057725,1.0,4/15,4.70%,ABCG2;SLC12A2;SLC1A2;SLC1A1
prerank,protein export from nucleus (GO:0006611),0.580020592033623,1.4819934613463581,0.07081174438687392,0.8219106635694706,1.0,1/27,0.01%,RANBP3L
prerank,positive regulation of cell communication (GO:0010647),-0.5180452320561733,-1.4819583408852344,0.02702702702702703,0.29390284262685573,1.0,11/28,12.24%,GRIK2;SYT1;RIMS2;CLSTN2;ANK3;RIMS1;LGI1;EDN1;EDN3;HOMER1;ILK
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.6508761207756487,-1.4816190253703088,0.04835164835164835,0.29351411905364944,1.0,7/11,24.08%,GSN;ST18;FAS;HTRA2;LGALS9;PRR7;PLAUR
prerank,neuron migration (GO:0001764),-0.4588798266521996,-1.4813987342804582,0.03287671232876712,0.2926759125756896,1.0,24/48,15.01%,NRP1;ADGRL3;MEF2C;MARK1;ASTN2;MAP1B;ASTN1;NDNF;DNER;CDKL5;NTRK2;DISC1;NRCAM;DCX;RELN;SPOCK1;TUBGCP2;FGF13;DDIT4;MARK2;VEGFA;GPM6A;CDK5R1;TUBB2B
prerank,peptidyl-lysine modification (GO:0018205),0.46984677852433426,1.4806366447455204,0.019099590723055934,0.8239071123135603,1.0,33/99,23.21%,NNAT;EYA1;SENP3;LOXL1;LOXL3;PIAS1;SIRT5;NDUFAB1;SIRT3;HDAC4;SIRT1;CTH;NUP42;NUP98;SIRT4;NSMCE2;NUP43;VIPAS39;KAT2B;PIAS3;NUP155;SUMO1;PIAS4;NUP188;P3H4;ATP7A;UBE2I;NUP153;EP300;VPS33B;EEF1AKMT1;ESCO1;USPL1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.38034680949931227,-1.4804229560768798,0.0,0.29348901559462154,1.0,33/138,10.35%,PTPRD;TEK;ERBB4;NTRK3;BMPR2;PTPRG;ROR1;EPHB1;MPZL1;LIFR;EPHA5;MERTK;PTPRT;EPHA6;TIE1;PTK2B;NGF;TRIO;NTRK2;IL6ST;KDR;LYN;ROR2;MET;PTPRF;EPHA7;EPHB2;PTK2;PTN;ABI1;FLT4;ERBB2;BCAR1
prerank,regulation of catecholamine secretion (GO:0050433),0.5724730804198711,1.4796989184271487,0.06666666666666667,0.8232630043725337,1.0,5/29,4.05%,SYT9;SYT11;SYT12;PRKN;DTNBP1
prerank,signal release from synapse (GO:0099643),-0.47403083834077053,-1.4795860130260425,0.022332506203473945,0.2939167938764232,1.0,9/43,6.77%,NRXN1;SYT1;SNAP25;RIMS1;LIN7A;PCLO;PTPRN2;SYN2;HSPA8
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6388423422329828,-1.4795034850858264,0.05154639175257732,0.2928550269188854,1.0,6/12,18.31%,PTPRJ;F3;APOD;SNCA;CBL;NDRG4
prerank,lysine metabolic process (GO:0006553),0.700755839490115,1.4792907545231384,0.0718232044198895,0.8144412748712424,1.0,6/12,13.24%,ALDH7A1;PIPOX;OGDH;DLD;AASS;GCDH
prerank,lysine catabolic process (GO:0006554),0.700755839490115,1.4792907545231384,0.0718232044198895,0.8144412748712424,1.0,6/12,13.24%,ALDH7A1;PIPOX;OGDH;DLD;AASS;GCDH
prerank,positive regulation of signaling (GO:0023056),-0.4820129011920674,-1.4781728628720894,0.0273224043715847,0.2941549602716232,1.0,16/37,17.66%,GRIK2;SYT1;RIMS2;CLSTN2;RIMS1;ECE1;LGI1;NSF;EDN1;EDN3;HOMER1;ILK;SNCA;NMU;SCRIB;CDKN2AIP
prerank,regulation of histone methylation (GO:0031060),0.6949690282037555,1.4778110590572116,0.076171875,0.8171934880937052,1.0,6/13,15.19%,JARID2;CTR9;NSD1;MTHFR;AASS;TET1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.3874540495902707,-1.477727991096858,0.0034602076124567475,0.29384870289954484,1.0,36/118,12.71%,ADGRB3;MEF2C;LRRC4C;HECW2;PID1;FMNL2;BMPER;PPFIA2;CDH2;SHANK3;HECW1;CLASP2;EFNA5;TANC2;PAK3;PHLDB1;CHN1;NEDD4L;GSK3B;TBX1;PAK1;SEMA4D;TSPAN12;LZTS1;TGFB1;CEACAM1;FGF2;FLT4;RAP2A;ERBB2;LFNG;MARK2;ABI3;CTNNB1;EMP2;MAPT
prerank,skeletal system morphogenesis (GO:0048705),0.5418427904735789,1.4777072184131745,0.04617834394904458,0.8123362992139149,1.0,11/42,9.73%,WWOX;FGFR2;HOXB4;FGFR1;TGFBR1;HOXB3;CYP26B1;HOXB9;HOXA3;HOXC4;DYNC2I1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.43974224751794283,1.476903253408727,0.007633587786259542,0.8112699713571058,1.0,32/186,9.99%,DAB2;TMEM64;WWOX;RNF43;LRP4;BICC1;NXN;MCC;PRKN;TRABD2B;DKK3;RNF213;GLI3;APCDD1;CXXC4;VGLL4;LZTS2;APC2;WWTR1;UBAC2;PTPRU;INVS;TMEM170B;CSNK1A1;GLI1;LRP1;TLE1;HDAC1;SOX13;CBY1;GRB10;TCF7L2
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6220638222224566,-1.4764070342554898,0.05785123966942149,0.2954239899168609,1.0,4/12,9.22%,CXCL12;APP;JAM2;DOCK8
prerank,regulation of TORC1 signaling (GO:1903432),0.5539192593061522,1.4762252349261993,0.04844290657439446,0.809280613125566,1.0,10/33,17.13%,RNF152;SESN1;GPR137;SESN2;ATM;DEPDC5;FLCN;KPTN;TELO2;RRAGD
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5711214719669324,1.475877577374455,0.08067226890756303,0.8060346194090623,1.0,10/31,9.73%,OSR1;FGFR2;HOXB4;TGFBR1;HOXB3;HOXB9;HOXA3;TGFBR2;HOXC4;DYNC2I1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.48774465395173355,1.4756840454848812,0.031294452347083924,0.8019112449836059,1.0,15/76,7.34%,UACA;BMP7;C1QTNF3;SASH1;DLG1;SPHK1;NFAT5;TLR3;EZR;TLR4;DDX3X;CD27;IL12B;EIF2AK2;PTPN22
prerank,myofibril assembly (GO:0030239),0.5339764631385214,1.4749157713404075,0.04430379746835443,0.8008039997494288,1.0,9/42,6.37%,ACTN2;CSRP3;OBSL1;CFLAR;TMOD2;TMOD3;TPM1;KLHL41;PDGFRB
prerank,mesoderm formation (GO:0001707),-0.5648239986699217,-1.474172946697812,0.05934065934065934,0.29879741540593063,1.0,6/17,14.64%,BMPR2;ITGB4;ITGB1;ITGA8;ITGB3;ITGA2
prerank,carnitine metabolic process (GO:0009437),0.6815781971528171,1.4739158068874976,0.08502772643253234,0.8010774918337074,1.0,6/12,12.40%,CPT1A;BBOX1;TMLHE;CPT2;ACADM;CRAT
prerank,regulation of dopamine secretion (GO:0014059),0.5985533099879781,1.4734147598711014,0.06797853309481217,0.7984928002502318,1.0,5/25,4.05%,SYT9;SYT11;SYT12;PRKN;DTNBP1
prerank,carboxylic acid catabolic process (GO:0046395),0.6929638442317142,1.4712806306318011,0.08045977011494253,0.8044990989254478,1.0,5/12,12.41%,RENBP;NPL;PON3;GNPDA1;ACOT8
prerank,regulation of tube diameter (GO:0035296),0.648185962570871,1.471164582331783,0.08867924528301886,0.7951824895857257,1.0,3/13,1.93%,ROCK2;ACE;NPR1
prerank,vascular process in circulatory system (GO:0003018),0.648185962570871,1.471164582331783,0.08867924528301886,0.7951824895857257,1.0,3/13,1.93%,ROCK2;ACE;NPR1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.46023190976656914,-1.4706336505546955,0.03389830508474576,0.3048231027063484,1.0,13/46,3.62%,NLGN1;NRXN1;MEF2C;SYT1;GRM7;GRM5;CDH2;SHANK3;GRM3;DGKI;GRIK1;GRM8;PTK2B
prerank,cellular amino acid catabolic process (GO:0009063),0.4822901065974531,1.4702079527181176,0.028169014084507043,0.7951946121693195,1.0,22/87,13.24%,DDO;ALDH7A1;IVD;ASPA;PRODH;ACADSB;ALDH4A1;HNMT;PIPOX;BCAT2;GOT2;OGDH;DLD;GLUL;MCCC1;AASS;UROC1;FAH;ABAT;MTRR;ALDH6A1;GCDH
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5807650115374692,-1.4699622956584122,0.07112068965517242,0.30500468335253744,1.0,4/15,6.31%,SCARB1;PLTP;APOE;ABCG1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.4852840787470359,-1.469710725638348,0.028795811518324606,0.30437970881276366,1.0,10/33,10.43%,MEF2C;THBS1;ACVRL1;MEOX2;NOTCH1;APOE;TGFB1;FGF2;STARD13;ATP2B4
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.48491828484137633,-1.4690583312809509,0.030456852791878174,0.3046719201214358,1.0,12/35,6.19%,PDE4D;PDE3A;RIMS2;ADGRG6;AKAP6;ADCY2;EPHA5;HTR2C;PDE7B;GUCY1B1;CAP2;APOE
prerank,regulation of ossification (GO:0030278),-0.4777666648645047,-1.4688632818277325,0.031578947368421054,0.30386734730725673,1.0,15/36,13.90%,MEF2C;BMPR2;SGMS2;TGFB2;NOTCH1;ZBTB16;ENPP1;ECM1;BMP2;PTN;S1PR1;BMP4;TWIST1;ACVR1;TXLNG
prerank,negative regulation of chemotaxis (GO:0050922),-0.4969683011320221,-1.4683347953764903,0.0488997555012225,0.3038436095252625,1.0,14/31,12.46%,SLIT2;ROBO2;SEMA3C;SEMA6A;SEMA6D;THBS1;SEMA5A;SEMA7A;NOTCH1;SEMA3E;SEMA4D;DUSP3;SEMA3D;SEMA3G
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.42480369453953265,-1.468096413959187,0.012422360248447204,0.3031660886536713,1.0,22/67,14.56%,UTRN;NRP1;CDH13;FN1;VIT;CARMIL1;PTK2B;NDNF;ARHGEF7;DOCK1;GSK3B;FBLN2;FLNA;CRK;LIMS2;MYOC;CALR;ILK;EMP2;DMTN;PPM1F;LIMS1
prerank,ubiquinone metabolic process (GO:0006743),0.6450004259994864,1.4677761282178852,0.08333333333333333,0.8026837956291356,1.0,7/15,14.80%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5799562674455153,-1.4660015816329777,0.06502242152466367,0.30648575448604565,1.0,3/16,11.51%,CLDN5;CLDN11;CLDN14
prerank,negative regulation of platelet activation (GO:0010544),-0.5842687256864904,-1.4658380093051853,0.07158351409978309,0.3056575972173988,1.0,7/16,10.25%,PRKG1;CD9;SERPINE2;NOS3;APOE;CEACAM1;PDGFA
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6679972185886045,1.4657385804694794,0.07114624505928854,0.8081595378464157,1.0,4/13,5.45%,RNF152;SESN1;SESN2;ATM
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.6128112517772178,-1.465513515277334,0.05707762557077625,0.30516735976270914,1.0,8/13,32.04%,TBX3;NOTCH1;TGFB1;BMP4;SOX8;EID2B;SOSTDC1;ANKRD2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6506667651891677,1.465460747505194,0.08395522388059702,0.8046791741093033,1.0,6/15,15.96%,DAB2;AAK1;WASL;NEU3;BMP2K;SMAP1
prerank,epithelial cell morphogenesis (GO:0003382),0.6222550061625294,1.4653885213432336,0.08875739644970414,0.8002156759796091,1.0,5/17,5.01%,COL22A1;PKHD1;COL18A1;RILPL1;DACT2
prerank,ceramide transport (GO:0035627),-0.6378431652018044,-1.4640923358097016,0.05165289256198347,0.30692996179603765,1.0,6/12,14.29%,CERT1;PLTP;PSAP;GLTP;PLEKHA3;ABCB4
prerank,polyol biosynthetic process (GO:0046173),0.6607569069269956,1.4637833967334906,0.06813996316758748,0.8039188986152046,1.0,5/16,9.75%,ISYNA1;CYP27A1;CYP2R1;ITPKB;PPIP5K2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6167539851961771,1.4620863822652241,0.07317073170731707,0.8075672409249902,1.0,10/21,21.38%,DCDC2;TTC23;SMO;RAB34;GLI1;EVC;STK36;IHH;GAS8;DLG5
prerank,atrial septum development (GO:0003283),0.660824589343193,1.4617895579672835,0.0817490494296578,0.8042392339865269,1.0,2/13,0.80%,NOTCH2;ANK2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.4712594483664882,-1.4617225777013,0.031496062992125984,0.31071768784363957,1.0,16/39,19.77%,TEK;THBS1;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;ITGA4;GATA2;GPER1;ECSCR;SCG2;PDCD4;RGCC;PAK4
prerank,cell junction assembly (GO:0034329),-0.39678777393766945,-1.4612307844605597,0.014598540145985401,0.3105902443636121,1.0,28/100,7.82%,NLGN1;ADGRL3;CDH11;CTNND2;NRXN1;DNM3;CDH8;CDH2;KIRREL3;ITGA6;SHANK3;SPOCK2;ACTB;CLDN5;FN1;CDH10;DNER;CDH12;ACTG1;GJC1;VMP1;CDH6;FLNA;NRCAM;CDH20;CDH19;CDH7;LIMS2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.47043231911278743,1.4609819283584264,0.034139402560455195,0.8037117439821098,1.0,7/90,2.00%,EPAS1;ACSL1;PPARGC1B;APPL2;LEPR;PPARGC1A;IL18
prerank,positive regulation of integrin activation (GO:0033625),-0.6234780942083777,-1.4594665603119619,0.06790123456790123,0.3131517301699335,1.0,5/11,16.19%,RASIP1;RAP1B;PIEZO1;P2RY12;SKAP1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.699101824327755,1.458899847914044,0.0888468809073724,0.809632550177281,1.0,5/10,16.98%,KMT2A;RAPGEF3;CAMK1;SPHK2;SMAD4
prerank,positive regulation of cell division (GO:0051781),0.5351830719045342,1.4581244853195565,0.0499194847020934,0.8088645950380708,1.0,7/38,11.35%,FGF1;PKP4;FGFR2;CDC14A;AURKB;CDC14B;CDC42
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.643466021675782,1.4578481932725489,0.09124767225325885,0.8057206359845457,1.0,4/13,5.77%,RENBP;LARGE1;MGAT3;PGM3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5649228476352525,-1.456874217219389,0.06183368869936034,0.3174609765921422,1.0,9/19,15.66%,PTPRJ;GRM5;RYR2;VCAM1;KDR;PTPRC;DMTN;TRPM2;STIMATE
prerank,bile acid and bile salt transport (GO:0015721),-0.5165774061194568,-1.4561233125665836,0.04576659038901602,0.31787582126625136,1.0,6/24,9.00%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1;STARD5
prerank,mitotic sister chromatid cohesion (GO:0007064),0.6226426933074223,1.4558364743172065,0.1059245960502693,0.8109007837008104,1.0,7/16,19.18%,DSCC1;NIPBL;PDS5A;MAU2;REC8;RB1;PDS5B
prerank,response to progesterone (GO:0032570),-0.5525467568907607,-1.4551977817794577,0.07045454545454545,0.3185979724374893,1.0,6/18,8.45%,ABHD2;CAV1;THBS1;TGFB2;TGFB3;TGFB1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6907122670360343,1.4545218194910348,0.10420841683366733,0.8127409893231781,1.0,5/11,8.76%,DAB2;PRKN;EZR;PTPN23;EIPR1
prerank,regulation of striated muscle contraction (GO:0006942),0.5824667785774262,1.454393574054935,0.07832422586520947,0.8087908881283361,1.0,3/27,1.99%,ATP1A2;ANK2;SLC8A3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6525518970087889,-1.453459419397135,0.08565310492505353,0.3211824387937426,1.0,5/10,8.90%,PRKG1;CD9;SERPINE2;RDX;CEACAM1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.7117406022314123,1.453413809323667,0.0854368932038835,0.8089032494249243,1.0,3/10,7.30%,APPL2;CD300A;ANO6
prerank,response to metal ion (GO:0010038),-0.4254094203742286,-1.4523597700889175,0.02040816326530612,0.32245881910548785,1.0,21/67,14.18%,CAV1;KCNMA1;THBS1;GPHN;NEDD4L;TRPC3;SLC25A13;CALM1;CALM2;TRPC1;PAM;PPP3CA;CALM3;MT1A;MT1X;HOMER1;CRIP1;MAPT;HIF1A;SNCA;MT3
prerank,cellular response to organonitrogen compound (GO:0071417),-0.38784830300857226,-1.452036023626276,0.010452961672473868,0.3218559102907196,1.0,29/99,15.28%,SLIT2;MEF2C;PDE3A;ACTB;AKAP6;HCN1;GABRB3;GABRB1;RYR3;GABRB2;RAP1B;RAP1A;KCNQ1;SH3BP4;GLRA1;EGR1;GABRG2;PDE2A;CAPN2;P2RY12;CDH1;CTNNB1;SPAAR;DMTN;GLRA2;HTR1B;P2RY1;TRPM2;HRH1
prerank,tRNA wobble uridine modification (GO:0002098),0.6384427740094119,1.450652995044002,0.10476190476190476,0.8183045355754897,1.0,1/14,0.80%,TRMT9B
prerank,response to muscle stretch (GO:0035994),-0.5899011879708911,-1.4503778913651189,0.06359649122807018,0.3243195509085239,1.0,6/15,12.06%,SLC8A1;CDH2;GSN;RYR2;PTK2;CTNNB1
prerank,cardiac conduction system development (GO:0003161),0.5894902766580759,1.4500758348983736,0.06712564543889846,0.8169020915623485,1.0,3/24,3.18%,NOTCH2;GJB6;BMPR1A
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.4496060871177844,-1.4493456331158585,0.03783783783783784,0.3254155325064653,1.0,21/48,17.82%,RHOJ;TMSB4X;NOS3;THBS1;HDAC7;HDAC9;AKT3;KDR;ANXA1;GATA2;TGFB1;PTGS2;FGF2;JCAD;HIF1A;PRKD1;VEGFA;SRPX2;NUS1;PIK3C2A;HSPB1
prerank,regulation of glucose metabolic process (GO:0010906),0.5404612944495893,1.4488343821289462,0.07512520868113523,0.818732737486047,1.0,8/34,13.91%,RORA;PRKN;RORC;SIRT1;SLC45A3;MLYCD;USP7;OGT
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6611824918536664,1.447902605816321,0.09325396825396826,0.8187883157523397,1.0,5/14,13.88%,TLR3;ANKRD17;DDX60;DHX58;TLR5
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.6123017263903485,-1.447700296574455,0.07974137931034483,0.32811160944289597,1.0,6/12,20.19%,JAG1;NOTCH1;HES1;N4BP2L2;NELFB;YTHDF2
prerank,positive regulation of interleukin-13 production (GO:0032736),0.7116951439927628,1.44677727413399,0.09961685823754789,0.8197735382786171,1.0,2/10,2.00%,PRKCZ;IL18
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.37425612227543437,-1.4463340115884398,0.004032258064516129,0.3299118766958377,1.0,31/124,14.09%,FRY;NLGN1;CNTNAP2;PTPRM;CNTN4;PLP1;CARMIL1;SH3GL2;TMEM108;GPM6B;LYN;GSK3B;STX3;LIMA1;APOE;APP;STMN2;PLEKHA1;ULK1;LGI1;MYOC;GPRIN3;RASGRF1;UHMK1;ARMC2;NCDN;MAP4;MAPT;ERCC6;GPM6A;CDK5R1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.4556836844913838,-1.4460668332617208,0.03759398496240601,0.3293316554412036,1.0,14/41,10.43%,SLC8A1;SLC24A2;RYR2;CACNA2D1;HTR2C;GRIN2B;RYR3;PTPRC;PLCG2;HTR2A;GRIN2A;FGF2;TRPV4;ATP2B4
prerank,apoptotic cell clearance (GO:0043277),-0.4910280765632151,-1.445766539581697,0.0611764705882353,0.3286894466567895,1.0,9/30,10.38%,RHOBTB1;XKR4;THBS1;SCARB1;GAS6;XKR6;ANXA1;RHOH;ITGB3
prerank,microvillus organization (GO:0032528),-0.6121459683223456,-1.445559738137511,0.0700218818380744,0.3279587468656192,1.0,6/13,9.64%,FXYD5;RAP1B;MINK1;RAP1A;RAPGEF6;RAP2A
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5677053774254514,1.445488945494094,0.06548672566371681,0.8218812443597457,1.0,7/30,9.55%,DAB2;DDX5;KLK2;NCOR2;SMARCA4;SIRT1;HDAC1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.6057626207078155,-1.4449792314163696,0.07021276595744681,0.32801507024509835,1.0,4/13,8.56%,PTPRT;PTPRC;HES1;MGAT5
prerank,anion transmembrane transport (GO:0098656),0.4972087310713635,1.4449519337504249,0.028315946348733235,0.8198613707181948,1.0,10/67,8.27%,SLC13A4;SLC13A3;SLC6A13;SLC16A12;SLC7A2;SFXN2;SLC6A9;SLC19A1;SLC27A1;SLC1A3
prerank,negative chemotaxis (GO:0050919),-0.4762964948041141,-1.44456481976925,0.041463414634146344,0.32781266193259867,1.0,14/33,12.46%,SLIT2;SEMA3C;UNC5C;SEMA6A;SEMA6D;SEMA7A;NTN1;SEMA3E;EPHA7;SEMA4D;PDGFA;ITGB3;SEMA3D;SEMA3G
prerank,regulation of viral entry into host cell (GO:0046596),-0.48642097954851304,-1.4435281394091104,0.060240963855421686,0.328990828064636,1.0,12/30,24.80%,GSN;HS3ST5;LY6E;MID2;TRIM14;TRIM27;IFITM3;CD74;TRIM68;LGALS9;IFITM1;IFITM2
prerank,negative regulation of leukocyte migration (GO:0002686),-0.6461958603240348,-1.4426602176012129,0.07894736842105263,0.32975090438465093,1.0,3/10,1.98%,SLIT2;BMP5;CD200
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5808935883230463,1.4424755015717363,0.08759124087591241,0.8276848415074148,1.0,3/22,1.85%,NOTCH2;STXBP4;FGFR2
prerank,mitochondrion distribution (GO:0048311),0.6711257935655353,1.4424275520112946,0.09551656920077972,0.8235277787483133,1.0,5/12,8.88%,TRAK1;LRRK2;CLUH;MEF2A;DNM1L
prerank,quinone biosynthetic process (GO:1901663),0.651104180947604,1.4413309564880064,0.10256410256410256,0.8245585299543765,1.0,7/14,14.80%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7
prerank,regulation of mitotic nuclear division (GO:0007088),0.5029496284583324,1.4407177675419578,0.049689440993788817,0.8231794795813555,1.0,8/55,6.37%,BMP7;IGF1;ANAPC15;OBSL1;TOM1L2;PHIP;CD28;PDGFRB
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6979748737441492,1.4403688483809696,0.09034907597535935,0.8206065699767344,1.0,5/10,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.4223973300760843,-1.439412502806865,0.023529411764705882,0.3357570599711265,1.0,23/59,11.40%,CADM1;PTPRM;ROBO2;HMCN1;CDH2;CDH13;PECAM1;KIRREL3;BSG;CNTN4;NPTN;TENM3;PTPRT;DSCAML1;IGSF11;CNTN6;ITGB1;ROBO4;EMB;CEACAM1;PKD1;PVR;CDH1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5543403834824869,1.4391998055323167,0.08465608465608465,0.8218217396323231,1.0,9/29,12.56%,LPGAT1;SORBS1;PPARA;ZBTB20;CREBL2;SLC27A1;SLC45A3;MLXIPL;SIRT4
prerank,organic hydroxy compound transport (GO:0015850),-0.46513735251787103,-1.4388824342149624,0.03674540682414698,0.3356703171841989,1.0,9/36,9.00%,ABCC4;ATP8B1;SLCO1C1;SLC16A1;SLCO2B1;NPC2;STRA6;CEACAM1;STARD5
prerank,triglyceride biosynthetic process (GO:0019432),0.6134606976313897,1.4387447328351637,0.09090909090909091,0.8198903812000626,1.0,4/18,7.27%,LPGAT1;MOGAT3;GPAT2;GK
prerank,negative regulation of nuclear division (GO:0051784),0.6848966855011664,1.4387333850862216,0.10486891385767791,0.8157285795740692,1.0,2/11,2.84%,BMP7;TOM1L2
prerank,phospholipid catabolic process (GO:0009395),-0.5150790548498929,-1.438373420667718,0.075,0.3354781760182972,1.0,6/24,11.86%,PLA2G4A;GPCPD1;ENPP6;GDPD1;ENPP2;SMPDL3A
prerank,ubiquinone biosynthetic process (GO:0006744),0.6355678158410737,1.4376356901472895,0.1036468330134357,0.8169352757233048,1.0,10/15,23.84%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7;NDUFA9;COQ9;COQ6
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.48578262118255167,1.4374833105912368,0.05082212257100149,0.8134442870616526,1.0,15/72,12.27%,FGF1;FGFBP1;FGFR2;KL;POLR2A;FRS2;FGFR1;HNRNPH1;FLRT1;TIA1;POLR2D;FIBP;GTF2F1;KLB;PTPN11
prerank,response to cadmium ion (GO:0046686),-0.510131294162262,-1.4371795235984524,0.05721393034825871,0.3370304928234938,1.0,16/26,32.29%,MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;MT3;MT2A;MAPK8;HSF1;FOS;MAPK3;JUN;NCF1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.579049688846634,1.4368136671296519,0.09090909090909091,0.8123463807373683,1.0,4/23,5.56%,TGFBR3;FGFR2;TPM1;ADAMTS9
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.5152287411239486,1.43513408422572,0.06678082191780822,0.8158053337422618,1.0,11/44,14.08%,PRKAG2;CYP27A1;ALOX12;INSIG2;AMACR;OSBPL9;TM7SF2;ACOT8;SRD5A2;LBR;PER2
prerank,xenobiotic transport (GO:0042908),-0.5555454472590002,-1.4349222658196024,0.07692307692307693,0.3411545277706886,1.0,3/17,3.07%,SLC47A1;ABCG2;SLC7A5
prerank,negative regulation of receptor binding (GO:1900121),-0.6408351296832259,-1.4348950726206835,0.06391752577319587,0.33997847532922326,1.0,4/10,9.27%,B2M;PTPRF;ADAM15;ATP2A3
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.43456310737123127,-1.432199953744829,0.01662049861495845,0.3449551153866298,1.0,16/55,10.87%,GPC5;GPC6;DCN;CEMIP;BGN;LUM;CSPG4;HSPG2;VCAN;SDC3;TGFB1;HEXB;FGF2;CD44;AGRN;GPC4
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6637340369628555,1.4321911645679266,0.10526315789473684,0.8260090806703961,1.0,7/12,16.15%,DAB2;NCOR2;SMARCA4;SIRT1;HDAC1;NCOR1;NODAL
prerank,cellular response to cadmium ion (GO:0071276),-0.5241667636030066,-1.431872891460168,0.06205250596658711,0.344521636986702,1.0,16/24,32.29%,MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;MT3;MT2A;MAPK8;HSF1;FOS;MAPK3;JUN;NCF1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4705341827169393,-1.4317510477999567,0.047619047619047616,0.3435759663262024,1.0,10/33,7.53%,SLIT2;PTPRM;PTPRG;DCN;THBS1;EVL;ACVRL1;DAB2IP;APOE;CORO1C
prerank,ERBB2 signaling pathway (GO:0038128),-0.47902206061105523,-1.4308484396197119,0.03970223325062035,0.34435820109506565,1.0,9/31,10.34%,ERBB4;PIK3R1;PTPN12;GAB1;NRG2;MYOC;ERBIN;ERBB2;HSP90AA1
prerank,regulation of secretion by cell (GO:1903530),-0.42997705202751335,-1.4301284569181394,0.043731778425655975,0.34471168238241673,1.0,11/54,9.50%,MEF2C;SYT1;RIMS2;MCTP1;RIMS1;STXBP5L;RAB3C;ANXA1;DNAJC1;DISP1;NSF
prerank,monocarboxylic acid metabolic process (GO:0032787),0.4461035971730278,1.4268204716207686,0.045133991537376586,0.8483327904196969,1.0,29/117,15.29%,ALDH1A2;ME2;IGF1;PCCA;PPARA;ECHDC3;ALOX12;LDHB;ACADSB;CPT1A;GPAT2;ACSBG2;ALDH4A1;CYP26B1;AMACR;NAAA;GOT2;SCPEP1;DLD;ACOT11;MCCC1;MECR;AASDH;ABAT;HLCS;PER2;THEM4;DLAT;GPAM
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5923739059416968,-1.4267434653537823,0.09545454545454546,0.35096102867554124,1.0,5/13,17.93%,NOS3;CYP1B1;GCH1;NOS1;CYB5R3
prerank,regulation of endothelial cell migration (GO:0010594),-0.39230947449343406,-1.4265676060489723,0.015873015873015872,0.3500829290044322,1.0,35/85,13.86%,NRP1;SLIT2;PTPRM;TEK;BMPER;RHOJ;BMPR2;DCN;THBS1;NRP2;PTK2B;SCARB1;ACVRL1;KDR;GPI;DAB2IP;FOXP1;APOE;RHOB;PTK2;PROX1;CALR;ATOH8;PTN;CEACAM1;FGF2;FLT4;BCAR1;ITGB3;EDN1;BMP4;EMP2;PRKD1;VEGFA;ADGRB1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5378245171473914,-1.4263510130204657,0.06744186046511629,0.3493456692365207,1.0,8/20,15.41%,KCNB2;CAV1;PLCE1;CHRM3;CHRM2;ATP2B1;MYOCD;NMU
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4720754084896804,-1.426196239674348,0.05188679245283019,0.3484755253843325,1.0,13/35,18.37%,HEG1;TGFB2;RASIP1;DAB2IP;MET;KCTD10;EPHB2;MYOC;CUL3;SPRY1;STMN1;KANK1;SPRY4
prerank,regulation of insulin secretion (GO:0050796),0.45653794587247204,1.426137912279779,0.04269972451790634,0.8475759211249627,1.0,20/101,9.99%,NNAT;ADCY5;CACNA1D;ITPR2;ITPR1;STXBP4;KCNA5;PRKN;NLGN2;MCU;ADRA2A;RAPGEF3;DPP4;CACNA1C;GCK;RBP4;EIPR1;MIDN;PICK1;TCF7L2
prerank,protein localization to synapse (GO:0035418),-0.6124226731625356,-1.4260565484216168,0.09787234042553192,0.34764028431127636,1.0,5/12,13.89%,NLGN1;NRXN1;PCLO;NRXN2;SHANK1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5631676767206757,-1.4259584978218307,0.078125,0.3466845515676113,1.0,10/17,31.48%,NLGN1;CACNA1G;RAB27A;KCNB1;CACNA1H;SYT10;DOC2B;STX1A;RAB3A;SCAMP5
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.4059731680767389,-1.4254210232414173,0.0473186119873817,0.34669831138469537,1.0,31/70,34.29%,B2M;PSMB2;MFSD6;CALR;PSMD14;PDIA3;NCF2;PSMC6;CYBA;IKBKB;PSMA4;PSMB9;TAP1;PSMD11;PSMB10;PSMD2;CYBB;PSMA2;PSMB3;SNAP23;PSMB5;PSMA7;CD36;FCGR1A;PSMF1;PSMD7;SEC22B;NCF1;PSMA5;PSMD4;PSME4
prerank,response to nitric oxide (GO:0071731),-0.5892393829598636,-1.4252375457029662,0.09166666666666666,0.34593488585341264,1.0,9/13,32.65%,KCNC2;GUCY1B1;FOXO1;TXN;MT3;CCL19;MMP3;AQP1;DPEP1
prerank,ribosomal large subunit assembly (GO:0000027),-0.5087317503310399,-1.4250885503053001,0.07556675062972293,0.34510523917874186,1.0,16/24,28.66%,RPL3;RPLP0;RPL5;RPL23A;RPL6;MDN1;NOP53;BRIX1;MRPL20;RPL24;RPL11;RSL24D1;RRS1;DDX28;FASTKD2;RPL10
prerank,protein localization to cilium (GO:0061512),0.5493927376601005,1.4249714225502612,0.08571428571428572,0.8490115788615625,1.0,10/32,15.70%,TULP3;ZNF423;IFT122;WDR19;INVS;ATP6V1D;ROPN1;WDR35;RAB29;ARL6
prerank,BMP signaling pathway (GO:0030509),0.4872662994853242,1.4245666457552255,0.06515151515151515,0.8469466817294411,1.0,9/62,5.75%,TGFBR3;BMP6;BMP7;SMAD3;DDX5;BMPR1A;SMAD6;RGMB;USP9X
prerank,acylglycerol homeostasis (GO:0055090),0.588634289687515,1.4242030535030457,0.10120068610634649,0.8446003486685737,1.0,5/20,12.36%,RORA;IL18;ANGPTL8;PLA2G12B;MLXIPL
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.6332281702425567,-1.4238000325962823,0.08879492600422834,0.3468208448363727,1.0,5/10,8.45%,CST3;FAP;NOTCH1;TNFRSF1B;TGFB1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.6364916520279934,-1.4228472327424155,0.07170542635658915,0.34774503231992593,1.0,5/10,20.78%,GALNT13;GALNT16;GALNT2;MGAT5B;POGLUT1
prerank,hepaticobiliary system development (GO:0061008),0.5839844585375109,1.4224845867009905,0.11531531531531532,0.8487220059304719,1.0,6/20,13.89%,TGFBR3;WNT4;NIPBL;CDK5RAP3;PHF2;PRKCSH
prerank,GTP metabolic process (GO:0046039),0.6413358697004499,1.422438582219779,0.09596928982725528,0.8448540674218087,1.0,5/15,9.47%,RHOQ;LRRK2;OPA1;AK4;AK3
prerank,epithelial to mesenchymal transition (GO:0001837),0.5167179900977229,1.421811347721509,0.05521472392638037,0.8438200522082573,1.0,8/47,4.57%,TGFBR3;BMP7;ROCK2;WNT4;DDX5;FGFR1;TGFBR1;LOXL3
prerank,synaptic vesicle localization (GO:0097479),-0.5873136448521087,-1.4207229816440534,0.07142857142857142,0.35150016713350046,1.0,5/13,13.26%,NLGN1;SYNDIG1;RAB27A;KIF5C;TMEM230
prerank,neurotransmitter uptake (GO:0001504),0.6533657853796344,1.4203393294765985,0.1111111111111111,0.8465776762643279,1.0,4/12,9.52%,ATP1A2;SLC38A1;SLC1A3;GLUL
prerank,cellular biogenic amine catabolic process (GO:0042402),0.684282704795553,1.420145773018389,0.11641221374045801,0.8434886704313683,1.0,4/10,8.51%,ALDH7A1;HNMT;SMOX;LRTOMT
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.6404760891130142,-1.4197350205813961,0.08456659619450317,0.35261740010614495,1.0,5/10,14.58%,HSP90AB1;SORL1;EGR1;HSP90AA1;CLU
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5950871352741199,1.4196535418319063,0.09983079526226735,0.8418485959304352,1.0,4/20,3.91%,DAB2;PICALM;RHOQ;PPFIA1
prerank,lipid translocation (GO:0034204),-0.5350926310973929,-1.4191253700195665,0.08076009501187649,0.352758536277725,1.0,9/21,14.29%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;TMEM30A;ATP8B2;ABCB4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5607581487065723,1.4188786229817203,0.09624796084828711,0.8412677048766241,1.0,5/27,7.34%,C1QTNF3;SYT11;TLR4;ARRB1;PTPN22
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.625194236438103,-1.418846324224081,0.06694560669456066,0.3521816345527027,1.0,6/11,21.86%,MERTK;CXCL12;GAS6;NOD2;CCL19;HCLS1
prerank,regulation of neuron differentiation (GO:0045664),-0.39176950275830796,-1.4182961099756548,0.02727272727272727,0.3523267638222549,1.0,22/76,10.06%,NLGN1;MEF2C;ZFHX3;BRINP3;CNTN4;BRINP1;NGF;VWC2;ARHGEF2;TIAM1;BEND6;HES1;NRCAM;YWHAG;HEYL;BIN1;BMP2;SIX1;CALR;BRINP2;ID2;CDK5RAP2
prerank,steroid biosynthetic process (GO:0006694),0.4886481943539084,1.418248630559978,0.06466876971608833,0.8402795294917103,1.0,8/56,6.67%,PRKAG2;CYP27A1;INSIG2;CYP21A2;AMACR;FDXR;OSBPL9;DHRS11
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.6126353908506745,-1.41824452623044,0.0899581589958159,0.3512859459352055,1.0,7/11,32.88%,GPX1;CAT;PRDX1;GPX3;PRDX2;PRDX4;PRDX3
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.40184832651740304,-1.4175891773858507,0.027777777777777776,0.3515716065132472,1.0,22/75,10.92%,CTNNA2;MEF2C;MAP1B;ANK3;KLF7;ACTB;CNTN4;DCC;PAK3;NTNG1;S100A6;DSCAML1;SHTN1;MINK1;APP;NRCAM;BTBD3;MAP6;S100B;SLITRK1;PLPPR4;MFSD2A
prerank,positive regulation of metabolic process (GO:0009893),0.4481118949404545,1.417469005667441,0.03905160390516039,0.8398920424326253,1.0,7/103,2.00%,EPAS1;ACSL1;PPARGC1B;APPL2;LEPR;PPARGC1A;IL18
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6253947874689952,1.4172425983503762,0.11090573012939002,0.8371356184733458,1.0,6/15,15.80%,PRODH;ALDH4A1;GGACT;GOT2;ABHD12;SARDH
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.4652459910264592,-1.4169364460358682,0.05,0.35188992341023206,1.0,12/39,9.38%,UTRN;FGF14;HECW2;FGF12;ANK3;HECW1;CAMK2D;FXYD5;NEDD4L;WNK2;NETO1;FGF13
prerank,fibrinolysis (GO:0042730),0.6433751122041975,1.4168008564791807,0.13503649635036497,0.8355811246454161,1.0,5/13,15.65%,KRT1;F2;SERPINE1;HRG;PLAT
prerank,establishment of endothelial barrier (GO:0061028),-0.47872587096172275,-1.415851874842723,0.07425742574257425,0.35325569987126915,1.0,13/29,12.21%,PDE4D;PECAM1;PPP1R16B;F11R;RAP1B;ICAM1;RAP1A;ROBO4;RDX;RAPGEF6;PDE2A;MSN;SOX18
prerank,protein autoubiquitination (GO:0051865),0.4875477990184543,1.4149672587779087,0.06567164179104477,0.8408256821898924,1.0,16/61,16.33%,RNF220;SH3RF2;PRKN;RNF213;RNF181;RNF8;RNF141;SH3RF1;RNF41;RNF13;WWP2;DDB2;RNF115;AMFR;RNF146;RNF19B
prerank,early endosome to late endosome transport (GO:0045022),0.5983176548327739,1.4141385853399606,0.09549549549549549,0.8408283492119433,1.0,14/20,25.11%,HOOK2;PTPN23;BECN1;ANKRD27;SNF8;HOOK3;EEA1;WDR91;WDR81;RAB7A;HOOK1;RILP;PIK3C3;KIF16B
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.6331844208009709,1.4139566876375886,0.10085470085470086,0.8377873794255472,1.0,3/16,2.62%,FGF1;NPNT;FOXD1
prerank,T cell differentiation (GO:0030217),0.5178016610171042,1.413366993068626,0.06543624161073826,0.8365393191048685,1.0,11/40,12.63%,LEPR;KIT;GLI3;NHEJ1;CD28;PTPN22;CHD7;TCF7;SOX13;ADAM17;LMBR1L
prerank,cellular metal ion homeostasis (GO:0006875),0.44533048513035967,1.4129709498905385,0.04316546762589928,0.8345508044688312,1.0,11/102,3.58%,ATP1A2;ATP13A5;SLC24A3;SLC41A1;ATP1B3;ANK2;ATP13A3;SLC8A3;PKHD1;CSRP3;DMPK
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.6188457201440225,-1.4127294098372838,0.08921161825726141,0.3589720364496721,1.0,3/11,5.42%,MEF2C;LYN;ANXA1
prerank,myoblast differentiation (GO:0045445),0.6510379616177366,1.4125147351799348,0.12154696132596685,0.8330066985431166,1.0,3/14,1.44%,EPAS1;DDX5;IGF1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.67901150926958,1.4123085207440895,0.10420841683366733,0.8301943634039213,1.0,5/10,18.90%,ADRA2A;HBEGF;ADAM17;TGFA;BTC
prerank,peptidyl-lysine acetylation (GO:0018394),0.6753468808851766,1.410194091769505,0.11173184357541899,0.8366007128139751,1.0,7/10,23.60%,SIRT1;KAT7;KAT2B;CREBBP;EP300;ESCO1;BAG6
prerank,regulation of TOR signaling (GO:0032006),0.479149303863543,1.4100909999518794,0.06309148264984227,0.8333681551309488,1.0,31/67,24.28%,PRKAA2;FNIP1;PKHD1;NPRL3;DEPTOR;NPRL2;UBR2;RICTOR;PIK3CA;SIRT1;ARAF;ROS1;DEPDC5;FLCN;TSC1;WDR24;RPTOR;TMEM127;UBR1;TELO2;RRAGD;TBC1D7;LAMTOR1;ITFG2;TSC2;GSK3A;DYRK3;TBCK;RRAGB;SLC38A9;DGKQ
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4642750197519145,-1.4100745322908648,0.06217616580310881,0.36379666900873914,1.0,10/36,10.69%,RHOBTB1;XKR4;GSN;THBS1;XKR6;MYH9;DOCK1;ARHGAP25;RHOH;ELMO1
prerank,amyloid-beta metabolic process (GO:0050435),0.6110618675030536,1.4096001939064047,0.09523809523809523,0.8318823989980798,1.0,5/16,10.70%,ACE;BACE2;MGAT3;APH1B;DYRK1A
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.4052260183424816,-1.4089599853474144,0.050793650793650794,0.36519601421784137,1.0,30/67,34.29%,B2M;PSMB2;CALR;PSMD14;PDIA3;NCF2;PSMC6;CYBA;IKBKB;PSMA4;PSMB9;TAP1;PSMD11;PSMB10;PSMD2;CYBB;PSMA2;PSMB3;SNAP23;PSMB5;PSMA7;CD36;FCGR1A;PSMF1;PSMD7;SEC22B;NCF1;PSMA5;PSMD4;PSME4
prerank,regulation of lipid metabolic process (GO:0019216),0.4598173787499543,1.4086215542773513,0.04073033707865169,0.8326563728785978,1.0,15/88,8.29%,PRKAG2;RORA;NFYC;PPARA;CHD9;NCOR2;NFYB;GPS2;C1QTNF2;TBL1X;RORC;SMARCD3;ANGPTL8;NR1D2;TBL1XR1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.4232763349397439,-1.4082313005102354,0.03529411764705882,0.3657507391782775,1.0,19/54,18.09%,MEF2C;TMSB4X;NOS3;THBS1;ACVRL1;AKT3;KDR;APOE;GATA2;TGFB1;FGF2;ATP2B4;HIF1A;PRKD1;VEGFA;NUS1;ANGPT2;HSPB1;RGCC
prerank,regulation of protein dephosphorylation (GO:0035304),-0.4510368484828207,-1.4080891771340562,0.05093833780160858,0.3648730385602339,1.0,11/37,10.44%,PPP1R16B;PPP2R5A;PPIA;YWHAB;CALM1;CALM2;CAMTA1;TGFB1;PPP1R16A;MFHAS1;CALM3
prerank,regulation of protein neddylation (GO:2000434),0.7057403365587229,1.4067245894989997,0.1042830540037244,0.8378926612467821,1.0,1/10,0.14%,EPAS1
prerank,organonitrogen compound catabolic process (GO:1901565),0.48175924106386087,1.4066906130932724,0.06976744186046512,0.8343568731137809,1.0,13/57,9.82%,ACE;CPQ;RENBP;NPL;NAALADL1;GGACT;TPP1;CLPX;CLN6;PLA2G6;NPEPPS;CTH;GNPDA1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5149841368069827,-1.4061158204531559,0.07399103139013453,0.3683717387144376,1.0,3/22,0.98%,PDE4B;CACNB2;AHNAK
prerank,positive regulation of hormone secretion (GO:0046887),0.5995471511178259,1.405243840778834,0.10377358490566038,0.8374908193623098,1.0,2/17,2.52%,C1QTNF3;SPP1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.6065310355626492,1.4051946192620257,0.10795454545454546,0.834092046640643,1.0,7/18,15.23%,DAB2;EZR;PTPN23;SNX12;MAP2K1;MAP2K2;RAB21
prerank,neuron projection morphogenesis (GO:0048812),-0.35850767886528123,-1.4049452980257073,0.003875968992248062,0.3698295258575851,1.0,37/137,10.21%,NLGN1;CNTNAP2;CTNND2;CTNNA2;DCLK1;DOCK10;MAP1B;ANK3;SHANK3;KLF7;ACTB;EPHB1;CNTN4;DCC;NYAP2;IQGAP1;PAK3;EPB41L3;NGF;NTNG1;S100A6;TRIO;DSCAML1;NRK;SHTN1;DAB2IP;MINK1;PAK1;APP;NRCAM;EPHB2;SLC9A6;BTBD3;MAP6;S100B;SLITRK1;PLPPR4
prerank,regulation of plasminogen activation (GO:0010755),-0.5957962057318608,-1.4048485962555095,0.11133603238866396,0.36887345436563307,1.0,3/12,3.67%,SERPINE2;THBS1;RUNX1
prerank,regulation of heart contraction (GO:0008016),0.4537169803566518,1.4046922925864433,0.04492753623188406,0.8330372131303798,1.0,13/90,6.24%,ATP1A2;CELF2;ATP1B3;ANK2;CORIN;ITPR2;ITPR1;NPR1;SLC8A3;DMPK;TPM1;NPR2;AHCYL1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6405558455861874,-1.4042568577960604,0.08982035928143713,0.36906676969496877,1.0,5/10,10.44%,PDE4B;CACNB2;CACNA2D1;CALM1;CALM3
prerank,cellular response to interleukin-6 (GO:0071354),-0.4800410805051135,-1.403784381150596,0.07398568019093078,0.368858960457455,1.0,9/26,11.88%,PID1;PTPRT;ST18;STAT3;PTGIS;IL6ST;ST3GAL6;JAK1;SBNO2
prerank,striated muscle contraction (GO:0006941),0.48103208664923636,1.4033560510123992,0.05972434915773354,0.8355643331857983,1.0,11/53,9.18%,ATP1A2;CSRP3;RCSD1;PGAM2;DTNA;TPM1;KLHL41;ARHGEF11;CCDC78;PIK3CA;MYL4
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.5468729028071946,-1.4023398386581383,0.08225108225108226,0.3712370218433269,1.0,7/18,14.08%,NAV3;CD34;HDAC7;PTPRC;TRIM27;HAVCR2;LAPTM5
prerank,activin receptor signaling pathway (GO:0032924),0.6265449990924173,1.401882205211073,0.11275415896487985,0.8388704109287319,1.0,2/15,3.46%,SMAD3;TGFBR1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4000095016082884,-1.4017918050228784,0.029411764705882353,0.3713879933851441,1.0,20/67,10.69%,NRP1;PIK3R1;VEGFC;NRP2;NCK2;PTK2B;DOCK1;KDR;CLEC14A;DAB2IP;CRK;PTK2;ABI1;NCF2;FLT4;HSP90AA1;BCAR1;ITGB3;CYBA;ELMO1
prerank,T cell migration (GO:0072678),-0.5827679126047535,-1.4007752381905174,0.08559498956158663,0.3725911355317368,1.0,7/13,29.86%,SLC12A2;S1PR1;CXCL16;MSN;CXCL10;PIK3CD;MYO1G
prerank,regulation of urine volume (GO:0035809),0.6761612042006871,1.4007094910873847,0.13255360623781676,0.8408085595927012,1.0,4/10,13.47%,NPR1;NPR3;ADM;ADCY6
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.38047084426709116,1.399918346595935,0.0010604453870625664,0.8408642903677632,1.0,116/572,14.62%,PRDM6;AEBP1;DAB2;WWOX;BMP6;THRB;SMAD3;GLIS3;OSR1;FHL2;DDX5;MXI1;CUX1;DLG1;PPARA;FGFR2;PRKN;FOXP4;DNMT3A;GLI2;FNIP1;KANK2;ZHX2;ZNF568;MOSPD1;HDAC8;NR2F2;KCNIP3;NCOR2;CTR9;NR6A1;GLI3;MITF;SUFU;CXXC5;FOXC1;PHF21A;NFIB;NEDD4;PCGF2;IFI27;NACC2;EZR;FOXP2;CUX2;RREB1;NSD1;WWC2;OTP;MAP2K5;GPS2;USP9X;ATRX;LCOR;TP53;TBL1X;BHLHE41;SMURF2;RORC;NIPBL;LDB1;LDB2;BCOR;CBX7;MEF2A;KDM2B;SMARCA4;NR1D2;SPEN;TBL1XR1;CPEB3;NUPR2;IRX1;PARP9;HDAC4;SIRT1;NR2C2;HDAC1;SOX13;LARP7;ZFP90;FOXC2;TCF7L2;ZNF219;ATN1;AURKB;PRDM5;AASS;RTF1;NFATC3;RARG;MNT;WWP2;IMPACT;ZBTB1;SKOR1;CBX5;DICER1;ZNF148;DEAF1;ZMYM5;FRK;KMT5A;BEND3;SIN3A;CBX6;NCOR1;ZBTB32;SNAI1;PER2;FLCN;ACVR2B;GADD45A;ZKSCAN3;MIER3;HOXA7
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.434181087770713,-1.399804037756728,0.052770448548812667,0.37362552178243685,1.0,12/45,10.35%,RPS6KA5;PIK3R1;REPS2;PLCE1;IQGAP1;NCK2;GAB1;PTK2B;TGFB1;PTK2;ERBIN;BCAR1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5319678550809613,1.3996442885998643,0.09228187919463088,0.8385399837887056,1.0,8/29,16.39%,SMAD3;ZC3H7B;SNIP1;HNRNPA2B1;TUT4;DICER1;PUS10;TUT7
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.6068659526743407,-1.3990248533516014,0.09341825902335456,0.3742827536194502,1.0,4/12,10.79%,TMEFF2;AR;TGFB1;EDN1
prerank,Rac protein signal transduction (GO:0016601),-0.5369408359978751,-1.398724361801623,0.08986175115207373,0.37385333534504217,1.0,8/18,19.46%,CDH13;TIAM1;RHOH;EPS8;ELMO1;HACE1;WASF1;NCKAP1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5878511912611526,1.39859244745298,0.08695652173913043,0.8398504397415686,1.0,4/20,3.91%,DAB2;PICALM;RHOQ;PPFIA1
prerank,lamellipodium assembly (GO:0030032),-0.4834960020059443,-1.398483698960512,0.07913669064748201,0.37311029526645967,1.0,14/26,13.12%,CDH13;ABLIM1;PARVB;CARMIL1;SPATA13;CCDC88A;ARHGEF7;ABLIM3;ITGB1;S1PR1;P2RY12;ABLIM2;SPEF1;DMTN
prerank,transcription by RNA polymerase II (GO:0006366),0.3983660297570575,1.3982851407233654,0.010638297872340425,0.8376832568209428,1.0,71/305,16.37%,NOTCH2;RORA;MAF;THRB;GLIS3;DDX5;PPARGC1A;CCN2;PPARA;POLR2A;SOX5;NCOR2;CTR9;ELOF1;NR6A1;DTX1;PABPN1;ATOH1;RREB1;TTF2;PHAX;AFF4;ESRRA;TEAD3;TBL1X;WWTR1;RORC;TSC22D1;CCNT2;RPRD2;POLR2D;NR1D2;TBL1XR1;TEAD2;TFDP1;NR2C2;HDAC1;ELL;GTF2A1L;MED17;INTS10;GTF2F1;SCAF8;RTF1;RARG;MNT;ZBTB1;NOCT;TEAD1;NELFCD;TAF11;INTS2;DEAF1;NR3C2;INTS5;TBP;TAF4;NCOR1;PMF1;KAT2B;CTDP1;INTS3;NFKB1;TAF7;MED23;RXRA;TAF13;CPSF3;CREBBP;MED26;GTF2I
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5883914659849124,-1.3982368740136362,0.1101511879049676,0.37257660981895185,1.0,3/12,6.89%,MBNL1;TGFB2;PTCH1
prerank,cellular response to BMP stimulus (GO:0071773),0.47371250954782923,1.3974308505430852,0.06518518518518518,0.8378678115556742,1.0,9/66,5.75%,TGFBR3;BMP6;BMP7;SMAD3;DDX5;BMPR1A;SMAD6;RGMB;USP9X
prerank,aminoglycan catabolic process (GO:0006026),-0.4809551926364095,-1.3973957937178998,0.07862407862407862,0.37341694620253324,1.0,6/28,10.87%,GPC5;GPC6;HSPG2;SDC3;AGRN;GPC4
prerank,inorganic cation transmembrane transport (GO:0098662),0.39730089973282007,1.396600736580745,0.017793594306049824,0.8381229487136522,1.0,31/268,8.65%,TRPM3;ATP1A2;SLC6A13;KCNK2;SLC6A1;CACNA1D;SLC24A3;SLC41A1;SLC6A12;ATP1B3;TRPM6;KCND3;KCNA5;LRRC38;SLC8A3;SLC30A10;ATP6V0E1;SLC30A2;CACNA1C;SLC6A9;KCNS1;P2RX3;ATP4A;CCDC51;TRPM5;ANO6;KCNH4;SLC39A13;SLC1A3;SLC6A4;KCNJ14
prerank,peptide metabolic process (GO:0006518),0.4658722606182626,1.3964095355033874,0.04512372634643377,0.835574944688176,1.0,11/75,10.03%,AEBP1;ACE;CPQ;BACE2;GSTT1;MGAT3;NAALADL1;TPP1;CTNS;NPEPPS;GSTA3
prerank,ephrin receptor signaling pathway (GO:0048013),-0.38339737908787175,-1.3960300249790265,0.030821917808219176,0.37549593483447125,1.0,31/82,14.09%,ARHGEF28;ACTB;EPHB1;EPHA5;GRIN2B;EFNA5;EPHA6;PAK3;NCK2;CHN1;ACTG1;ARHGEF7;LYN;ACTR2;TIAM1;PAK1;EPHA7;PSEN1;CRK;DNM1;EPHB2;ANKS1B;PTK2;AP2B1;ACTR3;AP2M1;ARPC1B;RASA1;ARPC5;ARPC4;CDK5R1
prerank,histone H3-K9 demethylation (GO:0033169),0.6483544351726933,1.3958963436695682,0.11195445920303605,0.8345698776270115,1.0,3/11,11.87%,KDM7A;HR;KDM3B
prerank,negative regulation of histone methylation (GO:0031061),0.6772177549822854,1.3949512220656066,0.13813229571984437,0.8353854906103082,1.0,5/10,17.73%,JARID2;BCOR;AASS;PHF1;KDM1A
prerank,positive regulation of neuron projection development (GO:0010976),-0.3920106527305531,-1.3936079689292762,0.02364864864864865,0.3801098828068858,1.0,33/85,16.18%,BMP5;NTRK3;ITGA6;ROR1;LRRC7;NPTN;TENM3;RIT2;PTK2B;TOX;FUT9;NDNF;SERPINI1;NTRK2;LYN;ROR2;DAB2IP;RAP1A;APOE;STMN2;RELN;PTN;SCARF1;PLPPR5;MARK2;VLDLR;LRP8;PRKD1;RET;FES;COBL;BDNF;PACSIN1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6167262184099851,1.3935337199128535,0.10954063604240283,0.8384092626787438,1.0,5/15,9.55%,WNT6;GLI2;FOXC1;EDA;HDAC1
prerank,melanosome organization (GO:0032438),0.5563968535387872,1.3932948721825587,0.10469314079422383,0.8361018609394225,1.0,12/26,24.27%,SHROOM2;DTNBP1;PIKFYVE;BLOC1S6;HPS1;BLOC1S2;RAB29;KIF13A;AP1M1;SNAPIN;LYST;HPS4
prerank,fatty acid beta-oxidation (GO:0006635),0.49226437778607673,1.3929334340170354,0.08841463414634146,0.8343839272569474,1.0,23/51,20.45%,IVD;ACAD11;AMACR;ACAD10;BDH2;CPT2;ACADM;ACOXL;MECR;CRAT;ACOT8;GCDH;ACOX3;ECHDC1;DECR1;EHHADH;SLC25A17;ECI2;ETFDH;CROT;ACADS;HADHA;HADH
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.6055349177921897,-1.3927840142074555,0.09071274298056156,0.38087791620166106,1.0,5/12,6.58%,PODXL;IQGAP1;PROM1;JAG1;BASP1
prerank,homocysteine metabolic process (GO:0050667),0.6402884652715015,1.3922160208189227,0.14666666666666667,0.8343111287436006,1.0,5/11,12.38%,CPS1;MTHFR;CTH;NOX4;MTRR
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5466285197834966,-1.3920918455436644,0.08478260869565217,0.3813243702060077,1.0,8/17,21.84%,PODXL;TGFB2;PIEZO1;P2RY12;RET;SKAP1;SYK;RAC3
prerank,tRNA wobble base modification (GO:0002097),0.6141947949134238,1.3912919568368394,0.12571428571428572,0.8350570571025074,1.0,1/14,0.80%,TRMT9B
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6064349770555804,-1.3910076405928442,0.09349593495934959,0.3827830514403477,1.0,7/10,28.27%,APOE;TMEM30A;ABCB4;TRIAP1;PRELID1;ABCA3;DBI
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.6135636950647384,-1.3898614688311834,0.10101010101010101,0.383044196142041,1.0,5/11,20.08%,PTK2B;STAT5B;JAK1;SYK;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),-0.6135636950647384,-1.3898614688311834,0.10101010101010101,0.383044196142041,1.0,5/11,20.08%,PTK2B;STAT5B;JAK1;SYK;SHC1
prerank,microvillus assembly (GO:0030033),-0.574002709421815,-1.3888013430548551,0.09409190371991247,0.3844308566197382,1.0,6/14,9.64%,FXYD5;RAP1B;MINK1;RAP1A;RAPGEF6;RAP2A
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6026909324235862,1.3887462790967948,0.13464991023339318,0.8432426750019841,1.0,3/20,3.46%,EPAS1;PRKN;TGFBR1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.39152140859278683,-1.3884589065908053,0.040268456375838924,0.38414420159922935,1.0,24/79,14.15%,SLIT2;BMPER;BMPR2;THBS1;HTRA3;CASK;VWC2;NOTCH1;VWC2L;EPN2;DAB2IP;SMAD5;SORL1;SMAD1;BMP2;SMAD7;FGF2;ATP2B4;CREB3L1;LEMD3;UBE2D3;SPRY1;BMPR1B;SMURF1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6156126092263253,-1.3882199866661704,0.08459869848156182,0.38240986299240115,1.0,6/11,21.42%,CALM1;CALM2;CALM3;FKBP1A;CASQ2;GSTM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6156126092263253,-1.3882199866661704,0.08459869848156182,0.38240986299240115,1.0,6/11,21.42%,CALM1;CALM2;CALM3;FKBP1A;CASQ2;GSTM2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5772555017179725,1.3880385471296361,0.12411347517730496,0.8431699328619144,1.0,4/20,2.07%,ROCK2;RHOQ;DLG1;FHOD1
prerank,extracellular matrix organization (GO:0030198),-0.3273833628024488,-1.3879212936378644,0.0,0.381934825675285,1.0,75/276,10.42%,COL8A1;FLRT2;VWF;ELN;COL25A1;LAMA1;COL12A1;TLL1;PECAM1;ADAMTSL3;ITGA6;SH3PXD2A;BSG;GSN;SPOCK2;COL6A3;COL4A1;ADAMTSL1;MFAP5;DCN;THBS1;COL15A1;FN1;ADAMTS5;TGFB2;LAMC3;COL6A1;VIT;VCAM1;COL4A2;DST;LAMA2;COL6A2;NDNF;F11R;GAS6;CYP1B1;ADAMTS17;BGN;FBN2;ITGB4;COLGALT2;GPM6B;COL14A1;KDR;LUM;COL23A1;ICAM1;ITGB8;APP;ADAMTS3;JAM2;TIMP2;ITGB1;ADAM15;COL8A2;TGFBI;HSPG2;VCAN;LAMA3;ITGA4;PPIB;ADAMTS6;MMP16;DPT;TGFB1;TNR;FGF2;CD47;ITGA8;CD44;CAPN2;PDGFA;ITGB3;AGRN
prerank,heart morphogenesis (GO:0003007),-0.42409209492583616,-1.3871134286020192,0.05507246376811594,0.38272468022282785,1.0,18/50,13.77%,FLRT2;ENG;NOS3;RYR2;TGFB2;TBX3;ACVRL1;NOTCH1;TBX1;SOX17;HES1;HEYL;BMP2;PTK2;HEY2;FKBP1A;ACVR1;VEGFA
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5950010567414945,-1.3862010027774057,0.11205073995771671,0.383609315905999,1.0,4/12,10.81%,SLIT2;BMP5;CCN3;DUSP1
prerank,respiratory tube development (GO:0030323),0.545492161070151,1.3861207449575668,0.11054421768707483,0.848840583019086,1.0,6/28,7.53%,FGF1;FGFR2;GLI2;PDPN;LOXL3;RBP4
prerank,endothelial cell development (GO:0001885),-0.4952963330102353,-1.3860921693426873,0.07906976744186046,0.3826950253969448,1.0,13/25,12.21%,PDE4D;PECAM1;COL15A1;PPP1R16B;RAP1B;ICAM1;RAP1A;MET;ROBO4;RDX;PDE2A;MSN;SOX18
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6495437151704729,1.3856611906528222,0.13653846153846153,0.847624331708919,1.0,3/11,9.72%,COLEC12;TLR3;RIPK1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4180979958020525,1.3854441862008073,0.03911342894393742,0.8451368218927745,1.0,20/152,8.64%,RNF220;WNT5B;LRRK1;LGR4;RSPO2;WLS;PTK7;FGFR2;LRRK2;SULF2;DDX3X;CAPRIN2;TBL1X;SMURF2;SMARCA4;TNKS2;ADGRA2;TBL1XR1;TERT;GPRC5B
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3801673407247148,-1.3850164012517507,0.026022304832713755,0.38410278221968047,1.0,36/94,29.52%,RPS6KA5;IL1R1;IL1RAP;ST18;NOD1;NFKBIA;PSMB2;MAP3K7;IRAK3;PSMD14;EGR1;PSMC6;IKBKB;UBB;PSMA4;PSMB9;PELI1;NOD2;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;UBC;RPS27A;RELA;PSMB3;TAB1;PSMB5;PSMA7;MAP3K8;IRAK4;MAPK3;PSMF1;TOLLIP;PSMD7
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5116326481178762,-1.384939476400129,0.09490740740740741,0.38316158488832797,1.0,11/20,26.52%,GSN;THBS1;SFRP4;ITGA4;GPER1;ECSCR;PDCD4;RGCC;CD40;PLCG1;CCL2
prerank,regulation of T cell chemotaxis (GO:0010819),0.6519771325238676,1.3846383865551133,0.1359026369168357,0.8455802148696693,1.0,5/11,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5883645930401205,-1.3846206772026377,0.10337972166998012,0.3827632802977758,1.0,5/12,10.43%,SEMA6A;DCN;DAB2IP;XDH;ATP2B4
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6568803478379556,1.3842564016067425,0.1316270566727605,0.8439159121271083,1.0,3/12,6.47%,IL18;IL17D;IL12B
prerank,protein K63-linked ubiquitination (GO:0070534),0.5146099444925478,1.3839580700188185,0.08373590982286634,0.8418514220762537,1.0,7/41,7.45%,RNF152;UBE2E2;PRKN;NEDD4;RNF135;TRIM56;RNF8
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6660262360955403,1.3836278997212026,0.13706563706563707,0.8401397469489199,1.0,4/10,9.82%,ST6GAL1;RENBP;NPL;GNPDA1
prerank,neuron projection fasciculation (GO:0106030),-0.606948249396073,-1.3833545803585983,0.11434511434511435,0.3846852746172586,1.0,6/10,14.09%,CNTN4;RTN4;SEMA5A;NRCAM;EPHB2;CDK5R1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.579635239006287,1.382365900496957,0.12159709618874773,0.8425971144193044,1.0,4/18,6.92%,GPR137;TLR3;TLR4;FBN1
prerank,metanephric mesenchyme development (GO:0072075),0.6748546523669634,1.3822570405613928,0.15606936416184972,0.8398190770951253,1.0,2/10,1.09%,WNT4;OSR1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.49501782194592714,-1.3819269157247767,0.06633906633906633,0.38702666371528016,1.0,12/26,14.18%,SLC39A10;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;SLC30A1;SLC39A12;MT3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5917235396888014,-1.3811379285715686,0.10775862068965517,0.38775927907486185,1.0,6/12,18.29%,HSPA5;SEC62;SEC61B;SGTB;CHMP4B;CHMP4A
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5364145880229202,1.3810431091077957,0.11979166666666667,0.8421145343256674,1.0,4/30,5.59%,ROBO1;LPAR1;AKAP13;ARRB1
prerank,regulation of neuroinflammatory response (GO:0150077),0.5781761966279129,1.3809539909148107,0.1400709219858156,0.83923805136095,1.0,5/19,6.61%,IGF1;IL18;SPHK1;NUPR1;DAGLA
prerank,response to histamine (GO:0034776),-0.6280764986819487,-1.3809278626199726,0.09563409563409564,0.3871155581541501,1.0,5/10,15.28%,GABRB3;GABRB1;GABRB2;GABRG2;HRH1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.5418209820122484,-1.3805633553671801,0.09615384615384616,0.3868629794187571,1.0,6/15,21.60%,GNAS;UBR3;GNAL;SYT10;ADCY3;DRD2
prerank,regulation of catabolic process (GO:0009894),-0.5205027182158577,-1.3793658966363778,0.09375,0.38851942850577187,1.0,7/18,18.68%,FAP;NEDD4L;ITGB1;ZDHHC2;RARRES2;CHEK2;HPGD
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5893197725207497,-1.3787703948872392,0.1014799154334038,0.3888240992447942,1.0,9/13,20.17%,TGFB2;SEMA7A;PLCG2;TGFB3;TGFB1;IRAK3;LAPTM5;CD74;CUEDC2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5464493189106403,1.3781634478978433,0.10362694300518134,0.8485357184489756,1.0,6/26,9.55%,DAB2;KANK2;NCOR2;SMARCA4;SIRT1;HDAC1
prerank,chromatin disassembly (GO:0031498),0.6176335196535268,1.3777538292380875,0.14154411764705882,0.8439067845924644,1.0,6/14,9.11%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,nucleosome disassembly (GO:0006337),0.6176335196535268,1.3777538292380875,0.14154411764705882,0.8439067845924644,1.0,6/14,9.11%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.6014682821384215,1.3776639384219063,0.12943262411347517,0.8411322735999761,1.0,10/18,16.81%,MSRA;ASPA;ASPG;GOT2;MTHFR;ADI1;SLC25A12;FOLH1;GOT1;MTHFD1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6005485637226795,1.3776575439761516,0.12593984962406016,0.8380062727615648,1.0,5/15,13.15%,RENBP;LARGE1;MGAT3;GNPDA1;CHST3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.556718091011712,1.3774818715508301,0.10746812386156648,0.8357068259668544,1.0,2/23,0.80%,ATP1A2;ANK2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5734847685049306,-1.3772312898429906,0.09221311475409837,0.3912518745719262,1.0,7/13,26.86%,SYT1;CACNA1G;KCNB1;CACNA1H;SYT10;DOC2B;STX1A
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4490817996456643,-1.377070907479466,0.07692307692307693,0.3905235824778401,1.0,12/36,14.82%,CAV1;NOS3;NOSTRIN;SCARB1;CALM1;APOE;GCH1;HSP90AA1;ATP2B4;HIF1A;CYGB;NUS1
prerank,regulation of protein localization to membrane (GO:1905475),-0.4893687012152167,-1.3766939126397904,0.0594059405940594,0.39020824378573266,1.0,8/28,11.20%,SPTBN1;GPC5;GSN;ACTB;GPC6;AR;GPC4;ZDHHC2
prerank,monocarboxylic acid transport (GO:0015718),0.48769575828118783,1.3761942914917686,0.08571428571428572,0.8383330307142527,1.0,8/51,6.88%,SLC16A6;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC10A4;SLC16A13;SLC27A1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5268867777061632,-1.3761053290623246,0.07982261640798226,0.39053745838952103,1.0,7/18,10.98%,MDFIC;GSK3B;OTUD7B;APOD;MFHAS1;UFM1;CABP1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6300647161081263,-1.3752221744400792,0.11198428290766209,0.3913040074346933,1.0,5/10,18.31%,PTPRJ;PTPN12;APOD;SNCA;NDRG4
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5955381659622301,-1.375063470224631,0.1047008547008547,0.3905570971227813,1.0,3/12,10.92%,ACSL3;MTTP;MFSD2A
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.6129015090581197,-1.3743738918722972,0.1067193675889328,0.3911393051600899,1.0,3/10,5.34%,CXCL12;GAS6;LYN
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6115719413605684,1.3743071147622183,0.11673151750972763,0.8435135225711318,1.0,6/15,12.36%,LPGAT1;PPARGC1A;PPARA;SLC45A3;MLYCD;MLXIPL
prerank,arachidonic acid secretion (GO:0050482),0.6567189801407456,1.3733935118138862,0.1383399209486166,0.8413689423934689,1.0,2/10,4.74%,ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),0.6567189801407456,1.3733935118138862,0.1383399209486166,0.8413689423934689,1.0,2/10,4.74%,ACE;BDKRB2
prerank,regulation of biomineral tissue development (GO:0070167),-0.4832964758543773,-1.3728183813749055,0.061274509803921566,0.39376930475781635,1.0,11/26,13.90%,NOS3;SGMS2;GAS6;NOTCH1;ENPP1;ECM1;TGFB1;S1PR1;HEY2;TWIST1;TXLNG
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6721516428328314,1.372465231315703,0.125,0.8393473660701114,1.0,7/10,18.05%,SIRT3;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6721516428328314,1.372465231315703,0.125,0.8393473660701114,1.0,7/10,18.05%,SIRT3;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A
prerank,protein modification by small protein conjugation (GO:0032446),0.3816218448654332,1.3724578011047606,0.011286681715575621,0.8362980925451586,1.0,91/361,19.26%,RNF220;EPAS1;EYA1;RNF152;PDZRN3;RNF43;ASB2;PRKN;FBXL17;SPSB1;TRIM63;RNF213;CTR9;DTX1;CAND2;NEDD4;RNF151;ATG10;PIAS1;RNF135;KLHL41;ARRB1;USP9X;RNF181;SPSB4;MGRN1;UBR2;SMURF2;RNF8;FBXW11;HUWE1;FBH1;BTRC;CDK5RAP3;KLHL7;EIPR1;RNF34;SIRT1;NUP42;ZSWIM8;ATG7;RTF1;UBE2M;RNF41;NUP98;FBXW8;FBXO4;PRKDC;WWP2;PEX10;DCUN1D5;CUL4A;CUL9;UBA6;FBXO10;NUB1;ASB5;USP7;NSMCE2;TRIM62;NUP43;ASB12;FBXO11;DTX3;SDE2;PEX14;UBE2H;AMFR;PIAS3;ANAPC16;BIRC6;NUP155;UBR1;RNF7;UBE2E1;KCTD13;SYVN1;PEX5;CDC34;RNF25;RNF20;CCDC22;ARIH1;MIB2;ASB1;SUMO1;PIAS4;NUP188;KLHL18;MIB1;UBA5
prerank,ether lipid biosynthetic process (GO:0008611),-0.6047382990536492,-1.3724430153167864,0.10927835051546392,0.39357051980003904,1.0,5/10,24.50%,PLA2G4A;LPCAT2;AGPS;GNPAT;DHRS7B
prerank,response to purine-containing compound (GO:0014074),-0.5298372156931024,-1.3724074498955308,0.08798283261802575,0.3925680875132194,1.0,5/17,15.03%,RYR2;ABCC9;TRPC3;P2RY1;TRPM2
prerank,chromatin assembly or disassembly (GO:0006333),0.6587847096800933,1.3723714783116336,0.14594594594594595,0.8336801147979003,1.0,5/11,15.38%,HDAC8;CHAF1B;TP53;CDAN1;MTA2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6022909113565742,-1.3711639153079858,0.11087420042643924,0.39425892461120426,1.0,6/11,8.00%,KCNJ3;KCNJ2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.49392962598420526,-1.3705904365935246,0.09839816933638444,0.39453771230622187,1.0,7/23,10.79%,MAP3K5;TNFRSF11A;DAB2IP;PAK1;RPS3;MAP3K7;EDN1
prerank,regulation of macroautophagy (GO:0016241),0.4297445800737966,1.370041789150985,0.05649717514124294,0.8410107253532768,1.0,18/105,11.08%,PRKAG2;PRKAA2;SNX6;PRKAG3;SESN1;CASP3;ATP6V0E1;LRRK2;NEDD4;SESN2;SNX32;SMG1;ATP6V0B;PIK3CA;LARP1;SIRT1;ATP6V1D;ATP6V1E1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.51184437820082,-1.3699360962502176,0.09907834101382489,0.3949078398908512,1.0,10/19,31.45%,THBS1;PTK2;MPP1;CMKLR1;RARRES2;MDK;JAM3;MAPK3;BST1;CSF1R
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.602571122223486,-1.3696136864754176,0.1090146750524109,0.39453210711297604,1.0,7/11,24.08%,ANK3;LYN;RDX;JAK1;SYK;PRKCQ;PLAUR
prerank,sympathetic nervous system development (GO:0048485),-0.5487634129889503,-1.3692021578386475,0.12366737739872068,0.3944528383898371,1.0,2/15,2.99%,NRP1;NRP2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.49553149258666057,1.3690794752961266,0.08032786885245902,0.8421785701193275,1.0,6/41,7.20%,ACSL1;PTGS1;ALOX12;EPHX1;DAGLA;SCD5
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6282597945486119,1.368286573635608,0.1320754716981132,0.8426150798252782,1.0,2/12,2.92%,IL18;NUPR1
prerank,wound healing (GO:0042060),0.4629052563637834,1.366683533522553,0.08018154311649017,0.84663638467902,1.0,11/62,8.44%,FGF1;SMAD3;SYT11;IGF1;MYOF;CFLAR;TGFBR1;TPM1;FER1L5;FUT10;NRG1
prerank,membrane assembly (GO:0071709),-0.4474816315260726,-1.3658466860678116,0.09414758269720101,0.40096868244951717,1.0,8/34,4.66%,NLGN1;NRXN1;SPTBN1;PTPRD;IL1RAPL1;ANK3;RFTN1;UGCG
prerank,regulation of microtubule depolymerization (GO:0031114),-0.48892111261802257,-1.3654426590547029,0.08577878103837472,0.40083503481586524,1.0,8/25,12.35%,MAP1B;NAV3;CLASP2;ARHGEF2;STMN2;FGF13;TRPV4;SPEF1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4740828258275219,-1.3651121497695708,0.1025,0.4005446512584391,1.0,10/28,14.41%,NAV3;PAK1;RPS3;MET;OCLN;CDK5RAP2;MAPT;CLIP1;CDK5R1;FES
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.49571072394058474,1.3650768194055007,0.10361067503924647,0.8506873490909149,1.0,6/41,13.91%,PRKAG2;GCK;NUP42;NUP98;NUP43;OGT
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6850643206026304,1.3650628770609483,0.137546468401487,0.8477113232075802,1.0,8/10,25.26%,IVD;ACAD11;ACADM;GCDH;ETFDH;ACADS;ETFA;ETFB
prerank,mesenchyme development (GO:0060485),0.6022009466451463,1.3645993030129009,0.13602941176470587,0.8466523344311873,1.0,3/15,3.46%,BMP7;FGFR2;TGFBR1
prerank,epiboly involved in wound healing (GO:0090505),-0.5406457632516227,-1.3642881331836076,0.11231101511879049,0.4013322390558574,1.0,7/16,14.35%,TMEFF2;FLNA;MRTFA;CCN1;CEACAM1;CD44;CD151
prerank,regulation of epithelial cell migration (GO:0010632),-0.4129220117928459,-1.363519737927908,0.06510416666666667,0.4021269710212171,1.0,20/51,12.89%,BMPER;RHOJ;BMPR2;PTPRG;RTN4;CLASP2;TGFB2;EVL;DOCK1;DAB2IP;PLCG2;CORO1C;PTK2;PTN;CEACAM1;ENPP2;ADIPOR1;EMP2;PFN2;HIF1A
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5917676123271237,1.3634629366675646,0.1347248576850095,0.8486691313267343,1.0,5/17,12.32%,BMP6;SASH1;LY96;TRIB1;PRKCA
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5325156449177655,1.3628610034508835,0.10082644628099173,0.8483083439812439,1.0,6/32,2.92%,PPARGC1A;IGF1;PRKAA2;PPARA;ZBTB20;NUPR1
prerank,retinoid metabolic process (GO:0001523),0.4534941371268004,1.3619769250634195,0.07352941176470588,0.8492558469243028,1.0,13/71,7.53%,ALDH1A2;ABCA4;NAPEPLD;ALDH1A1;RBP1;AKR1B10;CYP26B1;APOM;RHO;PNLIP;DHRS3;SCPEP1;RBP4
prerank,neuron maturation (GO:0042551),-0.5272488669668046,-1.3618049530931626,0.10714285714285714,0.4050302611846189,1.0,12/18,26.26%,ADGRB3;APP;B4GALT5;SRRM4;SCARF1;CLN5;C1QA;ANKS1A;LGI4;RND1;B4GALT6;C3
prerank,diol metabolic process (GO:0034311),-0.5120677156289191,-1.3613562516704352,0.09443099273607748,0.4049923080067799,1.0,8/19,11.77%,NOS3;PLPP1;DEGS2;CALM1;GCH1;HSP90AA1;PRKG2;ASAH2
prerank,cellular response to nitrogen compound (GO:1901699),0.5770760203637938,1.3611046218612037,0.1387900355871886,0.8500689582656136,1.0,3/20,5.94%,ROCK2;CPS1;ATRX
prerank,negative regulation of angiogenesis (GO:0016525),-0.3766109567451303,-1.3608734825602706,0.049342105263157895,0.405005401312659,1.0,25/84,13.89%,PTPRM;TEK;SEMA6A;CLDN5;PDE3B;DCN;THBS1;TGFB2;COL4A2;SLC12A2;EPN2;SEMA3E;DAB2IP;SERPINF1;HSPG2;KLF2;STAB1;AMOT;ATP2B4;CREB3L1;CTNNB1;ISM1;ECSCR;ADGRB1;SPRED1
prerank,microglial cell activation (GO:0001774),-0.5088239290644644,-1.3601416925794614,0.10321100917431193,0.405669176720341,1.0,11/21,28.49%,APP;MAPT;SNCA;CLU;CX3CR1;ITGB2;C1QA;TYROBP;JAK2;GRN;IFNGR1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4625582710121237,1.3600921208236423,0.07578008915304606,0.8514426446318821,1.0,15/66,12.28%,APPL2;UBE2E2;DLG1;KANK2;DDX3X;ANKRD17;PLK5;PTEN;RBL2;CCND3;HYAL1;TFDP1;RBL1;ADAM17;BRD7
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5610230930085397,-1.3593720715494606,0.12915851272015655,0.40638280410465805,1.0,5/13,8.51%,DCN;BGN;CSPG4;VCAN;HEXB
prerank,artery morphogenesis (GO:0048844),-0.4567100423697064,-1.3590144932686905,0.07989690721649484,0.4061987556497698,1.0,12/30,11.37%,NRP1;BMPR2;ENG;TGFB2;JAG1;NOTCH1;TBX1;HES1;STRA6;SMAD7;HEY2;BMP4
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6573702551708189,1.3583564695086483,0.15606936416184972,0.8561790870263004,1.0,2/10,2.98%,DNMT3A;PCGF5
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.35955210327622406,1.3579181156810967,0.0,0.8551231029825461,1.0,294/1667,12.98%,PRDM6;AEBP1;EPAS1;HLF;ZKSCAN2;DAB2;FGF1;WWOX;RORA;MAF;BMP6;KDM7A;PPARGC1B;THRB;SMAD3;TFDP2;GLIS3;AUTS2;OSR1;ZIC2;TRAK1;KIT;FHL2;DDX5;PPARGC1A;MXI1;IGF1;RHOQ;NFYC;BRD8;CUX1;KMT2A;DLG1;PPARA;PKNOX2;SSBP2;CREBRF;FGFR2;ZFHX2;PRKN;FOXP4;IL18;IKZF2;FHOD1;CREB5;HOXB4;DNMT3A;GLI2;FNIP1;ZBTB20;ZNF160;HOXB6;KANK2;CSRP3;NPAS3;GABPB1;GABPB2;ZHX2;FOXD1;HOXC6;HOXA1;TNRC6A;ZNF568;ARID4A;MOSPD1;NFAT5;SOX5;PCGF5;HDAC8;PHIP;NR2F2;KCNIP3;NCOR2;CTR9;BMPR1A;ELF1;TSHZ3;NR6A1;GLI3;MITF;SUFU;ARNT2;CXXC5;FOXC1;PHF21A;MLLT10;NFIB;VGLL3;PCGF2;RFX8;HOXB3;VEZF1;IFI27;ZBTB38;MAFG;ASCL3;ATOH1;NACC2;ZNF462;NFYB;CREB3L2;TLR3;EZR;NHLH2;PRKCB;SMAD6;FOXP2;SALL4;CUX2;RREB1;CHD4;PPP1R13L;PIAS1;TLR4;MEIS1;FBXL19;NSD1;TEF;TET2;FZD5;ATM;DDX3X;WWC2;OTP;ARRB1;ARID3A;NCOA3;CAPRIN2;MAP2K5;GPS2;USP9X;CAMK1;SOD2;ATRX;ABHD14B;ESRRA;TEAD3;STAT2;LCOR;HMGA1;HOXB9;HOXA3;BAZ1B;HOXB5;TP53;TSHZ1;TBL1X;BCAS3;BCLAF3;CAMTA2;WWTR1;BHLHE41;SMURF2;RORC;MED12;SOX12;SERPINE1;MGA;CCNT2;SMARCD3;ZSCAN29;PLSCR1;NIPBL;ZIC5;LDB1;LDB2;LAGE3;BCOR;TNRC6B;ATAD2B;CBX7;ELF2;MEF2A;PTEN;KDM2B;SMARCA4;NR1D2;HOXC4;SRCAP;SPEN;SSBP3;ZSCAN25;TBL1XR1;CPEB3;KAT6B;ZIC1;KDM2A;SLTM;GDNF;TMF1;JMJD6;NUPR2;IRX1;SMARCC2;NEUROD4;TEAD2;KLF3;CALCOCO1;PARP9;SMARCE1;HDAC4;GLI1;ZBTB26;SIRT1;ZIC4;WASL;TFDP1;TCF7;RIPK2;NR2C2;HDAC1;SOX13;LARP7;RIPK1;MAVS;ZFP90;FOXC2;TCF7L2;TCF4;MOV10;HBP1;ZBTB8B;ZNF219;MYBL1;MED17;ATN1;HIVEP2;FOXL1;ZFP28;RBL1;GTF2F1;KMT2C;ZFP3;AURKB;THRAP3;ABL1;PRDM5;AASS;RTF1;ZBTB6;SAP18;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;HR;MNT;ATF2;ZFX;RBBP8;PRKDC;ZMIZ2;WWP2;BAZ1A;IMPACT;MLLT6;TFAP2D;ZNF467;ZBTB1;SKOR1;MYBL2;CBX5;TEAD1;ZMIZ1;DICER1;ZSCAN22;NOP2;KDM3B;CCDC62;ZNF148;HES6;ZNF235;BRWD3;HOXB2;BRD7;FOXA2;DEAF1;MLXIPL;NR3C2;TGFA;BRD9;ZMYM5;IRF1;ZKSCAN7;PHF2;FRK;ZNF483;KMT2D;KAT7;ZXDC;PBX4;ZBTB48;FOXJ2
prerank,neuromuscular process controlling balance (GO:0050885),-0.5815440951163314,-1.357716468202956,0.11894273127753303,0.4081760226956622,1.0,2/12,1.81%,NRXN1;PCDH15
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6628802089567716,1.3570248109049707,0.15030060120240482,0.8561667215589565,1.0,2/10,3.64%,ATP1A2;ADRA2A
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5597195692564987,1.3559088001584116,0.12411347517730496,0.8581284232252607,1.0,4/23,6.97%,TGFBR3;SMAD3;DKK3;SMURF2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.5037090195671488,-1.3556756661268228,0.12472160356347439,0.4120466333708925,1.0,11/21,21.92%,TOX;DISC1;PROX1;NAP1L1;CTNNB1;VEGFA;CX3CR1;DLL4;DISP3;DRD2;MDK
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4412054178212137,1.355561351726689,0.08052708638360176,0.8567505888909752,1.0,14/85,8.93%,EYA1;CACNA1D;GSDME;WHRN;ALDH7A1;DCDC2;EML2;HOXA1;COL4A3;TBL1X;CDC14A;NIPBL;LRTOMT;EPS8L2
prerank,lipid biosynthetic process (GO:0008610),0.4424965609312151,1.3555319283310023,0.08529411764705883,0.8539446748746142,1.0,10/77,7.40%,ACSL1;PRKAA2;AGPAT4;GPAT2;CYP21A2;FDXR;DHRS11;PDSS2;SCD5;NDUFAB1
prerank,regulation of metal ion transport (GO:0010959),0.5923259323137493,1.3552212606231273,0.15955473098330242,0.8522306597941074,1.0,3/16,2.04%,ANK2;DLG1;SLC30A10
prerank,regulation of wound healing (GO:0061041),-0.42487615696408554,-1.3548408533665763,0.06091370558375635,0.41283604757342535,1.0,12/42,9.38%,CAV1;CASK;ACTG1;ANXA1;AJAP1;OCLN;ITGB1;CD109;CRK;EPHB2;PTK2;FGF2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.47655445732319696,-1.3548369769083903,0.10046728971962617,0.41176357936956093,1.0,6/27,2.27%,PDE4D;PDE4B;CAV1;CTNNA3;RYR2;CAMK2D
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5542931742998928,1.3544234224656388,0.11705685618729098,0.852806780191169,1.0,4/24,3.91%,DAB2;PICALM;RHOQ;PPFIA1
prerank,ceramide metabolic process (GO:0006672),-0.411757090638692,-1.3542370202979164,0.07105263157894737,0.41220391580033267,1.0,11/49,11.77%,ST6GALNAC3;SGMS1;SGMS2;ACER3;ACER2;PLPP1;SPTLC2;DEGS2;PPP2R1A;CERS4;ASAH2
prerank,proton transmembrane transport (GO:1902600),0.5018445762909715,1.3542149294781458,0.11298482293423272,0.8507995672873853,1.0,3/36,6.16%,ATP1A2;ATP6V0E1;ATP4A
prerank,sodium ion homeostasis (GO:0055078),0.5546139662936529,1.3540118131555567,0.14963503649635038,0.8487864446039989,1.0,2/21,0.71%,ATP1A2;ATP1B3
prerank,neuron projection organization (GO:0106027),-0.548200390405252,-1.353709749221717,0.11521739130434783,0.41234681847466664,1.0,5/15,9.30%,GSK3B;PLS1;APP;PSEN1;ABCD2
prerank,gene silencing by miRNA (GO:0035195),0.5185629377866988,1.3530856723549427,0.11616161616161616,0.849971746208755,1.0,16/32,26.19%,TNRC6A;ZC3H7B;SNIP1;TNRC6B;MOV10;AJUBA;DICER1;TNRC6C;WTIP;RBM4;XPO5;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,digestive tract development (GO:0048565),0.5187606177934593,1.352814258688116,0.11945392491467577,0.8482643041999124,1.0,8/33,9.30%,KIT;CLMP;FGFR2;GLI2;GLI3;SMO;NIPBL;GLI1
prerank,peptide cross-linking (GO:0018149),-0.4748137710094477,-1.3518737707454263,0.09280742459396751,0.4155536821753142,1.0,4/25,5.42%,THBS1;FN1;NDNF;ANXA1
prerank,ketone body metabolic process (GO:1902224),0.6436897929195898,1.3514237180072204,0.16875,0.8515557700399552,1.0,5/10,8.70%,OXCT1;ACSS3;BDH1;BDH2;HMGCS2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.591097992046697,1.3513703718950747,0.1596153846153846,0.848966283692212,1.0,4/17,4.75%,ATP1A2;CACNA1D;ANK2;CACNA1C
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.509711766832418,-1.3509276497362481,0.12,0.4166831906828952,1.0,10/20,28.14%,CHRM3;CHRM2;AGRN;CDK5R1;GNB1;LYPD1;CHRNA7;RGS10;LY6H;RGS8
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6173100617942743,1.3502575448063374,0.17315175097276264,0.8511096319933902,1.0,1/12,0.35%,ACSL1
prerank,signal peptide processing (GO:0006465),-0.5923583329747449,-1.3501595328750335,0.14465408805031446,0.41727042859418484,1.0,5/11,23.85%,PCSK5;SPPL3;SPCS1;CLN5;PARL
prerank,mRNA destabilization (GO:0061157),0.4952636171592967,1.3500252926063832,0.12057877813504823,0.8493511555653036,1.0,9/38,17.07%,ROCK2;TUT4;POLR2D;CPEB3;MOV10;YTHDF3;ZFP36L1;TUT7;PLEKHN1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5229317972879707,1.3496155707110022,0.11703958691910499,0.8482621883641036,1.0,10/32,13.33%,FOXN3;BABAM2;ATM;DONSON;CDK5RAP3;BRSK1;CDC14B;UIMC1;FZR1;BABAM1
prerank,gene expression (GO:0010467),-0.3080699719242941,-1.3494294034466592,0.0,0.41790103753197844,1.0,136/348,25.22%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;ADARB1;AGFG1;ADARB2;RPL18A;ELAVL4;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;PTMA;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;TSPAN14;RPL4;RPL32;RPL21;RPS16;RPL18;SYNCRIP;RPL5;RPS7;SORL1;RPL39;TASP1;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;DROSHA;HNRNPK;NUP210;RPS4X;RPS5;CHTOP;RPL36A;RPL6;SMG5;THOC5;TAF1B;APOBEC1;POLR2J;RPL31;HBS1L;GLE1;RPSA;RPS26;GALNT2;RBM15B;RPL36;BCL3;ANGPT2;HHEX;RNPS1;EIF4E;NXT1;TSPAN17;RPL13A;XRN2;RPL35;PAX8;COPS5;NUP107;WDR33;RPL24;RBM3;RPS13;MRPL34;RPL11;EIF4A3;RSL24D1;TSPAN33;POM121;MRPS16;POLR2C;POLR2L;TSPAN15;MRPS21;MLF1;MRPL10;MRPL13;NCBP2;ZC3H11A;RPS27A;STUB1;RBM8A;MRPS33;SRSF6;NUP93;NUP85;NUP50;HOXD3;EIF4EBP2;MRPL35;EEF1A2
prerank,peptide catabolic process (GO:0043171),0.5467039946780298,1.348614408083922,0.12457337883959044,0.849803494418223,1.0,6/23,9.71%,ACE;CPQ;CTSH;NAALADL1;TPP1;NPEPPS
prerank,endocrine system development (GO:0035270),0.556883703754179,1.3485071853217427,0.1256637168141593,0.8474663088422025,1.0,4/21,3.46%,WNT4;GLI2;DKK3;TGFBR1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5370317700550645,1.3472068100176842,0.14991181657848324,0.8499805648984331,1.0,10/26,17.96%,UBE2E2;DDX3X;ANKRD17;CCND3;HYAL1;TFDP1;ADAM17;RPTOR;KMT2E;EIF4G1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4818311459500047,1.3470753066835175,0.12241653418124006,0.8477734984387353,1.0,17/46,16.29%,LGR4;LAMA4;ZNF423;ALDH1A1;NPR3;PCTP;TLR4;NOVA1;ACOT11;DOCK7;FOXC2;ADAM17;FLCN;ACVR2B;MAP2K6;NRDC;RB1
prerank,ribosome assembly (GO:0042255),-0.42094249028661146,-1.347036939250517,0.06340057636887608,0.4225280720246666,1.0,21/47,21.96%,RPL3;RPS19;RPS28;RPLP0;RPS15;RPL5;RPL23A;RPS27;RPS5;RPL6;MDN1;NOP53;RPSA;BRIX1;RPS27L;MRPL20;RPL24;RPL11;RSL24D1;NPM1;MRPS2
prerank,positive regulation of neuron differentiation (GO:0045666),-0.43214126759354066,-1.346991176287378,0.078125,0.4215423632857473,1.0,12/40,10.02%,MEF2C;BRINP3;BRINP1;NGF;VWC2;ARHGEF2;BEND6;NRCAM;HEYL;BMP2;PROX1;BRINP2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.569897681812808,-1.3469485870097457,0.12422360248447205,0.42057525325158235,1.0,6/12,26.87%,PIK3R1;DAB2IP;PTPN1;BCL2L11;ERN1;ATF6
prerank,regulation of stress fiber assembly (GO:0051492),0.4487308921976633,1.3468512507442398,0.1,0.8459697160088158,1.0,16/74,5.17%,ARHGAP28;ROCK2;LPAR1;CGNL1;CCN2;ARHGEF10L;ARHGEF18;FHOD1;PPM1E;TGFBR1;ASAP3;CLASP1;ARHGAP6;PPFIA1;RAPGEF3;TPM1
prerank,fatty acid metabolic process (GO:0006631),0.41902408029296584,1.3465405509681247,0.055248618784530384,0.8445156836311863,1.0,28/115,17.08%,ACSL1;PPARGC1A;PPARA;ECHDC3;ALOX12;CEL;ACADSB;CPT1A;GPAT2;ACSBG2;NAAA;NDUFAB1;PON3;CPT2;ACADM;ACOT11;MECR;MLYCD;AASDH;CRAT;ACOT8;PER2;THEM4;ACBD5;GPAM;NUDT19;SGPL1;ACOT12
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5694127041511199,-1.3463454880780883,0.13071895424836602,0.420912670234487,1.0,3/14,0.36%,PRKG1;SLIT2;MEF2C
prerank,synapse assembly (GO:0007416),-0.3894981135173899,-1.3457758329308782,0.050314465408805034,0.4212133315154928,1.0,22/67,11.40%,NLGN1;ADGRL3;NRXN1;GRID2;DNM3;CDH2;KIRREL3;SHANK3;SPOCK2;GABRB3;LRRTM3;DNER;GABRA2;GABRB2;NRCAM;GABRG2;FGF13;SLITRK1;LGI2;SHANK2;NRXN2;CDH1
prerank,heart looping (GO:0001947),-0.4283474233158014,-1.3453489314878622,0.08051948051948052,0.42112537918071946,1.0,9/40,13.22%,MEF2C;ENG;MICAL2;TBX3;NOTCH1;SOX17;VANGL2;SOX18;AHI1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3864680031407902,1.344906001357009,0.030660377358490566,0.8487695168070071,1.0,38/248,9.99%,RNF220;DAB2;TMEM64;LRRK1;LGR4;WLS;LRP4;BICC1;PTK7;FGFR2;MCC;PRKN;DKK3;GLI3;LRRK2;LZTS2;DDX3X;CAPRIN2;APC2;TBL1X;WWTR1;SMURF2;UBAC2;PTPRU;TNKS2;BTRC;ADGRA2;TBL1XR1;GPRC5B;INVS;TMEM170B;CSNK1A1;GLI1;TLE1;HDAC1;SOX13;UBR5;TCF7L2
prerank,positive regulation of protein polymerization (GO:0032273),-0.4015723468739531,-1.3446892129794024,0.05688622754491018,0.4215553560119285,1.0,23/65,16.81%,NAV3;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;PAK1;RPS3;MET;OCLN;BIN1;CDK5RAP2;HSP90AA1;MAPT;PFN2;CLIP1;PINK1;CDK5R1;FES;CDC42EP2;NCK1;ARF6;TPPP
prerank,negative regulation of cell differentiation (GO:0045596),0.3992864118322435,1.344674989678274,0.03530895334174023,0.8470661839621926,1.0,18/181,6.90%,RANBP3L;COL5A1;TMEM64;RORA;BMP7;SMAD3;OSR1;PPARA;CTR9;SUFU;TGFBR1;DTX1;SMAD6;MEIS1;GPS2;LDLRAD4;TRIB2;WWTR1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6262646781594501,1.3441728996799236,0.15976331360946747,0.8465350344327479,1.0,2/11,2.04%,PPARA;SLC30A10
prerank,mesonephric tubule development (GO:0072164),0.6018058694383361,1.3440731216009216,0.1615798922800718,0.8442555543483218,1.0,5/15,3.63%,BMP7;OSR1;FGFR2;NPNT;FOXC1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.46974554515961436,1.3437352580304673,0.10078740157480315,0.8430040483575789,1.0,9/56,6.74%,DAB2;BMP6;BMP7;BMPR1A;PMEPA1;TGFBR1;SMAD6;LDLRAD4;TWSG1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5952666641615287,-1.3435049911603225,0.1331923890063425,0.4232294585591233,1.0,3/10,8.37%,LRCH1;CD200;APOD
prerank,type I interferon signaling pathway (GO:0060337),0.5055021191278702,1.3434692582109,0.12685337726523888,0.8389291271499142,1.0,14/41,16.59%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;STAT2;GBP2;SAMHD1;RSAD2;IRF1;OAS3;IFI35;IFNAR2;SP100
prerank,cellular response to type I interferon (GO:0071357),0.5055021191278702,1.3434692582109,0.12685337726523888,0.8389291271499142,1.0,14/41,16.59%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;STAT2;GBP2;SAMHD1;RSAD2;IRF1;OAS3;IFI35;IFNAR2;SP100
prerank,cellular potassium ion homeostasis (GO:0030007),0.6086656689542195,1.3427212578040217,0.16252390057361377,0.8395023832653831,1.0,2/13,0.71%,ATP1A2;ATP1B3
prerank,regulation of neuron migration (GO:2001222),-0.46761873540078125,-1.3423772267750123,0.10309278350515463,0.42489510604294844,1.0,7/26,5.82%,CTNNA2;SEMA6A;NEXMIF;NTNG1;SHTN1;ARHGEF2;DAB2IP
prerank,Wnt signaling pathway (GO:0016055),0.42659179310735035,1.3421954887518655,0.07834757834757834,0.8392641764722506,1.0,18/92,11.84%,WNT5B;WLS;NXN;WNT4;WNT6;FZD8;LRRK2;FZD5;DDX3X;PTEN;BTRC;RYK;CSNK1A1;TCF7;TCF7L2;USP34;RARG;PORCN
prerank,cilium-dependent cell motility (GO:0060285),0.5596675741699656,1.3413716543450502,0.14010507880910683,0.8402655249840811,1.0,1/22,0.21%,CFAP44
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5519631466190374,-1.3412612603104637,0.12658227848101267,0.42660824327491725,1.0,5/14,10.43%,SLC8A1;SLC24A2;CACNA2D1;TRPV4;ATP2B4
prerank,circulatory system development (GO:0072359),-0.34713054119439246,-1.3401544095865097,0.03018867924528302,0.42819332781630526,1.0,34/118,13.46%,MEF2C;TEK;ZFPM2;ERBB4;NTRK3;FGF12;HEG1;PLCE1;FN1;TGFB2;MICAL2;ECE1;ACVRL1;HDAC9;NOTCH1;RAMP2;TBX1;SOX17;HSPG2;STRA6;PCSK5;BMP2;TGFB1;PDLIM1;HEY2;FLT4;ID2;PKD1;RBM20;SOX18;CDKN1A;CRIP1;PDLIM3;ACVR1
prerank,calcium ion transport into cytosol (GO:0060402),-0.5042215807987664,-1.3395137230976935,0.10154525386313466,0.42871934691216496,1.0,11/21,17.86%,SLC8A1;RYR2;CACNA2D1;GRIN2B;GRIN2A;TRPV4;ATP2B4;JPH2;TRPM2;GRIN1;ITPR3
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.34552792953982675,-1.3389708166941146,0.02553191489361702,0.42902617074011457,1.0,33/151,10.25%,NRP1;TEK;BMPER;ERBB4;NTRK3;PDE8A;GCNT2;ROR1;HTR2C;SEMA7A;PTK2B;GAS6;NOTCH1;NTRK2;KDR;TNFRSF11A;ROR2;PDGFC;ICAM1;PTPRC;RAP1A;APOE;APP;ACKR3;HTR2A;BMP2;TGFB1;MFHAS1;TNFAIP8L3;FGF2;FLT4;CD44;PDGFA
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3635568526127486,-1.337782415155345,0.0625,0.4305854636916891,1.0,29/100,12.47%,TEK;PIP5K1B;NTRK3;PIK3R1;ROR1;DCN;FN1;PIP4K2A;TGFB2;PPP1R16B;GAB1;NTRK2;KDR;LYN;ROR2;PDGFC;DAB2IP;SEMA4D;MYOC;PTK2;CEACAM1;FBXL2;FGF2;PIK3AP1;PDGFA;PIK3IP1;GPER1;UNC5B;TWIST1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.38396045768328424,-1.3373407165197377,0.05396825396825397,0.4305733989475174,1.0,15/71,6.90%,ELOVL7;CERT1;SGMS1;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;PPM1L;PLPP1;SPTLC2;DEGS2;SPNS2;ST8SIA1;ST6GALNAC5
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4940038293989742,-1.3372567436365144,0.0995260663507109,0.42967536819552027,1.0,6/22,11.24%,PDE3B;PPP2R5A;APOD;CEACAM1;CCDC3;GPER1
prerank,metal ion transport (GO:0030001),-0.3669520269338561,-1.3369499662034798,0.03115264797507788,0.4293335248860638,1.0,29/86,15.03%,SLC8A1;CALCRL;CAV1;CACNA1E;RYR2;CACNA2D1;TPT1;ATP2C1;RYR3;GRIN3A;TRPC3;ATP2B2;RAMP2;TRPC4;NIPAL2;TRPC1;CACNA1B;PSEN1;NDFIP2;ATP2A3;TRPV4;SELENOK;SLC30A1;RAMP1;MT3;NIPA1;TRPC5;CACNG8;TRPM2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.5675428825473123,-1.3368349578429277,0.12638580931263857,0.4285395023023395,1.0,7/13,25.47%,RPS15;XPO1;LTV1;ABCE1;RAN;NPM1;RRS1
prerank,regulation of phospholipase activity (GO:0010517),0.6610745107809406,1.3363494781899063,0.14867617107942974,0.8589919128815819,1.0,4/10,9.35%,FGFR2;FGFR1;PDPK1;LRP1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6236662859667934,1.336334662352891,0.1689059500959693,0.8563899358579796,1.0,6/10,24.28%,USP7;OGT;GNMT;PDK2;SELENOS;DGKQ
prerank,ceramide biosynthetic process (GO:0046513),-0.4309874667541227,-1.3351827516620478,0.07756232686980609,0.43142342724632865,1.0,10/40,11.77%,ST6GALNAC3;ST8SIA4;SGMS1;SGMS2;SPTLC2;DEGS2;ST6GALNAC5;ST8SIA6;CERS4;ASAH2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.49053741173327475,1.3342729617998275,0.12396694214876033,0.8622828664503631,1.0,14/43,18.62%,FOXN3;BABAM2;ATM;DONSON;CDK5RAP3;BRSK1;CDC14B;HUS1;UIMC1;FZR1;BABAM1;INTS3;CLSPN;NBN
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.48540992276524697,1.3339394088320853,0.12,0.8610490675817558,1.0,5/45,3.46%,DAB2;BMP6;BMP7;BMPR1A;TGFBR1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5988377513527828,-1.3337780717549117,0.1276595744680851,0.4337740574852995,1.0,4/10,8.92%,SEMA6A;DCN;DAB2IP;XDH
prerank,respiratory system development (GO:0060541),0.5143037808790096,1.3337394713144837,0.13758389261744966,0.859251815856206,1.0,7/32,7.54%,FGF1;FGFR2;GLI2;PDPN;LOXL3;RBP4;CHD7
prerank,response to fatty acid (GO:0070542),-0.5224983965197522,-1.3333427134545743,0.1367713004484305,0.4337621227438171,1.0,5/17,20.04%,PID1;FOXO1;SCD;NR1H4;IRS1
prerank,axonal fasciculation (GO:0007413),-0.562494991441398,-1.3332505583601781,0.12958963282937366,0.4329133793360628,1.0,5/12,7.96%,CNTN4;RTN4;SEMA5A;NRCAM;EPHB2
prerank,lipid oxidation (GO:0034440),0.615965984874574,1.3331661403815476,0.16367265469061876,0.8590053381915804,1.0,2/12,2.35%,PPARGC1A;ALOX12
prerank,dendrite morphogenesis (GO:0048813),-0.4329617349115508,-1.3327001645433838,0.09571788413098237,0.4332179500473008,1.0,12/35,9.13%,CTNND2;CTNNA2;DOCK10;SHANK3;KLF7;EPHB1;PAK3;MINK1;EPHB2;BTBD3;PTN;MAP6
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.4649631202020202,1.3326023483018756,0.1078125,0.858825063177141,1.0,10/55,10.39%,WWOX;TPD52L1;GSDME;NUPR1;TGFBR1;BID;TP53;DNM1L;RIPK1;BECN1
prerank,sterol biosynthetic process (GO:0016126),0.49658690792153215,1.3322782854224766,0.132569558101473,0.8575992623829184,1.0,2/33,2.51%,PRKAG2;INSIG2
prerank,response to interleukin-4 (GO:0070670),-0.5917099839363804,-1.3320305953724934,0.1598360655737705,0.4338269107831979,1.0,1/10,0.47%,LEF1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.627536391454294,1.331916338261408,0.16795366795366795,0.8564919801108909,1.0,2/12,1.42%,ROCK2;PICALM
prerank,positive regulation of transmembrane transport (GO:0034764),0.6135279355616576,1.3312697693475444,0.17570093457943925,0.8567289138579063,1.0,7/13,19.11%,ACSL1;BRAF;ANO6;AZIN1;CLIP3;C2CD5;AZIN2
prerank,cellular sodium ion homeostasis (GO:0006883),0.5800699672622976,1.3306357436085825,0.18761726078799248,0.8568307790243355,1.0,2/15,0.71%,ATP1A2;ATP1B3
prerank,protein homotetramerization (GO:0051289),0.4759394875979766,1.3302640705248494,0.09559939301972686,0.8557966414402541,1.0,8/49,9.80%,ALDH1A2;APPL2;UPB1;SOD2;SAMHD1;SSBP1;CBY1;CTH
prerank,platelet degranulation (GO:0002576),-0.35339847315694595,-1.3300607963541207,0.041379310344827586,0.43746113548711574,1.0,44/118,19.27%,PCDH7;ABCC4;VWF;ACTN4;PECAM1;TMSB4X;CD9;VEGFC;THBS1;ACTN1;FN1;TGFB2;GAS6;LYN;OLA1;LHFPL2;CALM1;APP;FLNA;PSAP;TGFB3;CD109;ECM1;TAGLN2;TGFB1;PDGFA;ITGB3;WDR1;FAM3C;RAB27B;PROS1;CDC37L1;VEGFA;CLU;RARRES2;ALDOA;NHLRC2;MAGED2;CLEC3B;BRPF3;MANF;QSOX1;TUBA4A;CHID1
prerank,nervous system development (GO:0007399),-0.30251589227181636,-1.3298544523030598,0.01,0.43699789982186465,1.0,89/429,10.06%,LSAMP;NLGN1;ADGRL3;NRXN1;DNM3;MEF2C;ROBO2;DCLK1;MBNL1;ERBB4;SEMA6A;CDH2;ADGRG6;KIRREL3;FGF12;SLC2A1;GSN;SHANK3;SPOCK2;ST8SIA4;RBFOX1;WWP1;EPHB1;NAV3;CNTN4;CHRM3;MERTK;GRIK1;EFNA5;ADAM23;FN1;TBX3;SEMA5A;MAL;IL1RAPL2;MOBP;EVL;STAT3;NELL1;APAF1;GLRB;DNER;SERPINI1;SH3GL2;NGF;NFASC;SCN2A;JAG1;DSCAML1;APBA2;MYT1L;ZBTB16;GPM6B;MBP;SNTG2;CNTN6;PDGFC;MARCKS;RBFOX3;HES1;FKTN;MET;NRCAM;DCX;PCDH1;SRRM4;MOG;SREBF2;VCAN;LGI1;DACT1;FEZ1;RELN;EPHB2;PTPRZ1;TGFB1;SPOCK1;CHRM2;PROX1;BTBD3;PTN;ADAM22;FGF13;FGF2;PPT1;S100B;ECRG4;SLITRK1;CDK5RAP2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3816630360226456,-1.3293150419476343,0.08176100628930817,0.4372284203525778,1.0,24/73,14.04%,NTRK3;CAV1;BCAR3;GAS6;NGF;TFRC;HSP90AB1;PAK1;APP;TGFB1;FNIP2;CD44;HSP90AA1;ATP2B4;TNKS1BP1;NOS1;PFN2;AXIN1;SNCA;PRKD1;VEGFA;TXN;PINK1;TERF2IP
prerank,ureteric bud development (GO:0001657),0.5811249015887153,1.3292267899509564,0.17989417989417988,0.8576131022271978,1.0,5/17,3.63%,BMP7;OSR1;FGFR2;NPNT;FOXC1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5787801890929104,-1.3290587520269483,0.1413934426229508,0.4367781602255583,1.0,4/11,12.04%,LYN;MFHAS1;CYBA;TIRAP
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.4836387236840249,-1.3290443419765194,0.125,0.4357688440894496,1.0,6/23,21.03%,CADM1;PIK3R6;PVR;ARRB2;LGALS9;RAET1E
prerank,melanocyte differentiation (GO:0030318),0.6319218230204511,1.32863043864155,0.2084130019120459,0.8573975879468652,1.0,3/11,3.38%,LRMDA;KIT;MITF
prerank,negative regulation of cell activation (GO:0050866),-0.5533892041474167,-1.328240766645996,0.15010570824524314,0.43661372922245567,1.0,6/14,11.24%,CD200;NOS3;APOE;LDLR;PDGFA;GPER1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6227854875218187,1.3282387794805501,0.16100178890876565,0.8564571332152536,1.0,5/11,14.01%,DDX5;TP53;RIPK1;MAP2K1;MAP2K2
prerank,regulation of cellular localization (GO:0060341),0.47916311947781803,1.3281265759833405,0.11710323574730354,0.8544232992190364,1.0,7/46,5.20%,PARD6G;ADCY5;STXBP4;PRKN;LRRK2;STXBP2;MAP2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5137215850704863,-1.32703853210852,0.13211845102505695,0.4384705503621443,1.0,3/17,1.12%,NRP1;TEK;NTRK3
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.36560757555763346,-1.3261116766594025,0.041666666666666664,0.4396175931142316,1.0,40/86,22.96%,NRP1;GHR;PTPRJ;PECAM1;EFNA5;PTK2B;ARHGEF2;PTPRC;APP;PLCG2;EPHA7;CSPG4;SEMA4D;RELN;TGFB1;TEC;CD44;PDGFA;ITGB3;ENPP2;SAMSN1;LRP8;FGF7;DMTN;ACVR1;VEGFA;CD74;PDCL3;ITGA5;ITGB2;VTN;AGT;SFRP1;CNOT7;IL6R;HCLS1;CD81;FYN;THBS4;HGF
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.40865096660906497,-1.3255321556703012,0.08357348703170028,0.43994422467705135,1.0,16/51,14.15%,BMPER;GREM2;BMPR2;HTRA3;VWC2;NOTCH1;VWC2L;SMAD5;SORL1;SMAD1;BMP2;SMAD7;LEMD3;UBE2D3;BMPR1B;SMURF1
prerank,positive regulation of ion transport (GO:0043270),0.47499331398555145,1.325483798657313,0.11501597444089456,0.8628650539961759,1.0,8/48,8.43%,CACNA1D;ACTN2;ANK2;DLG1;ADRA2A;AHCYL1;ANO6;GDNF
prerank,mesoderm development (GO:0007498),-0.5034478190960182,-1.3253392294920492,0.13501144164759726,0.4393207889886159,1.0,7/18,18.36%,TBX3;TIE1;TBX1;BMX;IKZF1;VEGFA;BTK
prerank,regulation of platelet aggregation (GO:0090330),-0.5185405842914556,-1.325195092234166,0.1352549889135255,0.43863522076231254,1.0,6/17,8.90%,PRKG1;CD9;SERPINE2;F11R;LYN;CEACAM1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5469034265973136,1.3247390341050418,0.16129032258064516,0.8634900474756935,1.0,4/21,6.68%,PPARA;PRKN;SLC30A10;SIRT5
prerank,neuromuscular junction development (GO:0007528),0.5464848382016886,1.3245090023424424,0.1478102189781022,0.861955542927971,1.0,7/24,8.47%,PDZRN3;LRP4;UNC13C;LRRK2;NEDD4;CACNB3;PPFIBP2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.4216382335631218,-1.321835094888451,0.09831460674157304,0.44561502798420627,1.0,18/41,15.39%,ANK3;AKAP6;KCNJ3;KCNMA1;KCNJ2;KCNN2;KCNMB2;GNG2;FLNA;KCNQ1;GABBR2;CTSS;NOS1;ACE2;KCNJ6;GNB1;STAC;KCNJ12
prerank,actomyosin structure organization (GO:0031032),0.4320518969218794,1.3205610449133756,0.10086455331412104,0.8763983653449985,1.0,15/75,6.51%,ROCK2;ACTN2;SORBS1;CSRP3;FRMD6;PHACTR1;TMOD2;EPB41L5;MYO18A;FAM171A1;TMOD3;TPM1;KLHL41;ARRB1;CDC42BPG
prerank,cardiac muscle cell contraction (GO:0086003),-0.5046969496108427,-1.3194983234953617,0.14055299539170507,0.45004545019556075,1.0,8/19,5.60%,FGF12;GSN;CAMK2D;CACNA2D1;KCNJ2;SCN1A;CACNA1G;ATP1A1
prerank,stress fiber assembly (GO:0043149),0.5925051050944218,1.319067743272653,0.15900383141762453,0.8775574021125849,1.0,4/15,5.59%,SORBS1;PHACTR1;FAM171A1;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.5925051050944218,1.319067743272653,0.15900383141762453,0.8775574021125849,1.0,4/15,5.59%,SORBS1;PHACTR1;FAM171A1;ARRB1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.38097760901893574,-1.3188804181130407,0.07062146892655367,0.45045804433947967,1.0,18/65,16.10%,HIP1;PTPRJ;CDH13;SH3KBP1;PTPN12;BCAR3;SH3GL2;CCDC88A;ARHGEF7;DAB2IP;CEACAM1;MVB12B;DUSP3;GPER1;PTPN3;SPRY1;ZFYVE28;CBL
prerank,regulation of filopodium assembly (GO:0051489),-0.42531382308743637,-1.3183279739036275,0.08857142857142856,0.45069759187287817,1.0,16/38,16.20%,NRP1;NLGN1;TENM2;PIK3R1;MYO10;FNBP1L;PPP1R16B;TGFB3;GAP43;PLPPR5;AGRN;FXR1;DMTN;GPM6A;TRPM2;ARF6
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3721860152746264,-1.3179940507936956,0.054441260744985676,0.4503942024410511,1.0,19/76,16.20%,NRP1;TEK;NTRK3;SEMA5A;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;BIN1;PROX1;WDR1;EDN1;SYNPO2;PFN2;FES;CDC42EP2;NCK1;ARF6
prerank,cardiac muscle cell action potential (GO:0086001),0.5104401927368881,1.3179749159181453,0.13993174061433447,0.8794200661789373,1.0,4/30,1.34%,ATP1A2;CACNA1D;ANK2;KCND3
prerank,regulation of ATP metabolic process (GO:1903578),0.4626631483704748,1.3176632031836644,0.12347560975609756,0.8782053869980784,1.0,10/54,16.26%,PRKAG2;GCK;AK4;NUP42;NUP98;NUP43;BEND3;OGT;SPHK2;NUP155
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4057648069210585,1.3175222774492914,0.0641025641025641,0.8763176577422829,1.0,36/138,16.31%,NOTCH2;RORA;THRB;PPARGC1A;CCN2;PPARA;POLR2A;NCOR2;NR6A1;ESRRA;TEAD3;TBL1X;WWTR1;RORC;POLR2D;NR1D2;TBL1XR1;TEAD2;NR2C2;HDAC1;MED17;GTF2F1;RARG;TEAD1;TAF11;NR3C2;TBP;TAF4;NCOR1;KAT2B;TAF7;MED23;RXRA;TAF13;CREBBP;MED26
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.43660525083529333,1.3169570928715513,0.0970464135021097,0.8760777921796236,1.0,17/74,10.57%,EYA1;EYA2;IGF1;EYA4;CFLAR;PHIP;TGFBR1;DDX3X;MAP2K5;SERPINE1;TERT;GDNF;HTT;RNF34;RIPK1;TCF7L2;SH3RF1
prerank,protein localization to mitochondrion (GO:0070585),0.6265379791445136,1.3169405576872042,0.19318181818181818,0.8736084962401004,1.0,2/11,3.85%,HK2;LRRK2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.47292999218904996,-1.3164563598385355,0.12418300653594772,0.45311338151529107,1.0,10/25,21.74%,CTNNA3;CD200;VCAM1;ITGB1;ITGA4;ITGB3;ITGA5;ITGB2;ITGA7;PKP2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.35231904312841833,1.315970057625329,0.0062047569803516025,0.8751352103029554,1.0,157/807,14.62%,PRDM6;AEBP1;DAB2;WWOX;BMP6;BMP7;THRB;SMAD3;TFDP2;GLIS3;WNT4;OSR1;ZIC2;FOXN3;FHL2;DDX5;MXI1;CUX1;DLG1;PPARA;FGFR2;PRKN;FOXP4;ZNF423;DNMT3A;JARID2;GLI2;FNIP1;KANK2;ZHX2;SNX6;FOXD1;ZNF568;DKK3;ARID4A;MOSPD1;HDAC8;NR2F2;KCNIP3;NCOR2;CTR9;TSHZ3;NR6A1;GLI3;MITF;SUFU;CXXC5;FOXC1;PHF21A;PCGF2;IFI27;ZBTB38;NACC2;VGLL4;LOXL3;EZR;FOXP2;CUX2;RREB1;NSD1;WWC2;OTP;SFMBT1;MAP2K5;GPS2;USP9X;CBFA2T2;LCOR;HMGA1;LBH;ZNF318;TP53;TBL1X;BHLHE41;SMURF2;RORC;NIPBL;LDB1;LDB2;FBXW11;BCOR;CBX7;MEF2A;KDM2B;SMARCA4;NR1D2;BTRC;RBM15;SPEN;TBL1XR1;CPEB3;KAT6B;KDM2A;NRG1;NUPR2;IRX1;SMARCC2;NIBAN2;PARP9;SMARCE1;HDAC4;SCML4;SIRT1;TLE1;NR2C2;HDAC1;SOX13;CBY1;LARP7;SPINDOC;ZFP90;CHMP1A;FOXC2;TCF7L2;ZNF219;ATN1;AURKB;PRDM5;AASS;RTF1;SAP18;RARG;MNT;BAHD1;WWP2;IMPACT;ZBTB1;SKOR1;CBX5;DICER1;ZNF148;UIMC1;BRD7;DEAF1;MLXIPL;ZMYM5;IRF1;FRK;KAT7;KMT5A;BEND3;SIN3A;PML;CBX6;TLE2;BCL7A;NCOR1;ZBTB32;CRYAB;SNAI1;PER2;FLCN;ACVR2B;GADD45A;ZKSCAN3;MIER3;HOXA7
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.388272538508189,-1.3159510148557407,0.0855457227138643,0.4532342514818755,1.0,19/63,22.40%,MEF2C;VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;CD38;PTPRC;EPHB2;TIRAP;NCK1;CD74;IRS2;CCL19;CD320;CD86;CD276;CD81
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6349939434900125,1.3157723933721877,0.1926977687626775,0.8734487435323469,1.0,3/10,9.34%,JARID2;ATRX;SIRT1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5395369494397892,1.3157523579169605,0.16283185840707964,0.8710520836425324,1.0,3/22,3.64%,TIMP3;SH3D19;ADRA2A
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6190203040256655,1.3157346219770791,0.17681728880157171,0.868649902625572,1.0,6/12,10.70%,PARP10;TIPARP;PARP12;TNKS2;PARP11;PARP6
prerank,regulation of potassium ion transport (GO:0043266),0.5115826425035849,1.3157212616539147,0.14009661835748793,0.8662149292110083,1.0,7/31,3.64%,CACNA1D;ACTN2;ANK2;DLG1;KCNA5;KCNIP3;ADRA2A
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5682546779830615,-1.3157181682164945,0.14947368421052631,0.45274527777915624,1.0,5/11,11.37%,ZFPM2;TGFB2;JAG1;HEY2;BMP4
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.5100000368718576,-1.315643458658206,0.1346578366445916,0.4518713024576723,1.0,9/18,19.62%,RPS6KA5;CD200;EPHA5;RELN;LRP8;PRKD1;VEGFA;CRTC2;ADCY8
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4459687420495975,-1.3152248703253715,0.11221945137157108,0.45188905576620403,1.0,17/34,19.06%,NRP1;SEMA6A;VEGFC;GAB1;NOTCH1;KDR;RAMP2;ANXA1;DAB2IP;FLT4;MT1G;PRKD1;VEGFA;NUS1;NR4A1;HSPB1;DLL4
prerank,determination of heart left/right asymmetry (GO:0061371),-0.41545453240586666,-1.3151039419133752,0.10483870967741936,0.4511382031132396,1.0,9/43,13.22%,MEF2C;ENG;MICAL2;TBX3;NOTCH1;SOX17;VANGL2;SOX18;AHI1
prerank,response to prostaglandin E (GO:0034695),0.6432588075834638,1.3140888524508587,0.17669172932330826,0.8704323679035312,1.0,1/10,0.31%,TGFBR3
prerank,embryonic heart tube development (GO:0035050),-0.5433270271772274,-1.3139634017608661,0.14565217391304347,0.45268620183927877,1.0,7/14,22.24%,RYR2;SOX17;HES1;SOX18;ACVR1;NDRG4;TBX2
prerank,positive regulation of DNA repair (GO:0045739),0.4774467882235429,1.3133835573790642,0.1411229135053111,0.8708637673783391,1.0,10/46,14.73%,EYA1;EYA2;EYA4;BABAM2;RNF8;SIRT1;UIMC1;BABAM1;SMCHD1;MGMT
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5110690231604053,-1.3130620836473927,0.1368421052631579,0.4537462321479478,1.0,4/18,11.20%,SPTBN1;ACTB;AR;ZDHHC2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5624833124743365,1.3130297810157534,0.16636528028933092,0.8698652269527214,1.0,2/19,0.51%,BMP6;AFDN
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5048232512576035,-1.31260254895442,0.15011547344110854,0.45388551679085964,1.0,6/18,3.62%,NLGN1;NRXN1;RIMS2;SHANK3;RIMS1;PTK2B
prerank,neutral amino acid transport (GO:0015804),-0.43887758675143984,-1.311926651236886,0.10981308411214953,0.454478640198223,1.0,10/28,12.51%,SLC6A6;SLC1A5;SLC7A5;SLC38A6;SLC1A1;SLC1A4;SLC38A5;SLC43A2;SLC6A7;SLC43A1
prerank,regulation of cholesterol esterification (GO:0010872),-0.5877390576548075,-1.3117473018125998,0.14343434343434344,0.45385827772567466,1.0,5/10,19.80%,APOE;ABCG1;AGTR1;STARD4;AGT
prerank,regulation of cell growth (GO:0001558),-0.3202985400102527,-1.3117060296372276,0.005050505050505051,0.45292309493925204,1.0,52/204,16.25%,NRG3;APBB2;SLIT2;PTPRJ;LTBP4;BMPR2;AKAP6;PLCE1;CAMK2D;RTN4;TGFB2;PAK5;ACVRL1;CCN3;TFRC;NET1;SOX17;SOCS2;ENPP1;ADAM15;LGI1;PPP2R1A;RERG;SH3BP4;TGFB1;SPOCK1;AGTR1;SERTAD2;CEACAM1;BTG1;CXCL16;PPT1;H3-3A;ERBB2;FRZB;KIF26A;RPS6KA3;BCAR1;SLC25A33;MFSD2A;FAM107A;CDKN1A;JADE1;TAF9B;EI24;RPS6KA1;MT3;PTCH2;DCBLD2;RASGRP2;CCDC85B;EGLN2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5404629732094914,-1.3106113329457678,0.1419068736141907,0.45449634784892406,1.0,8/13,29.80%,SORL1;GCC2;TMEM30A;CD81;SEC16B;SAR1B;TMEM30B;SAR1A
prerank,regulation of axon extension (GO:0030516),-0.4252261415920506,-1.3100073556811485,0.10789473684210527,0.4548671113527455,1.0,12/37,14.18%,RTN4;SEMA7A;CDKL5;NTN1;SHTN1;GSK3B;APOE;NRCAM;DIP2B;SEMA3G;MAPT;MT3
prerank,vesicle transport along actin filament (GO:0030050),-0.5141174401995525,-1.3098275712426346,0.14563106796116504,0.45422519324333666,1.0,6/19,8.98%,MYO1D;ACTN4;MYO1B;FNBP1L;MYO5A;MYO6
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.512213965058853,-1.3096722232527107,0.1291759465478842,0.45356471101867146,1.0,10/18,29.01%,CCT8;CCT2;CCT6A;NHP2;CCT7;DCP2;EXOSC10;RUVBL2;DKC1;NAF1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.33313960798223086,-1.3094703573910627,0.0330188679245283,0.45292861776636373,1.0,42/163,19.78%,PDE4D;MEF2C;PDE4B;PTPRJ;PIK3R1;RFTN1;PAK3;INPP5D;PSMB2;CD38;PAK1;PTPRC;BMX;PLCG2;PLEKHA1;MAP3K7;MOG;TNFRSF21;PSMD14;TEC;PSMC6;BCAR1;EIF2B3;IKBKB;SH2B2;RBCK1;SPPL3;BTN3A3;NCK1;PSMA4;NFKBIZ;PSMB9;BLNK;SKAP1;SKP1;SYK;PSMD11;BTK;PSMB10;PRKCQ;PSMD2;TXK
prerank,regulation of supramolecular fiber organization (GO:1902903),0.538533152650729,1.3093422460512412,0.16234887737478412,0.8828587878543691,1.0,6/22,10.68%,AEBP1;AKAP13;MAP2;PIK3CA;ABL1;PRUNE1
prerank,sodium-independent organic anion transport (GO:0043252),-0.5955552701656844,-1.3091605735565823,0.14634146341463414,0.45266097433359886,1.0,7/10,29.32%,SLCO1C1;SLCO2B1;SLCO4A1;SLC16A2;SLCO5A1;SLCO2A1;SLCO1B1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4157835935655104,1.309153702012856,0.10231923601637108,0.8810403319476523,1.0,23/108,10.26%,WWOX;RSPO2;RNF43;WLS;NXN;PTK7;FGFR2;PRKN;DCDC2;TRABD2B;APCDD1;CXXC4;LRRK2;SULF2;VGLL4;SMARCA4;BTRC;TERT;LRP1;TLE1;CBY1;GRB10;FOXL1
prerank,sulfur amino acid metabolic process (GO:0000096),0.5274912770103533,1.3090647735122167,0.14612676056338028,0.8789553721046587,1.0,7/24,12.38%,MSRA;CPS1;MTHFR;ADI1;CTH;NOX4;MTRR
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5915709844452456,-1.3090154224935664,0.17427385892116182,0.45193738269486533,1.0,4/10,9.31%,DGKH;PRKD3;PLPP1;GAP43
prerank,positive regulation of reproductive process (GO:2000243),-0.444364881001466,-1.3087849865613963,0.12652068126520682,0.451441546432929,1.0,12/31,21.61%,PDE3A;LHFPL2;GLRA1;PGAM4;VEGFA;CFAP69;CACNA1H;SIRT2;INHBA;SYDE1;TACR3;PRDM9
prerank,intracellular cholesterol transport (GO:0032367),-0.526399473339003,-1.3083248350430137,0.16326530612244897,0.45153036707928745,1.0,8/15,21.98%,ABCG1;LDLR;NPC2;STARD4;RELCH;LDLRAP1;OSBP;LRP6
prerank,negative regulation of wound healing (GO:0061045),-0.44215773382416834,-1.3081707414098565,0.1262135922330097,0.4509152993773184,1.0,11/28,10.79%,SERPINE2;CLASP2;CASK;CD34;SLC12A2;AJAP1;APOE;CD109;CRK;FGF2;EDN1
prerank,negative regulation of ATPase activity (GO:0032780),0.5778256397494024,1.3081130918353487,0.18299445471349354,0.8803454129859339,1.0,5/16,14.27%,IFIT1;TP53;SIRT1;TNNI3;TSC1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5174356606888607,-1.3080863006051269,0.1571753986332574,0.45012220088381144,1.0,5/16,10.35%,NRP1;PTPRJ;PDGFC;PDGFA;BCAR1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.493193609852358,1.307474068466928,0.1416803953871499,0.8804776448421341,1.0,9/33,11.57%,UBE2E2;STXBP4;DDX3X;ANKRD17;CCND3;HYAL1;GLI1;TFDP1;ADAM17
prerank,regulation of microglial cell activation (GO:1903978),0.5675971891990562,1.3072218889913751,0.18304431599229287,0.8790668468023699,1.0,2/15,2.32%,SYT11;SPHK1
prerank,positive regulation of glycolytic process (GO:0045821),0.5480662791401545,1.3070370723789388,0.16202090592334495,0.8749281505265893,1.0,3/20,2.21%,IGF1;PRKAA2;ZBTB20
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5480662791401545,1.3070370723789388,0.16202090592334495,0.8749281505265893,1.0,3/20,2.21%,IGF1;PRKAA2;ZBTB20
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.40821635354041647,-1.3069140536622934,0.096,0.45185068295106834,1.0,15/42,14.56%,GCNT2;VIT;NDNF;NOTCH1;FBLN2;MINK1;FZD4;CORO2B;CORO1C;SPOCK1;PTK2;EMP2;DMTN;PPM1F;LIMS1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.48548100787677906,-1.3067305443538544,0.16247139588100687,0.45131144216716906,1.0,5/21,6.42%,PRKCH;SLC39A10;PTPRC;FOXP1;RPS3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.4438358014994202,-1.305920211223284,0.11056511056511056,0.4523673675006619,1.0,17/32,26.21%,AKAP6;CEMIP;CALM1;CALM2;TRPC1;CALM3;JPH2;GPER1;SNCA;APLNR;GSTM2;NPSR1;HAP1;THY1;F2R;CXCL10;PLCG1
prerank,protein-DNA complex disassembly (GO:0032986),0.5621569429827333,1.305912246782664,0.18871252204585537,0.8772004384457885,1.0,6/16,9.11%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,neuromuscular synaptic transmission (GO:0007274),0.5570754851439561,1.3057711966695456,0.17158671586715868,0.8753714780738823,1.0,7/18,20.47%,FCHSD2;DTNA;KIF1B;TSPOAP1;ERC2;CHRNB1;TBC1D24
prerank,regulation of innate immune response (GO:0045088),0.4533181559939058,1.30561614664834,0.11755725190839694,0.8736076860816682,1.0,18/57,16.00%,APPL2;RNF135;IFNK;TKFC;PTPN22;PLSCR1;SAMHD1;PARP9;DHX58;NMI;PTPN11;IRF1;IFI35;ERAP1;ACOD1;USP18;IFNAR2;BIRC3
prerank,negative regulation of chemokine production (GO:0032682),0.5894132759755148,1.3055811843802343,0.1684981684981685,0.8713949750125858,1.0,2/14,5.70%,C1QTNF3;MAP2K5
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5276052661562773,1.3052564586413895,0.16554054054054054,0.8704119742133023,1.0,5/25,6.75%,ERRFI1;PPARA;SNX6;SLC6A9;CNRIP1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.5241370671843064,-1.3050084602951373,0.15777777777777777,0.45363038965702435,1.0,7/14,31.45%,THBS1;PTK2;CMKLR1;RARRES2;MDK;MAPK3;CSF1R
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5842671059183577,1.3045819107404903,0.17037037037037037,0.8709171015434138,1.0,3/15,7.05%,IGF1;PRKN;OPA1
prerank,nucleoside catabolic process (GO:0009164),0.6247241321308932,1.304453935139686,0.20825515947467166,0.8690414751357812,1.0,3/11,6.52%,UPB1;DPYD;DERA
prerank,regulation of fat cell differentiation (GO:0045598),0.43101821684313074,1.304044826220979,0.1172106824925816,0.8683708384442449,1.0,12/74,9.62%,TMEM64;RORA;SMAD3;MEDAG;ADIG;GPS2;TRIB2;CREBL2;WWTR1;RORC;SIRT1;LRP3
prerank,negative regulation of metabolic process (GO:0009892),0.4543102784922297,1.3036397056154079,0.14329738058551617,0.8677115622058212,1.0,17/54,16.29%,LGR4;LAMA4;ZNF423;ALDH1A1;NPR3;PCTP;TLR4;NOVA1;ACOT11;DOCK7;FOXC2;ADAM17;FLCN;ACVR2B;MAP2K6;NRDC;RB1
prerank,regulation of cellular pH (GO:0030641),-0.4445527060724633,-1.3034966737558784,0.10933940774487472,0.45620431627529107,1.0,6/29,12.97%,SLC4A10;SLC9A2;CA2;SLC9A6;SLC9A7;SLC9B1
prerank,response to thyroid hormone (GO:0097066),0.589022541589592,1.3033842004114093,0.20761904761904762,0.8664474059639878,1.0,3/13,4.94%,THRB;BRD8;CTSH
prerank,membrane depolarization (GO:0051899),-0.43923185223924915,-1.302359921251846,0.11435523114355231,0.45799085903949516,1.0,10/32,12.17%,CAV1;CACNA1E;SCN1A;SCN2A;CACNA1G;SCN7A;CACNA1B;SCN3A;SCN9A;SCN8A
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5862407724870936,1.3022919817824863,0.17115384615384616,0.8685427719372635,1.0,4/14,7.34%,IL18;IL12B;TGFBR2;PTPN22
prerank,Rho protein signal transduction (GO:0007266),0.45983879891812207,1.3020526407090303,0.130298273155416,0.8671395416140696,1.0,16/53,12.26%,CELSR1;ARHGAP29;ROCK2;RHOD;ADRA2A;PDPN;ARHGAP6;ARHGEF11;COL1A2;ARHGEF1;EPS8L2;CTNNAL1;PHACTR4;CDC42;EPS8L1;CDC42EP1
prerank,aortic valve development (GO:0003176),-0.42913400917617905,-1.3020156736125394,0.10626702997275204,0.45782781299679104,1.0,16/34,12.47%,SLIT2;ROBO2;ELN;BMPR2;NOS3;TIE1;JAG1;NOTCH1;TNFRSF1B;HEYL;NFATC1;BMP2;TGFB1;HEY2;BMP4;TWIST1
prerank,detection of mechanical stimulus (GO:0050982),-0.5159153326489949,-1.3019683407970164,0.1325581395348837,0.4569389049832895,1.0,6/19,12.06%,PIEZO2;CDH2;PIEZO1;PTK2;PKD1;CTNNB1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5968994382732722,1.3014852413605544,0.1773308957952468,0.86716316572699,1.0,3/14,8.60%,MOXD1;DAGLA;SLC6A4
prerank,generation of neurons (GO:0048699),-0.3245855791813005,-1.3014048918219467,0.04945054945054945,0.45727369635523707,1.0,42/190,10.30%,NRP1;ADGRL3;MEF2C;PTPRD;IL1RAPL1;MARK1;ASTN2;MAP1B;TGFB2;TAFA1;ASTN1;RUNX1;FUT9;NDNF;DNER;CIT;CDKL5;ACSL3;NTRK2;MYT1L;ATP2B2;MYEF2;FZD4;HES1;MET;DISC1;NRCAM;ACSL4;DCX;LHX6;RELN;HEYL;WNT9A;SIX1;SPOCK1;ATOH8;TUBGCP2;HEY2;FGF13;ERBB2;DDIT4;RUNX2
prerank,calcium ion import into cytosol (GO:1902656),-0.5300000984299248,-1.3013083721237584,0.1488469601677149,0.4565046855296315,1.0,5/15,10.43%,SLC8A1;SLC24A2;CACNA2D1;TRPV4;ATP2B4
prerank,positive regulation of cellular component movement (GO:0051272),-0.4786632918335225,-1.3009104236525304,0.12439024390243902,0.4564952302972818,1.0,9/24,15.01%,ACTN4;SPOCK2;CAVIN1;NTN1;LYN;RPS19;TWIST1;VEGFA;TUBB2B
prerank,amide transport (GO:0042886),-0.4550381579331367,-1.300830348363003,0.11617312072892938,0.45567635478834867,1.0,8/26,8.48%,ABCG2;CERT1;PLTP;SLC5A6;AQP11;SLC38A5;GLTP;DISP1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.58433970689483,1.300804801292302,0.18148820326678766,0.8676738437335481,1.0,3/16,5.31%,UPB1;DPYD;TET2
prerank,positive regulation of protein binding (GO:0032092),-0.38723846354997643,-1.3006656299863417,0.11176470588235295,0.4550960290525707,1.0,26/56,22.78%,CAV1;CLDN5;EPB41;B2M;GSK3B;TIAM1;APOE;APP;PSEN1;DACT1;BMP2;RALB;ADD2;PKD1;FKBP1A;BMP4;SPPL3;BDNF;HIPK2;MEN1;HIP1R;RAN;VTN;RPL11;TRIB3;FLOT1
prerank,brain development (GO:0007420),-0.3374970837765623,-1.3003514138573484,0.047619047619047616,0.4548437810418691,1.0,30/136,10.06%,CNTNAP2;ADGRL3;CTNNA2;ROBO2;ADGRL2;ZFHX3;CDH2;SHANK3;COL4A1;CNTN4;GRIN2B;SHROOM4;PBX3;DSCAML1;PTCH1;EPHA7;GRIN2A;HSPG2;MEIS2;RELN;PCDH18;APOD;PROX1;TUBGCP2;PPT1;RAB18;PBX1;DDIT4;UFM1;CDK5RAP2
prerank,protein localization to membrane (GO:0072657),-0.3228349483295287,-1.2999839352424267,0.04205607476635514,0.4546585019447252,1.0,48/187,11.47%,NLGN1;KCNIP4;DLG2;NRXN1;SPTBN1;DPP10;CACNB2;KCNB2;CAV1;BSG;ANK3;SHANK3;DPP6;EFR3B;LRRC7;CLASP2;MAP7;LIN7A;RFTN1;EPB41L3;ATP1B1;F11R;GAS6;MYO5A;EHD4;RAMP2;RAB3C;RAP1A;NKD2;FLNA;SH3GLB1;TSPAN14;PTCH1;EHD2;ITGA4;FRMPD1;RDX;PTN;RAPGEF6;FGF13;RAP2A;AGRN;ARL5A;KCNB1;ZDHHC2;NRXN2;CDH1;PACS2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5222047436444683,-1.298666059027976,0.1613588110403397,0.4567523389652695,1.0,9/15,30.58%,RYR2;SRPRA;SRP14;SPCS1;SRPRB;ZFAND2B;EDEM1;RAB3GAP2;SEC61A1
prerank,positive regulation of biosynthetic process (GO:0009891),0.47924142511754236,1.298570268445398,0.1579778830963665,0.8743457590420736,1.0,8/40,6.42%,SORBS1;WNT4;PPARA;ZBTB20;SLC5A3;TLR4;F2;CREBL2
prerank,regulated exocytosis (GO:0045055),-0.32550784647303704,-1.2984013332820246,0.0211864406779661,0.4564076794237511,1.0,50/173,15.64%,PCDH7;ABCC4;SYT1;VWF;ACTN4;RIMS2;PECAM1;TMSB4X;CD9;SNAP25;RIMS1;VEGFC;THBS1;ACTN1;FN1;TGFB2;PCLO;GAS6;RAB31;MYH9;LYN;OLA1;LHFPL2;CALM1;APP;FLNA;PSAP;TGFB3;CD109;ECM1;TAGLN2;TGFB1;PDGFA;ITGB3;WDR1;FAM3C;RAB27B;PROS1;RAB11FIP1;RAB11FIP5;SNCA;CDC37L1;VEGFA;SDF4;SYT7;CLU;SYNGR2;RARRES2;ALDOA;NHLRC2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5660461706062344,1.298055144670345,0.1944990176817289,0.87407362579057,1.0,9/18,19.69%,KMT2A;SETD7;KMT2D;SETD1B;EHMT2;EHMT1;ASH1L;SETD3;SETD1A
prerank,nucleic acid-templated transcription (GO:0097659),0.4744625546441637,1.2979528307732138,0.14614121510673234,0.8721884405373163,1.0,7/42,8.38%,THRB;POLR2A;DTX1;CREBL2;POLR2D;MEF2A;TERT
prerank,triglyceride metabolic process (GO:0006641),0.4677433777619364,1.297158170216066,0.1424,0.8730768193504617,1.0,8/48,9.34%,LPGAT1;MOGAT3;GPAT2;CPS1;GK5;GK;APOBR;SIRT1
prerank,engulfment of apoptotic cell (GO:0043652),-0.5227715057338715,-1.296985820657585,0.15486725663716813,0.45884096935588164,1.0,6/15,13.86%,RHOBTB1;XKR4;THBS1;XKR6;RHOH;ADGRB1
prerank,sterol metabolic process (GO:0016125),0.44609334782745685,1.2968876220485286,0.1437216338880484,0.8718837821146845,1.0,12/60,13.24%,PRKAG2;CYP27A1;INSIG2;LIPA;CYP21A2;CYP26B1;FDXR;CLN6;SULT2B1;ARV1;TM7SF2;LBR
prerank,positive regulation of type 2 immune response (GO:0002830),0.58773742082438,1.2967876999467982,0.18762475049900199,0.8700190809330643,1.0,3/14,9.32%,PRKCZ;IL18;RSAD2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.39227642297394905,-1.2963382120516156,0.09487179487179487,0.4594663997376254,1.0,25/48,24.99%,PDE4D;AKAP6;CAMK2D;UBASH3B;PTK2B;CEMIP;CALM1;CALM2;TRPC1;CALM3;FKBP1A;JPH2;GPER1;NOS1;SNCA;SELENON;APLNR;CASQ2;GSTM2;JPH3;NPSR1;THY1;DMD;F2R;CXCL10
prerank,regulation of blood coagulation (GO:0030193),-0.4460648322025359,-1.2963066290164886,0.1475826972010178,0.4585517470430935,1.0,11/27,13.12%,CAV1;ST3GAL4;SERPINE2;THBS1;FAP;CD34;APOE;EPHB2;EDN1;ENPP4;DMTN
prerank,striated muscle tissue development (GO:0014706),-0.4543807212298457,-1.296295295903205,0.12285012285012285,0.4575983627378586,1.0,8/29,4.11%,SGCZ;MEF2C;SGCD;PGM5;BMP5;CAV1;BMPR2;MYL6
prerank,catecholamine metabolic process (GO:0006584),0.5935137282537359,1.2961802909234408,0.19659735349716445,0.8701924774065262,1.0,3/14,8.51%,SNCAIP;PRKN;LRTOMT
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.49150603616134214,-1.2960769157422132,0.14385150812064965,0.4570809846939329,1.0,9/20,14.18%,NOTCH1;SMAD5;SMAD1;BMP2;RUNX2;ATF4;HIF1A;VEGFA;MT3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.5405980019629713,-1.2959048032590534,0.15495867768595042,0.4564362549766925,1.0,5/13,11.44%,LTBP1;GREM2;FBN2;BMP2;NRROS
prerank,visual system development (GO:0150063),0.4725756727150122,1.295593946964471,0.15483870967741936,0.8703300056624229,1.0,5/37,7.53%,SMOC1;FOXC1;MEIS1;SH3PXD2B;RBP4
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6007788192735696,1.2953809993606702,0.20229007633587787,0.8689372215808026,1.0,5/11,15.62%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5558522539298414,-1.2951748308934143,0.16988416988416988,0.45714262403998795,1.0,2/12,0.36%,PRKG1;MEF2C
prerank,renal system development (GO:0072001),0.4583525115077999,1.2948077706420151,0.1362940275650842,0.8690499502079477,1.0,8/52,3.92%,ACE;LRP4;WNT4;GREB1L;GLI2;TGFBR1;FOXC1;SULF2
prerank,receptor internalization (GO:0031623),-0.41112302026091624,-1.294362626677279,0.11290322580645161,0.4580372857195925,1.0,14/44,13.29%,DNM3;CALCRL;CAV1;CD9;RAB31;TFRC;RAMP2;ACKR3;ITGB1;DNM1;CEACAM1;AP2M1;SNCA;RAMP1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.47444705225197176,1.2941927889291356,0.16086235489220563,0.8692513188475748,1.0,7/40,7.86%,SLC13A3;SLC38A4;SLC38A3;SLC7A11;SLC19A1;SLC27A1;SLC38A1
prerank,muscle organ development (GO:0007517),-0.3931397106867145,-1.2938283252136824,0.09418282548476455,0.4583223029703978,1.0,11/54,6.46%,UTRN;MEF2C;SGCD;COL6A3;MKX;LAMA2;TEAD4;SGCE;TBX1;SMTN;FKTN
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5011637283748805,1.293026369872818,0.16302521008403362,0.8717802690491526,1.0,5/30,6.97%,TGFBR3;SMAD3;DKK3;TWSG1;SMURF2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5841828367772798,-1.2921757056589485,0.19230769230769232,0.46133021539957425,1.0,4/10,4.47%,PDE3B;ACER2;NEXMIF;CYP1B1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.601699510968597,1.291748998443583,0.20502901353965183,0.8745181591349359,1.0,3/12,4.94%,THRB;BRD8;CTSH
prerank,regulation of protein targeting to membrane (GO:0090313),-0.43991951192400286,-1.2912402107369685,0.145985401459854,0.4625596931224729,1.0,8/28,18.53%,ANK3;CEMIP;MTCL1;ERBB2;KCNB1;DMTN;GDI1;ITGB2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4182194407240388,-1.2907849228873356,0.10498687664041995,0.4626305815989978,1.0,8/35,8.92%,MEF2C;PTPRM;CAV1;THBS1;CAV2;APOE;ATOH8;XDH
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2978163104512008,-1.2903749304997754,0.017543859649122806,0.4626747643199886,1.0,114/390,17.05%,NRP1;FLRT2;ARHGEF28;GHR;PTPRJ;TEK;GRB14;ERBB4;NTRK3;PIK3R1;ACTB;PTPRG;ROR1;EPHB1;MPZL1;VEGFC;EPHA5;MERTK;UBASH3B;ATP6V0A1;GRIN2B;EFNA5;PTPRT;NRP2;EPHA6;TIE1;PAK3;COL4A2;NCK2;STAT3;CHN1;GAB1;PTK2B;BCAR3;ACTG1;CAV2;NGF;NTRK2;ARHGEF7;DOCK1;KDR;LYN;GSK3B;ROR2;PDGFC;ACTR2;TIAM1;PAK1;AP3S1;NAMPT;MET;SOCS2;EPHA7;FOXO1;PSEN1;ATP6V0A4;CRK;DNM1;SORT1;EPHB2;ANKS1B;PTK2;AP2B1;ABI1;NCF2;FGF2;FLT4;ERBB2;DDIT4;PDGFA;HSP90AA1;BCAR1;ITGB3;ACTR3;CYBA;ELMO1;AP2M1;TIAL1;ARPC1B;RASA1;SH2B2;MTSS1;FGF7;ARPC5;COL1A1;PRKD1;AHI1;POLR2J;FGF9;RET;VEGFA;ARPC4;SPRED1;CDK5R1;FES;FGFR3;NUS1;NCK1;RARRES2;STMN1;GRIN1;IL31RA;EIF2AK3;ANGPT2;BDNF;CBL;BLNK;VAV1;GFRA2;PIK3C2A;RBFOX2;APC;TYRO3;WASF2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5067581541600602,-1.2903050328306978,0.15384615384615385,0.4618819768507079,1.0,5/17,12.53%,PRKG1;MEF2C;TGFB3;GPER1;CDKN1A
prerank,modulation by symbiont of host process (GO:0044003),-0.5855073395992918,-1.2902979522715634,0.160676532769556,0.4609346741547031,1.0,6/10,23.93%,B2M;UBB;MRC1;PGK1;UBC;RPS27A
prerank,oligosaccharide metabolic process (GO:0009311),-0.3943022758544198,-1.2901209257212365,0.1002710027100271,0.460426545961744,1.0,15/46,17.10%,ST6GALNAC3;ST3GAL4;ST8SIA4;FUT9;ST6GAL2;ST8SIA1;ST6GALNAC5;B3GALT1;ST3GAL6;ST8SIA6;B3GALT5;MAN1B1;AMY1B;AMY1A;AMY1C
prerank,response to iron ion (GO:0010039),0.5905816046086992,1.2895973540191297,0.2054263565891473,0.8810073064177012,1.0,1/12,0.40%,BMP6
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5150061937136181,1.289057455043281,0.18166383701188454,0.8808891071425722,1.0,13/27,24.56%,BRD8;CPA4;KAT6B;KAT7;KAT2B;CREBBP;SGF29;TAF6L;RUVBL1;EP300;BAG6;MSL3;PHF20
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4833838658716162,1.2884226338600049,0.17940199335548174,0.8810137457791931,1.0,7/40,3.18%,BMP6;BMP7;WNT4;OSR1;KL;WNT6;BMPR1A
prerank,regulation of Rac protein signal transduction (GO:0035020),0.5775339471760008,1.2881388362976434,0.19626168224299065,0.879902797012892,1.0,3/16,6.19%,AUTS2;ALS2;ARHGAP17
prerank,mRNA splice site selection (GO:0006376),0.4969081577570942,1.2881015887082623,0.17666666666666667,0.8778383026885637,1.0,11/30,20.07%,CELF2;SRSF5;PRPF39;KHDC4;LUC7L3;SFSWAP;PSIP1;SRSF1;SRSF10;SNRPC;SF1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.37428084214155477,-1.2878266764759774,0.09230769230769231,0.46489047209436435,1.0,21/72,12.16%,TEK;NTRK3;PIK3R1;ROR1;DCN;FN1;TGFB2;GAB1;NTRK2;KDR;LYN;ROR2;PDGFC;SEMA4D;MYOC;PTK2;FGF2;PIK3AP1;PDGFA;GPER1;UNC5B
prerank,cholesterol transport (GO:0030301),-0.4023813150494571,-1.286939161409813,0.11141304347826086,0.4661188239811247,1.0,15/45,21.36%,CAV1;SCARB1;LIMA1;APOE;ABCG1;LDLR;NPC2;STARD5;STX12;STARD4;CLU;RELCH;LDLRAP1;OSBP;STARD3
prerank,negative regulation of secretion by cell (GO:1903531),-0.4119297290242448,-1.2868738812362166,0.11049723756906077,0.46531406405265396,1.0,11/38,16.27%,STXBP6;IL1RAPL1;GRM7;NOTCH1;ANXA1;APOE;TNFRSF1B;SLC30A1;SNCA;HTR1B;ERP29
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5356946472189152,1.2865776693561077,0.16283185840707964,0.8816121445472295,1.0,7/20,15.30%,TNRC6A;MOV10L1;TNRC6B;MOV10;AJUBA;TNRC6C;WTIP
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.5029182918974333,-1.2864490754337201,0.13347022587268995,0.4653260707013576,1.0,7/18,28.12%,PIK3R1;USP13;NCK1;BCL2L11;ERN1;TMEM259;PMAIP1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.41330973428807866,1.2861214750543293,0.11549295774647887,0.881229892896524,1.0,14/95,9.34%,DAB2;TGFBR3;SMAD3;PPARA;SNX6;DKK3;PMEPA1;TGFBR1;SMAD6;LDLRAD4;SMURF2;TGFBR2;PDPK1;SIRT1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5953738909534877,1.2857656710968468,0.2158671586715867,0.8804581550243705,1.0,3/12,4.06%,PTPN14;NEDD4;IFI27
prerank,glycerol metabolic process (GO:0006071),0.6311871012297299,1.2850664867795407,0.22690763052208834,0.8809748356278948,1.0,4/10,16.21%,GK5;TKFC;GK;GOT1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.593466795561669,1.285051182184468,0.18975332068311196,0.8788300948423204,1.0,2/12,0.71%,WNK4;ATP1B3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.409327051452948,1.2849248216260127,0.12078651685393259,0.8771516743625816,1.0,14/101,9.34%,FGF1;ROBO1;TPD52L1;KIT;FGFR1;ADRA2A;LRRK2;DDX3X;CAMK1;FLT1;PDGFRB;SLC27A1;CCND3;SIRT1
prerank,positive regulation of cell growth (GO:0030307),-0.3445749067989357,-1.2844221007451464,0.07516339869281045,0.4693233988186647,1.0,24/96,14.15%,SYT1;RIMS2;AKAP6;RIMS1;TGFB2;SEMA7A;CDKL5;NGF;NEDD4L;NTN1;SHTN1;SEMA4D;LGI1;CXCL16;H3-3A;ERBB2;RPS6KA3;SLC25A33;EDN1;MFSD2A;MAPT;TAF9B;RPS6KA1;SMURF1
prerank,photoperiodism (GO:0009648),0.5101380165272655,1.2835579179099552,0.15736040609137056,0.8802106917961107,1.0,14/28,20.36%,FBXL17;PPP1CB;TP53;SIK1;FBXL12;PML;PER2;RBM4;PER3;CRY1;CRTC1;FBXL22;MTA1;PDE6B
prerank,granulocyte chemotaxis (GO:0071621),-0.384980394981874,-1.2835523625091638,0.10427807486631016,0.4704375817582199,1.0,13/55,20.36%,PDE4B;BSG;TGFB2;ANXA1;PPIA;PPIB;EDN1;EDN3;SCG2;CCL13;SYK;ITGB2;CCL19
prerank,integrin-mediated signaling pathway (GO:0007229),-0.3590053429025445,-1.283029779843382,0.06547619047619048,0.47072364413158535,1.0,22/73,10.38%,NRP1;ITGBL1;FN1;SEMA7A;DST;PTK2B;MYH9;DOCK1;ITGB4;ITGB8;ITGB1;ADAM15;LAMA3;PTK2;CUL3;PTN;CEACAM1;TEC;CD47;ERBIN;BCAR1;ITGB3
prerank,negative regulation of hydrolase activity (GO:0051346),0.45574220802361,1.2827710289406973,0.14516129032258066,0.8812645066156112,1.0,7/49,6.80%,CPEB2;SH3RF2;LRRK2;GMIP;MAP2;BCAS3;SH2D4A
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.48225046675443917,-1.2825928228696706,0.18831168831168832,0.47079768849818204,1.0,8/20,21.32%,CAMK2D;PSEN1;SELENOK;PACS2;KCTD17;THADA;BCAP31;ATP2A2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5326944842548906,-1.2825660803273353,0.16150442477876106,0.46989875664723524,1.0,7/13,27.83%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B4GAT1;B3GNT6
prerank,receptor metabolic process (GO:0043112),-0.3790126967705332,-1.2816757487930532,0.10743801652892562,0.47105201761182997,1.0,21/53,19.16%,DNM3;CALCRL;CAV1;CD9;RAB31;TFRC;RAMP2;SH3GLB1;ACKR3;ITGB1;DNM1;TGFB1;AP2M1;SNCA;RAMP1;SMURF1;EHD3;SYK;ITGB2;ARRB2;LDLRAP1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3865633651783226,-1.2804882956432317,0.09826589595375723,0.4729341125563622,1.0,15/52,11.24%,SPTBN1;DPP10;PRKCH;PIK3R1;EPB41;EPB41L2;STX3;PLS1;NKD2;GNAI1;ITGB1;EPHB2;EFCAB7;ATP2B4;GPER1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6166489732793429,1.280252797835807,0.21935483870967742,0.8892347567810838,1.0,3/10,3.86%,ATP1A2;OSR1;NEDD4
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.5467453622159011,-1.279986393402683,0.1738241308793456,0.4731674242880191,1.0,6/13,22.09%,TGFB1;MAPT;SYK;ITGB2;TYROBP;SOD1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5536273557273017,1.2795025063716319,0.20677361853832443,0.889952422582813,1.0,4/18,3.52%,ROCK2;PICALM;EPHA4;CASP3
prerank,positive regulation of cell differentiation (GO:0045597),0.3692824448216513,1.2789423738007075,0.06235011990407674,0.8899228486803646,1.0,43/237,12.15%,RANBP3L;DAB2;TMEM64;BMP6;BMP7;SMAD3;WNT4;IGF1;RIN2;CCN2;MEDAG;IL18;HOXB4;NPNT;ADIG;SOX5;FGFR1;BMPR1A;TGFBR1;FOXC1;PDPN;ATOH1;PPP1R13L;CAMK1;CREBL2;WWTR1;TGFBR2;MEF2A;IGFBP3;GDNF;GPRC5B;NEUROD4;NBL1;LRP3;BLOC1S6;TCF4;ABL1;SUCO;CDC42;IMPACT;NOCT;AXIN2;ATRAID
prerank,epithelial cell-cell adhesion (GO:0090136),0.6095349752989695,1.278883590118417,0.22030651340996169,0.8879725726536946,1.0,2/11,2.63%,KIT;PLEKHA7
prerank,manganese ion transport (GO:0006828),-0.528091307169025,-1.2787957555678515,0.17738359201773837,0.475076002865595,1.0,7/14,15.04%,ATP2C1;TRPC3;TRPC4;TRPC1;TRPC6;TRPC5;TRPC7
prerank,negative regulation of translation (GO:0017148),0.41292281238637896,1.2784197335757155,0.12160228898426323,0.887603892523865,1.0,13/87,10.35%,CPEB2;ROCK2;CPEB4;IGF2BP1;DDX3X;EIF2AK2;SAMD4A;LARP1;CPEB3;IGF2BP2;CNOT10;LSM14A;YTHDF3
prerank,ribosomal small subunit assembly (GO:0000028),-0.5141871119548569,-1.278221940902895,0.162227602905569,0.47551662452432375,1.0,8/16,18.84%,RPS19;RPS28;RPS15;RPS27;XRCC5;RPS5;RPSA;RPS27L
prerank,cellular response to organic cyclic compound (GO:0071407),0.38998219890041186,1.2778079710802488,0.10430247718383312,0.8877965800324825,1.0,19/141,7.02%,ATP1A2;RORA;ADCY5;ROCK2;TFPI;SLC5A5;ADCY1;IL18;SPP1;CASP3;LRRK2;RAPGEF3;EZR;SLC26A3;NCOA3;P2RX3;TIPARP;LCOR;RORC
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4486776104716597,-1.2775286770476095,0.1511627906976744,0.4762185198288682,1.0,10/26,8.85%,NLGN1;NRXN1;RIMS2;SHANK3;RIMS1;PTK2B;TMEM108;APP;RELN;MTMR2
prerank,heart development (GO:0007507),-0.3314515611610568,-1.2774295973573115,0.043478260869565216,0.47552880723283647,1.0,41/150,13.77%,SGCZ;MEF2C;SGCD;FLRT2;TEK;BMP5;ZFPM2;ERBB4;NTRK3;FGF12;HEG1;BMPR2;PLCE1;FN1;TGFB2;MICAL2;ECE1;ACVRL1;HDAC9;NOTCH1;RAMP2;TBX1;SOX17;STRA6;PCSK5;BMP2;TGFB1;PTK2;PDLIM1;ID2;PKD1;FKBP1A;BMP4;RBM20;SOX18;CDKN1A;CRIP1;PDLIM3;ACVR1;MYOCD;VEGFA
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.45117111691232803,-1.2764621012426463,0.15724815724815724,0.4768743968616122,1.0,6/24,6.44%,GHR;ERBB4;PTK2B;CYP1B1;NOTCH1;HES1
prerank,muscle cell differentiation (GO:0042692),0.48681972140189944,1.2761955968710312,0.173109243697479,0.8918628923733523,1.0,5/32,3.63%,WNT5B;RORA;NEBL;DUSP29;SPEG
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.593530030735895,1.2756777265100552,0.2033898305084746,0.8917822364722578,1.0,3/11,7.33%,TGFBR3;TGFBR1;TGFBR2
prerank,synapse organization (GO:0050808),-0.3349948528292429,-1.2754839476642814,0.04184100418410042,0.4781977459653187,1.0,28/125,7.16%,NLGN1;ADGRL3;CTNND2;NRXN1;DNM3;APBB2;LRRC4C;PTPRD;CACNB2;GRM5;PPFIA2;CDH2;KIRREL3;ANK3;SHANK3;SPOCK2;GPC6;LRFN5;PAK3;GPHN;DNER;NTNG1;UNC13B;SEMA3E;APP;NRCAM;PTPRF;PSEN1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4964877832426929,1.2754223442042043,0.18416523235800344,0.8905723195604979,1.0,5/30,6.50%,ACE;KIT;HOXB4;FLT1;TP53
prerank,regulation of AMPA receptor activity (GO:2000311),-0.45726719040225966,-1.2754033398509417,0.1357142857142857,0.47746612421021556,1.0,7/25,7.93%,NLGN1;MEF2C;SHANK3;SHISA6;SHISA9;MINK1;RELN
prerank,regulation of phosphatase activity (GO:0010921),0.508707759393688,1.2753220988092024,0.18760757314974183,0.888758236325639,1.0,4/24,8.59%,SH3RF2;SH2D4A;CDK5RAP3;HTT
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5845700795523211,1.2752263500351964,0.2202486678507993,0.8869970484110136,1.0,3/14,6.47%,IL18;IL17D;IL12B
prerank,ear morphogenesis (GO:0042471),0.5332991003992654,1.2748927283432823,0.198943661971831,0.8861688792772888,1.0,6/20,8.36%,OSR1;FGFR2;HOXA1;NIPBL;CHD7;ZIC1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5199212940241851,1.274422663265846,0.18035714285714285,0.8859248909317611,1.0,3/23,2.21%,IGF1;PRKAA2;ZBTB20
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.45143381400018523,1.2740889665504516,0.14501510574018128,0.8851078769679722,1.0,16/58,13.33%,PAXX;POLM;BABAM2;DNTT;ATM;UVRAG;NHEJ1;RNF8;KDM2A;XRCC4;IFFO1;PRKDC;UIMC1;RAD50;NSMCE2;BABAM1
prerank,clathrin-dependent endocytosis (GO:0072583),0.5157684315089377,1.2740187420209514,0.18652849740932642,0.8832319455185681,1.0,3/26,2.14%,DNAJC6;PICALM;FCHSD2
prerank,regulation of acute inflammatory response (GO:0002673),-0.48748146311778556,-1.2739340245691626,0.16666666666666666,0.4800935783457586,1.0,3/18,7.80%,OSMR;IL6ST;PTGES
prerank,neutrophil migration (GO:1990266),-0.37883836201710047,-1.273862191683132,0.09192200557103064,0.4793506179671503,1.0,27/58,37.96%,PDE4B;PECAM1;BSG;TGFB2;PPIA;PPIB;EDN1;EDN3;CCL13;SYK;ITGB2;CCL19;PRTN3;CXCL10;PIK3CD;CCL2;IRAK4;JAML;CXCL5;CCL11;CXCL1;PIP5K1C;CCL4;PF4;PPBP;CCL8;PIK3CG
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5536585606943931,-1.273399119970884,0.2033898305084746,0.4794975706227452,1.0,3/11,13.88%,ANXA1;SMAD7;SOCS5
prerank,positive regulation of cell migration (GO:0030335),-0.3021168187359613,-1.2731386326718437,0.030120481927710843,0.47915749025255033,1.0,73/253,13.77%,NRP1;LEF1;SEMA3C;ACTN4;SEMA6A;NTRK3;SEMA6D;CDH13;CAV1;PECAM1;ITGA6;BMPR2;GCNT2;PODXL;RTN4;THBS1;CLASP2;FN1;TGFB2;CXCL12;SEMA5A;SEMA7A;STAT3;CARMIL1;GAB1;PTK2B;ACTG1;F3;CEMIP;NOTCH1;ARHGEF7;SEMA3E;DOCK1;SHTN1;ARHGEF2;KDR;ROR2;PDGFC;DAB2IP;TIAM1;PAK1;PTPRC;PLCG2;SEMA4D;ITGB1;VSIR;EPHB2;CCN1;PPP3CA;BMP2;MYOC;HSPA5;TGFB1;PTK2;MGAT5;RDX;DDRGK1;CXCL16;PDGFA;BCAR1;EDN1;ENPP2;TWIST2;GPER1;FAM107A;SEMA3D;SEMA3G;HIF1A;DMTN;COL1A1;ACVR1;RET;VEGFA
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4835246206331223,-1.2731007780748222,0.14545454545454545,0.47831450577135864,1.0,3/17,4.12%,ANK3;AKAP6;KCNAB1
prerank,regulation of integrin activation (GO:0033623),-0.5125985248713216,-1.2730524728975834,0.17763157894736842,0.4774914765908845,1.0,9/15,32.43%,RASIP1;RAP1B;PIEZO1;FBLIM1;SKAP1;KIF14;SELP;JAM3;PTGER4
prerank,T cell proliferation (GO:0042098),-0.5307972676140554,-1.273022627939731,0.17463617463617465,0.4766405492301194,1.0,3/13,10.85%,CADM1;DOCK8;MSN
prerank,cellular response to alkaloid (GO:0071312),-0.49413652139081427,-1.272978978212107,0.167420814479638,0.4758136728683234,1.0,8/17,22.82%,SLC8A1;RYR2;RYR3;HTR1B;CASP6;CASQ2;GSTM2;BLM
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.48878404938108816,1.272400959754014,0.1753472222222222,0.8874650787654552,1.0,4/31,3.64%,SYT9;SYT11;SYT12;ADRA2A
prerank,regulation of mitochondrial fission (GO:0090140),0.5105226681829407,1.2723555154677115,0.1835334476843911,0.885544387684808,1.0,8/24,11.94%,PRKN;MCU;LRRK2;STAT2;MYO19;DNM1L;CYRIB;RALBP1
prerank,positive regulation of heart contraction (GO:0045823),0.5265388575436064,1.2717673432667205,0.1930783242258652,0.8857821567988904,1.0,1/19,0.08%,ATP1A2
prerank,glycolipid metabolic process (GO:0006664),-0.3966944885143406,-1.2717012528448361,0.12082262210796915,0.47791326467630874,1.0,11/47,10.36%,ST6GALNAC3;ST3GAL4;ESYT2;UGCG;PSAP;GLTP;ST3GAL6;HEXB;ST8SIA6;B3GALNT1;ESYT3
prerank,insulin secretion (GO:0030073),-0.4801313480370941,-1.271214139828979,0.18080357142857142,0.47813529475731664,1.0,4/19,12.79%,RIMS2;PTPRN2;ANXA1;RAB11FIP5
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5132587735918963,1.271127404974573,0.19429590017825313,0.8862398314874345,1.0,4/24,7.26%,SORBS1;IGF1;PPP1R3B;GCK
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5525596932682928,1.2710839454820915,0.2198952879581152,0.8843265657029736,1.0,4/16,9.66%,ACE;KLK2;ADM;SPX
prerank,fatty acid transport (GO:0015908),0.5455082857669197,1.2709063206280917,0.20550458715596331,0.8830074523633226,1.0,4/17,7.36%,ACSL1;SLC5A8;SLC27A1;GOT2
prerank,negative regulation of heart contraction (GO:0045822),0.5994652713102389,1.2708222583191755,0.2127659574468085,0.8813076419924181,1.0,1/11,0.08%,ATP1A2
prerank,neuropeptide signaling pathway (GO:0007218),-0.38266468510306023,-1.2707881649627306,0.10091743119266056,0.47828232480465627,1.0,14/58,16.69%,SORCS1;SORCS3;GLRB;GLRA3;SORL1;SORT1;GLRA1;CYSLTR1;HCRTR2;CYSLTR2;GLRA2;NXPH2;NMU;CPE
prerank,regulation of blood circulation (GO:1903522),0.4854857599025134,1.2707640350887552,0.1891891891891892,0.8795074620861745,1.0,5/34,5.17%,CELF2;ACE;DMPK;BDKRB2;TPM1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5122578677835591,1.270447897410435,0.16379310344827586,0.8785962469049683,1.0,14/27,20.36%,FBXL17;PPP1CB;TP53;SIK1;FBXL12;PML;PER2;RBM4;PER3;CRY1;CRTC1;FBXL22;MTA1;PDE6B
prerank,outflow tract septum morphogenesis (GO:0003148),-0.45243695491335445,-1.2702286479891336,0.1463963963963964,0.478698024827027,1.0,9/24,5.71%,NRP1;ROBO2;SEMA3C;ZFPM2;BMPR2;ENG;TGFB2;NRP2;TBX1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3429442713378705,1.269420416597395,0.016511867905056758,0.8804145863172859,1.0,131/834,11.69%,EPAS1;HLF;DAB2;FGF1;WWOX;RORA;BMP6;PPARGC1B;THRB;SMAD3;TFDP2;GLIS3;AUTS2;OSR1;PPARGC1A;IGF1;RHOQ;BRD8;KMT2A;PPARA;SSBP2;CREBRF;FGFR2;PRKN;IL18;FHOD1;HOXB4;GLI2;CSRP3;GABPB1;GABPB2;HOXA1;MOSPD1;NFAT5;PCGF5;HDAC8;PHIP;NR2F2;BMPR1A;ELF1;GLI3;MITF;ARNT2;FOXC1;MLLT10;NFIB;HOXB3;VEZF1;ZBTB38;ASCL3;ZNF462;NFYB;TLR3;NHLH2;RREB1;TLR4;MEIS1;TET2;FZD5;ATM;DDX3X;ARRB1;NCOA3;CAPRIN2;MAP2K5;GPS2;CAMK1;ATRX;ABHD14B;ESRRA;HMGA1;TP53;TBL1X;BCAS3;BCLAF3;CAMTA2;WWTR1;MED12;SOX12;SERPINE1;CCNT2;SMARCD3;PLSCR1;LDB1;LDB2;LAGE3;ATAD2B;MEF2A;SMARCA4;NR1D2;HOXC4;SSBP3;TBL1XR1;KAT6B;TERT;GDNF;APLN;TMF1;JMJD6;CALCOCO1;HDAC4;GLI1;SIRT1;WASL;TFDP1;RIPK2;NR2C2;HDAC1;LARP7;ELL;RIPK1;MAVS;FOXC2;TCF7L2;TCF4;MYBL1;MED17;RBL1;GTF2F1;KMT2C;THRAP3;ABL1;NFATC3;RARG;ATF2;PRKDC;ZMIZ2;MLLT6;MYBL2;TEAD1;ZMIZ1
prerank,regulation of viral genome replication (GO:0045069),0.44377033726593407,1.269324137315174,0.14576802507836992,0.8787635670145139,1.0,15/56,13.47%,PPARA;IFIT1;OAS2;PARP10;DDX3X;CD28;EIF2AK2;PLSCR1;LARP1;RSAD2;ZC3HAV1;MAVS;SRPK2;OAS3;HACD3
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.49303733586476806,-1.2690735591131803,0.16252821670428894,0.48052750208802486,1.0,9/18,25.02%,FLNA;ERBB2;ATF4;EIF2AK3;MAF1;UTP15;PHF8;POLR2L;LYAR
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5364779093188847,1.2684884941872574,0.19434628975265017,0.8800318775360585,1.0,11/20,22.88%,AMPD3;LHPP;AK4;AK3;NT5C2;AMPD2;ADSS1;GART;GMPR2;ADSL;GMPS
prerank,cellular response to chemical stress (GO:0062197),0.4053593202236566,1.2683052558417065,0.13128491620111732,0.878712917353551,1.0,17/96,10.62%,CPEB2;MSRA;PPARGC1A;PRKAA2;MGAT3;LRRK2;SESN2;SOD3;ATM;DDX3X;ALDH3B1;NOX1;SOD2;PIK3CA;NOX4;ATG7;ABL1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.44088435971869594,-1.2677978496847648,0.16927083333333334,0.48275935171439566,1.0,8/27,8.00%,SLC47A1;SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.5123706265459969,-1.2676424385154352,0.18292682926829268,0.48221177564691403,1.0,7/15,16.34%,STOX2;TGFB2;CELF4;UBR3;SCEL;USP22;NR5A2
prerank,regulation of response to biotic stimulus (GO:0002831),0.49747616093587205,1.2674995564459939,0.19223985890652556,0.8797039089202588,1.0,10/28,16.00%,APPL2;RNF135;TKFC;PTPN22;SAMHD1;DHX58;IRF1;ERAP1;ZMPSTE24;BIRC3
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2893089287576479,-1.2672140687087448,0.0,0.48228629505552834,1.0,104/428,19.59%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;RAB31;PTPRN2;HSP90AB1;PRG2;GPI;ACTR2;PPIA;RAP1B;PTPRC;RAP1A;CD93;STK10;CTSD;PSAP;CTSC;RAB27A;TSPAN14;HSPA8;TIMP2;PSEN1;TNFRSF1B;DYNLL1;PGLYRP1;NPC2;SLC44A2;FTL;CKAP4;OSTF1;MME;EEF1A1;HEXB;CTSB;STOM;CEACAM1;PSMD14;CRACR2A;CD47;DOCK2;RAB18;CD44;HSP90AA1;CYBA;IMPDH1;XRCC5;GOLGA7;CTSS;ENPP4;HRNR;SLC2A3;ARPC5;TNFAIP6;LRG1;SRP14;PGAM1;FABP5;TMEM30A;QPCT;SCAMP1;DOK3;RAB6A;TRPM2;ALDOA;CCT8;APEH;PKM;CAT;CCT2;PDXK;STXBP3;SVIP;SYK;RAB37;GCA;CYB5R3;C3AR1;PSMD11;CTSZ;ITGB2;CAND1;SLC27A2;QSOX1;TMEM63A;EEF2;SPTAN1;PSMD2;ATP11B;TYROBP
prerank,regulation of axon guidance (GO:1902667),-0.564292104614605,-1.2669904484826362,0.18936170212765957,0.48184962116335167,1.0,4/10,15.01%,NRP1;MYCBP2;VEGFA;TUBB2B
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5584595837793236,-1.266847919803784,0.17735042735042736,0.48125616446485414,1.0,10/11,43.27%,STAT3;IL6ST;JAK1;JAK2;STAT4;IL27RA;IL12A;STAT1;EBI3;CANX
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4106067815758727,-1.2668093372101459,0.13131313131313133,0.48045410834978974,1.0,7/40,5.87%,SYT1;RIMS2;SNAP25;RIMS1;PCLO;UNC13B;STX3
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.47774358649964555,1.2667664260081244,0.18319327731092436,0.880588166501255,1.0,9/34,13.76%,LGR4;CD300A;TLR3;TLR4;GPS2;RAB7B;LY96;LRRC14;ACOD1
prerank,positive regulation of embryonic development (GO:0040019),0.5325641557042722,1.2666081253901256,0.19064124783362218,0.8791928459486288,1.0,5/19,12.31%,WNT4;OSR1;NIBAN2;NR2C2;FOXA2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.40466817638180896,-1.2665217081230946,0.13333333333333333,0.4801772616309904,1.0,15/39,11.40%,PTPRG;PODXL;EFNA5;TENM3;FUT9;JAG1;MINK1;EPHA7;TGFB1;PTK2;CEACAM1;SMAD7;CD47;ZDHHC2;CDH1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4472738552081405,-1.2663108147726663,0.16666666666666666,0.47972574100605136,1.0,8/26,11.00%,PDE8A;PTPN12;IQGAP1;DAB2IP;EEF1A1;STAT5B;ERBB2;DUSP3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.45433489469048727,-1.2662812530374556,0.163855421686747,0.47886063536840956,1.0,11/25,26.28%,HIP1;RTN4;BCAR3;CCDC88A;GPER1;CBL;HIP1R;AGT;HAP1;PLAUR;CNOT9
prerank,cell junction organization (GO:0034330),0.41846619731934703,1.2656615163753624,0.14749262536873156,0.8810203437888059,1.0,9/71,3.91%,SDK1;SLC6A1;SMAD3;LRP4;SDK2;SLC8A3;PKHD1;NLGN2;PPFIA1
prerank,DNA methylation (GO:0006306),0.514340310659302,1.2654514609401708,0.20499108734402852,0.8798642172728608,1.0,12/23,24.16%,DNMT3A;ATRX;PICK1;MTRR;BEND3;EHMT2;EHMT1;KMT2E;METTL4;N6AMT1;DMAP1;PPM1D
prerank,cellular calcium ion homeostasis (GO:0006874),-0.32440253316702466,-1.2653520546763994,0.05860805860805861,0.4800412286234849,1.0,39/133,12.96%,SLC8A1;CAV1;SLC24A2;RYR2;CAMK2D;NPTN;HTR2C;STIM2;CXCL12;TPT1;ATP2C1;ATP1B1;SLC35G1;CAV2;TRPC3;YWHAE;ATP2B2;TRPC4;MICU3;SLC10A7;HTR2A;TRPC1;TRPC6;PSEN1;CALR;ATP2A3;TRPV4;ATP2B4;EDN1;PTH1R;GPER1;SELENOK;SMDT1;PACS2;HCRTR2;ATP2B1;EDN3;SLC30A1;MCUB
prerank,regulation of interferon-beta production (GO:0032648),0.45455975715026575,1.2652015434655426,0.1779935275080906,0.8788828180853315,1.0,15/46,14.42%,OAS2;TLR3;TLR4;RNF135;DDX3X;TRIM56;RIPK2;MAVS;TOMM70;DHX58;PTPN11;IRF1;POLR3A;OAS3;PPM1B
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4493620988040359,1.2649919808516858,0.14906832298136646,0.877706114646829,1.0,18/52,19.92%,ME2;ADHFE1;GPT2;SLC19A1;GOT2;MTHFR;OGDH;IDH1;ALDH1L1;MTRR;ACOT8;D2HGDH;GOT1;MTHFD1;IDH2;PHYH;FOLR2;ACLY
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4148086630040583,1.264699670083402,0.13497822931785197,0.8767231502559051,1.0,16/87,12.27%,FGF1;FGFBP1;FGFR2;KL;POLR2A;FRS2;FGFR1;HNRNPH1;FLRT1;TIA1;POLR2D;HYAL1;FIBP;GTF2F1;KLB;PTPN11
prerank,glucose homeostasis (GO:0042593),0.4184388422256306,1.2645711365912595,0.12177650429799428,0.8752245129670647,1.0,12/83,9.99%,APPL2;LEPR;PPARGC1A;BACE2;PRKAA2;HK2;MCU;ADRA2A;GCK;RBP4;SIRT1;TCF7L2
prerank,cellular response to lipid (GO:0071396),0.3728748324447696,1.264562266624992,0.08827238335435057,0.8732813065796265,1.0,18/191,7.11%,ATP1A2;WNT5B;RORA;ADCY5;ROCK2;TFPI;PTK7;WNT6;ADCY1;SPP1;CTR9;PABPN1;TLR4;ATM;NCOA3;LCOR;RORC;SERPINE1
prerank,chordate embryonic development (GO:0043009),0.44156221212046903,1.2636835609600618,0.14992272024729522,0.8746711747211291,1.0,11/55,7.54%,ALDH1A2;BMP7;FGFR2;ZNF568;FGFR1;TGFBR1;ARNT2;SULF2;FUT8;RBP4;CHD7
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5811650643601973,1.2634445960233514,0.20446096654275092,0.8735650141084467,1.0,2/12,1.76%,PPARGC1A;PPARA
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.44825916103853797,1.263068426254945,0.16485225505443235,0.8729857884963619,1.0,6/47,7.26%,C1QTNF3;ROCK2;WNT4;SIK1;SLC27A1;GCK
prerank,dopamine metabolic process (GO:0042417),0.5464879698505387,1.262542971234519,0.19073083778966132,0.8731611629101144,1.0,3/18,1.98%,MOXD1;SNCAIP;PRKN
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.436176673498051,1.261560883122951,0.15821812596006143,0.8748859617365562,1.0,6/61,9.69%,PRKAG2;PPARA;NCOR2;SIRT5;SIRT1;AZIN1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5658994869738238,1.2615049109061824,0.22777777777777777,0.8731223342052511,1.0,5/14,8.38%,ATRX;TPP1;ACD;TNKS2;TERT
prerank,neuron differentiation (GO:0030182),-0.3227471720506921,-1.2610882943582957,0.06132075471698113,0.48923484353402774,1.0,33/165,10.30%,TENM2;MEF2C;PTPRD;IL1RAPL1;EPHA5;TENM3;TGFB2;TENM4;PBX3;RUNX1;FUT9;ATP8A2;ACSL3;UGCG;NTRK2;MYT1L;ATP2B2;MYEF2;RORB;FZD4;MET;ACSL4;VSX1;LHX6;WNT9A;SPOCK1;ATOH8;PPT1;ERBB2;PBX1;DDIT4;ID2;RUNX2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5374129666390159,-1.260671793412063,0.19205298013245034,0.48933485547953165,1.0,7/12,27.83%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B4GAT1;B3GNT6
prerank,cellular response to ketone (GO:1901655),0.47469504019626246,1.260155360342237,0.1805111821086262,0.8762626093367739,1.0,4/35,2.52%,ADCY5;ROCK2;ADCY1;SPP1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.5294862880987639,1.2600810778873548,0.18785578747628084,0.8746151378644705,1.0,7/19,15.62%,RENBP;UAP1L1;PGM3;GNPDA1;SLC35D1;GMPPB;GFPT1
prerank,positive regulation of macrophage migration (GO:1905523),-0.4802583539701878,-1.2596891559914734,0.16704805491990846,0.49071299141141395,1.0,5/19,15.16%,THBS1;PTK2;P2RY12;CMKLR1;RARRES2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4231717638670402,-1.2592051601502692,0.14209115281501342,0.490905687234129,1.0,10/31,14.97%,CTNNA2;MEF2C;CDH2;HDAC9;CDON;ID2;BOC;CTNNB1;MYOCD;MAPK12
prerank,macroautophagy (GO:0016236),0.39337856232820506,1.2584479762681875,0.12167832167832168,0.8788536007437445,1.0,28/118,18.19%,PRKAG2;PRKAA2;PRKN;MTMR3;PRKAG3;LAMP2;ATG10;UVRAG;ATG5;WIPI1;AMBRA1;LIX1L;TOMM70;BECN1;ATG7;CSNK2A2;CSNK2A1;VIPAS39;MFN2;ACBD5;VPS37A;SNF8;VPS4A;SNX14;CHMP4C;ZFYVE1;SQSTM1;MFN1
prerank,neutrophil degranulation (GO:0043312),-0.2881986025515976,-1.2584086499609568,0.0,0.4919128897318266,1.0,103/425,19.59%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;RAB31;PTPRN2;HSP90AB1;PRG2;GPI;ACTR2;PPIA;RAP1B;PTPRC;RAP1A;CD93;STK10;CTSD;PSAP;CTSC;RAB27A;TSPAN14;HSPA8;TIMP2;PSEN1;TNFRSF1B;DYNLL1;PGLYRP1;NPC2;SLC44A2;FTL;CKAP4;OSTF1;MME;EEF1A1;HEXB;CTSB;STOM;CEACAM1;PSMD14;CRACR2A;CD47;DOCK2;RAB18;CD44;HSP90AA1;CYBA;IMPDH1;XRCC5;GOLGA7;CTSS;ENPP4;HRNR;SLC2A3;ARPC5;TNFAIP6;LRG1;SRP14;PGAM1;FABP5;TMEM30A;QPCT;SCAMP1;DOK3;RAB6A;TRPM2;ALDOA;CCT8;APEH;PKM;CAT;CCT2;PDXK;STXBP3;SVIP;RAB37;GCA;CYB5R3;C3AR1;PSMD11;CTSZ;ITGB2;CAND1;SLC27A2;QSOX1;TMEM63A;EEF2;SPTAN1;PSMD2;ATP11B;TYROBP
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.564051891078278,1.258296489095468,0.2084942084942085,0.8774614174166079,1.0,2/14,2.00%,PRKCZ;IL18
prerank,sensory organ development (GO:0007423),0.4398928341154972,1.2578616034007746,0.1687116564417178,0.8772263418398503,1.0,7/51,7.54%,SMOC1;SHROOM2;FOXC1;MEIS1;SH3PXD2B;RBP4;CHD7
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5242204662231661,-1.2572522101564856,0.1702127659574468,0.4938951242612352,1.0,9/13,29.80%,SORL1;TMEM30A;BCAP31;CD81;SEC16B;SAR1B;EDEM1;TMEM30B;SAR1A
prerank,acidic amino acid transport (GO:0015800),0.5520135827686756,1.256432196953513,0.21869488536155202,0.8807240959398465,1.0,2/17,0.37%,SLC6A13;SLC6A1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5444306448607277,1.2562936623538723,0.19180633147113593,0.8793136932275655,1.0,2/17,1.91%,ANK2;SNTA1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.48196570990392085,-1.2551359797032455,0.18807339449541285,0.4979469943509365,1.0,8/18,28.14%,CHRM3;CHRM2;AGRN;CDK5R1;GNB1;OPRM1;RGS10;RGS8
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3792236064355049,1.255082729702454,0.10199004975124377,0.8820285412053233,1.0,39/166,16.31%,NOTCH2;RORA;THRB;PPARGC1A;CCN2;PPARA;POLR2A;NCOR2;NR6A1;TAF1D;ESRRA;TEAD3;TBL1X;WWTR1;RORC;POLR2D;NR1D2;TBL1XR1;TEAD2;NR2C2;HDAC1;MED17;GTF2F1;RARG;TEAD1;TAF11;NR3C2;POLR1G;TBP;TAF4;NCOR1;KAT2B;BRF1;TAF7;MED23;RXRA;TAF13;CREBBP;MED26
prerank,regulation of BMP signaling pathway (GO:0030510),-0.356379426138132,-1.2548273354025905,0.12624584717607973,0.4977579985242036,1.0,21/73,14.15%,BMPER;BMPR2;ENG;HTRA3;ACVRL1;VWC2;NOTCH1;VWC2L;SFRP4;SMAD5;SORL1;SMAD1;CCN1;BMP2;PCSK6;SMAD7;BMP4;LEMD3;UBE2D3;BMPR1B;SMURF1
prerank,neuron remodeling (GO:0016322),-0.5569529353614271,-1.2547967432510896,0.2051792828685259,0.49686939017576126,1.0,7/10,26.26%,ADGRB3;APP;SCARF1;C1QA;ANKS1A;RND1;C3
prerank,cell-matrix adhesion (GO:0007160),-0.33715369429610553,-1.25414995169438,0.06930693069306931,0.49754206972766757,1.0,25/95,12.49%,ITGBL1;PPFIA2;THSD1;PTPRK;ACTN1;PEAK1;FN1;VCAM1;CD34;ARHGEF7;ITGB4;SGCE;TIAM1;BCAM;ITGB8;MSLN;ITGB1;ADAM15;ITGA4;ITGA8;CD44;ITGB3;PKD1;ILK;EMP2
prerank,regulation of superoxide anion generation (GO:0032928),-0.5258166986289009,-1.2541163176483774,0.1991701244813278,0.49670054027092186,1.0,6/14,22.09%,TGFB1;MAPT;SYK;ITGB2;TYROBP;SOD1
prerank,pore complex assembly (GO:0046931),0.5291701943021433,1.2531822938841388,0.21525423728813559,0.887215628355606,1.0,4/19,10.90%,AFDN;PLEKHA7;ANO6;NUP98
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5389443832018096,-1.2527388386219767,0.2,0.4990569657317838,1.0,3/11,9.15%,PTPRC;CEACAM1;SMAD7
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.46959793464491884,1.2523181911471952,0.17647058823529413,0.8884557404337877,1.0,6/39,9.99%,NNAT;NLGN2;MCU;GCK;RBP4;TCF7L2
prerank,RNA metabolic process (GO:0016070),0.38742368468443783,1.251901508417475,0.12685560053981107,0.8880905615107726,1.0,31/127,16.46%,CELF2;POLR2A;RBMS2;TP53RK;PCBP2;PABPN1;HNRNPR;HNRNPH1;DDX3X;SIDT2;HNRNPA2B1;POLR2D;LAGE3;ATXN2;RBM39;EXOSC7;NOVA1;SND1;TENT2;RBMS1;TBRG4;GTF2F1;HNRNPL;DICER1;WTAP;HNRNPC;SNRNP40;RBM4;TFIP11;HNRNPM;PAPOLG
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3922483661554435,-1.2516186085317524,0.12430939226519337,0.5007291536937326,1.0,16/48,20.57%,FMN2;HSP90AB1;APOE;FLNA;LDLR;IRAK3;ITGB3;EDN1;CD84;ADGRB1;CLU;IAPP;EDNRB;SIRT2;CYP51A1;MAD2L1
prerank,negative regulation of cell communication (GO:0010648),-0.4587858871651941,-1.2511322168332137,0.15825688073394495,0.5010466881808927,1.0,9/21,25.57%,UBASH3B;HHIP;GLRA1;KIF26A;ACVR1;SOCS5;PTPN1;OPRM1;ERBB3
prerank,phospholipid translocation (GO:0045332),-0.4392423881247022,-1.250463707997677,0.17422434367541767,0.5016564953575278,1.0,10/28,14.29%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;MFSD2A;TMEM30A;ATP8B2;ABCB4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3538812273251764,1.2495780947019304,0.06214039125431531,0.8948604492134903,1.0,74/327,16.35%,DENND4A;RORA;PPARGC1B;FOXN3;TULP3;PPARGC1A;NFYC;SSBP2;POLR2A;ZNF423;CXXC1;CRABP2;CTR9;MITF;SUFU;TGFBR1;ARNT2;FOXC1;ZBTB38;NFYB;RREB1;BNC2;NSD1;IFNK;WWC2;ASCC2;SBNO1;ATRX;ESRRA;HMGA1;CREBL2;TP53;WWTR1;SOX12;LDB1;CHD7;NR1D2;KAT6B;TEAD2;TCF7;NSD3;NR2C2;SOX13;CCAR1;ZNF219;MYBL1;AJUBA;ABL1;ZKSCAN5;ATF2;MLLT6;SKOR1;MYBL2;ZMIZ1;HES6;MLXIPL;PHF1;KMT2D;KAT7;NFIA;DNM2;PML;ACVR2B;CELSR2;ATXN1L;APBB3;ACVR1B;WTIP;MED23;MZF1;TGIF2;RB1;CREBBP;GPBP1L1
prerank,carbohydrate homeostasis (GO:0033500),0.42829392615261286,1.2495243613602176,0.14499252615844543,0.8931304163260707,1.0,8/67,7.53%,APPL2;LEPR;BACE2;PRKAA2;MCU;ADRA2A;GCK;RBP4
prerank,regulation of vasoconstriction (GO:0019229),-0.42890924209853926,-1.2488353298947248,0.17661691542288557,0.5047342248296636,1.0,9/27,12.72%,CAV1;BMPR2;CHRM3;ADRA1B;ECE1;KCNMB2;AGTR1;ATP2B1;ACE2
prerank,T cell receptor signaling pathway (GO:0050852),-0.32151572155742536,-1.2487276007598311,0.06896551724137931,0.504062211976124,1.0,49/138,27.70%,PDE4D;PDE4B;PTPRJ;PIK3R1;RFTN1;PAK3;INPP5D;PSMB2;PAK1;PTPRC;PLCG2;MAP3K7;MOG;TNFRSF21;PSMD14;TEC;PSMC6;BCAR1;EIF2B3;IKBKB;RBCK1;SPPL3;BTN3A3;NCK1;PSMA4;NFKBIZ;PSMB9;SKAP1;SKP1;PSMD11;PSMB10;PRKCQ;PSMD2;TXK;CD276;FYN;PSMA2;THY1;RELA;STOML2;PSMB3;PIK3CD;PLCG1;ICOSLG;PSMB5;LCP2;CARD11;PSMA7;EIF2B2
prerank,negative regulation of cell motility (GO:2000146),-0.3320558013890877,-1.2486617839384004,0.06884057971014493,0.5032953984815963,1.0,19/108,4.49%,TMEFF2;FRMD5;SLIT2;LIMCH1;DACH1;PTPRJ;CLIC4;CLDN5;MCTP1;ENG;NAV3;PTPRK;SPOCK3;PTPRT;SRGAP1;ADARB1;ACVRL1;CYP1B1;JAG1
prerank,regulation of cartilage development (GO:0061035),-0.476952842975816,-1.2486145417882868,0.1831578947368421,0.5024945072903019,1.0,7/18,13.95%,BMPR2;TRPS1;ZBTB16;BMP2;BMP4;PTHLH;BMPR1B
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6145927671603802,1.2484249502593532,0.25996204933586337,0.8953502611520583,1.0,2/10,3.85%,UPB1;DPYD
prerank,central nervous system neuron differentiation (GO:0021953),-0.4196606645815842,-1.2481060972778812,0.1478494623655914,0.502787861410862,1.0,8/33,12.71%,GRID2;MDGA2;TOX;NTRK2;SPOCK1;PROX1;CTNNB1;MAPT
prerank,regulation of protein transport (GO:0051223),-0.43568052380534295,-1.248101615199127,0.1662531017369727,0.5018844179637312,1.0,10/27,18.41%,STXBP5L;DNAJC1;HSPA8;DISP1;NDFIP2;GAPVD1;PPM1F;DNAJA1;P3H1;PTPN1
prerank,regulation of vasculogenesis (GO:2001212),-0.513895939958017,-1.2480852124510893,0.19480519480519481,0.5010074532599231,1.0,9/14,15.16%,CD34;KDR;RAP1A;TMEM100;CEACAM1;XDH;HEY2;EMP2;RRAS
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3835116723369525,1.24788041729716,0.12533692722371967,0.8954936698038007,1.0,15/129,8.64%,RNF220;LRRK1;LGR4;WLS;PTK7;FGFR2;LRRK2;DDX3X;CAPRIN2;TBL1X;SMURF2;TNKS2;ADGRA2;TBL1XR1;GPRC5B
prerank,necroptotic process (GO:0070266),0.537826462591644,1.2475840845188786,0.22264150943396227,0.8946623925168261,1.0,5/16,10.97%,TLR3;TLR4;DNM1L;RIPK1;LY96
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5373550298343974,1.2472450778490354,0.20930232558139536,0.8939735507761385,1.0,8/18,14.01%,DDX5;NCOR2;TP53;TERT;RIPK1;MAP2K1;NCOR1;MAP2K2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5217729450035253,-1.2471136468402155,0.18736383442265794,0.5023853192213074,1.0,7/14,14.82%,NRP1;VEGFC;GAB1;KDR;FLT4;VEGFA;NUS1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.33470798265323043,1.247060555230139,0.01016260162601626,0.8928244469933687,1.0,188/1082,13.68%,EPAS1;HLF;DAB2;FGF1;WWOX;RORA;BMP6;PPARGC1B;BMP7;THRB;SMAD3;TFDP2;GLIS3;AUTS2;WNT4;OSR1;ZIC2;PPARGC1A;PICALM;IGF1;RHOQ;BRD8;KMT2A;PPARA;SSBP2;CREBRF;FGFR2;PRKN;IL18;FHOD1;ZNF423;CREB5;HOXB4;GLI2;CSRP3;NPAS3;CXXC1;SPP1;GABPB1;GABPB2;HOXA1;MOSPD1;NFAT5;PCGF5;HDAC8;PHIP;NR2F2;BMPR1A;ELOF1;ELF1;GLI3;MITF;TGFBR1;ARNT2;FOXC1;MLLT10;NFIB;CAND2;HOXB3;VEZF1;ZBTB38;ASCL3;ZNF462;NFYB;CREB3L2;TLR3;NHLH2;RREB1;RGMB;TLR4;MEIS1;NSD1;TET2;FZD5;ATM;DDX3X;TRIM56;ARRB1;NCOA3;CAPRIN2;MAP2K5;GPS2;CAMK1;ATRX;ABHD14B;ESRRA;HMGA1;LBH;CREBL2;ZNF318;TP53;TBL1X;BCAS3;BCLAF3;AFAP1L2;CAMTA2;WWTR1;ARHGEF11;RORC;MED12;SOX12;SERPINE1;CCNT2;SMARCD3;PLSCR1;LDB1;LDB2;LAGE3;FBXW11;ATAD2B;ELF2;MEF2A;SMARCA4;NR1D2;HOXC4;BTRC;SSBP3;TBL1XR1;KAT6B;ZIC1;GDNF;TMF1;JMJD6;SMARCC2;TEAD2;NIBAN2;CALCOCO1;PARP9;HDAC4;GLI1;SIRT1;WASL;TFDP1;NSD3;RIPK2;NR2C2;HDAC1;ELL;RIPK1;MAVS;ZFP90;FOXC2;TCF7L2;TCF4;MYBL1;MED17;RBL1;GTF2F1;SCAF8;KMT2C;THRAP3;ABL1;DYRK1A;NFATC3;RARG;ATF2;PRKDC;ZMIZ2;MLLT6;MYBL2;MSANTD1;TEAD1;ZMIZ1;PHF5A;CCDC62;HOXB2;BRD7;FOXA2;DEAF1;MLXIPL;WDR43;IRF1;KMT2D;KAT7;ZXDC;EDRF1;PBX4;ZBTB48;FOXJ2;DHX33;NFIA;SIN3A;DNM2;MAP2K1;MLLT11;ATF6B;PML;PTOV1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5027162523844434,1.2466970328877258,0.2039355992844365,0.8922064751793135,1.0,2/26,3.64%,ATP1A2;ADRA2A
prerank,liver development (GO:0001889),0.4780751604844483,1.246077328614392,0.2164048865619546,0.8926165874394344,1.0,2/32,1.03%,TGFBR3;WNT4
prerank,regulation of hydrolase activity (GO:0051336),-0.3569231673582561,-1.24592901684727,0.11746031746031746,0.5042950325154386,1.0,17/71,8.88%,PRKG1;CHN2;CAV1;FGD5;EPHA5;EFNA5;CHN1;RASIP1;NTRK2;DAB2IP;CRK;PLXNC1;ARHGAP15;PTK2;RDX;PLXNA4;RAPGEF6
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5581653350156498,1.2458141879827607,0.21153846153846154,0.8916893845021462,1.0,2/16,1.27%,PPARGC1B;DDX5
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4251785741429314,1.244867978104844,0.17664670658682635,0.8933762063943591,1.0,19/63,16.59%,WWOX;IGF1;CFLAR;PHIP;FGFR1;DEPTOR;TGFBR1;BID;HTT;RIPK1;TCF7L2;SH3RF1;TMC8;ITGAV;PML;AGTR2;LGALS3;BIRC6;SP100
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.31865269373730176,-1.2448434477242103,0.0502092050209205,0.5059884390579465,1.0,25/151,8.21%,ST3GAL4;ELOVL7;CERT1;SGMS1;PLA2G4A;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;GPHN;PPM1L;PLPP1;CEPT1;SPTLC2;DEGS2;SPNS2;APOE;GCH1;B4GALT5;SLC44A5;PAM;PCSK5;SLC44A2;LPCAT2
prerank,sulfation (GO:0051923),0.5910450288724125,1.244347946699322,0.2607003891050584,0.8934067999445725,1.0,2/11,9.11%,UST;SULT2B1
prerank,sulfur compound transport (GO:0072348),0.5017616522834218,1.2440495234858813,0.20379965457685664,0.8926267387278465,1.0,5/27,7.85%,SLC13A4;SLC6A13;SLC35F3;SLC27A1;SLC26A1
prerank,cellular response to oxygen levels (GO:0071453),0.5930630245129263,1.2440173476775909,0.24612403100775193,0.890861892911923,1.0,4/10,20.56%,CPEB4;PICK1;ATP6V0D1;CCDC115
prerank,positive regulation of dendritic spine development (GO:0060999),-0.45949695272797547,-1.2439556253010946,0.20705882352941177,0.5072347269572645,1.0,8/20,13.89%,NLGN1;SHANK3;APOE;PSEN1;RELN;LLPH;LRP8;SHANK1
prerank,cellular response to fluid shear stress (GO:0071498),-0.5330772798365204,-1.243236826588664,0.22440087145969498,0.5080726883328849,1.0,4/12,12.92%,MEF2C;SREBF2;KLF2;MTSS1
prerank,primary alcohol metabolic process (GO:0034308),0.4956723511969321,1.2432360369714544,0.1969178082191781,0.8919344338459481,1.0,5/25,7.53%,IGF1;NAPEPLD;NAAA;DHRS3;RBP4
prerank,cardiac muscle tissue development (GO:0048738),0.44468687317683586,1.242587760471992,0.17637540453074432,0.8926271392997083,1.0,11/50,9.62%,NOTCH2;BMP7;GJB6;CSRP3;AKAP13;BMPR1A;ADAMTS9;SIK1;RBP4;NRG1;CBY1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4444546014438847,-1.2424236300585727,0.18615751789976134,0.509113935329804,1.0,5/24,1.96%,NRP1;NLGN1;TENM2;PIK3R1;FNBP1L
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.529379357467967,1.2415372745122049,0.21335807050092764,0.8947482013119531,1.0,3/20,2.05%,ATP1A2;ATP1B3;LACC1
prerank,regulation of cell communication (GO:0010646),-0.40988820574499063,-1.2411863440714843,0.16216216216216217,0.5110877048977785,1.0,10/35,7.77%,SLC8A1;RYR2;CAMK2D;MGLL;UGCG;ANXA1;TBX18;SOCS2;CRK;YWHAG
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4040101425632617,-1.2408960965458562,0.15555555555555556,0.5108672962311162,1.0,17/34,21.92%,NRP1;CARMIL1;ARHGEF7;DOCK1;FLNA;CRK;LIMS2;MYOC;CALR;ILK;DMTN;LIMS1;MYADM;CSPG5;S100A10;RAC3;MDK
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.555265957265057,1.2390766934958897,0.22264150943396227,0.9022501880540413,1.0,3/16,5.34%,APPL2;PPARA;F2
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4378876434994595,-1.238582282541354,0.18248175182481752,0.5158366564139165,1.0,8/24,14.97%,CTNNA2;MEF2C;CDH2;CDON;BOC;CTNNB1;MYOCD;MAPK12
prerank,epithelium development (GO:0060429),0.3869371905225654,1.238223338000773,0.14647887323943662,0.9035418530413242,1.0,13/107,8.24%,ALDH1A2;WNT4;OSR1;ERRFI1;FGFR2;KANK2;DAG1;CPT1A;LOXL3;SMO;TPP1;BDH2;IFT122
prerank,positive regulation of nervous system process (GO:0031646),-0.4782240373711747,-1.2380760172751075,0.20086393088552915,0.5160693910619907,1.0,5/18,7.20%,RIMS2;RIMS1;TENM4;UNC13B;TNFRSF1B
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.44159162814881425,1.2380420793391438,0.18769716088328076,0.9023054090892159,1.0,6/46,5.16%,DUSP29;FBLN1;TIMP3;DLG1;EZR;TLR4
prerank,regulation of protein secretion (GO:0050708),0.387369922156213,1.2380313613978648,0.1273972602739726,0.900469862350821,1.0,20/119,9.69%,BMP6;CACNA1D;FRMD4A;ITPR2;IGF1;ITPR1;KCNA5;ADRA2A;MYO18A;RAPGEF3;EZR;DPP4;CACNA1C;IL12B;GCK;EIPR1;DNM1L;GOLPH3L;RSAD2;PICK1
prerank,negative regulation of phagocytosis (GO:0050765),0.533946894962645,1.23762573521697,0.21554770318021202,0.9001885451925332,1.0,4/17,7.37%,SYT11;CD300A;FER1L5;PLSCR1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5113395363975891,1.2375613481620125,0.22527472527472528,0.898586940489149,1.0,6/23,8.24%,TULP3;GLI3;SUFU;MGRN1;BTRC;IFT122
prerank,regulation of gene expression (GO:0010468),0.33090610477487,1.2373661158260314,0.015463917525773196,0.8974268982590153,1.0,147/903,12.87%,PRDM6;DENND4A;NOTCH2;FGF1;ROBO1;RORA;BMP6;PPARGC1B;BMP7;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;WNT4;OSR1;FOXN3;TULP3;PPARGC1A;PICALM;IGF1;NFYC;PRKAA2;SSBP2;AFF3;WNT6;PRKN;POLR2A;ZNF423;SON;CXXC1;FOXD1;TNRC6A;CRABP2;CTR9;BMPR1A;ZC3H7B;MITF;SUFU;TGFBR1;ARNT2;FOXC1;SNRNP70;PARP10;DTNBP1;PCBP2;ZBTB38;PABPN1;MBNL2;ZNF462;NFYB;TLR3;EZR;PARP14;SMO;CTSH;CUX2;RREB1;BNC2;TLR4;NSD1;IGF2BP1;HNRNPH1;IFNK;ATM;DDX3X;WWC2;ASCC2;SBNO1;TIPARP;ATRX;AFF4;BRAF;ESRRA;CLK4;CD28;HMGA1;CREBL2;IL12B;TP53;WWTR1;SOX12;TOB2;PTPN22;PLSCR1;LDB1;CHD7;TNRC6B;NR1D2;RBL2;LARP1;KAT6B;TERT;GDNF;HRG;APLN;IGF2BP2;NOVA1;CDH5;TEAD2;CALCOCO1;PARP9;HDAC4;SIRT1;C1D;TCF7;TLE1;NSD3;NR2C2;HDAC1;SOX13;LRP3;UBR5;CCAR1;MOV10;DHH;ZNF219;MYBL1;RBL1;CRKL;PIK3R3;AJUBA;SRPK2;ABL1;PRDM5;ZKSCAN5;ATF2;C1QTNF1;HNRNPL;WWP2;MLLT6;SKOR1;NOCT;HMG20B;MYBL2;GLMN;DICER1;ZNF148;HES6;ATRAID;MLXIPL;FLOT2;TDG;PHF1;SNX12;KMT2D;KAT7
prerank,smooth muscle tissue development (GO:0048745),-0.549736836933663,-1.2371739722841388,0.2205240174672489,0.5173179494393211,1.0,5/10,11.37%,ENG;PTCH1;STRA6;PROX1;BMP4
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5279335192905713,1.2367034356604658,0.24385964912280703,0.8979977704594598,1.0,3/18,6.47%,IGF1;IL18;IL12B
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5758031636248189,1.2364820896342643,0.24427480916030533,0.8969152634288865,1.0,7/11,16.73%,ENPP3;CTPS2;SLC19A2;THTPA;NT5C3A;TPK1;SLC25A19
prerank,regulation of keratinocyte differentiation (GO:0045616),0.49655321161799126,1.2364153051195175,0.2197986577181208,0.8953296514893387,1.0,4/24,5.65%,ROCK2;ERRFI1;FOXC1;NCOA3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.46366392390522887,-1.23634261913991,0.19419642857142858,0.5184581000028864,1.0,5/20,9.63%,FAR2;ACSL3;ACSL4;PPT1;SCD
prerank,positive regulation of protein acetylation (GO:1901985),0.5886192838501165,1.2357957836609839,0.24517374517374518,0.8958815289975727,1.0,4/12,5.82%,PRKAA2;RAPGEF3;DDX3X;CAMK1
prerank,negative regulation of neuron projection development (GO:0010977),0.4271931259148107,1.2356313271708936,0.1816816816816817,0.8946264028543418,1.0,10/56,8.37%,EFNB2;LRP4;LPAR1;EPHA4;PTPN9;NGEF;RUFY3;CBFA2T2;PTEN;DENND5A
prerank,anterior/posterior pattern specification (GO:0009952),0.44043693998395533,1.2355136653111671,0.18294573643410852,0.8932660725492748,1.0,11/53,8.07%,WLS;HOXB4;HOXB6;HOXC6;TGFBR1;HOXB3;HOXB9;HOXA3;HOXB5;BHLHE41;HOXC4
prerank,adenine nucleotide transport (GO:0051503),-0.4760908530499577,-1.2353910325400161,0.2079646017699115,0.5198356449945013,1.0,3/17,3.31%,ABCC4;LRRC8C;LRRC8D
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5494415947675834,1.235310991245422,0.22524271844660193,0.8921944780090325,1.0,3/14,9.52%,PPARGC1A;SIRT1;SLC45A3
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4589833043577424,-1.235264429716347,0.18584070796460178,0.5191990181463683,1.0,9/21,9.18%,NOS3;PTK2B;GAS6;NOTCH1;ASPN;ENPP1;ECM1;TGFB1;HEY2
prerank,positive regulation of insulin secretion (GO:0032024),0.47274626314995594,1.2351948569364761,0.21393841166936792,0.8908368133472766,1.0,7/36,9.99%,NNAT;NLGN2;MCU;GCK;RBP4;PLA2G6;TCF7L2
prerank,regulation of phosphate metabolic process (GO:0019220),-0.49618119686334283,-1.2349319788808277,0.22123893805309736,0.5191229404972603,1.0,8/16,18.69%,PSEN1;IKBKB;SMG5;PGAM1;SRPX2;BARD1;SIRT2;TIGAR
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5675295828487626,1.2345787405830577,0.25285171102661597,0.8914353074784894,1.0,5/13,12.23%,ATG10;ATG7;UBA6;DESI2;DESI1
prerank,regulation of neuron projection arborization (GO:0150011),-0.4932481160427197,-1.234244147644618,0.21263157894736842,0.5198258407833853,1.0,4/15,10.92%,GRIP1;NTNG1;FZD4;MFSD2A
prerank,positive regulation of bone mineralization (GO:0030501),0.4657943311507979,1.233878348046064,0.22039473684210525,0.8921388652071447,1.0,6/35,3.18%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A
prerank,regulation of protein localization to cell surface (GO:2000008),0.4744001425926822,1.2338108299929609,0.21490467937608318,0.8905691665397176,1.0,3/33,1.42%,ACTN2;LEPROT;PICALM
prerank,mitochondrial membrane organization (GO:0007006),0.47399933663909094,1.2334237599049287,0.22635135135135134,0.890253573620626,1.0,10/32,18.19%,CHCHD3;SAMM50;OPA1;TMEM11;MICOS10;MFN2;MICOS13;IMMT;MTX2;MFN1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.481487593856312,-1.2332107420166905,0.20944558521560575,0.521371006280105,1.0,10/17,35.68%,SNAP25;STX3;SYNGR2;STX1B;SNAP23;AP3D1;STX1A;SYP;SYNGR1;PRRT2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3860330593199017,1.2323412391397475,0.13642384105960265,0.8925210197081238,1.0,23/128,11.81%,TGFBR3;BMP6;BMP7;SMAD3;APPL2;PRKCZ;DDX5;ARHGEF18;BMPR1A;TGFBR1;SMAD6;RGMB;USP9X;TWSG1;SMURF2;TGFBR2;COL1A2;CDH5;SIRT1;ZFYVE16;ZMIZ2;ZMIZ1;GDF15
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.28595204628366466,-1.231953437108321,0.036231884057971016,0.5235576397829321,1.0,94/348,14.40%,NRP1;LIMCH1;GHR;PTPRJ;RPS6KA5;TEK;BMP5;ERBB4;NTRK3;CAV1;PECAM1;PDE8A;BMPR2;ENG;RASSF2;VEGFC;NPTN;NIBAN1;EFNA5;TGFB2;IQGAP1;PTK2B;BCAR3;GAS6;NGF;ACVRL1;CEMIP;TFRC;NTRK2;HSP90AB1;KRAS;ARHGEF2;KDR;LYN;TBX1;PDGFC;PPIA;PAK1;CALM1;PTPRC;RAP1A;APP;CALM2;CARD14;PLCG2;LIMK2;TGFB3;CSPG4;SEMA4D;RELN;CCN1;BMP2;TGFB1;PTK2;RALB;DDRGK1;TEC;FGF2;FLT4;RAP2A;FNIP2;ERBB2;CAMKK2;CD44;PDGFA;HSP90AA1;ITGB3;ATP2B4;CALM3;ENPP2;GPER1;FXR1;BMP4;XRCC5;ILK;TNKS1BP1;FAS;CDKN1A;NOS1;MMD;PFN2;AXIN1;LRP8;FGF7;SNCA;PRKD1;ACVR1;FGF9;VEGFA;TXN;PINK1;TERF2IP;MT3;P2RY1
prerank,regulation of myelination (GO:0031641),-0.4404036648902507,-1.2309404911636674,0.2151029748283753,0.5251000843386331,1.0,11/25,24.20%,TENM4;JAM2;TNFRSF1B;PTPRZ1;TNFRSF21;PTN;EIF2AK3;TPPP;SIRT2;LGI4;KIF14
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5454612509634396,1.230875910759429,0.2158894645941278,0.8958863319167705,1.0,6/16,14.03%,KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1
prerank,transition metal ion transport (GO:0000041),-0.41160899662760975,-1.2305107696101125,0.16890080428954424,0.5252117657061602,1.0,14/35,15.04%,ATP2C1;FTH1;TFRC;TRPC3;TRPC4;TRPC1;TRPC6;ATOX1;SLC30A1;SLC31A1;MT3;TRPC5;TTYH1;TRPC7
prerank,positive regulation of binding (GO:0051099),-0.34323049628851066,-1.230510658983242,0.13377926421404682,0.5242870971045649,1.0,34/84,20.73%,CAV1;CLDN5;EPB41;B2M;NGF;GSK3B;TIAM1;APOE;APP;HES1;MET;PSEN1;DACT1;BMP2;RALB;ADD2;PKD1;FKBP1A;BMP4;TXN;SPPL3;STMN1;HIPK2;DHX9;KDM4D;MEN1;SIRT2;CLN5;HIP1R;RAN;VTN;HMBOX1;RPL11;EDF1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5300268880134144,1.2303900972674482,0.25788497217068646,0.8959005387936048,1.0,1/18,0.08%,ATP1A2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.34430332708114453,1.2298834728330221,0.07803790412486064,0.8960672323890108,1.0,81/366,16.39%,DENND4A;RORA;PPARGC1B;FOXN3;TULP3;PPARGC1A;NFYC;SSBP2;POLR2A;ZNF423;CXXC1;CCNA2;CRABP2;CTR9;MITF;SUFU;TGFBR1;ARNT2;FOXC1;ZBTB38;NFYB;RREB1;BNC2;NSD1;IFNK;WWC2;ASCC2;SBNO1;ATRX;ESRRA;DSCC1;ANKRD17;HMGA1;CREBL2;TP53;WWTR1;SOX12;LDB1;CHD7;ATXN2;NR1D2;KAT6B;TEAD2;TCF7;NSD3;NR2C2;SOX13;CCAR1;ZNF219;MYBL1;AJUBA;ABL1;ZKSCAN5;ATF2;MLLT6;SKOR1;MYBL2;HES6;MLXIPL;PHF1;KMT2D;KAT7;NFIA;ORC3;DNM2;PML;ACVR2B;TSC1;CELSR2;ATXN1L;APBB3;ACVR1B;WTIP;MED23;MZF1;EHMT2;TGIF2;RB1;CREBBP;GPBP1L1;SMC3
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.45486577536531886,1.229787001330138,0.19806763285024154,0.8946010344582951,1.0,6/43,3.18%,BMP6;BMP7;WNT4;IGF1;NPNT;BMPR1A
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4098145972963961,-1.2292939610695608,0.1630695443645084,0.5262954213978421,1.0,16/32,28.65%,CAV1;AKAP6;CEMIP;TRPC3;TRPC1;GPER1;SNCA;GRIN1;APLNR;NPSR1;THY1;F2R;CXCL10;PLCG1;P2RX7;CASQ1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.43939639383133944,1.2292915890484155,0.18441971383147854,0.8946869622529798,1.0,5/45,3.88%,BMP7;SMAD3;TOM1L2;FOXC1;GAS1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5564943063131442,-1.229284902147444,0.2210065645514223,0.5253887763414906,1.0,4/10,19.19%,BASP1;BMP4;PAX2;PAX8
prerank,cellular response to interleukin-4 (GO:0071353),-0.550056362582217,-1.2289390596450918,0.24152542372881355,0.5252827063463561,1.0,1/10,0.47%,LEF1
prerank,long-term memory (GO:0007616),-0.47389584877988583,-1.228882013762732,0.20754716981132076,0.5244955084309679,1.0,5/19,13.89%,APOE;LDLR;RASGRF1;CAMK4;SHANK1
prerank,entry into host (GO:0044409),-0.5086335227137759,-1.228813127259701,0.21961620469083157,0.5237903354043536,1.0,5/13,16.10%,PPIA;MET;CDH1;CTNNB1;CBL
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5132709177002286,-1.2279866373503847,0.22690763052208834,0.5248912556039065,1.0,4/13,8.86%,NRP1;NRP2;PLXNC1;PLXNA4
prerank,atrioventricular valve development (GO:0003171),-0.5010713376835212,-1.2277848271254574,0.22875816993464052,0.5244799689415506,1.0,9/14,21.10%,BMPR2;TGFB2;NOTCH1;HEYL;BMP2;ACVR1;APLNR;ZFPM1;SLIT3
prerank,response to steroid hormone (GO:0048545),0.4804118107656435,1.2276599575706824,0.1903114186851211,0.8989011148475082,1.0,4/31,3.36%,ATP1A2;TFPI;PAQR7;CATSPERD
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5864522256458393,1.2274520485012221,0.2710951526032316,0.8978402989358517,1.0,2/11,7.82%,GNAT2;GNAT3
prerank,primary miRNA processing (GO:0031053),0.6005368901590408,1.2271887109116304,0.2485089463220676,0.8970551680144454,1.0,2/10,7.10%,SMAD3;HNRNPA2B1
prerank,positive regulation of neurogenesis (GO:0050769),-0.354741264083552,-1.2271221851542677,0.13559322033898305,0.5251540366528241,1.0,20/68,12.06%,SLIT2;PTPRD;ROBO2;IL1RAPL1;SHANK3;NPTN;CDKL5;NGF;NTRK2;TIAM1;DISC1;SERPINF1;PLXNC1;MME;PLXNA4;MAP6;NAP1L1;SLITRK1;GPER1;CTNNB1
prerank,potassium ion import across plasma membrane (GO:1990573),0.4502736090299858,1.226981439645092,0.19778481012658228,0.8959220905278079,1.0,3/41,0.87%,ATP1A2;ATP1B3;KCNJ13
prerank,positive regulation of nuclear division (GO:0051785),0.48927415674904834,1.226974341817572,0.22852233676975944,0.8941727415678664,1.0,4/25,6.37%,IGF1;PHIP;CD28;PDGFRB
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.44301262917950485,-1.2268885723819194,0.19856459330143542,0.5247547054239645,1.0,5/24,10.93%,ANK3;CEMIP;MTCL1;ERBB2;KCNB1
prerank,mitochondrion organization (GO:0007005),0.3698139634820754,1.2267899506047764,0.12207792207792208,0.8930973492746603,1.0,51/165,19.96%,TRAK1;PPARGC1A;HK2;PRKN;CHCHD3;GABPB1;IFIT2;PYROXD2;BID;LRRK2;AFG1L;SAMM50;MIGA2;ESRRA;SIRT5;CLUH;NIPSNAP2;OPA1;TIMM44;MEF2A;MTFR2;TWNK;TERT;SIRT3;TMEM11;DNM1L;SSBP1;ADCK1;CXADR;TOMM70;NDUFS1;SIRT4;DNM2;MFN2;ATP5F1D;RAB29;PITRM1;TIMM10;FMC1;SLC25A36;MSTO1;MTX2;MTFP1;TRAK2;MFN1;RHOT1;TIMM17B;RAB5IF;AFG3L2;ATP7A;WDR81
prerank,regulation of T cell proliferation (GO:0042129),-0.3629206840412985,-1.2267494538406907,0.13544668587896252,0.5241922622049376,1.0,9/61,8.57%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;TNFRSF1B;TNFRSF21
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.4306934731274389,-1.2267121915255388,0.16705882352941176,0.5233653772364261,1.0,12/27,20.68%,UTRN;FGF12;CAMK2D;FXYD5;NEDD4L;ATP2B4;PTPN3;NOS1;SCN2B;FXYD6;COMMD1;SCN1B
prerank,positive regulation of B cell activation (GO:0050871),-0.37420252226630313,-1.2264154356640915,0.15517241379310345,0.5231387647607183,1.0,13/50,18.36%,MEF2C;SH3KBP1;TFRC;CD38;PTPRC;EPHB2;HMCES;TIRAP;NOD2;CD74;SYK;IRS2;BTK
prerank,RNA destabilization (GO:0050779),0.5177973356243784,1.2260311244814777,0.2465277777777778,0.8940518287503003,1.0,3/18,10.35%,ROCK2;ZC3H18;YTHDF3
prerank,negative regulation of transposition (GO:0010529),0.5231455638553093,1.2259370910618852,0.2423076923076923,0.8926231457905458,1.0,5/16,16.39%,UBR2;TUT4;MOV10;MYBL1;TUT7
prerank,snRNA metabolic process (GO:0016073),0.5350367182985382,1.2254558125171295,0.23297491039426524,0.8926245366615286,1.0,9/17,21.64%,INTS10;INTS2;INTS5;INTS3;INTS7;INTS1;INTS8;INTS4;TUT1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.4269194504834507,1.2251297842514721,0.19470404984423675,0.8920998675462454,1.0,16/57,14.35%,FOXN3;BABAM2;ATM;TP53;DONSON;CDK5RAP3;BRSK1;EME2;CDC14B;ATF2;PRKDC;HUS1;UIMC1;FZR1;BABAM1;SDE2
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3445772513610149,-1.2251230700547746,0.11073825503355705,0.5254421473814905,1.0,19/76,12.12%,MAML2;NOS3;NOTCH3;TGFB2;STAT3;CCN3;JAG1;NOTCH1;IL6ST;EPN2;BEND6;TSPAN14;PRAG1;SREBF2;JAG2;GATA2;LFNG;MFNG;TM2D3
prerank,histone H2B ubiquitination (GO:0033523),0.5800012040002808,1.225073808294001,0.25769230769230766,0.8905554289428937,1.0,4/10,18.42%,CTR9;RNF8;UBE2E1;RNF20
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.4876790908451197,-1.224983862773004,0.214123006833713,0.5249132460765499,1.0,8/17,16.55%,SFRP4;TMEM100;ATOH8;BTG1;FGF2;BMP4;AHI1;RFX3
prerank,male meiosis I (GO:0007141),0.5265393383252366,1.224308613553969,0.23581560283687944,0.8916144838410581,1.0,4/16,12.98%,CCNA1;MOV10L1;MYBL1;FOXJ2
prerank,calcium ion transmembrane transport (GO:0070588),0.39730679840441135,1.2233005348270312,0.15797101449275364,0.8937734749371116,1.0,12/86,7.30%,TRPM3;CACNA1D;SLC24A3;TRPM6;SLC8A3;MCU;CACNA1C;SLC25A23;MICU1;CACNB3;TRPM5;ANO6
prerank,protein localization to vacuole (GO:0072665),-0.4971084847151254,-1.2219024480092913,0.21691973969631237,0.5315654355359966,1.0,9/13,35.78%,RTN4;SH3GLB1;SH3BP4;RNF128;CD81;LMBRD1;SZT2;LAMTOR4;MFSD1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.506559325623005,-1.2218030785047242,0.21521739130434783,0.5308867638669877,1.0,3/14,12.33%,THBS1;IRAK3;CMKLR1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3834050205780327,1.2216133300926715,0.13411458333333334,0.8982869197420884,1.0,21/112,11.81%,WWOX;TGFBR3;SMAD3;APPL2;WNT4;PRKCZ;ARHGEF18;SOX5;BMPR1A;TGFBR1;SMAD6;USP9X;TWSG1;TGFBR2;COL1A2;CDH5;SIRT1;CRKL;ZMIZ2;ZMIZ1;GDF15
prerank,regulation of autophagy (GO:0010506),0.35828728174020746,1.2214466571765883,0.13740458015267176,0.8971140347480779,1.0,24/216,7.47%,PRKAG2;RNF152;LEPR;ITPR1;PRKAA2;PRKN;SNX6;MTMR3;PRKAG3;NUPR1;GPR137;CASP3;ATP6V0E1;TPCN1;LRRK2;NEDD4;SNX32;FZD5;ATM;WDR41;NPRL2;ATP6V0B;PTPN22;PIP4K2C
prerank,regulation of fibroblast migration (GO:0010762),-0.4601527103011865,-1.2213069437456314,0.2097130242825607,0.5312668279182732,1.0,9/20,9.38%,PRR5L;THBS1;ARHGEF7;ITGB1;CORO1C;TGFB1;PTK2;GNA12;FGF2
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.4741646928062003,-1.2211588333118981,0.22048997772828507,0.5307063585382971,1.0,4/17,9.06%,HDAC9;PCSK5;SORT1;PCSK6
prerank,purine ribonucleotide transport (GO:0015868),-0.4769366716701071,-1.2208289902555813,0.2185430463576159,0.5306067186045804,1.0,3/16,3.31%,ABCC4;LRRC8C;LRRC8D
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5318361755986036,1.2206501657762252,0.2604735883424408,0.8982900740433609,1.0,5/15,7.38%,FGFR2;HOXA1;TGFBR1;TGFBR2;NIPBL
prerank,anterior/posterior axis specification (GO:0009948),0.5552719565311123,1.2203401517138426,0.24770642201834864,0.8976983112616258,1.0,2/15,5.39%,WLS;FZD5
prerank,negative regulation of cellular component movement (GO:0051271),0.5321679730817339,1.2201721190718613,0.26247689463955637,0.8965055096413386,1.0,3/15,2.28%,TGFBR3;FBLN1;PKHD1
prerank,regulation of transport (GO:0051049),-0.40577110583455067,-1.219475059516891,0.1937984496124031,0.5331322866457615,1.0,14/36,16.82%,NRP1;ICA1;ACTB;EPB41;ACTG1;REEP5;WWC1;MYO6;GAPVD1;SNCA;PINK1;FES;ICA1L;DNAJA1
prerank,barbed-end actin filament capping (GO:0051016),0.5146517149428165,1.2193718318172366,0.2534722222222222,0.895982909993031,1.0,4/18,6.82%,ADD3;AVIL;CAPZB;TRIOBP
prerank,actin filament capping (GO:0051693),0.5146517149428165,1.2193718318172366,0.2534722222222222,0.895982909993031,1.0,4/18,6.82%,ADD3;AVIL;CAPZB;TRIOBP
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3651350990305822,1.2193574709429835,0.1392081736909323,0.8943148524721829,1.0,36/148,16.15%,PRKAG2;PRKAA2;PRKAG3;TP53RK;CHD4;PPP1R13L;ATM;TP53;RICTOR;CDK5RAP3;PDPK1;RNF34;HDAC1;AURKB;RBBP8;HUS1;NOP2;TAF11;CSNK2A2;CSNK2A1;MAPKAP1;BRD7;RAD50;TOP3A;USP7;PPP1R13B;KMT5A;TBP;PML;TAF4;MAP2K6;CCNG1;MTA2;TAF7;EHMT2;TAF13
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5369105913911245,1.2187791895620164,0.24007561436672967,0.8948379821431637,1.0,3/16,4.75%,ATP1A2;ANK2;CACNA1C
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3699242756525004,-1.2184389478217998,0.13505747126436782,0.5347614594469732,1.0,14/52,11.24%,SPTBN1;DPP10;PRKCH;PIK3R1;ATP2C1;ACSL3;STX3;PLS1;NKD2;ITGB1;EPHB2;ATP2B4;ZDHHC2;GPER1
prerank,retrograde axonal transport (GO:0008090),-0.4960766449040105,-1.217992452646898,0.23129251700680273,0.5349025468937311,1.0,3/16,4.92%,DLG2;DST;TMEM108
prerank,negative regulation of viral genome replication (GO:0045071),0.4415081537699824,1.2173536574741828,0.2,0.8982512810250362,1.0,12/40,16.94%,IFIT1;OAS2;PARP10;EIF2AK2;PLSCR1;RSAD2;ZC3HAV1;MAVS;SRPK2;OAS3;MPHOSPH8;ILF3
prerank,T cell mediated immunity (GO:0002456),-0.503695112104968,-1.2171949655924446,0.22672064777327935,0.5359154593439396,1.0,4/13,14.73%,CADM1;JAG1;EMP2;BTN3A3
prerank,negative regulation of proteolysis (GO:0045861),0.46086371424388184,1.217117055600238,0.21114864864864866,0.8974491177290986,1.0,7/34,6.96%,TIMP3;EPHA4;LRRK2;GAS1;F2;TM4SF20;KNG1
prerank,negative regulation of developmental growth (GO:0048640),-0.4128156245850841,-1.216678097322147,0.1716937354988399,0.5362593366637817,1.0,12/30,14.68%,RTN4;DCC;PTCH1;DIP2B;ULK1;ULK2;WWC1;FGF13;SEMA3G;CDKN1A;MT3;FGFR3
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3101597469917104,-1.216673190611417,0.07264957264957266,0.5353657096084491,1.0,36/149,14.95%,PRKCH;RPS6KA5;CAV1;ROR1;IL1RAP;STAT3;MID2;NOD1;TFRC;NFKBIA;ARHGEF2;TNFRSF11A;AR;PPIA;TRAF5;APP;RPS3;CARD14;MAP3K7;RTKN2;DDRGK1;IRAK3;TRIM14;ERC1;TRIM27;TIRAP;IKBKB;AIM2;PRKD1;RBCK1;CARD16;TERF2IP;TRIM37;CLU;UBB;MTDH
prerank,positive regulation of stress fiber assembly (GO:0051496),0.441367459273632,1.2163804671419687,0.2204724409448819,0.8983387719385039,1.0,9/44,5.17%,ROCK2;LPAR1;CCN2;ARHGEF10L;FHOD1;PPM1E;TGFBR1;RAPGEF3;TPM1
prerank,positive regulation of lyase activity (GO:0051349),0.5404491190291902,1.2159521316936073,0.24057450628366248,0.8982488132020381,1.0,3/14,9.72%,CACNA1D;CACNA1C;STIM1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.4426245939591831,-1.2155485114406361,0.21728971962616822,0.5372495158789333,1.0,6/23,8.56%,GHR;ERBB4;CYP1B1;NOTCH1;HES1;MGAT5
prerank,chondrocyte differentiation (GO:0002062),0.46742836829044354,1.2153583543818947,0.24052718286655683,0.8987704628374681,1.0,6/32,4.63%,WNT5B;OSR1;SOX5;NFIB;SULF2;CREB3L2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.45181250152363756,-1.2153069233493274,0.19399538106235567,0.5369697718721125,1.0,6/21,10.66%,CAV1;PLTP;NFKBIA;APOE;PTCH1;EEPD1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.5518364758490741,-1.2150569630904986,0.24180327868852458,0.5366714690025158,1.0,4/10,26.52%,HSPA5;ATF4;EIF2AK3;CCL2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4805914083046747,1.21499277886169,0.24108658743633277,0.8983522073511684,1.0,4/28,4.12%,ARHGAP28;FCHSD2;ARHGAP18;NAA80
prerank,potassium ion transport (GO:0006813),0.380413221292788,1.214960572599691,0.16263440860215053,0.8967557946402256,1.0,8/120,1.93%,ATP1A2;KCNK2;SLC24A3;ATP1B3;KCNJ13;KCND3;KCNA5;LRRC38
prerank,artery development (GO:0060840),-0.43940104921384754,-1.2149047904991317,0.2149321266968326,0.5361228907698548,1.0,10/23,9.51%,NRP1;ROBO2;BMPR2;ENG;ACVRL1;TBX1;HES1;STRA6;SMAD7;PDE2A
prerank,presynapse assembly (GO:0099054),-0.48273867036142837,-1.2146618481795675,0.2234762979683973,0.5358217020146655,1.0,5/16,3.66%,NLGN1;PTPRD;IL1RAPL1;LRRTM3;PCLO
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5742800486233195,1.2142543247061752,0.2665406427221172,0.8976528788354947,1.0,1/11,0.51%,AFDN
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.4336675007549794,-1.2138327218475637,0.22144522144522144,0.5369377152697498,1.0,8/24,14.04%,DACH1;BMPR2;ACVRL1;RPS3;XRCC5;CDKN1A;ERCC1;TERF2IP
prerank,metanephros development (GO:0001656),0.4837055387252086,1.2134654383538803,0.25689655172413794,0.8988598754727374,1.0,6/26,8.43%,BMP7;OSR1;FOXD1;CTSH;NIPBL;GDNF
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.42175280060071385,-1.2133146285543295,0.22195121951219512,0.5372418506420673,1.0,11/27,14.38%,PDE4D;CACNB2;AHNAK;CAMK2D;YWHAE;CALM1;CALM2;FKBP1A;JPH2;NOS1;SELENON
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5344672875280332,1.2130773497702498,0.2554347826086957,0.8985476258090517,1.0,9/14,29.19%,SEC31B;MIA3;SEC31A;SCAP;SEC24C;SEC24A;SEC13;SEC24D;SEC23B
prerank,positive regulation of telomerase activity (GO:0051973),-0.41056496411346327,-1.2129656749329958,0.18814432989690721,0.5372109989743743,1.0,16/33,29.14%,PARM1;HSP90AB1;NEK7;HSP90AA1;XRCC5;CTNNB1;CCT2;PRKCQ;HMBOX1;PTGES3;MAP2K7;KLF4;TNKS;DKC1;NAF1;MAPK3
prerank,protein K48-linked ubiquitination (GO:0070936),0.42370333788983927,1.212769344631835,0.20149253731343283,0.8980128348172297,1.0,16/54,17.38%,RNF152;UBE2E2;PRKN;IFI27;NHLRC4;TTC3;RNF8;RNF34;UBR5;UBE2H;RNF115;AMFR;RNF146;UBE2E1;SYVN1;CDC34
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4859301231984734,-1.2125355086915657,0.2229580573951435,0.5373609986310808,1.0,8/15,21.77%,RPL5;RPS7;SMAD7;RPL23;MAD2L1;RPL11;BAG5;BAG2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.4483157249598027,-1.2123550295971495,0.2091346153846154,0.5368833088359449,1.0,17/22,47.49%,PSMB2;PSMA4;PSMB9;PSMB10;PSMA2;PSMB3;PSMB5;PSMA7;PSMA5;ENC1;PSME4;PSMB8;PSMB11;NFE2L2;PSMB1;PSMB7;PSMA8
prerank,positive regulation of axonogenesis (GO:0050772),-0.3916900483393551,-1.212233947429266,0.16535433070866143,0.5362357956352025,1.0,14/43,9.95%,SLIT2;ROBO2;SEMA7A;CDKL5;NGF;NTRK2;NTN1;SHTN1;TIAM1;SEMA4D;PLXNC1;PLXNA4;MAP6;SLITRK1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3945814623175344,1.2121333529653386,0.15064562410329985,0.898724370936343,1.0,16/87,9.35%,NOTCH2;CELSR1;ROCK2;RHOQ;RHOBTB2;RHOD;ARHGAP18;RAPGEF3;EZR;ARHGAP17;PDGFRB;BAIAP2;RICTOR;PIK3CA;HRG;LRP1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.550214529394696,1.211754822980174,0.2730844793713163,0.8984087333069612,1.0,5/13,15.62%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,cholesterol efflux (GO:0033344),-0.4519324888029995,-1.21165892315363,0.215311004784689,0.5367271609481851,1.0,5/20,11.29%,SCARB1;APOE;ABCG1;NPC2;STX12
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4613448489746702,-1.2109366690509589,0.19912472647702406,0.5374487581548726,1.0,10/19,9.43%,CSGALNACT1;HS6ST2;NDST3;HS6ST3;HS3ST5;EXT1;XYLT1;GLCE;NDST4;EXT2
prerank,amino sugar biosynthetic process (GO:0046349),0.5695416984477132,1.2108102355602168,0.267578125,0.900096421275105,1.0,5/12,15.62%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,magnesium ion transport (GO:0015693),0.5593257175492646,1.2107701893764495,0.26045627376425856,0.8985921711155475,1.0,4/12,14.32%,SLC41A1;MRS2;NIPA2;MAGT1
prerank,epithelial cell migration (GO:0010631),-0.3924565209845769,-1.2096466529433882,0.18090452261306533,0.5398056828208974,1.0,14/37,15.78%,NRP1;CDH13;NOS3;FAP;CYP1B1;ANLN;PLEKHG5;STARD13;LPXN;PKN3;FAT2;SCG2;PTP4A3;PLXND1
prerank,actin filament bundle assembly (GO:0051017),0.4625844387729767,1.2094707004702876,0.214170692431562,0.9015208284459935,1.0,6/33,6.37%,PAWR;SHROOM2;RHOD;EZR;BAIAP2L1;BAIAP2
prerank,response to amino acid starvation (GO:1990928),0.4021247344098777,1.209464795252956,0.2113323124042879,0.8998660885983805,1.0,22/72,19.47%,RNF152;NPRL3;SESN1;ATP6V0E1;SESN2;NPRL2;ATP6V0B;EIF2AK2;LARP1;ATP6V1D;ATP6V1E1;ATF2;IMPACT;DEPDC5;FLCN;KPTN;WDR24;RPTOR;RRAGD;ATP6V0D1;LAMTOR1;ITFG2
prerank,limb morphogenesis (GO:0035108),-0.44521085386872555,-1.2093594704689896,0.20224719101123595,0.5396371800642226,1.0,5/20,7.72%,MBNL1;TGFB2;TBX3;PTCH1;PCSK5
prerank,response to calcium ion (GO:0051592),-0.3276965004679114,-1.2090638786641656,0.10830324909747292,0.5394397412524308,1.0,19/102,7.04%,NLGN1;MEF2C;SYT1;CAV1;CLIC4;KCNMA1;RYR2;CAMK2D;THBS1;IQGAP1;KCNMB2;RYR3;TRPC3;SLC25A13;CPNE8;CALM1;CALM2;PLCG2;TRPC1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3803605693113968,1.2086838529899093,0.17422096317280453,0.900997228335276,1.0,10/113,3.46%,NOTCH2;FGF1;BMP6;OSR1;IGF1;STXBP4;FGFR2;LAMC1;PKHD1;TGFBR1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.5117101537502963,-1.2086286936958328,0.23010752688172043,0.5396430021986904,1.0,5/13,26.54%,CAV1;USP13;BCAP31;UBQLN2;TMEM259
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.4715357618752183,-1.2083316703415625,0.2148936170212766,0.5394686770639325,1.0,7/18,8.63%,LTBP1;CD200;FN1;TGFB2;CD34;ITGB8;PTGS2
prerank,protein localization to cell periphery (GO:1990778),-0.31341962987634797,-1.2080176377901857,0.10583941605839416,0.5393795039039422,1.0,37/133,12.49%,KCNIP4;SPTBN1;DPP10;CACNB2;KCNB2;CAV1;BSG;ANK3;DPP6;EFR3B;CLASP2;MAP7;LIN7A;EPB41L3;ATP1B1;F11R;GAS6;MYO5A;EHD4;RAMP2;RAB3C;RAP1A;NKD2;FLNA;TSPAN14;PTCH1;EHD2;RDX;RAPGEF6;FGF13;RAP2A;KCNB1;ZDHHC2;CDH1;PACS2;IKBKB;EMP2
prerank,"transcription, DNA-templated (GO:0006351)",0.3542226031462303,1.2080068358860836,0.13092269326683292,0.9017544750378065,1.0,41/207,16.15%,MAF;THRB;GLIS3;DDX5;POLR2A;SOX5;CTR9;DTX1;ATOH1;RREB1;TTF2;AFF4;CREBL2;TP53;TSC22D1;CCNT2;POLR2D;MEF2A;TWNK;TFDP1;ELL;GTF2A1L;GTF2F1;RTF1;MNT;NOCT;NELFCD;TAF11;HIPK3;DEAF1;POLR3A;TBP;TAF4;PMF1;CTDP1;NFKB1;BRF1;TAF7;FUBP3;TTF1;TAF13
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.4174319531971767,-1.2079017646917347,0.19813519813519814,0.5387701690356124,1.0,9/28,14.07%,MAP3K5;DAB2IP;DNAJC10;ATP2A3;AIFM1;TMEM117;SELENOK;ATF4;BBC3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4717175682297632,1.2076004162806173,0.2529711375212224,0.9015349031602853,1.0,7/27,3.91%,ARHGAP28;CGNL1;PRKN;ARHGEF18;CLASP1;ARHGAP6;PPFIA1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5477277664540694,1.2071439475166645,0.2504854368932039,0.901479063896235,1.0,2/13,5.45%,DDX5;ATM
prerank,negative regulation of cell cycle process (GO:0010948),0.41799616583284827,1.207048318133177,0.19469026548672566,0.9001807675045621,1.0,15/61,16.91%,BMP7;TFDP2;TOM1L2;PCGF2;MGA;TFDP1;NME6;AURKB;RBBP8;CBX5;WAPL;EHMT2;VPS4A;EHMT1;CHMP4C
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.4383330085969057,-1.2064801791263424,0.21212121212121213,0.5413096982943333,1.0,4/24,5.34%,SLIT2;CXCL12;CCN3;LYN
prerank,myelin assembly (GO:0032288),-0.5433519479780349,-1.2063870936406378,0.24335378323108384,0.5406304965257358,1.0,3/10,3.60%,CD9;TENM4;EPB41L3
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4474029988911947,-1.2062684113524205,0.2219626168224299,0.5400306731661064,1.0,8/21,19.13%,PPP1R16B;YWHAE;GSK3B;YWHAB;MFHAS1;FKBP1A;CRY2;PPP1R11
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5213481823985645,-1.2058099578259918,0.2564102564102564,0.5402649139356529,1.0,5/12,26.86%,SNAP25;STX3;STX1B;SNAP23;STX1A
prerank,regulation of interleukin-1 production (GO:0032652),-0.49115701185555155,-1.2057775257810361,0.21551724137931033,0.5394539470402636,1.0,4/15,8.90%,GAS6;ANXA1;FOXP1;CEACAM1
prerank,neuron projection extension (GO:1990138),-0.4000437691990693,-1.2054895152012923,0.19106699751861042,0.5393060733964431,1.0,14/32,12.76%,NRP1;MAP1B;IQGAP1;NRP2;SEMA5A;SH3GL2;TMEM108;HSP90AB1;ULK1;ULK2;SLC9A6;HSP90AA1;CTNNB1;LLPH
prerank,regulation of protein autophosphorylation (GO:0031952),-0.39487017720985185,-1.2052550111275258,0.19801980198019803,0.5389968066512304,1.0,13/36,13.77%,ENG;RASSF2;PPP2R5A;PDGFC;CALM1;CALM2;EPHA7;ENPP1;RAP2A;PDGFA;CALM3;TNKS1BP1;VEGFA
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.501743248934316,-1.2049295032047924,0.22894168466522677,0.538916490320151,1.0,9/14,26.52%,THBS1;ITGA4;GPER1;ECSCR;PDCD4;RGCC;CD40;PLCG1;CCL2
prerank,positive regulation of phosphorylation (GO:0042327),-0.2905357308929281,-1.204654875035311,0.06451612903225806,0.5387124477880544,1.0,68/240,14.68%,NRP1;LIMCH1;TEK;ERBB4;NTRK3;PECAM1;ITGA6;PDE8A;ROR1;ENG;EPHB1;VEGFC;THBS1;NPTN;EPHA5;MERTK;NIBAN1;EFNA5;EPHA6;TIE1;GAS6;TFRC;NTRK2;KRAS;KDR;LYN;ROR2;TBX1;AR;PPIA;PAK1;APP;MET;CARD14;LIMK2;EPHA7;SEMA4D;PSEN1;EPHB2;CCN1;BMP2;BTBD10;TGFB1;PTK2;RALB;FGF2;FLT4;RAP2A;ERBB2;CAMKK2;HSP90AA1;ITGB3;GPER1;FXR1;BMP4;ILK;FAS;PFKFB1;HIF1A;AXIN1;FGF7;FGF9;RET;VEGFA;PINK1;MT3;P2RY1;FGFR3
prerank,positive regulation of viral genome replication (GO:0045070),0.4810643962203536,1.2042468988469832,0.2543859649122807,0.9086726697291775,1.0,8/29,13.47%,PPARA;TOP2B;IFIT1;DDX3X;CD28;LARP1;SRPK2;HACD3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3195524953507293,1.2037705540055126,0.004020100502512563,0.9087079741458238,1.0,285/1645,14.08%,DENND4A;EPAS1;HLF;ZKSCAN2;RORA;MAF;KDM7A;PPARGC1B;BMP7;SMAD3;TFDP2;GLIS3;WNT4;OSR1;ZIC2;FOXN3;TULP3;TRAK1;KIT;DDX5;PPARGC1A;MXI1;PICALM;IGF1;NFYC;CUX1;KMT2A;PPARA;PKNOX2;SSBP2;CREBRF;ZFHX2;FOXP4;IKZF2;POLR2A;ZNF423;CREB5;HOXB4;JARID2;GLI2;ZBTB20;ZNF160;HOXB6;NPAS3;CXXC1;SPP1;ZHX2;SNX6;FOXD1;HOXC6;HOXA1;ZNF568;DKK3;ARID4A;NFAT5;SOX5;PCGF5;CRABP2;PHIP;NR2F2;NCOR2;CTR9;ELF1;TSHZ3;NR6A1;GLI3;MITF;SUFU;TGFBR1;ARNT2;FOXC1;NFIB;VGLL3;CAND2;RFX8;HOXB3;VEZF1;ZBTB38;MAFG;ASCL3;ATOH1;NACC2;VGLL4;NFYB;LOXL3;CCNA1;CREB3L2;NHLH2;PRKCB;SMAD6;FOXP2;SALL4;CUX2;RREB1;CHD4;PPP1R13L;RGMB;BNC2;PIAS1;MEIS1;FBXL19;NSD1;TEF;IFNK;WWC2;TRIM56;ARRB1;ASCC2;ARID3A;SFMBT1;SBNO1;SOD2;ATRX;ESRRA;TEAD3;CBFA2T2;STAT2;LCOR;HMGA1;LBH;HOXB9;CREBL2;HOXA3;BAZ1B;ZNF318;HOXB5;TP53;TSHZ1;TBL1X;AFAP1L2;CAMTA2;WWTR1;BHLHE41;SMURF2;ARHGEF11;RORC;MED12;SOX12;MGA;CCNT2;SMARCD3;ZSCAN29;NIPBL;ZIC5;LDB1;CHD7;FBXW11;BCOR;ELF2;MEF2A;KDM2B;SMARCA4;NR1D2;HOXC4;SRCAP;BTRC;RBM15;SPEN;ZSCAN25;TBL1XR1;KAT6B;ZIC1;KDM2A;SLTM;NRG1;JMJD6;NUPR2;IRX1;SMARCC2;NEUROD4;TEAD2;NIBAN2;KLF3;CALCOCO1;PARP9;SMARCE1;HDAC4;GLI1;ZBTB26;SCML4;SIRT1;ZIC4;TFDP1;TCF7;TLE1;NSD3;NR2C2;HDAC1;SOX13;CBY1;SPINDOC;CCAR1;ZFP90;CHMP1A;FOXC2;TCF7L2;TCF4;HBP1;ZBTB8B;ZNF219;MYBL1;MED17;HIVEP2;FOXL1;ZFP28;ZFP3;AJUBA;THRAP3;ABL1;PRDM5;DYRK1A;ZBTB6;SAP18;ZKSCAN5;ZNF569;ZNF367;NFATC3;HR;MNT;ATF2;ZFX;RBBP8;BAHD1;ZMIZ2;WWP2;BAZ1A;MLLT6;TFAP2D;ZNF467;ZBTB1;SKOR1;MYBL2;MSANTD1;CBX5;TEAD1;ZMIZ1;PHF5A;ZSCAN22;NOP2;KDM3B;ZNF148;HES6;ZNF235;BRWD3;UIMC1;HOXB2;BRD7;FOXA2;DEAF1;MLXIPL;NR3C2;TGFA;BRD9;IRF1;ZKSCAN7;PHF1;PHF2;ZNF483;KMT2D;KAT7;ZXDC;EDRF1;PBX4;ZBTB48;FOXJ2;KMT5A;PRKAR1A;NFIA;SIN3A;DNM2;MAP2K1;MLLT11;ATF6B;PML;TLE2;PSIP1;BCL7A;NCOR1;ZBTB32;CRYAB;OGT;ILF2;MAP2K2;SNAI1;PER2
prerank,histone deubiquitination (GO:0016578),0.5060577988584043,1.2037465233317675,0.24508050089445438,0.9071785635520826,1.0,7/18,19.48%,USP3;USP49;UIMC1;USP7;EPOP;USP21;USP16
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.5295554231794471,1.203102296827357,0.2718808193668529,0.9078639697275623,1.0,2/14,0.89%,ACE;CORIN
prerank,potassium ion homeostasis (GO:0055075),0.49280190116705336,1.2028482229921116,0.24955752212389382,0.9070773222487093,1.0,2/23,0.71%,ATP1A2;ATP1B3
prerank,regulation of myoblast differentiation (GO:0045661),0.4639524851052203,1.202728499858834,0.24448217317487267,0.9058407067423455,1.0,1/32,0.01%,RANBP3L
prerank,regulation of cellular respiration (GO:0043457),-0.4524212810369125,-1.2025418106028232,0.2080536912751678,0.5429534663245811,1.0,4/17,14.08%,PRDM16;PNPT1;CBFA2T3;NOP53
prerank,pyroptosis (GO:0070269),0.5306989925697284,1.2023139171004735,0.25045703839122485,0.9056574449039042,1.0,1/15,1.39%,GSDME
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5254782083968285,-1.2022460793086025,0.2563559322033898,0.5428079412558181,1.0,2/10,5.71%,ACTN4;TBX1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.528658714965433,1.2021894668803048,0.2687385740402194,0.9044749171600958,1.0,3/16,3.63%,HOXB4;SOX5;FOXC1
prerank,signal transduction by p53 class mediator (GO:0072331),0.4725818592039611,1.2014583180249427,0.2413793103448276,0.9054720150643293,1.0,5/30,6.50%,DDX5;FHIT;SESN2;ATRX;TP53
prerank,macrophage activation (GO:0042116),-0.40029061408343314,-1.2011730686707545,0.17955112219451372,0.5444883678085453,1.0,13/34,19.15%,FOXP1;CD93;APP;PLCG2;DYSF;SBNO2;MAPT;SNCA;CLU;LBP;SYK;ITGB2;C1QA
prerank,negative regulation of cell migration (GO:0030336),-0.3068421232652164,-1.1998824002613504,0.10126582278481013,0.5468958286474747,1.0,30/137,9.64%,TMEFF2;SLIT2;LIMCH1;DACH1;PTPRJ;CLIC4;PTPRG;CLDN5;MCTP1;ENG;NAV3;PTPRK;CLASP2;PTPRT;SRGAP1;NEXMIF;EVL;ADARB1;ACVRL1;CYP1B1;JAG1;DAB2IP;RHOB;ADAM15;CORO1C;ARHGDIB;CALR;SMAD7;FGF2;RAP2A
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3119056983303178,-1.1998618489034194,0.09665427509293681,0.546080872184176,1.0,26/110,14.77%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;ADGRG6;GNAS;ADCY2;ADRA1B;ADGRE5;ADCY7;GNG2;RAMP2;ADCY4;S1PR1;LGR5;PTH1R;GPER1;PTHLH;RAMP1;ADGRB1;GPR26;ADGRG1;IAPP;GNAL;GNB1
prerank,snRNA processing (GO:0016180),0.5242496535888672,1.19916058336992,0.26865671641791045,0.9119747813062875,1.0,9/16,21.64%,INTS10;INTS2;INTS5;INTS3;INTS7;INTS1;INTS8;INTS4;TUT1
prerank,response to muramyl dipeptide (GO:0032495),-0.5234651991457879,-1.1986934802030822,0.2560706401766004,0.548099637309746,1.0,7/12,18.19%,NOD1;ARHGEF2;ERBIN;VIM;NOD2;TRIM41;IRF5
prerank,nuclear export (GO:0051168),0.3978029691611936,1.1986578661336476,0.18352601156069365,0.9120052960900173,1.0,20/80,21.33%,RANBP3L;SRSF5;PHAX;POLDIP3;NUP42;RANBP3;NXF1;SRSF11;DESI1;SARNP;NUP155;NEMF;CCHCR1;SRSF1;CDC40;NUP188;U2AF1;SRSF7;U2AF2;NUP153
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.36718611086358055,-1.1984616183991716,0.1723076923076923,0.547780815456097,1.0,14/47,20.60%,GRM5;NFKBIA;APOE;APP;TGFB1;AGTR1;EDN1;EDNRB;EIF4E;PUM3;INHBA;RBM4B;AGT;RBM3
prerank,canonical Wnt signaling pathway (GO:0060070),0.40210896006874197,1.198264698609154,0.19970193740685543,0.9117952998437738,1.0,13/68,11.84%,WNT5B;WNT4;WNT6;FZD8;LRRK2;FZD5;PTEN;RYK;CSNK1A1;TCF7;TCF7L2;RARG;PORCN
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.47976660242077096,-1.1977811242193483,0.22435897435897437,0.5484758231116093,1.0,4/15,20.43%,HECW2;CENPE;CDC23;NEK6
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5166794705797709,-1.1974623315177018,0.23605150214592274,0.5483633412918174,1.0,9/12,41.00%,GNL3L;CCT8;CCT2;CCT6A;CCT7;DKC1;CCT3;GNL3;CCT5
prerank,positive regulation of developmental process (GO:0051094),-0.30119053731193485,-1.1972667807435746,0.12727272727272726,0.5479269359932865,1.0,43/164,14.01%,NLGN1;NRXN1;SLC6A6;BMP5;SHANK3;BMPR2;DCN;RTN4;CLASP2;GRIP1;PHLDB1;TFRC;ARHGEF7;ZBTB16;HSP90AB1;KDR;AR;DAB2IP;FZD4;APOE;BASP1;B4GALT5;PSEN1;CORO1C;SORL1;RELN;BMP2;PTN;RPS6KA3;ENPP2;HMCES;BMP4;EDN3;LLPH;VLDLR;LRP8;CFL1;ACVR1;VEGFA;SHANK1;BMPR1B;RPS6KA1;PINK1
prerank,regulation of B cell proliferation (GO:0030888),-0.37300333238379435,-1.197228089372918,0.19689119170984457,0.5471414399535072,1.0,13/44,22.40%,MEF2C;TFRC;LYN;CD38;PTPRC;EPHB2;TNFRSF21;TIRAP;CD74;IRS2;TYROBP;CD320;CD81
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.525453435009567,-1.1971948744712375,0.2613861386138614,0.5463550892782848,1.0,4/11,8.63%,CD200;THBS1;CD34;PTGS2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3397698245344785,1.1969417804827227,0.1050228310502283,0.9149698025323175,1.0,39/308,9.87%,EPAS1;DAB2;ACSL1;PPARGC1B;C1QTNF3;SMAD3;APPL2;LEPR;PPARGC1A;NPR1;IL18;FOXD1;SOX5;BMPR1A;TGFBR1;FOXC1;ADRA2A;PDPN;KMT5C;SMO;RREB1;NCOA3;CD28;KMT5B;IL12B;EIF2AK2;SLC27A1;WWTR1;SMURF2;SERPINE1;TGFBR2;TERT;CPT2;GDNF;NIBAN2;SIRT1;LRP1;NR2C2;GRB10
prerank,positive regulation of cell development (GO:0010720),-0.39420420479795915,-1.196387849971062,0.20512820512820512,0.5474095445897177,1.0,9/31,19.59%,PDE3A;SERPINF1;MME;NAP1L1;GPER1;BMP4;CX3CR1;RFX3;TYROBP
prerank,maturation of LSU-rRNA (GO:0000470),0.4744522472940043,1.1958649964496582,0.23648648648648649,0.9172075114544432,1.0,7/26,18.39%,NSA2;DDX18;NOP2;RSL1D1;MRPL1;ZNHIT6;WDR12
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.42450098804452996,1.1956736629964617,0.2037037037037037,0.9162943655299141,1.0,6/48,13.91%,PRKAG2;GCK;NUP42;NUP98;NUP43;OGT
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3640451518137994,-1.1953957850556867,0.18010752688172044,0.5490287564764967,1.0,13/47,8.69%,NRP1;ACTN4;EFNA5;CARMIL1;ARHGEF7;DOCK1;FLNA;CRK;CORO1C;LIMS2;MYOC;PTK2;CALR
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.33041069826432545,-1.1952502569249672,0.17378048780487804,0.5485350288140696,1.0,32/84,15.16%,NRP1;TEK;BMPR2;TMSB4X;NOS3;THBS1;NRP2;SEMA5A;PTK2B;SCARB1;AKT3;KDR;GPI;FOXP1;MET;RHOB;GATA2;TGFB1;PROX1;CALR;ATOH8;FGF2;FLT4;BCAR1;ITGB3;EDN1;BMP4;HIF1A;PRKD1;VEGFA;NUS1;RRAS
prerank,protein targeting to peroxisome (GO:0006625),0.4584102379157523,1.1948901627714876,0.2625418060200669,0.9174879919057672,1.0,11/29,17.33%,ZFAND6;PEX11B;PXMP2;PEX10;PEX14;ACBD5;PEX19;RAB8B;SLC25A17;PEX16;PEX5
prerank,positive regulation of TOR signaling (GO:0032008),0.4414982104122641,1.1938426835324687,0.23728813559322035,0.9197349570841035,1.0,17/40,26.68%,FNIP1;GPR137;RICTOR;PIK3CA;FLCN;WDR24;RPTOR;TELO2;RRAGD;LAMTOR1;RRAGB;SLC38A9;SIK3;HTR6;RRAGC;SEC13;GPR137B
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.4995590560261383,1.1938025859691634,0.2618629173989455,0.9182661000353937,1.0,5/21,6.99%,ADCY5;NPR1;ADCY1;NPR2;ADCY9
prerank,protein heterooligomerization (GO:0051291),-0.4724431743774531,-1.1933085378637305,0.23593073593073594,0.5525135726854347,1.0,5/17,15.27%,KCNC2;GRIN2B;MAT2A;PKD1;GRIN1
prerank,central nervous system neuron development (GO:0021954),-0.4683069190569853,-1.1932713566370834,0.26,0.5517448066836824,1.0,6/15,12.71%,NTRK2;HSP90AB1;B4GALT5;LHX6;HSP90AA1;MAPT
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5014243348247569,1.1930545394334475,0.263254113345521,0.9191970795866373,1.0,5/19,9.78%,TLR3;TLR4;DDX3X;RIPK2;MAVS
prerank,Golgi localization (GO:0051645),0.5781840243130227,1.192994943284582,0.28733459357277885,0.9177565495899704,1.0,6/11,20.24%,TBCCD1;UVRAG;CDC42;ARHGAP21;HOOK3;RIPOR1
prerank,"phototransduction, visible light (GO:0007603)",0.550823864219979,1.1928518334598877,0.2892249527410208,0.9166564041180293,1.0,2/14,5.76%,ABCA4;RHO
prerank,lytic vacuole organization (GO:0080171),0.45682673206298324,1.192806394900419,0.2482758620689655,0.9151591941535001,1.0,13/32,20.57%,HOOK2;LRRK2;TPP1;CLN6;ARSB;HPS1;MBTPS1;ZKSCAN3;HOOK3;MYO7A;LAMTOR1;TPCN2;SNAPIN
prerank,positive regulation of phagocytosis (GO:0050766),-0.3619698321059589,-1.1927691357978922,0.1856763925729443,0.5520645702361998,1.0,12/47,10.68%,PTPRJ;MERTK;GAS6;RAB31;PTPRC;RAB27A;GATA2;CALR;CD47;DOCK2;C4B;CYBA
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.449421110539158,-1.1927242461784506,0.2261072261072261,0.5513285686853175,1.0,9/21,9.43%,HS6ST2;NDST3;HS6ST3;HS3ST4;HS3ST5;EXT1;XYLT1;GLCE;EXT2
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4753980107770578,1.1925828833857515,0.259927797833935,0.9143999168258249,1.0,6/24,3.91%,ARHGAP28;CGNL1;ARHGEF18;CLASP1;ARHGAP6;PPFIA1
prerank,membrane raft organization (GO:0031579),-0.4725123695128009,-1.1924719256143586,0.26914660831509846,0.5510473743911355,1.0,7/15,24.45%,RFTN1;PPT1;EMP2;MYADM;S100A10;FLOT1;NAXE
prerank,response to ionizing radiation (GO:0010212),0.3983293019279424,1.1924590977295781,0.21286370597243492,0.9132505447466347,1.0,23/70,20.24%,EYA1;BABAM2;ATM;NHEJ1;TP53;RNF8;XRCC4;SIRT1;BRSK1;HUS1;UIMC1;BABAM1;GADD45A;BRAT1;INTS3;CLK2;INTS7;MAPK14;MTA1;FANCD2;LIG4;TANK;RAD9A
prerank,protein dephosphorylation (GO:0006470),0.36705350153018795,1.1924465659670733,0.1794871794871795,0.9117013047153093,1.0,29/135,12.27%,EYA1;PTPN13;EYA2;DUSP29;PPP2R2B;PTPN14;PTPN9;MTMR3;PPEF2;EYA4;PPP1CB;PPM1E;TNS2;LHPP;DAPP1;PTPRU;PTPN22;FBXW11;PTEN;PP2D1;BTRC;PPP2R1B;PTPN21;DUSP10;CDC14B;PPP2R5E;PTPN4;CTDSP2;PTPN11
prerank,positive regulation of transferase activity (GO:0051347),-0.3056378436300036,-1.1922861520334345,0.13559322033898305,0.550609331734531,1.0,34/142,14.68%,TEK;ERBB4;NTRK3;ROR1;CD200;EPHB1;EPHA5;MERTK;EPHA6;PARM1;TIE1;NTRK2;HSP90AB1;NEK7;KDR;ROR2;MET;EPHA7;SORL1;EPHB2;TGFB1;FLT4;RPS2;ERBB2;HSP90AA1;SERINC1;XRCC5;CTNNB1;ARRDC4;AXIN1;SERINC5;RET;PINK1;FGFR3
prerank,lipid transport (GO:0006869),-0.3190689130994143,-1.1917574404949973,0.15140845070422534,0.5510650252640462,1.0,23/97,9.78%,ABCC4;ATP8A1;ATP8B1;SLCO1C1;CERT1;PPARD;PITPNC1;SCARB1;PLTP;SLCO2B1;UGCG;SPNS2;APOE;ABCG1;LDLR;NPC2;GLTP;PITPNB;CEACAM1;STARD5;ABCD2;TNFAIP8L3;MTTP
prerank,positive regulation of cellular component organization (GO:0051130),0.37424114312974127,1.1916036283829328,0.1790633608815427,0.9131047357661556,1.0,20/107,9.35%,DAB2;BMP7;LRP4;FNIP1;TRABD2B;FRMPD4;TGFBR1;BID;RAPGEF3;ADGRL1;MPP7;ANAPC2;CAMK1;PTPN23;NOX1;ASAP1;NRG1;CDH5;HYAL1;LRP1
prerank,positive regulation of response to wounding (GO:1903036),-0.4289069763226589,-1.1912014165055012,0.24822695035460993,0.5514423266782176,1.0,11/24,21.92%,ACTG1;ANXA1;OCLN;ITGB1;PTK2;PTN;SCARF1;DMTN;KANK1;VTN;MDK
prerank,glycoprotein catabolic process (GO:0006516),0.5262325136251612,1.1911567940565773,0.2753623188405797,0.9130970510801429,1.0,4/17,8.42%,NGLY1;NEU2;ADAMTS9;MANBA
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.32880278018205017,-1.190987798591452,0.14144736842105263,0.5511152732050898,1.0,32/80,18.81%,MAP3K5;THBS1;NOD1;GAS6;NGF;YWHAE;TNFSF10;CTSD;EPHA7;SIAH2;CD44;GRAMD4;ARL6IP1;RPS6KA3;GPER1;SOX7;DAPK1;SNCA;VEGFA;RPS6KA1;CARD16;MT3;PPM1F;PAX2;GPX1;SYK;SOX2;DHCR24;HTRA2;CYCS;FOXL2;BCAP31
prerank,sulfate transport (GO:0008272),0.542622064403249,1.1907233585826162,0.2966417910447761,0.9130624952200742,1.0,1/14,0.15%,SLC13A4
prerank,positive regulation of T cell activation (GO:0050870),-0.36028681487369546,-1.1904690798619704,0.1783625730994152,0.5515043929701618,1.0,21/62,23.71%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;DOCK8;CD47;RHOH;NCK1;NOD2;PRKCQ;CCL19;LGALS9;PYCARD;MDK;CD86;CD276;CD81;THY1
prerank,glucose import (GO:0046323),-0.49227967324301736,-1.1904331507062758,0.25738396624472576,0.5507413405669128,1.0,3/13,12.80%,SLC2A1;SORT1;SLC2A3
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.48297620030714733,-1.190309336108155,0.26096997690531176,0.5502085258698955,1.0,7/15,8.00%,KCNJ3;KCNJ2;KCNN2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,regulation of cellular component movement (GO:0051270),0.4215691721889835,1.1903043606934773,0.24251968503937008,0.9128484932352003,1.0,12/49,11.57%,TGFBR3;ROCK2;PKHD1;ARHGAP18;TGFBR1;PDPN;NRG1;DIAPH1;HBEGF;ZSWIM8;ABL1;ADAM17
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.37559509766673854,-1.1902448065575861,0.1931216931216931,0.5495375787090641,1.0,18/40,20.70%,PTK2B;RPL5;RPS7;XPO1;PTK2;GNA12;RPL23;RAD23B;FOXF2;AXIN1;LAPTM5;SMURF1;CLU;HIPK2;UBE3A;PDCL3;COMMD1;RPL11
prerank,ESCRT complex disassembly (GO:1904896),0.5664254466500205,1.190240308644457,0.29558541266794625,0.909889102045713,1.0,6/10,28.40%,CHMP1A;VPS4A;CHMP2A;IST1;VTA1;CHMP1B
prerank,ESCRT III complex disassembly (GO:1904903),0.5664254466500205,1.190240308644457,0.29558541266794625,0.909889102045713,1.0,6/10,28.40%,CHMP1A;VPS4A;CHMP2A;IST1;VTA1;CHMP1B
prerank,neutrophil mediated immunity (GO:0002446),-0.27247814488356087,-1.1898922872659206,0.011627906976744186,0.5495648560232146,1.0,103/432,19.59%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;RAB31;PTPRN2;HSP90AB1;PRG2;GPI;ACTR2;PPIA;RAP1B;PTPRC;RAP1A;CD93;STK10;CTSD;PSAP;CTSC;RAB27A;TSPAN14;HSPA8;TIMP2;PSEN1;TNFRSF1B;DYNLL1;PGLYRP1;NPC2;SLC44A2;FTL;CKAP4;OSTF1;MME;EEF1A1;HEXB;CTSB;STOM;CEACAM1;PSMD14;CRACR2A;CD47;DOCK2;RAB18;CD44;HSP90AA1;CYBA;IMPDH1;XRCC5;GOLGA7;CTSS;ENPP4;HRNR;SLC2A3;ARPC5;TNFAIP6;LRG1;SRP14;PGAM1;FABP5;TMEM30A;QPCT;SCAMP1;DOK3;RAB6A;TRPM2;ALDOA;CCT8;APEH;PKM;CAT;CCT2;PDXK;STXBP3;SVIP;RAB37;GCA;CYB5R3;C3AR1;PSMD11;CTSZ;ITGB2;CAND1;SLC27A2;QSOX1;TMEM63A;EEF2;SPTAN1;PSMD2;ATP11B;TYROBP
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.42186390210930763,-1.1898310742574372,0.22139303482587064,0.5488872325913965,1.0,4/25,1.39%,SLC8A1;TMTC2;CAV1;ANK3
prerank,regulation of vacuole organization (GO:0044088),0.5019847443714504,1.189815005121734,0.25432525951557095,0.9098436609805959,1.0,5/20,11.12%,MTMR3;NPRL3;NPRL2;PIKFYVE;IFT88
prerank,lymphocyte chemotaxis (GO:0048247),-0.40042930044561975,-1.1897605392518156,0.2100238663484487,0.5482068312123161,1.0,11/34,26.52%,CYP7B1;SLC12A2;GAS6;CXCL16;CCL13;CH25H;CCL19;HSD3B7;CXCL10;PIK3CD;CCL2
prerank,positive regulation of cyclase activity (GO:0031281),0.5300646389159647,1.1893625063965638,0.2857142857142857,0.9099500343737658,1.0,3/14,9.72%,CACNA1D;CACNA1C;STIM1
prerank,protein ubiquitination (GO:0016567),0.32554361633542955,1.1893524161187974,0.09130913091309131,0.9084023451809602,1.0,104/471,19.25%,RNF220;EPAS1;RNF152;PDZRN3;SH3RF2;UBE2E2;RNF43;ASB2;SASH1;PRKN;FBXL17;SPSB1;TRIM63;RNF213;CTR9;DTX1;CAND2;NEDD4;RNF151;RNF135;FBXL19;KLHL41;ARRB1;USP9X;RNF181;SPSB4;MGRN1;UBR2;SMURF2;RNF8;FBXW11;RNF141;HUWE1;TRIP12;FBH1;RNF217;TNKS2;BTRC;RNF19A;KLHL7;EIPR1;RNF34;HERC6;SIRT1;NPEPPS;UBR5;FBXO22;ZSWIM8;FBXL12;SH3RF1;RTF1;RNF41;FBXW8;FBXO4;RNF13;PRKDC;WWP2;PEX10;CUL4A;CUL9;UBA6;FBXO10;NUB1;ASB5;USP7;TRIM62;ASB12;DDB2;FBXO11;DTX3;FBXL20;SDE2;DZIP3;LONRF1;PEX14;UBE2H;RNF115;RMND5A;AMFR;RNF31;ANAPC16;RNF146;BIRC6;RNF19B;UBR1;RNF7;UBE2E1;KCTD13;SYVN1;PEX5;CDC34;RNF25;FBXW10;RNF20;CCDC22;TAF1;ARIH1;MIB2;ASB1;NHLRC3;UBE4B;FBXL22;KLHL18;MIB1
prerank,actin nucleation (GO:0045010),-0.43681738166385464,-1.1892510705956052,0.23385300668151449,0.5486123863877705,1.0,6/21,13.79%,ACTR2;ACTR3;TRIM27;ARPC1B;ARPC5;ARPC4
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4177622746781157,-1.1886751633643204,0.21136363636363636,0.5491683109438732,1.0,7/27,19.38%,PLA2G4A;GPCPD1;ENPP6;GDPD1;ENPP2;PLA2G4E;PLA2G15
prerank,cellular response to interleukin-7 (GO:0098761),-0.46688977024370243,-1.1886614885702145,0.25646551724137934,0.5475158609649013,1.0,6/17,20.04%,STAT3;SOCS2;STAT5B;JAK1;IRS2;IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.46688977024370243,-1.1886614885702145,0.25646551724137934,0.5475158609649013,1.0,6/17,20.04%,STAT3;SOCS2;STAT5B;JAK1;IRS2;IRS1
prerank,oxoacid metabolic process (GO:0043436),0.47449273443070855,1.1885140526528775,0.26405451448040884,0.9096883499304645,1.0,4/27,12.04%,DDO;ABHD14B;SULT2B1;TPST1
prerank,keratan sulfate catabolic process (GO:0042340),0.5543650354788388,1.1884530864471563,0.26595744680851063,0.9082989792345357,1.0,2/11,5.04%,OGN;FMOD
prerank,activation of adenylate cyclase activity (GO:0007190),0.4476492923388579,1.1884144898604272,0.2627257799671593,0.9068597733827882,1.0,3/35,1.98%,ADCY5;LGR4;ADCY1
prerank,negative regulation of gene expression (GO:0010629),0.3357453209060848,1.1881564475154969,0.14066193853427897,0.9062251985617966,1.0,64/302,15.75%,NOTCH2;ROBO1;LGR4;SLC24A3;ROCK2;WNT4;SYT11;PICALM;IGF1;PRKAA2;PRKN;DNMT3A;JARID2;TNRC6A;NCOR2;BMPR1A;PARP10;PARP14;SRGN;SMO;IGF2BP1;DDX3X;TIPARP;CD28;EIF2AK2;TWSG1;PTPN22;TNRC6B;SAMD4A;RBL2;LARP1;CPEB3;TERT;APLN;IGF2BP2;CNOT10;PARP9;SIRT1;HDAC1;LRP3;MOV10;LSM14A;RBL1;CRKL;WWP2;NOCT;DICER1;ZNF148;DDX6;FLOT2;PHF1;SNX12;MAP2K1;NCOR1;MAP2K2;FLCN;TSC1;KAT2B;TNRC6C;NFKB1;ANXA7;MPHOSPH8;SETDB2;RBM4
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4643227470499427,1.1878679457306003,0.24684684684684685,0.9056851675365246,1.0,7/27,14.06%,DDX5;ATM;YJU2;SIRT1;DYRK1A;KMT5A;SNAI1
prerank,regulation of angiogenesis (GO:0045765),-0.29118212728241727,-1.1874519514167372,0.06976744186046512,0.5495094405629469,1.0,53/192,13.89%,PTPRM;TEK;BMPER;RHOJ;SEMA6A;CLDN5;PDE3B;DCN;NOS3;VEGFC;THBS1;TGFB2;SEMA5A;TIE1;COL4A2;PPP1R16B;GAB1;CD34;RUNX1;PTGIS;F3;CYP1B1;SEMA3E;KDR;RAMP2;DAB2IP;ITGB8;SERPINF1;RHOB;PIK3R6;ITGB1;TSPAN12;HSPG2;ECM1;STAB1;GATA2;CEACAM1;BTG1;AMOT;FGF2;ERBB2;ATP2B4;HIPK1;CTNNB1;TWIST1;EMP2;ISM1;HIF1A;PRKD1;VEGFA;ECSCR;ADGRB1;SPRED1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4659240253071184,-1.187329964673745,0.26153846153846155,0.5489593284211566,1.0,3/16,2.23%,MEF2C;MCTP1;RIMS1
prerank,organic anion transport (GO:0015711),-0.3365106119485483,-1.1872543378651728,0.1762917933130699,0.5483132448858694,1.0,10/76,6.93%,SLC4A10;ABCC4;ABCG2;SLC26A7;SLCO1C1;LRRC8C;LRRC8D;SLCO2B1;CA4;CA2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3532365972404532,1.186987550115061,0.16536458333333334,0.9071986296013874,1.0,43/182,15.24%,NOTCH2;ROBO1;SLC24A3;ROCK2;WNT4;PICALM;IGF1;PRKAA2;PRKN;TNRC6A;BMPR1A;PARP10;PARP14;SMO;TIPARP;RIN3;CD28;PTPN22;TNRC6B;ATXN2;RBL2;TERT;APLN;PARP9;SIRT1;HDAC1;LRP3;MOV10;RBL1;CRKL;WWP2;NOCT;DICER1;ZNF148;FLOT2;SNX12;MAP2K1;MAP2K2;FLCN;TNRC6C;NFKB1;TET1;ANXA7
prerank,C4-dicarboxylate transport (GO:0015740),-0.49033670915489275,-1.186959771199039,0.24269662921348314,0.5481549714437036,1.0,4/14,5.29%,LRRC8D;SLC1A2;SLC1A1;SLC25A13
prerank,positive regulation of protein depolymerization (GO:1901881),-0.5194797173274368,-1.1866505238258402,0.2646420824295011,0.5480290920444225,1.0,4/11,10.63%,SEMA5A;STMN2;TRPV4;WDR1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.49482121307568544,1.1865783351146317,0.2822719449225473,0.9070631481066148,1.0,4/22,3.52%,ROCK2;PICALM;EPHA4;CASP3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.33335599189411447,-1.1859654494892788,0.1625,0.548893085599806,1.0,21/75,13.89%,PTPRM;TEK;SEMA6A;CLDN5;PDE3B;DCN;THBS1;TGFB2;COL4A2;SEMA3E;DAB2IP;SERPINF1;HSPG2;STAB1;AMOT;ATP2B4;CTNNB1;ISM1;ECSCR;ADGRB1;SPRED1
prerank,sarcomere organization (GO:0045214),0.47664694278544334,1.1858056989435122,0.2570921985815603,0.9082376184880855,1.0,3/27,5.17%,ACTN2;CSRP3;TPM1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5187887965250039,1.1852729255223646,0.28073394495412846,0.9085644303588828,1.0,1/16,0.73%,LEPROT
prerank,SNARE complex assembly (GO:0035493),-0.5344343957033079,-1.1849837903278062,0.2830957230142566,0.5504258733471383,1.0,2/10,4.59%,STXBP6;VAMP4
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4823335219767386,1.184788373879108,0.27364864864864863,0.9086464585946089,1.0,8/26,14.57%,ROCK2;PRKN;FHOD1;ASAP3;CDC42;VIL1;TSC1;ALMS1
prerank,response to leucine (GO:0043201),0.5710618720674147,1.184540418886497,0.2980392156862745,0.9064007787177248,1.0,6/10,17.13%,SESN1;SESN2;UBR2;RPTOR;UBR1;RRAGD
prerank,cellular response to leucine (GO:0071233),0.5710618720674147,1.184540418886497,0.2980392156862745,0.9064007787177248,1.0,6/10,17.13%,SESN1;SESN2;UBR2;RPTOR;UBR1;RRAGD
prerank,negative regulation of biosynthetic process (GO:0009890),0.515611455503503,1.184394877341231,0.26534296028880866,0.9053942800039475,1.0,2/16,2.04%,PPARA;SLC30A10
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.5213817497042179,-1.1843815466618337,0.2598752598752599,0.5510183689284107,1.0,6/11,27.82%,TERF1;CCT8;CCT2;CCT6A;CCT7;DKC1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3142559693053102,-1.1836955492417223,0.125,0.5519326719658285,1.0,37/114,27.67%,ACTN4;TMSB4X;ST18;PTK2B;TNFRSF11B;NFKBIA;PSMB2;TNFRSF11A;TRAF5;CARD14;TNFRSF1B;PSMD14;PSMC6;ILK;IKBKB;AIM2;LIMS1;PSMA4;PSMB9;EDAR;MAP3K14;TRAF1;TNFRSF25;PSMD11;PSMB10;PSMD2;PYCARD;TXNDC17;PSMA2;RELA;JAK2;TNFSF8;PSMB3;CD40;PSMB5;CDIP1;PSMA7
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3801882710606276,-1.183556939936356,0.19452054794520549,0.5513966116592083,1.0,9/39,8.98%,MYO1D;ACTN4;PPFIA2;MYO1B;FNBP1L;TANC2;MYO5A;DYNC1I1;MYO6
prerank,DNA catabolic process (GO:0006308),0.5615292288144171,1.1834566779865798,0.29158512720156554,0.9070307225352635,1.0,5/11,22.80%,DNASE1L1;FBH1;DFFB;DNASE1L2;REXO4
prerank,glucan catabolic process (GO:0009251),0.5218161595723412,1.1834067511085276,0.29014598540145986,0.905660075947024,1.0,4/15,8.85%,PYGM;PHKB;MGAM;PHKG1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.5263560065377586,-1.1831744518576062,0.27157894736842103,0.551464692694941,1.0,8/10,45.99%,SMAD7;NFKBIZ;RC3H2;MALT1;IL4;ZC3H12A;FOXP3;TBX21
prerank,regulation of protein phosphorylation (GO:0001932),-0.28316124251402436,-1.1831376708364736,0.08196721311475409,0.5507398638193763,1.0,71/256,14.40%,SLIT2;LIMCH1;PID1;TEK;BMPER;GRM5;PRR5L;ERBB4;NTRK3;PECAM1;PDE8A;ENG;PLCE1;VEGFC;NPTN;NIBAN1;EFNA5;FN1;SH3GL2;GAS6;CCDC88A;TFRC;NTRK2;KRAS;PPP2R5A;KDR;LYN;TBX1;DAB2IP;PPIA;PAK1;APP;CARD14;OCLN;LIMK2;EPHA7;SEMA4D;CORO1C;EPHB2;CCN1;BMP2;TGFB1;PTK2;RALB;DNAJC10;XDH;FGF2;FLT4;RAP2A;FNIP2;ERBB2;CAMKK2;PDGFA;HSP90AA1;ITGB3;GPER1;FXR1;BMP4;ATF4;ILK;FAS;AXIN1;FGF7;FGF9;VEGFA;PINK1;TERF2IP;NOP53;CCDC88C;MT3;P2RY1
prerank,sterol transport (GO:0015918),-0.4473201048572495,-1.1829753430776597,0.24358974358974358,0.5503451604312858,1.0,9/19,32.22%,CAV1;LDLR;NPC2;LDLRAP1;OSBP;STARD3;CD36;MSR1;NPC1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.44995662694022887,1.1820642613368963,0.2542087542087542,0.9087993421034073,1.0,9/35,12.44%,PPARGC1B;DDX5;PMEPA1;NEDD4;TMF1;CALCOCO1;UBR5;ZMIZ1;NR3C2
prerank,hexose biosynthetic process (GO:0019319),0.4386372725715156,1.1819987241828775,0.26515151515151514,0.90749174369302,1.0,14/42,17.87%,PPARGC1A;SORD;CHST15;PGAM2;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;SLC25A10;GOT1;SLC37A4;CRY1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4044636710632202,-1.1819612442645977,0.22358722358722358,0.5518015413803352,1.0,4/29,7.62%,RPS8;RPS19;RPS21;RPS16
prerank,regulation of steroid metabolic process (GO:0019218),0.47130989947764856,1.1811374264821721,0.26608695652173914,0.9089168455348701,1.0,11/23,24.28%,RORA;RORC;ARV1;TTC39B;EPHX2;LAMTOR1;NR5A1;GNB3;ABCA2;STAR;DGKQ
prerank,negative regulation of glycolytic process (GO:0045820),0.5635447853122271,1.181135282935358,0.298828125,0.9058834220050428,1.0,4/10,13.81%,PPARA;NUPR1;HDAC4;NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5635447853122271,1.181135282935358,0.298828125,0.9058834220050428,1.0,4/10,13.81%,PPARA;NUPR1;HDAC4;NCOR1
prerank,regulation of synapse maturation (GO:0090128),-0.5368423916478762,-1.180832966482116,0.2735229759299781,0.5536151586350607,1.0,4/10,7.93%,NRXN1;DAB2IP;ARHGEF15;RELN
prerank,alpha-amino acid metabolic process (GO:1901605),0.4274716225858169,1.1806046203517107,0.2519561815336463,0.906165877819945,1.0,13/45,12.51%,ASPA;ASPG;CPS1;KYAT3;GPT2;GOT2;MTHFR;SRR;GLUL;SLC25A12;NOX4;MTRR;FOLH1
prerank,cellular response to amino acid starvation (GO:0034198),0.39287106304099595,1.1804064329508466,0.22664624808575803,0.905301479421041,1.0,21/71,19.47%,RNF152;NPRL3;SESN1;ATP6V0E1;SESN2;NPRL2;ATP6V0B;EIF2AK2;ATP6V1D;ATP6V1E1;ATF2;IMPACT;DEPDC5;FLCN;KPTN;WDR24;RPTOR;RRAGD;ATP6V0D1;LAMTOR1;ITFG2
prerank,regulation of neuron death (GO:1901214),-0.3259961662876085,-1.1798926912747116,0.1353135313531353,0.5550231099452043,1.0,38/82,23.30%,GRID2;MEF2C;MAP3K5;CD200;EPHB1;DCC;GRIN2B;TRIM2;CD34;GSK3B;TNFRSF1B;SORL1;BTBD10;EGR1;DDIT4;NENF;MAPT;SNCA;CLU;UBB;EGLN2;FAIM2;CHRNA7;DHCR24;HTRA2;CHMP4B;CHMP4A;CTSZ;ITGB2;C1QA;TYROBP;EGLN3;AKT1S1;GRM4;SNCG;FYN;LANCL1;CHGA
prerank,positive regulation of MAPK cascade (GO:0043410),0.3378903640895573,1.1796483639363025,0.14547677261613692,0.9064719682447401,1.0,24/245,6.57%,NOTCH2;FGF1;ROBO1;ROCK2;LPAR1;TPD52L1;KSR1;PRKCZ;KIT;GSDME;IGF1;CCN2;FGFR2;SLC30A10;NPNT;FGFR1;ADRA2A;LRRK2;ARRB1;BRAF;EPHA8;FLT1;PDGFRB;EIF2AK2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.4908262029846111,1.179451504528707,0.26278659611992944,0.905680216571644,1.0,10/23,24.40%,CASP3;DNASE1L1;FBH1;DICER1;DFFB;DFFA;DNASE1L2;CECR2;REXO4;H1-0
prerank,muscle tissue development (GO:0060537),-0.4940757111479586,-1.178981797170474,0.2683982683982684,0.5564550962344792,1.0,6/13,11.37%,PGM5;ENG;PTCH1;CSRP2;STRA6;BMP4
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.38016567441450533,1.1787812835639917,0.20728291316526612,0.9065208759646922,1.0,30/104,16.65%,KSR1;SLC8A3;CCNA2;PPEF2;CCNA1;DDX3X;UVRAG;CAMK1;TRIB2;SLC27A1;CCNT2;CCND3;CDK5RAP3;HTT;CDC25A;SIRT1;GTPBP4;CCNB2;IRGM;ABL1;TRIB1;MAP2K1;MAP2K2;GADD45A;CCNG1;SNF8;RPTOR;RB1;CCNE1;TELO2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.47039500076016993,-1.1787483388121363,0.2826086956521739,0.556195704960907,1.0,10/16,42.81%,CADM1;PVR;RAET1E;RASGRP1;LAMP1;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3355095653655387,-1.1785724699195512,0.17114093959731544,0.5557839321281195,1.0,21/72,15.24%,SLIT2;SHANK3;NAV3;CLASP2;KANK3;KANK4;ARHGEF2;LIMA1;APOE;STMN2;LDLR;HSPA8;FGF13;TUBB4A;SPEF1;PFN2;SNCA;SHANK1;CLU;IAPP;STMN1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5369828366298318,1.1784577420456621,0.3018867924528302,0.9061567453945445,1.0,7/12,22.34%,PTEN;BTRC;CDC14B;FZR1;GOLGA2;UBE2S;GORASP1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.43141051109644823,1.1784531809336287,0.23595505617977527,0.9046732705187259,1.0,10/43,11.68%,SMAD3;DDX5;PPARA;NFIB;TP53;SMARCA4;TERT;APLN;NFATC3;TEAD1
prerank,presynapse organization (GO:0099172),-0.5274955322874298,-1.1784517839489086,0.27253218884120173,0.5552657056437393,1.0,2/10,3.65%,NLGN1;LRRTM3
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5415368323678122,1.1781226249327597,0.28166351606805295,0.9042483314654063,1.0,2/12,2.84%,COLEC12;IFIT1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.494520428359712,-1.1779214470368804,0.25223214285714285,0.5557290747152809,1.0,3/13,10.24%,NLGN1;P2RY12;EPS8
prerank,electron transport chain (GO:0022900),0.528653679035588,1.1779135565786725,0.30474452554744524,0.9034540914145158,1.0,2/15,5.34%,PPARGC1A;POR
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3539542749067019,-1.1776856462481613,0.18181818181818182,0.5555111767752805,1.0,22/55,34.29%,FBXL7;PSMB2;PSMD14;PSMC6;ATF5;PSMA4;PSMB9;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;FHL1;PSMB5;PSMA7;PSMF1;PSMD7;AURKA;PSMA5;PSMD4;PSME4
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.36732188127267706,1.1776486032557463,0.20833333333333334,0.9028190411347918,1.0,10/107,3.58%,ATP13A5;SLC24A3;SLC41A1;ANK2;ATP13A3;SLC8A3;SLC30A10;PKHD1;CSRP3;DMPK
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3892649669599273,1.1774879496177435,0.23714285714285716,0.9018402775427544,1.0,7/86,3.46%,DAB2;BMP6;BMP7;ZNF423;FOXD1;BMPR1A;TGFBR1
prerank,regulation of developmental growth (GO:0048638),-0.39728123405852916,-1.177472637864026,0.20094562647754138,0.5552069207900813,1.0,10/29,14.68%,GHR;GSK3B;APOE;APP;NRCAM;SIX1;STAT5B;MFSD2A;SPAAR;FGFR3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.5028813049888615,-1.1774656518698783,0.26422764227642276,0.553594237964821,1.0,3/13,9.42%,STAT3;STAT5B;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),-0.5028813049888615,-1.1774656518698783,0.26422764227642276,0.553594237964821,1.0,3/13,9.42%,STAT3;STAT5B;JAK1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.35242742536761346,-1.177203775568538,0.18232044198895028,0.5534039427490366,1.0,11/51,15.16%,VEGFC;THBS1;CXCL12;GAS6;PTK2;CALR;PTN;EDN3;CMKLR1;VEGFA;RARRES2
prerank,negative regulation of MAPK cascade (GO:0043409),0.3818884533753166,1.1771449476664204,0.223943661971831,0.9014984365090832,1.0,10/87,5.16%,BMP7;DUSP29;FBLN1;TIMP3;DLG1;CD300A;PPEF2;DAG1;EZR;TLR4
prerank,intestinal lipid absorption (GO:0098856),-0.5033141558392747,-1.1769451504605053,0.25308641975308643,0.5532234707544266,1.0,3/11,6.74%,UGCG;LIMA1;LDLR
prerank,eye morphogenesis (GO:0048592),0.5066481655412006,1.1768973933169204,0.29772329246935203,0.9008838694556587,1.0,6/19,11.13%,COL5A1;SHROOM2;FBN1;NIPBL;IFT122;RARG
prerank,myelin maintenance (GO:0043217),-0.5487708994599777,-1.1768095209601424,0.2807377049180328,0.5527227455118349,1.0,6/10,23.09%,EPB41L3;ABCD2;PRX;CLU;SOD1;CXCR4
prerank,prostanoid metabolic process (GO:0006692),0.5440498986424258,1.1768045872273518,0.3020257826887661,0.8997056607570285,1.0,2/13,9.97%,PTGS1;PTGR2
prerank,protein sumoylation (GO:0016925),0.42602977925275015,1.176768904363025,0.23233908948194662,0.8983603092623909,1.0,13/49,21.33%,EYA1;PIAS1;NUP42;NUP98;NSMCE2;NUP43;PIAS3;NUP155;SUMO1;PIAS4;NUP188;UBE2I;NUP153
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5334692146042191,1.1762215551397657,0.29571984435797666,0.8988000321231724,1.0,2/12,7.53%,TLR4;RBP4
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3897455654577327,1.1757069827213946,0.21796759941089838,0.899089784372156,1.0,5/75,1.99%,ATP1A2;SLC6A1;ATP1B3;KCNJ13;SLC8A3
prerank,skeletal system development (GO:0001501),0.35740544965466026,1.1756656403440668,0.1970509383378016,0.897758228902034,1.0,25/148,9.22%,WWOX;BMP6;BMP7;DYM;IGF1;FGFR2;GLI2;SOX5;NPR3;AKAP13;FGFR1;SUFU;TGFBR1;SULF2;CREB3L2;COL9A2;SH3PXD2B;COL13A1;FBN1;COMP;RBP4;CHD7;COL1A2;EXTL1;HYAL1
prerank,negative regulation of kinase activity (GO:0033673),0.4038821519103642,1.1752246649122924,0.22685185185185186,0.8978087187843261,1.0,8/62,8.74%,PRKAG2;PPM1E;DEPTOR;DTNBP1;NPRL2;TRIB2;WWTR1;PDPK1
prerank,bicellular tight junction assembly (GO:0070830),0.4219090991113682,1.17509543079137,0.2409448818897638,0.8967496206628937,1.0,9/46,13.42%,PARD6G;AFDN;DLG1;MPP7;CDH5;RAB13;PATJ;PRKCI;PARD3
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5248159330057374,-1.174517489772531,0.28087649402390436,0.5573361614184975,1.0,6/10,16.82%,CORO2B;NDFIP2;MAPT;PPM1F;TERF1;DNAJA1
prerank,regulation of multicellular organism growth (GO:0040014),-0.4788882937275061,-1.1739506352577338,0.2689075630252101,0.5578058236157073,1.0,6/15,10.92%,GHR;APP;PTCH1;PPIB;STAT5B;MFSD2A
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.36378964333309005,-1.1737445097096726,0.20365535248041775,0.5574725959837217,1.0,16/44,17.95%,THBS1;GAS6;NGF;YWHAE;SIAH2;CD44;ARL6IP1;RPS6KA3;SNCA;VEGFA;RPS6KA1;CARD16;MT3;PAX2;GPX1;DHCR24
prerank,regulation of cation transmembrane transport (GO:1904062),-0.40316552860312926,-1.1734869755735666,0.21921182266009853,0.5573151271608,1.0,7/29,4.12%,KCNIP4;DPP10;FGF12;DPP6;KCNN2;KCNIP1;KCNAB1
prerank,programmed necrotic cell death (GO:0097300),0.4952466398666726,1.173465909897275,0.2740740740740741,0.9007909173595298,1.0,5/18,10.97%,TLR3;TLR4;DNM1L;RIPK1;LY96
prerank,cardiac muscle cell differentiation (GO:0055007),-0.431295278538482,-1.1734619655046659,0.24782608695652175,0.5565640724440235,1.0,7/21,13.77%,SLC8A1;MEF2C;BMP2;MYH11;ACVR1;MYOCD;VEGFA
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4200161865200027,-1.1731858926712662,0.23908045977011494,0.5564511811818734,1.0,10/24,16.75%,PTK2B;APOE;CTSC;PSMD14;PKD1;PINK1;UBB;GPX1;USP14;UBE3A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.4963123235306857,1.173119643727799,0.28063943161634103,0.9005834624311765,1.0,1/17,0.83%,LPGAT1
prerank,mRNA metabolic process (GO:0016071),0.3794948412938555,1.1730855309779922,0.19627507163323782,0.8992292531738183,1.0,25/90,21.54%,DDX5;PPARGC1A;SON;PCBP2;HNRNPR;SRSF5;TP53;HNRNPA2B1;CNOT10;TBRG4;PRPF18;SRSF11;HIPK3;SCAF11;PRPF3;CPSF3;USP39;ALKBH5;SRSF1;PCF11;U2AF1;DXO;SRSF7;U2AF2;SF3B2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.418312721501354,1.1730764209471407,0.24345146379044685,0.8978082828004396,1.0,9/51,5.17%,ROCK2;LPAR1;CCN2;ARHGEF10L;FHOD1;PPM1E;TGFBR1;RAPGEF3;TPM1
prerank,maturation of SSU-rRNA (GO:0030490),-0.3787786431656017,-1.171993827892274,0.23037974683544304,0.5584896124445535,1.0,5/34,8.78%,RPS8;RPS19;RPS28;RPS16;WDR3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4332336066001297,1.170920434663015,0.2757527733755943,0.9035830747178575,1.0,4/44,0.80%,WNK4;ACTN2;ATP1B3;ANK2
prerank,regulation of kinase activity (GO:0043549),-0.3218692865736345,-1.1707351482630397,0.18037974683544303,0.5606685040580286,1.0,23/89,12.71%,TEK;ERBB4;NTRK3;ROR1;EPHB1;PLCE1;EPHA5;MERTK;EPHA6;TIE1;NTRK2;KDR;ROR2;MET;EPHA7;EPHB2;EEF1A1;FLT4;ERBB2;CAMKK2;NLRC5;EMP2;MAPT
prerank,DNA methylation or demethylation (GO:0044728),0.4873222104631146,1.1706806820192415,0.27486437613019893,0.9014608929253661,1.0,7/19,17.67%,DNMT3A;ATRX;MTRR;BEND3;EHMT2;EHMT1;KMT2E
prerank,DNA alkylation (GO:0006305),0.4873222104631146,1.1706806820192415,0.27486437613019893,0.9014608929253661,1.0,7/19,17.67%,DNMT3A;ATRX;MTRR;BEND3;EHMT2;EHMT1;KMT2E
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.45964879148376586,-1.1701350512874842,0.23829787234042554,0.5612519265945425,1.0,5/16,8.77%,ST6GALNAC3;ST8SIA4;ST8SIA1;ST6GALNAC5;ST8SIA6
prerank,steroid catabolic process (GO:0006706),0.5624074312512447,1.1700902478192454,0.29880478087649404,0.9020439168371859,1.0,1/10,2.52%,SPP1
prerank,regulation of cellular component size (GO:0032535),0.46199630125688124,1.1699085115591845,0.25980392156862747,0.9012800608703534,1.0,10/30,15.83%,PICALM;PEX11A;EZR;RIN3;PTEN;PEX11B;RARG;RAB22A;VAV3;RPTOR
prerank,monocyte differentiation (GO:0030224),-0.5293865489460445,-1.1698786925767721,0.270042194092827,0.5610630189281269,1.0,6/10,15.38%,MYH9;MT1G;BMP4;THOC5;VEGFA;IL31RA
prerank,keratinocyte differentiation (GO:0030216),-0.4161756642132072,-1.1696062639692006,0.23366834170854273,0.5608761719381598,1.0,9/29,21.91%,CLIC4;JAG1;UGCG;ANXA1;TXNIP;SCEL;EXPH5;WNT16;ASAH1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3680891966489096,-1.169569006290348,0.21448467966573817,0.5601593798658895,1.0,12/39,7.95%,ROBO2;MAML2;NOS3;TGFB2;STAT3;CCN3;JAG1;NOTCH1;IL6ST;EPN2;TSPAN14;JAG2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.42658991926492623,-1.169450567805291,0.23766816143497757,0.5596671245543778,1.0,10/24,24.47%,CXCL12;TPT1;ACKR3;CD44;TAF9B;CLU;CD74;TRIAP1;CCAR2;SNAI2
prerank,axon extension (GO:0048675),-0.4165893988565676,-1.1692471137573555,0.24647887323943662,0.5593561252545692,1.0,10/23,10.34%,NRP1;SLIT2;MAP1B;NRP2;SEMA5A;HSP90AB1;ULK1;ULK2;SLC9A6;HSP90AA1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.38955695414879826,1.169233911348851,0.21940298507462686,0.9021065108865562,1.0,22/76,18.64%,DAB2;SH3RF2;PRKN;LRRK2;PIAS1;TRIB2;PTEN;RNF217;CDK5RAP3;RNF19A;CSNK1A1;FBXO22;TRIB1;NUB1;DNAJB2;ZYG11B;HECTD1;RNF19B;CCDC22;TAF1;ARIH1;SUMO1
prerank,neutrophil chemotaxis (GO:0030593),-0.35170424409158985,-1.1691705040851255,0.19414893617021275,0.5587215440567836,1.0,24/53,37.96%,PDE4B;BSG;TGFB2;PPIA;PPIB;EDN1;EDN3;CCL13;SYK;ITGB2;CCL19;CXCL10;PIK3CD;CCL2;JAML;CXCL5;CCL11;CXCL1;PIP5K1C;CCL4;PF4;PPBP;CCL8;PIK3CG
prerank,stabilization of membrane potential (GO:0030322),0.5149945603785174,1.1688758765122413,0.27256317689530685,0.9018219647703762,1.0,1/16,0.26%,KCNK2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4894535179257807,1.1687609316687575,0.292817679558011,0.9007766697147708,1.0,3/20,4.75%,ATP1A2;ANK2;CACNA1C
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5233752079077516,1.1685032033080505,0.2907801418439716,0.9002726380120593,1.0,2/15,1.44%,ROCK2;IGF1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.47705701791257527,-1.168270004833608,0.29473684210526313,0.5600720012724839,1.0,8/15,29.01%,CCT8;CCT2;CCT6A;NHP2;CCT7;RUVBL2;DKC1;NAF1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5140039160315691,1.1682303561331198,0.301556420233463,0.8998204117370818,1.0,3/16,6.36%,PIGN;PIGW;PIGQ
prerank,cellular response to hypoxia (GO:0071456),0.3649500051620616,1.1680025918725327,0.21148825065274152,0.8991007294703799,1.0,5/126,1.99%,EPAS1;CPEB2;RORA;BMP7;SLC8A3
prerank,negative regulation of cell projection organization (GO:0031345),0.416779418379645,1.1676019585139987,0.2366288492706645,0.8990643280170705,1.0,7/48,8.37%,EFNB2;LPAR1;EPHA4;PTPN9;CBFA2T2;PTEN;DENND5A
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.39159068147505033,-1.1675668950725395,0.22084367245657568,0.5609159860050329,1.0,12/33,11.29%,BMPER;RHOJ;SEMA6A;THBS1;PPP1R16B;EPN2;KLF2;SMAD1;CEACAM1;FGF2;JAK1;CREB3L1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.5066393413451764,-1.167509093137339,0.2839248434237996,0.560293915769758,1.0,4/12,14.72%,APOE;LDLR;CLU;IAPP
prerank,regulation of peptide hormone secretion (GO:0090276),0.38873906836010524,1.1673167959115756,0.2411764705882353,0.8986237127879373,1.0,12/67,9.69%,CACNA1D;ITPR2;ITPR1;KCNA5;ADRA2A;RAPGEF3;DPP4;CACNA1C;GCK;CHD7;EIPR1;PICK1
prerank,protein K11-linked ubiquitination (GO:0070979),0.45803246333637215,1.167250897041963,0.2696817420435511,0.8974164086607911,1.0,3/27,5.78%,UBE2E2;PRKN;ANAPC2
prerank,negative regulation of cell growth (GO:0030308),-0.3044239598457865,-1.1668867933997917,0.16363636363636364,0.5610556563202731,1.0,40/121,21.10%,APBB2;SLIT2;PTPRJ;BMPR2;RTN4;DCC;TGFB2;ACVRL1;CCN3;SOX17;ENPP1;DIP2B;ADAM15;ULK1;PPP2R1A;RERG;SH3BP4;TGFB1;ULK2;SERTAD2;BTG1;FGF13;PPT1;FRZB;SEMA3G;CDKN1A;JADE1;EI24;MT3;DCBLD2;CCDC85B;NDRG3;SIPA1;CDKN2AIP;INHBA;DCUN1D3;RTN4R;ESR2;SFRP1;SLIT3
prerank,negative regulation by host of viral process (GO:0044793),0.5575014118994959,1.166856352923596,0.3181818181818182,0.8972696039826785,1.0,1/10,1.98%,PRKN
prerank,response to estradiol (GO:0032355),-0.3980081408797017,-1.1667344379620208,0.2334152334152334,0.5606239588793807,1.0,8/31,12.06%,ESR1;STAT3;ANXA1;SOCS2;TGFB1;STAT5B;GPER1;CTNNB1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.44208784081852526,-1.1661791327972513,0.25,0.5611765792318815,1.0,8/19,15.28%,PLCE1;PPP3R1;NFATC1;PPP3CA;EDN1;EDN3;PPP3CC;HRH1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.4975250367137654,-1.1658930386037947,0.29411764705882354,0.5610462707337044,1.0,6/12,10.04%,SERPINE2;NOTCH1;HES1;BIN1;BMP2;ID2
prerank,membrane repolarization during action potential (GO:0086011),-0.48809692256307313,-1.1652329883961714,0.275,0.5617429605269076,1.0,5/13,8.00%,KCNJ2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,hyaluronan catabolic process (GO:0030214),-0.4476845049637755,-1.1651183655830488,0.2587991718426501,0.5612173687209087,1.0,5/18,9.92%,CEMIP;TGFB1;HEXB;FGF2;CD44
prerank,organophosphate biosynthetic process (GO:0090407),0.4412831792549294,1.1649644529765875,0.2665589660743134,0.9022779449293234,1.0,14/37,20.17%,AGPAT4;GPAT2;CPS1;GK5;MOCOS;GK;ITPKB;PPIP5K2;GPAM;TPK1;NFS1;IP6K3;PCYT2;MOCS1
prerank,cellular response to interleukin-1 (GO:0071347),-0.29870229875020127,-1.1648938539110727,0.13043478260869565,0.5610265490981111,1.0,48/143,29.52%,RPS6KA5;IL1R1;IL1RAP;ST18;NOD1;PTGIS;NFKBIA;PSMB2;DAB2IP;MAP3K7;IRAK3;PSMD14;EGR1;CD47;PSMC6;IKBKB;HIF1A;UBB;PSMA4;PSMB9;PELI1;NOD2;CCL13;SKP1;PSMD11;PSMB10;PSMD2;CCL19;HAS2;SFRP1;PYCARD;PSMA2;UBC;RPS27A;RELA;HYAL2;PSMB3;TAB1;CD40;CCL2;PSMB5;PSMA7;MAP3K8;IRAK4;MAPK3;PSMF1;TOLLIP;PSMD7
prerank,gland development (GO:0048732),0.39867627306454695,1.164839644677529,0.2367601246105919,0.9012948142511917,1.0,9/59,8.44%,TGFBR3;WNT4;FGFR2;GLI2;DKK3;TGFBR1;EZR;CDK5RAP3;NRG1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5100726628085542,1.1637648131410352,0.30386740331491713,0.9034985701040026,1.0,4/16,16.81%,APPL2;SIRT4;NCOR1;ERLIN2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.45381710795400937,-1.1637178033998234,0.2737556561085973,0.5629268099436024,1.0,4/18,3.62%,NLGN1;NRXN1;SHANK3;PTK2B
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5350857774775968,1.163634886549633,0.3009009009009009,0.9025646079095617,1.0,2/13,2.62%,ERRFI1;SNX6
prerank,neurotransmitter transport (GO:0006836),-0.33869703315108524,-1.1632961413225014,0.20294117647058824,0.5631391836112153,1.0,15/73,7.19%,NRXN1;SYT1;PPFIA2;SNAP25;RIMS1;CASK;LIN7A;SLC1A2;PTPRN2;GABRA2;UNC13B;SLC1A1;SYN2;HSPA8;GLS
prerank,receptor clustering (GO:0043113),-0.40545911519583344,-1.1625997064233866,0.2566585956416465,0.5639525109052309,1.0,9/27,11.22%,NLGN1;DLG2;NRXN1;LRRC7;FLNA;ITGA4;PTN;AGRN;NRXN2
prerank,regulation of cellular response to heat (GO:1900034),-0.3266069825060989,-1.1625462305436522,0.17445482866043613,0.5632765886092795,1.0,32/77,29.92%,CAMK2D;CD34;YWHAE;HSP90AB1;GSK3B;HSPA8;HSP90AA1;NUP210;MAPT;DNAJC2;HSPB8;RPA1;FKBP4;CAMK2B;HSPH1;NUP107;DNAJB1;PTGES3;AKT1S1;BAG5;BAG2;POM121;CCAR2;NUP93;NUP85;NUP50;MLST8;NUP54;HSF1;MAPK3;RPA3;CAMK2A
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3123425950090085,-1.1619322270911887,0.16666666666666666,0.5639101481877444,1.0,33/107,22.78%,PIK3R1;MAP3K5;THBS1;NIBAN1;RASGRF2;GSK3B;DAB2IP;HSPA5;DDRGK1;DNAJC10;RASGRF1;PDIA3;ATP2A3;AIFM1;UFM1;TMEM117;SELENOK;CREB3L1;ATF4;BBC3;NCK1;EIF2AK3;RHBDD1;TMX1;BCL2L11;BCAP31;CASP4;RCN3;CFTR;ATP2A2;TRIB3;THBS4;FLOT1
prerank,autonomic nervous system development (GO:0048483),-0.46172710075269097,-1.1612795458260048,0.2725274725274725,0.5646776785826454,1.0,5/17,18.48%,NRP1;FN1;KIF26A;EDNRB;SOX8
prerank,cellular amide metabolic process (GO:0043603),0.36647523739656557,1.160778411354817,0.23087621696801114,0.9107253663194973,1.0,26/102,19.62%,AEBP1;ST6GAL1;PCCA;NAPEPLD;PM20D1;NAAA;SLC19A1;MTHFR;ALDH1L1;ACOT11;MCCC1;MLYCD;MTRR;ACOT8;HLCS;THEM4;CERK;NSMAF;SMPD3;SGPL1;MTHFD1;ACOT12;SMPD2;MCCC2;FOLR2;AASDHPPT
prerank,protein tetramerization (GO:0051262),0.3943945451197337,1.1603624967337487,0.23845007451564829,0.910668404626863,1.0,9/67,9.80%,ALDH1A2;APPL2;UPB1;KRT1;SOD2;SAMHD1;SSBP1;CBY1;CTH
prerank,cellular response to dsRNA (GO:0071359),0.5160676623272175,1.1602241822262933,0.3014705882352941,0.9097157145001155,1.0,2/15,2.84%,COLEC12;IFIT1
prerank,cellular response to peptide (GO:1901653),-0.3459326920288726,-1.159858382489185,0.23140495867768596,0.5672612224164527,1.0,15/56,12.51%,GRM5;CAV1;CACNA2D1;VCAM1;NOD1;ARHGEF2;GSK3B;ICAM1;APP;GRIN2A;PSEN1;ITGA4;RPL23;GPER1;VIM
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3257707646962204,1.1596896201310483,0.15675057208237986,0.9100928443456194,1.0,45/348,10.61%,FGF1;ROBO1;BMP6;BMP7;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;OSR1;PPARGC1A;IGF1;WNT6;PRKN;FOXD1;TNRC6A;MAGI2;MITF;TGFBR1;DTNBP1;TLR3;EZR;SMO;CTSH;CUX2;TLR4;ATM;DDX3X;ARRB1;MAP2K5;BRAF;CD28;TP53;PTPN22;PLSCR1;TNRC6B;CDH5;CALCOCO1;TLE1;LRP3;PICK1;UBR5;MOV10;PIK3R3;SRPK2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3740902780805383,-1.1595343614709819,0.24078624078624078,0.5671921170689135,1.0,12/39,16.10%,PTPRJ;SH3KBP1;PTPN12;SH3GL2;ARHGEF7;DAB2IP;ERBB2;DUSP3;PTPN3;SPRY1;ZFYVE28;CBL
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.4803862289981144,-1.1584617102745625,0.2668112798264642,0.5687981881504498,1.0,3/14,8.63%,OSMR;IL6ST;PTGS2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5139763517405909,1.1582330147519326,0.29310344827586204,0.9134607975772006,1.0,5/14,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.4802670884260161,-1.1578975173747352,0.27880184331797236,0.5693125703301253,1.0,4/14,10.04%,THBS1;MEOX2;NOTCH1;STARD13
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.48312536489044405,1.157458633987072,0.2913793103448276,0.9147821745548785,1.0,9/23,22.62%,NMT2;METAP2;RHO;FNTB;SAG;FNTA;PDE6B;GRK4;CAMKMT
prerank,purine ribonucleotide metabolic process (GO:0009150),0.385640950528172,1.1573219480994545,0.24169184290030213,0.9138319847378461,1.0,22/68,20.58%,RHOQ;AMPD3;LRRK2;ABHD14B;OPA1;SULT2B1;ACOT11;AK4;AK3;NT5C2;MLYCD;TPST1;ACOT8;THEM4;AMPD2;ACOT12;MFN1;ADSS1;ACLY;CROT;ACSF2;GMPR2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.41713427026303534,-1.157268283339631,0.26573426573426573,0.5700013506965877,1.0,9/24,14.18%,NOTCH1;KLF2;HSPA5;CREB3L1;ATF4;HIF1A;GCN1;VEGFA;MT3
prerank,regulation of ion transport (GO:0043269),0.38262296174088045,1.1569009930654666,0.21965317919075145,0.9138774432546602,1.0,16/76,11.43%,SYT9;KCNJ13;SYT11;SYT12;KCNA5;PRKN;SNX6;NEDD4;DTNBP1;SIK1;GDNF;KCNJ14;HTR1A;RAB11B;SCN10A;WWP2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.40946861139628365,-1.156876158043162,0.2553699284009546,0.5701322149393157,1.0,9/25,12.19%,CSGALNACT1;NDST3;FUT9;EXT1;NDST4;B3GALT1;B3GALNT1;EXT2;B3GALT5
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3767471920177997,1.156592442150016,0.24066390041493776,0.9135780634705397,1.0,18/87,11.81%,TGFBR3;SMAD3;APPL2;PRKCZ;ARHGEF18;BMPR1A;TGFBR1;SMAD6;FMOD;USP9X;TWSG1;TGFBR2;COL1A2;CDH5;SIRT1;ZMIZ2;ZMIZ1;GDF15
prerank,spliceosomal complex assembly (GO:0000245),0.41787474394557705,1.1562768132762613,0.2721518987341772,0.9132515381617823,1.0,13/46,22.74%,CELF2;SRSF5;KHDC4;LUC7L3;SRPK2;SCAF11;USP39;PRPF6;SRSF1;SRSF10;SF1;SF3B1;GCFC2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4916239750498752,-1.1562436876713873,0.2951167728237792,0.5707828885606208,1.0,4/12,4.54%,SYT1;RIMS2;RIMS1;UNC13B
prerank,iron ion transmembrane transport (GO:0034755),-0.5310608012682845,-1.1557348186612075,0.28874734607218683,0.5712099758566719,1.0,5/10,28.24%,SCARA5;SLC40A1;SLC25A28;SLC39A14;SLC25A37
prerank,cellular response to increased oxygen levels (GO:0036295),-0.4988602686343616,-1.1557269430184927,0.2616632860040568,0.5704497853989802,1.0,3/11,12.36%,CAV1;FOXO1;FAS
prerank,regulation of synapse organization (GO:0050807),-0.40383645457387674,-1.1556007620374795,0.282560706401766,0.5699681614994386,1.0,4/26,4.04%,CTNNA2;MEF2C;IL1RAPL1;CDKL5
prerank,atrial septum morphogenesis (GO:0060413),0.5576587282744477,1.1553546438597946,0.31952662721893493,0.9150852012823284,1.0,1/10,0.19%,NOTCH2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.49826443788833963,1.15502755314784,0.3118279569892473,0.9148236348409939,1.0,6/18,17.61%,PPARA;PTPN22;MIA3;WNK1;GPNMB;LAX1
prerank,B cell activation (GO:0042113),-0.32841336338089955,-1.1549162031432851,0.1871345029239766,0.5708741354144895,1.0,10/68,7.96%,MEF2C;PTPRJ;TPD52;VCAM1;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4;EPHB2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5254555502837864,1.1545160950193865,0.31190926275992437,0.9151407135384634,1.0,3/12,3.79%,GLI2;EPHA4;NFIB
prerank,lysosome organization (GO:0007040),0.4311434612709258,1.1544915295527856,0.2664359861591695,0.9138242976066553,1.0,13/36,20.57%,HOOK2;LRRK2;TPP1;CLN6;ARSB;HPS1;MBTPS1;ZKSCAN3;HOOK3;MYO7A;LAMTOR1;TPCN2;SNAPIN
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.4984279029965791,-1.1543117713342486,0.2928870292887029,0.5715004564399703,1.0,3/11,19.80%,ABCG1;AGTR1;AGT
prerank,neural tube development (GO:0021915),0.5092914330311293,1.1536364677673834,0.29558541266794625,0.9153234172443604,1.0,1/15,0.34%,ALDH1A2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4809538762700334,-1.153298956453481,0.28662420382165604,0.5730698916600002,1.0,3/13,9.18%,TMSB4X;PSEN1;HEY2
prerank,extracellular structure organization (GO:0043062),0.33643268879367955,1.1532497217697724,0.19254658385093168,0.9152474981198352,1.0,32/204,8.64%,SMOC1;COL5A1;ADAM12;ADAMTS10;LAMA4;COL22A1;LAMC2;COL4A5;SMOC2;ITGA9;LAMC1;NPNT;SPP1;COL18A1;COL4A3;LOXL1;ADAMTS2;TGFBR1;ADAMTS15;DAG1;ITGA10;ADAMTSL5;ADAMTS9;COL9A2;COL13A1;FBN1;SERPINE1;COMP;COL4A4;COL1A2;MMP19;COL27A1
prerank,membrane depolarization during action potential (GO:0086010),0.46064203418539373,1.1532272318525278,0.28970331588132636,0.9139266919567298,1.0,3/26,4.75%,ATP1A2;CACNA1D;CACNA1C
prerank,positive regulation of cell death (GO:0010942),0.39130360375820294,1.152735603851615,0.2481089258698941,0.914143501163206,1.0,10/59,11.86%,SLC6A13;EFNB2;PICALM;PRODH;LRRK2;LRP1;RIPK2;RIPK1;RARG;AXIN2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.43394227918627,1.1526305191191102,0.2825342465753425,0.9131387063435725,1.0,7/34,9.62%,RORA;SMAD3;GPS2;TRIB2;WWTR1;SIRT1;LRP3
prerank,cell-substrate junction assembly (GO:0007044),0.4427189967376508,1.1524203316663713,0.288961038961039,0.9124555470721956,1.0,5/33,2.19%,ACTN2;SORBS1;LAMC2;LAMC1;RHOD
prerank,positive regulation of response to external stimulus (GO:0032103),0.3535138384269735,1.1522669678424622,0.23004059539918809,0.9116103106814223,1.0,24/128,13.76%,BMP6;SASH1;IL18;NAPEPLD;TLR3;TLR4;F2;IFNK;ANKRD17;PDGFRB;IL12B;SERPINE1;PLSCR1;HRG;GPRC5B;IL17RA;DDX60;RIPK1;LY96;DHX58;NMI;PRKCA;IFI35;ACOD1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4114619803989674,1.1522220968493901,0.26677316293929715,0.910416630925164,1.0,9/48,9.40%,ADCY5;NPR1;ADCY1;AMPD3;NPR2;ADCY9;PANK1;SLC26A1;DCAKD
prerank,granulocyte differentiation (GO:0030851),-0.43546827226662854,-1.1519215037639463,0.2616136919315403,0.5754816065822139,1.0,4/18,14.28%,LEF1;CBFA2T3;CDKN1A;TAL1
prerank,regulation of cholesterol efflux (GO:0010874),-0.3914343428418298,-1.1518025487068704,0.24623115577889448,0.5749877224986271,1.0,7/30,10.66%,CAV1;PLTP;NFKBIA;APOE;PTCH1;SREBF2;EEPD1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.4644553584886433,-1.1516809252204658,0.303347280334728,0.5744692103953849,1.0,5/15,13.29%,RTN4;REEP1;RAB18;ARL6IP1;ATL2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.49384184559675626,1.1513820175595195,0.31716417910447764,0.9117710346732283,1.0,6/19,16.02%,POLD2;AMPD3;TERT;AMPD2;POLL;APRT
prerank,positive regulation of TORC1 signaling (GO:1904263),0.49602005341438465,1.1512077124106732,0.29523809523809524,0.9109595611737881,1.0,7/16,26.68%,GPR137;FLCN;TELO2;RRAGD;RRAGB;SIK3;GPR137B
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.44152687282572955,1.1508444745562172,0.28907563025210087,0.9108175838964404,1.0,5/33,9.30%,APPL2;STXBP4;PLK5;PTEN;GLI1
prerank,aortic valve morphogenesis (GO:0003180),-0.38883850089401806,-1.150827669049796,0.25065963060686014,0.5758473195393312,1.0,13/30,12.47%,SLIT2;ROBO2;ELN;NOS3;TIE1;JAG1;NOTCH1;HEYL;NFATC1;TGFB1;HEY2;BMP4;TWIST1
prerank,long-chain fatty acid import into cell (GO:0044539),0.545632718645892,1.1495702301846968,0.32661290322580644,0.9136675323318935,1.0,3/10,9.66%,ACSL1;SLC27A1;SPX
prerank,protein localization to organelle (GO:0033365),0.35680883743035813,1.149397836804428,0.2222222222222222,0.9129043685476661,1.0,24/133,15.83%,BMP7;ANK2;TULP3;ZNF423;CSRP3;OBSL1;CEP250;LRRK2;LAMP2;DDX3X;TRAM2;TIA1;UBAC2;GBP2;IFT122;PIKFYVE;ATP6V1D;DCP1A;ROPN1;STX5;WDR35;MICALL1;ARL6;BBS2
prerank,cellular response to hormone stimulus (GO:0032870),0.3958633391118113,1.1491776893576835,0.27896341463414637,0.9122541642807098,1.0,10/69,7.26%,ATP1A2;THRB;TFPI;SLC5A5;BRD8;ADRA2A;CTSH;NCOA3;BCAS3;GCK
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.33183170486106106,-1.1488233123613096,0.18238993710691823,0.5798022634637613,1.0,19/72,10.24%,NRP1;ARHGEF28;HEG1;RIT2;ARHGEF3;F11R;RASIP1;NET1;ARHGEF2;STARD8;APOE;MET;PRAG1;KCTD10;MYOC;ARHGDIB;CUL3;STARD13;EPS8
prerank,embryonic skeletal system development (GO:0048706),0.43491764257794424,1.1488108235416057,0.2922824302134647,0.9121053614597345,1.0,11/35,13.29%,OSR1;HOXB4;SULF2;HOXB3;HOXB9;HOXA3;RBP4;HOXC4;DYNC2I1;DEAF1;SULF1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4283858515273448,1.148017230332796,0.26991869918699185,0.9132840458065504,1.0,6/36,7.34%,SH3RF2;DLG1;PRKN;EZR;GPS2;PTPN22
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5054970058999306,1.1478742818727314,0.32571428571428573,0.9124201042951671,1.0,2/14,1.44%,SYT11;IGF1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4744522977466494,1.1478570403083106,0.29259896729776247,0.9111229359490949,1.0,2/22,1.52%,MAN1A2;MAN1C1
prerank,Notch signaling involved in heart development (GO:0061314),0.5514990975722209,1.1475514921703547,0.32879377431906615,0.9107940752529841,1.0,1/11,0.19%,NOTCH2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3209831024066015,-1.147317336305963,0.20261437908496732,0.5827863292584896,1.0,17/80,10.46%,NRP1;NLGN1;TENM2;PIK3R1;FNBP1L;PLCE1;CCDC88A;ACTR2;CDC42EP3;OCLN;TGFB3;ANLN;PLPPR5;P2RY12;EPS8;AGRN;ACTR3
prerank,defense response to virus (GO:0051607),0.3643591168845338,1.1472066411674597,0.23595505617977527,0.91060722436748,1.0,24/100,15.45%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;NDUFAF4;TLR3;RNF135;TRIM56;STAT2;EIF2AK2;PLSCR1;SAMHD1;RSAD2;MAVS;MOV10;ATG7;ZDHHC1;IRF1;AKAP1;OAS3;ACOD1;IFNAR2;NT5C3A
prerank,regulation of Ras protein signal transduction (GO:0046578),0.37232301581422467,1.147048650671784,0.24132947976878613,0.9097665796579711,1.0,17/86,14.23%,DENND4A;NOTCH2;IGF1;ARHGEF18;KANK2;AKAP13;ARHGAP17;SYNGAP1;EPS8L2;OPHN1;CRKL;EPS8L1;MAPKAP1;DENND4C;OGT;MFN2;FLCN
prerank,positive regulation of apoptotic process (GO:0043065),-0.26607937930287173,-1.1464287894000686,0.0728476821192053,0.5841159430400027,1.0,94/293,21.40%,SLIT2;ITGA6;MAP3K5;RASSF2;KCNMA1;MCF2L;ABR;TGFB2;RASGRF2;FAP;ARHGEF3;APAF1;CSRNP3;RPS6;PTGIS;NGF;CYP1B1;UNC13B;TRIO;ARHGEF9;ARHGEF7;NET1;TNFSF10;ARHGEF2;SFRP4;DAB2IP;TIAM1;RPS3;CTSD;ARHGEF17;TGFB3;RYBP;RHOB;EPHA7;FOXO1;PSEN1;ITGB1;BIN1;BMP2;BTG1;PLEKHG5;AIFM1;ARHGEF26;FRZB;RPS6KA2;GPER1;BMP4;ATF4;CTNNB1;DAPK1;FAS;SNCA;SUDS3;GADD45G;CDK5R1;CLU;KLF11;IAPP;UBB;PHLDA3;CRADD;VAV1;TOP2A;DNAJA1;MYBBP1A;APC;RNPS1;SCRIB;CASP2;BARD1;DIABLO;PHLDA1;HTRA2;IRF5;APH1A;STPG1;RNF122;SIRT2;BCL2L11;FOXL2;HIP1R;CALHM2;PREX1;PNMA2;GADD45B;DCUN1D3;ECT2;PTRH2;DAPK2;TIAM2;SFRP1;MAP3K11;PYCARD;MCF2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.424009273594757,-1.146392543535181,0.2947845804988662,0.5833950540721922,1.0,7/21,11.53%,MEF2C;HSP90AB1;CALM1;CALM2;BMP2;CALM3;MTMR9
prerank,regulation of amyloid-beta formation (GO:1902003),0.4440892637432908,1.1462128133617264,0.2816666666666667,0.911166955422956,1.0,5/34,3.52%,ROCK2;PICALM;IGF1;EPHA4;CASP3
prerank,neuron projection regeneration (GO:0031102),-0.5042860443611347,-1.1452951718162054,0.29713114754098363,0.585257036215291,1.0,3/10,13.86%,PTN;GAP43;RTN4RL1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4554090396403567,-1.14517017826973,0.27872340425531916,0.5848081629782815,1.0,4/16,11.13%,CAV1;HS3ST5;TRIM14;TRIM27
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3474109451740019,-1.1451183302696535,0.21159420289855072,0.5841520749940887,1.0,12/48,8.69%,NRP1;PTPRD;IL1RAPL1;CARMIL1;CDKL5;ARHGEF7;DOCK1;FLNA;CRK;LIMS2;MYOC;CALR
prerank,cell part morphogenesis (GO:0032990),-0.4786388882727204,-1.1451070281329259,0.28969957081545067,0.583383704874871,1.0,6/13,28.96%,PID1;PNPT1;WASF1;CSPG5;NUBPL;FIS1
prerank,regulation of microtubule-based process (GO:0032886),-0.37606627554317235,-1.145012897659684,0.254278728606357,0.5827967971412635,1.0,14/36,16.95%,CLASP2;EFNA5;PHLDB1;GSK3B;MAP6;ERBB2;MARK2;FAM107A;TRIM36;MAPT;BICD2;ATF5;TPPP;APC
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3141021717551367,-1.14497057056302,0.17721518987341772,0.5821076760641464,1.0,34/92,15.16%,NRP1;TEK;BMPR2;RTN4;THBS1;CLASP2;TGFB2;NRP2;PTK2B;SCARB1;DOCK1;EPB41L4B;KDR;GPI;IQSEC1;FOXP1;PLCG2;RHOB;PROX1;CALR;ATOH8;FGF2;FLT4;BCAR1;ITGB3;EDN1;ENPP2;BMP4;HIF1A;FGF7;PRKD1;VEGFA;PPM1F;RRAS
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4176202630553148,-1.144749700104442,0.28761061946902655,0.5818662602308325,1.0,8/22,11.03%,AKAP6;RYR2;ATP1B1;VMP1;CALM1;CALM2;CALM3;JPH2
prerank,L-glutamate transmembrane transport (GO:0015813),-0.5071905063860905,-1.144689776497061,0.2796610169491525,0.5812426305093887,1.0,3/10,5.29%,SLC1A2;SLC1A1;SLC25A13
prerank,cellular response to fatty acid (GO:0071398),-0.5005329238271582,-1.1446451562738482,0.2937365010799136,0.5805470351776617,1.0,1/12,0.40%,PID1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4358034190525309,1.1445616073633118,0.30210016155088854,0.9153614993714382,1.0,6/37,9.00%,APPL2;PPARA;TLR4;F2;IL17D;IL17RA
prerank,mitochondrion morphogenesis (GO:0070584),-0.5016653362877829,-1.144461644623753,0.29936305732484075,0.5802478670323663,1.0,3/11,16.33%,PID1;PNPT1;WASF1
prerank,actin filament bundle organization (GO:0061572),0.4435868272577218,1.1444586185467907,0.2871287128712871,0.9143716975752197,1.0,6/33,6.37%,PAWR;SHROOM2;RHOD;EZR;BAIAP2L1;BAIAP2
prerank,positive regulation of ossification (GO:0045778),0.42874741825733287,1.144423364088748,0.28595317725752506,0.9131726881979039,1.0,6/39,3.18%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A
prerank,positive regulation of programmed cell death (GO:0043068),-0.26885118866585905,-1.1443637247323168,0.11258278145695365,0.5797221152570866,1.0,86/272,21.40%,SLIT2;ITGA6;MAP3K5;RASSF2;KCNMA1;MCF2L;ABR;RASGRF2;ARHGEF3;APAF1;CSRNP3;RPS6;NGF;CYP1B1;UNC13B;TRIO;ARHGEF9;ARHGEF7;NET1;TNFSF10;ARHGEF2;SFRP4;DAB2IP;TIAM1;CTSD;ARHGEF17;TGFB3;RYBP;RHOB;FOXO1;PSEN1;ITGB1;BIN1;BMP2;PLEKHG5;AIFM1;ARHGEF26;FRZB;RPS6KA2;GPER1;BMP4;ATF4;CTNNB1;DAPK1;FAS;SNCA;SUDS3;GADD45G;LAPTM5;CLU;KLF11;IAPP;UBB;PHLDA3;CRADD;VAV1;TOP2A;DNAJA1;APC;RNPS1;SCRIB;CASP2;BARD1;DIABLO;SYK;PHLDA1;HTRA2;IRF5;APH1A;STPG1;RNF122;BCL2L11;FOXL2;HIP1R;CALHM2;PREX1;PNMA2;GADD45B;DCUN1D3;ECT2;DAPK2;TIAM2;SFRP1;MAP3K11;PYCARD;MCF2
prerank,protein deacylation (GO:0035601),0.459483407569552,1.14408802583049,0.3019197207678883,0.913023528111224,1.0,8/23,13.50%,ABHD17C;SIRT5;LYPLA1;SIRT3;HDAC4;SIRT1;HDAC1;SIN3A
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.49437126673647985,1.1436950093599714,0.3123844731977819,0.912956584173448,1.0,2/17,1.91%,ANK2;SNTA1
prerank,cation transport (GO:0006812),0.3406112974678683,1.1431358755461376,0.22093023255813954,0.9134769362783788,1.0,16/167,7.65%,TRPM3;ATP1A2;SLC41A1;KCNJ13;TRPM6;SLC5A5;KCND3;KCNA5;SLC8A3;SLC22A18;SLC6A9;KCNS1;SLC5A8;TRPM5;ANO6;KCNH4
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4971149598039707,1.1425954732291963,0.32926829268292684,0.9139549970808248,1.0,2/17,0.55%,ROBO1;EFNB2
prerank,establishment of protein localization to membrane (GO:0090150),0.39209637097751404,1.1420303597539534,0.2764350453172205,0.9145018522355457,1.0,26/66,24.33%,AFDN;SYNE3;BID;RAB3IP;BRAF;PIKFYVE;RAB11B;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MICALL1;VPS37A;ARL6;RABGEF1;ZDHHC23;GORASP2;NECTIN3;ZDHHC12;GORASP1;SDCBP;ICMT;ZDHHC19;RAB10;RAB3GAP1
prerank,response to exogenous dsRNA (GO:0043330),0.4909837942718749,1.1418459421372982,0.30918727915194344,0.9138051566731742,1.0,4/18,5.44%,COLEC12;IFIT1;TLR3;IFNK
prerank,positive regulation of phospholipase C activity (GO:0010863),0.42383117257581043,1.141249421296578,0.2823920265780731,0.9143996279954891,1.0,7/40,6.37%,LPAR1;KIT;LPAR2;FGFR1;ARHGAP6;FLT1;PDGFRB
prerank,plasma membrane tubulation (GO:0097320),-0.4728974249097795,-1.1409309926163569,0.3150105708245243,0.5870764547347045,1.0,5/13,18.29%,FNBP1L;CAVIN2;EHD2;PACSIN1;CHMP4A
prerank,muscle contraction (GO:0006936),0.34652566367514803,1.1408163927508148,0.23214285714285715,0.9145129663561371,1.0,18/126,9.20%,ROCK2;ACTN2;SORBS1;SNTA1;MYOF;TMOD2;PABPN1;PGAM2;TLN1;BDKRB2;DTNA;TMOD3;TPM1;KLHL41;ARHGEF11;CHRNG;MYL4;NMUR1
prerank,focal adhesion assembly (GO:0048041),0.48002635701528173,1.1406114020883584,0.3022847100175747,0.9138541795006203,1.0,3/21,2.19%,ACTN2;SORBS1;RHOD
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3260351957364399,-1.1403583596537352,0.2262295081967213,0.587657166368476,1.0,13/67,11.28%,ATP8B1;CAV1;MYO10;PODXL;TBC1D1;PPP1R16B;CDKL5;TBC1D8;TBC1D5;RDX;GAP43;TBC1D2B;FXR1
prerank,negative regulation of DNA replication (GO:0008156),0.5095806193614068,1.1401955247327036,0.3141263940520446,0.9139749480019422,1.0,4/13,13.16%,PDS5A;GTPBP4;WAPL;CDAN1
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.42678230925566973,-1.1401363151198622,0.28159645232815966,0.5874246780654973,1.0,6/21,12.35%,NAV3;CLASP2;ARHGEF2;STMN2;FGF13;SPEF1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.391751741971953,1.1400981130158137,0.2676923076923077,0.9129681598691237,1.0,17/59,15.04%,ROCK2;OXSR1;TGFBR1;LRRK2;CDC42BPG;TGFBR2;PDPK1;DYRK1A;PRKDC;CSNK2A2;CSNK2A1;PRKCA;HIPK3;WNK1;MAP2K1;CAD;ACVR1B
prerank,regulation of epidermal cell differentiation (GO:0045604),0.47904231832234745,1.1395163589393231,0.31560283687943264,0.9135651038221112,1.0,3/21,4.12%,ROCK2;ERRFI1;MAFG
prerank,icosanoid biosynthetic process (GO:0046456),-0.510523767598628,-1.1379807542503888,0.2984749455337691,0.5917148844320752,1.0,5/10,29.00%,PLA2G4A;LTA4H;FADS1;ALOX5AP;MGST2
prerank,heart trabecula morphogenesis (GO:0061384),0.4841028616534205,1.1379622309275217,0.32642487046632124,0.9174197914892978,1.0,6/18,8.44%,TGFBR3;BMP7;BMPR1A;TGFBR1;RBP4;NRG1
prerank,regulation of actin filament-based process (GO:0032970),0.38063462841225687,1.1376975757817032,0.25667655786350146,0.9169680165398687,1.0,14/70,10.62%,CELSR1;ROCK2;RHOQ;RHOBTB2;RHOD;ARHGAP18;EZR;ARHGAP17;PDGFRB;BAIAP2;RICTOR;HRG;LRP1;ABL1
prerank,regulation of cell migration (GO:0030334),0.31366556479939073,1.1376069845409411,0.18099547511312217,0.9159488802536844,1.0,69/382,11.71%,DAB2;FGF1;ROBO1;WNT5B;AFDN;SH3RF2;SYNE2;ROCK2;APPL2;ACE;KIT;LAMC2;IGF1;ZMYND8;SASH1;KIF2A;PLXNA2;EPHA4;RHOD;SPHK1;LMO4;SRGAP2;SRGAP3;PHACTR1;ARID2;MAGI2;MITF;MGAT3;TGFBR1;ADRA2A;PDPN;DAG1;RUFY3;SMO;CTSH;TPM1;SEMA3B;ATM;TBCCD1;SOD2;LDLRAD4;FLT1;PDGFRB;CPNE3;SERPINE1;PTPRU;LDB1;LDB2;PTEN;CDH5;AMOTL2;GTPBP4;CCAR1;HBEGF;FER;CYRIB;TRIP6;SLURP1;ARSB;YTHDF3;PIK3R3;CASS4;RNF41;DUSP10;MMP14;VIL1;MYLK;ADAM17;OSGIN1
prerank,cellular component assembly (GO:0022607),-0.27366901248926956,-1.1375800972655967,0.10059171597633136,0.5918844781295894,1.0,51/253,13.12%,NLGN1;SPTBN1;RHOJ;SLC2A1;GSN;ANK3;ACTB;MYO1B;REPS2;RIMS1;RTN4;PARVB;IL1RAP;LIN7A;PTK2B;LRRTM3;PCLO;ACTG1;SKAP2;GAS6;VMP1;GPM6B;LIMA1;PLS1;FLNA;HES1;OCLN;DCX;CD2AP;PPP2R1A;ELOB;LIMS2;TGFB1;TUBGCP2;RP1;RHOH;ADD2;SHROOM1;ARL6IP1;EPS8;PDGFA;CALD1;CAPZA2;CLDN14;FAM107A;ILK;SPEF1;FAS;LPXN;MDN1;DMTN
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.482473710207784,1.1375251924708336,0.32854578096947934,0.9135924074215027,1.0,4/19,7.53%,POLR2A;ATRX;ACD;POLR2D
prerank,regulation of DNA recombination at telomere (GO:0072695),0.482473710207784,1.1375251924708336,0.32854578096947934,0.9135924074215027,1.0,4/19,7.53%,POLR2A;ATRX;ACD;POLR2D
prerank,regulation of monooxygenase activity (GO:0032768),-0.42213898183289217,-1.137215426641352,0.3070652173913043,0.5919891722259663,1.0,7/23,13.76%,CAV1;NOS3;NOSTRIN;CALM1;HSP90AA1;SNCA;CYGB
prerank,response to cholesterol (GO:0070723),0.5038270485658413,1.1369388921671963,0.31784386617100374,0.9141874586866741,1.0,4/17,7.33%,GRAMD1B;TGFBR1;SMO;TGFBR2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3392392307080891,1.1367253569305908,0.2503160556257901,0.9135935896831674,1.0,24/166,9.52%,SMAD3;LPGAT1;SORBS1;PPARGC1A;IGF1;SMOC2;GLI2;LARP4B;DUOXA1;SLC6A9;TLR4;DDX3X;CD28;PDGFRB;POLDIP3;SLC27A1;GCK;LDB1;SAMD4A;PAOX;CPEB3;GLI1;SIRT1;SLC45A3
prerank,response to unfolded protein (GO:0006986),-0.34483987867287386,-1.1364566505561131,0.2471590909090909,0.5930002873021889,1.0,18/48,20.85%,HSP90AB1;DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;HSP90AA1;TM7SF3;HSPB8;SERPINH1;RHBDD1;DNAJA1;HSPB1;PTPN1;HSPE1;HSPH1;DNAJB1;HSPA4L
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.34592963752313,-1.1364389455360902,0.25761772853185594,0.5922606113867214,1.0,11/53,15.28%,CALCRL;CHRM3;HTR2C;ANXA1;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,secretory granule organization (GO:0033363),0.5420089504001814,1.136206166213889,0.33532934131736525,0.914017971366971,1.0,5/10,22.68%,DTNBP1;SRGN;BLOC1S2;VPS33B;LYST
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4590278909391188,1.1357578521835072,0.30689655172413793,0.9141777639857919,1.0,7/24,13.50%,IL12B;PTPN22;PARP9;MAVS;TOMM70;ZDHHC1;SIN3A
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4799864300522214,1.1355318321052743,0.30664395229982966,0.9136782238150692,1.0,7/19,9.30%,TGFBR3;FGFR2;BMPR1A;TGFBR1;VGLL4;RBP4;GLI1
prerank,female gonad development (GO:0008585),0.4786380904678228,1.1355062070378346,0.31684981684981683,0.9124483001083211,1.0,2/19,3.08%,KIT;NR2F2
prerank,sensory perception of smell (GO:0007608),-0.4841397246742629,-1.135065231367057,0.3240343347639485,0.5946851584815542,1.0,4/11,21.60%,UBR3;SYT10;ADCY3;DRD2
prerank,protein oxidation (GO:0018158),0.5418679805698139,1.134961136143742,0.3385518590998043,0.9129511205083444,1.0,2/11,4.57%,LOXL1;LOXL3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.36707364854854213,-1.1348329809473081,0.2572178477690289,0.5944413643468893,1.0,7/38,6.02%,BMP5;NOS3;THBS1;TNFSF10;ARHGEF2;GSK3B;ICAM1
prerank,regulation of protein polymerization (GO:0032271),0.4285976590401592,1.1347175280344213,0.2977346278317152,0.9124554459603021,1.0,6/35,10.68%,ARHGAP28;FCHSD2;ARHGAP18;MAP2;ABL1;PRUNE1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5445050074358998,1.1346717437050464,0.34541984732824427,0.9112964967389834,1.0,1/10,1.21%,KIT
prerank,regulation of regulated secretory pathway (GO:1903305),0.4351956545048301,1.134414937294509,0.2996742671009772,0.9108698505016367,1.0,5/34,4.05%,SYT9;SYT11;SYT12;LRRK2;DTNBP1
prerank,amino acid import (GO:0043090),0.47918328344980365,1.13421172314209,0.3125,0.9102610525829484,1.0,3/21,4.61%,SLC6A13;SLC6A1;SFXN2
prerank,regulation of cell projection organization (GO:0031344),-0.4689082400563005,-1.1341124396394968,0.2972972972972973,0.5953743273464461,1.0,5/13,20.36%,NTNG1;SEMA4D;MFSD2A;ERMN;CCL19
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3311817351570226,1.1332788755014913,0.23722627737226276,0.9120654442121,1.0,31/199,9.92%,ROBO1;LGR4;ROCK2;LRP4;LAMA4;SYT11;MCC;ZNF423;ALDH1A1;NPR3;NFIB;PCTP;SMAD6;SRGN;APOM;TLR4;IL17D;WWC2;SFMBT1;PTPN23;LDLRAD4;TWSG1;PTEN;SLC6A4;NOVA1;ADM;ACOT11;CHSY1;SPX;DOCK7;FOXC2
prerank,aminoglycan metabolic process (GO:0006022),-0.5067009543121392,-1.1332216281077812,0.3425742574257426,0.5966982109427171,1.0,6/10,25.17%,XYLT1;B3GAT2;CHST9;B3GALT6;B3GAT3;B3GAT1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3866399535594667,1.133000605620061,0.28550074738415543,0.9116232652008659,1.0,7/66,3.79%,ROBO1;TGFBR3;FGFR2;MCC;NUPR1;NR2F2;NFIB
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4168710476865125,1.1329941055379253,0.2892690513219285,0.9103694964821915,1.0,7/40,7.33%,DAB2;SMAD3;TGFBR1;FOXC1;PDPN;WWTR1;TGFBR2
prerank,import into cell (GO:0098657),0.4161788033440804,1.1328715334524615,0.3059210526315789,0.9094433861222518,1.0,8/41,9.52%,ATP1A2;SLC6A13;SLC5A3;SLC19A1;SLC27A1;SLC38A1;SLC1A3;GLUL
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4829329139026536,1.1326649822813895,0.31094049904030713,0.9088664829442082,1.0,1/17,0.26%,FGF1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5145841070030248,1.1321699016720603,0.340036563071298,0.9091437111502443,1.0,3/14,7.05%,PRKN;LRRK2;OPA1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3819833258214136,-1.131966935359301,0.27586206896551724,0.5987626870850504,1.0,6/30,6.02%,BMP5;NOS3;TNFSF10;ARHGEF2;GSK3B;ICAM1
prerank,external encapsulating structure organization (GO:0045229),0.3292708228520391,1.1317713471587136,0.22304832713754646,0.9091686671852228,1.0,31/205,8.64%,SMOC1;COL5A1;ADAM12;ADAMTS10;LAMA4;COL22A1;LAMC2;COL4A5;SMOC2;ITGA9;LAMC1;NPNT;SPP1;COL18A1;COL4A3;LOXL1;ADAMTS2;ADAMTS15;DAG1;ITGA10;ADAMTSL5;ADAMTS9;COL9A2;COL13A1;FBN1;SERPINE1;COMP;COL4A4;COL1A2;MMP19;COL27A1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4900304780212701,1.1310972138143878,0.3231597845601436,0.9100463736390885,1.0,4/16,8.85%,PYGM;PHKB;MGAM;PHKG1
prerank,protein maturation (GO:0051604),0.35669888243233294,1.1308276405214894,0.2818696883852691,0.9096917966182966,1.0,16/95,15.39%,AEBP1;NNAT;TSPAN5;SRGN;METAP2;NDUFAB1;APH1B;MMP14;ADAM17;NFU1;PCSK7;OGT;SDE2;ISCA1;PITRM1;NAA16
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.31449425225403854,-1.1307568414258744,0.19148936170212766,0.6010352459451096,1.0,32/91,22.55%,ABCG2;SCARA5;SLC39A10;FTH1;HMOX2;TFRC;SLC40A1;APP;FBXL5;FTL;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;ATOX1;SLC30A1;SLC31A1;SLC39A12;MT3;SLC22A17;ISCU;SKP1;CAND1;GLRX3;IREB2;MT2A;SOD1;CYBRD1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4508198645511684,-1.1303869669104647,0.2982832618025751,0.6004048858171585,1.0,7/16,13.12%,THBS1;CLASP2;ACVRL1;CORO1C;APOD;FAM107A;DMTN
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4508198645511684,-1.1303869669104647,0.2982832618025751,0.6004048858171585,1.0,7/16,13.12%,THBS1;CLASP2;ACVRL1;CORO1C;APOD;FAM107A;DMTN
prerank,calcium ion homeostasis (GO:0055074),0.3600766878168487,1.1298867377546449,0.27246376811594203,0.911462309815384,1.0,9/95,3.58%,ATP13A5;SLC24A3;ANK2;ATP13A3;FAM20A;SLC8A3;PKHD1;CSRP3;DMPK
prerank,regulation of endocytic recycling (GO:2001135),0.542748714691203,1.1295953592328838,0.3383742911153119,0.9111508846510424,1.0,3/11,10.13%,ACTN2;EIPR1;RAB11B
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.2835993969093627,-1.1292726761668705,0.1532258064516129,0.6022479626323552,1.0,30/150,10.34%,KITLG;HIP1;PTPRJ;TEK;ERBB4;PIK3R1;ESR1;GCNT2;ENG;RTN4;THBS1;SEMA5A;GAB1;GAS6;F3;NRG2;HSP90AB1;MET;ITGB1;MYOC;TGFB1;PTK2;MFHAS1;TNFAIP8L3;FGF2;PIK3AP1;ERBB2;P2RY12;PDGFA;HSP90AA1
prerank,synaptic vesicle endocytosis (GO:0048488),0.430335813978638,1.1292299788252982,0.30584192439862545,0.9110900747592324,1.0,6/33,4.57%,DNAJC6;PICALM;NLGN2;STON1;CEL;SYNJ2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4168433511255928,-1.1291503839073942,0.31724137931034485,0.6017568724875457,1.0,8/21,11.00%,LIMCH1;EFNA5;PEAK1;ACTG1;GPM6B;CORO1C;PTK2;DUSP3
prerank,negative regulation of leukocyte activation (GO:0002695),-0.4582380344118823,-1.1284953326880414,0.30787037037037035,0.6024873811580955,1.0,6/15,15.38%,CD200;LRFN5;GPER1;HAVCR2;CD84;IL31RA
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.41881677167609904,1.128273070791138,0.3044189852700491,0.9129659807680787,1.0,7/40,8.88%,IGF1;PRKN;BID;FAM162A;TP53;OPA1;DNM1L
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4339968410911069,1.1281768873382347,0.30915371329879104,0.9120451055939265,1.0,2/30,1.44%,NOTCH2;IGF1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4753907665010797,-1.127830106436358,0.32421052631578945,0.6033081487082055,1.0,5/13,27.34%,RPS21;ABT1;RRS1;KRI1;NOL9
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5411413569998524,1.1276988729498298,0.33271028037383177,0.9111207926985937,1.0,6/11,26.18%,TNRC6A;TNRC6C;RBM4;AGO1;AGO4;AGO2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5411413569998524,1.1276988729498298,0.33271028037383177,0.9111207926985937,1.0,6/11,26.18%,TNRC6A;TNRC6C;RBM4;AGO1;AGO4;AGO2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.42479781712779335,1.1276563206578594,0.3129251700680272,0.9100033413033085,1.0,8/37,10.39%,GSDME;NUPR1;BID;NACC2;TP53;FBH1;DNM1L;BECN1
prerank,regulation of extracellular matrix organization (GO:1903053),0.5097734858808863,1.1267299792039889,0.3375224416517056,0.9116770931455191,1.0,1/15,0.12%,AEBP1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.35829617620584603,1.1265655249244004,0.26406926406926406,0.9109336302285201,1.0,14/95,6.99%,HS3ST3A1;UST;HS3ST3B1;OGN;NDST1;CHST15;CHST11;HS2ST1;HS3ST6;ST3GAL3;FMOD;B4GALT1;DSE;PXYLP1
prerank,positive regulation of signal transduction (GO:0009967),0.3307117642573588,1.1264627349522287,0.20636792452830188,0.9100389870080544,1.0,28/238,6.25%,FGF1;ROBO1;BMP6;RSPO2;WLS;TSPAN5;SORBS1;TPD52L1;PRKCZ;IGF1;SMOC2;SASH1;FGFR2;DCDC2;NLGN2;PHIP;TTC23;TGFBR1;AAK1;LRRK2;SULF2;LOXL3;PRKCB;SMO;CUX2;GPS2;RAB34;GKAP1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.34229732496001763,1.1252475969602294,0.2636363636363636,0.9127874428921571,1.0,21/161,9.99%,DAB2;TMEM64;LRP4;BICC1;MCC;PRKN;DKK3;GLI3;LZTS2;APC2;WWTR1;UBAC2;PTPRU;INVS;TMEM170B;CSNK1A1;GLI1;TLE1;HDAC1;SOX13;TCF7L2
prerank,regulation of protein localization (GO:0032880),0.383904744119118,1.1250256905576876,0.28177641653905056,0.9122720842340959,1.0,6/58,5.82%,AFDN;PICALM;DLG1;AAK1;MAP2;CAMK1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5220412055024889,1.124473035940299,0.34990439770554493,0.9128433943727217,1.0,1/12,0.46%,BMP7
prerank,diterpenoid metabolic process (GO:0016101),0.3918878049145336,1.124442566397585,0.30526315789473685,0.9116882973231388,1.0,11/55,9.35%,ABCA4;NAPEPLD;ALDH1A1;RBP1;AKR1B10;APOM;RHO;PNLIP;DHRS3;RBP4;LRP1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.43720516224085504,1.1244212964635567,0.2996632996632997,0.9105114263281155,1.0,5/30,4.75%,CACNA1D;ANK2;KCNA5;SNTA1;CACNA1C
prerank,Rap protein signal transduction (GO:0032486),-0.5030190659613323,-1.1242425629498902,0.32231404958677684,0.6113005158379908,1.0,4/10,9.64%,RAP1B;PLK2;RAP1A;RAP2A
prerank,negative regulation of anoikis (GO:2000811),-0.46220484201022316,-1.124228638546647,0.2997946611909651,0.6105381743316185,1.0,4/14,8.55%,CAV1;NOTCH1;ITGB1;PTK2
prerank,ganglioside metabolic process (GO:0001573),-0.41392173988985304,-1.1242188079603372,0.30892448512585813,0.6097736997987702,1.0,5/20,8.77%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;HEXB;ST8SIA6
prerank,response to cytokine (GO:0034097),0.34590217824123226,1.1233664221245718,0.272608125819135,0.9125723709064257,1.0,24/141,12.43%,ALDH1A2;PTPN13;SMAD3;TIMP3;PTPN14;AFF3;PTPN9;SPHK1;NFAT5;CASP3;IKBKE;TRIM56;PTPN23;EIF2AK2;PLSCR1;MAPKAPK3;HDAC4;RIPK1;CD274;PTPN4;PTPN11;FOXA2;PRKCA;NUB1
prerank,response to peptide (GO:1901652),-0.3721410703685834,-1.1233316606688997,0.29949238578680204,0.6111322472034053,1.0,15/33,28.39%,STAT3;ANXA1;GNAI1;CACNA1B;STAT5B;ERBIN;EIF2B3;CHRNA7;NOD2;IRF5;IRS1;FYN;STAT4;EIF2B2;MMP3
prerank,negative regulation of signal transduction (GO:0009968),0.31951941086274405,1.1225848373918483,0.23384253819036427,0.9137760001349647,1.0,45/249,12.06%,WWOX;LGR4;LEPROT;RNF43;NXN;PRKCZ;TULP3;KANK2;TRABD2B;DKK3;GLI3;SUFU;APCDD1;CXXC4;LRRK2;NEDD4;SULF2;VGLL4;CYP26B1;PRKCB;TNS2;ARRB1;GPS2;IL12B;MGRN1;PIP4K2C;PTEN;IGFBP3;BTRC;IFT122;HRG;APLN;NIBAN2;LRP1;TLE1;CBY1;GRB10;PHACTR4;CNMD;TRIB1;MMP14;WWP2;GDF15;CSNK2A2;CSNK2A1
prerank,serine family amino acid metabolic process (GO:0009069),0.4942434110981711,1.1225135973293974,0.3291139240506329,0.91280098849332,1.0,7/16,26.12%,SRR;CTH;SEPSECS;MTHFD1;THNSL2;CBS;CDO1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3799794354177066,-1.1224760904274242,0.3049095607235142,0.6124558468063063,1.0,8/30,11.60%,SPTBN1;ANK3;RAB31;VAMP4;PREPL;NSF;GCC2;GOLGA7
prerank,response to ATP (GO:0033198),-0.4363668296008318,-1.121415412875289,0.3294392523364486,0.6142919500919554,1.0,5/18,14.40%,ABCC9;RYR3;TRPC3;P2RY12;P2RY1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.4729239179393576,1.1211539681151301,0.3157894736842105,0.9147613408459787,1.0,6/20,12.68%,IVD;ACADSB;BCAT2;DLD;MCCC1;ALDH6A1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.4729239179393576,1.1211539681151301,0.3157894736842105,0.9147613408459787,1.0,6/20,12.68%,IVD;ACADSB;BCAT2;DLD;MCCC1;ALDH6A1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4448584585896246,1.120943024720186,0.33037300177619894,0.9141988397423109,1.0,3/27,1.32%,SYT9;SYT11;SYT12
prerank,lipid homeostasis (GO:0055088),0.38422399212060276,1.1208097574669638,0.30547112462006076,0.9133740672540229,1.0,11/57,13.58%,PRKAA2;ZBTB20;RBP1;DDX3X;TLCD2;NR1D2;SIRT1;ADCK1;ACOXL;MLXIPL;ACOX3
prerank,histone ubiquitination (GO:0016574),0.4597954601825366,1.1203181704729448,0.3435804701627486,0.9137480119164634,1.0,4/21,7.66%,CTR9;UBR2;RNF8;HUWE1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4787519426314618,-1.1195445182128383,0.31422505307855625,0.6180098686178693,1.0,5/13,10.70%,NFKBIA;YWHAB;FLNA;GOPC;PKD1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.46500390539310593,-1.119264600854482,0.3248407643312102,0.6179063964636111,1.0,5/13,18.41%,HSPA5;DDRGK1;NCK1;BFAR;PTPN1
prerank,response to peptide hormone (GO:0043434),0.40190489390698414,1.1189663514943204,0.30983606557377047,0.9168178490814751,1.0,10/43,15.98%,TGFBR3;ROCK2;STAT2;SLC27A1;SIRT1;OGT;TSC1;EIF2B1;ZFP36L1;STAT6
prerank,negative regulation of GTPase activity (GO:0034260),0.456127094758333,1.1189135170120572,0.2992957746478873,0.9157612165699002,1.0,4/22,6.71%,CPEB2;LRRK2;GMIP;BCAS3
prerank,negative regulation of protein modification process (GO:0031400),-0.3115893088993786,-1.118317752679948,0.24615384615384617,0.6194578336757809,1.0,20/79,10.43%,SLIT2;PID1;PRR5L;NTRK3;NIBAN1;PPP1R16B;SH3GL2;LYN;GSK3B;DAB2IP;PPIA;YWHAB;OCLN;CORO1C;EPHB2;TGFB1;DNAJC10;XDH;MFHAS1;ATP2B4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3545401023640838,1.1176969489654722,0.27453769559032715,0.9183211983162687,1.0,38/100,23.65%,DAB2;SH3RF2;FHIT;PRKN;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;ARAF;TRIB1;GLMN;DESI1;NUB1;USP7;OGT;DNAJB2;ZYG11B;HECTD1;TLK2;RNF19B;HFE;TAF1;ARIH1;SUMO1;ZER1;USP5;CAMLG;GSK3A;ANKIB1;TRIM39;SDCBP;ARIH2;PRICKLE1;BAG6;PSMD10
prerank,positive regulation of cholesterol transport (GO:0032376),-0.39297090739262946,-1.117462147879756,0.2833333333333333,0.6207595098655233,1.0,7/27,14.29%,CAV1;PLTP;NFKBIA;APOE;PTCH1;EEPD1;ABCB4
prerank,cellular response to oxidative stress (GO:0034599),0.3502553239053491,1.1171666619032088,0.2750677506775068,0.9187962081065477,1.0,12/118,6.50%,CPEB2;MSRA;PPARGC1A;PRKAA2;MGAT3;LRRK2;SESN2;SOD3;TPM1;ALDH3B1;SOD2;TP53
prerank,maintenance of protein location in nucleus (GO:0051457),-0.41628797833871745,-1.116623140793135,0.31234866828087166,0.622003599442441,1.0,9/20,29.52%,SYNE1;MORC3;BCL3;BARD1;SKP1;SUN2;RANGAP1;CHCHD10;PARK7
prerank,T cell activation (GO:0042110),0.37341042783726464,1.1164675438165694,0.290519877675841,0.9198074635934925,1.0,9/69,7.54%,LEPR;KIT;KIF13B;DPP4;IFNK;NHEJ1;CD28;PTPN22;CHD7
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3657614603944971,1.1164353644688754,0.2824207492795389,0.9186778241503983,1.0,30/85,23.65%,DAB2;SH3RF2;PRKN;NUPR1;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;TRIB1;NUB1;DNAJB2;ZYG11B;HECTD1;RNF19B;TAF1;ARIH1;SUMO1;ZER1;USP5;FMR1;GSK3A;ANKIB1;ARIH2;PRICKLE1;KCNE2;BAG6;PSMD10
prerank,regulation of proteolysis (GO:0030162),-0.34354253394819234,-1.1163571468246163,0.27393617021276595,0.6218481344883853,1.0,7/48,7.47%,CAV1;LTBP4;SERPINE2;CST3;DNAJC1;GSAP;PERP
prerank,plasma membrane organization (GO:0007009),0.38641034980984956,1.1160486686016782,0.30526315789473685,0.9186966464530174,1.0,12/61,11.51%,COL5A1;ANK2;SYT11;MYOF;FER1L5;ANO6;PLSCR1;PLSCR2;TLCD2;ARV1;BIN3;A4GALT
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4436409310259813,1.1160418504083987,0.3185689948892675,0.9174906238021217,1.0,10/26,19.03%,ERRFI1;SNX6;ADRA2A;HBEGF;ADAM17;TGFA;GPRC5A;SOCS4;BTC;ZGPAT
prerank,defense response to bacterium (GO:0042742),0.3531451403133172,1.1160371060458179,0.26038781163434904,0.916285252931473,1.0,19/105,14.47%,COLEC12;OAS2;TLR3;TLR4;DEFB1;ANKRD17;IL12B;GBP7;SERPINE1;GBP2;PLA2G6;MAVS;IRGM;ANXA3;ADAM17;CAMP;OAS3;GBP6;CFP
prerank,regulation of B cell activation (GO:0050864),-0.39825100114659445,-1.115679590325099,0.3047619047619048,0.6226602085800755,1.0,14/25,42.71%,SH3KBP1;SAMSN1;LAPTM5;NOD2;AHR;TNFAIP3;FOXJ1;THEMIS2;BANK1;IL4;CD22;IL4I1;IL6;FCGR2B
prerank,cellular macromolecule catabolic process (GO:0044265),0.3949817665006087,1.1156665219704922,0.3157894736842105,0.9162470055491024,1.0,11/49,11.40%,PRKN;NGLY1;NEU2;ADAMTS9;SIDT2;DNASE1L1;EXOSC7;MANBA;SND1;RIPK1;MAGEC2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4631018967293242,1.1153213764063834,0.34464285714285714,0.9161244636998701,1.0,6/21,15.26%,IGF1;CTSH;ITGAV;MAP2K1;MAP2K2;ZFP36L1
prerank,negative regulation of lipid storage (GO:0010888),0.4671269828015321,1.1151306424444092,0.3464285714285714,0.9155310225374925,1.0,2/19,1.76%,OSBPL8;PPARA
prerank,positive regulation of intracellular transport (GO:0032388),0.41706362271302333,1.1150128596684037,0.30756578947368424,0.9147019425707236,1.0,6/38,8.76%,ACTN2;STX18;NEDD4;RUFY3;BCAS3;EIPR1
prerank,regulation of cellular component organization (GO:0051128),-0.2888824839657207,-1.1150027542616363,0.19838056680161945,0.6233742907958992,1.0,34/135,16.25%,NRG3;HIP1;CDH13;LTBP4;PLCE1;CAMK2D;RIT2;STON2;PAK5;TFRC;NET1;DAB2IP;RAP1B;RAP1A;APOE;SOCS2;HSPA8;SEMA4D;SPOCK1;AGTR1;IRAK3;CEACAM1;HJURP;HSP90AA1;BCAR1;FAM107A;SNX17;PINK1;ATF5;ERMN;PTCH2;RASGRP2;PACSIN1;EGLN2
prerank,synaptonemal complex assembly (GO:0007130),0.49162576615231673,1.1149928389737922,0.3570127504553734,0.9123647738453864,1.0,7/15,25.31%,TEX12;REC8;STAG3;P3H4;SYCE2;BAG6;TRIP13
prerank,synaptonemal complex organization (GO:0070193),0.49162576615231673,1.1149928389737922,0.3570127504553734,0.9123647738453864,1.0,7/15,25.31%,TEX12;REC8;STAG3;P3H4;SYCE2;BAG6;TRIP13
prerank,membrane organization (GO:0061024),-0.2745897893450217,-1.114992303509662,0.16,0.6226051388402282,1.0,42/227,10.82%,SGCZ;DNM3;SPTBN1;HIP1;SGIP1;SYT1;ANK3;ACTB;FNBP1;SH3KBP1;CERT1;FNBP1L;REPS2;RIMS1;REEP1;ATP2C1;STON2;ACTG1;SH3GL2;AGFG1;CCDC88A;TFRC;VAMP4;EPN2;ACTR2;FZD4;SH3GLB1;LDLR;HSPA8;AMPH;DNM1;CORO1C;BIN1;LPCAT2;GLTP;DYSF;CHRM2;AP2B1;PPT1;TRIP10;ACTR3;PDCD6IP
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.45496071896657214,1.1147787699113392,0.32922535211267606,0.9118759765917691,1.0,11/25,24.40%,IGF1;NSD1;NIBAN2;SIN3A;PER2;DOT1L;RB1;POU4F1;MSX2;MAD2L2;H1-0
prerank,regulation of cellular protein localization (GO:1903827),-0.34871343985445274,-1.1147690511151152,0.27249357326478146,0.622380978900432,1.0,13/45,16.05%,GPC5;GPC6;HSP90AB1;RALB;HSP90AA1;GPC4;CTNNB1;SETD2;MAPT;RAB11FIP5;PPM1F;VCPIP1;BDNF
prerank,response to amyloid-beta (GO:1904645),-0.3476327554159671,-1.1143552779518433,0.2644628099173554,0.6225934137808496,1.0,10/44,7.59%,GRM5;CACNA2D1;VCAM1;GSK3B;ICAM1;APP;GRIN2A;CACNA1B;PSEN1;ITGA4
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2522781599283759,-1.1142550666057813,0.10091743119266056,0.622058021849547,1.0,81/423,12.53%,MEF2C;PID1;LEF1;KITLG;PRKCH;BMP5;ZFPM2;ERBB4;NTRK3;CDH13;OSMR;CLDN5;GCNT2;LIFR;VEGFC;THBS1;FN1;ACER3;TGFB2;TBX3;ACER2;PTK2B;TOX;RPS6;GAS6;S100A6;NOTCH1;NTRK2;IL6ST;KRAS;RPS15A;KDR;LYN;TNFRSF11A;TBC1D8;TBX1;PDGFC;AR;STX3;TIAM1;PAK1;PTPRC;FOXP1;NAMPT;HES1;TGFB3;MEIS2;AQP11;SSR1;RTKN2;CCN1;BMP2;TGFB1;PTK2;PROX1;CUL3;CALR;DDRGK1;PTN;FGF2;FLT4;S100B;RPS9;CD47;NAP1L1;ERBB2;ID2;PDGFA;RPL23;SLC25A33;EDN1;ESM1;SHANK2;GPER1;BMP4;EDN3;RPS4X;CHTOP;PTHLH;EMP2;CDKN1A
prerank,amino acid transport (GO:0006865),0.39087597130066454,1.1140673787062199,0.2916666666666667,0.9129234850307616,1.0,7/49,4.27%,SLC6A12;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN;SLC25A48
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5387174753117059,1.1139187281771263,0.36822429906542054,0.9121881869826273,1.0,1/10,0.40%,BMP6
prerank,positive regulation of gene expression (GO:0010628),0.3101084926791553,1.113606072778257,0.2100656455142232,0.9119495444264334,1.0,58/442,11.32%,FGF1;ROBO1;BMP6;BMP7;C1QTNF3;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;OSR1;DDX5;PPARGC1A;IGF1;WNT6;PRKN;POLR2A;FOXD1;TNRC6A;MITF;TGFBR1;LARP4B;ADRA2A;TAF1D;DTNBP1;TLR3;EZR;SMO;CTSH;CUX2;TLR4;ATM;DDX3X;BRAF;CD28;BAZ1B;POLDIP3;TP53;EIF2AK2;PTPN22;PLSCR1;TNRC6B;SAMD4A;CPEB3;CDH5;CALCOCO1;TLE1;LRP3;RIPK1;UBR5;MOV10;YTHDF3;PIK3R3;SRPK2;DYRK1A;ATF2;C1QTNF1;PRKDC
prerank,hemopoiesis (GO:0030097),0.36690955164221034,1.1135707688219902,0.3,0.9108459581385792,1.0,13/87,7.33%,NOTCH2;TGFBR3;KIT;KMT2A;FGFR2;ZNF160;MEIS1;TET2;PGM3;FLT1;TP53;FUT10;TGFBR2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4727397135737509,1.1134104538778702,0.3279279279279279,0.9101440442535923,1.0,3/18,3.72%,SMAD3;CLASP1;PDPN
prerank,glucose transmembrane transport (GO:1904659),-0.43294576620284436,-1.1133748089830546,0.33182844243792325,0.6234421832829539,1.0,5/18,18.25%,SLC2A1;PPARD;SORT1;SLC2A3;SLC45A1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.37804513459882344,1.1133034686704497,0.3100303951367781,0.9092750907224237,1.0,6/59,7.78%,ALDH1A2;CYP27A1;AMACR;OSBPL9;NDUFAB1;SRR
prerank,cellular respiration (GO:0045333),0.4099092060926345,1.1132370233699183,0.3165905631659056,0.9082800301115698,1.0,14/41,19.65%,PPARGC1A;MTFR2;SIRT3;COQ10A;UQCRC2;NDUFS1;COX10;LYRM7;SDHAF4;ATP5F1D;SDHB;NDUFS4;ETFDH;UQCRC1
prerank,androgen metabolic process (GO:0008209),0.466742191537104,1.113114666126678,0.35855855855855856,0.9074836629782446,1.0,3/18,17.32%,SPP1;SRD5A2;MED1
prerank,apical junction assembly (GO:0043297),0.3867428809755523,1.112600355099814,0.30615384615384617,0.9078782001849146,1.0,3/53,1.68%,PARD6G;AFDN;DLG1
prerank,acylglycerol biosynthetic process (GO:0046463),0.4467819588207026,1.1122039380106665,0.3238434163701068,0.9078880695659782,1.0,4/23,7.27%,LPGAT1;MOGAT3;GPAT2;GK
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4981649782069507,-1.111763128503191,0.3486973947895792,0.6264945956996062,1.0,4/10,16.20%,EPB41L4B;IQSEC1;FGF7;ARF6
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.37447243861441193,-1.111599030376508,0.27680798004987534,0.6261022383445771,1.0,8/33,10.23%,PDE3B;TGFB2;ACER2;NEXMIF;CYP1B1;LYN;PTK2;P2RY12
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3685444723997352,-1.1113157725835765,0.29292929292929293,0.6260491946983503,1.0,8/36,6.44%,GHR;ERBB4;CAV1;CYP1B1;NOTCH1;NLK;PTPRC;HES1
prerank,diol biosynthetic process (GO:0034312),-0.44891413810294334,-1.1111592265109844,0.33916849015317285,0.6256276749663048,1.0,6/15,13.39%,ACER3;ACER2;SPTLC2;GCH1;ASAH2;QDPR
prerank,endomembrane system organization (GO:0010256),0.3258233744341234,1.111063982899361,0.2610340479192938,0.9103169509702068,1.0,55/178,19.10%,FAM174B;DYM;HOOK2;MYOF;OBSL1;ALS2;SEC31B;DMPK;CLASP1;LRRK2;MYO18A;SRGN;ATL1;ARFGEF2;BCAS3;FER1L5;HUWE1;TLCD2;LEMD2;HTT;DNM1L;TRAPPC12;GOLPH3L;CSNK1A1;RAB43;FBXW8;RAB22A;CDC42;A4GALT;MIA3;TRAPPC11;PLEKHF1;REEP4;TANGO2;ARHGAP21;SEC23IP;RAB29;VPS51;GOLGA5;GOLGA8B;VPS4A;HOOK3;NUP155;RAB30;WASHC5;PI4K2B;OPTN;COG4;PHETA1;NPLOC4;SQSTM1;SEC31A;GORASP2;GOLGA2;LAMTOR1
prerank,regulation of inclusion body assembly (GO:0090083),0.5224199168216692,1.1110502507799365,0.3489278752436647,0.9091819518106513,1.0,1/11,1.24%,SNCAIP
prerank,negative regulation of growth (GO:0045926),-0.29324240330274276,-1.1107872541730655,0.23484848484848486,0.6257180872626599,1.0,29/121,10.59%,APBB2;SLIT2;PTPRJ;BMPR2;RTN4;TGFB2;ACVRL1;CCN3;NOTCH1;SOX17;ENPP1;ADAM15;PPP2R1A;RERG;SH3BP4;TGFB1;SERTAD2;BTG1;PNPT1;PPT1;FRZB;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F
prerank,negative regulation of response to stimulus (GO:0048585),-0.32886880553251907,-1.1106717026015698,0.2604501607717042,0.625214121089199,1.0,16/60,14.58%,SLIT2;KLF7;MCTP1;UBASH3B;CASK;CD34;YBX1;AKT3;LYN;HHIP;AQP11;KIF26A;TWIST1;ACVR1;SOCS5;CLU
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.4192004090019626,-1.1105706093184713,0.31414868105515587,0.6246701789114731,1.0,7/19,13.46%,BMPR2;TGFB2;NOTCH1;HEYL;BMP2;HEY2;ACVR1
prerank,B cell proliferation (GO:0042100),-0.4260177579532314,-1.1102303845142105,0.35157894736842105,0.6247176032184971,1.0,2/17,6.05%,MEF2C;PTPRC
prerank,lipid droplet organization (GO:0034389),-0.40609955036028994,-1.1101009446644785,0.3296943231441048,0.6242353734762152,1.0,8/22,28.62%,PPIA;RAB18;PNPLA3;CDS1;SQLE;AUP1;CDS2;FAF2
prerank,nitric oxide metabolic process (GO:0046209),-0.45244351952600026,-1.1098784413900475,0.3541666666666667,0.6239704087050171,1.0,5/14,17.93%,NOS3;CYP1B1;GCH1;NOS1;CYB5R3
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5184598109304291,1.1096663008305117,0.35834896810506567,0.9123908606781357,1.0,5/12,18.69%,HDAC8;WAPL;AXIN2;RB1;FEN1
prerank,protein homooligomerization (GO:0051260),0.3497372702418155,1.1096054732286869,0.29506008010680906,0.9113933098259984,1.0,18/114,9.80%,ALDH1A2;APPL2;UPB1;ALS2;RNF213;CLYBL;ITLN1;NACC2;RNF135;P2RX3;SOD2;ATL1;MICU1;SAMHD1;JMJD6;SSBP1;CBY1;CTH
prerank,positive regulation of coagulation (GO:0050820),-0.49476634325441726,-1.1094297487082871,0.3374485596707819,0.6235376652738186,1.0,4/10,13.12%,ST3GAL4;THBS1;ENPP4;DMTN
prerank,positive regulation of hemostasis (GO:1900048),-0.49476634325441726,-1.1094297487082871,0.3374485596707819,0.6235376652738186,1.0,4/10,13.12%,ST3GAL4;THBS1;ENPP4;DMTN
prerank,positive regulation of chromosome organization (GO:2001252),0.5048801438725352,1.1094280492377806,0.3390151515151515,0.9107246911331458,1.0,8/15,26.38%,ATRX;RAD50;PML;NBN;FEN1;LIG4;PPP1R10;RTEL1
prerank,neuromuscular process (GO:0050905),-0.4322099404058849,-1.1093482225599947,0.3185840707964602,0.6229550005744956,1.0,4/16,7.68%,NRXN1;GCH1;MYCBP2;STRA6
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4619910374067514,1.108640027031322,0.34946236559139787,0.910885982161112,1.0,1/23,0.24%,DAB2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4619910374067514,1.108640027031322,0.34946236559139787,0.910885982161112,1.0,1/23,0.24%,DAB2
prerank,heart contraction (GO:0060047),0.3982282564776607,1.1082271642830088,0.31743421052631576,0.9110457254650135,1.0,6/41,9.18%,ATP1A2;ACE;CSRP3;TPM1;PIK3CA;MYL4
prerank,response to hydroxyurea (GO:0072710),0.5333802699601206,1.1080952171445446,0.34714003944773175,0.9103078894534691,1.0,5/11,21.07%,ATRX;KAT7;DDI1;RTF2;FMR1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3841621882240944,-1.108049139698276,0.2914798206278027,0.6253663084629268,1.0,14/27,21.28%,CSGALNACT1;DCN;CHSY3;BGN;XYLT1;CSPG4;VCAN;CHST12;B3GAT2;CHST9;CHST7;B3GAT3;CSPG5;BCAN
prerank,negative regulation of cation channel activity (GO:2001258),-0.3877089234267601,-1.1078007331436108,0.29832935560859186,0.625209598003252,1.0,9/26,21.60%,KCNAB1;CALM1;CALM2;EPHB2;CALM3;FKBP1A;CASQ2;GSTM2;DRD2
prerank,cytoskeleton organization (GO:0007010),-0.29512555815177255,-1.1075020990785902,0.22262773722627738,0.6251282662521822,1.0,19/114,6.96%,FMNL2;ARHGAP10;RHOBTB1;SEMA6A;MARK1;FGD5;SH3KBP1;PLCE1;MAST4;MICAL2;RND3;DST;EPB41L3;PCLO;PAK5;ARAP3;STRIP2;APOE;RHOB
prerank,response to ketone (GO:1901654),-0.3940952555807222,-1.1074903923654216,0.31234866828087166,0.624387534121654,1.0,7/24,8.45%,SLIT2;ABHD2;CAV1;THBS1;TGFB2;TGFB3;TGFB1
prerank,organelle fusion (GO:0048284),0.4559095928635262,1.106871922103828,0.333955223880597,0.9131077385429074,1.0,8/22,22.35%,CHCHD3;MIGA2;OPA1;MFN2;EEA1;MFN1;AFG3L2;STX4
prerank,regulation of muscle contraction (GO:0006937),0.44538331059091274,1.1060368326103334,0.3539518900343643,0.9144938263798064,1.0,2/26,5.17%,ATP1A2;TPM1
prerank,regulation of cell differentiation (GO:0045595),0.3338381334430301,1.1055921385262615,0.3116883116883117,0.9147061353066908,1.0,22/148,8.83%,SMOC1;DDX5;CCN2;FGFR2;ZFHX2;FGFR1;TGFBR1;CLASP1;DAG1;PRKCB;PPP1R13L;KLHL41;GPS2;APC2;CAMK1;SIK1;EIF2AK2;RORC;NR1D2;CDK5RAP3;GDNF;NEUROD4
prerank,fatty acid oxidation (GO:0019395),0.38039687948032075,1.1055237244300011,0.3046757164404223,0.9137319202798609,1.0,20/57,22.19%,PPARGC1A;ALOX12;ACAD11;ACAD10;BDH2;CPT2;ACADM;MECR;ECHDC1;DECR1;EHHADH;SLC25A17;PHYH;ECI2;CROT;ACADS;HADHA;HADH;ECHS1;HAO1
prerank,intestinal absorption (GO:0050892),-0.4651885886340118,-1.1047131313113776,0.3413566739606127,0.630228601565381,1.0,3/13,8.00%,F11R;UGCG;KCNQ1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.37062422672032935,-1.1040940069014484,0.3004807692307692,0.6309526620858799,1.0,14/29,31.81%,RAD23B;UBB;RPA1;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;UBC;RPS27A;DDB1;RPA3;ERCC3;RPA2
prerank,blood vessel diameter maintenance (GO:0097746),0.41727638979675086,1.1040017115956522,0.3333333333333333,0.9174278630070725,1.0,6/34,7.47%,ROCK2;ACE;NPR1;CPS1;BDKRB2;SCPEP1
prerank,erythrocyte differentiation (GO:0030218),0.4065477140172807,1.103733197374329,0.328525641025641,0.917092089582093,1.0,3/44,3.52%,TGFBR3;KIT;CASP3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.5312672578867459,1.1035391545842097,0.38,0.9165348870783206,1.0,3/12,10.49%,FYCO1;UVRAG;IRGM
prerank,visual perception (GO:0007601),0.355745344829788,1.103372902919659,0.29385964912280704,0.9159006076374046,1.0,11/84,7.85%,ZIC2;EML2;COL18A1;CEP250;EYA4;RGS16;IMPG2;GNAT2;OPA1;DHRS3;RABGGTA
prerank,chromosome organization (GO:0051276),0.35251001468767135,1.103345233960838,0.3020689655172414,0.914822053441936,1.0,31/99,20.20%,TOP2B;HDAC8;SETD7;MTHFR;LDB1;SMARCA4;SIRT1;HDAC1;TCF7L2;ABL1;BAHD1;MSH3;AXIN2;CUL4A;PHF1;CDAN1;HMGN3;DDB2;DOT1L;LRWD1;NUP155;EHMT1;CENPV;TCF7L1;PADI4;EZH1;COPS8;CENPT;XPA;LIG4;BRWD1
prerank,retina homeostasis (GO:0001895),-0.40253678902503753,-1.1032061728959528,0.30679156908665106,0.6323085156286723,1.0,4/23,3.94%,POTEF;ACTB;B2M;ACTG1
prerank,regulation of cellular catabolic process (GO:0031329),0.3814189007086717,1.1030984239327473,0.30518518518518517,0.9144399205905166,1.0,24/62,24.04%,ITPR1;PRKN;MTMR3;NUPR1;GPR137;LRRK2;ATM;WDR41;PIP4K2C;ABL1;DEPDC5;WDR24;RPTOR;WDR91;RRAGD;TYSND1;USP33;TPCN2;MTMR4;CISD2;EP300;BOK;RRAGB;RMC1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.480869431036757,1.1030722935139174,0.3582608695652174,0.9133622977549755,1.0,4/16,3.18%,TGFBR3;IGF1;FGFR2;BMPR1A
prerank,regulation of T cell cytokine production (GO:0002724),-0.45259672292353853,-1.1026821854448259,0.35267857142857145,0.6327954845777571,1.0,4/15,9.15%,B2M;MAP3K7;TNFRSF1B;SMAD7
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.3332614716398666,-1.1025731618242938,0.2905982905982906,0.6323005722415173,1.0,31/50,47.49%,PSMB2;PSMD14;PSMC6;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;PSMB5;OAZ1;PSMA7;OAZ2;ODC1;PSMF1;PSMD7;PSMA5;PSMD4;PSME4;PSMD3;OAZ3;PSMC2;PSMD1;PSMB8;PSMC3;PSMD8;PSMB11;PSMB1;PSMB7;PSMA8
prerank,snRNA transcription (GO:0009301),0.3740580607990514,1.1024707021160567,0.3263473053892216,0.914061742178796,1.0,24/70,23.34%,POLR2A;PHAX;CCNT2;RPRD2;POLR2D;ELL;INTS10;GTF2F1;TAF11;INTS2;INTS5;TBP;INTS3;TAF13;INTS7;INTS1;INTS8;INTS4;POLR2G;GTF2A1;SP1;TAF8;USPL1;POLR2F
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4991044633723567,1.1024548452030978,0.37340619307832423,0.9129458922863503,1.0,4/13,13.82%,IL18;IL12B;ZBTB1;AXL
prerank,positive regulation of type I interferon production (GO:0032481),0.37262917338893725,1.102219326169835,0.3190546528803545,0.9125352041893464,1.0,20/73,16.30%,OAS2;TLR3;TLR4;RNF135;DDX3X;TRIM56;PTPN22;RIPK2;MAVS;TOMM70;PRKDC;DHX58;PTPN11;IRF1;POLR3A;DHX33;OAS3;NFKB1;STAT6;CREBBP
prerank,sphingolipid catabolic process (GO:0030149),-0.44654979729275734,-1.1018695012736095,0.34623655913978496,0.6331815262455359,1.0,6/15,11.86%,ACER3;ACER2;PPT1;ENPP2;ASAH2;SMPDL3A
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5220449278515531,1.1016700621744462,0.3629191321499014,0.9130762184080835,1.0,3/10,12.36%,LPGAT1;SLC45A3;MLXIPL
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.40327581780014427,1.1015864883468243,0.32838283828382836,0.9121686022507095,1.0,11/41,12.65%,ACE;EPHA4;ADRA2A;DLG3;GPRC5B;HBEGF;NOX4;CASS4;ADAM17;TGFA;SRCIN1
prerank,sensory perception of light stimulus (GO:0050953),0.35382143460488047,1.1013843824315066,0.31693198263386396,0.9116549503633631,1.0,11/87,7.85%,ZIC2;WHRN;EML2;COL18A1;EYA4;RGS16;IMPG2;GNAT2;OPA1;DHRS3;RABGGTA
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4349958513883053,-1.1009947454418374,0.32158590308370044,0.6345930746039051,1.0,6/17,19.71%,MID1;TGFB2;LYN;SEMA4C;NOD2;KLHDC10
prerank,cytosolic calcium ion transport (GO:0060401),-0.3831279606530512,-1.100619005921338,0.3284671532846715,0.6347131520050869,1.0,10/28,12.96%,SLC8A1;RYR2;CACNA2D1;SLC35G1;MICU3;ATP2A3;JPH2;SMDT1;ATP2B1;MCUB
prerank,carbohydrate catabolic process (GO:0016052),0.4103389912117822,1.100173737813514,0.33690658499234305,0.9143301798577639,1.0,7/38,9.51%,HK2;NEU2;PGAM2;DERA;GCK;MANBA;NEU3
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.48447489025020796,1.1001641079147089,0.3352272727272727,0.9132151564198164,1.0,7/16,22.88%,AMPD3;LHPP;AMPD2;ADSS1;GART;ADSL;GMPS
prerank,cortical cytoskeleton organization (GO:0030865),0.40955271082704797,1.0995708532236186,0.3178036605657238,0.913929500940362,1.0,7/41,4.65%,ROCK2;RHOQ;DLG1;RHOBTB2;FHOD1;RHOD;EZR
prerank,glycoprotein biosynthetic process (GO:0009101),-0.30814213684111924,-1.099493885420679,0.26732673267326734,0.636710572834271,1.0,19/79,15.63%,CSGALNACT1;ST3GAL4;ST8SIA4;BMPR2;GCNT2;FUT9;XYLT1;ST8SIA1;B4GALT5;B3GALT1;ST3GAL6;ST8SIA6;B3GALNT1;DAD1;B3GALT5;BMPR1B;CHST12;NUS1;CHST9
prerank,vasculogenesis (GO:0001570),-0.3740539046994678,-1.0993811119498533,0.3165829145728643,0.6361840412320526,1.0,14/32,13.89%,CAV1;ENG;RASIP1;NOTCH1;KDR;RAMP2;ITGB8;SOX17;TGFB1;HEY2;RASA1;SOX18;VEGFA;SPRED1
prerank,cell-cell junction organization (GO:0045216),0.3619369006054475,1.0982905703381216,0.32122093023255816,0.9168029495641666,1.0,8/79,2.77%,SDK1;AFDN;SMAD3;PKP4;SDK2;PKHD1;NLGN2;ARVCF
prerank,steroid metabolic process (GO:0008202),0.3648892134241441,1.098129398472553,0.3266563944530046,0.9161734368204882,1.0,12/72,12.67%,CYP27A1;LIPA;CYP21A2;CYP26B1;AMACR;FDXR;DHRS11;CYP2R1;SULT2B1;GC;ARV1;SRD5A2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5098049140978971,1.09794968322608,0.38323353293413176,0.9144455421875175,1.0,1/12,1.22%,FHL2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5098049140978971,1.09794968322608,0.38323353293413176,0.9144455421875175,1.0,1/12,1.22%,FHL2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.46160590488302955,-1.097809211345688,0.3600867678958785,0.6391391398314417,1.0,7/13,26.52%,KDR;IL33;NAMPT;EDN1;NOD2;JAK2;CCL2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3039719082388355,1.0972155040490303,0.2572347266881029,0.9156196877745216,1.0,87/476,14.06%,RORA;BMP7;SMAD3;WNT4;ZIC2;PPARGC1A;PICALM;IGF1;KMT2A;PPARA;ZNF423;CREB5;GLI2;NPAS3;CXXC1;SPP1;PHIP;NR2F2;ELF1;GLI3;MITF;TGFBR1;ARNT2;FOXC1;NFIB;CAND2;CREB3L2;RREB1;RGMB;NSD1;TRIM56;HMGA1;LBH;CREBL2;ZNF318;TP53;TBL1X;AFAP1L2;ARHGEF11;RORC;MED12;SMARCD3;FBXW11;ELF2;SMARCA4;NR1D2;BTRC;TBL1XR1;KAT6B;ZIC1;JMJD6;SMARCC2;TEAD2;NIBAN2;CALCOCO1;PARP9;HDAC4;GLI1;NSD3;HDAC1;ZFP90;FOXC2;TCF4;MYBL1;MED17;THRAP3;DYRK1A;MSANTD1;TEAD1;ZMIZ1;PHF5A;BRD7;FOXA2;DEAF1;MLXIPL;IRF1;ZXDC;EDRF1;PBX4;ZBTB48;DNM2;MAP2K1;MLLT11;PML;ILF2;MAP2K2;SNAI1
prerank,cell projection organization (GO:0030030),-0.3757157082083566,-1.0970057651851117,0.32211538461538464,0.6403793827824451,1.0,7/30,10.25%,RHOJ;GSN;PARVB;ITGB1;RHOH;P2RY12;PDGFA
prerank,positive regulation of kinase activity (GO:0033674),-0.2953586928383647,-1.0969943780732931,0.2508591065292096,0.6396343559543861,1.0,30/107,12.77%,TEK;ERBB4;NTRK3;ROR1;EPHB1;RASSF2;EPHA5;MERTK;IQGAP1;EPHA6;TIE1;PTK2B;GAS6;NTRK2;KDR;ROR2;PTPRC;RAP1A;MET;EPHA7;RELN;EPHB2;CCN1;PTK2;FLT4;ERBB2;XRCC5;CDKN1A;MAPT;MMD
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.28910423244612504,-1.0969475735824818,0.21830985915492956,0.638967346934025,1.0,32/105,30.01%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;RELB;PSMA4;PSMB9;SKP1;SYK;ICAM2;PSMD11;PSMB10;PSMD2;TYROBP;FYN;PSMA2;RELA;PSMB3;TAB1;PSMB5;CARD11;PSMA7;PSMF1;PSMD7;MALT1
prerank,cellular response to amyloid-beta (GO:1904646),-0.35721105700717287,-1.0968895482510985,0.3054187192118227,0.6383316340967803,1.0,9/35,7.59%,GRM5;CACNA2D1;VCAM1;GSK3B;ICAM1;APP;GRIN2A;PSEN1;ITGA4
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.4332775785713309,-1.0967821744924788,0.3463203463203463,0.6377966717684018,1.0,8/17,18.68%,CALM1;CALM2;SMAD7;DDIT4;CALM3;DMTN;SPRED1;SIRT2
prerank,cellular response to lectin (GO:1990858),-0.2912713238536923,-1.096681450279818,0.2222222222222222,0.6365006052672367,1.0,32/104,30.01%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;RELB;PSMA4;PSMB9;SKP1;SYK;ICAM2;PSMD11;PSMB10;PSMD2;TYROBP;FYN;PSMA2;RELA;PSMB3;TAB1;PSMB5;CARD11;PSMA7;PSMF1;PSMD7;MALT1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2912713238536923,-1.096681450279818,0.2222222222222222,0.6365006052672367,1.0,32/104,30.01%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;RELB;PSMA4;PSMB9;SKP1;SYK;ICAM2;PSMD11;PSMB10;PSMD2;TYROBP;FYN;PSMA2;RELA;PSMB3;TAB1;PSMB5;CARD11;PSMA7;PSMF1;PSMD7;MALT1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.29581388813444626,-1.0966731638256504,0.24516129032258063,0.6357477523417655,1.0,11/91,6.05%,NRP1;HIP1;SYT1;RIMS2;CDH13;STXBP5L;RIT2;STON2;SCARB1;RAB3C;PTPRC
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.49471940067217884,-1.096490303927734,0.3559670781893004,0.6354582674708438,1.0,6/10,34.75%,CCT8;CCT2;CCT6A;CCT7;DKC1;CCT3
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.4069684191759516,-1.0964880028814572,0.3200883002207506,0.6346956980470629,1.0,5/19,6.59%,PRKCH;CLDN5;RUNX1;F11R;OCLN
prerank,positive regulation of cartilage development (GO:0061036),-0.4278647635463846,-1.0959984681141333,0.34810126582278483,0.6350668487618576,1.0,7/17,18.23%,BMPR2;ACVRL1;ZBTB16;BMP2;BMP4;BMPR1B;PKDCC
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3302350478597361,-1.0959721738534625,0.2768817204301075,0.6343615253150938,1.0,18/47,19.80%,PID1;THBS1;PLCG2;RAB27A;TGFB1;AGTR1;XDH;CYBA;CDKN1A;MAPT;ACE2;ADGRB1;GRIN1;SYK;ITGB2;ROMO1;TYROBP;AGT
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3557834166812801,1.095867439637417,0.2949640287769784,0.9186110006773117,1.0,19/88,16.17%,BMP7;SMAD3;STX18;FNIP1;TRABD2B;BID;MPP7;NRG1;CDH5;HYAL1;AJUBA;VIL1;PRKCA;SDC4;LGALS3;FAF1;SMPD3;SNF8;VPS4A
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.41496894323564737,1.0955661024021768,0.3596774193548387,0.918416656730264,1.0,8/33,12.28%,DLG1;KANK2;NACC2;PLK5;PTEN;RBL2;RBL1;BRD7
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4438236151730547,-1.094639590784162,0.3697813121272366,0.6368628761687855,1.0,4/15,9.33%,PTK2B;KDR;BMX;TEC
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.24623175191754548,-1.0943475962736189,0.13131313131313133,0.6368375774304439,1.0,106/509,14.08%,NLGN1;KITLG;HIP1;PTPRJ;TEK;VWF;ACTN4;ERBB4;NTRK3;PIK3R1;CDH13;CAV1;ESR1;GCNT2;ROR1;ENG;DCN;RTN4;ADRA1B;THBS1;FN1;TGFB2;IQGAP1;RIT2;SEMA5A;ATP2C1;GAB1;MID2;NOD1;BCAR3;CAV2;GAS6;F3;RPS20;TFRC;NRG2;NTRK2;RPL37;HSP90AB1;TNFSF10;ALPK1;KDR;LYN;ROR2;TBX1;PDGFC;DAB2IP;PTPRC;PLK2;TRAF5;APP;RPS15;FLNA;RPS3;MET;PLCG2;MAP3K7;TNFRSF19;SEMA4D;ITGB1;ECM1;SLC44A2;RELN;RTKN2;BMP2;MYOC;TGFB1;PTK2;SHISA5;WWC1;NDFIP2;MFHAS1;TNFAIP8L3;FGF2;FLT4;S100B;PLEKHG5;PIK3AP1;ERBB2;JCAD;P2RY12;TRIM14;PDGFA;RPL23;HSP90AA1;FKBP1A;TRIM27;GPER1;REL;TIRAP;UNC5B;ILK;IKBKB;FGF7;PRKD1;FGF9;RET;VEGFA;RBCK1;TXN;CARD16;PINK1;TERF2IP;PPM1A;BBC3;LAPTM5
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.36021634569343597,1.094329173890605,0.31314623338257014,0.9211291398720953,1.0,15/78,14.09%,DAB2;SH3RF2;PRKN;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;TRIB1;FZR1;NUB1;DNAJB2;ZYG11B
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.27502547823225315,-1.0943119724786867,0.22522522522522523,0.636165762470462,1.0,35/152,14.76%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;ADGRG6;GNAS;ADCY2;ADRA1B;ADGRE5;GRM8;ADCY7;RAMP2;ADCY4;PSAP;GNAI1;CHRM2;GNA12;S1PR1;HTR1F;PDE2A;P2RY12;LGR5;PTH1R;GPER1;GNA14;PTHLH;RAMP1;ADGRB1;GPR26;HTR1B;ADGRG1;GNAO1;IAPP;GNAL
prerank,vesicle transport along microtubule (GO:0047496),0.45289547252198986,1.094242161957153,0.3533697632058288,0.9202572352924808,1.0,8/23,17.78%,TRAK1;FYCO1;FBXW11;HTT;KIF1C;KIF5B;TRAK2;KIF13A
prerank,regulation of protein ubiquitination (GO:0031396),0.34393254399301165,1.0940601148833808,0.30935251798561153,0.9196666699098783,1.0,14/108,9.67%,SH3RF2;NXN;SASH1;PRKN;SPHK1;HDAC8;TGFBR1;LRRK2;ARRB1;FANCI;HUWE1;CDK5RAP3;RIPK2;GTPBP4
prerank,replicative senescence (GO:0090399),0.5093121615050336,1.0937893459051296,0.3641509433962264,0.9193873789336103,1.0,4/12,8.38%,ATM;TP53;SERPINE1;TERT
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2923647506377127,-1.0935140493691924,0.265625,0.6372715119495593,1.0,45/109,30.01%,PIK3R1;LYN;PSMB2;PAK1;CALM1;PLCG2;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;TEC;PSMC6;IKBKB;PSMA4;PSMB9;VAV1;SKP1;SYK;PSMD11;BTK;PSMB10;PRKCQ;PSMD2;SHC1;SOS1;PSMA2;MAP2K7;RELA;PSMB3;TAB1;PLCG1;PSMB5;NR4A3;LCP2;CARD11;MAPK8;PSMA7;FOS;MAPK3;PSMF1;PSMD7;JUN;MAP2K4;MALT1
prerank,nucleosome organization (GO:0034728),0.38056653001724744,1.0932138486088951,0.32558139534883723,0.9199251914869426,1.0,11/55,9.11%,ARID2;CHAF1B;ATRX;HMGA1;SMARCD3;RNF8;SMARCA4;SRCAP;KAT6B;SMARCC2;SMARCE1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.44824515462341696,1.092743702691082,0.3476027397260274,0.920169270456297,1.0,3/23,8.43%,WNT5B;SMO;GDNF
prerank,regulation of intracellular pH (GO:0051453),-0.3649283143955162,-1.0926293441915025,0.32629107981220656,0.6386145823732101,1.0,10/34,22.43%,SLC4A10;SLC9A2;CA2;SLC9A6;SLC9A7;SLC9B1;GPR89A;GPR89B;CFTR;SLC4A2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.47028019470464066,-1.0920551791342135,0.35913978494623655,0.6392619877424239,1.0,4/12,8.07%,CAV1;CTNNA3;RYR2;BIN1
prerank,potassium ion transmembrane transport (GO:0071805),0.33925840457561474,1.091956220512722,0.3149394347240915,0.9215975391666414,1.0,8/135,1.93%,ATP1A2;KCNK2;SLC24A3;ATP1B3;KCNJ13;KCND3;KCNA5;LRRC38
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5004961936985447,1.0918083567588996,0.40264650283553877,0.9209200343804255,1.0,2/14,3.85%,UPB1;DPYD
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.37121256165605365,1.091447274925855,0.33634992458521873,0.9209156639262345,1.0,21/69,21.09%,POLR2A;PHAX;CCNT2;RPRD2;POLR2D;ELL;INTS10;GTF2F1;TAF11;INTS2;INTS5;TBP;INTS3;TAF13;INTS7;INTS1;INTS8;INTS4;POLR2G;GTF2A1;SP1
prerank,positive regulation of phospholipase activity (GO:0010518),0.45342513605645773,1.0912333291003384,0.36493738819320215,0.9204618455246518,1.0,6/22,8.74%,KIT;FGFR2;FGFR1;FLT1;PDGFRB;PDPK1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.35948757020553335,-1.091146553016697,0.3294392523364486,0.6407679198466154,1.0,9/34,11.00%,PTPRB;PTPRJ;PTPN12;UBASH3B;PTPRT;PTPRF;PTPRZ1;DUSP1;DUSP3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3598178798363403,-1.090933831118386,0.29850746268656714,0.6404990094004004,1.0,13/37,16.81%,CLASP2;EFNA5;PHLDB1;GSK3B;STMN2;MAP6;MARK2;FAM107A;TRIM36;MAPT;BICD2;STMN1;TPPP
prerank,secondary palate development (GO:0062009),0.4882962352769503,1.0908319692499453,0.3817504655493482,0.92059153932273,1.0,3/14,7.54%,TGFBR3;TGFBR2;CHD7
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5227382517165733,1.0906877046857586,0.381957773512476,0.9198997159329025,1.0,2/10,6.47%,TLR4;IL12B
prerank,negative regulation of signaling (GO:0023057),-0.3794960166225638,-1.0906794295764837,0.3222748815165877,0.6403394165998385,1.0,7/25,18.41%,UBASH3B;HHIP;GLRA1;KIF26A;ACVR1;SOCS5;PTPN1
prerank,response to organophosphorus (GO:0046683),-0.42784132036852085,-1.0906732091013214,0.36404494382022473,0.6395933076578184,1.0,2/16,4.89%,ABCC9;TRPC3
prerank,negative regulation of protein polymerization (GO:0032272),-0.3774938760023956,-1.0906246593238915,0.34005037783375314,0.6389473092467713,1.0,13/27,21.68%,SLIT2;KANK3;KANK4;STMN2;TUBB4A;PFN2;SNCA;STMN1;KANK1;HIP1R;MYADM;SSH2;TWF2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.32345795371427927,1.0899141637450718,0.2919254658385093,0.921157545494152,1.0,38/190,14.42%,UACA;RORA;BMP7;C1QTNF3;CGNL1;ITPR1;PRKAA2;PPARA;FNIP1;PKHD1;PPEF2;NPRL3;DEPTOR;MAGI2;DAG1;VGLL4;DDX3X;WWC2;NPRL2;MGRN1;UBR2;PTEN;RNF34;SIRT1;TLE1;RIPK1;CYRIB;AJUBA;ARHGAP12;PHLPP2;NMI;MAPKBP1;IFI35;DEPDC5;FLCN;TSC1;THEM4;PPM1B
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.3876374354469131,-1.0898025260080675,0.3333333333333333,0.6402343660632445,1.0,12/25,38.46%,HSPA8;HSPA5;HSPE1;DNAJB1;PTGES3;HSPA13;ERO1A;HSPA1L;HSPA9;DNAJB4;ST13;SDF2L1
prerank,muscle cell migration (GO:0014812),-0.4813564264407192,-1.089694453982089,0.35456475583864117,0.6397337708879983,1.0,5/10,23.02%,CCN3;SIX1;ITGB3;THBS4;AAMP
prerank,positive regulation of cell motility (GO:2000147),0.31552380368633964,1.0896053378381927,0.29826732673267325,0.9209457599247882,1.0,36/205,12.32%,DAB2;FGF1;WNT5B;SH3RF2;SYNE2;ROCK2;KIT;LAMC2;IGF1;RHOD;SPHK1;TGFBR1;ADRA2A;PDPN;RUFY3;SMO;CTSH;SEMA3B;ATM;SOD2;FLT1;PDGFRB;CPNE3;CDH5;CCAR1;HBEGF;FER;TRIP6;PIK3R3;CASS4;MMP14;VIL1;MYLK;ADAM17;MYO1C;PRKCA
prerank,V(D)J recombination (GO:0033151),0.5110417027170371,1.0893939590048347,0.38786764705882354,0.9204699919997166,1.0,4/11,21.43%,XRCC4;PRKDC;LIG4;LIG1
prerank,regulation of anoikis (GO:2000209),-0.4090271797039776,-1.0893328053134725,0.3248407643312102,0.6398134476799947,1.0,8/19,19.92%,CAV1;NOTCH1;ITGB1;PTK2;ANKRD13C;MYBBP1A;ITGA5;PTRH2
prerank,megakaryocyte differentiation (GO:0030219),0.5265915813359263,1.088924167645299,0.39325842696629215,0.9207151220435847,1.0,1/11,1.21%,KIT
prerank,muscle cell development (GO:0055001),0.42355174398562256,1.0887045887151579,0.3547297297297297,0.9202689403320856,1.0,4/30,2.06%,NEBL;ANK2;IGF1;MYOF
prerank,in utero embryonic development (GO:0001701),0.43729670311178354,1.0885743958075074,0.339041095890411,0.9195626544006495,1.0,6/25,7.54%,FGFR2;ZNF568;TGFBR1;ARNT2;FUT8;CHD7
prerank,tight junction assembly (GO:0120192),0.3854587866401574,1.0885463299908507,0.3328149300155521,0.9185258535486756,1.0,3/49,1.68%,PARD6G;AFDN;DLG1
prerank,positive regulation of immune effector process (GO:0002699),0.42580694138558633,1.0878530458968525,0.33728813559322035,0.9194661926118394,1.0,6/27,11.40%,APPL2;MYO18A;ANKRD17;IL12B;DDX60;DHX58
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.48787653329989145,-1.087304740964006,0.38301886792452833,0.6438212450177073,1.0,4/10,4.88%,HECW2;HECW1;CAMK2D;NEDD4L
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5119774060967395,1.087142433005721,0.37209302325581395,0.920513946963049,1.0,2/11,3.11%,EFNB2;FRS2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4803336183958139,-1.087083574708552,0.3919491525423729,0.6435700619623912,1.0,3/11,10.43%,NOTCH1;FOXO1;ATP2B4
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4632449450392349,-1.0869780441320296,0.36116910229645094,0.6430503635503537,1.0,6/12,24.63%,ANK3;CNKSR3;NOS1;SCN1B;PKP2;GPD1L
prerank,cell projection assembly (GO:0030031),-0.39479651136024096,-1.086756397374593,0.33940774487471526,0.6428044378843912,1.0,5/22,10.25%,RHOJ;GSN;PARVB;RHOH;PDGFA
prerank,regulation of cytoplasmic transport (GO:1903649),0.5155360109746201,1.0865555320697748,0.3768939393939394,0.9212409574480689,1.0,4/11,14.01%,LRRK2;USP7;MAP2K1;MAP2K2
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.48506855736729226,-1.0862681683358437,0.37258687258687256,0.6432995834101172,1.0,3/10,8.32%,DCN;KDR;MYOC
prerank,glycosphingolipid metabolic process (GO:0006687),-0.34283476420896336,-1.0857732935986355,0.33251231527093594,0.6437311975724249,1.0,10/42,10.36%,ST6GALNAC3;ESYT2;UGCG;ST8SIA1;PSAP;ST6GALNAC5;GLTP;HEXB;B3GALNT1;ESYT3
prerank,defense response to symbiont (GO:0140546),0.3474405744539284,1.0849507024481908,0.3188202247191011,0.9251641847297744,1.0,21/92,15.45%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;NDUFAF4;TLR3;TRIM56;STAT2;EIF2AK2;PLSCR1;SAMHD1;RSAD2;MAVS;MOV10;ATG7;IRF1;OAS3;ACOD1;IFNAR2;NT5C3A
prerank,heterochromatin assembly (GO:0031507),0.4506493479729411,1.0846303251430816,0.36607142857142855,0.9250570894649061,1.0,9/20,21.14%,HMGA1;SIRT1;HDAC1;BAHD1;BEND3;SMCHD1;CENPV;EZH1;MBD2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4822428516020776,-1.0845491783946055,0.3887733887733888,0.64602297858819,1.0,3/11,10.81%,SLIT2;CCN3;DUSP1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.35057336783804666,-1.084402920619599,0.3397790055248619,0.6456067290099358,1.0,12/36,14.77%,LEF1;GNG2;NLK;CALM1;FZD4;MAP3K7;PPP3R1;NFATC1;PPP3CA;CTNNB1;GNAO1;GNB1
prerank,nucleotide metabolic process (GO:0009117),0.4393669940966034,1.084289452257316,0.3703071672354949,0.9249409620141241,1.0,7/23,16.79%,FHIT;NMNAT1;ENPP3;AK4;CTPS2;AK8;NMNAT2
prerank,zinc ion homeostasis (GO:0055069),-0.38160823503275254,-1.0839615043873483,0.3471882640586797,0.6459620207185348,1.0,12/28,14.18%,SLC39A10;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;SLC30A1;SLC39A12;MT3
prerank,reverse cholesterol transport (GO:0043691),-0.44522725573773175,-1.0837073268327222,0.3710691823899371,0.6458323387270476,1.0,4/13,14.58%,SCARB1;APOE;ABCG1;CLU
prerank,regulation of cell development (GO:0060284),0.40608127560821494,1.0831438516915057,0.3575949367088608,0.9273445431778611,1.0,8/36,14.08%,NOTCH2;BHLHE41;ADGRA2;DOCK7;FBXO22;PRUNE1;HES6;PER2
prerank,positive regulation of protein sumoylation (GO:0033235),0.5263767030154581,1.0829669799817379,0.3763837638376384,0.926718490167648,1.0,4/10,18.95%,PIAS1;HDAC4;PIAS3;PIAS4
prerank,negative regulation of viral transcription (GO:0032897),-0.45912242200048553,-1.0828527462355477,0.38169642857142855,0.6471933501220157,1.0,4/13,11.73%,MID2;TRIM14;TRIM27;IFITM3
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4571224059746633,1.0816529208526076,0.3707052441229656,0.9296094146219421,1.0,3/22,9.34%,BMP7;TP53;SIRT1
prerank,negative regulation of cell population proliferation (GO:0008285),0.30436799320111024,1.08156403398998,0.27746319365798416,0.9287764163403427,1.0,69/351,14.28%,TGFBR3;ALDH1A2;APPL2;FBLN1;OGN;GSDME;FGFBP1;PTPN14;MCC;KANK2;COL18A1;CD300A;NUPR1;COL4A3;ARID2;MAGI2;IGFBP7;SPEG;PARP10;PDPN;IFIT3;NACC2;VGLL4;SMAD6;TNS2;CLMN;IFNK;SOD2;HMGA1;IL12B;TP53;EIF2AK2;SSTR3;DLG3;PTPRU;RBP4;PTEN;KDM2B;IGFBP3;HRG;NUPR2;NIBAN2;SULT2B1;TFDP1;GTPBP4;SLURP1;NOX4;RNF41;DUSP10;RARG;MNT;TRIB1;GLMN;AXIN2;NMI;ATRAID;BRD7;IRF1;FRK;IFI35;PODN;MAP2K1;PML;DNAJB2;MFN2;PER2;FLCN;TSC1;KAT2B
prerank,receptor-mediated endocytosis (GO:0006898),-0.27805622967239907,-1.0814310861601586,0.26811594202898553,0.6500645815498005,1.0,30/132,11.27%,LRP1B;DNM3;SGIP1;CALCRL;CAV1;CD9;FNBP1L;SCARB1;CAV2;RAB31;TFRC;TMEM108;RAMP2;APOE;SNAP91;LDLR;ACKR3;ITGB1;HSPG2;DNM1;SORL1;STAB1;CALR;AP2B1;SCARF1;CXCL16;PPT1;HSP90AA1;CTSL;AP2M1
prerank,positive regulation of organelle organization (GO:0010638),0.4128140006389721,1.0812906955715658,0.3643926788685524,0.9284706645150099,1.0,4/32,5.81%,PPARGC1A;STX18;FYCO1;UVRAG
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.37202393020128915,-1.0810407554567891,0.32779097387173395,0.6502398062959728,1.0,7/29,12.99%,ESR1;RUNX1;PAK1;DDRGK1;CNOT2;UFM1;AXIN1
prerank,regulation of histone acetylation (GO:0035065),0.4154181781344311,1.080965062908662,0.3576271186440678,0.9283847166042092,1.0,5/33,5.82%,PPARGC1A;KMT2A;RAPGEF3;ARRB1;CAMK1
prerank,cAMP biosynthetic process (GO:0006171),0.5302401423783905,1.080858760750058,0.3764478764478765,0.9275930297653964,1.0,3/10,6.99%,ADCY5;ADCY1;ADCY9
prerank,regulation of signal transduction (GO:0009966),-0.26520619933500006,-1.080851494677241,0.21777777777777776,0.6499216272712377,1.0,45/190,13.88%,ESR1;RSPO3;PLCE1;RGS3;LIFR;MDFIC;UBASH3B;RGS5;KCTD8;RGS6;SEMA5A;NCK2;RUNX1;MGLL;UGCG;TMEM108;IGFBP4;PPIA;APP;HHIP;SOCS2;PTCH1;PRAG1;IGFBP6;TSPAN12;CRK;SREBF2;TMEM204;PPP2R1A;YWHAG;FRMPD1;TGFB1;LFNG;KIF26A;MFNG;RGS4;GLRX2;HOMER1;ILK;AXIN1;PRKD1;ACVR1;RGS20;RGS12;SOCS5
prerank,regulation of DNA replication (GO:0006275),0.38368761069516444,1.080800473553182,0.36363636363636365,0.9266675079706066,1.0,16/49,16.62%,GLI2;CCNA2;ZBTB38;DSCC1;ANKRD17;PDS5A;GLI1;GTPBP4;WAPL;KAT7;CDAN1;ORC3;FAF1;EHMT2;SMC3;USP37
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.28487575778165425,-1.0803860059862946,0.2814814814814815,0.6502422369833777,1.0,38/117,23.54%,CALCRL;ADCY2;ADCY7;MYH9;GNG2;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;HTR7;PTH1R;CYSLTR1;PRKAR1B;CYSLTR2;PRKAR2B;HTR4;PTHLH;RAMP1;IAPP;GNB1;VIPR2;SYK;GPR45;ADCY3;ADCY8;PRKAR2A;GPR176;HRH2;ADCYAP1R1;YES1;MC5R;NPSR1;CD81;FYN;LHCGR;RHBDF2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4391413530117695,1.0797161981823695,0.3826086956521739,0.9288185765933622,1.0,3/26,2.17%,ROCK2;PICALM;EPHA4
prerank,positive regulation of cell adhesion (GO:0045785),-0.3070466639698046,-1.0796777221047908,0.29878048780487804,0.6511981666089552,1.0,20/74,14.56%,FRMD5;ZFHX3;PTPRJ;TGFB2;CXCL12;VIT;NDNF;EPB41L4B;FBLN2;STX3;PPP3CA;SMAD7;CD47;ERBB2;P2RY12;RET;VEGFA;ADGRG1;PPM1F;LIMS1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.33662230794325887,1.0793543946364113,0.348,0.9288118012703711,1.0,32/140,11.95%,ARHGAP28;ARHGAP29;CGNL1;RHOQ;ARHGEF18;RHOD;ARHGEF16;SRGAP2;SRGAP3;ARHGAP18;FGD4;SYDE2;ARHGAP9;NGEF;AKAP13;ARHGAP6;GMIP;ARHGAP26;ARHGAP17;ARHGEF11;ARHGEF12;ARHGAP23;ARHGEF1;OPHN1;CYRIB;ARHGAP12;FGD1;OCRL;SOS2;CDC42;RALBP1;ITGAV
prerank,histone deacetylation (GO:0016575),0.39188712233677253,1.078549638256341,0.3443163097199341,0.9302789683258837,1.0,16/43,23.66%,HDAC8;TBL1X;TBL1XR1;HDAC4;SIRT1;HDAC1;PRDM5;SIN3A;PER2;MIER3;MTA2;MTA1;RCOR1;REST;MIDEAS;MSL3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.468299083712481,1.0779597604337556,0.37809187279151946,0.9309676342402641,1.0,2/17,3.18%,NOTCH2;BMPR1A
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4790733177437906,1.0778310092310321,0.3702290076335878,0.9302459853346663,1.0,5/15,13.93%,STAT2;SAMHD1;YTHDF3;OAS3;USP18
prerank,negative regulation of neuron death (GO:1901215),-0.2923886700887143,-1.077297467727007,0.28113879003558717,0.656318429694987,1.0,34/93,19.61%,MEF2C;CD200;PTK2B;CD34;NDNF;NGF;NTRK2;GSK3B;APOE;TGFB3;TNFRSF1B;SORL1;PTPRZ1;SIX1;BTBD10;FOXQ1;TOX3;PPT1;RASA1;ATF4;UNC5B;NENF;SNCA;PINK1;MT3;FBXO7;BDNF;TYRO3;HTRA2;CRLF1;CHMP4B;CHMP4A;VSTM2L;SIX4
prerank,regulation of protein acetylation (GO:1901983),0.501050624063888,1.0772052392705485,0.3803339517625232,0.9310187082924336,1.0,4/12,9.34%,RAPGEF3;DDX3X;CAMK1;SIRT1
prerank,mitochondrion localization (GO:0051646),0.4642180775933473,1.0771691134944135,0.3689839572192513,0.9300317884973067,1.0,8/19,18.19%,TRAK1;LRRK2;MEF2A;MFN2;BRAT1;MSTO1;TRAK2;MFN1
prerank,embryonic organ development (GO:0048568),0.3654158951482245,1.0769509351266413,0.34775888717156106,0.9295872557130852,1.0,14/61,10.08%,KIT;KMT2A;FGFR2;GLI2;BMPR1A;GLI3;TEAD3;COL13A1;TGFBR2;RBP4;IFT122;GDNF;TEAD2;FLT3LG
prerank,second-messenger-mediated signaling (GO:0019932),-0.2994265493752613,-1.0769066735699402,0.2948328267477204,0.6565689818921983,1.0,28/82,20.28%,MCTP1;PLCE1;CHRM3;NOS3;RYR2;NDNF;GUCY1B1;KSR2;APOE;GUCY1A1;PLCG2;ACKR3;PPP2R1A;AGTR1;CAMKK2;P2RY12;EDN1;EDN3;NOS1;EDNRB;HRH1;EIF2AK3;CX3CR1;BTK;MCTP2;RCAN3;AGT;PPP1R9A
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.475005269360734,1.0766226653910067,0.3850267379679144,0.9295215891358576,1.0,2/15,1.51%,FGF1;SMOC2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4641749518460477,1.0763232832738991,0.375,0.9293230898651763,1.0,7/17,17.73%,PRKN;YJU2;RNF34;SIRT1;DYRK1A;SNAI1;KDM1A
prerank,positive regulation of protein transport (GO:0051222),0.3616529148613391,1.076253110512927,0.3653250773993808,0.9284563634625329,1.0,9/67,9.14%,BMP6;FRMD4A;IGF1;MYO18A;EZR;RUFY3;BCAS3;DNM1L;GOLPH3L
prerank,smoothened signaling pathway (GO:0007224),0.41388389666138997,1.0761106139673027,0.34717607973421927,0.927761776460295,1.0,12/32,18.83%,CC2D2A;GLI2;GLI3;SMO;GLI1;DHH;TMEM231;STK36;EVC2;TMEM17;TCTN3;IHH
prerank,calcium ion import (GO:0070509),-0.3640768376916826,-1.0755513939466483,0.3325581395348837,0.6591971146193307,1.0,10/28,12.96%,SLC8A1;CACNB2;CACNA1E;CACNA1G;TRPC4;MICU3;CACNA1B;TRPV4;SMDT1;MCUB
prerank,covalent chromatin modification (GO:0016569),0.4763506493866132,1.0754983537995282,0.37057728119180633,0.9286035428478602,1.0,4/14,12.65%,SIRT1;HDAC1;AURKB;HLCS
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.46218049661669935,1.0751519465240278,0.399624765478424,0.9285756214560625,1.0,4/20,3.86%,ACTN2;OSR1;ADRA2A;NEDD4
prerank,regulation of smooth muscle cell migration (GO:0014910),0.46580389902659114,1.0747039225527306,0.38461538461538464,0.9288878868625247,1.0,8/20,11.27%,ACE;IGF1;BMPR1A;PDGFRB;SERPINE1;IGFBP3;LRP1;TRIB1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.45205367825707166,-1.074493028419004,0.3952991452991453,0.6610473825387972,1.0,10/13,40.70%,HSP90AB1;STX3;TYROBP;GPD1L;RANGRF;TMEM35A;TM9SF4;ABCA7;MAP1A;TNF
prerank,apical protein localization (GO:0045176),0.5265617467224146,1.073826076688189,0.4046242774566474,0.930414969307637,1.0,3/10,2.25%,CELSR1;SHROOM2;SHROOM3
prerank,cardiac muscle cell development (GO:0055013),-0.40245226882995994,-1.0737860561896133,0.3622222222222222,0.6620697946169393,1.0,5/20,9.58%,SORBS2;SLC8A1;FHOD3;HEY2;MYH11
prerank,regulation of autophagosome maturation (GO:1901096),0.5029948244268448,1.0735390580702475,0.40150093808630394,0.9301178473752868,1.0,4/13,16.17%,FYCO1;UVRAG;IRGM;TBC1D25
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.44339665264715045,1.073288865485199,0.3734290843806104,0.9297538612044933,1.0,4/21,6.74%,SLC8A3;MCU;SLC25A23;MICU1
prerank,regulation of adaptive immune response (GO:0002819),-0.4201971003684911,-1.0732779518368958,0.3624733475479744,0.6625622415803669,1.0,6/18,21.18%,ADCY7;IL6ST;TRIM27;SAMSN1;SKAP1;PYCARD
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.483423807128132,1.0729959724971265,0.39344262295081966,0.9295380601038438,1.0,3/15,8.74%,FGF1;FUT1;PDPK1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3241247929818761,-1.0729651728961924,0.3092485549132948,0.6625510176476561,1.0,21/53,34.29%,PSMB2;PSMD14;PSMC6;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;BCKDK;PSMA2;PSMB3;PSMB5;OAZ1;PSMA7;OAZ2;ODC1;PSMF1;PSMD7;PSMA5;PSMD4;PSME4
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3255635877240291,1.072757865780325,0.3196286472148541,0.9292048093198817,1.0,10/142,5.34%,ATP1A2;ADCY5;SMAD3;LPAR1;CCR9;ACKR2;LPAR2;BDKRB2;CACNA1C;F2
prerank,isotype switching (GO:0045190),0.5139378834345396,1.072356711812966,0.38878143133462284,0.9293189159627041,1.0,6/10,31.16%,RNF8;EXOSC3;LIG4;HSPD1;BATF;MSH6
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3703833075341292,-1.071854635980387,0.3355855855855856,0.6645415132662009,1.0,7/29,13.89%,BMP5;DAB2IP;IL17RD;SMAD7;ADIPOR1;SPRY1;SPRED1
prerank,response to glucocorticoid (GO:0051384),-0.3768018024856393,-1.0718375667795672,0.3747016706443914,0.6638204997267023,1.0,5/26,21.10%,SLIT2;ANXA1;FAM107A;BCL2L11;SLIT3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3975853566122335,1.0716109174482449,0.3605220228384992,0.9304672105489828,1.0,7/38,12.05%,LEPROT;PRKN;LRRK2;FZD5;HUWE1;NPEPPS;CSNK2A2
prerank,regulation of GTPase activity (GO:0043087),0.31508367195641135,1.071186365046507,0.33548387096774196,0.9306668987750754,1.0,18/177,4.59%,CPEB2;DOCK11;AFDN;PKP4;PICALM;SIPA1L1;PLXNA2;EPHA4;SRGAP2;FGD4;ARHGAP9;ALS2;NGEF;RGS16;ASAP3;LRRK2;GMIP;RAPGEF3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4511282693227358,1.0710657241272437,0.3892857142857143,0.9299268804600191,1.0,4/20,6.74%,SLC8A3;MCU;SLC25A23;MICU1
prerank,dephosphorylation (GO:0016311),-0.27558779755016527,-1.0710053400370434,0.30962343096234307,0.6651238134259932,1.0,29/147,11.00%,PTPRB;PTPRM;PTPRD;PTPRJ;PTPRG;PTPN12;PPM1H;PTPRK;PTPRT;PPM1L;PLPP1;PTPRN2;PLPPR1;PPP1R12A;PPP2R5A;PTPRC;PTPRF;ALPL;MTMR6;PPP2R1A;PTPRZ1;PPP3CA;PTPRE;MTMR2;PLPPR5;PLPPR4;DUSP1;MTMR7;DUSP3
prerank,regulation of bone mineralization (GO:0030500),0.3818839563781202,1.0710029711902793,0.38207547169811323,0.9290433910404992,1.0,9/55,7.62%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A;SRGN;ANO6;BCOR
prerank,regulation of activated T cell proliferation (GO:0046006),0.42278321566529786,1.070897216768108,0.39273356401384085,0.9283036264716028,1.0,7/30,18.04%,IGF1;IL18;IL12B;CD274;PRKAR1A;IGFBP2;AGER
prerank,glycolipid biosynthetic process (GO:0009247),0.39787989990065015,1.0708486589258792,0.3803786574870912,0.9273928662423451,1.0,6/38,6.36%,GBGT1;LARGE1;PIGN;ST3GAL5;PIGW;PIGQ
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.33652930519018964,-1.0708335398819775,0.3125,0.6648078571039019,1.0,12/44,16.20%,GSN;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;BIN1;PFN2;ARPC4;CDC42EP2;NCK1;ARF6
prerank,negative regulation of apoptotic process (GO:0043066),0.2964915993571043,1.0705994862151405,0.3047404063205418,0.9270740877275949,1.0,54/444,9.72%,NOTCH2;DAB2;SH3RF2;OSR1;FHL2;PPARGC1A;IGF1;PRKAA2;PRKN;SLC30A10;RETREG1;FNIP1;PKHD1;GRK5;SPHK1;ALOX12;SON;SNX6;CPEB4;RNF213;NUPR1;CFLAR;PHIP;CASP3;PDPN;IFIT3;BID;TNFAIP8;ZFAND6;BABAM2;MYO18A;SMAD6;CTSH;DDX3X;CD27;MAP2K5;SOD2;AVEN;BRAF;CD28;NUAK2;TP53;OPA1;COMP;ANXA5;KDM2B;PIK3CA;GDNF;NIBAN2;SIRT1;TLE1;RIPK2;HDAC1;RIPK1
prerank,regulation of fibrinolysis (GO:0051917),0.4838026897907922,1.0699632182021774,0.38669064748201437,0.9279777849539478,1.0,4/13,8.46%,F11;F2;SERPINE1;HRG
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.356032668138851,-1.0698897439411947,0.3237597911227154,0.6663939326759069,1.0,13/33,20.04%,PIK3R1;NYAP2;PIK3C2B;PLEKHA1;HTR2A;ERBB2;EDN1;MYO16;PIK3C2A;PIK3R5;TYRO3;SIRT2;IRS1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.44418780691067616,1.069187078961144,0.3852596314907873,0.9292413850146415,1.0,2/22,3.34%,ROCK2;PPP4R4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.32728628379208646,-1.0685237060094894,0.3287292817679558,0.6690473488203782,1.0,21/50,25.39%,THBS1;GAS6;NGF;YWHAE;SIAH2;CD44;ARL6IP1;RPS6KA3;SNCA;VEGFA;RPS6KA1;CARD16;MT3;PAX2;GPX1;DHCR24;RFFL;TRIAP1;HGF;PLAUR;KLF4
prerank,postsynaptic membrane organization (GO:0001941),-0.4150673415962557,-1.0670730082994613,0.36036036036036034,0.6717735091366107,1.0,5/17,6.19%,NLGN1;NRXN1;SHANK3;GPHN;APOE
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.47199649943628236,-1.0670176905416078,0.39832285115303984,0.6711509279196917,1.0,6/10,26.52%,KDR;IL33;NAMPT;NOD2;JAK2;CCL2
prerank,response to insulin (GO:0032868),0.3565037363251032,1.066974704564563,0.3442857142857143,0.9347522092773188,1.0,20/80,17.04%,CPEB2;SORBS1;RHOQ;INSIG2;SLC27A1;GCK;PDPK1;SIRT1;FER;RAB13;PRKDC;PRKCI;DENND4C;OGT;TSC1;KAT2B;ZFP36L1;GOT1;RAB8B;C2CD5
prerank,apoptotic mitochondrial changes (GO:0008637),0.413210087668582,1.0669459158584542,0.37954939341421146,0.9337871976432249,1.0,6/32,10.52%,HK2;IFIT2;BID;SOD2;DNM1L;NDUFS1
prerank,negative regulation of dephosphorylation (GO:0035305),0.46203213119758846,1.0666982638372209,0.3867403314917127,0.9334252718202956,1.0,2/18,6.80%,SH3RF2;SH2D4A
prerank,endochondral bone morphogenesis (GO:0060350),-0.4602550650178731,-1.066530856286465,0.37423312883435583,0.671560776424841,1.0,7/11,15.48%,MEF2C;BMPR2;TRPV4;BMP4;BMPR1B;FGFR3;TMEM119
prerank,serine family amino acid biosynthetic process (GO:0009070),0.4878656692278534,1.066516869958581,0.3950850661625709,0.9328762781717824,1.0,5/12,21.91%,SRR;CTH;PHGDH;MTHFD1;CBS
prerank,glycoprotein metabolic process (GO:0009100),0.3738174715342658,1.0665038940398461,0.3611532625189681,0.9318538147325076,1.0,14/53,13.89%,MAN1A2;MAN1C1;LARGE1;NGLY1;NEU2;ADAMTS9;FUT8;ST6GALNAC6;MANBA;GAL3ST4;CNMD;MAN2A1;GANC;PRKCSH
prerank,negative regulation of defense response (GO:0031348),0.35604206764718005,1.066489863342855,0.3342776203966006,0.930823771570015,1.0,13/77,14.42%,RORA;C1QTNF3;PPARA;PCBP2;METRNL;GPS2;ENPP3;CDH5;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,acyl-CoA metabolic process (GO:0006637),0.40248081061263175,1.0664757026331606,0.3927958833619211,0.9298015956602329,1.0,9/35,17.08%,SUCLG2;OGDH;HMGCS2;ACOT11;MLYCD;ACOT8;SUCLA2;THEM4;ACOT12
prerank,response to axon injury (GO:0048678),-0.4136523036680001,-1.0660638796198973,0.37188208616780044,0.6720047397489519,1.0,6/18,22.09%,APOD;GAP43;P2RY12;RTN4RL1;TYROBP;SOD1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4552335872543048,1.0658258222894867,0.40398550724637683,0.9307544795001929,1.0,5/18,15.34%,NXF2;PABPN1;POLDIP3;NXF1;SARNP
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2875210429298123,-1.0654348171789272,0.3076923076923077,0.6727676312722617,1.0,36/96,22.09%,GRID2;MEF2C;TGFB2;PTK2B;TRIM2;NDNF;NGF;NTRK2;APOE;TGFB3;EPHA7;PTPRZ1;SIX1;FOXQ1;TOX3;PPT1;KCNB1;RASA1;ATF4;CTNNB1;UNC5B;PINK1;CDK5R1;MT3;BDNF;EGLN2;FAIM2;TYRO3;CRLF1;VSTM2L;SIX4;EGLN3;AKT1S1;GRM4;MDK;SOD1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.44005602844129826,-1.0653171168365274,0.41745283018867924,0.6722818248680853,1.0,7/14,36.66%,ENTPD1;ENTPD2;ENTPD3;NUDT9;NUDT16;NUDT15;ENTPD5
prerank,leukotriene biosynthetic process (GO:0019370),-0.42791655316436983,-1.0653027012348983,0.40582959641255606,0.6715525968804745,1.0,6/14,33.07%,PLA2G4A;GGT7;LTA4H;ALOX5AP;MGST2;GGT1
prerank,double-strand break repair (GO:0006302),0.3211577034538945,1.0652965036844722,0.3286082474226804,0.9312590005729159,1.0,37/158,20.38%,EYA1;PAXX;POLM;BABAM2;DNTT;ATM;NHEJ1;BAZ1B;RNF8;SAMHD1;FBH1;KDM2A;XRCC4;PARP9;IFFO1;EME2;RBBP8;PRKDC;HUS1;UIMC1;RAD50;NSMCE2;BABAM1;ZFYVE26;TDP2;POLL;NBN;SUMO1;FEN1;RAD51D;PIAS4;SLX4;APTX;MTA1;XRCC3;LIG4;MCM9
prerank,cilium organization (GO:0044782),0.3129864752323537,1.0652961346522671,0.33664596273291925,0.9301970172447028,1.0,59/210,19.22%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;CPLANE2;RILPL1;RAB3IP;CYS1;RHO;PTPN23;ASAP1;EXOC2;CCDC28B;SSTR3;CEP162;CDC14A;IFT122;WDR19;CATIP;DYNC2I1;MKKS;TMEM231;CLUAP1;CDC14B;CENPJ;ATP6V1D;IFT88;OCRL;GALNT11;PDE6D;TTC17;ROPN1;UNC119B;WDPCP;CFAP410;WDR35;EXOC4;EXOC3;PARVA;B9D2;ARL6;RP2;BBS2;STK36;RFX2;RAB8B;RILPL2;PIBF1;TMEM237;TRAPPC14;ATP6V0D1;TMEM17;TCTN3;PCM1;CEP164;OFD1;PCNT
prerank,glycogen catabolic process (GO:0005980),0.47383942973612064,1.0649240424544058,0.41697416974169743,0.9302481808841874,1.0,3/15,8.85%,PYGM;PHKB;PHKG1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.41019006623657783,1.0648321838984065,0.3722871452420701,0.9294460499135795,1.0,5/31,5.17%,TGFBR3;FGFR2;BMPR1A;TGFBR1;TPM1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.280863523315374,-1.0647284247583795,0.33948339483394835,0.6721184771979806,1.0,37/116,23.54%,CALCRL;ADCY2;ADCY7;MYH9;GNG2;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;HTR7;PTH1R;CYSLTR1;PRKAR1B;CYSLTR2;PRKAR2B;HTR4;PTHLH;RAMP1;IAPP;GNB1;VIPR2;SYK;GPR45;ADCY3;ADCY8;PRKAR2A;GPR176;HRH2;ADCYAP1R1;YES1;MC5R;NPSR1;FYN;LHCGR;RHBDF2
prerank,cell differentiation in spinal cord (GO:0021515),-0.477911099318831,-1.0644561027322073,0.37916666666666665,0.6720521050864164,1.0,1/10,0.35%,MDGA2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.480001131050664,1.0639761228833222,0.3897338403041825,0.9310601494611906,1.0,2/15,3.64%,SH3D19;ADRA2A
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4189872721539535,1.0636785453342923,0.3625632377740304,0.9308763129806731,1.0,3/29,5.17%,TGFBR3;FGFR2;TPM1
prerank,acylglycerol catabolic process (GO:0046464),-0.35768229009003505,-1.0634799105060926,0.369620253164557,0.673630530640018,1.0,5/30,13.92%,ABHD2;MGLL;LIPE;FABP5;PNPLA3
prerank,cartilage development (GO:0051216),0.3797039799855153,1.0632664381382932,0.3837753510140406,0.9310159756717843,1.0,6/49,4.63%,WNT5B;OSR1;SOX5;NFIB;SULF2;CREB3L2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3196902289562168,-1.0631217734491953,0.3512064343163539,0.6738084103595683,1.0,4/48,3.07%,PDE4D;PDE4B;IL1R1;SLC7A5
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3687756280408728,1.0623129164297838,0.3856920684292379,0.9328245023297997,1.0,7/54,8.05%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6;PXYLP1;CLN6
prerank,zinc ion transport (GO:0006829),0.4408106536618696,1.062138915394911,0.39824561403508774,0.932314764206261,1.0,3/21,8.10%,SLC30A10;SLC30A2;SLC39A13
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3741138452810986,-1.061352478574713,0.3793103448275862,0.6774018696437862,1.0,8/26,12.67%,NOS3;ACER3;ACER2;CYP1B1;SPTLC2;GCH1;ASAH2;NOS1
prerank,peroxisome organization (GO:0007031),0.42627800635479673,1.061316313662856,0.3953900709219858,0.9337489696464035,1.0,8/25,17.16%,PEX11A;PEX11B;DNM1L;PEX10;ACOT8;PEX14;PEX19;PEX16
prerank,regulation of establishment of cell polarity (GO:2000114),0.4594147459669386,1.0610456634842185,0.40535714285714286,0.9335663932533347,1.0,6/16,12.82%,ROCK2;RUFY3;BCAS3;CDH5;CYRIB;KRIT1
prerank,nucleic acid metabolic process (GO:0090304),0.35762270972552535,1.0609527963609338,0.3692077727952167,0.9328133438265669,1.0,21/69,20.42%,POLR2A;PCBP2;DNTT;HNRNPR;POLG;HNRNPH1;DNASE1L1;HNRNPA2B1;POLR2D;ATXN2;GTF2F1;HNRNPL;RAD50;WTAP;HNRNPC;HNRNPM;DNASE1L2;FEN1;MMS19;DXO;POLR2G
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5138579603916474,1.0606536262107014,0.4157303370786517,0.9326322339257258,1.0,2/10,12.40%,TLR4;MIA3
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3461341793702075,-1.0606336737344306,0.3480392156862745,0.6784029797262419,1.0,7/36,12.89%,NRP1;SHANK3;ITGB1;RELN;EPHB2;EDN1;HIF1A
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.40176344486663373,1.0604993112220218,0.380718954248366,0.9320281224956315,1.0,6/34,12.70%,IGF1;PHIP;CD28;PDGFRB;TGFA;NSMCE2
prerank,negative regulation of programmed cell death (GO:0043069),0.2953125094252431,1.0602082375740285,0.3344748858447489,0.9318483033047258,1.0,41/355,9.72%,NOTCH2;DAB2;SH3RF2;OSR1;FHL2;IGF1;PRKAA2;PKHD1;KANK2;GRK5;SPHK1;SON;NUPR1;CFLAR;PHIP;CASP3;PDPN;IFIT3;BID;TNFAIP8;ZFAND6;BABAM2;MYO18A;SMAD6;CTSH;DDX3X;CD27;AVEN;BRAF;CD28;NUAK2;TP53;OPA1;COMP;ANXA5;GDNF;NIBAN2;SIRT1;RIPK2;HDAC1;RIPK1
prerank,positive regulation of secretion (GO:0051047),0.5022035658065163,1.0601919904900783,0.408,0.9308509836748101,1.0,1/11,1.93%,NPR1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4768674688295623,1.0601380766941646,0.4048964218455744,0.9299735401286316,1.0,4/15,13.25%,TLR4;DDX3X;EIF2AK2;DHX33
prerank,carbohydrate biosynthetic process (GO:0016051),-0.38804289381899576,-1.059810904175817,0.38926174496644295,0.6796958047258378,1.0,7/21,12.19%,ST3GAL4;FUT9;ST6GALNAC5;B3GALT1;ST3GAL6;ST8SIA6;B3GALT5
prerank,actin filament network formation (GO:0051639),-0.46411986054871535,-1.0598038452405247,0.4,0.6789468859042317,1.0,4/11,6.11%,ACTN1;CARMIL1;FHOD3;PLS1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.4545685597085178,1.059755568432649,0.39377289377289376,0.9300391863839677,1.0,1/17,0.83%,LPGAT1
prerank,plasma membrane repair (GO:0001778),0.4801910946190501,1.0594508903418092,0.3707865168539326,0.9298204037166938,1.0,3/13,6.79%,SYT11;MYOF;FER1L5
prerank,cell differentiation in hindbrain (GO:0021533),-0.4566484581264968,-1.059375425883003,0.3817427385892116,0.6792560731195716,1.0,2/11,8.60%,GRID2;PROX1
prerank,negative regulation of phosphorylation (GO:0042326),0.3465089828319191,1.0591455248244435,0.36182336182336183,0.9297021432370626,1.0,17/85,11.45%,BMP7;PTPN13;FBLN1;PPARA;PRKN;NUPR1;LRRK2;NPRL2;WWTR1;PTEN;IGFBP3;CDK5RAP3;HDAC4;SIRT1;CRKL;PRKDC;IMPACT
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5164846800719566,1.058999979169293,0.436399217221135,0.9290695002971564,1.0,2/10,7.33%,FGFR2;TGFBR2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3746376656987753,1.058954431935434,0.3693972179289026,0.9281624519843797,1.0,13/50,13.39%,SASH1;SPHK1;NFAT5;TLR3;TLR4;DDX3X;CD27;IL12B;EIF2AK2;TRIP6;NMI;NR3C2;IFI35
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3426805545185013,1.0580377686211102,0.3743169398907104,0.9298324264659832,1.0,24/102,17.04%,CPEB2;ADCY5;SORBS1;RHOQ;ADCY1;SLC30A10;INSIG2;ADCY9;GCK;PDPK1;FER;RAB13;PRKDC;PRKCI;PRKAR1A;ADCY6;DENND4C;KAT2B;NFKB1;ZFP36L1;GOT1;RAB8B;PRKACB;C2CD5
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.38671698688747547,-1.057990345743955,0.36507936507936506,0.6818084039436847,1.0,5/23,18.32%,PLA2G4A;MBOAT1;PLA2G12A;ABHD4;PLA2G4E
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4594255125286745,-1.0578160484687857,0.3927038626609442,0.6814867230870219,1.0,2/11,6.61%,CDH13;PLCG2
prerank,lipoprotein transport (GO:0042953),0.5049909575159608,1.057809716259866,0.40681362725450904,0.9294919467959862,1.0,4/10,13.02%,PRKCB;LRP1;MIA3;UNC119B
prerank,histone H3 deacetylation (GO:0070932),0.47266200453417395,1.0575100230993733,0.3958333333333333,0.9293757790464741,1.0,5/15,14.08%,HDAC8;HDAC4;SIRT1;HDAC1;PER2
prerank,negative regulation of defense response to virus (GO:0050687),0.504060994666035,1.0574154754622627,0.394990366088632,0.9286273470091962,1.0,2/10,14.42%,PCBP2;PPM1B
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3623580210709365,-1.0572590179400347,0.36619718309859156,0.6821984150197007,1.0,8/30,8.51%,CSGALNACT1;DCN;CHSY3;NDNF;BGN;CSPG4;VCAN;HEXB
prerank,cellular response to cytokine stimulus (GO:0071345),-0.24093113376696684,-1.0569892117237434,0.22321428571428573,0.6820704971665283,1.0,79/416,13.06%,PID1;LEF1;LRCH1;GHR;IL1RAPL1;PTPRJ;PIK3R1;IL1R1;GREM2;OSMR;AKAP6;PTPN12;LIFR;IL1RAP;FN1;PTPRT;CXCL12;VCAM1;STAT3;INPP5D;SLC12A2;MAOA;GAS6;PTGIS;F3;IL6ST;ARHGEF2;GSK3B;ANXA1;RO60;DAB2IP;STX3;ICAM1;RPS3;AQP4;SOCS2;HSPA8;FOXO1;ITGB1;TNFRSF1B;CRK;SYNCRIP;PTPRZ1;MME;ST3GAL6;TGFB1;TNFRSF21;PTGS2;IRAK3;EGR1;S1PR1;STAT5B;DOCK8;PNPT1;TEC;IFNGR2;FGF2;JAK1;PDE2A;CD47;GBP4;ERBIN;HSP90AA1;MT1X;IL4R;DUSP1;GPER1;ASAH2;SBNO2;DAPK1;YBX3;IKBKB;TWIST1;VIM;CDKN1A;CNTFR;AIM2;HIF1A;LRP8
prerank,ethanol metabolic process (GO:0006067),0.4952597786926207,1.0568700687659733,0.423828125,0.9292381363905394,1.0,2/12,7.88%,ALDH1A1;ALDH2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4389367192658878,1.056017677276391,0.37992831541218636,0.9307057666733619,1.0,4/20,9.32%,PRKCZ;IL18;FZD5;RSAD2
prerank,negative regulation of endocytosis (GO:0045806),0.4326321981382422,1.0560129563952698,0.41736227045075125,0.9296889284663674,1.0,3/24,2.79%,SYT11;PICALM;CD300A
prerank,regulation of protein processing (GO:0070613),-0.3883390832857646,-1.0558955504061287,0.376940133037694,0.6839703304900356,1.0,5/21,10.91%,SERPINE2;CCBE1;RUNX1;NKD2;TMEM59
prerank,negative regulation of macrophage activation (GO:0043031),-0.4179342896196374,-1.0558003357249814,0.41739130434782606,0.6834096196853353,1.0,4/16,6.74%,CD200;LRFN5;PTPRC;LDLR
prerank,collagen fibril organization (GO:0030199),0.3409380118322154,1.0556292676899797,0.3788732394366197,0.9297923121538886,1.0,16/88,8.64%,COL5A1;COL22A1;COL26A1;LAMC2;COL4A5;COL18A1;COL4A3;LOXL1;ADAMTS2;TGFBR1;LOXL3;COL9A2;COL13A1;COL4A4;COL1A2;COL27A1
prerank,UV protection (GO:0009650),-0.47035851152850877,-1.0555547925873372,0.40784313725490196,0.683294971187815,1.0,5/10,20.22%,MFAP4;SDF4;GPX1;CAT;ERCC2
prerank,positive regulation of cell cycle process (GO:0090068),0.33718459321916955,1.0554587039951777,0.35260115606936415,0.9292271252900078,1.0,20/91,20.39%,PKP4;IGF1;PHIP;ATRX;CD28;PDGFRB;CDC14A;PLSCR1;AURKB;CDC14B;CDC42;TGFA;CENPV;DYNC1LI1;PKN2;FEN1;BTC;CEP120;XRCC3;CEP295
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.350045347715164,-1.0552310801778724,0.37894736842105264,0.6833873719130772,1.0,12/34,14.68%,TEK;PIK3R1;PTK2B;DAB2IP;TGFB1;PTK2;TNFAIP8L3;FGF2;P2RY12;PIK3IP1;PRKD1;FGFR3
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.46420674205451,1.0550007364415328,0.4068441064638783,0.9296237297632689,1.0,5/16,19.01%,TOP2B;FANCM;EME2;MSH4;SLX4
prerank,brain morphogenesis (GO:0048854),-0.44649576575905886,-1.0549530534004268,0.4094650205761317,0.683301332930835,1.0,2/12,1.42%,CTNNA2;SHANK3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.3004437370790288,-1.0549322865777386,0.3522012578616352,0.6825776279952914,1.0,24/69,21.18%,PTPRJ;THBS1;STAT3;ARHGEF2;IL33;PTPRC;APP;PLCG2;PSEN1;EPHB2;CYBA;TIRAP;HAVCR2;TWIST1;CLU;LBP;DHX9;NOD2;SYK;HSPB1;TYROBP;CCL19;LGALS9;PYCARD
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.41137689627842716,1.0547072735033065,0.40316901408450706,0.9294893576785641,1.0,3/30,5.53%,ACSL1;HACD4;HACD1
prerank,serine family amino acid catabolic process (GO:0009071),0.5032626871453564,1.0546542011385787,0.40555555555555556,0.9286351368103289,1.0,4/10,21.91%,DLD;THNSL2;AMT;CBS
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3498398849345139,1.054389468593384,0.38226744186046513,0.9283667404018237,1.0,8/78,3.91%,DAB2;SORBS1;PICALM;RHOQ;DLG1;PTPN9;ARHGEF16;PPFIA1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3269284638287089,-1.0543221582511348,0.34794520547945207,0.6832664460800905,1.0,11/47,11.60%,STXBP6;SPTBN1;ANK3;EXOC6;RAB31;VAMP4;PREPL;GOPC;NSF;GCC2;GOLGA7
prerank,alcohol catabolic process (GO:0046164),0.5125948394982118,1.0541618399778108,0.4244306418219462,0.9280260209645242,1.0,2/10,3.73%,CYP27A1;CEL
prerank,negative regulation of autophagy (GO:0010507),0.37168510654290426,1.0540477322032809,0.37577639751552794,0.9273356073005874,1.0,16/54,18.89%,LEPR;NUPR1;SNRNP70;LRRK2;SMG1;PTPN22;PIK3CA;TAB2;ATG7;TSC1;ZKSCAN3;TLK2;MCL1;TBC1D14;EIF4G1;GOLGA2
prerank,protein kinase A signaling (GO:0010737),0.4823431201662424,1.0533759383427321,0.4225352112676056,0.9282641442799555,1.0,5/12,17.03%,TCP11X2;EZR;RAB13;TCP11;PRKACB
prerank,epidermal cell differentiation (GO:0009913),-0.34600165423578594,-1.0533125448646186,0.38016528925619836,0.6850301444808184,1.0,11/41,21.91%,CLIC4;JAG1;UGCG;ANXA1;TXNIP;SCEL;CTNNB1;WNT16;GATA6;ERCC2;ASAH1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.48636573621618395,1.0532557609131996,0.40227703984819735,0.9275655030787656,1.0,4/12,7.77%,CD300A;ELF1;PTPN22;ELF2
prerank,muscle tissue morphogenesis (GO:0060415),0.46608009388448024,1.0528256508490654,0.4,0.927821579016726,1.0,1/16,0.31%,TGFBR3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.36025190915742555,-1.0528112383274997,0.36674259681093396,0.6855008337901395,1.0,9/30,17.31%,CXCL12;TPT1;RPS3;ACKR3;CD44;TWIST1;THOC5;CLU;CD74
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5052685545915423,1.052745854098039,0.41682242990654206,0.927003040177184,1.0,3/11,11.47%,DONSON;FBH1;MSH3
prerank,mitochondrial fusion (GO:0008053),0.44898305967348395,1.0527189590081925,0.3992740471869328,0.9260676625888387,1.0,6/18,19.69%,CHCHD3;MIGA2;OPA1;MFN2;MFN1;AFG3L2
prerank,positive regulation of vacuole organization (GO:0044090),-0.46444477026029013,-1.0522426367392428,0.4134419551934827,0.6861066373400303,1.0,7/10,28.79%,PIP4K2A;SH3GLB1;RALB;PIP4K2B;LRSAM1;GRN;RAB3GAP2
prerank,amino acid import across plasma membrane (GO:0089718),-0.3732357122776547,-1.0521004419108648,0.36792452830188677,0.6856875104603848,1.0,8/24,7.84%,SLC6A6;SLC47A1;SLC1A5;SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC1A4
prerank,negative regulation of cyclase activity (GO:0031280),-0.42028923899746357,-1.051987334449645,0.3924050632911392,0.6852119244848092,1.0,5/14,21.60%,GRM3;GABBR2;EDNRB;PALM;DRD2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.31991949970052175,-1.051756339954562,0.3609625668449198,0.6850052978844144,1.0,11/51,6.00%,CNTNAP2;DCLK1;NYAP2;EPB41L3;NGF;TRIO;NRK;SHTN1;DAB2IP;MINK1;PAK1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4217687154290674,1.0516612444173603,0.38980263157894735,0.9280694750912655,1.0,3/26,3.64%,ADCY5;STXBP4;ADRA2A
prerank,androgen receptor signaling pathway (GO:0030521),0.4969665875682777,1.051345383454644,0.4046692607003891,0.9279310737170138,1.0,4/11,11.69%,DDX5;PMEPA1;TMF1;ZMIZ1
prerank,regulation of organelle assembly (GO:1902115),0.3517023276584759,1.0510906226670265,0.3872340425531915,0.927623463184232,1.0,15/73,11.12%,STX18;DCDC2;MTMR3;NPRL3;TBC1D16;EZR;ATG5;NPRL2;RABEP2;ATXN2;TRAPPC12;PIKFYVE;SDCCAG8;CENPJ;IFT88
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3883514552186903,-1.051057144958104,0.4034229828850856,0.6860121364571758,1.0,8/23,14.77%,PDE4B;RYR2;GNG2;KCNQ1;ATP2B4;ATF4;SNCA;GNB1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.46404222928873706,-1.0510296801890333,0.415506958250497,0.6853194813523782,1.0,3/10,20.09%,SACS;SORL1;DNAJB1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4337047379859399,1.0507774110367336,0.40808823529411764,0.927562148749011,1.0,7/21,15.74%,CEL;CYP26B1;LDHD;FAH;ACOT8;ACBD5;NUDT19
prerank,macrophage activation involved in immune response (GO:0002281),-0.4381341913310353,-1.0506905310902221,0.4004424778761062,0.6854165858187654,1.0,7/13,19.59%,PLCG2;DYSF;SBNO2;LBP;CX3CR1;SYK;TYROBP
prerank,organelle fission (GO:0048285),0.43093198123363174,1.0503173038280147,0.3985637342908438,0.9278716187052686,1.0,11/24,17.50%,PRKN;PEX11A;OPA1;PEX11B;MTFR2;DNM1L;ACOT8;DNM2;PEX19;WASHC5;MTFP1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.43115085185523994,-1.0500357493022012,0.3912133891213389,0.686206494032511,1.0,5/13,21.60%,GRM3;GABBR2;EDNRB;PALM;DRD2
prerank,signal transduction in response to DNA damage (GO:0042770),0.3759245005331603,1.0499127938879982,0.3896940418679549,0.928057348599935,1.0,25/49,28.42%,BID;SESN2;ATM;ATRX;TP53;DONSON;ABL1;HUS1;GADD45A;DOT1L;CEP63;CLSPN;INTS7;NBN;MAPK14;RAD9A;CASP9;CDC5L;MAD2L2;NDRG1;TIPRL;USP28;E2F7;CHEK1;GRB2
prerank,regulation of osteoclast differentiation (GO:0045670),0.3982579475863691,1.0497614053753854,0.39429530201342283,0.9274790178580992,1.0,5/33,6.92%,GPR137;TLR3;TLR4;IL12B;FBN1
prerank,pulmonary valve morphogenesis (GO:0003184),0.4617575154609467,1.0497225816432445,0.42526690391459077,0.9265689155176069,1.0,2/17,0.29%,NOTCH2;ROBO1
prerank,regulation of lamellipodium organization (GO:1902743),0.47651626003598807,1.0496754900542868,0.4076086956521739,0.9256909285840015,1.0,6/14,14.15%,CAPZB;PDPN;FER;CDC42;VIL1;CARMIL2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.42904802340304005,1.0494347813640907,0.3986013986013986,0.9253942932663513,1.0,8/24,15.62%,LEPR;PPARGC1A;COQ10A;NDUFS1;COX10;LYRM7;SDHAF4;GFPT1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.45759140920961705,1.0492830982352956,0.39636363636363636,0.9248306667573367,1.0,2/15,2.90%,WNT5B;RNF213
prerank,negative regulation of binding (GO:0051100),0.34362864809351384,1.0490382305991686,0.36588921282798836,0.9245190183486627,1.0,24/81,19.18%,DAB2;ARHGAP28;IFIT1;IFIT2;LRRK2;SMO;CAMK1;GTPBP4;GTF2F1;AURKB;TMC8;WAPL;STYX;DNAJB2;EFHB;PEX14;TFIP11;PEX19;SP100;KDM1A;SUMO1;GOLGA2;USP33;ITGB1BP1
prerank,skeletal muscle contraction (GO:0003009),0.439976265880547,1.0488716250215995,0.40394973070017953,0.9239948109031927,1.0,4/19,13.05%,RCSD1;CCDC78;TNNI3;TNNC1
prerank,regulation of gastrulation (GO:0010470),0.46536360650354414,1.0483215487898592,0.4180790960451977,0.9245791275784584,1.0,5/14,12.31%,OSR1;CLASP1;DAG1;PHLDB2;FOXA2
prerank,glial cell development (GO:0021782),-0.3690584673626215,-1.0483049620713722,0.40046838407494145,0.6896799122688343,1.0,14/25,34.02%,APP;NRROS;EIF2B3;MT3;TPPP;CSPG5;MDK;SOX10;NF1;EIF2B2;PRDM8;EIF2B5;TLR2;MYRF
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4175622784756397,1.0481681056888534,0.3979591836734694,0.9240126010064731,1.0,5/26,9.57%,PPARA;SLC30A10;SLC5A3;TLR4;PIKFYVE
prerank,aorta development (GO:0035904),0.47852579739918394,1.0479414757788268,0.42395437262357416,0.9236577702338745,1.0,4/14,9.35%,ROBO1;ADAMTS9;PDGFRB;LRP1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4455197258658416,1.0477429043935889,0.399624765478424,0.92328720953696,1.0,2/17,4.75%,ATP1A2;CACNA1C
prerank,calcium ion transport (GO:0006816),0.3277174695693688,1.0471824686337134,0.3949930458970793,0.9239037567278442,1.0,12/113,7.30%,TRPM3;CACNA1D;SLC24A3;ANK2;TRPM6;ITPR1;SLC8A3;CACNA1C;MICU1;CACNB3;TRPM5;ANO6
prerank,membrane lipid catabolic process (GO:0046466),-0.4703230467391933,-1.0470785791805373,0.4098671726755218,0.6918951898144363,1.0,4/10,19.10%,CYP1B1;PPT1;ENPP2;SMPDL3B
prerank,aminoglycan biosynthetic process (GO:0006023),0.3704371965081672,1.0469222308834574,0.3952380952380952,0.9236622824129422,1.0,5/49,4.33%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6
prerank,negative regulation of phosphatase activity (GO:0010923),0.42367303958115865,1.0464479977799268,0.41116751269035534,0.9240202725185466,1.0,3/25,6.80%,SH3RF2;PPP4R4;SH2D4A
prerank,regulation of protein export from nucleus (GO:0046825),0.4304501983004673,1.0461678718522147,0.4054982817869416,0.9238889990297627,1.0,6/23,9.99%,PTPN14;IFI27;RAPGEF3;CAMK1;TP53;TCF7L2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2745916100260648,-1.0461393137830712,0.3293172690763052,0.6935135415935771,1.0,24/121,10.80%,NRP1;GHR;PTPRJ;GRM5;ERBB4;PECAM1;EFNA5;STAT3;PTK2B;GAS6;IL6ST;ARHGEF2;LYN;PTPRC;HES1;PLCG2;CSPG4;SEMA4D;RELN;TGFB1;TEC;CD44;ITGB3;ENPP2
prerank,negative regulation of cell junction assembly (GO:1901889),0.4194436117501743,1.0460348402839519,0.4128113879003559,0.9232823287392161,1.0,6/25,9.70%,ROCK2;ACE;ARHGAP6;BCAS3;PTEN;PHLDB2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.31891286713582495,-1.046016853710982,0.3716012084592145,0.6930247864839123,1.0,17/53,16.88%,HSP90AB1;DAB2IP;APOE;XPO1;DDRGK1;PSMD14;GNA12;PSMC6;PKD1;RAD23B;FOXF2;ECSCR;PINK1;UBB;GPX1;USP14;GABARAPL2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.34662734465754985,1.045400054057851,0.3830104321907601,0.924095292470253,1.0,11/74,7.92%,DAB2;SMAD3;TGFBR1;CLASP1;FOXC1;PDPN;DAG1;LDLRAD4;WWTR1;TGFBR2;PTEN
prerank,regulation of interleukin-13 production (GO:0032656),0.48235089690572236,1.0453990607103654,0.43830570902394106,0.9231142583400894,1.0,2/13,2.00%,PRKCZ;IL18
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.41644266951701014,-1.0452136029839283,0.4170403587443946,0.6942236612450977,1.0,9/16,19.06%,THBS1;PPP1R16B;GATA2;AGTR1;FGF2;JCAD;VEGFA;APLNR;DLL4
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.35569416691633476,-1.0442575096631828,0.38929440389294406,0.6958167887538143,1.0,10/30,22.49%,DACH1;BMPR2;ACVRL1;GNL3L;CDKN1A;TERF1;STN1;MEN1;DCP2;EXOSC10
prerank,neural crest cell differentiation (GO:0014033),-0.40626823827610403,-1.0441591698946542,0.4288939051918736,0.6953063132279721,1.0,2/18,1.17%,MEF2C;CDH2
prerank,mitochondrion transport along microtubule (GO:0047497),-0.42995777429334525,-1.043829491165676,0.4134419551934827,0.6953014929084093,1.0,6/13,23.64%,SYBU;MAPT;HIF1A;UBB;SPAST;NEFL
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.49537703543004874,1.043791401180153,0.4280155642023346,0.9268411448916839,1.0,3/10,16.52%,EMC2;EMC1;EMC3
prerank,regulation of postsynapse organization (GO:0099175),-0.35941790788439415,-1.0428465700110185,0.3669724770642202,0.6969112919185626,1.0,10/28,14.09%,IL1RAPL1;PPFIA2;SHANK3;TANC2;CDKL5;ABI3;HOMER1;ABHD17B;CFL1;CDK5R1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4094580298188464,-1.0425684816890026,0.40461215932914046,0.6968160252198857,1.0,4/16,6.84%,CXCL12;TPT1;RPS3;ACKR3
prerank,lipoprotein localization (GO:0044872),0.4962428133469619,1.0425002658532643,0.4213709677419355,0.9296199507301595,1.0,4/11,13.02%,PRKCB;LRP1;MIA3;UNC119B
prerank,dendritic cell differentiation (GO:0097028),-0.38464865089319294,-1.0424293732998091,0.4080717488789238,0.6963734306997115,1.0,8/22,24.73%,GAS6;LYN;CAMK4;TRPM2;IRF8;CCL19;LGALS9;PRTN3
prerank,regulation of cytoskeleton organization (GO:0051493),0.3255652258914426,1.0422486679689458,0.40607734806629836,0.9292826875979444,1.0,18/108,10.62%,CELSR1;ROCK2;RHOQ;PRKAA2;RHOBTB2;RHOD;ARHGAP18;CLASP1;EZR;ARHGAP17;PDGFRB;BAIAP2;RICTOR;HRG;DIAPH1;LRP1;PHLDB2;ABL1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.34951287792382746,-1.0422209091382206,0.39650872817955113,0.6960938827204007,1.0,10/31,11.23%,DLG2;LRRC7;LIN7A;MTCL1;RAP2A;ERBIN;WDR1;PDCD6IP;MSN;MARK2
prerank,respiratory electron transport chain (GO:0022904),0.4623918890919419,1.041873113883452,0.4028268551236749,0.929390270156052,1.0,4/14,18.94%,PPARGC1A;SLC25A12;SDHB;ETFDH
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.26618504785507263,-1.041646754536358,0.36554621848739494,0.6967393059949516,1.0,56/146,31.20%,FBXL7;YWHAE;RAD51B;PSMB2;DYNLL1;PPP2R1A;YWHAG;PSMD14;TUBA1A;HAUS2;PSMC6;TUBB4A;CDK5RAP2;HSP90AA1;KCNH5;PRKAR2B;HAUS5;PSMA4;PSMB9;CEP78;SKP1;CETN2;PSMD11;PSMB10;TUBA4A;SSNA1;PSMD2;CEP131;PSMA2;DTL;CCP110;HMMR;TPX2;KIF14;MECP2;NEDD1;HAUS4;CEP135;PSMB3;ACTR1A;NDE1;HAUS6;FHL1;CEP76;PSMB5;CCND1;PSMA7;CENPF;CDC7;PSMF1;PSMD7;AURKA;CDK1;CEP43;BRD4;CSNK1D
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.35311310067206625,1.0413505799076748,0.4106060606060606,0.9299188996231569,1.0,12/65,9.34%,SMAD3;PPARA;SNX6;PMEPA1;TGFBR1;SMAD6;LDLRAD4;FBN1;SMURF2;TGFBR2;PDPK1;SIRT1
prerank,regulation of intracellular signal transduction (GO:1902531),0.2872375768794893,1.0410899176929345,0.37,0.9296687921679563,1.0,88/420,15.49%,PRKAG2;FGF1;ARHGAP28;PTPN13;ARHGAP29;RHOQ;PRKAA2;DLG1;ARHGEF18;RHOD;PKHD1;ARHGEF16;SRGAP2;SRGAP3;ARHGAP18;FGD4;SYDE2;ARHGAP9;PRKAG3;NGEF;AKAP13;ARHGAP6;LRRK2;AKAP12;ZFAND6;GMIP;TP53RK;EZR;ARHGAP26;CHD4;PPP1R13L;ATM;WWC2;ARHGAP17;LBH;TP53;RICTOR;ARHGEF11;ARHGEF12;PTPN22;PIP4K2C;ARHGAP23;PTEN;ARHGEF1;PDPK1;RNF34;OPHN1;HDAC1;AURKB;ARAF;RNF41;ARHGAP12;FGD1;OCRL;SOS2;RBBP8;CDC42;HUS1;NOP2;TAF11;RALBP1;ITGAV;CSNK2A2;CSNK2A1;MAPKAP1;BRD7;RAD50;TOP3A;USP7;PPP1R13B;KMT5A;PRKAR1A;TBP;ROS1;PML;TAF4;ULK4;ARHGAP21;FLCN;MOB3B;MAP2K6;SPHK2;AKAP7;CCNG1;STK4;MTA2;TAF7;VAV3
prerank,cellular protein modification process (GO:0006464),0.2773730873577028,1.0400938068388608,0.3473792394655704,0.9315536309084967,1.0,171/983,14.42%,PRKAG2;EPAS1;UST;WNK4;PTPN13;ROCK2;APLP2;UBE2E2;DUSP29;ITIH2;OXSR1;MSRA;PRKCZ;ASB2;SERPIND1;CP;FAM20A;PRKAA2;PTPN14;LAMC1;PTPN9;GRK5;MACROD1;OBSL1;SPP1;LARGE1;SPSB1;MTMR3;PRKAG3;PPEF2;PPP1CB;PPM1E;NGLY1;FGFR1;BMPR1A;LOXL1;TGFBR1;DMPK;IGFBP7;AAK1;PARP10;CEL;LRRK2;TP53RK;NAA80;KRT1;FUT1;DCAF11;PRKCB;PARP14;ST3GAL3;IKBKE;ATG10;LHPP;DAPP1;METAP2;FBXL19;ST3GAL5;ATM;PRRT1;KLHL41;CAMK1;TIPARP;BRAF;ATG5;SPSB4;NUAK2;TRIB2;CDC42BPG;SIK1;EIF2AK2;SIRT5;LGALS1;TRIOBP;FUT10;FBN1;KNG1;PARP4;WIPI1;PTPRU;TGFBR2;PTPN22;FBXW11;RABGGTA;PTEN;IGFBP3;PP2D1;TNKS2;BTRC;RYK;SIRT3;PPP2R1B;MANBA;COQ8B;PDPK1;NUCB1;PTPN21;PARP9;CSNK1A1;RCE1;SIRT1;ASB15;ZC3HAV1;PICK1;CTH;FBXO22;LRRC41;RAB11B;MKNK1;FER;DCAF10;BRSK1;RAB13;FBXL12;ATG7;AURKB;SRPK2;ABL1;PARP6;DYRK1A;MYLK3;UBE2M;ARAF;DUSP10;FBXW8;FBXO4;CDC14B;FNTB;TRIB1;PRKDC;SOCS3;PPP2R5E;PTPN4;WWP2;MAPK6;ASB14;PORCN;CUL4A;CUL9;CSNK2A1;CTDSP2;FBXO10;PRKCA;HIPK3;MIA3;NUB1;MAN2A1;ASB5;SIRT4;HLCS;MAPK10;MAP3K1;FRK;MBTPS1;PRKCI;ART4;WNK1;BMP2K;ASB12;DDB2;MAP2K1;ROS1;COQ8A;GRK3;PRKCSH;FBXO11;SERPINC1;ACVR2B;FBXL20;DUSP2;PPM1B
prerank,cellular response to osmotic stress (GO:0071470),0.4353830588944624,1.0400162744905794,0.41843971631205673,0.9308032658530457,1.0,7/21,15.26%,OXSR1;RCSD1;DDX3X;MYLK;LRRC8E;ZFAND1;ZFP36L1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.27084188583412316,-1.039701478658828,0.3603238866396761,0.7007590396898895,1.0,29/137,10.44%,DOCK9;DOCK10;ITGA6;RGS7;CD200;RGS6;F11R;BCAR3;CDKL5;CAV2;ARHGEF7;NET1;GSK3B;TBC1D30;CALM1;RAP1A;CALM2;RPS3;PSAP;SEMA4D;ITGB1;BMP2;MTCL1;RASGRF1;RAPGEF6;DOCK8;ERBB2;AGRN;CALM3
prerank,autophagy of peroxisome (GO:0030242),0.4893888880557404,1.0395390450542068,0.44402985074626866,0.9311407209794307,1.0,6/12,26.80%,ATM;ACBD5;PEX5;SQSTM1;PIK3C3;TRAPPC8
prerank,regulation of peptidase activity (GO:0052547),-0.39578597893173034,-1.0391154163148884,0.4080717488789238,0.7014827913176417,1.0,5/19,14.97%,CAV1;CST3;ECM1;PINK1;MAPK12
prerank,regulation of interferon-alpha production (GO:0032647),0.42658303244527934,1.0387440047560175,0.4010889292196007,0.9324107286884056,1.0,5/23,9.78%,TLR3;TLR4;DDX3X;RIPK2;MAVS
prerank,MAPK cascade (GO:0000165),-0.24415580109742077,-1.0383267630722302,0.3333333333333333,0.7027360437875073,1.0,82/295,20.08%,DLG2;SPTBN1;MEF2C;KITLG;TEK;ERBB4;PIK3R1;SHANK3;RASAL2;MAP3K5;RASGRP3;LRRC7;GRIN2B;RIT2;RASGRF2;NRG2;NRK;YWHAE;KRAS;MBP;KDR;PSMB2;DAB2IP;YWHAB;MINK1;PAK1;CALM1;IL17RD;MET;MAP3K7;ZDHHC9;TGFB1;PTK2;CUL3;RASGEF1A;PEBP1;RASGRF1;PSMD14;FGF13;FGF2;JAK1;ERBB2;PSMC6;CAMKK2;PDGFA;PRKG2;GOLGA7;RASA1;IKBKB;PTPN3;FGF7;ABHD17B;SPTB;FGF9;RET;SPRED1;MT3;FGFR3;UBB;MAPK12;SCG2;GRIN1;IL31RA;PSMA4;PSMB9;GFRA1;GFRA2;SHOC2;SKP1;IRS2;PSMD11;MEN1;SPTBN2;CAMK2B;PSMB10;PRKCQ;SPTAN1;RASA3;PSMD2;PPP1CC;IRS1;SHC1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4487916029205065,1.0382367218250883,0.42300194931773877,0.9328640885663447,1.0,5/16,12.62%,ANK2;LRRK2;UBAC2;MIA3;TAPT1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3423140595548951,-1.0376241886306703,0.3910761154855643,0.7036984702782513,1.0,13/35,20.36%,HIP1;SGIP1;B2M;SNAP91;PPT1;HNRNPK;CLU;CBL;ARF6;HIP1R;LDLRAP1;VTN;CCL19
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4050524132455375,-1.0376151003222118,0.4144736842105263,0.7029502779538727,1.0,6/17,13.51%,CAV1;KLF7;AJAP1;CEACAM1;APOLD1;MAFF
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4235761329616945,1.0375818058505772,0.42158516020236086,0.9337619454095523,1.0,2/22,1.44%,ROCK2;IGF1
prerank,protein trimerization (GO:0070206),-0.43383411297819574,-1.0375708992932835,0.4476987447698745,0.7015282519868175,1.0,6/14,12.09%,SCARA5;SLC1A5;SLC1A2;DISP1;PNPT1;MLKL
prerank,protein homotrimerization (GO:0070207),-0.43383411297819574,-1.0375708992932835,0.4476987447698745,0.7015282519868175,1.0,6/14,12.09%,SCARA5;SLC1A5;SLC1A2;DISP1;PNPT1;MLKL
prerank,ceramide catabolic process (GO:0046514),-0.4208710693733826,-1.0373155360330375,0.41935483870967744,0.7014097869158752,1.0,4/14,11.77%,ACER3;ACER2;HEXB;ASAH2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.44056179967035547,1.0369705721945168,0.41144901610017887,0.9346236109771384,1.0,3/18,5.53%,ACSL1;ACSBG2;HACD1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.37975364969009556,1.0368961773363912,0.41812400635930047,0.9338435000657733,1.0,7/44,10.35%,ROCK2;TNRC6A;TNRC6B;CPEB3;ZC3HAV1;MOV10;YTHDF3
prerank,cellular response to growth factor stimulus (GO:0071363),0.3153118109184283,1.0368746103809614,0.41743725231175693,0.9329180131159971,1.0,18/151,7.33%,WWOX;BMP6;BMP7;SMAD3;APPL2;WNT4;SPHK1;SOX5;BMPR1A;MAGI2;TGFBR1;FOXC1;GAS1;MAP2K5;FLT1;PLK5;CPNE3;TGFBR2
prerank,Ras protein signal transduction (GO:0007265),0.316970748417494,1.0367169736136166,0.39389920424403185,0.932409883763459,1.0,21/137,10.34%,CELSR1;ARHGAP29;ROCK2;KSR1;IGF1;RHOD;CCNA2;ADRA2A;PDPN;ARHGAP6;RAPGEF3;RREB1;TP53;ARHGEF11;COL1A2;ARHGEF1;EPS8L2;RRAS2;CTNNAL1;PHACTR4;CRKL
prerank,superoxide anion generation (GO:0042554),0.4715028728144785,1.0366072930558754,0.42829827915869984,0.9317098924334075,1.0,3/13,10.41%,ALOX12;NOX1;NOX4
prerank,regulation of axonogenesis (GO:0050770),0.3623449446861665,1.0358985541615127,0.4028892455858748,0.9326906581441954,1.0,6/51,2.17%,ROBO1;LRP4;KIF13B;SIPA1L1;PLXNA2;EPHA4
prerank,actin filament organization (GO:0007015),0.3152963124788597,1.0357891465301636,0.39097744360902253,0.9320289343797695,1.0,28/151,11.39%,NEBL;CGNL1;DLG1;SHROOM2;RHOBTB2;AVIL;FHOD1;RHOD;SHROOM3;INPPL1;TMOD2;MYO5C;MCU;RUFY3;TMOD3;TPM1;BAIAP2L1;ARHGAP17;MPRIP;BAIAP2;TRIOBP;MYO19;WASL;CASS4;ARHGAP12;CDC42;BIN3;VIL1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.41899520260576745,-1.0356983287610746,0.4412470023980815,0.7047223685823255,1.0,9/15,22.93%,SIX1;BMP4;VEGFA;PAX2;SOX8;PAX8;SIX4;AGT;LHX1
prerank,polyol metabolic process (GO:0019751),0.3793233070111781,1.0356190710377917,0.4224683544303797,0.9315619118901066,1.0,10/46,11.18%,ISYNA1;NUDT4;INPPL1;SLC5A3;PLCD3;PTEN;ITPKB;PLCD1;PPIP5K2;OCRL
prerank,regulation of nervous system development (GO:0051960),-0.34290079305600607,-1.0355555373111536,0.4307692307692308,0.7043371878374941,1.0,14/37,24.20%,TENM4;HES1;TNFRSF1B;HEYL;PTPRZ1;PTN;HEY2;CTNNB1;CX3CR1;SIRT2;YTHDF2;LGI4;GBX1;KIF14
prerank,negative regulation of viral process (GO:0048525),0.36059887842777166,1.035378801314389,0.4102167182662539,0.9312949866445357,1.0,13/57,13.65%,IFIT1;OAS2;PARP10;EIF2AK2;PLSCR1;RSAD2;ZC3HAV1;LARP7;MAVS;SRPK2;TRIM62;OAS3;PML
prerank,cellular response to unfolded protein (GO:0034620),-0.37065787407637263,-1.0346185788367404,0.4116222760290557,0.7059487903176824,1.0,9/26,18.41%,DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;TM7SF3;HSPB8;RHBDD1;PTPN1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.41914959003222474,1.0344809589096735,0.415929203539823,0.9328718592970076,1.0,10/25,23.64%,FBXL17;NGLY1;ZYG11B;UFD1;CLPP;ZER1;TOR1A;DERL1;BAG6;RNF5
prerank,ventricular septum morphogenesis (GO:0060412),0.4088585426542167,1.034310119973858,0.40931780366056575,0.9323954308800021,1.0,4/27,3.46%,ROBO1;TGFBR3;BMPR1A;TGFBR1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.46466928459986356,1.0341788972734767,0.44876325088339225,0.9318082691541888,1.0,11/16,31.35%,NAA80;NAA20;KAT2B;NAA16;CREBBP;EP300;AANAT;NAA50;NAA15;NAA60;NAA40
prerank,rRNA transcription (GO:0009303),-0.40999998165321583,-1.0339251231021194,0.4175824175824176,0.7068655036939262,1.0,4/17,12.97%,CAVIN1;SPIN1;GTF3C5;TAF1B
prerank,cellular component disassembly (GO:0022411),-0.3084492649380132,-1.0338693780392252,0.3716012084592145,0.7062482797016859,1.0,12/53,13.31%,TLL1;BSG;GSN;ADAMTS5;TIMP2;ADAM15;MMP16;CD44;CAPN2;CTSL;CTSS;MMP15
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.3383108640449032,-1.0338161394352021,0.40404040404040403,0.7056335084540492,1.0,7/35,4.98%,NRP1;TEK;NTRK3;ESAM;PTK2B;F11R;SEMA3E
prerank,cellular response to organic substance (GO:0071310),0.3252769778366029,1.0336311734739672,0.4139344262295082,0.9323892046788115,1.0,18/116,7.33%,PTPN13;SMAD3;PTPN14;IL18;PTPN9;SPHK1;NFAT5;BMPR1A;TGFBR1;ADRA2A;LRRK2;NCOA3;MAP2K5;PTPN23;TIPARP;PLK5;CPNE3;TGFBR2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4365042158635528,-1.0333443816169507,0.42424242424242425,0.7060775975565193,1.0,10/13,32.95%,PDE8A;MET;TXN;HGF;GPR37L1;NR4A3;PYCR1;PARK7;RACK1;GPR37
prerank,regulation of mRNA processing (GO:0050684),0.3934517925918731,1.033332560721591,0.43094841930116473,0.9322223496602228,1.0,9/32,10.61%,SON;PABPN1;AHCYL1;TIA1;RBM39;SLTM;JMJD6;LARP7;SRPK2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.44145975330571785,1.0325896273969606,0.42678571428571427,0.9333485869743864,1.0,7/18,14.46%,ROCK2;RUFY3;BCAS3;CDH5;CYRIB;KRIT1;LLGL2
prerank,icosanoid metabolic process (GO:0006690),0.372928988439127,1.03247796741988,0.3948220064724919,0.9327181641568244,1.0,6/40,7.72%,PTGS1;ALOX12;EPHX1;DAGLA;PON3;ABCC10
prerank,regulation of leukocyte activation (GO:0002694),-0.4056866442283463,-1.0324516257902336,0.4122448979591837,0.7075399078085255,1.0,5/14,17.31%,CD200;LYN;MFHAS1;GPER1;CD74
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3908627548013962,1.0321210249499828,0.40770465489566615,0.932755914140897,1.0,5/38,4.75%,CACNA1D;ANK2;KCND3;KCNA5;CACNA1C
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2880594671466786,1.032092739021784,0.38181818181818183,0.9318825398481588,1.0,88/336,20.38%,UBE2E2;PAXX;STXBP4;MACROD1;BID;BABAM2;KMT5C;ZBTB38;USP3;SUSD6;IKBKE;ATM;UVRAG;RAD54L;PLK5;BAZ1B;KMT5B;TP53;SETD7;PARP4;NIPBL;RNF8;SAMHD1;TRIP12;FBH1;NUPR2;PDS5A;SIRT1;UBR5;ASH2L;WDR76;BRSK1;ABL1;ATF2;RBBP8;PRKDC;MSH3;ZBTB1;HUS1;DCUN1D5;CBX5;CUL4A;UBA6;IGHMBP2;FANCA;RAD50;SIRT4;PNKP;PHF1;POLE2;MCM7;DDB2;PML;GADD45A;DOT1L;MAP2K6;MGMT;BRAT1;INTS3;CEP63;VAV3;TLK2;MCL1;ZBTB40;MBD4;PIDD1;CRY1;OGG1;TAF1;NBN;SUMO1;FEN1;MAPK14;RAD51D;SLX4;MMS19;YAP1;PDS5B;APTX;USP16;XPA;BCL6;ASF1A;XRCC3;TANK;RAD9A;NCOA6;MCM9
prerank,negative regulation of transport (GO:0051051),0.3664563129312474,1.0320884847400456,0.4169230769230769,0.9309317385151785,1.0,13/51,15.10%,SYT11;PRKN;FER1L5;PLSCR1;PTEN;NRG1;WWP2;ITGAV;SNX12;EPHA3;PIP4P2;CRYAB;LGALS3
prerank,protein lipidation (GO:0006497),0.35394376793526305,1.0317269413938062,0.4169278996865204,0.9309682419565707,1.0,11/59,11.84%,PIGN;ATG10;PIGW;ATG5;PIGQ;WIPI1;GLUL;ATG7;ZDHHC18;ZDHHC1;PORCN
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3636523462799718,-1.031615161413674,0.41687344913151364,0.7088750779081476,1.0,11/25,24.04%,SLIT2;EVL;TBC1D30;LIMK2;ABI3;PFN2;KANK1;ODF2L;ARHGAP44;CCP110;PLXNB3
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.22973821004735867,-1.031197709942962,0.34328358208955223,0.7091036835024758,1.0,117/532,18.87%,GHR;PTPRJ;RPS6KA5;ACTN4;PIK3R1;ADIPOR2;IL1R1;GREM2;OSMR;TMSB4X;CAMK2D;LIFR;MID1;IL1RAP;FN1;CXCL12;ST18;VCAM1;B2M;STAT3;INPP5D;PTK2B;NOD1;MAOA;F3;TNFRSF11B;NFKBIA;UGCG;IL6ST;ANXA1;PSMB2;TNFRSF11A;IL33;STX3;PPIA;RAP1B;ICAM1;TRAF5;RPLP0;CARD14;SOCS2;HSPA8;ACKR3;MAP3K7;FOXO1;ITGB1;TNFRSF1B;CRK;PTPRZ1;TGFB1;PTGS2;IRAK3;CEACAM1;PSMD14;EGR1;S1PR1;STAT5B;TEC;IFNGR2;FGF2;JAK1;PSMC6;CD44;HSP90AA1;IL4R;MSN;IFITM3;PITPNA;ILK;ADIPOR1;IKBKB;TWIST1;VIM;CDKN1A;CNTFR;AIM2;HIF1A;TALDO1;LRP8;CFL1;VEGFA;SOCS5;MT3;JUNB;LIMS1;LBP;UBB;IL31RA;PSMA4;PSMB9;PIM1;CBL;VAV1;CAPZA1;AIP;EDAR;NDN;PELI1;NOD2;CCL13;SKP1;SYK;MAP3K14;SOX2;TRAF1;IRS2;PDCD4;IL22;CRLF1;IRF5;TNFRSF25;PSMD11;IRF2;ITGB2;CAMK2B;BCL2L11;PSMB10
prerank,glycine metabolic process (GO:0006544),0.48531277227222663,1.0306956943546342,0.4368029739776952,0.9329535759920021,1.0,2/12,8.98%,GCAT;DLD
prerank,cardiac muscle contraction (GO:0060048),0.3815896583836035,1.0303422344333952,0.4184514003294893,0.933055063313889,1.0,5/34,9.18%,ATP1A2;CSRP3;TPM1;PIK3CA;MYL4
prerank,icosanoid secretion (GO:0032309),0.47126389557710335,1.0302557680853475,0.42610364683301344,0.932310130005388,1.0,2/12,4.74%,ACE;BDKRB2
prerank,positive regulation of catabolic process (GO:0009896),-0.29945487819761996,-1.0298721372171615,0.38006230529595014,0.7117371443416843,1.0,18/65,17.51%,HECW2;WWP1;HECW1;NEDD4L;GSK3B;DAB2IP;PLK2;FOXO1;DACT1;VSIR;SORL1;NSF;AXIN1;SMURF1;HACE1;EGLN2;APC;BARD1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4294896086556038,1.0296904868030319,0.43278084714548803,0.932950015721897,1.0,3/21,4.75%,ATP1A2;ANK2;CACNA1C
prerank,positive regulation of lipid localization (GO:1905954),0.47695191156966377,1.0296766878707784,0.412962962962963,0.9320413621108592,1.0,3/11,14.87%,IKBKE;LRP1;NFKB1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.34784708867895936,-1.029269808080322,0.4236453201970443,0.7124510919084817,1.0,9/32,10.44%,PPP1R16B;HSP90AB1;PPP2R5A;PPIA;CALM1;CALM2;CAMTA1;TGFB1;CALM3
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.47005525086755107,1.0288914890249077,0.44858156028368795,0.9333576638617248,1.0,3/13,3.18%,TGFBR3;FGFR2;BMPR1A
prerank,regulation of RNA export from nucleus (GO:0046831),-0.45179159805014946,-1.0288389547162289,0.469601677148847,0.7127627353097042,1.0,4/11,24.21%,SETD2;DHX9;NCBP2;IWS1
prerank,regulation of microtubule polymerization (GO:0031113),-0.3281867869277806,-1.0283851153613621,0.4131578947368421,0.71317240554216,1.0,14/40,15.24%,NAV3;PAK1;RPS3;MET;STMN2;OCLN;TUBB4A;CDK5RAP2;MAPT;CLIP1;SNCA;CDK5R1;FES;STMN1
prerank,regulation of protein import into nucleus (GO:0042306),-0.33271528657938365,-1.0278575337440095,0.4225721784776903,0.7136853921041335,1.0,11/36,11.40%,PIK3R1;MDFIC;FLNA;PSEN1;APOD;TGFB1;UFM1;EFCAB7;CABP1;BMP4;CDH1
prerank,negative regulation of cytokine production (GO:0001818),0.3110136172268729,1.027464147065647,0.4086845466155811,0.9364825122151689,1.0,19/163,7.34%,C1QTNF3;LGR4;APPL2;SYT11;PPARA;PCBP2;EZR;IKBKE;SSC5D;SRGN;TLR4;RNF135;F2;ARRB1;MAP2K5;TRIB2;IL12B;TWSG1;PTPN22
prerank,error-prone translesion synthesis (GO:0042276),-0.37257915108708595,-1.0272575338491496,0.41387024608501116,0.7144737056250777,1.0,13/21,33.77%,REV3L;PRIMPOL;UBB;RPA1;RFC4;RFC2;POLK;UBC;RPS27A;RFC5;RPA3;RPA2;POLI
prerank,modification-dependent protein catabolic process (GO:0019941),0.30172968552995616,1.0272023884606156,0.4002463054187192,0.9362510652975959,1.0,49/193,19.25%,RNF43;ASB2;ANAPC15;PRKN;SPSB1;RNF213;NEDD4;ARRB1;ANAPC2;SPSB4;UBR4;SMURF2;TTC3;RNF8;TRIP12;RNF217;BTRC;RNF19A;RNF34;FBXO22;AURKB;RNF13;UBA6;FZR1;FBXO10;NUB1;FBXO11;UBE2H;AMFR;ANAPC16;RNF146;BIRC6;RNF19B;WDR91;RNF7;UFD1;UBE2E1;SYVN1;CDC34;NPLOC4;SQSTM1;NDFIP1;RNF20;TAF1;ARIH1;KCTD21;USP33;UBE4B;MIB1
prerank,regulation of protein modification process (GO:0031399),-0.31422949864153626,-1.0270324011137568,0.42618384401114207,0.7142508870812467,1.0,19/50,18.66%,GRM5;FN1;PPP1R16B;CCDC88A;LYN;FKTN;CORO1C;PPIB;PTK2;PPP1R16A;FNIP2;SPRED1;NOP53;CCDC88C;MT3;HPF1;HSPB1;KDM4D;PUM3
prerank,extracellular matrix disassembly (GO:0022617),-0.3086027313836823,-1.026839905223113,0.3772455089820359,0.7139626532351395,1.0,12/53,13.31%,TLL1;BSG;GSN;ADAMTS5;TIMP2;ADAM15;MMP16;CD44;CAPN2;CTSL;CTSS;MMP15
prerank,T-helper cell differentiation (GO:0042093),-0.4146226004992962,-1.0268057509375432,0.42391304347826086,0.7132767806804998,1.0,2/14,6.10%,LEF1;FOXP1
prerank,clathrin coat assembly (GO:0048268),-0.4120361436412455,-1.0260033714341414,0.43317972350230416,0.7144488827323083,1.0,3/15,6.80%,HIP1;SGIP1;NSG2
prerank,organelle disassembly (GO:1903008),0.38835029239559976,1.0258303265470459,0.43434343434343436,0.9391666266683415,1.0,11/33,19.26%,RETREG1;PLK5;KLC1;KIF5B;ZFAND1;ATG2A;STX5;TEX264;GFM2;GOLGA2;UBA5
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.42824577859158675,-1.0257890090146384,0.42444444444444446,0.7142492932786496,1.0,6/14,14.56%,FLNA;LIMS2;EMP2;DMTN;PRKD1;LIMS1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.2891312402558295,-1.0251664787999093,0.42038216560509556,0.7150542747229679,1.0,25/73,22.11%,PTPRJ;THBS1;STAT3;ARHGEF2;IL33;PTPRC;APP;PLCG2;PSEN1;EPHB2;CYBA;TIRAP;HAVCR2;TWIST1;CLU;LBP;DHX9;NOD2;SYK;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;CD86
prerank,positive regulation of viral process (GO:0048524),0.35858127054429123,1.0251338673849797,0.4188562596599691,0.9401902507020763,1.0,15/60,16.17%,PPARA;POLR2A;IFIT1;DDX3X;CD28;POLR2D;LARP1;GTF2F1;KPNA6;SRPK2;NELFCD;HACD3;AXL;CTDP1;VPS4A
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.38380106791685603,-1.0251154660556283,0.42626728110599077,0.7144256814979755,1.0,11/21,21.28%,CSGALNACT1;DCN;CHSY3;BGN;CSPG4;VCAN;CHST12;CHST9;CHST7;CSPG5;BCAN
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3477629657779804,-1.0248832565122803,0.422680412371134,0.7142256356936024,1.0,13/29,21.68%,SLIT2;SHANK3;KANK3;KANK4;LIMA1;PFN2;SHANK1;FKBP4;KANK1;HIP1R;MYADM;SSH2;TWF2
prerank,purine-containing compound salvage (GO:0043101),0.4757628561209528,1.0238194062032782,0.421259842519685,0.9430567433948195,1.0,4/12,20.58%,AMPD3;AMPD2;APRT;GMPR2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.42690447250250124,1.0234782533437028,0.43462897526501765,0.9430980698492933,1.0,4/19,8.46%,ROBO1;SMOC2;IL12B;HRG
prerank,regulation of endopeptidase activity (GO:0052548),0.34731926636757726,1.0232487121898604,0.4162826420890937,0.9428005540620167,1.0,9/59,9.55%,TIMP3;SERPIND1;PICALM;KNG1;SERPINE1;SERPINA9;HRG;APH1B;HDAC1
prerank,positive regulation of protein maturation (GO:1903319),-0.4582173154599588,-1.023156966954425,0.43326039387308535,0.7177218011024151,1.0,4/11,21.77%,CCBE1;NKD2;RHBDD1;BAG2
prerank,amino acid transmembrane transport (GO:0003333),0.36903178714164514,1.0231262266459524,0.4201550387596899,0.942174979579955,1.0,5/45,4.61%,SLC6A13;SLC38A4;SLC38A3;SLC7A11;SFXN2
prerank,regulation of coagulation (GO:0050818),-0.45006365855514463,-1.022952294374439,0.425,0.7174655666493956,1.0,3/11,7.96%,CAV1;HS3ST5;EPHB2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3125602657180953,1.0227302945257606,0.4247669773635153,0.9423495745981313,1.0,25/150,11.45%,PRKAG2;PTPN13;FBLN1;PRKCZ;ERRFI1;PRKN;PPEF2;PPM1E;DEPTOR;PMEPA1;LRRK2;DTNBP1;SMAD6;LDLRAD4;TRIB2;WWTR1;PTEN;IGFBP3;CDK5RAP3;PDPK1;MVP;CRKL;TRIB1;PRKDC;IMPACT
prerank,ion transport (GO:0006811),0.32345046134048366,1.0226515523132234,0.4268292682926829,0.9416001692212445,1.0,13/111,8.49%,TRPM3;WNK4;SLC24A3;SLC5A5;SLC8A3;VDAC2;SLC26A3;SLC5A8;SLC20A2;ANO6;SLC26A1;SLC1A3;CTNS
prerank,positive regulation of cellular protein localization (GO:1903829),0.3460080585459127,1.0223881279306526,0.41409691629955947,0.94137148771884,1.0,11/69,9.10%,SYT11;PRKAA2;PRKN;CEP250;SESN2;SLC5A3;F2;WWTR1;CDK5RAP3;TRAPPC12;PARP9
prerank,embryonic digestive tract development (GO:0048566),0.4306007050552947,1.0223133460368956,0.4618181818181818,0.9406420679870863,1.0,4/18,7.38%,FGFR2;GLI2;GLI3;NIPBL
prerank,phosphatidylserine metabolic process (GO:0006658),0.38717034756609403,1.0222203868976942,0.4240400667779633,0.9399480821771312,1.0,11/32,21.45%,OSBPL8;PLA1A;SLC27A1;PLSCR1;ABHD12;OSBPL10;PLA2G5;MBOAT2;LPCAT4;PLAAT3;PTDSS1
prerank,cellular response to retinoic acid (GO:0071300),0.37463348595864,1.0218923611959807,0.4251968503937008,0.9399553734071776,1.0,4/42,5.45%,WNT5B;PTK7;WNT6;ATM
prerank,regulation of transmembrane transport (GO:0034762),-0.35568530012870236,-1.0217864091192337,0.44075829383886256,0.7195782306272281,1.0,12/31,16.02%,SLC2A1;ACTB;KCNJ3;KCNJ2;NEDD4L;OCLN;ACE2;SNCA;KCNJ8;KCNJ6;KCNJ12;PIM1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.43964563417047264,1.021753005019537,0.44028520499108736,0.9393845248565197,1.0,8/17,28.89%,EMC2;EMC1;EMC3;CAMLG;GET4;BAG6;UBL4A;SGTA
prerank,regulation of macrophage activation (GO:0043030),-0.34462757378458986,-1.0217131742261485,0.4041994750656168,0.7190089698931987,1.0,8/30,17.31%,CD200;LRFN5;THBS1;IL33;MFHAS1;LBP;IL31RA;CD74
prerank,potassium ion export across plasma membrane (GO:0097623),0.4693723630415544,1.021298015214871,0.41788321167883213,0.939727092067469,1.0,2/13,1.80%,KCND3;KCNA5
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.346409920844585,-1.0211585283857054,0.4252336448598131,0.7196949092651016,1.0,9/28,11.72%,SHANK3;GSK3B;APOE;APP;RELN;EPHB2;PTN;ZDHHC2;FAM107A
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3294208119514707,-1.0209448964178456,0.4087403598971722,0.7194795888180422,1.0,17/39,17.82%,ACTB;GNAS;ACTN1;UBASH3B;FN1;ACTG1;MYH9;PPIA;FLNA;MYL12A;P2RY12;ITGB3;ILK;MYL9;TYRO3;STXBP3;HSPB1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4539730839275429,-1.0204919826695618,0.4407484407484408,0.7198771960510093,1.0,2/11,1.12%,GHR;PIK3R1
prerank,cGMP biosynthetic process (GO:0006182),0.48534887163727547,1.0203738152404187,0.4622823984526112,0.9413891239770689,1.0,2/10,6.12%,NPR1;NPR2
prerank,embryonic limb morphogenesis (GO:0030326),0.3881145736838599,1.0202484691126763,0.42601626016260163,0.9407760747964097,1.0,8/34,11.13%,OSR1;AFF3;GLI3;CYP26B1;CACNA1C;NIPBL;HDAC1;RARG
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4498276753839169,-1.0202268565725643,0.4766146993318486,0.7198084918667826,1.0,3/10,14.31%,ESR1;PSMC6;ATF7IP
prerank,positive regulation of vasculature development (GO:1904018),0.325113989213948,1.0200275086084976,0.41631504922644164,0.9404700014450671,1.0,16/94,9.72%,FGF1;ADAM12;SMOC2;SASH1;HK2;SPHK1;RAPGEF3;PRKCB;CTSH;FLT1;SERPINE1;PDPK1;CDH5;HYAL1;SIRT1;STIM1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.26641715901614876,-1.0199277725569598,0.36727272727272725,0.7198047886413588,1.0,30/112,17.82%,PTPRJ;THBS1;STAT3;CD34;GAS6;ARHGEF2;IL33;PTPRC;FOXP1;APP;PLCG2;PSEN1;VSIR;EPHB2;IRAK3;CD47;CYBA;TRIM27;TIRAP;HAVCR2;TWIST1;CLU;LBP;CX3CR1;DHX9;CHRNA7;NR1H4;NOD2;SYK;HSPB1
prerank,neural tube closure (GO:0001843),0.3899225062275713,1.019773720410502,0.43295638126009695,0.9402252439908918,1.0,14/34,23.33%,CELSR1;LMO4;MTHFR;KDM2B;IFT122;PHACTR4;DEAF1;MTHFD1;VASP;FOLR1;TSC2;FUZ;PRICKLE1;DVL3
prerank,positive regulation of translational initiation (GO:0045948),0.44201399355331283,1.0196228947513766,0.4555160142348754,0.9397008693624979,1.0,7/18,21.04%,DDX3X;POLR2D;LARP1;YTHDF3;BOLL;POLR2G;RPS6KB2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.34869070925855844,1.019351176843845,0.4350453172205438,0.9395217980942168,1.0,14/56,19.15%,UBE2E2;DDX3X;ANKRD17;CCND3;HYAL1;CDC25A;TFDP1;ADAM17;NSMCE2;RPTOR;RB1;KMT2E;EIF4G1;KLHL18
prerank,epidermis development (GO:0008544),0.36012991150474005,1.01915047420525,0.4292237442922374,0.9391279002619866,1.0,7/56,9.55%,LAMC2;CCN2;FGFR2;CRABP2;SVEP1;GLI1;HDAC1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3820091823429534,-1.018862966280666,0.43803418803418803,0.7216196212095954,1.0,11/19,35.38%,SLCO1C1;APP;KLF2;CHRNA7;PAX8;KLF4;MAPK8;HPN;MTPN;TMEM106A;GATA3
prerank,ion homeostasis (GO:0050801),-0.3511482128032958,-1.0186530664170903,0.40100250626566414,0.7213825769787984,1.0,6/30,7.27%,SLC4A10;CAMK2D;UNC80;NEDD4L;KLHL3;WNK2
prerank,regulation of interferon-gamma production (GO:0032649),-0.2881548202115785,-1.0181770761682958,0.43119266055045874,0.7218769676136322,1.0,18/71,21.18%,PDE4D;PDE4B;IL1R1;SLC7A5;GAS6;VSIR;CD47;TRIM27;HAVCR2;LAPTM5;NR1H4;SCRIB;ZFPM1;INHBA;TLR7;TXK;LGALS9;PYCARD
prerank,protein localization to plasma membrane (GO:0072659),0.31873900985226944,1.0178807341229479,0.422554347826087,0.941650313769726,1.0,16/129,6.76%,AFDN;ROCK2;ACTN2;ATP1B3;ANK2;TSPAN5;TTC7B;DLG1;FYB1;KCNIP3;EZR;TMEM150A;RAB34;FYB2;PIGW;CACNB3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.28768649223992815,-1.0178731820260765,0.39666666666666667,0.7219083570963057,1.0,15/76,12.33%,GRM5;ESR1;PLCE1;ADRA1B;HTR2C;ANO1;HTR2A;AGTR1;CHRM2;GRM1;P2RY12;PTH1R;GNA14;HOMER1;CMKLR1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3776528642228968,-1.017757938726296,0.4444444444444444,0.7214235034285719,1.0,2/20,2.36%,PDE4D;ADRA1B
prerank,regulation of establishment of protein localization (GO:0070201),-0.414213188532475,-1.0175597378780483,0.4304932735426009,0.7211657932052192,1.0,5/14,16.82%,CTSD;CORO2B;GAPVD1;PTP4A3;DNAJA1
prerank,regulation of apoptotic process (GO:0042981),-0.22358141232837916,-1.0173727348013288,0.3050847457627119,0.7208496831727572,1.0,180/676,20.22%,GRID2;SLIT2;MEF2C;LEF1;HIP1;TEK;ARHGAP10;ACTN4;PIK3R1;ITGA6;MAP3K5;RASSF2;FMN2;KCNMA1;RTN4;THBS1;ACTN1;MCF2L;ABR;TBX3;TPT1;RASGRF2;ACER2;RNF144B;PTK2B;ARHGEF3;TRIM2;APAF1;CSRNP3;RPS6;GAS6;NGF;CYP1B1;TFRC;UNC13B;TRIO;NFKBIA;ARHGEF9;ARHGEF7;IL6ST;NET1;TNFSF10;ARHGEF2;KDR;GSK3B;ANXA1;SFRP4;DAB2IP;TIAM1;PPIA;CD38;PTMA;PLK2;PHLPP1;FLNA;RPS3;CTSD;CARD14;SOCS2;ARHGEF17;TGFB3;RYBP;RHOB;FOXO1;SEMA4D;PSEN1;ITGB1;PERP;BIN1;BMP2;SIAH2;HSPA5;PTK2;CALR;DDRGK1;CTSB;VDAC1;TMBIM6;TOX3;PPT1;ANP32A;FLT4;PLEKHG5;AIFM1;CD44;UFM1;ARHGEF26;FRZB;ARL6IP1;HSP90AA1;RPS6KA3;BCAR1;RPS6KA2;ERC1;MAGED1;GPER1;HNRNPK;BMP4;RASA1;ATF4;CTNNB1;DAPK1;ANKRD13C;LCMT1;FAS;IKBKB;SERPINB9;LRP8;SNCA;AHI1;CFL1;SUDS3;TAF9B;VEGFA;GADD45G;RPS6KA1;PINK1;NOP53;MT3;ATF5;DNAJA3;CLU;KLF11;IAPP;CASP6;UBB;MTDH;PHLDA3;PAX2;IL31RA;CRADD;BFAR;BCL3;PIM1;CBL;EGLN2;VAV1;FAIM2;CAT;RHBDD1;TOP2A;DNAJA1;ARHGDIA;APC;RNPS1;NR1H4;SCRIB;CASP2;PIM2;CD74;BARD1;DIABLO;PHLDA1;HSPB1;DHCR24;HTRA2;IRF5;TNFRSF25;APH1A;SOX8;STPG1;RNF122;BCL2L11;FOXL2;HIP1R;CALHM2;PAX8;PREX1;PNMA2;GADD45B;GATA6;SIX4;COPS5;DCUN1D3;AGT;ECT2;IER3IP1;SHC1;EGLN3;DAPK2
prerank,regulation of exosomal secretion (GO:1903541),0.4302000357626152,1.017058301636744,0.4491525423728814,0.9429932546719014,1.0,8/19,22.43%,PRKN;SDC4;SMPD3;SNF8;VPS4A;CHMP2A;RAB7A;SDCBP
prerank,regulation of transferase activity (GO:0051338),0.44322854829637465,1.0168792054640599,0.42803030303030304,0.94254439863122,1.0,4/17,7.43%,ATM;PARP4;LDB1;LDB2
prerank,aorta morphogenesis (GO:0035909),-0.40226280383196483,-1.016769129532208,0.4473684210526316,0.7216222572108693,1.0,6/17,9.18%,ENG;ACVRL1;JAG1;TBX1;PROX1;HEY2
prerank,negative regulation of cell development (GO:0010721),0.40707104378009346,1.0166788721742412,0.43564356435643564,0.9421902042898325,1.0,3/25,6.92%,APPL2;IGF1;FBN1
prerank,regulation of MAPK cascade (GO:0043408),0.3041947344929043,1.0161178950474286,0.44063324538258575,0.9427734665545829,1.0,16/157,6.40%,TGFBR3;ROCK2;LPAR1;KSR1;KIT;GSDME;IGF1;FGFR2;PKHD1;PPEF2;FGFR1;ADRA2A;DAG1;EPHA8;FLT1;LBH
prerank,skin development (GO:0043588),0.34450500826072,1.015582123585904,0.4332833583208396,0.943359390086169,1.0,5/65,5.01%,COL5A1;ERRFI1;ALOX12;CASP3;DACT2
prerank,peroxisomal membrane transport (GO:0015919),0.40201036872548973,1.0153382644392188,0.44173913043478263,0.94312087213726,1.0,10/27,17.33%,PEX11B;PXMP2;PEX10;PEX14;ACBD5;PEX19;RAB8B;SLC25A17;PEX16;PEX5
prerank,establishment of skin barrier (GO:0061436),-0.4132553986906372,-1.0151214110047693,0.4684873949579832,0.7242353663729738,1.0,5/15,15.24%,UGCG;LSR;MET;HRNR;STMN1
prerank,regulation of water loss via skin (GO:0033561),-0.4132553986906372,-1.0151214110047693,0.4684873949579832,0.7242353663729738,1.0,5/15,15.24%,UGCG;LSR;MET;HRNR;STMN1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.2916090637117791,-1.0147770438604806,0.4124629080118694,0.7242934483378431,1.0,14/67,9.84%,GHR;TEK;ERBB4;PTK2B;KDR;LYN;BMX;RELN;EPHB2;PTK2;ABI1;TEC;FLT4;ERBB2
prerank,fatty acid catabolic process (GO:0009062),0.3420615083918757,1.0144556684588582,0.43843843843843844,0.9446230557466021,1.0,23/67,22.19%,PCCA;CEL;ACAD11;ACAD10;BDH2;CPT2;ACADM;MECR;ACOT8;ECHDC1;ACBD5;DECR1;NUDT19;EHHADH;SLC25A17;PHYH;ECI2;CROT;ACADS;HADHA;HADH;ECHS1;HAO1
prerank,epithelial structure maintenance (GO:0010669),0.47169061155621655,1.013680166300641,0.4735772357723577,0.9457833227540055,1.0,2/11,10.27%,RBP4;CXADR
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.40849535819286587,-1.0135559649115422,0.475,0.7265163569150073,1.0,7/15,13.77%,TMSB4X;SEMA5A;KDR;MET;FGF2;PRKD1;VEGFA
prerank,actin cytoskeleton reorganization (GO:0031532),0.34674266209507704,1.0134242490610939,0.4358974358974359,0.945560235578813,1.0,11/63,6.94%,AUTS2;KIT;SIPA1L1;PTK7;NPHS2;PHACTR1;MCU;DTNBP1;EZR;CDC42BPG;RICTOR
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.4710088004566262,1.0134123296253192,0.4461839530332681,0.9446648458276369,1.0,5/11,20.74%,ARRB1;ADM;GRK3;SAG;ARR3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4676760803788915,1.0133514296872193,0.46449136276391556,0.9439126643027022,1.0,3/13,11.07%,PPARA;NFIB;NFATC3
prerank,regulation of actin filament-based movement (GO:1903115),-0.4519972773856642,-1.0126938260196645,0.4612159329140461,0.7279494393923241,1.0,2/10,0.65%,PDE4D;PDE4B
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.358292438891765,1.0124344656889164,0.4342948717948718,0.9455185625931707,1.0,10/52,13.13%,TFDP2;LEPROT;BID;FZD5;TP53;HUWE1;TFDP1;NPEPPS;CSNK2A2;PPP1R13B
prerank,modulation by host of viral genome replication (GO:0044827),0.46596028211077145,1.0123265641566248,0.4527938342967245,0.9449195525565747,1.0,2/13,4.06%,PRKN;IFI27
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4389704943946522,1.0118868602765705,0.4540229885057471,0.9452208602615313,1.0,3/17,8.88%,BID;SOD2;DNM1L
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.417047786712332,-1.011868018017685,0.4613861386138614,0.7292809834355851,1.0,7/13,19.62%,SHANK3;APP;RELN;EPHB2;ZDHHC2;CHRNA7;ADCY8
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.42162716010047574,-1.0117897778969331,0.4519650655021834,0.7287134465354412,1.0,6/13,31.52%,ALG6;ALG8;ALG9;ALG13;ALG3;DPAGT1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.469244089563186,1.0117331018553068,0.4346076458752515,0.9447055821447713,1.0,3/12,12.32%,PRKCB;CCNB2;PRKCA
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.4192687543090102,-1.0113497419233757,0.4391304347826087,0.7290618385665979,1.0,4/14,10.70%,TMSB4X;NFKBIA;G3BP2;PKD1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.33960201836529824,-1.0113455094346113,0.41330166270783847,0.7283228576405087,1.0,10/31,18.41%,DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;TM7SF3;HSPB8;UBE2W;RHBDD1;PTPN1
prerank,amyloid fibril formation (GO:1990000),-0.3081168088130991,-1.0104303802594146,0.47126436781609193,0.729829864610659,1.0,17/51,14.92%,GSN;CST3;B2M;APP;TSPAN14;TGFBI;HSPG2;SORL1;SIAH2;H3-3A;FKBP1A;ITM2B;MAPT;SNCA;MFGE8;IAPP;UBB
prerank,spinal cord development (GO:0021510),0.4636973215401333,1.010156992156717,0.4637404580152672,0.94812652920378,1.0,3/12,7.08%,GLI2;LOXL3;SOX12
prerank,apoptotic process (GO:0006915),-0.2460362784649367,-1.0100973417667072,0.41025641025641024,0.7299054792148135,1.0,44/203,14.80%,HIP1;MAGI3;SEMA6A;RTN4;DCC;EFNA5;MAL;PPARD;FAP;PTK2B;PAK5;APAF1;CIT;SCN2A;NFKBIA;ZBTB16;PLAGL1;TBX1;PPIA;APP;RHOB;MAP3K7;TNFRSF19;FOXO1;PRUNE2;ADAM15;PPP2R1A;TNFRSF21;VDAC1;AIFM1;DDIT4;ELMO1;FXR1;GLRX2;PAEP;DAPK1;FAS;RFK;JADE1;BBC3;TRPC5;DAP;IAPP;CASP6
prerank,L-amino acid transport (GO:0015807),-0.34152369485725276,-1.0098112590621424,0.4358974358974359,0.7299066352083645,1.0,7/28,8.00%,SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5
prerank,negative regulation of locomotion (GO:0040013),-0.4305436630545979,-1.0096746094547577,0.44936708860759494,0.7295043715326545,1.0,4/12,11.00%,FRMD5;SPOCK3;CRK;DUSP3
prerank,piRNA metabolic process (GO:0034587),0.4265281315318707,1.0096644953211646,0.4416058394160584,0.9485964952265962,1.0,5/19,21.03%,GPAT2;MOV10L1;MYBL1;EXD1;ASZ1
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2757429544913248,-1.0094952090836842,0.44074074074074077,0.7292168429207597,1.0,27/98,19.80%,PID1;SLCO1C1;THBS1;PPARD;ECE1;NFKBIA;SFRP4;TBC1D5;APOE;TGFB1;AGTR1;XDH;NSF;STARD4;CDKN1A;ACE2;SNCA;AHI1;VEGFA;MT3;SCRIB;ATAD1;ARRB2;PAX8;INHBA;ROMO1;AGT
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2549513932069233,-1.0094551293801257,0.42105263157894735,0.7285884961544821,1.0,41/160,20.20%,STXBP6;HIP1;SGIP1;RTN4;NCK2;VAMP4;HSP90AB1;RPL38;TIAM1;NSG2;PDE4DIP;BIN1;SMAD1;TGFB1;IMMP2L;ANLN;AIFM1;HSP90AA1;CYBA;FKBP1A;AP2M1;PSMG2;MAPT;AXIN1;SNCA;CLU;NCK1;PIK3C2A;DHX9;DNAAF3;CCT2;CENPE;CHMP4B;CHMP4A;PSMD11;CASQ2;TBCE;HIP1R;POMP;NUP107;PTGES3
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3341365905925165,-1.0093872428355912,0.4699738903394256,0.7280086153521075,1.0,7/33,6.96%,MAP3K5;CYP1B1;NET1;ANXA1;RPS3;PLEKHA1;RHOB
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.33948283034567955,-1.0090602199232876,0.4489311163895487,0.728060974383952,1.0,15/30,38.46%,HSPA8;HSPA5;CCT2;HSPE1;DNAJB1;PTGES3;HSPA13;ERO1A;ENTPD5;HSPA1L;HSPA9;DNAJB4;ST13;UGGT1;SDF2L1
prerank,oligodendrocyte development (GO:0014003),-0.40140085458154756,-1.0088829419675258,0.45652173913043476,0.7277664404755211,1.0,10/15,34.02%,PLP1;B4GALT5;EIF2B3;TPPP;SOX10;B4GALT6;EIF2B2;PRDM8;EIF2B5;MYRF
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.4923819105847445,1.008256530056641,0.48760330578512395,0.9516156786519024,1.0,3/10,9.87%,APPL2;PRKCB;GRB10
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.43955514554794367,1.0076127522839884,0.47036328871892924,0.952458979196626,1.0,3/17,6.99%,AKAP13;ADRA2A;ADCY9
prerank,long-term synaptic potentiation (GO:0060291),-0.3803909945695443,-1.0072573429206817,0.4624413145539906,0.731037370395404,1.0,6/21,7.11%,SLC24A2;NPTN;GRIN2B;PTK2B;PLK2;GRIN2A
prerank,positive regulation of cellular catabolic process (GO:0031331),0.30478548891892715,1.006326902826207,0.45165562913907287,0.9551391581001997,1.0,17/132,10.49%,RNF152;IGF1;SH3D19;PRKAA2;PPARA;ZBTB20;ADRA2A;TPCN1;LRRK2;VGLL4;EZR;NPRL2;ZC3H18;ZC3HAV1;MOV10;ZSWIM8;IRGM
prerank,regulation of defense response to virus by host (GO:0050691),0.3915209776012672,1.0061126616472045,0.44499178981937604,0.9548503232144364,1.0,7/30,13.50%,IL12B;PTPN22;PARP9;MAVS;TOMM70;ZDHHC1;SIN3A
prerank,epithelial cell differentiation (GO:0030855),0.3264516724562778,1.0060497976795253,0.44722222222222224,0.9541019094138544,1.0,8/88,9.55%,DAB2;MAF;FGFR2;CPT1A;TPP1;BDH2;GLI1;HDAC1
prerank,organophosphate ester transport (GO:0015748),-0.3639230414154604,-1.005647645435936,0.45080091533180777,0.7343380033145985,1.0,9/24,11.95%,PITPNC1;SCARB1;PLTP;LDLR;NPC2;PITPNB;TNFAIP8L3;MTTP;PITPNA
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2710090954772722,-1.0052816877792206,0.4452054794520548,0.7344520509992991,1.0,21/98,11.24%,SPTBN1;DPP10;PRKCH;PIK3R1;ANK3;CEMIP;YWHAE;STX3;YWHAB;PLS1;NKD2;ITGB1;PPP3R1;YWHAG;EPHB2;MTCL1;ERBB2;EFCAB7;ATP2B4;KCNB1;GPER1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.4500098020027372,1.005221771316714,0.45567375886524825,0.9555136420197607,1.0,5/15,15.44%,TNRC6A;TNRC6B;CPEB3;TNRC6C;TENT4B
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.39788374130632864,-1.0051919479732891,0.4535637149028078,0.7339475829715606,1.0,7/17,16.77%,RTN4;NTRK2;APOE;SORL1;BIN1;CLU;CHRNA7
prerank,protein acetylation (GO:0006473),0.38985756756357687,1.0050956665256028,0.4555921052631579,0.9549281825894266,1.0,7/30,16.30%,SPHK1;NAA80;DSCC1;SIRT1;KAT2B;NAA16;CREBBP
prerank,regulation of JUN kinase activity (GO:0043506),-0.3333246623964887,-1.0050588691099591,0.42857142857142855,0.7335335865526712,1.0,8/33,10.79%,MAP3K5;TNFRSF11A;DAB2IP;PAK1;RPS3;MAP3K7;AIDA;EDN1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4040975660782508,1.0047608292187045,0.4663382594417077,0.9549543467392718,1.0,16/29,22.95%,SMARCA4;TERT;TCF7;TLE1;HDAC1;ASH2L;TCF7L2;AXIN2;KMT2D;TLE2;CREBBP;TCF7L1;PYGO2;RUVBL1;EP300;BCL9
prerank,negative regulation of mitochondrion organization (GO:0010823),0.38335643647579426,1.0045913331244096,0.4426229508196721,0.9545314615153204,1.0,5/33,9.43%,IGF1;PRKN;OPA1;HUWE1;ADCK1
prerank,tRNA 5'-leader removal (GO:0001682),0.44392907305112655,1.0043401862720724,0.4397031539888683,0.9542897575806705,1.0,5/13,20.85%,RPP21;RPP25L;PRORP;POP7;POP1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.37227497847492963,-1.0042572306089383,0.45278969957081544,0.7347481336081061,1.0,6/21,9.36%,SLIT2;TGFB2;DAB2IP;CD2AP;EPHB2;ARHGAP25
prerank,regulation of protein catabolic process (GO:0042176),-0.2745370769358471,-1.0040398696632535,0.4444444444444444,0.7345403464894219,1.0,25/99,18.68%,HECW2;WWP1;HECW1;FMN2;NEDD4L;GSK3B;DAB2IP;PLK2;FLNA;FOXO1;DACT1;SORL1;EEF1A1;IRAK3;NSF;ZDHHC2;AXIN1;ADGRB1;SMURF1;HACE1;EGLN2;APC;BARD1;CHEK2;SIRT2
prerank,transition metal ion homeostasis (GO:0055076),0.40028444202520386,1.0037086103263637,0.4607329842931937,0.955090417386685,1.0,3/28,1.98%,CP;PICALM;PRKN
prerank,activation of phospholipase C activity (GO:0007202),0.39672811856799123,1.003379539014084,0.45293072824156305,0.9550762169304181,1.0,3/29,3.81%,LPAR1;LPAR2;ARHGAP6
prerank,Golgi organization (GO:0007030),0.3166530476557929,1.002956404731246,0.45454545454545453,0.9552977863197437,1.0,34/112,18.89%,FAM174B;DYM;OBSL1;CLASP1;LRRK2;MYO18A;PLK5;BCAS3;HUWE1;HTT;TRAPPC12;GOLPH3L;CSNK1A1;RAB43;FBXW8;CDC42;TRAPPC11;VTI1A;STX5;TANGO2;ARHGAP21;SEC23IP;RAB29;VPS51;GOLGA5;GOLGA8B;RAB30;PI4K2B;OPTN;COG4;NPLOC4;GORASP2;BET1;GOLGA2
prerank,ventricular septum development (GO:0003281),0.3742191581849935,1.0029310592851712,0.453525641025641,0.9544418918260277,1.0,4/37,3.46%,ROBO1;TGFBR3;BMPR1A;TGFBR1
prerank,regulation of tissue remodeling (GO:0034103),0.421383092515907,1.002679828206531,0.4608540925266904,0.9542079531957979,1.0,3/18,6.47%,LEPR;IL18;IL12B
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.48352446890987094,1.0024022062947089,0.47,0.9540014101442637,1.0,3/10,17.63%,HK2;GFPT1;PFKM
prerank,protein import into peroxisome membrane (GO:0045046),0.416641195580992,1.0022303551024732,0.45729537366548045,0.9535344443752903,1.0,9/22,17.33%,PEX11B;PXMP2;PEX14;ACBD5;PEX19;RAB8B;SLC25A17;PEX16;PEX5
prerank,cellular glucose homeostasis (GO:0001678),0.37468031932107304,1.0020938567899473,0.4761092150170648,0.9529793588820595,1.0,4/41,2.21%,PPARGC1A;PRKAA2;HK2;ZBTB20
prerank,heart process (GO:0003015),-0.4143164428754248,-1.0020774338823004,0.4487704918032787,0.7387348851342707,1.0,2/14,0.41%,SGCZ;SGCD
prerank,regulation of actin filament polymerization (GO:0030833),-0.2918716152637708,-1.001800512262441,0.4423076923076923,0.7386985210839913,1.0,25/69,21.86%,SLIT2;ESAM;KANK3;PAK3;NCK2;EVL;CARMIL1;PTK2B;KANK4;CDC42EP3;BIN1;RASA1;PFN2;CDC42EP2;NCK1;ARF6;KANK1;HIP1R;NCKAP1;MYADM;SSH2;GBA2;PYCARD;TWF2;HCLS1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.2700664550619558,-1.0017448064151724,0.42585551330798477,0.7380932278640824,1.0,30/104,16.37%,BMPER;CAV1;BMPR2;HTRA3;CCN3;VWC2;NOTCH1;VWC2L;PRDM16;ASPN;SMAD5;IL17RD;CD109;SORL1;SMAD1;BMP2;TGFB1;SMAD7;FKBP1A;LEMD3;UBE2D3;ACVR1;SPRY1;SPRED1;BMPR1B;PPM1A;SMURF1;UBB;CILP;HIPK2
prerank,ovarian follicle development (GO:0001541),0.45519612074129434,1.0015846195726006,0.4645669291338583,0.9534981161908019,1.0,1/13,1.21%,KIT
prerank,protein deacetylation (GO:0006476),0.3665582760805795,1.0008040345287639,0.4420529801324503,0.9547803463229351,1.0,12/41,15.38%,TBL1X;SIRT5;TBL1XR1;SIRT3;HDAC4;SIRT1;HDAC1;PRDM5;SIRT4;SIN3A;MIER3;MTA2
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.23896836627126308,-1.000672684987448,0.3972602739726027,0.7400370354812674,1.0,56/291,14.77%,SLIT2;MEF2C;PID1;PDE4B;PDE3A;KCNC2;ACTB;ESR1;BRINP3;AKAP6;HCN1;PTPRK;PTK2B;BRINP1;RYR3;GNG2;GUCY1B1;LYN;RORB;TBX1;DAB2IP;RAP1B;FZD4;RAP1A;RPS3;FOXO1;TNFRSF1B;KCNQ1;WNT9A;SH3BP4;GLRA1;EGR1;PDE2A;CAMKK2;BRINP2;CAPN2;P2RY12;ATP2B4;GPER1;SBNO2;TIRAP;DAPK1;VIM;MAPT;SPAAR;DMTN;PRKD1;GLRA2;RET;CARD16;MT3;ABCB4;P2RY1;FES;LBP;GNB1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.38375962418236503,0.9997834436859881,0.4548440065681445,0.9566786815740198,1.0,9/33,16.21%,PRODH;CPS1;ALDH4A1;GOT2;GLUL;SIRT4;ART4;CAD;GOT1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.41944092136057887,-0.9991431591875403,0.47345132743362833,0.7430957579709282,1.0,3/13,2.22%,PID1;TMSB4X;NOS3
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3623020599234083,0.9989662240637422,0.4682926829268293,0.958022825388771,1.0,12/46,13.99%,OGN;IGF1;IL18;NOX1;PDGFRB;IL12B;IGFBP3;TCF7L2;TRIB1;PRKDC;RBPMS2;MFN2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33129575191108873,0.9985889202841018,0.4460856720827179,0.9581526930719279,1.0,8/75,6.60%,ROCK2;TULP3;NMT2;GRK5;RGS16;METAP2;RHO;MGRN1
prerank,cellular response to hydroxyurea (GO:0072711),0.48805831563996194,0.998547591636665,0.461839530332681,0.9573409898060466,1.0,4/10,21.07%,ATRX;DDI1;RTF2;FMR1
prerank,negative regulation of JNK cascade (GO:0046329),0.3845136380114048,0.9983979101904052,0.44501718213058417,0.9568522976243259,1.0,7/31,13.81%,SH3RF2;PRKN;GPS2;PTPN22;DUSP10;HIPK3;NCOR1
prerank,AMP metabolic process (GO:0046033),0.4529844687541925,0.9982557937213042,0.4564393939393939,0.9563415358329468,1.0,6/13,20.76%,AMPD3;AK4;AK3;AMPD2;ADSS1;ADSL
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.27274005532447526,-0.9981187272232057,0.4551083591331269,0.7448774951988575,1.0,17/88,8.69%,STXBP6;MYO1B;SORCS1;CLINT1;FTH1;SH3GL2;MYO5A;EXOC6;DOP1B;CLVS1;APP;HSPA8;AP1S2;SORL1;SORT1;FTL;GOPC
prerank,response to retinoic acid (GO:0032526),0.34414911890002864,0.9979146411294344,0.4651851851851852,0.9563530030966485,1.0,7/59,7.53%,WNT5B;PTK7;WNT6;CTSH;ATM;OVCA2;RBP4
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4345253236752912,0.9977125190813421,0.4791666666666667,0.9559998283902875,1.0,2/16,1.44%,ROCK2;IGF1
prerank,lipoprotein biosynthetic process (GO:0042158),0.4631040340455508,0.9975392111423987,0.46741154562383613,0.9555647470943939,1.0,4/11,11.84%,ATG10;WIPI1;ATG7;PORCN
prerank,actin filament-based transport (GO:0099515),-0.37799667370026824,-0.9970246634422859,0.49261083743842365,0.7468213640503252,1.0,5/21,4.23%,MYO1D;ACTN4;MYO1B;FNBP1L;MYO5A
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.47594734294759383,0.9967407173520825,0.49056603773584906,0.9569253691985566,1.0,1/11,0.65%,ACTN2
prerank,regulation of aerobic respiration (GO:1903715),-0.4051485117986209,-0.9965737627565816,0.4745011086474501,0.7472104675307069,1.0,4/15,14.08%,CBFA2T3;SLC25A33;PINK1;NOP53
prerank,peptidyl-methionine modification (GO:0018206),0.4681237401577746,0.9965511392257115,0.481216457960644,0.956535110064223,1.0,3/12,15.39%,METAP2;NAA20;NAA16
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.42332833064171066,-0.9963086819064517,0.46361746361746364,0.7470890193690223,1.0,3/13,9.18%,RYR2;NOTCH1;HEY2
prerank,vasodilation (GO:0042311),-0.4230491744530284,-0.9961463112943025,0.4781704781704782,0.7467447453264269,1.0,5/13,12.67%,KCNMA1;NOS3;KLF2;GPER1;NOS1
prerank,regulation of immunoglobulin production (GO:0002637),-0.3585909709734431,-0.9961286972180097,0.4567307692307692,0.7460511202339011,1.0,3/23,7.96%,GPI;PTPRC;EPHB2
prerank,hexose metabolic process (GO:0019318),0.3608687635573691,0.9960729382984983,0.4595419847328244,0.9568610789734915,1.0,10/39,19.58%,SORD;CHST15;GALM;GALK2;GALK1;PGM1;BRAT1;FPGT;SLC37A4;GDPGP1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3109591282047757,-0.9951988065101889,0.4519774011299435,0.7475998190722056,1.0,14/45,21.33%,CAMK2D;MID1;VCAM1;B2M;ICAM1;IFNGR2;JAK1;CD44;IRF5;IRF2;CAMK2B;IRF8;TRIM68;MT2A
prerank,motor neuron axon guidance (GO:0008045),-0.3935561064824161,-0.9950355023982813,0.4809843400447427,0.7472455727035647,1.0,5/15,9.70%,SLIT2;TMEFF1;CHN1;NTN1;RHOH
prerank,histone H2A monoubiquitination (GO:0035518),0.4361241701488116,0.9946068277903135,0.47924528301886793,0.9599304760643845,1.0,5/17,13.59%,PCGF5;PCGF2;BCOR;KDM2B;DDB2
prerank,digestive tract morphogenesis (GO:0048546),0.4383335080887051,0.9945969264674192,0.4542190305206463,0.9590426045121057,1.0,5/14,16.34%,FGFR2;NIPBL;GLI1;RBPMS2;PDGFRA
prerank,regulation of ERAD pathway (GO:1904292),-0.43570642034705787,-0.9944025978307773,0.4784394250513347,0.7481046013325694,1.0,2/11,8.03%,AQP11;USP13
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.37480981853514805,-0.9942767054135196,0.4755244755244755,0.7476667974539731,1.0,6/19,11.23%,DLG2;CLIC4;LRRC7;MTCL1;ERBIN;MARK2
prerank,renal absorption (GO:0070293),0.4781079635895155,0.9941996588809349,0.4749034749034749,0.9591736754484996,1.0,1/10,0.45%,WNK4
prerank,negative regulation of blood pressure (GO:0045776),-0.4238431938265558,-0.9940958582329902,0.4620253164556962,0.7473710645624253,1.0,2/13,2.22%,BMPR2;NOS3
prerank,positive regulation of blood coagulation (GO:0030194),-0.38944436906455365,-0.9937152467180936,0.47072072072072074,0.7475576254393083,1.0,5/17,13.12%,ST3GAL4;THBS1;F3;ENPP4;DMTN
prerank,protein O-linked glycosylation (GO:0006493),0.3176546386682813,0.9936205135159091,0.4879089615931721,0.9598477364065509,1.0,9/96,5.77%,GXYLT2;TRAK1;ST6GAL1;TMTC4;GALNT12;LARGE1;ST3GAL3;TET2;PGM3
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.24250188410479073,-0.9935136487078703,0.45161290322580644,0.747345052093555,1.0,32/198,11.39%,PTPRB;PTPRD;PLCB4;INPP4B;PLA2G4A;PLCE1;PIP4K2A;STAT3;INPP5D;PLPP1;PLPPR1;GPI;PAK1;CALM1;PTPRC;PLCG2;LIMK2;EPHA7;ALPL;ENPP1;EPHB2;PPP3CA;TGFB1;ITPK1;PLCH1;TNFAIP8L3;PLPPR5;PLPPR4;GFPT2;DUSP3;LIMD1;PGM2L1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.35266839156827207,0.9934949454942427,0.48177496038034867,0.9592830005880041,1.0,8/50,14.08%,SH3RF2;NXN;HDAC8;ARRB1;GTPBP4;ABL1;OGT;PER2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.39567193143501567,0.9934395302227762,0.45454545454545453,0.9585264664717152,1.0,5/27,9.08%,NAPEPLD;NAAA;ETNK2;SLC27A1;PLA2G6
prerank,regulation of mRNA polyadenylation (GO:1900363),0.42421271369190694,0.9930469112047827,0.47186932849364793,0.9586429874774501,1.0,7/17,23.34%,CTR9;CPEB3;VIRMA;RNF20;CPSF7;ZC3H3;NUDT21
prerank,regulation of mitochondrion organization (GO:0010821),0.35696803617014594,0.9927873251240756,0.4578696343402226,0.9584523738734567,1.0,13/47,18.49%,PPARGC1A;PRKN;LRRK2;FZD5;STAT2;MYO19;DNM1L;CYRIB;CSNK2A2;FLCN;VPS35;SQSTM1;RHOT1
prerank,activation of protein kinase A activity (GO:0034199),0.4357738899957162,0.9923617565491724,0.47950089126559714,0.9587075426381539,1.0,5/16,13.47%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6
prerank,positive regulation of vasculogenesis (GO:2001214),-0.44968014425252123,-0.9923143768298449,0.48975409836065575,0.7494167581530706,1.0,5/10,8.90%,CD34;KDR;RAP1A;TMEM100;CEACAM1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3781285500924504,-0.9922281051374408,0.5011820330969267,0.7488881380030232,1.0,6/21,17.20%,CAV1;GSK3B;CTNNB1;AXIN1;APC;PPP1CA
prerank,negative regulation of blood coagulation (GO:0030195),0.3663626689592582,0.9921498451044439,0.47275641025641024,0.9583767479672588,1.0,11/38,16.34%,TFPI;F11;KRT1;F2;KNG1;SERPINE1;HRG;C1QTNF1;F8;PLAT;PDGFRA
prerank,DNA conformation change (GO:0071103),0.42693776340592715,0.9921239721826373,0.46313799621928164,0.9575286496202985,1.0,3/17,12.53%,TOP2B;ABL1;TOP3A
prerank,blood vessel endothelial cell migration (GO:0043534),0.41733021200895637,0.9918721258388054,0.4873096446700508,0.957299998546606,1.0,2/22,0.55%,ROBO1;EFNB2
prerank,negative regulation of developmental process (GO:0051093),-0.28445031193552445,-0.9916584965931744,0.4855305466237942,0.749503361628492,1.0,17/69,14.68%,KLF7;NOS3;DCC;CST3;GAS6;TFRC;NOTCH1;GRIN3A;TBX1;ARHGEF15;BMP2;TGFB1;HEY2;BMP4;MAPT;PINK1;FGFR3
prerank,sphingosine metabolic process (GO:0006670),-0.3861581407645989,-0.991623415387944,0.47085201793721976,0.7488550824643628,1.0,4/17,5.65%,ACER3;ACER2;PLPP1;SPTLC2
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3574865587122286,-0.9912803539512918,0.48036951501154734,0.7490203858567638,1.0,7/24,12.35%,NAV3;CLASP2;ARHGEF2;LIMA1;STMN2;FGF13;SPEF1
prerank,peptidyl-threonine modification (GO:0018210),0.33257802480008586,0.9912124345288803,0.45982142857142855,0.9581111060435364,1.0,17/66,13.78%,ROCK2;OXSR1;TGFBR1;LRRK2;CDC42BPG;TGFBR2;PDPK1;DYRK1A;PRKDC;GALNT11;CSNK2A2;CSNK2A1;PRKCA;HIPK3;WNK1;MAP2K1;CAD
prerank,negative regulation of cell cycle (GO:0045786),0.33287956083069875,0.9911675414060062,0.47398843930635837,0.9573270443922812,1.0,6/73,3.88%,BMP7;SMAD3;NUPR1;NR2F2;FOXC1;GAS1
prerank,regulation of telomere maintenance (GO:0032204),0.39609173331616704,0.9908887662603607,0.48404255319148937,0.9571795100246243,1.0,13/26,26.89%,HDAC8;SMG1;ATRX;RAD50;USP7;PML;TINF2;NBN;YLPM1;SMG6;PPP1R10;RTEL1;UPF1
prerank,regulation of cholesterol storage (GO:0010885),-0.39521322940380627,-0.9907494348986123,0.4722838137472284,0.7495506476386647,1.0,4/15,7.44%,PPARD;SCARB1;ABCG1;SREBF2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3613876579904537,-0.9907353147644687,0.46403712296983757,0.7488492845994551,1.0,11/22,30.10%,RAD23B;UBB;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;UBC;RPS27A;DDB1;ERCC3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.42149777496016727,0.9904180362832093,0.46819787985865724,0.957617145995809,1.0,3/20,8.91%,IGF1;FOXC1;NIBAN2
prerank,positive regulation of GTPase activity (GO:0043547),0.291629265595118,0.9903946888253683,0.4659090909090909,0.9567790253804448,1.0,16/188,4.59%,DOCK11;AFDN;ARHGAP29;PKP4;PICALM;SIPA1L1;ARHGEF16;SRGAP2;SYDE2;ALS2;NGEF;RGS16;TBC1D16;ASAP3;GMIP;RAPGEF3
prerank,response to amino acid (GO:0043200),-0.332267945609623,-0.9903651664031901,0.45905707196029777,0.7490327501156233,1.0,9/31,15.27%,GLRB;GLRA3;SH3BP4;GLRA1;TMBIM6;CAPN2;SPAAR;GLRA2;GRIN1
prerank,O-glycan processing (GO:0016266),0.34992287976557696,0.9900899492884031,0.4876543209876543,0.956681892229176,1.0,4/54,4.86%,GXYLT2;ST6GAL1;GALNT12;ST3GAL3
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3846356078236937,-0.9896492530889995,0.47115384615384615,0.7501118952307663,1.0,5/18,18.27%,LYN;BCAR1;CMKLR1;SH2B2;C3AR1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4288931354284729,0.9895866379771071,0.4755877034358047,0.9571987502191147,1.0,2/16,4.81%,LEPROT;PARP14
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4147433574795486,-0.9893784615858795,0.45222929936305734,0.7499960679890656,1.0,3/13,11.86%,ENTPD1;ENPP1;SMPDL3A
prerank,vitamin transport (GO:0051180),0.3755315733343492,0.9891655661977115,0.4784853700516351,0.957436307290249,1.0,8/29,12.24%,PDPN;SLC35F3;SLC19A1;SLC27A1;TCN2;SLC19A2;GC;TCN1
prerank,homeostasis of number of cells (GO:0048872),-0.42799465304190604,-0.9891494716750343,0.47568710359408034,0.7498567159170152,1.0,3/12,4.65%,NOS3;CCN3;NOTCH1
prerank,camera-type eye morphogenesis (GO:0048593),0.4851862877853526,0.9887224792638609,0.47752808988764045,0.9577505648472674,1.0,3/10,8.24%,SHROOM2;KDM2B;IFT122
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.47356005226783066,0.988591333373486,0.4805194805194805,0.957218239282097,1.0,3/10,11.04%,BMP7;PHACTR4;ARHGAP12
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3994093433515563,0.9885487794919169,0.4794069192751236,0.9564272537394922,1.0,9/27,15.30%,DDX5;TP53;TNRC6B;RIPK1;AJUBA;DDX6;MAP2K1;MAP2K2;WTIP
prerank,regulation of sodium ion transport (GO:0002028),0.3784815268117603,0.9885205469135006,0.4866220735785953,0.9556135878568992,1.0,6/34,6.53%,WNK4;DLG1;SNTA1;NEDD4;AHCYL1;SIK1
prerank,regulation of membrane depolarization (GO:0003254),-0.3812827179174573,-0.9877736908751055,0.4851694915254237,0.7525330245248101,1.0,9/18,27.33%,CAMK2D;NEDD4L;SMAD7;PTPN3;SCN2B;SCN1B;GPD1L;FHL1;RANGRF
prerank,urogenital system development (GO:0001655),0.472032988498302,0.9876423130312832,0.4780114722753346,0.9570919490152708,1.0,1/11,1.09%,OSR1
prerank,cellular response to virus (GO:0098586),0.39360339791043375,0.9874151122615811,0.46766169154228854,0.9568425685813774,1.0,4/30,10.49%,GSDME;DDX3X;TOMM70;IRGM
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2469355840639943,-0.9871616007484009,0.47863247863247865,0.7533695554124098,1.0,53/173,25.59%,SPTBN1;ANK3;GRIA1;GAS6;VAMP4;CTSC;DYNC1I1;LMAN2L;DYNLL1;CUL3;GOPC;KDELR3;DYNC1LI2;NSF;COG5;DCTN4;CAPZA2;TMED1;PROS1;TMED5;CNIH1;ATL2;SPTB;TMED4;LMAN2;CAPZA1;TMED7;KLHL12;COPE;CTSZ;SPAST;SPTBN2;ATL3;BCAP31;TFG;SPTAN1;TMED9;IER3IP1;MCFD2;VAPA;BCAP29;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;DCTN6;TRAPPC3;ACTR1A;RAB1B;ARFGAP2;COG1
prerank,primary neural tube formation (GO:0014020),0.3849143605476261,0.9870122773642027,0.49585406301824214,0.9570441244325376,1.0,6/30,12.35%,CELSR1;LMO4;MTHFR;IFT122;PHACTR4;DEAF1
prerank,regulation of vasculature development (GO:1901342),-0.3507339806234694,-0.9869333758385422,0.4792176039119804,0.7532098188430038,1.0,15/26,33.71%,BMPER;TSPAN12;FGF2;ERBB2;CTNNB1;EMP2;PLXND1;SFRP1;HTATIP2;VASH1;NF1;HMOX1;VASH2;PROK2;RNH1
prerank,regulation of phosphorylation (GO:0042325),0.30812055382958237,0.9866775234369425,0.46567967698519513,0.957028745028036,1.0,22/120,14.23%,PRKAG2;BMP7;FNIP1;PHIP;SESN2;ROPN1L;STAT2;GCK;LDB1;LDB2;CDH5;SIRT1;NUP42;FER;NUP98;GLMN;ROPN1;NUP43;MCM7;PML;OGT;FLCN
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3116411272838022,0.9863985327872989,0.5006802721088436,0.9568976453469008,1.0,22/119,11.34%,PTPN13;TTC7B;INPPL1;PI4KA;MTMR3;PIGN;SYNJ2;SMG1;PLEKHA2;TMEM150A;PIGW;PIGQ;SLC27A1;PIP4K2C;PTEN;PIK3CA;ITPKB;PIKFYVE;PLEKHA8;PIK3R3;OCRL;SOCS3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.43619373301173414,0.9852243496732007,0.46862745098039216,0.959177472499474,1.0,7/15,24.43%,ZC3H12B;DICER1;ZC3H12C;NYNRIN;POP7;POP1;LACTB2
prerank,cellular lipid catabolic process (GO:0044242),-0.34309997407872994,-0.985199190871542,0.49176470588235294,0.7567936220863084,1.0,9/27,19.38%,PPARD;CYP1B1;ENPP2;LPIN3;MT3;AOAH;SIRT2;SMPDL3B;PLA2G15
prerank,cellular defense response (GO:0006968),0.357577469281369,0.9845486364136523,0.4765751211631664,0.9601333226041575,1.0,6/40,11.91%,CCR9;DCDC2;VEZF1;BECN1;LY96;ZNF148
prerank,tube closure (GO:0060606),0.38065716671035943,0.9841523498334073,0.4901639344262295,0.9602971688288242,1.0,11/31,20.98%,CELSR1;LMO4;MTHFR;IFT122;PHACTR4;DEAF1;MTHFD1;VASP;FOLR1;TSC2;FUZ
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3172449339380968,-0.9841312142665759,0.48031496062992124,0.7586882037931276,1.0,20/37,31.81%,POLD3;ERCC1;UBB;RPA1;GTF2H1;GTF2H4;GTF2H5;RFC4;ERCC2;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;DDB1;RPA3;ERCC3;RPA2
prerank,calcium import into the mitochondrion (GO:0036444),0.4636718002617549,0.9840457168095647,0.48987108655616945,0.9597004770208565,1.0,3/10,6.74%,MCU;SLC25A23;MICU1
prerank,positive regulation of cytokinesis (GO:0032467),0.3741515322317136,0.9839905213950199,0.4672268907563025,0.9589657404105566,1.0,5/32,11.35%,PKP4;CDC14A;AURKB;CDC14B;CDC42
prerank,motile cilium assembly (GO:0044458),0.4605912030759748,0.9836925668352202,0.48175182481751827,0.9589115015469454,1.0,7/12,25.46%,E2F4;CCDC39;BBOF1;CCDC40;SPATA6;RSPH6A;BBS5
prerank,muscle filament sliding (GO:0030049),0.360977373141077,0.9836611045283444,0.4720394736842105,0.9572362955705424,1.0,5/38,13.05%,ACTN2;TPM1;MYL4;TNNI3;TNNC1
prerank,actin-myosin filament sliding (GO:0033275),0.360977373141077,0.9836611045283444,0.4720394736842105,0.9572362955705424,1.0,5/38,13.05%,ACTN2;TPM1;MYL4;TNNI3;TNNC1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3693756252052094,-0.9836511627549176,0.4701834862385321,0.759071991446387,1.0,10/20,13.58%,ENG;TGFB2;TBX3;ACVRL1;NOTCH1;HEYL;BMP2;HEY2;BMP4;SPRY1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.3912325568164512,0.9835469227374862,0.5050505050505051,0.9566628144452773,1.0,6/28,9.87%,APPL2;PRKCZ;PRKCB;TNS2;PIP4K2C;GRB10
prerank,negative regulation of peptidase activity (GO:0010466),-0.3028025241215634,-0.9833592028193916,0.5144356955380578,0.7590950321024358,1.0,9/47,8.46%,SPOCK2;SERPINE2;CST3;SPOCK3;SERPINI1;SERPINF1;TIMP2;ECM1;SPOCK1
prerank,positive regulation of telomere maintenance (GO:0032206),0.37936858011205854,0.9833573370953027,0.46243739565943237,0.9562677090805262,1.0,10/31,19.01%,ATM;ATRX;HNRNPA2B1;TNKS2;AURKB;RAD50;PNKP;PML;NBN;SLX4
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.394686190176136,0.9833101434842046,0.46748681898066785,0.955513717690991,1.0,2/24,6.88%,LPGAT1;SLC27A1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.3952986925686698,-0.9832807970242246,0.4926315789473684,0.758533976830049,1.0,4/15,18.79%,ANXA1;GPER1;FAM107A;BCL2L11
prerank,embryonic hemopoiesis (GO:0035162),0.4552155664362558,0.9832507062388578,0.48731884057971014,0.9547857637780222,1.0,4/12,10.08%,KIT;KMT2A;TGFBR2;FLT3LG
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.27656217679832523,-0.9832000700654591,0.49032258064516127,0.7580210971607698,1.0,30/75,24.71%,SLC8A1;PTPRJ;HEG1;RASIP1;LYN;DAB2IP;APOE;SORL1;IRAK3;UCHL1;DUSP1;BMP4;PRKAR1B;PRKAR2B;MYOCD;SPRY1;HHEX;APC;MEN1;SPRY4;PTPN1;PRKAR2A;AGT;PYCARD;LRP6;STK38;PAQR3;TFAP4;HYAL2;PKIG
prerank,UV-damage excision repair (GO:0070914),-0.42481257694517277,-0.9828660475548108,0.48722986247544203,0.7580788362514764,1.0,3/12,12.57%,POLA1;POLD3;ERCC1
prerank,receptor catabolic process (GO:0032801),0.4018762805486528,0.9828158312726053,0.48983050847457626,0.9550832116908878,1.0,6/24,14.64%,RNF43;NEDD4;UVRAG;BECN1;CLTC;AP2A1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4602204810060733,0.9826713641427415,0.4659090909090909,0.954572332415121,1.0,4/10,12.26%,EPHA4;CDK5RAP3;ATRAID;RGP1
prerank,regulation of cell adhesion (GO:0030155),0.30397956037604795,0.9825937916642282,0.5055096418732782,0.953905192365951,1.0,25/129,12.40%,ROCK2;PKP4;FBLN1;IL18;PLXNA2;EPHA4;RHOD;PKHD1;PPP1CB;C2CD4B;FUT1;DACT2;TPM1;ATM;EPHA8;IL12B;KNG1;TNFRSF18;HRG;HYAL1;ABL1;ITGAV;PTPN11;PRKCA;MIA3
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.3017539626087418,-0.9823995982042572,0.4985507246376812,0.7584950727828396,1.0,8/46,14.40%,DGKH;DGKB;PLA2G4A;PLA2G12A;DGKG;DGKZ;PNPLA3;ABHD4
prerank,positive regulation of protein deacetylation (GO:0090312),0.43053553218145324,0.9822193533002609,0.48028673835125446,0.9540148708857569,1.0,6/14,25.14%,NIPBL;DYRK1A;FNTA;ZBTB7B;AKAP8;ING2
prerank,regulation of response to external stimulus (GO:0032101),0.30217316037461306,0.9819419618823199,0.48339973439575035,0.953880661016105,1.0,28/121,16.96%,EFNB2;APPL2;NMT2;LACC1;METAP2;RNF135;F2;RHO;TKFC;PTPN22;SAMHD1;NR1D2;ADGRA2;HRG;CYRIB;NLRP6;FNTB;DHX58;FOXA2;IRF1;ERAP1;USP18;ZMPSTE24;BIRC3;PDGFRA;SAG;FNTA;CCR2
prerank,post-translational protein modification (GO:0043687),0.2768389693608606,0.9818499949468895,0.5304948216340621,0.9532781539821288,1.0,50/332,14.34%,EPAS1;APLP2;ITIH2;ASB2;SERPIND1;CP;LAMC1;OBSL1;SPP1;SPSB1;IGFBP7;DCAF11;FBXL19;KLHL41;ATG5;SPSB4;DSCC1;LGALS1;FBN1;KNG1;FBXW11;RABGGTA;IGFBP3;BTRC;NUCB1;ASB15;FBXO22;LRRC41;RAB11B;DCAF10;RAB13;FBXL12;UBE2M;FBXW8;FBXO4;SOCS3;ASB14;CUL4A;CUL9;FBXO10;MIA3;NUB1;ASB5;MBTPS1;ASB12;DDB2;PRKCSH;FBXO11;SERPINC1;FBXL20
prerank,supramolecular fiber organization (GO:0097435),0.27713627449559636,0.9815833105232968,0.5304054054054054,0.9530984846662123,1.0,36/334,6.82%,COL5A1;TSPAN5;COL22A1;COL26A1;SNCAIP;CGNL1;LAMC2;COL4A5;DLG1;SHROOM2;HOOK2;KIF2A;RHOBTB2;AVIL;PRKN;RHOD;SHROOM3;INPPL1;COL18A1;COL4A3;TMOD2;MYO5C;LOXL1;ADAMTS2;TGFBR1;LOXL3;RUFY3;TMOD3;TPM1;KLHL41;COL9A2;USP9X;ARHGAP17;MPRIP;COL13A1;TRIOBP
prerank,negative regulation of response to wounding (GO:1903035),-0.3814806805121235,-0.9811406879952087,0.5114155251141552,0.7607548941361872,1.0,9/19,22.06%,CASK;AJAP1;CD109;CRK;FGF2;RTN4RL1;RTN4R;MDK;GIT1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.35599564988495136,-0.9809703856019839,0.5059101654846335,0.7604519104025038,1.0,8/25,10.44%,CAV1;CTNNA3;RYR2;CAMK2D;TBX18;CALM1;FGF13;CALM3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4321176151647561,0.9807918984209544,0.488245931283906,0.9543318272710007,1.0,5/16,13.34%,HMGA1;TWNK;SSBP1;MCM7;MCM2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.4191412758954784,0.9800453141463769,0.5183150183150184,0.9554327940003217,1.0,1/19,1.44%,IGF1
prerank,pre-replicative complex assembly (GO:0036388),-0.2820673475430382,-0.9799446522870487,0.5059171597633136,0.7622755853615495,1.0,25/64,34.29%,PSMB2;PSMD14;PSMC6;UBB;PSMA4;PSMB9;ORC5;ORC2;PSMD11;PSMB10;PSMD2;PSMA2;UBC;RPS27A;PSMB3;MCM6;PSMB5;PSMA7;PSMF1;PSMD7;MCM4;MCM8;PSMA5;PSMD4;PSME4
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.24381422706100012,-0.9796290488033017,0.5125628140703518,0.7623330185546131,1.0,42/175,21.96%,PID1;ACTN4;TMSB4X;ST18;PTK2B;TNFRSF11B;NFKBIA;ARHGEF2;PSMB2;TNFRSF11A;DAB2IP;TRAF5;RPS3;CARD14;TNFRSF1B;TNFRSF21;PSMD14;ERBIN;PSMC6;GPER1;ILK;YBX3;IKBKB;AIM2;LIMS1;PSMA4;PSMB9;DHX9;EDAR;CCL13;MAP3K14;TRAF1;TNFRSF25;PSMD11;PSMB10;PSMD2;CCL19;HAS2;SFRP1;PYCARD;ASAH1;TXNDC17
prerank,positive regulation of interleukin-10 production (GO:0032733),0.37926309811585224,0.9795932834573857,0.4930555555555556,0.9556914489287711,1.0,5/30,10.07%,PRKCZ;TLR4;CD28;IL12B;CD274
prerank,polyamine metabolic process (GO:0006595),0.44453763666340085,0.9793496902806833,0.4781783681214421,0.9554814735524692,1.0,3/13,8.05%,SMOX;SAT1;PAOX
prerank,regulation of autophagosome assembly (GO:2000785),0.3745356391548112,0.9793492832700563,0.5,0.9546186142604604,1.0,8/33,11.12%,MTMR3;NUPR1;NPRL3;LRRK2;NPRL2;PIP4K2C;PIKFYVE;IFT88
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3319267692229326,0.9792727867764632,0.47085201793721976,0.9539809660259683,1.0,10/62,11.77%,POLR2A;CTR9;ELOF1;AFF4;CCNT2;POLR2D;ELL;GTF2F1;RTF1;NELFCD
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.2714992982565365,-0.9792540300289411,0.4854368932038835,0.7625316710784533,1.0,31/79,25.09%,SH3GL2;CTSD;MFSD6;DYNC1I1;DYNLL1;AP1S2;DYNC1LI2;AP2B1;KIF26A;DCTN4;CTSL;AP2M1;CAPZA2;CTSS;KIF3A;AP1S3;CAPZA1;CENPE;KIF15;CD74;SPTBN2;KIF11;AP1S1;KIF5A;KIF22;KIF4A;KIF3B;SAR1B;DCTN6;ACTR1A;KIF23
prerank,genitalia development (GO:0048806),-0.4155676535298953,-0.9791872083471584,0.5059288537549407,0.7619802929044102,1.0,4/12,12.26%,TBX3;STRA6;PKD1;FOXF2
prerank,positive regulation of angiogenesis (GO:0045766),0.30743700642896393,0.9790185612380048,0.48700410396716826,0.9537748456398546,1.0,18/108,9.92%,FGF1;ADAM12;SMOC2;SASH1;HK2;SPHK1;FUT1;RAPGEF3;PRKCB;CTSH;FLT1;SERPINE1;PDPK1;CDH5;HYAL1;SIRT1;STIM1;FOXC2
prerank,RNA biosynthetic process (GO:0032774),0.37871436442762174,0.9789117192809544,0.4654605263157895,0.95320078640647,1.0,10/31,16.15%,POLR2A;TTF2;TERT;TBP;TAF4;POLA2;BRF1;TAF7;TTF1;TAF13
prerank,activation of protein kinase activity (GO:0032147),0.3131032504378542,0.9786133636193809,0.49363507779349364,0.9531146410324255,1.0,13/106,8.74%,FGF1;ADCY5;OSBPL8;IGF1;ADCY1;IL18;ADRA2A;TLR3;RICTOR;ADCY9;TGFBR2;NRG1;PDPK1
prerank,positive regulation of secretion by cell (GO:1903532),0.3294158877461997,0.9781562700051637,0.4962630792227205,0.9535289631149749,1.0,7/70,4.65%,BMP6;FRMD4A;IGF1;CLASP1;DTNBP1;MYO18A;EZR
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.45367465244213434,0.9777234598537363,0.4979508196721312,0.9537753406746335,1.0,4/11,8.81%,PCBP2;IGF2BP1;IGF2BP2;NOVA1
prerank,mitotic cytokinesis (GO:0000281),-0.3005051515839911,-0.9775912565176913,0.4787234042553192,0.7652344904970753,1.0,21/47,25.09%,SPTBN1;ANK3;CIT;RHOB;ANLN;PDCD6IP;RASA1;TRIM36;STMN1;USP8;APC;NUSAP1;CHMP4B;EFHC2;SPAST;ECT2;CUL7;RHOC;KIF4A;CENPA;KIF23
prerank,positive regulation of JNK cascade (GO:0046330),-0.2776206896923261,-0.9766152949912678,0.5299145299145299,0.7669018741539105,1.0,25/70,21.18%,MAP3K5;RASSF2;SH3RF3;PTK2B;DAB2IP;MINK1;TRAF5;APP;TNFRSF19;ANKRD6;MFHAS1;FLT4;TIRAP;AXIN1;GADD45G;MBIP;HIPK2;EDAR;NOD2;TRAF1;WNT16;GADD45B;CCL19;MAP3K11;PYCARD
prerank,inner mitochondrial membrane organization (GO:0007007),0.35072121899096353,0.976581768494908,0.48985959438377535,0.9559038048648861,1.0,14/47,20.02%,CHCHD3;SAMM50;OPA1;TMEM11;MICOS10;TOMM70;ATP5F1D;MICOS13;IMMT;ATP5F1C;TIMM10;MTX2;AFG3L2;DMAC2L
prerank,skeletal muscle organ development (GO:0060538),0.3928308557370332,0.9762326975002978,0.4841549295774648,0.9560023251883428,1.0,4/26,3.02%,IGSF8;CSRP3;LARGE1;CFLAR
prerank,regulation of cell motility (GO:2000145),0.30052664056155665,0.9758461399313507,0.48732394366197185,0.9561870660555363,1.0,17/121,10.62%,FGF1;ROCK2;FBLN1;KIF2A;PLXNA2;LMO4;ARHGAP18;MGAT3;TBCCD1;LDB1;LDB2;NRG1;DIAPH1;AMOTL2;HBEGF;CYRIB;ABL1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3744571946670808,-0.9757448045965629,0.4737991266375546,0.7682490345978276,1.0,6/18,10.85%,APOE;CTSC;DACT1;RDX;HSP90AA1;MSN
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.387625704555406,-0.9757063878339571,0.5042735042735043,0.7676123293123668,1.0,5/17,14.08%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.45053585334450463,0.9756628041273091,0.5114068441064639,0.9557914046957251,1.0,3/13,4.75%,ANK2;KCNA5;CACNA1C
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27163137297680606,0.9756586824062572,0.5310734463276836,0.9549471290644947,1.0,76/417,14.08%,BMP7;TFDP2;WNT4;ZIC2;FOXN3;ZNF423;JARID2;ZHX2;SNX6;FOXD1;ZNF568;DKK3;ARID4A;NR2F2;NCOR2;TSHZ3;GLI3;ZBTB38;NACC2;VGLL4;LOXL3;FOXP2;SFMBT1;CBFA2T2;HMGA1;LBH;ZNF318;TP53;BHLHE41;SMURF2;NIPBL;LDB1;FBXW11;BCOR;SMARCA4;NR1D2;BTRC;RBM15;SPEN;KAT6B;NRG1;SMARCC2;NIBAN2;SMARCE1;HDAC4;SCML4;SIRT1;TLE1;HDAC1;SOX13;CBY1;SPINDOC;CHMP1A;TCF7L2;ZNF219;PRDM5;SAP18;EIF4A2;BAHD1;WWP2;CBX5;ZNF148;UIMC1;BRD7;DEAF1;MLXIPL;IRF1;KAT7;KMT5A;SIN3A;PML;TLE2;BCL7A;NCOR1;CRYAB;PER2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4283685119564636,-0.9756417226520905,0.5063025210084033,0.7670465963506998,1.0,4/11,16.57%,STAT3;LIMD1;FXR1;DHX9
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.3611641317454168,-0.9754669199897427,0.4935897435897436,0.7667707929223514,1.0,10/19,32.88%,CYBA;GPX1;CAT;PRDX1;SOD1;GPX3;PARK7;PRDX2;PRDX4;PRDX3
prerank,gluconeogenesis (GO:0006094),0.3683075466807441,0.9752585065851889,0.4907120743034056,0.955148690244976,1.0,12/39,17.87%,PPARGC1A;PGAM2;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;SLC25A10;GOT1;SLC37A4;CRY1
prerank,meiosis I (GO:0007127),0.39102623701101397,0.9749268059711663,0.5,0.9551940709080841,1.0,4/23,12.98%,CCNA1;MOV10L1;MYBL1;FOXJ2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4076757284872608,0.9746989330837342,0.49225473321858865,0.9549357509031323,1.0,3/20,5.59%,PPARGC1A;PRKAA2;ARRB1
prerank,GPI anchor metabolic process (GO:0006505),0.3902420116354011,0.9744770671982553,0.47950089126559714,0.954646096897157,1.0,3/26,6.36%,PIGN;PIGW;PIGQ
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.40234507214991133,0.9743700499114182,0.4634146341463415,0.9540719129167804,1.0,5/21,17.11%,IGF1;BMPR1A;FOXJ2;MFN2;MEF2D
prerank,cellular response to nutrient levels (GO:0031669),0.335153019423952,0.9742035788139979,0.4843260188087774,0.9536634528785501,1.0,17/62,19.05%,PRKAA2;PPARA;FNIP1;LRRK2;LAMP2;WIPI1;NUPR2;SIRT1;ATG7;FLCN;TSC1;RPTOR;EHMT2;RRAGD;ZFYVE1;EIF4G1;USP33
prerank,catecholamine biosynthetic process (GO:0042423),0.45322553462838183,0.9741540321174378,0.46393762183235865,0.952948898641764,1.0,1/11,1.04%,MOXD1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.45600033946119867,0.9741193436566188,0.5262206148282098,0.9521893777400873,1.0,3/12,12.68%,DPYD;CTPS2;ALDH6A1
prerank,Notch signaling pathway (GO:0007219),-0.291097455837664,-0.9741029116270113,0.5030487804878049,0.7694034336263723,1.0,14/59,9.92%,SORBS2;MAML2;NOTCH3;YBX1;JAG1;NOTCH1;HES1;PSEN1;JAG2;HEYL;BMP2;WWC1;HEY2;PBX1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3464885813723485,0.9740230170044042,0.4776357827476038,0.9515980347994102,1.0,9/46,9.99%,SMAD3;NEDD4;RAPGEF3;CAMK1;TP53;ZIC1;UBR5;MAVS;TCF7L2
prerank,negative regulation of immune system process (GO:0002683),-0.3822916663298671,-0.9738967139850776,0.49665924276169265,0.7691773171816307,1.0,3/16,11.24%,CD200;LYN;GPER1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.24258505479170264,-0.9734848103170657,0.5215311004784688,0.769439053284955,1.0,34/172,14.40%,DGKH;DGKB;PIP5K1B;PIK3R1;INPP4B;PLA2G4A;PIP4K2A;PIK3C2B;INPP5D;CEPT1;BMX;PLCG2;PLEKHA1;PIK3R6;SLC44A5;MTMR6;SLC44A2;LPCAT2;MTMR2;FGF2;PLA2G12A;MTMR7;MFSD2A;MTMR9;ETNK1;SLC44A1;DGKG;DGKZ;PLEKHA3;PITPNM3;LPIN3;PNPLA3;CDS1;ABHD4
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3201330107106589,-0.9734493539315701,0.49504950495049505,0.7688028407443276,1.0,9/32,10.80%,PIK3R1;PLCE1;CARMIL1;ARHGEF7;ACTR2;OCLN;CORO1C;ACTR3;ENPP2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.43583523773551924,0.9732303008674471,0.5054545454545455,0.9528155606445952,1.0,5/15,20.59%,GLI3;IL12B;CCR2;IHH;CD55
prerank,intermediate filament organization (GO:0045109),-0.38108249725598964,-0.9732074425866549,0.49667405764966743,0.7686653894647284,1.0,6/17,25.86%,VIM;BFSP2;PKP2;NEFL;GFAP;DES
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3891492694817321,0.9731738138533849,0.49110320284697506,0.9521128378107964,1.0,3/25,5.39%,KIT;LACC1;FZD5
prerank,mRNA modification (GO:0016556),-0.35451339365812695,-0.9731716181292012,0.5181818181818182,0.7680240924949895,1.0,13/22,37.75%,TRMT61B;METTL3;TRMT6;PUS1;PUS7;TRUB1;DKC1;ZC3H13;CBLL1;TRMT10C;RPUSD2;TRUB2;TRMT61A
prerank,negative regulation of cellular process (GO:0048523),0.26697783412338655,0.9730440879786532,0.556975505857295,0.9516127274343322,1.0,89/521,14.30%,TGFBR3;ALDH1A2;BMP7;SMAD3;APPL2;FBLN1;SYT11;GSDME;FGFBP1;CCN2;PTPN14;NPR1;PRKN;PLXNA2;PKHD1;KANK2;SRGAP2;COL18A1;NUPR1;COL4A3;ARID2;MAGI2;IGFBP7;SPEG;PDPN;IFIT3;SESN2;NACC2;VGLL4;SMAD6;TNS2;DACT2;CLMN;IFNK;DDX3X;CAPRIN2;SOD2;ATG5;HMGA1;TP53;EIF2AK2;UBR2;FER1L5;SSTR3;KNG1;DLG3;PTPRU;PLSCR1;PTEN;SMARCA4;IGFBP3;OSGIN2;HRG;NUPR2;NIBAN2;SULT2B1;HYAL1;SIRT1;GTPBP4;CHMP1A;MYBL1;SLURP1;BECN1;NOX4;NME6;RNF41;RARG;MNT;IMPACT;OSGIN1;GLMN;AXIN2;NMI;BRD7;MIA3;IRF1;FRK;PPP1R13B;IFI35;PODN;PIP4P2;MAP2K1;PML;CRYAB;DNAJB2;FLCN;TSC1;KAT2B;AGTR2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3440127705971153,0.9730359802972861,0.4834123222748815,0.9507929687589749,1.0,9/57,9.43%,PPARGC1A;PRKN;MCU;BID;FAM162A;TP53;HTT;DNM1L;ADCK1
prerank,proteolysis (GO:0006508),0.27929323148111107,0.9728934179436094,0.525609756097561,0.9503110962796869,1.0,41/252,15.78%,AEBP1;ACE;CPQ;BACE2;TRABD2B;SUFU;CASP3;DPP4;CPA4;SRGN;CTSH;DPP8;METAP2;ADAMTS9;TPP1;CLPX;TBL1X;MMP19;APH1B;NPEPPS;BMP1;MMP14;ADAM17;DESI2;DESI1;ATG4D;FOLH1;MBTPS1;ERAP1;PCSK7;OGT;SDE2;CAPN15;ATG4C;PITRM1;TMPRSS5;ADAMTS7;ZMPSTE24;PLAT;CELA3A;ANPEP
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.32820529427249157,0.9719957578861129,0.4873323397913562,0.9517788161263876,1.0,10/64,11.77%,POLR2A;CTR9;ELOF1;AFF4;CCNT2;POLR2D;ELL;GTF2F1;RTF1;NELFCD
prerank,negative regulation of neuron differentiation (GO:0045665),0.4079916839768005,0.9713980327241479,0.5135135135135135,0.9525152972687385,1.0,2/22,3.66%,BMP7;DTX1
prerank,mitotic recombination (GO:0006312),0.4306516381876263,0.971385177460297,0.497164461247637,0.9517180253303645,1.0,7/15,19.85%,TPRKB;TEP1;MSH3;RAD50;NSMCE2;RAD51D;XRCC3
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3664024661543153,0.9710095440139764,0.5072933549432739,0.9518226576379637,1.0,6/36,11.67%,TFDP2;PCGF2;MGA;TFDP1;RBBP8;CBX5
prerank,regulation of phospholipase C activity (GO:1900274),0.4427617335757862,0.9706063398327177,0.5113636363636364,0.9520263186291613,1.0,5/15,10.62%,KIT;FGFR1;FLT1;PDGFRB;ABL1
prerank,pulmonary valve development (GO:0003177),0.42699055290312726,0.9704453281618295,0.526032315978456,0.9515831849230615,1.0,2/18,0.29%,NOTCH2;ROBO1
prerank,small GTPase mediated signal transduction (GO:0007264),0.3063377237054097,0.9702371179272827,0.5221606648199446,0.9513092815637977,1.0,10/103,5.01%,RAPGEF5;KSR1;IGF1;RIN2;ARHGEF18;ARHGAP18;CCNA2;RGL1;ADRA2A;RREB1
prerank,response to alcohol (GO:0097305),0.38164379785443103,0.9701564679215705,0.4826989619377163,0.9506865698647433,1.0,4/27,7.36%,TGFBR3;TGFBR1;TGFBR2;GOT2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4448771137931685,0.9701369543214695,0.5009345794392523,0.949903558391762,1.0,2/12,6.47%,IL18;IL12B
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.39031602924149644,0.9698587559916144,0.47758620689655173,0.9497947920938262,1.0,5/22,13.76%,APPL2;PTPN22;RAB7B;IFI35;ACOD1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3117457527248612,-0.9695681693666391,0.48633879781420764,0.7759697720032351,1.0,13/39,14.49%,PODXL;FXYD5;NEXMIF;JAG1;NOTCH1;MBP;BMP2;TGFB1;PTK2;RDX;CDH1;VEGFA;PPM1F
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3526648294554342,0.9691641514802721,0.49382716049382713,0.9507372340723678,1.0,14/45,19.70%,DDX5;POLR2A;TP53;ZC3H18;RIOK2;RIPK1;DYRK1A;WDR43;MAP2K1;MAP2K2;NFKB1;GRSF1;BUD23;DXO
prerank,cellular response to leucine starvation (GO:1990253),0.4601547128601663,0.9688811625347703,0.4885057471264368,0.950664167050874,1.0,4/10,17.13%,SESN1;SESN2;IMPACT;RRAGD
prerank,B cell differentiation (GO:0030183),-0.2979432088206544,-0.9687995275664393,0.496,0.7771419212374996,1.0,8/46,7.59%,PTPRJ;TPD52;VCAM1;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4
prerank,oogenesis (GO:0048477),-0.38940004111320164,-0.9687729793590922,0.5,0.7764693796916984,1.0,6/15,26.22%,FMN2;PTN;METTL3;MEI4;MDK;NANOS3
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4389339951945638,0.9686568635543968,0.50293542074364,0.950453134096358,1.0,2/12,6.70%,UST;DSE
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.28122644155239157,0.9682974186247817,0.5416149068322982,0.9505672119190919,1.0,17/214,6.37%,NOTCH2;TGFBR3;DUSP29;FBLN1;TIMP3;PRKCZ;CCN2;DLG1;FGFR2;SLC30A10;PKHD1;NPNT;EZR;TLR4;ARRB1;BRAF;PDGFRB
prerank,glucose metabolic process (GO:0006006),0.33708047936282975,0.968235464901054,0.5165945165945166,0.94990440929648,1.0,15/58,17.87%,PPARGC1A;SORD;PGAM2;GALM;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;BRAT1;SLC25A10;GOT1;SLC37A4;CRY1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.321387884195937,0.9681725916313045,0.5021337126600285,0.9492209288343317,1.0,18/77,16.74%,IGF1;PRKN;CFLAR;PHIP;TGFBR1;DDX3X;OPA1;HTT;RIPK1;TCF7L2;SH3RF1;ITGAV;CSNK2A2;CSNK2A1;LGALS3;BIRC6;RB1;MCL1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.43565982639556017,0.967767304860606,0.5020080321285141,0.9494045891933401,1.0,1/13,1.44%,IGF1
prerank,retinal metabolic process (GO:0042574),0.4554914917693064,0.9677470783965375,0.5178571428571429,0.9486254858839991,1.0,1/12,1.07%,ABCA4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.3231488671424203,-0.9676127620745401,0.5112219451371571,0.7785491938656793,1.0,8/33,8.32%,TEK;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;GATA2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3514102107341591,0.9675921480002915,0.4984076433121019,0.9482263509483083,1.0,8/43,9.87%,SORBS1;PRKCZ;PRKCB;TNS2;GKAP1;PIP4K2C;SIRT1;GRB10
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.4351776639798205,0.9674355316576291,0.4892086330935252,0.9477919238040592,1.0,2/15,1.53%,KIT;WHRN
prerank,hexose transmembrane transport (GO:0008645),0.3986202868549686,0.9672085853933499,0.4893238434163701,0.9475915459341947,1.0,3/21,9.52%,SLC2A12;SLC5A3;SLC45A3
prerank,cristae formation (GO:0042407),0.3844624721621019,0.9669947347859582,0.4911660777385159,0.9473321991647675,1.0,10/27,23.86%,CHCHD3;SAMM50;ATP5F1D;MICOS13;IMMT;ATP5F1C;AFG3L2;DMAC2L;LETM1;CHCHD6
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3958983718515626,0.9669086809719073,0.46608695652173915,0.9467135354799152,1.0,7/21,20.92%,OSBPL8;PLA1A;OSBPL10;PLA2G5;MBOAT2;LPCAT4;PLAAT3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4059867153554742,0.9668653420667123,0.5080789946140036,0.9459975326194296,1.0,9/20,26.19%,ZC3H7B;SNIP1;TERT;DICER1;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,cognition (GO:0050890),-0.3051131268832346,-0.9664389110649585,0.4935064935064935,0.7806110804663381,1.0,11/42,11.72%,GRM5;ST3GAL4;SHROOM4;DOP1B;APP;PTCHD1;STRA6;SLC1A4;GPR155;MFSD2A;FAM107A
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.377598249103827,-0.9662087616848849,0.48853211009174313,0.7804164480826724,1.0,3/17,10.92%,PDE3B;SORL1;MFSD2A
prerank,nuclear membrane disassembly (GO:0051081),0.4298347261843231,0.9657990556687709,0.4873294346978557,0.9478392735409666,1.0,3/14,12.32%,PRKCB;CCNB2;PRKCA
prerank,dermatan sulfate metabolic process (GO:0030205),0.42948324473243693,0.9657496271730113,0.5085714285714286,0.9471568381869665,1.0,2/13,6.70%,UST;DSE
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4434114884445425,0.964530727334822,0.5,0.9494385914905957,1.0,4/13,14.62%,TNRC6A;TNRC6B;CPEB3;TNRC6C
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.3699263912792274,-0.964136400940718,0.5022522522522522,0.7846972350444625,1.0,7/17,31.52%,NUS1;ALG6;ALG8;ALG9;ALG13;ALG3;DPAGT1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.46631000049318966,0.9637954961045351,0.5196850393700787,0.9504888372940928,1.0,2/10,11.12%,WHRN;IFT88
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.3827136028776706,-0.9636864388199026,0.526431718061674,0.785132964314063,1.0,1/17,0.39%,CADM1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3452476788677203,0.9636002937581336,0.5015384615384615,0.9501604633409431,1.0,13/49,14.62%,KMT2A;TNRC6A;TNRC6B;RBM15;HDAC1;ASH2L;MOV10;KMT2C;RAB7B;KMT2D;SIN3A;KAT2B;TNRC6C
prerank,regulation of cellular component biogenesis (GO:0044087),0.35166659547300017,0.9635885814115628,0.47572815533980584,0.9493630542583131,1.0,8/39,12.27%,ROCK2;SNCAIP;PARP10;EZR;HRG;IRGM;BBS10;PTPN11
prerank,response to lipid (GO:0033993),-0.260161338843228,-0.9635818856000723,0.5179856115107914,0.7846289468808164,1.0,23/105,13.16%,ESR1;NOS3;ACER2;PPARD;STAT3;ANXA1;TNFRSF11A;FOXP1;ABCG1;GCH1;SOCS2;ALPL;FOXO1;TGFB1;IRAK3;STAT5B;SCD;ERBIN;RPS6KA3;TIRAP;CTNNB1;NOS1;SNCA
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3579014766014398,0.9635517620285495,0.5275974025974026,0.9486383114284206,1.0,4/41,7.23%,BMP7;AFDN;PTPN23;PTPRU
prerank,mRNA processing (GO:0006397),0.2749320140052955,0.9634102199199397,0.5444191343963554,0.9481724046526004,1.0,79/287,23.46%,SRRM2;DDX5;PPARGC1A;POLR2A;SON;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;POLDIP3;SNIP1;HNRNPA2B1;RPRD2;POLR2D;RBM15;SPEN;NOVA1;GPKOW;CCAR1;CWC27;TBRG4;GTF2F1;PRPF18;HNRNPL;CWC15;IK;USP49;PHF5A;SRSF11;CMTR2;PRCC;RAMAC;HNRNPC;SCAF11;PRPF3;SARNP;SNRNP40;RBM4;TFIP11;HNRNPM;CPSF3;CWF19L1;FRG1;USP39;ALKBH5;ZCRB1;PRPF6;FUS;SRSF1;CSTF1;HNRNPH3;CDC40;PCF11;SRSF10;U2AF1;EFTUD2;SNRPC;SRSF7;SF1;PNN;POLR2G;WBP4;PRPF31;SNRPA1;U2AF2;SF3B2;SF3B1;PPWD1;SF3B5;CPSF7;GCFC2;PQBP1;CDC5L;RNPC3;NUDT21;POLR2F;CMTR1
prerank,lymphocyte proliferation (GO:0046651),-0.356184355364296,-0.9632811481030052,0.4964871194379391,0.7846391652480472,1.0,3/22,10.85%,MEF2C;PTPRC;MSN
prerank,protein glycosylation (GO:0006486),-0.2500297061924508,-0.9629859201766428,0.5490909090909091,0.7846155749954344,1.0,29/125,17.46%,MGAT4C;ST3GAL4;ST8SIA4;GCNT2;EOGT;FUT9;MGAT4A;ST3GAL1;ST8SIA1;FKTN;GALNT7;B4GALT5;AQP11;B3GALT1;ST3GAL6;MGAT5;ST8SIA6;B3GALNT1;GFPT2;DAD1;B3GALT5;GAL3ST1;NUS1;RPN1;GALNT2;MGAT5B;GALNT10;ALG6;TUSC3
prerank,antibacterial humoral response (GO:0019731),0.42433069715305494,0.9627976961733228,0.48484848484848486,0.948918822849964,1.0,4/16,16.60%,DEFB1;PLA2G6;CAMP;DMBT1
prerank,iron ion homeostasis (GO:0055072),0.33126992876498174,0.9627908615664736,0.5147744945567652,0.9481252239795624,1.0,3/58,1.42%,BMP6;CP;PICALM
prerank,positive regulation of autophagy (GO:0010508),0.3143878034790741,0.9624187746296318,0.5295857988165681,0.9483350736773798,1.0,12/81,10.49%,RNF152;PRKAA2;PRKN;SESN1;TPCN1;LRRK2;SESN2;NPRL2;LARP1;HTT;SIRT1;IRGM
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3438712108065829,0.9620427998270313,0.5158371040723982,0.9476428167165311,1.0,26/50,30.67%,POLR2A;TNRC6A;POLR2D;NUP42;NUP98;NUP43;NUP155;EIF4G1;NUP188;POLR2G;FMR1;NUP153;AGO1;POLR2F;AAAS;NUP88;AGO2;PUM2;SEC13;POLR2K;IPO8;NUP160;RANBP2;NUP37;RAE1;NUP133
prerank,regulation of gene silencing by RNA (GO:0060966),0.3438712108065829,0.9620427998270313,0.5158371040723982,0.9476428167165311,1.0,26/50,30.67%,POLR2A;TNRC6A;POLR2D;NUP42;NUP98;NUP43;NUP155;EIF4G1;NUP188;POLR2G;FMR1;NUP153;AGO1;POLR2F;AAAS;NUP88;AGO2;PUM2;SEC13;POLR2K;IPO8;NUP160;RANBP2;NUP37;RAE1;NUP133
prerank,response to estrogen (GO:0043627),-0.3281907703059577,-0.9620307727267453,0.5254691689008043,0.7862163671658012,1.0,7/31,21.03%,CAV1;ESR1;AR;SERPINB9;NCOA4;ARID5A;SFRP1
prerank,negative regulation of cell death (GO:0060548),0.317686907350714,0.9619532049793786,0.5248933143669986,0.9470400788142868,1.0,9/88,6.02%,BMP7;PPARGC1A;CCN2;PRKN;KANK2;SRGAP2;LRRK2;PM20D1;ATG5
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.35165266600329875,0.9619239104024871,0.47974068071312803,0.9463066462771822,1.0,9/38,14.28%,PPARA;PKHD1;MAGI2;DAG1;PTEN;SIRT1;PHLPP2;FLCN;THEM4
prerank,hyaluronan metabolic process (GO:0030212),-0.34344089001280653,-0.9616935495296346,0.5220264317180616,0.7862756551235035,1.0,5/23,9.92%,CEMIP;TGFB1;HEXB;FGF2;CD44
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.37445408688050474,0.9616013660031588,0.5083612040133779,0.9462983457472125,1.0,4/29,7.20%,ACSL1;ACSBG2;HACD1;SCD5
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3718463261688413,0.9615917825915331,0.5082236842105263,0.9455100908589297,1.0,6/32,13.65%,DDX5;FHIT;TP53;SIRT1;PPP1R13B;PML
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.34338968909451306,-0.9613394657781204,0.4892086330935252,0.7864329417267373,1.0,7/24,9.38%,RYR2;HTR2C;RYR3;PTPRC;PLCG2;HTR2A;FGF2
prerank,regulation of programmed cell death (GO:0043067),-0.2388908246780116,-0.960382082718363,0.5689655172413793,0.7879730754206445,1.0,46/161,22.70%,MECOM;HIP1;ACTN4;RTN4;ACTN1;ACER3;TPT1;ACER2;APAF1;PHLPP1;RPS3;PERP;CALR;CTSB;TOX3;ANP32A;HSP90AA1;BCAR1;MAGED1;DAPK1;LCMT1;FAS;TM7SF3;LRP8;PINK1;NOP53;DNAJA3;CLU;CASP6;PAX2;CRADD;BCL3;CASP2;TNFRSF25;TIGAR;BCL2L11;PAX8;AGT;DAPK2;USP42;AKT1S1;BNIP3;ASAH1;CHM;TRIAP1;SLK
prerank,regulation of interleukin-17 production (GO:0032660),0.36975370282890413,0.9603094890640231,0.49918166939443537,0.9479331858276097,1.0,4/31,6.47%,IL18;SPHK1;TLR4;IL12B
prerank,regulation of platelet activation (GO:0010543),-0.3555317084146166,-0.9600400795578621,0.5303370786516854,0.7880740747161595,1.0,6/21,10.25%,PLA2G4A;NOS3;LYN;APOE;TEC;PDGFA
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.27354237594594755,-0.9598886760347372,0.5210843373493976,0.7877064650931807,1.0,12/70,14.40%,PLA2G4A;MBOAT1;CEPT1;SLC44A5;SLC44A2;LPCAT2;PLA2G12A;ENPP2;MFSD2A;SLC44A1;LPIN3;ABHD4
prerank,endoplasmic reticulum organization (GO:0007029),-0.2692021594943651,-0.959340094871954,0.5497076023391813,0.7883051260814747,1.0,24/72,23.55%,RTN4;REEP1;CAV2;DOP1B;SHTN1;APP;REEP5;LMAN2L;RAB18;SEC61B;ATL2;EIF2AK3;VCPIP1;LMAN2;CYB5A;EMD;SPTSSB;ATL3;VAPA;TLE6;RTN3;TRAM1;REEP3;SEC16B
prerank,regulation of G0 to G1 transition (GO:0070316),0.35708868108596176,0.9591651949171799,0.5272435897435898,0.9500321577906092,1.0,6/38,11.67%,TFDP2;PCGF2;MGA;TFDP1;RBBP8;CBX5
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.46629395065540674,0.9588220059027476,0.5088757396449705,0.9501100658215571,1.0,1/10,1.98%,PRKN
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2558999666521047,-0.9587330518436659,0.5305343511450382,0.7890634494418441,1.0,34/110,17.88%,GSN;TFRC;GSK3B;DAB2IP;APOE;RPS3;SH3GLB1;HSPA8;ULK1;SORL1;HSPA5;TGFB1;AIDA;RALB;HJURP;FNIP2;GNL3L;HSP90AA1;TIRAP;LCMT1;VEGFA;PINK1;NOP53;TAL1;ATF7IP;CDC42EP2;CLU;FBLIM1;IAPP;NAPB;TPPP;SVIP;SYK;STX1B
prerank,global genome nucleotide-excision repair (GO:0070911),-0.33935505781637315,-0.9586669029450231,0.5169902912621359,0.7884840712805815,1.0,12/26,30.10%,RAD23B;ERCC1;UBB;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;UBC;RPS27A;DDB1;ERCC3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.27531486838014196,-0.95863389880056,0.5638629283489096,0.7878201177325284,1.0,13/69,10.79%,PLCB4;PIK3R1;PLCL1;PLCE1;NYAP2;PIK3C2B;NGF;PLEKHA1;PLCL2;HTR2A;PLCH1;ERBB2;EDN1
prerank,regulation of inflammatory response (GO:0050727),0.28250433617914933,0.9586262450835181,0.5520304568527918,0.949816795907486,1.0,21/190,9.72%,RORA;C1QTNF3;PPARA;IL18;LACC1;NAPEPLD;SPHK1;SNX6;METRNL;TLR3;TLR4;GPS2;IL12B;DAGLA;ENPP3;SERPINE1;NR1D2;GPRC5B;CDH5;IL17RA;RIPK1
prerank,regulation of endocytosis (GO:0030100),0.3355528206579283,0.9585022987116939,0.5296803652968036,0.9493186099680578,1.0,5/61,3.71%,DAB2;SYT11;PICALM;SPHK1;STON1
prerank,N-glycan processing (GO:0006491),0.42155227053298333,0.9584110388583149,0.5018450184501845,0.948752585208039,1.0,6/18,13.89%,MAN1A2;MAN1C1;FUT8;MAN2A1;GANC;PRKCSH
prerank,organelle organization (GO:0006996),0.26727628131158304,0.9583935772755824,0.6047835990888383,0.9479873580777968,1.0,90/388,17.30%,FAM174B;SYNE3;PPARGC1A;DYM;MICAL3;SH3D19;PRKN;OBSL1;FGD4;GABPB1;CAPZB;PHIP;PYROXD2;SEC31B;CLASP1;LRRK2;PEX11A;MYO18A;AFG1L;TPM1;RAB34;ATL1;ESRRA;SIRT5;BCAS3;CLUH;NIPSNAP2;OPA1;HUWE1;CNTNAP1;PEX11B;MTFR2;TWNK;TERT;SIRT3;HTT;TMEM11;DIAPH1;DNM1L;TRAPPC12;GOLPH3L;CSNK1A1;SSBP1;WASL;CATIP;ADCK1;PIKFYVE;CHMP1A;RAB43;CXADR;YTHDF3;AJUBA;FBXW8;ZFYVE16;FGD1;CDC42;PEX10;BRWD3;MIA3;TTC17;SIRT4;ROPN1;TRAPPC11;PRKCI;ZMYM6;PLEKHF1;WDPCP;TANGO2;CFAP410;ARHGAP21;SEC23IP;RAB29;PEX14;WTIP;ZMYM4;VPS51;PEX19;SLC25A36;MICAL1;GOLGA5;GOLGA8B;VPS4A;RAB30;PI4K2B;CHMP4C;MSTO1;OPTN;PEX16;MTX2;COG4
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4464293616221042,0.9579003049803111,0.5165692007797271,0.9484087022538786,1.0,4/12,14.03%,PCGF5;RBM15;LRIF1;SMCHD1
prerank,regulation of p38MAPK cascade (GO:1900744),0.36195635250690916,0.9578601320025883,0.5177664974619289,0.9476891078720338,1.0,8/35,14.38%,SASH1;DLG1;SPHK1;EZR;PTPN22;DUSP10;ULK4;GADD45A
prerank,protein catabolic process (GO:0030163),0.3361897610889618,0.9573090807472693,0.5261584454409567,0.9482705298094122,1.0,13/59,13.09%,PRKN;NGLY1;LAMP2;NEU2;ADAMTS9;TPP1;CLPX;CLN6;MANBA;RIPK1;RNF41;MAGEC2;DDI1
prerank,positive regulation of DNA binding (GO:0043388),0.37504251239087305,0.9573060275268438,0.5228426395939086,0.9474757334679839,1.0,3/31,3.63%,IGF1;PRKN;FOXC1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3743229318647866,-0.9572918675648394,0.5248380129589633,0.7903473031913686,1.0,9/18,30.83%,APOE;ABCG1;PSEN1;TMCC2;APH1A;LDLRAP1;ADAM19;BACE1;ACHE
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.387828259768115,0.9572807932234079,0.5174216027874564,0.9467457381309777,1.0,2/26,1.44%,FHL2;IGF1
prerank,pyruvate metabolic process (GO:0006090),0.3406397955901627,0.9570571692220838,0.5168374816983895,0.9465258228929933,1.0,7/52,8.98%,ME2;HK2;LDHB;PGAM2;GCK;SRR;DLD
prerank,axonal transport (GO:0098930),-0.31450096391970866,-0.9570037423681853,0.5035294117647059,0.7903157182398369,1.0,17/36,26.88%,SYBU;DST;TMEM108;AP3S1;MAPT;HIF1A;KIF3A;AP3S2;SPAST;AP3B2;SOD1;KIF4A;NEFL;HAP1;KIF3B;AP3D1;KIF1A
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.417970766829725,-0.9569332923257101,0.52,0.7897500934661444,1.0,3/11,10.92%,SCARB1;LDLR;MFSD2A
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3942870571106848,-0.9566770253812031,0.5164113785557987,0.7896141667539573,1.0,5/13,17.51%,MDFIC;APOD;UFM1;CABP1;BARD1
prerank,chromatin remodeling (GO:0006338),0.3040751696932128,0.9565102946932801,0.5275035260930888,0.9470859589104168,1.0,32/100,21.65%,JARID2;CHD4;ATRX;BAZ1B;SMARCD3;SMARCA4;SRCAP;SMARCC2;SMARCE1;HDAC4;SIRT1;HDAC1;BAHD1;BAZ1A;ZBTB1;HNRNPC;KAT2B;MTA2;RB1;ARID1B;KDM6B;PADI4;SATB2;EZH1;CHD8;MPND;TAF6L;CECR2;KDM6A;SMARCD2;MBD2;RUVBL1
prerank,placenta development (GO:0001890),-0.41507081637415655,-0.9561052450099156,0.5284872298624754,0.790228174820998,1.0,7/12,33.61%,PTK2;CUL7;SOD1;ADAM19;PLAC1;E2F8;PPARG
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3139965682691456,0.9560896900597586,0.5336134453781513,0.9472897208455184,1.0,16/84,11.38%,CELF2;DDX5;SON;MBNL2;TIA1;RBM15;RBM39;JMJD6;NOVA1;LARP7;THRAP3;SRPK2;SAP18;SFSWAP;NUP98;HNRNPL
prerank,lung epithelium development (GO:0060428),0.4543952367960945,0.9559038109756129,0.5124282982791587,0.9469547700634591,1.0,1/10,1.20%,ERRFI1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.417608813008389,0.9556257274162467,0.5026642984014209,0.9468593672121072,1.0,5/16,22.10%,NUPR1;AK4;MLXIPL;ATP7A;PPIF
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3713822643243737,0.9555828655473867,0.5160202360876898,0.9461724302766786,1.0,7/30,12.65%,PRKCZ;CD300A;PARP14;SH3BP5;MVP;SOCS3;SRCIN1
prerank,endosome organization (GO:0007032),0.34825722118066893,0.9555576724395168,0.5108153078202995,0.9454405500153881,1.0,18/41,23.24%,HOOK2;ALS2;ARFGEF2;RAB22A;PLEKHF1;HOOK3;EEA1;WASHC5;PI4K2B;PHETA1;SQSTM1;LAMTOR1;DNAJC13;SNX33;PI4K2A;VPS33B;HOOK1;RILP
prerank,positive regulation of potassium ion transport (GO:0043268),0.36221151155264836,0.9554413568219563,0.5273865414710485,0.9449240387465015,1.0,4/38,3.64%,ACTN2;ANK2;DLG1;ADRA2A
prerank,positive regulation of protein modification process (GO:0031401),0.28247968850162064,0.9552460206474163,0.5457967377666249,0.9446611088426631,1.0,32/203,11.94%,DAB2;FGF1;ROCK2;ACE;LEPR;FAM20A;FNIP1;TRABD2B;LRRK2;ITLN1;RAPGEF3;ATG10;F2;DDX3X;ARRB1;CAMK1;FBH1;CCND3;CDH5;SIRT1;RIPK1;MAVS;CRKL;PIK3R3;ATG7;IRGM;ABL1;DYRK1A;ADAM17;AXIN2;VEGFD;RALBP1
prerank,inorganic anion transport (GO:0015698),0.34086979606741924,0.9543842989745027,0.5141065830721003,0.9461403191909932,1.0,7/53,9.20%,SLC13A4;SLC5A5;CLCN2;ENPP3;ANO6;SLC26A1;NMUR1
prerank,regulation of cytokine production (GO:0001817),0.2933528483883071,0.9542634492990074,0.5619946091644205,0.9456462832793607,1.0,12/126,6.84%,C1QTNF3;LGR4;SYT11;ADRA2A;SRGN;IGF2BP1;TRIM56;CD28;IL12B;EIF2AK2;TWSG1;AFAP1L2
prerank,regulation of monocyte differentiation (GO:0045655),-0.38695740110925186,-0.9541523810030155,0.49789915966386555,0.7943284886403882,1.0,4/14,17.31%,FOXP1;CTNNBIP1;FES;CD74
prerank,methylguanosine-cap decapping (GO:0110156),-0.4152415908561693,-0.9538857387700339,0.5245901639344263,0.7942248922592636,1.0,4/10,21.06%,DCP1B;PNRC2;LSM1;DCP2
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2870200322394657,-0.9535867606567207,0.5505952380952381,0.7942123725034511,1.0,8/55,6.42%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;RPS3
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2619349696417186,0.9535263817503766,0.6052631578947368,0.9466687706436604,1.0,92/497,14.62%,BMP7;TFDP2;WNT4;ZIC2;FOXN3;ZNF423;JARID2;ZHX2;SNX6;FOXD1;ZNF568;DKK3;ARID4A;NR2F2;NCOR2;TSHZ3;GLI3;ZBTB38;NACC2;VGLL4;LOXL3;FOXP2;IGF2BP1;DDX3X;SFMBT1;CBFA2T2;HMGA1;LBH;ZNF318;TP53;EIF2AK2;BHLHE41;SMURF2;NIPBL;LDB1;FBXW11;BCOR;SAMD4A;SMARCA4;NR1D2;BTRC;RBM15;SPEN;LARP1;CPEB3;KAT6B;NRG1;IGF2BP2;CNOT10;SMARCC2;PDS5A;NIBAN2;SMARCE1;HDAC4;SCML4;SIRT1;TLE1;HDAC1;SOX13;CBY1;GTPBP4;SPINDOC;CHMP1A;TCF7L2;ZNF219;LSM14A;PRDM5;SAP18;BAHD1;WWP2;CBX5;WAPL;ZNF148;UIMC1;DDX6;BRD7;DEAF1;MLXIPL;IRF1;KAT7;CDAN1;KMT5A;SIN3A;PML;TLE2;BCL7A;NCOR1;CRYAB;PER2;TSC1;ZKSCAN3;HOXA7
prerank,purine nucleotide catabolic process (GO:0006195),-0.39929148509591694,-0.9533720930419568,0.525974025974026,0.7939733616656133,1.0,6/13,16.13%,XDH;HINT1;GDA;NT5E;NT5C1A;GPX1
prerank,protein transport (GO:0015031),-0.21976427050359024,-0.9528241951016996,0.6984126984126984,0.7945512462797408,1.0,66/332,17.31%,LRP1B;SPTBN1;CALCRL;ANK3;TBC1D4;TBC1D1;ATP6V0A1;RABGAP1L;RAB31;TFRC;VAMP4;MYH9;VMP1;SYNDIG1;ARHGEF2;RAMP2;RAB3C;TBC1D8;TBC1D30;TBC1D5;STX3;APOE;ABCG1;SLC10A7;TXNIP;ATP6V0A4;LMAN2L;SGSM1;PREPL;MYO6;NSF;PPT1;MTTP;RAB18;TBC1D2B;ARL5A;ARL1;STX12;GCC2;TMED1;GOLGA7;TMED5;ARRDC4;TVP23B;VLDLR;ARL5B;SNX17;RAMP1;KIF3A;SCAMP3;LAPTM5;SCAMP1;RAB38;CLU;RAB6A;RAB32;SCG2;TMED4;ARF5;SNX27;ARF6;ERP29;NAPB;TMED7;STXBP3;CD74
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2942407083721349,0.9522929474617575,0.543010752688172,0.9489714185795709,1.0,25/122,15.14%,SORBS1;IGF1;SMOC2;GLI2;LARP4B;SLC6A9;TLR4;DDX3X;NOX1;CD28;PDGFRB;POLDIP3;GCK;LDB1;SAMD4A;CPEB3;GLI1;SIRT1;YTHDF3;PRKDC;KAT7;PLD1;ZCCHC4;NFKB1;FAF1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4213031122739975,-0.9522541664316805,0.5433962264150943,0.7952031052687462,1.0,3/10,19.38%,PLA2G4A;ENPP2;PLA2G15
prerank,inositol phosphate metabolic process (GO:0043647),0.3462929969222537,0.9521101356228743,0.5269645608628659,0.9486571587101241,1.0,9/46,11.18%,ISYNA1;NUDT4;INPPL1;PLCD3;PTEN;ITPKB;PLCD1;PPIP5K2;OCRL
prerank,positive regulation of cation channel activity (GO:2001259),0.3539466402681478,0.9516996977446681,0.5260586319218241,0.9488631887257495,1.0,3/40,1.93%,ACTN2;ANK2;LRRC38
prerank,regulation of nervous system process (GO:0031644),0.41241417811952796,0.951698350858253,0.5357142857142857,0.9480751627128658,1.0,3/18,4.87%,ROCK2;SLC8A3;DLGAP4
prerank,positive regulation of interleukin-4 production (GO:0032753),0.4152091767673697,0.9515560256022986,0.5168539325842697,0.9476268976562878,1.0,2/17,6.17%,PRKCZ;CD28
prerank,cilium assembly (GO:0060271),0.2699369770605807,0.9513065573629682,0.5944380069524913,0.947417376960056,1.0,72/297,19.22%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;TNPO1;CLASP1;CPLANE2;RILPL1;NINL;RAB3IP;KIF3C;CYS1;RHO;PTPN23;ASAP1;EXOC2;CCDC28B;SSTR3;CEP162;CDC14A;IFT122;WDR19;DYNC2I1;MKKS;TMEM231;SDCCAG8;CLUAP1;CDC14B;CENPJ;ATP6V1D;IFT88;OCRL;GALNT11;NPHP1;BBS10;PDE6D;UNC119B;GORAB;WDPCP;CFAP410;WDR35;ALMS1;EXOC4;E2F4;EXOC3;PARVA;CCDC39;CEP63;B9D2;ARL6;RP2;BBS2;STK36;RFX2;RAB8B;RILPL2;PIBF1;TMEM237;BBOF1;TRAPPC14;CCDC40;CEP57;ATP6V0D1;AKAP9;TMEM17;TCTN3;PCM1;CEP164;OFD1;PCNT
prerank,chemical homeostasis (GO:0048878),0.32548037269296354,0.9510666045863524,0.5370919881305638,0.9472210158993983,1.0,12/61,15.44%,WNK4;ZBTB20;RBP1;DDX3X;TLCD2;NR1D2;ADCK1;ACOXL;WNK1;ACOX3;SLC66A1;TENT4B
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.2952377647141662,-0.9510142066894155,0.5845272206303725,0.7974768452524986,1.0,9/47,8.46%,SPOCK2;SERPINE2;SPOCK3;SERPINI1;SERPINF1;TIMP2;SORL1;BIN1;SPOCK1
prerank,positive regulation of dendrite development (GO:1900006),0.4541773034336025,0.9508347863812233,0.5299806576402321,0.9469849813522254,1.0,1/10,0.46%,BMP7
prerank,negative regulation of ossification (GO:0030279),0.38746442188097496,0.950259591490877,0.504258943781942,0.9476445991195513,1.0,5/23,9.44%,LRP4;SMAD6;SRGN;BCOR;CHSY1
prerank,connective tissue development (GO:0061448),0.3503118268799205,0.9499018369529171,0.5243697478991597,0.9477224842349774,1.0,9/35,13.29%,SOX5;SULF2;CREB3L2;SH3PXD2B;RORC;SLC39A13;HYAL1;COL11A2;SULF1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.32677703157464794,-0.9499010803072584,0.5333333333333333,0.7994088507520088,1.0,10/26,25.00%,NOD1;ALPK1;MAP3K7;UBB;NOD2;TIFA;AAMP;UBC;RPS27A;TAB1
prerank,regulation of cellular metabolic process (GO:0031323),0.3500847726759677,0.949746535762592,0.5260586319218241,0.9473613332074388,1.0,20/45,25.11%,PPARA;PRKN;NCOR2;TBC1D16;ANGPTL8;RNF34;RNF41;AGPAT1;COQ7;BCO2;VPS35;MKLN1;LAMTOR1;ACLY;GNB3;ABCA2;PDK2;PM20D2;FOXM1;KIF16B
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.3149312175640227,0.9495343890147107,0.5272459499263623,0.9471028420053662,1.0,26/80,20.46%,SNX6;SNX32;DENND2A;VPS54;DENND5A;PIKFYVE;RAB7B;VPS50;CLTC;RGP1;SNX12;SNX8;VTI1A;STX5;SGSM2;RAB29;VPS51;HEATR5B;RAB9A;PHETA1;VPS35;TBC1D14;EVI5;TMEM87B;STX16;ANKFY1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2476617233424756,-0.9495105827455755,0.5686274509803921,0.7995937786308779,1.0,33/113,20.22%,ESR1;TFRC;RASIP1;UNC13B;GSK3B;DAB2IP;RAP1B;RPS3;SH3GLB1;PIEZO1;TGFB1;FNIP2;GNL3L;PSMC6;HSP90AA1;TIRAP;ERCC1;SNCA;VEGFA;TAL1;CDC42EP2;TERF1;CLU;USP50;RPA1;SKAP1;TPPP;SYK;GTF2H1;BCL2L11;GTF2H4;GTF2H5;ERCC2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3173111226651594,0.9494451097573589,0.554904831625183,0.9465468169927019,1.0,6/73,6.10%,ROBO1;SMAD3;COL4A3;CFLAR;BID;FAM162A
prerank,cardiac atrium morphogenesis (GO:0003209),0.4203637286287275,0.9489639417288914,0.5227686703096539,0.9469652580696684,1.0,1/16,0.19%,NOTCH2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.38454556933463924,0.9487427875974971,0.5266781411359724,0.9467125081240836,1.0,6/25,12.71%,LDB1;RNF8;LARP7;ELL;NELFCD;WDR43
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.30206536483922664,0.948742596972305,0.5637860082304527,0.9459301010925761,1.0,8/108,6.10%,UACA;ROBO1;SMAD3;COL4A3;CFLAR;BID;DDX3X;FAM162A
prerank,myoblast fusion (GO:0007520),-0.41496483184822447,-0.948702600223214,0.5351239669421488,0.8008493465956545,1.0,5/12,6.96%,ADGRB3;CD9;ADAMTS5;PTGFRN;JAM2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3178485266170429,0.9484880292983544,0.5239520958083832,0.9457715282309584,1.0,19/70,18.81%,SMAD3;CASP3;BID;IFI27;TLR3;DDX3X;CD27;PDPK1;RIPK1;RNF41;ITGAV;BLOC1S2;MLLT11;DEDD;ACVR1B;MCL1;TNFRSF1A;G0S2;DELE1
prerank,telomere capping (GO:0016233),0.41799883744254096,0.9484477000472943,0.5126705653021443,0.9450879839148498,1.0,6/16,18.62%,ACD;PRKDC;RAD50;TFIP11;TINF2;NBN
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3769508371740635,-0.9483780514277417,0.5327510917030568,0.8008909806168641,1.0,6/17,10.44%,HSP90AB1;PPP1R12A;CALM1;PTPRC;CALM2;CALM3
prerank,negative regulation of neurogenesis (GO:0050768),0.3623189568669888,0.9480853015927132,0.531502423263328,0.9452458810252745,1.0,4/34,7.92%,APPL2;LRP4;RUFY3;PTEN
prerank,camera-type eye development (GO:0043010),-0.3355875046436275,-0.9478577668548951,0.5382716049382716,0.8013667346975961,1.0,9/25,19.86%,LAMA1;TENM3;CYP1B1;FBN2;STRA6;VEGFA;PAX2;FOXL2;ALDH1A3
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3265403092210299,-0.9476691141363748,0.5272277227722773,0.8010640716061881,1.0,10/28,14.58%,DAB2IP;CTSC;PTK2;DDRGK1;PSMC6;AXIN1;ECSCR;LAPTM5;SMURF1;CLU
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.41922194249141914,-0.9474452404301787,0.5271966527196653,0.80088095469577,1.0,2/11,4.21%,FAP;PTGIS
prerank,cellular response to metal ion (GO:0071248),0.29671895887931815,0.9469100937350559,0.562753036437247,0.9473576198856987,1.0,8/123,1.98%,BMP6;SLC41A1;SYT9;SYT11;SYT12;PRKAA2;PRKN;ADCY1
prerank,mesenchymal cell development (GO:0014031),-0.3615772542817646,-0.9466164948841167,0.5177777777777778,0.8021527980086874,1.0,4/18,9.18%,CDH2;NOTCH1;HEYL;HEY2
prerank,relaxation of muscle (GO:0090075),0.43067206937284686,0.9464380027966238,0.5146520146520146,0.9478196780885952,1.0,1/13,0.08%,ATP1A2
prerank,regulation of RNA splicing (GO:0043484),-0.2710426279045301,-0.9463127666802332,0.5799373040752351,0.8021698748151568,1.0,14/69,13.20%,QKI;MBNL1;AHNAK;PIK3R1;KHDRBS2;AHNAK2;HNRNPLL;SRRM4;TMBIM6;PRX;HNRNPK;RBM20;ZNF326;AFF2
prerank,ncRNA transcription (GO:0098781),-0.3942361363038019,-0.945841372354165,0.5470085470085471,0.8026258875920701,1.0,2/13,7.75%,CAVIN1;SPIN1
prerank,positive regulation of calcium ion transport (GO:0051928),0.35423210805097277,0.9457588289054331,0.5287162162162162,0.9486621388586582,1.0,4/36,6.37%,CACNA1D;ANK2;P2RX3;PDGFRB
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.39016421756414726,0.9456827561896911,0.5270506108202443,0.9472883537197887,1.0,4/23,9.41%,TFDP2;BID;TP53;TFDP1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.39016421756414726,0.9456827561896911,0.5270506108202443,0.9472883537197887,1.0,4/23,9.41%,TFDP2;BID;TP53;TFDP1
prerank,embryonic organ morphogenesis (GO:0048562),0.34232423301876097,0.9456479031307532,0.5454545454545454,0.9465996018024835,1.0,12/42,12.99%,FGFR2;HOXB4;HOXB3;HOXB9;HOXA3;FBN1;NIPBL;RBP4;HOXC4;DYNC2I1;RARG;RBPMS2
prerank,regulation of cell death (GO:0010941),0.3045273303124354,0.9455303276058254,0.5454545454545454,0.9461295224260909,1.0,19/94,15.14%,BMP7;CCN2;PRKN;SRGAP2;PRODH;LRRK2;RILPL1;OLFM4;ATG5;RRAS2;LRP1;RIPK2;BECN1;IMPACT;AXIN2;CRYAB;TSC1;RAB29;FAF1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.24235102312387224,-0.9451073152390416,0.5822222222222222,0.8036468673930992,1.0,49/158,21.48%,ROR1;ATP2C1;MID2;NOD1;TFRC;TNFSF10;ALPK1;PLK2;TRAF5;FLNA;MAP3K7;TNFRSF19;ECM1;SLC44A2;SHISA5;NDFIP2;S100B;PLEKHG5;TRIM14;FKBP1A;TRIM27;REL;TIRAP;IKBKB;PRKD1;RBCK1;CARD16;PINK1;TERF2IP;PPM1A;MTDH;TMED4;EDAR;PELI1;PIM2;NOD2;CD74;TMEM101;MAP3K14;GPR89A;TIFA;TFG;ECT2;CCL19;NEK6;TRIM68;LGALS9;EEF1D;VAPA
prerank,actin filament polymerization (GO:0030041),0.3730625815709742,0.9449625516717238,0.5190713101160862,0.9467115994063948,1.0,7/29,12.55%,GAS7;ARHGAP6;DIAPH1;WASL;CATIP;VIL1;TTC17
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.38759321116297096,-0.9439864368308671,0.5436241610738255,0.8055846916825581,1.0,9/15,31.27%,TSEN34;FAM98B;TSEN54;RTCB;ERN1;CPSF4;TSEN15;CLP1;CPSF1
prerank,cellular response to glucagon stimulus (GO:0071377),0.413450409440918,0.9438878508680716,0.5386029411764706,0.948584831338988,1.0,5/17,13.47%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6
prerank,lymphocyte differentiation (GO:0030098),-0.2718101102198324,-0.9438209628134848,0.5335365853658537,0.805234896676138,1.0,14/68,10.15%,PTPRJ;TPD52;VCAM1;TOX;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4;IKZF1;JAG2;RHOH;PBX1;LFNG
prerank,positive regulation of transporter activity (GO:0032411),0.42272058674206514,0.943759989998612,0.5055970149253731,0.948110350477151,1.0,4/13,19.90%,KMT2A;RXRA;SGK2;NR1H3
prerank,striated muscle cell development (GO:0055002),0.4253895389484304,0.9434731348536544,0.5388888888888889,0.9480420274353991,1.0,3/14,5.53%,TMOD2;TMOD3;KLHL41
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3944888501730457,-0.9432539564722238,0.5550935550935551,0.8058960136392577,1.0,2/13,4.65%,PLA2G4A;MGLL
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.33081897284104245,-0.9431070102740783,0.5507246376811594,0.8054639791211857,1.0,7/26,9.38%,RYR2;HTR2C;RYR3;PTPRC;PLCG2;HTR2A;FGF2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2802216034476884,0.9428594318672519,0.5717916137229987,0.9488176734415741,1.0,18/170,10.64%,PRDM6;ROCK2;IGF1;AFF3;MTMR3;TBC1D16;PCBP2;ZNF462;IGF2BP1;AFF4;TOB2;GDNF;HRG;IGF2BP2;NOVA1;C1D;DHH;PRDM5
prerank,proteasome assembly (GO:0043248),-0.41002202860935005,-0.9426783775815482,0.5423387096774194,0.8057437229284661,1.0,5/11,34.08%,PSMG2;PSMD11;POMP;ADRM1;PSMD4
prerank,lipid catabolic process (GO:0016042),0.4128539281495573,0.9425052879661756,0.5364120781527532,0.9489120283567852,1.0,3/18,7.25%,CEL;PLA1A;PNLIP
prerank,protein localization to chromosome (GO:0034502),0.3518322979687447,0.9420027125226107,0.5289256198347108,0.9493541941408113,1.0,8/34,11.77%,ATRX;TPP1;ACD;TNKS2;LEMD2;XRCC4;IFFO1;WAPL
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.37522596027865945,0.9418980060977946,0.5292096219931272,0.9488614420371594,1.0,4/26,6.92%,GPR137;TLR3;TLR4;FBN1
prerank,protein localization to lysosome (GO:0061462),-0.3203181602234527,-0.9418643868315155,0.5353075170842825,0.8069384552033237,1.0,12/28,25.73%,RTN4;SORL1;SH3BP4;GCC2;LAPTM5;NCOA4;M6PR;SCARB2;RNF128;CD81;LMBRD1;NAGPA
prerank,establishment of melanosome localization (GO:0032401),0.4025201363717842,0.9417736304508517,0.5368421052631579,0.9483913998162075,1.0,6/19,15.83%,SHROOM2;BLOC1S6;RAB11B;MKKS;ARL6;BBS2
prerank,glial cell differentiation (GO:0010001),-0.32725941859688124,-0.9414115400997535,0.514218009478673,0.8073150048403921,1.0,9/28,18.48%,CDH2;ADGRG6;STAT3;RELN;PTPRZ1;PAX2;TPPP;SOX2;SOX8
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3192437575900701,0.9410849256183239,0.5331278890600925,0.9492777504858732,1.0,7/64,8.40%,ACSL1;ALOX12;CPT1A;ACSBG2;EPHX1;DAGLA;CPT2
prerank,positive regulation of vascular permeability (GO:0043117),0.4358738611076962,0.940989301538831,0.5207920792079208,0.948709707890147,1.0,1/12,0.40%,BMP6
prerank,postreplication repair (GO:0006301),-0.2933390255853012,-0.9408981934810354,0.5646067415730337,0.8078458898105401,1.0,24/45,31.81%,UBE2V2;POLD3;RAD18;FAAP20;PRIMPOL;UBB;UBE2B;RPA1;RFC4;WDR33;NSMCE1;POLD4;POLD1;RFC2;POLK;DTL;UBC;RPS27A;RFC5;PCLAF;UBE2A;RPA3;BRCA1;RPA2
prerank,stress granule assembly (GO:0034063),0.40209931455243025,0.940425557971216,0.4982142857142857,0.9492907376368619,1.0,8/20,17.13%,DDX3X;ATXN2;LSM14A;YTHDF3;DDX6;UBAP2L;ATXN2L;OGFOD1
prerank,peptidyl-amino acid modification (GO:0018193),0.4620624157388248,0.9399281104634227,0.5431861804222649,0.9497554011158432,1.0,4/10,19.94%,METAP2;FKBP10;TTLL4;ATP7A
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.39160148554442153,0.9397218691035744,0.5418181818181819,0.949471223279683,1.0,3/20,7.34%,IL18;TLR4;PTPN22
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.339738496485978,0.9395806938117042,0.5333333333333333,0.9490348946453478,1.0,6/43,11.75%,SYT11;IGF1;TLR4;PTPN22;CD274;DICER1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.35467133199826345,-0.9393987092409545,0.5440860215053763,0.8106894115953653,1.0,6/20,13.87%,ENTPD1;HSP90AB1;APP;TXNIP;NT5E;TXN
prerank,eye photoreceptor cell development (GO:0042462),-0.38125714232639113,-0.9392373919027275,0.5565610859728507,0.8103747828128822,1.0,3/15,13.77%,RORB;RP1;VEGFA
prerank,protein phosphorylation (GO:0006468),0.2557420195663609,0.9389317125822049,0.6379498364231189,0.9499304259721346,1.0,78/479,13.88%,PRKAG2;TGFBR3;WNK4;ROCK2;OXSR1;PRKCZ;KIT;FAM20A;PRKAA2;FGFR2;EPHA4;GRK5;CCNA2;PRKAG3;STK32B;FGFR1;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;TLR3;SMG1;PRKCB;IKBKE;TLR4;ATM;PRRT1;CAMK1;BRAF;EPHA8;FLT1;NUAK2;TRIB2;PDGFRB;BAZ1B;CDC42BPG;SIK1;EIF2AK2;RICTOR;TGFBR2;IGFBP3;MAPKAPK3;RYK;COQ8B;PDPK1;CSNK1A1;RIOK2;PICK1;RIPK1;MKNK1;FER;BRSK1;AURKB;SRPK2;ABL1;DYRK1A;MYLK3;TRIB1;PRKDC;MAPK6;CSNK2A2;CSNK2A1;PRKCA;HIPK3;MAPK10;MAP3K1;FRK;PRKCI;EPHA3;WNK1;BMP2K;MAP2K1;ROS1;COQ8A;CAD;GRK3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.424878916153546,0.9389158380821138,0.5236294896030246,0.9492005862161786,1.0,4/14,9.78%,KIT;GPRC5B;SIRT1;MAVS
prerank,regulation of mast cell degranulation (GO:0043304),0.4227695221676828,0.9385894211840613,0.5406360424028268,0.9492036153167575,1.0,5/14,14.77%,CD300A;STXBP2;GAB2;FER;SPHK2
prerank,female gamete generation (GO:0007292),0.3639833057605489,0.9385016108207933,0.5238853503184714,0.9486509420122409,1.0,4/29,7.12%,SPO11;DIAPH2;USP9X;TOB2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3802133747176226,0.938424714921115,0.5478260869565217,0.9480634876705705,1.0,3/23,5.53%,ACSL1;ACSBG2;HACD1
prerank,cell chemotaxis (GO:0060326),0.3253154511701638,0.9382402182314049,0.5639097744360902,0.9477435329652608,1.0,10/60,10.36%,LPAR1;KIT;CCR9;ACKR2;ARHGEF16;PDGFRB;HOXB9;HBEGF;CCL25;RAB13
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3873852340027022,0.9381170038116957,0.5358361774744027,0.9472924728247715,1.0,6/23,12.73%,ERRFI1;SNX6;SH3BP5;MVP;SRCIN1;GPRC5A
prerank,protein K48-linked deubiquitination (GO:0071108),-0.334629396108108,-0.9377573843079027,0.5325842696629214,0.8131650761610449,1.0,8/23,23.12%,OTUD7A;OTUD7B;YOD1;USP50;VCPIP1;USP8;MINDY1;BAP1
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2847901218462945,-0.9375240901104611,0.5752212389380531,0.8129746354974566,1.0,8/48,14.40%,DGKH;DGKB;PLA2G4A;PLA2G12A;DGKG;DGKZ;PNPLA3;ABHD4
prerank,histone H4 deacetylation (GO:0070933),0.44966700043681795,0.9371833487626553,0.5395256916996047,0.9487367247582584,1.0,3/10,9.55%,HDAC8;HDAC4;HDAC1
prerank,organelle assembly (GO:0070925),0.2602921066616758,0.9371453475179345,0.6356502242152466,0.9480567850608913,1.0,96/385,19.22%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;TMOD2;CPLANE2;RILPL1;RAB3IP;TMOD3;CYS1;DDX3X;KLHL41;RHO;PTPN23;ASAP1;ATG5;EXOC2;CCDC28B;SH3PXD2B;SSTR3;CEP162;WIPI1;CDC14A;AMBRA1;ATXN2;IFT122;WDR19;DYNC2I1;CHMP1A;RAB43;LSM14A;MKKS;YTHDF3;BECN1;ATG7;IRGM;TMEM231;HPS1;CLUAP1;CDC14B;CENPJ;ATP6V1D;IFT88;OCRL;GALNT11;MAPRE2;PDE6D;DDX6;UNC119B;ATG2A;NCOR1;WDPCP;CFAP410;WDR35;UBAP2L;EXOC4;E2F4;EXOC3;PARVA;LMOD3;CEP63;B9D2;VPS37A;ARL6;SNF8;RP2;BBS2;STK36;GOLGA8B;VPS4A;RFX2;RAB8B;CENPC;LMOD1;RILPL2;CHMP4C;ATXN2L;PIBF1;TMEM237;OGFOD1;ZFYVE1;TRAPPC14;TMEM41B;ATP6V0D1;CCDC61;GORASP2;TMEM17;TCTN3;PCM1;CENPT;CEP164;GOLGA2;OFD1;PCNT
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3993357564193594,0.9365608877881086,0.49909584086799275,0.9486979240173041,1.0,5/19,12.05%,PRKN;FZD5;HTT;DNM1L;CSNK2A2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3933281791388857,-0.9362635215442653,0.5296610169491526,0.8152888811871752,1.0,5/13,17.44%,ELOVL7;ELOVL5;ELOVL6;TECRL;TECR
prerank,cellular response to chemokine (GO:1990869),-0.29416709832205745,-0.9362522387586535,0.5598958333333334,0.8145915040001018,1.0,7/46,10.81%,LRCH1;CXCL12;PTK2B;SLC12A2;ACKR3;DOCK8;DUSP1
prerank,negative regulation of B cell proliferation (GO:0030889),0.4310409050077292,0.9361613318132183,0.5424710424710425,0.9488788404315215,1.0,2/11,5.45%,CD300A;ATM
prerank,cellular response to amino acid stimulus (GO:0071230),0.35932260614308287,0.9360001487793841,0.5716666666666667,0.9484903692227858,1.0,10/33,19.10%,CPEB4;SESN1;SESN2;UBR2;CPEB3;RPTOR;UBR1;NSMF;RRAGD;LAMTOR1
prerank,response to glucagon (GO:0033762),0.3968962068579781,0.9356913810488714,0.5474060822898033,0.9484908610683604,1.0,7/19,17.87%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6;PRKACB;CRY1
prerank,plasma membrane invagination (GO:0099024),-0.31784507246063154,-0.9355850717326224,0.5545023696682464,0.8154414952353203,1.0,5/29,10.69%,GSN;MYH9;DOCK1;ARHGAP25;ELMO1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.319403555425589,0.9348885446419105,0.5545851528384279,0.9496723786750839,1.0,19/62,16.30%,KMT2A;TNRC6A;CTR9;PRKCB;MEIS1;TNRC6B;RBM15;HDAC1;ASH2L;MOV10;KMT2C;KMT2D;SIN3A;KAT2B;TNRC6C;PURB;LGALS3;HOXB8;CREBBP
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.37320953487129477,-0.9347845867320916,0.552,0.8166281626636382,1.0,2/15,7.53%,NLGN1;CNTNAP4
prerank,cellular response to interleukin-12 (GO:0071349),-0.2832239300283722,-0.9347630813810068,0.554945054945055,0.8159485467781278,1.0,16/48,25.99%,PPIA;RAP1B;RPLP0;JAK1;CD47;MSN;PITPNA;TALDO1;CFL1;CAPZA1;AIP;PDCD4;SOD1;MTAP;JAK2;STAT4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.40020612488215745,-0.9345752227931914,0.5802707930367504,0.8156418878926872,1.0,5/12,22.63%,RPL26;CD44;TAF9B;CD74;TRIAP1
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.33765035300394625,-0.9345354814409325,0.5663716814159292,0.815009853576105,1.0,9/22,13.77%,RASSF2;PDGFC;CALM1;CALM2;RAP2A;PDGFA;CALM3;TNKS1BP1;VEGFA
prerank,protein N-linked glycosylation (GO:0006487),0.3134979031034741,0.9344712368736057,0.5640625,0.9499242492934304,1.0,7/66,6.29%,MAN1C1;ST6GAL1;MGAT3;ASGR1;PGM3;B4GALT1;FUT8
prerank,neuron apoptotic process (GO:0051402),-0.35344022896676064,-0.9344182368477634,0.5602678571428571,0.8145436618772023,1.0,10/19,26.12%,CIT;SCN2A;APP;TNFRSF21;FAS;TRPC5;DIABLO;BNIP3;ERBB3;GAPDH
prerank,cell proliferation in forebrain (GO:0021846),0.4458350456855223,0.9339173901805904,0.5305343511450382,0.9504885655692298,1.0,7/10,30.64%,DOCK7;HOOK3;PCM1;CEP120;NUMBL;NUMB;AKNA
prerank,"wound healing, spreading of cells (GO:0044319)",0.3765508270946657,0.9339140962366308,0.5502555366269165,0.9497386060605475,1.0,2/24,3.72%,COL5A1;PDPN
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4361281652791765,0.9338974010319875,0.5347490347490348,0.9490297506077685,1.0,3/12,16.96%,IL12B;ZBTB1;CCR2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.35566133598082916,0.9336073216505867,0.5548387096774193,0.9489630957447891,1.0,4/36,5.93%,AFDN;VAMP5;RILPL1;RAB34
prerank,regulation of osteoblast proliferation (GO:0033688),0.40817562251263384,0.9335857112779365,0.5191256830601093,0.9482483256869413,1.0,4/17,12.15%,FGFR2;NPR3;EIF2AK2;ATRAID
prerank,RNA processing (GO:0006396),0.277992907135436,0.9335207462922369,0.609254498714653,0.9476388166386785,1.0,45/176,21.64%,CELF2;PPARGC1A;SON;RBMS2;PABPN1;HNRNPR;HNRNPH1;SRSF5;YJU2;TSEN2;HNRNPA2B1;TUT4;RBM39;NOVA1;TENT2;RBMS1;LUC7L3;SRPK2;PRPF18;HNRNPL;DICER1;SRSF11;HNRNPC;SCAF11;PRPF3;TENT4B;SNRNP40;RBM4;TFIP11;TUT7;USP39;ALKBH5;ZCRB1;PRPF6;FUS;SRSF1;HNRNPH3;U2AF1;SRSF7;WBP4;SNRPA1;U2AF2;SF3B2;SF3B1;TUT1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.39438505656763895,0.9330709723776702,0.5224416517055656,0.948021717434169,1.0,6/19,19.25%,SLC19A1;MTHFR;ALDH1L1;MTRR;MTHFD1;FOLR2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.412088864448668,-0.9329915545421777,0.5701754385964912,0.8171463548561696,1.0,2/11,4.47%,MAP3K5;CYP1B1
prerank,glutathione biosynthetic process (GO:0006750),-0.414857610565631,-0.9328768788096349,0.5435244161358811,0.8167055437614043,1.0,7/11,33.07%,GCLM;CHAC2;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,blood circulation (GO:0008015),0.3295442148547475,0.9323997725148656,0.5426229508196722,0.9489016286361255,1.0,6/49,4.74%,ROCK2;ACE;NPR1;MYOF;COL4A3;BDKRB2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.2593336896372873,-0.9321505262837173,0.6290322580645161,0.8169779645735483,1.0,30/78,25.09%,SH3GL2;CTSD;DYNC1I1;DYNLL1;AP1S2;DYNC1LI2;AP2B1;KIF26A;DCTN4;CTSL;AP2M1;CAPZA2;CTSS;KIF3A;AP1S3;CAPZA1;CENPE;KIF15;CD74;SPTBN2;KIF11;AP1S1;KIF5A;KIF22;KIF4A;KIF3B;SAR1B;DCTN6;ACTR1A;KIF23
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.2593336896372873,-0.9321505262837173,0.6290322580645161,0.8169779645735483,1.0,30/78,25.09%,SH3GL2;CTSD;DYNC1I1;DYNLL1;AP1S2;DYNC1LI2;AP2B1;KIF26A;DCTN4;CTSL;AP2M1;CAPZA2;CTSS;KIF3A;AP1S3;CAPZA1;CENPE;KIF15;CD74;SPTBN2;KIF11;AP1S1;KIF5A;KIF22;KIF4A;KIF3B;SAR1B;DCTN6;ACTR1A;KIF23
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3813635095541954,-0.9319933488042598,0.5677966101694916,0.8166298948924032,1.0,6/15,16.47%,TAFA1;DISC1;PTN;CTNNB1;VEGFA;CX3CR1
prerank,apoptotic DNA fragmentation (GO:0006309),0.4137182970134983,0.9318492073417761,0.56353591160221,0.9494463680883898,1.0,6/16,24.40%,CASP3;DICER1;DFFB;DFFA;CECR2;H1-0
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.34154456322149157,0.9318003073327805,0.5447647951441578,0.9488057896602419,1.0,14/48,16.40%,ELOF1;TAF1D;HMGA1;BAZ1B;ATAD2B;ZMIZ2;ZMIZ1;MYO1C;POLR1G;PHF2;TBP;KAT2B;SPHK2;ARID1B
prerank,relaxation of cardiac muscle (GO:0055119),0.42695186701640214,0.9316567746653074,0.5232774674115456,0.9483843232095069,1.0,1/13,0.08%,ATP1A2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.35899409244684505,0.9309997811712257,0.5419354838709678,0.9492131540871739,1.0,8/31,17.50%,DLG1;KANK2;PTEN;RBL2;RBL1;BRD7;RB1;GPNMB
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3267244668580809,0.9307811652943389,0.5534883720930233,0.9489838966967363,1.0,4/54,5.59%,SH3RF2;NXN;HDAC8;ARRB1
prerank,regulation of cell population proliferation (GO:0042127),0.2521976509850097,0.9306889025686118,0.6990496304118268,0.948443089022197,1.0,103/691,12.86%,FGF1;ALDH1A2;BMP6;EFNB2;KSR1;KIT;LAMC2;GSDME;IGF1;FGFBP1;IL13RA1;PTPN14;FGFR2;PKHD1;KANK2;GRK5;COL18A1;NUPR1;COL4A3;NPR3;PHIP;FGFR1;BMPR1A;ARID2;MAGI2;TGFBR1;IGFBP7;SPEG;ADRA2A;PDPN;IFIT3;NACC2;CDCA7L;DPP4;TNFSF13;SMAD6;TNS2;CTSH;PIAS1;MEIS1;CLMN;IFNK;KLHL41;NOX1;SOD2;FLT1;STAT2;HMGA1;PDGFRB;TP53;EIF2AK2;CACUL1;GAB2;WWTR1;SSTR3;DLG3;PTPRU;TGFBR2;PTEN;IGFBP3;GDNF;NRG1;HRG;NUPR2;NIBAN2;SULT2B1;HDAC4;GLI1;SIRT1;HDAC1;GTPBP4;ASH2L;CCAR1;HTR1A;TCF7L2;HBEGF;FLT3LG;FER;SLURP1;CRKL;TBRG4;NOX4;SRPK2;RNF41;RARG;MNT;PRKDC;TFAP2D;ADAM17;OSGIN1;GLMN;NOP2;AXIN2;VEGFD;ITGAV;CSNK2A1;NMI;BRD7;MLXIPL;TGFA;IRF1;FRK;KMT2D
prerank,estrogen metabolic process (GO:0008210),-0.37367266263900445,-0.9302351656620726,0.5454545454545454,0.8200072046760876,1.0,3/15,27.66%,CYP1B1;HSD17B2;HSD17B7
prerank,myeloid leukocyte differentiation (GO:0002573),-0.27128478473985185,-0.9301597158201528,0.6024096385542169,0.8194717378895384,1.0,14/65,15.38%,LEF1;RUNX1;MYH9;TNFRSF11A;FOXP1;CAMK4;CBFA2T3;MT1G;BMP4;SBNO2;CDKN1A;THOC5;VEGFA;IL31RA
prerank,renal water homeostasis (GO:0003091),0.37957458082565726,0.9295744076590646,0.5583756345177665,0.9503911469374001,1.0,3/23,6.99%,ADCY5;ADCY1;ADCY9
prerank,respiratory chain complex IV assembly (GO:0008535),0.3796430134749118,0.9293432375179692,0.5472027972027972,0.9501934039164475,1.0,12/21,30.07%,COX16;COX10;SMIM20;COX19;FASTKD3;COX15;TIMM21;COA5;SCO1;COX14;PET100;SURF1
prerank,carbohydrate transport (GO:0008643),-0.4079923159579066,-0.9292341117390231,0.56640625,0.820910953871356,1.0,5/11,30.19%,AQP11;SLC50A1;SLC23A1;SLC23A2;AQP1
prerank,cytosolic transport (GO:0016482),0.29178679085680115,0.9290410482691484,0.5772913816689467,0.9502069645199915,1.0,35/108,20.46%,HOOK2;SNX6;SNX32;DENND2A;PTPN23;VPS54;DENND5A;PIKFYVE;BECN1;VPS50;CLTC;RGP1;ANKRD27;VTI1A;STX5;AP2A1;RAB29;VPS13A;SNF8;VPS51;CCDC91;HOOK3;EEA1;HEATR5B;WDR91;RAB9A;PHETA1;VPS35;MON2;EVI5;AP4M1;TMEM87B;STX16;WDR81;ANKFY1
prerank,negative regulation of histone modification (GO:0031057),0.42066482252348053,0.928923967810602,0.5543478260869565,0.9497624521137608,1.0,4/14,15.43%,JARID2;AASS;SPHK2;TAF7
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.34876875584291744,0.9286267700539685,0.5402298850574713,0.9497081320044222,1.0,9/36,14.80%,PRKN;PARP14;PARP9;RIPK1;MAVS;IRGM;ADAM17;AXL;AGPAT1
prerank,apoptotic nuclear changes (GO:0030262),0.37400791352514284,0.928542967849673,0.5325131810193322,0.9491655232160626,1.0,8/24,20.69%,CASP3;CDK5RAP3;BLCAP;DICER1;DFFB;DFFA;ACIN1;CECR2
prerank,organelle transport along microtubule (GO:0072384),0.3545754702854841,0.9285311826316942,0.5376712328767124,0.9484459734590849,1.0,9/31,18.49%,TRAK1;FBXW11;HTT;CDC42;KIF5B;ARHGAP21;PEX14;TRAK2;RHOT1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.32400052864611417,-0.9284837147451124,0.5721153846153846,0.8219457038483915,1.0,12/27,29.14%,MAP3K5;MAP3K7;IKBKB;CCDC88C;UBB;SKP1;MAP2K7;UBC;RPS27A;MAPK8;MAP3K8;MAPK3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.32850232542361835,-0.9281770185459899,0.5888077858880778,0.8219222004283485,1.0,11/27,20.04%,PID1;GRB14;PIP4K2A;ENPP1;PTPRE;NCK1;KANK1;PTPN1;PRKCQ;PIP4K2B;IRS1
prerank,regulation of cell morphogenesis (GO:0022604),0.3576322199829564,0.928175128255355,0.5604575163398693,0.9485137730418093,1.0,11/30,18.46%,SH3D19;CAPZB;PHIP;PDPN;MOV10;VIL1;ZMYM6;WTIP;ZMYM4;MYO9A;LARP4
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3215887018105094,-0.9280808499543947,0.5813397129186603,0.821403807599163,1.0,7/27,12.84%,DACH1;BMPR2;ACVRL1;FGF2;PDGFA;CDKN1A;SMG5
prerank,central nervous system myelination (GO:0022010),-0.41792025200170757,-0.92770340260608,0.5895196506550219,0.8215671974261662,1.0,3/11,6.91%,PLP1;TENM4;B4GALT5
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.39072932691349455,0.9274897569766646,0.5602189781021898,0.9494071018700244,1.0,3/21,7.05%,PRKN;LRRK2;OPA1
prerank,myotube differentiation (GO:0014902),0.4103186085839042,0.927050011871496,0.5399644760213144,0.9497050069631495,1.0,3/17,3.50%,ADAM12;IGF1;ADAMTS15
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.2996683748594388,-0.9268327732774658,0.5905511811023622,0.82285969858975,1.0,7/39,7.12%,UTRN;FGF12;CHRM3;FXYD5;NEDD4L;YWHAE;TRPC6
prerank,myelination in peripheral nervous system (GO:0022011),-0.3835231664344427,-0.9267047777151814,0.5424063116370809,0.82244188464214,1.0,8/13,28.47%,ADGRG6;MYOC;PRX;SIRT2;LGI4;SOD1;NF1;NCMAP
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.30539841810784313,0.9266127916747838,0.5643153526970954,0.9499700141522028,1.0,19/80,15.31%,ROCK2;PICALM;EPHA4;CASP3;LARP4B;DDX3X;CD28;POLDIP3;SAMD4A;CPEB3;SIRT3;PLA2G6;YTHDF3;PRKDC;PLD1;SPHK2;ZCCHC4;NSMAF;SMPD3
prerank,heterochromatin organization (GO:0070828),-0.3805600809056365,-0.926357731444646,0.5646551724137931,0.8224815621138962,1.0,2/14,5.64%,MECOM;PRDM16
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.34873525160828434,-0.9260905217154091,0.5336322869955157,0.8224017161441521,1.0,8/19,27.82%,CORO2B;CCT8;PTP4A3;CCT2;CCT6A;CCT7;CEP135;DKC1
prerank,zymogen activation (GO:0031638),0.3442764175088775,0.9260574885906836,0.5555555555555556,0.9505300206895781,1.0,7/39,15.65%,KLK2;F11;CTSH;RIPK2;MMP14;ASPH;PLAT
prerank,regulation of protein kinase B signaling (GO:0051896),0.2686819080900485,0.9259514899272195,0.5935563816604709,0.9500439600116555,1.0,32/193,12.46%,FGF1;OSBPL8;KIT;PPARA;FGFR2;KL;IL18;PKHD1;FRS2;FGFR1;MAGI2;TGFBR1;DAG1;CD28;PDGFRB;GAB2;RICTOR;PTEN;PIK3CA;NRG1;PDPK1;SIRT1;TCF7L2;HBEGF;FLT3LG;CASS4;RNF41;KLB;GDF15;PHLPP2;PTPN11;TGFA
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3738946068836211,0.9259410262751749,0.5909090909090909,0.9493261592385481,1.0,5/26,8.75%,GBGT1;LARGE1;GK5;GK;GAL3ST4
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.31675481097500063,-0.9255082195196268,0.5874125874125874,0.8229905458917156,1.0,10/29,20.20%,HSP90AB1;PPIA;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;RPA1;ANKRD28;NHP2;PTGES3
prerank,cellular response to inorganic substance (GO:0071241),-0.3476775107732133,-0.9252260173783341,0.5736607142857143,0.8229075971545426,1.0,3/21,7.13%,KCNC2;GUCY1B1;FOXO1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3380015159865174,-0.9251659023762244,0.5690072639225182,0.8223110136641752,1.0,8/22,17.51%,MDFIC;APOD;UFM1;CABP1;DMTN;SIAH3;GDI1;BARD1
prerank,negative regulation of T cell differentiation (GO:0045581),0.44822463403861723,0.9250214613238426,0.5545454545454546,0.9508108723138562,1.0,4/10,21.02%,GLI3;IRF1;IHH;CTLA4
prerank,negative regulation of protein kinase activity (GO:0006469),0.3008505948651171,0.924198693337564,0.5877192982456141,0.9519739825954847,1.0,14/88,11.27%,PRKAG2;SLC8A3;PPM1E;DEPTOR;DTNBP1;TRIB2;WWTR1;CDK5RAP3;SH3BP5;PDPK1;MVP;ABL1;DUSP10;TRIB1
prerank,negative regulation of DNA recombination (GO:0045910),0.33559366012636366,0.9241250249204308,0.5588697017268446,0.9514012350276696,1.0,17/43,26.79%,POLR2A;ATRX;ACD;POLR2D;FBH1;MSH3;SMCHD1;TINF2;POLR2G;POLR2F;PARP3;MAD2L2;H1-0;SHLD2;UBQLN4;RTEL1;POLR2K
prerank,response to chemokine (GO:1990868),-0.3850647501794897,-0.9240137923446108,0.5648535564853556,0.8242793338994292,1.0,5/13,10.81%,LRCH1;CXCL12;SLC12A2;DOCK8;DUSP1
prerank,microtubule bundle formation (GO:0001578),-0.2951952203908212,-0.9237016663313807,0.5880758807588076,0.8243190441916451,1.0,20/42,33.41%,NCKAP5;DCX;MTCL1;RP1;CDK5RAP2;SPEF1;CLIP1;TPPP;CAPN6;SPAST;LRGUK;TPPP3;MARK4;KIF20A;PSRC1;RSPH9;CFAP206;FOXJ1;CCDC66;TTLL3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.3951631646480915,-0.9235485322405145,0.5730337078651685,0.8239715799023383,1.0,8/12,22.93%,SIX1;VEGFA;PAX2;SOX8;PAX8;SIX4;AGT;LHX1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3576495403636886,0.9234036146775854,0.5986277873070326,0.9523017918471355,1.0,9/29,20.23%,TLR3;IKBKE;TLR4;RIPK1;LY96;BIRC3;CD14;TANK;TRAF3
prerank,regulation of RNA metabolic process (GO:0051252),0.31776220189968407,0.9231941317591771,0.5813953488372093,0.9520444704760095,1.0,20/59,18.37%,SON;OAS2;MITF;SNRNP70;PCBP2;MBNL2;IGF2BP1;HNRNPH1;CLK4;IGF2BP2;NOVA1;HNRNPL;OAS3;CLK1;CLK2;GRSF1;FASTK;MED1;FUS;HNRNPH3
prerank,phospholipid dephosphorylation (GO:0046839),-0.30468123094635596,-0.9228660580231492,0.5813333333333334,0.8248434526306664,1.0,9/37,11.53%,PLPP1;PLPPR1;MTMR6;MTMR2;PLPPR5;MTMR11;PLPPR4;MTMR7;MTMR9
prerank,regulation of lymphocyte migration (GO:2000401),-0.4147587171413237,-0.9228644519746385,0.5842450765864332,0.8241226857831182,1.0,3/10,10.85%,STK10;JAM2;MSN
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.37473643747238367,0.9228311421169897,0.5702341137123745,0.9521455306162456,1.0,6/23,11.30%,EFNB2;IGF1;NRG1;NIBAN2;MYLK3;MMP14
prerank,regulation of JNK cascade (GO:0046328),0.2903943581070307,0.9227392824800545,0.592747559274756,0.951633550551818,1.0,5/101,1.98%,TGFBR3;SH3RF2;TPD52L1;CCN2;PRKN
prerank,mRNA 3'-end processing (GO:0031124),0.30373451200712576,0.9226309128387988,0.5824817518248175,0.9511477901857648,1.0,23/78,22.13%,PABPN1;SRSF5;AHCYL1;POLDIP3;RPRD2;POLR2D;TENT2;SCAF8;SRSF11;SARNP;TENT4B;CPSF3;PAPOLG;GRSF1;SRSF1;CSTF1;CDC40;PCF11;U2AF1;SRSF7;U2AF2;TUT1;CPSF7
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.440689014813553,0.9223605437001705,0.5415094339622641,0.9510610251707472,1.0,1/11,1.98%,PRKN
prerank,histone mRNA catabolic process (GO:0071044),0.39863495806352056,0.9222481320000908,0.5489443378119002,0.950570490896035,1.0,7/15,24.20%,ATM;TUT4;TENT2;TENT4B;TUT7;TUT1;XRN1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2798341859778671,-0.9221949928404837,0.5953757225433526,0.8250086375751992,1.0,20/57,18.81%,MAP3K5;GRIN2B;NOD1;TNFSF10;CTSD;GRIN2A;PERP;GRAMD4;GPER1;SOX7;DAPK1;AIM2;PPM1F;USP50;GRIN1;SYK;HTRA2;CYCS;FOXL2;BCAP31
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3304170389952628,-0.9215554312120396,0.5714285714285714,0.8258449348065988,1.0,10/23,27.77%,RAD23B;UBB;COPS4;CETN2;COPS6;COPS5;UBC;RPS27A;DDB1;COPS2
prerank,gonad development (GO:0008406),0.3337119687888443,0.9214566810820738,0.5754276827371695,0.9516704620113114,1.0,3/41,3.08%,WNT4;KIT;NR2F2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.2778573422827124,0.9210975514342771,0.6135135135135135,0.9517489791250945,1.0,41/153,19.06%,ROCK2;PRKCZ;STK32B;TGFBR1;DMPK;LRRK2;SMG1;PRKCB;IKBKE;ATM;CAMK1;RICTOR;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;PIKFYVE;RIPK1;MKNK1;BRSK1;SRPK2;DYRK1A;PRKDC;CSNK2A2;CSNK2A1;PRKCA;HIPK3;PRKCI;WNK1;MAP2K2;STK4;MAPK9;TLK2;CLSPN;PKN2;PAK2;TAF1;MAPK14;SGK2;SGK3;CAMK1D
prerank,regulation of protein kinase activity (GO:0045859),0.2923309011874582,0.9210912700110295,0.6023054755043228,0.9510296371748801,1.0,14/106,11.27%,PRKAG2;ALS2;PPM1E;DEPTOR;DTNBP1;UVRAG;TRIB2;CACUL1;WWTR1;PDPK1;TAB2;SIRT1;JTB;TRIB1
prerank,folic acid metabolic process (GO:0046655),0.3943731815205728,0.9206930131903416,0.5569620253164557,0.9512090060483175,1.0,6/18,19.25%,SLC19A1;MTHFR;ALDH1L1;MTRR;MTHFD1;FOLR2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.30959735391241866,0.9204267455581601,0.5787923416789397,0.9511002852888917,1.0,11/66,9.78%,SMAD3;SESN2;F2;WWTR1;CDK5RAP3;ZIC1;TERT;PARP9;LARP7;UBR5;MAVS
prerank,regulation of cell cycle (GO:0051726),0.26180548890936883,0.9204226566995551,0.6476868327402135,0.9503764242306113,1.0,48/271,14.68%,NOTCH2;BMP7;SMAD3;FGFR2;GRK5;SON;FBXL17;NUPR1;MAGI2;TGFBR1;ATM;ANKRD17;IL12B;TP53;SIK1;AFAP1L2;CDC14A;CDK5RAP3;NUPR2;SND1;LIN52;CDC25A;SIRT1;CHMP1A;CCNB2;TCF7L2;HBP1;PHACTR4;TBRG4;FBXL12;SRPK2;ABL1;CDC14B;MYBL2;CSNK2A2;CSNK2A1;MLXIPL;IRF1;PPP1R13B;MAP2K1;PML;PRCC;MFN2;PER2;TSC1;KAT2B;GADD45A;MAP2K6
prerank,tRNA 5'-end processing (GO:0099116),0.40003461158983455,0.9202777162129834,0.5437616387337058,0.950001195519343,1.0,5/15,20.85%,RPP21;RPP25L;PRORP;POP7;POP1
prerank,regulation of cell division (GO:0051302),0.30963038118441966,0.919747552667981,0.5920852359208524,0.9504850158125698,1.0,8/72,10.53%,FGF1;FGFR2;NCOA3;UVRAG;PLK5;MYO19;BECN1;AURKB
prerank,intraciliary retrograde transport (GO:0035721),0.4280637549979513,0.9194829769754245,0.5644283121597096,0.9503134275421675,1.0,4/12,14.33%,IFT122;WDR19;DYNC2I1;WDR35
prerank,negative regulation of synaptic transmission (GO:0050805),0.3728687244592329,0.9192984332665459,0.5660714285714286,0.9500376457920475,1.0,5/23,9.69%,SYT11;LRRK2;PRRT1;PTEN;PICK1
prerank,telomere maintenance (GO:0000723),0.3271517292611923,0.9192918101158953,0.5736925515055468,0.9493255319242435,1.0,16/50,19.85%,POLD2;TPRKB;ATM;ACD;TEP1;TERT;PRKDC;HUS1;RAD50;NSMCE2;ZBTB48;SP100;TINF2;NBN;RAD51D;XRCC3
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2376556578445735,-0.919250389502785,0.6692913385826772,0.8304248216367205,1.0,28/124,15.89%,LEF1;PRICKLE2;DAAM1;GNG2;SFRP4;PSMB2;NLK;ROR2;TIAM1;CALM1;FZD4;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;AP2B1;PSMC6;FRZB;VANGL2;AP2M1;CTNNB1;CCDC88C;SMURF1;GNAO1;GNB1;PSMA4;PSMB9
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3877077201136047,0.9190673780916395,0.5757042253521126,0.9491552315374561,1.0,4/22,13.22%,BMP7;MAP2K5;FLOT2;WNK1
prerank,Fc receptor signaling pathway (GO:0038093),-0.24505189058195925,-0.9190416186521866,0.6705426356589147,0.8301624927441943,1.0,44/110,30.01%,PIK3R1;LYN;PSMB2;PAK1;CALM1;PLCG2;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;TEC;PSMC6;IKBKB;PSMA4;PSMB9;VAV1;SKP1;SYK;PSMD11;BTK;PSMB10;PRKCQ;PSMD2;SHC1;SOS1;PSMA2;MAP2K7;RELA;PSMB3;TAB1;PLCG1;PSMB5;LCP2;CARD11;MAPK8;PSMA7;FOS;MAPK3;PSMF1;PSMD7;JUN;MAP2K4;MALT1
prerank,negative regulation of nervous system development (GO:0051961),-0.3578320123986801,-0.9190389522133329,0.5911111111111111,0.829441150533851,1.0,4/17,7.85%,ROBO2;B2M;NOTCH1;SORL1
prerank,B cell homeostasis (GO:0001782),0.43935614089162794,0.9190012283083623,0.572265625,0.9485727597273529,1.0,1/10,0.43%,DOCK11
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.3241895155599188,0.9188371989306636,0.5653495440729484,0.9482282603959907,1.0,8/48,13.93%,ROBO1;PARP14;GPS2;STAT2;SAMHD1;YTHDF3;OAS3;USP18
prerank,response to hydrogen peroxide (GO:0042542),-0.289189416827725,-0.9179940801372244,0.6016713091922006,0.8311316487705034,1.0,12/45,16.43%,MAP3K5;CYP1B1;NET1;ANXA1;RPS3;PLEKHA1;RHOB;GLRX2;TRPM2;PAX2;GPX1;CAT
prerank,regulation of centrosome duplication (GO:0010824),0.3540732046608853,0.9179674907976314,0.5454545454545454,0.9496259536480126,1.0,10/30,20.40%,PKHD1;SIRT1;CHMP1A;CENPJ;ALMS1;CHMP4C;CEP120;XRCC3;CEP295;CHMP2A
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4016327672253573,0.9176907023186575,0.5476635514018692,0.9495245259991403,1.0,4/18,11.94%,PRKN;MCU;DNM1L;RALBP1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3943199072773042,0.9176797426653717,0.5716783216783217,0.9488241848965779,1.0,7/21,24.76%,MITF;MED12;MED17;MED1;MED13;MED24;BCLAF1
prerank,protein destabilization (GO:0031648),0.3534075560411337,0.917506626229198,0.5663865546218487,0.948512208987621,1.0,7/32,10.49%,PRKN;CTSH;FBXW11;BTRC;HTT;SIRT1;IRGM
prerank,calcium-mediated signaling (GO:0019722),0.29503872718008545,0.9174212072227025,0.6,0.9479718970256418,1.0,11/93,5.50%,ANK2;NUDT4;CCR9;ACKR2;SPHK1;MCU;DMPK;LRRK2;CACNA1C;DEFB1;ADGRL1
prerank,macromolecule catabolic process (GO:0009057),0.3652152813986746,0.9173267396615142,0.5714285714285714,0.9474625532833203,1.0,6/26,10.39%,NEDD4;UVRAG;TPP1;CLPX;CLN6;BECN1
prerank,histone monoubiquitination (GO:0010390),0.36916657323983987,0.9169846161978834,0.5588235294117647,0.9475688566924474,1.0,7/24,19.45%,CTR9;BCOR;KDM2B;DDB2;UBE2E1;RNF20;RNF2
prerank,protein localization to cell junction (GO:1902414),0.3876604717348402,0.9167703431171451,0.5579831932773109,0.9473564202526417,1.0,3/22,2.47%,CGNL1;ARHGEF18;NLGN2
prerank,negative regulation of lyase activity (GO:0051350),-0.3524833651468232,-0.9163947203955058,0.583864118895966,0.8339971900728923,1.0,8/16,32.38%,GRM3;GABBR2;EDNRB;PALM;DRD2;GNAI3;PHPT1;DRD3
prerank,melanosome localization (GO:0032400),0.3857050075976758,0.9157956861077975,0.553415061295972,0.9488452706190739,1.0,6/21,15.83%,SHROOM2;BLOC1S6;RAB11B;MKKS;ARL6;BBS2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3488300426686639,0.9156852730779577,0.5858085808580858,0.948395448527695,1.0,3/38,5.16%,SMAD3;ROCK2;TLR4
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2947383970070287,-0.9155423987904969,0.6021505376344086,0.8352344665834825,1.0,20/39,31.81%,POLD3;ERCC1;UBB;RPA1;GTF2H1;GTF2H4;GTF2H5;RFC4;ERCC2;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;DDB1;RPA3;ERCC3;RPA2
prerank,organic substance transport (GO:0071702),0.2847216948539611,0.9153626297773227,0.5958333333333333,0.9484047767871551,1.0,18/121,10.34%,SLC22A6;ABCA4;SLC35F3;PCTP;SLC22A18;ABCA9;SLC19A1;SLC22A5;TCN2;SLC48A1;HRG;SLC6A4;TOM1;PICK1;MFSD2B;CHMP1A;PLEKHA8;SLC19A2
prerank,regulation of feeding behavior (GO:0060259),0.42709927776946577,0.914500373249314,0.5546719681908548,0.9496662265064011,1.0,1/11,0.73%,LEPR
prerank,negative regulation of ATP metabolic process (GO:1903579),0.39338338216531715,0.9144715893072743,0.5847299813780261,0.9490062038474243,1.0,6/17,14.23%,PPARA;NUPR1;HDAC4;MLXIPL;NCOR1;FLCN
prerank,homologous chromosome segregation (GO:0045143),-0.3340335650971818,-0.9137146923309925,0.5756207674943566,0.8386890732979768,1.0,4/20,21.61%,FMN2;ZCWPW1;MEI4;PRDM9
prerank,hemidesmosome assembly (GO:0031581),0.4351672980204325,0.9135688816212879,0.5452830188679245,0.9504318797268406,1.0,2/11,2.05%,LAMC2;LAMC1
prerank,telomere maintenance via recombination (GO:0000722),0.4318306153298818,0.9135544653958452,0.5755813953488372,0.9497408816499386,1.0,6/11,19.85%,TPRKB;TEP1;RAD50;NSMCE2;RAD51D;XRCC3
prerank,establishment of epithelial cell polarity (GO:0090162),0.38951570326925067,0.9134742275949645,0.56353591160221,0.9491932029831381,1.0,6/19,13.42%,CLASP1;MYO18A;EZR;OPHN1;CDC42;PARD3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2644956468839682,0.913191787084751,0.6489988221436984,0.9491413735899465,1.0,67/241,23.34%,SRRM2;DDX5;POLR2A;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;SNIP1;HNRNPA2B1;POLR2D;RBM15;SPEN;NOVA1;GPKOW;CCAR1;CWC27;GTF2F1;HNRNPL;CWC15;IK;USP49;PHF5A;SRSF11;PRCC;HNRNPC;PRPF3;SNRNP40;RBM4;TFIP11;HNRNPM;CPSF3;CWF19L1;FRG1;USP39;ZCRB1;PRPF6;FUS;SRSF1;CSTF1;HNRNPH3;CDC40;PCF11;SRSF10;U2AF1;EFTUD2;SNRPC;SRSF7;SF1;PNN;POLR2G;WBP4;PRPF31;SNRPA1;U2AF2;SF3B2;SF3B1;PPWD1;SF3B5;CPSF7;GCFC2;PQBP1;CDC5L;RNPC3;NUDT21;POLR2F
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.300700478625909,-0.913180989066326,0.6085918854415274,0.8391493941390021,1.0,8/37,14.22%,PRKG1;MEF2C;TGFB3;FGF2;GPER1;CDKN1A;FGF9;HTR1B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.36238953448460814,0.9126282707969903,0.588135593220339,0.9496986392630349,1.0,6/25,12.87%,CCNT2;LDB1;ELL;SCAF8;WDR43;KAT7
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3713924978837648,0.9125669352094108,0.5745762711864407,0.9491194791812199,1.0,2/25,5.16%,SMAD3;TLR4
prerank,positive regulation of lipid catabolic process (GO:0050996),0.37792805813950403,0.9121114772563341,0.5796847635726795,0.9494511558982273,1.0,1/19,1.76%,PPARA
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.37994798606564195,0.9120260553315881,0.5692599620493358,0.9489282979992963,1.0,6/21,16.39%,TUT4;SAMD4A;CNOT10;PAN3;PNLDC1;TUT7
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.3857128110987951,-0.9118516262760817,0.5918367346938775,0.8414886187608054,1.0,4/13,12.20%,BMP5;APOE;BMP2;ERLIN1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.43362506834333414,0.9118246266456457,0.5807692307692308,0.9486531677707625,1.0,1/11,1.93%,LRRC38
prerank,phosphatidylinositol metabolic process (GO:0046488),0.28922966361951574,0.9116692588724418,0.6068493150684932,0.9482949927714794,1.0,18/109,11.18%,PTPN13;LPGAT1;INPPL1;PI4KA;MTMR3;SYNJ2;PLEKHA2;PIGW;PDGFRB;SLC27A1;PIP4K2C;PTEN;PIK3CA;PLCD1;PIKFYVE;PLEKHA8;PIK3R3;OCRL
prerank,filopodium assembly (GO:0046847),-0.36492795875542494,-0.9115978760019273,0.5870967741935483,0.8413496425132272,1.0,3/16,4.20%,DNM3;FGD5;SPATA13
prerank,pharyngeal system development (GO:0060037),0.4173739668413312,0.9114087006327705,0.5834896810506567,0.9481578164808756,1.0,3/15,3.46%,BMP7;BMPR1A;TGFBR1
prerank,regulation of telomere capping (GO:1904353),0.37146270880216725,0.911065720419128,0.5632582322357019,0.9482382406952142,1.0,6/23,12.68%,ATM;TNKS2;AURKB;RAD50;USP7;PNKP
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.2344563957890979,-0.91067823585803,0.7226890756302521,0.8427767477918717,1.0,28/136,14.71%,ESR1;TMSB4X;CD200;ID1;GAS6;PTGIS;CYP1B1;NFKBIA;SFRP4;DAB2IP;FLNA;HES1;PTCH1;CTNNBIP1;HEYL;PROX1;IRAK3;SMAD7;ERBIN;ID2;PKD1;HAVCR2;NLRC5;CMKLR1;AIM2;RBCK1;TRIM37;DAP
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3976304409667164,-0.9105639116904382,0.6030701754385965,0.8415899584551161,1.0,5/12,15.66%,AKAP6;CAMTA1;LMCD1;SPPL3;STIMATE
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3976304409667164,-0.9105639116904382,0.6030701754385965,0.8415899584551161,1.0,5/12,15.66%,AKAP6;CAMTA1;LMCD1;SPPL3;STIMATE
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.26141022431435934,-0.9102714926443121,0.6441717791411042,0.8415418469976311,1.0,21/68,24.36%,STAT3;MBP;ARHGEF2;IL33;APP;PLCG2;CYBA;TIRAP;TWIST1;LBP;DHX9;NOD2;CD74;SYK;TLR7;TYROBP;LGALS9;PYCARD;IL6R;F2R;HYAL2
prerank,protein autophosphorylation (GO:0046777),0.2729399762511927,0.9102478176506327,0.6160949868073878,0.9494213483849269,1.0,25/157,10.70%,OXSR1;KIT;FGFR2;EPHA4;GRK5;FGFR1;AAK1;LRRK2;SMG1;ATM;EPHA8;FLT1;PDGFRB;SIK1;EIF2AK2;MAPKAPK3;PDPK1;RIOK2;PIKFYVE;RIPK1;MKNK1;FER;AURKB;ABL1;DYRK1A
prerank,TOR signaling (GO:0031929),0.35425643735727963,0.9101866799853153,0.576530612244898,0.9488466067956558,1.0,8/26,15.83%,FNIP1;NPRL3;SMG1;RICTOR;LARP1;MAPKAP1;FLCN;RPTOR
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.33434907796758206,0.9100705524101874,0.6087662337662337,0.948393472370225,1.0,4/41,7.34%,SYT11;IGF1;TLR4;PTPN22
prerank,negative regulation of cellular senescence (GO:2000773),0.41865338481542264,0.9098459021381794,0.5959780621572212,0.9481714861660072,1.0,5/13,14.53%,SLC30A10;TERT;SIRT1;RBL1;ZKSCAN3
prerank,nitrogen compound transport (GO:0071705),0.2768045463719937,0.9095942925105677,0.617687074829932,0.9480285231778243,1.0,22/141,12.40%,SLC6A13;SLC6A12;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN;SLC35F3;SLC25A48;SLC22A5;TCN2;SLC38A1;SLC48A1;HRG;SLC6A4;TOM1;PICK1;CHMP1A;SLC19A2;RALBP1;TCN1;MIA3
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3909934424740729,0.9093411585080828,0.5801801801801801,0.9478706256208141,1.0,4/18,12.56%,PRKN;ADRA2A;MIDN;SIRT4
prerank,response to organonitrogen compound (GO:0010243),-0.29145340695512556,-0.9092424799735567,0.6162162162162163,0.8431966837547505,1.0,11/38,21.60%,GLRB;GLRA3;IRAK3;GLRA1;GLRA2;TRPM2;RHBDD1;NR1H4;IRF5;RCN3;DRD2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3515551129583545,0.9088509759540041,0.5522648083623694,0.9482622474412447,1.0,6/29,14.30%,WWOX;BID;PPP2R1B;RIPK1;PML;AGTR2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3978570144944467,0.9085623240264944,0.562152133580705,0.948177162005384,1.0,3/15,9.52%,PPARA;ADM;SLC45A3
prerank,regulation of cell killing (GO:0031341),-0.358690775993743,-0.907758995148869,0.5838779956427015,0.8457819206480436,1.0,3/16,10.68%,TGFB2;ICAM1;CYBA
prerank,embryonic axis specification (GO:0000578),0.4056839534710464,0.9076699745364859,0.5931899641577061,0.9495338917660506,1.0,3/15,5.39%,CXXC4;SMAD6;FZD5
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3693831915250656,0.9074824918961015,0.5851602023608768,0.9492271801324801,1.0,3/22,6.47%,IL18;SPHK1;IL12B
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3574794639255502,-0.9071785238686306,0.5914893617021276,0.84633919133867,1.0,3/16,10.92%,SCARB1;LDLR;MFSD2A
prerank,regulation of transposition (GO:0010528),0.39750843594422636,0.9071063119358633,0.550561797752809,0.949390230476719,1.0,2/13,10.12%,UBR2;MYBL1
prerank,striated muscle cell differentiation (GO:0051146),-0.3594812194971386,-0.907017985315501,0.5767441860465117,0.8459665841619184,1.0,4/16,8.22%,MEF2C;MYEF2;SORT1;BMP2
prerank,regulation of primary metabolic process (GO:0080090),0.28320455625200974,0.9069913259090053,0.6243315508021391,0.9489749252028956,1.0,13/126,8.29%,ROCK2;NFYC;PPARA;CHD9;NCOR2;NFYB;GPS2;C1QTNF2;TBL1X;SMARCD3;ANGPTL8;NR1D2;TBL1XR1
prerank,sphingoid biosynthetic process (GO:0046520),-0.4028138505758486,-0.9064186797042534,0.5898520084566596,0.8458742348026965,1.0,4/11,11.77%,ACER3;ACER2;SPTLC2;ASAH2
prerank,sphingosine biosynthetic process (GO:0046512),-0.4028138505758486,-0.9064186797042534,0.5898520084566596,0.8458742348026965,1.0,4/11,11.77%,ACER3;ACER2;SPTLC2;ASAH2
prerank,cardiocyte differentiation (GO:0035051),0.4286482642987891,0.9063701783829857,0.5785288270377733,0.9496990959275808,1.0,4/10,9.62%,AKAP13;SIK1;NRG1;CBY1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.36700619924458955,0.9061647715704906,0.5769230769230769,0.9487136747972521,1.0,3/24,7.26%,HK2;PGAM2;GCK
prerank,canonical glycolysis (GO:0061621),0.36700619924458955,0.9061647715704906,0.5769230769230769,0.9487136747972521,1.0,3/24,7.26%,HK2;PGAM2;GCK
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.3644178128966238,0.9059581885880507,0.5827702702702703,0.9485134820209234,1.0,2/26,5.16%,SMAD3;TLR4
prerank,male gonad development (GO:0008584),0.33941340908872975,0.9058859111697793,0.6016129032258064,0.9479744496522874,1.0,2/34,1.21%,WNT4;KIT
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.41531310225918217,-0.9057697811281478,0.6155419222903885,0.8466502394258888,1.0,5/10,21.60%,DISC1;CTNNB1;VEGFA;CX3CR1;DRD2
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.41060370049682593,-0.9051769972199538,0.5824847250509165,0.8472315975667105,1.0,2/10,13.39%,ASRGL1;QDPR
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.43859983241522366,0.9050595604026921,0.6003787878787878,0.948432640676003,1.0,3/11,11.18%,SYNJ2;PTEN;OCRL
prerank,inositol phosphate dephosphorylation (GO:0046855),0.43859983241522366,0.9050595604026921,0.6003787878787878,0.948432640676003,1.0,3/11,11.18%,SYNJ2;PTEN;OCRL
prerank,chromatin assembly (GO:0031497),0.33902944267327617,0.9047002330778271,0.5930807248764415,0.9485523582680986,1.0,14/38,25.22%,CHAF1B;ATRX;TP53;KAT6B;SIRT1;BAHD1;CDAN1;PADI4;EZH1;ASF1A;NOC2L;NAP1L2;H1-0;M1AP
prerank,retinol metabolic process (GO:0042572),-0.3607513847380471,-0.9046524683489023,0.6033755274261603,0.8476568958255122,1.0,3/14,10.97%,CYP1B1;RDH10;ADH1A
prerank,T cell differentiation in thymus (GO:0033077),0.4061596116926456,0.9043915249818775,0.5738317757009346,0.9485363604327067,1.0,4/14,20.02%,GLI3;ADAM17;ZFP36L1;LIG4
prerank,cellular response to insulin stimulus (GO:0032869),0.28182324364281897,0.904190601675557,0.6300268096514745,0.9483029737558786,1.0,19/124,11.32%,CPEB2;SORBS1;RHOQ;INSIG2;PHIP;ATP6V0E1;BAIAP2;ATP6V0B;SLC27A1;GCK;PDPK1;GRB10;FOXC2;FER;RAB13;PIK3R3;ATP6V1D;ATP6V1E1;PRKDC
prerank,DNA repair (GO:0006281),0.25692486318454466,0.904100731628206,0.6830409356725147,0.9478113679214251,1.0,65/284,20.24%,EYA1;POLD2;BABAM2;KMT5C;USP3;ATM;ASCC2;UVRAG;RAD54L;BAZ1B;KMT5B;TP53;PARP4;RNF8;FANCI;HUWE1;FBH1;XRCC4;FANCM;PDS5A;PARP9;SIRT1;ABL1;EME2;RBBP8;PRKDC;MSH3;ZBTB1;HUS1;IGHMBP2;UIMC1;FANCA;RAD50;PNKP;TDG;POLE2;BABAM1;DDB2;GADD45A;DOT1L;MGMT;INTS3;TDP2;TEX264;POLL;ALKBH5;MBD4;OGG1;USP1;NBN;SUMO1;FEN1;RAD51D;PIAS4;SLX4;MMS19;PDS5B;APTX;MTA1;XPA;ASF1A;FANCD2;XRCC3;LIG4;RAD9A
prerank,protein localization to cell-cell junction (GO:0150105),0.40137911241641827,0.904047781173784,0.5783783783783784,0.9472365006619494,1.0,4/15,8.86%,CGNL1;ARHGEF18;MPP7;CDH5
prerank,lipid droplet formation (GO:0140042),-0.40700271297581647,-0.9039696936763002,0.6074950690335306,0.848462897616537,1.0,4/10,26.56%,CDS1;SQLE;AUP1;CDS2
prerank,establishment of spindle localization (GO:0051293),-0.3608257501737654,-0.9039239269780284,0.5601659751037344,0.8478462907530979,1.0,6/14,24.14%,CLASP2;MAP4;CFL1;NUSAP1;TLE6;KPNB1
prerank,regulation of embryonic development (GO:0045995),0.34140867293668875,0.9037291031485216,0.571912013536379,0.947251395771376,1.0,10/34,13.85%,CLASP1;DAG1;NIPBL;TRIP12;NIBAN2;NR2C2;PHLDB2;FOXA2;TDG;WDPCP
prerank,regulation of Golgi organization (GO:1903358),0.3987628029131528,0.90349759535671,0.5798922800718133,0.9470907208589191,1.0,5/17,14.01%,STX18;ARMH3;MAP2K1;STX5;MAP2K2
prerank,cellular response to hexose stimulus (GO:0071331),0.3774128372602077,0.9032766434794139,0.5889908256880734,0.9468898021218716,1.0,2/23,2.21%,PRKAA2;ZBTB20
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3871085818558797,-0.9032679759773236,0.5803212851405622,0.8486064314509737,1.0,2/13,9.29%,PRR5L;PNPT1
prerank,cellular response to heat (GO:0034605),0.34078701036277603,0.9031840522257595,0.6113821138211382,0.9464138273515179,1.0,3/35,7.87%,FGF1;POLR2D;HSBP1L1
prerank,stem cell development (GO:0048864),-0.3570996067516918,-0.9028574775436355,0.5802197802197803,0.8488411305260491,1.0,4/16,18.48%,CDH2;PTPRC;KLHL12;SOX8
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3122348013018111,0.9021779946747533,0.5851063829787234,0.9479241697733919,1.0,7/57,7.82%,ADCY5;LPAR1;ADCY1;ADRA2A;AKAP12;ADCY9;GNAT3
prerank,sodium ion import across plasma membrane (GO:0098719),0.3943416382200891,0.902126998277081,0.5561797752808989,0.9473354627831608,1.0,1/17,0.37%,SLC6A1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3668322999543588,0.9020260278683427,0.5763016157989228,0.9468580870175753,1.0,3/22,9.72%,CACNA1D;CACNA1C;STIM1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2732719192480293,-0.9018841810311798,0.6200527704485488,0.8503070102080657,1.0,15/46,25.99%,PPIA;RAP1B;RPLP0;JAK1;MSN;PITPNA;TALDO1;CFL1;CAPZA1;AIP;PDCD4;SOD1;MTAP;JAK2;STAT4
prerank,snRNA 3'-end processing (GO:0034472),0.38210642853915333,0.9018296080426859,0.572992700729927,0.9466078402955316,1.0,8/19,21.64%,EXOSC7;INTS2;INTS5;INTS7;INTS1;INTS8;EXOSC3;TUT1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.26030641587068404,0.901742391363861,0.6767554479418886,0.9461147320686376,1.0,29/234,11.27%,PPARGC1B;SMAD3;ZIC2;PRKCZ;KIT;PPARGC1A;ADCY1;IL18;SPHK1;CFLAR;EDA;NHLH2;PRKCB;IKBKE;SMO;TLR4;EIF2AK2;PTEN;SMARCA4;HDAC4;TAB2;TFDP1;RIPK2;RIPK1;MAVS;FER;RAB7B;ATF2;ANXA3
prerank,negative regulation of protein catabolic process (GO:0042177),-0.2896468471781432,-0.901686715416909,0.6229946524064172,0.8499724050040178,1.0,10/40,13.86%,FMN2;CST3;NELL1;DAB2IP;FLNA;TIMP2;IRAK3;PTPN3;SNCA;ADGRB1
prerank,embryonic digit morphogenesis (GO:0042733),0.3912147461589874,0.9015448554191063,0.6046931407942239,0.9458399637200663,1.0,5/18,16.30%,OSR1;GLI3;HDAC1;WDPCP;CREBBP
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.25853130659449436,0.9012885088309704,0.7105263157894737,0.9456976253880816,1.0,59/260,17.05%,CFAP44;ACTN2;KIT;AVIL;CC2D2A;RHOD;PKHD1;DCDC2;SRGAP2;FGD4;CEP250;CPLANE2;RILPL1;EZR;RAB3IP;CYS1;RHO;PTPN23;ASAP1;EXOC2;CCDC28B;SSTR3;CEP162;ANO6;CDC14A;IFT122;WDR19;OPHN1;DYNC2I1;MKKS;TMEM231;CLUAP1;CDC14B;CENPJ;ATP6V1D;FGD1;IFT88;OCRL;MYLK;GALNT11;PDE6D;UNC119B;WDPCP;CFAP410;WDR35;EXOC4;EXOC3;PARVA;B9D2;ARFIP2;ARL6;RP2;BBS2;STK36;RFX2;RAB8B;RILPL2;PIBF1;TMEM237
prerank,fatty acid elongation (GO:0030497),-0.3744225576671873,-0.9011254251494295,0.5856236786469344,0.8505397491904821,1.0,3/13,10.29%,ELOVL7;ELOVL5;ELOVL6
prerank,histone H2A acetylation (GO:0043968),0.392886517137151,0.900991114872948,0.581981981981982,0.9456782540089956,1.0,1/16,1.51%,BRD8
prerank,peptidyl-lysine methylation (GO:0018022),0.3592698870043754,0.9009334210841496,0.599271402550091,0.9451054946328614,1.0,8/26,22.70%,SMYD3;SETD7;KMT5A;EHMT2;EHMT1;SETD3;N6AMT1;EEF1AKMT1
prerank,positive regulation of T cell differentiation (GO:0045582),0.34208069256758894,0.9009230957611045,0.5947281713344317,0.9444363572499235,1.0,7/36,11.69%,GLI2;GLI3;IL12B;SOX12;DUSP10;ZBTB1;ZMIZ1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.40227228096145407,0.9009068568625179,0.58,0.9437787589230907,1.0,5/16,14.77%,PPARGC1A;PPARA;AK4;FLCN;SPHK2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3434985847561477,0.9007611949428457,0.6062176165803109,0.94341264419956,1.0,6/35,8.70%,ALOX12;ACSS3;BDH1;SCD5;BDH2;HMGCS2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.36719935102663553,0.9003357693396014,0.5967153284671532,0.9436677498677599,1.0,7/23,16.91%,PLK5;CDK5RAP3;AURKB;PRCC;INTS3;VPS4A;CHMP4C
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3823151817528988,0.9003163344429183,0.5825602968460112,0.943019880582566,1.0,8/16,26.38%,ATM;HNRNPA2B1;TNKS2;TINF2;SLX4;SMG6;PINX1;RTEL1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4272227938209581,0.8999943180585881,0.5694164989939637,0.9430439749282218,1.0,4/10,16.84%,PRKAA2;SIRT1;FLCN;KLF15
prerank,regulation of dephosphorylation (GO:0035303),-0.35844938270430315,-0.8993748408050257,0.6275862068965518,0.8538205644375576,1.0,5/15,12.84%,PPP1R16B;PPP1R16A;MTMR2;MTMR9;SMG5
prerank,endodermal cell fate commitment (GO:0001711),0.4278590659212277,0.8991752066073628,0.6023622047244095,0.9442575907838066,1.0,2/10,10.73%,CTR9;RTF1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3331670919338736,0.8990137751494475,0.5968253968253968,0.9439492324389025,1.0,18/42,22.68%,CHD4;RNF8;SMARCA4;SRCAP;SMARCC2;SMARCE1;HDAC1;NASP;HNRNPC;MTA2;ARID1B;ACTR6;CHD8;CECR2;SMARCD2;MBD2;DMAP1;SMARCB1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.37220346871351206,0.8988886140746005,0.5768535262206148,0.9435614813336549,1.0,6/22,16.17%,NEDD4;PTPN23;RNF115;VPS37A;SNF8;VPS4A
prerank,presynaptic endocytosis (GO:0140238),-0.327594564580694,-0.8987502162055513,0.6264501160092807,0.8544754482583246,1.0,4/24,7.30%,NLGN1;SYT1;STON2;AMPH
prerank,inner dynein arm assembly (GO:0036159),0.41507350384945557,0.8986720296809022,0.5592885375494071,0.9433408608732952,1.0,5/11,27.22%,CCDC39;CCDC40;DNAAF5;CFAP73;DNAH1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.34888594726763766,0.8980911186197543,0.6256499133448874,0.9439297082626257,1.0,9/30,20.23%,TLR3;IKBKE;TLR4;RIPK1;LY96;BIRC3;CD14;TANK;TRAF3
prerank,cellular response to interferon-gamma (GO:0071346),-0.24659113917733333,-0.8980350939997773,0.6918032786885245,0.8553539866332843,1.0,23/88,21.33%,CAMK2D;MID1;VCAM1;B2M;ICAM1;AQP4;SYNCRIP;IFNGR2;JAK1;CD47;GBP4;CD44;DAPK1;CCL13;RPL13A;IRF5;IRF2;CAMK2B;IRF8;CCL19;TRIM68;LGALS9;MT2A
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.39312653872721964,0.8977993724971381,0.5717017208413002,0.9438880441314123,1.0,7/16,20.48%,PRPF39;SFSWAP;CWC15;PSIP1;SRSF1;SNRPC;WBP4
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4229607148549432,0.897654825702042,0.5946969696969697,0.9435028604937354,1.0,3/12,5.16%,SLC5A3;DUOXA1;TLR4
prerank,positive regulation of rRNA processing (GO:2000234),0.4373006559174566,0.8975883832892485,0.5881188118811881,0.9429633183976714,1.0,5/10,28.94%,RIOK2;WDR43;BUD23;RIOK1;WDR75
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3293496041822478,0.8974462210117524,0.5825396825396826,0.9426344523035853,1.0,5/41,7.33%,TGFBR3;FGFR2;BMPR1A;TPM1;TGFBR2
prerank,regulation of keratinocyte migration (GO:0051547),-0.381053216609499,-0.8973158531129899,0.5949895615866388,0.8562939127688893,1.0,4/12,16.20%,EPB41L4B;IQSEC1;FGF7;ARF6
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.3723192743401659,0.8971321928016551,0.5865051903114187,0.9426391405211186,1.0,3/24,5.87%,RORA;SULF2;NOX1
prerank,negative regulation of coagulation (GO:0050819),-0.3617611973827601,-0.8971036498243489,0.6172043010752688,0.8560349110401919,1.0,5/14,10.79%,SERPINE2;HS3ST5;CD34;APOE;EDN1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3742049179313528,-0.8969066764498904,0.5843881856540084,0.8557359936129122,1.0,3/12,8.45%,ESR1;STAT3;TGFB1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.41548611240673855,0.8963534486469426,0.576427255985267,0.9436855027362754,1.0,3/12,13.22%,PPARA;MIA3;WNK1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.30245997865928353,-0.8963103078775361,0.628992628992629,0.8562789523231519,1.0,6/33,12.53%,PRKG1;MEF2C;TGFB3;APOD;GPER1;CDKN1A
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.41076672517948554,0.8959685074267608,0.5691382765531062,0.9438654627720947,1.0,1/14,1.09%,OSR1
prerank,histone methylation (GO:0016571),0.35278997488504016,0.8959230882967305,0.558303886925795,0.9432824143704741,1.0,6/26,16.82%,SMYD3;NSD1;NSD3;EHMT2;CREBBP;EHMT1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3786019703201482,0.895515787896296,0.569620253164557,0.9434790808294818,1.0,5/20,6.51%,FUT1;ST3GAL3;B4GALT1;FUT8;ST6GALNAC6
prerank,positive regulation of macrophage activation (GO:0043032),-0.35115048797083964,-0.8951934083253669,0.6181015452538632,0.8580394496303614,1.0,3/17,14.59%,THBS1;IL33;LBP
prerank,ruffle organization (GO:0031529),-0.35071026804911265,-0.8949270723494175,0.6119402985074627,0.8578853992108387,1.0,3/16,6.72%,CARMIL1;LIMA1;PLEKHA1
prerank,zinc ion transmembrane transport (GO:0071577),0.36763969856085743,0.8948375247268143,0.5868055555555556,0.9443017216059117,1.0,3/22,8.10%,SLC30A10;SLC30A2;SLC39A13
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.36899078945870617,0.8946400778600314,0.5897887323943662,0.9440568066420139,1.0,3/24,7.05%,PRKN;LRRK2;OPA1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.41357365401954665,0.8945228027787152,0.5988593155893536,0.9436444665921966,1.0,1/11,0.73%,LEPROT
prerank,positive regulation of neuron death (GO:1901216),0.3191478569015058,0.8944364981286853,0.6198738170347003,0.9431516632054079,1.0,4/46,5.16%,EFNB2;PICALM;NUPR1;TLR4
prerank,carboxylic acid metabolic process (GO:0019752),0.34009429832020466,0.8944354446176893,0.5793780687397708,0.9424768021306377,1.0,2/33,1.70%,DDO;ST6GAL1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3662439686118241,0.894260708230773,0.5775401069518716,0.9421923967177007,1.0,2/24,2.15%,DNMT3A;JARID2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.29641246913196756,-0.894085997434777,0.6692506459948321,0.8590409568895502,1.0,7/33,8.00%,AKAP6;KCNJ3;CHRM3;KCNJ2;NEDD4L;YWHAE;KCNQ1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.39876545760398063,-0.8939058861465189,0.5992141453831041,0.8587112929116392,1.0,4/10,18.23%,ACVRL1;ZBTB16;BMPR1B;PKDCC
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.35898058032283237,0.8934965107479185,0.6006884681583476,0.943201140312504,1.0,1/25,0.73%,LEPROT
prerank,regulation of viral life cycle (GO:1903900),-0.33367011692805726,-0.8931244129633827,0.6247139588100686,0.8598044208218527,1.0,6/21,20.61%,HS3ST5;PPIA;TRIM14;TRIM27;TYRO3;TRIM68
prerank,response to growth factor (GO:0070848),0.3316493733512009,0.8929269569071829,0.6113902847571189,0.9437628632537403,1.0,7/41,7.33%,SPHK1;BMPR1A;TGFBR1;MAP2K5;PLK5;CPNE3;TGFBR2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2653287294120029,-0.892286324782217,0.6859504132231405,0.8609616740395342,1.0,22/56,25.09%,SPTBN1;ANK3;CIT;RHOB;ANLN;PDCD6IP;RASA1;TRIM36;STMN1;SEPTIN9;USP8;APC;NUSAP1;CHMP4B;EFHC2;SPAST;ECT2;CUL7;RHOC;KIF4A;CENPA;KIF23
prerank,phagosome-lysosome fusion (GO:0090385),0.43430136018855175,0.8922328629703622,0.5742574257425742,0.9446040465020616,1.0,5/10,21.79%,RAB34;PIKFYVE;RAB7B;PLA2G5;RAB7A
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3201773344448789,0.8920272235439842,0.6329305135951662,0.9443892925189831,1.0,7/49,9.10%,KIT;IGF1;IL18;PARP14;IL12B;TNFRSF18;PARP9
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.25033239231576954,-0.8919695801750276,0.724025974025974,0.8609171514126739,1.0,32/83,26.46%,YWHAE;DYNLL1;PPP2R1A;YWHAG;TUBA1A;HAUS2;TUBB4A;CDK5RAP2;HSP90AA1;KCNH5;PRKAR2B;ATAD5;ATF5;HAUS5;CEP78;CETN2;TUBA4A;SSNA1;CEP131;NPM1;NEK10;CCP110;HMMR;TPX2;KIF14;NEDD1;HAUS4;CEP135;ACTR1A;NDE1;HAUS6;CEP76
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4255690376422581,0.8917226528083659,0.5865384615384616,0.9444154200221395,1.0,4/11,16.40%,ELOF1;ZMIZ2;ZMIZ1;ARID1B
prerank,positive regulation of peptidase activity (GO:0010952),-0.3355716261383435,-0.8916081920459978,0.6323851203501094,0.8609741624079154,1.0,9/20,27.30%,VSIR;DDRGK1;PINK1;MAPK12;APH1A;RCN3;PRELID1;NDUFA13;GRN
prerank,regulation of programmed necrotic cell death (GO:0062098),0.37169820702401,0.8903910086317369,0.5948905109489051,0.9466423182316892,1.0,6/20,16.00%,NUPR1;CFLAR;RIPK1;FLOT2;OGT;BIRC3
prerank,establishment of spindle orientation (GO:0051294),0.3471654076039526,0.8903030848125274,0.6081560283687943,0.9461505437488673,1.0,6/28,14.46%,PKHD1;CLASP1;FBXW11;HTT;MISP;LLGL2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3239924881784417,-0.8896642561537695,0.6123456790123457,0.8646280476249454,1.0,10/24,19.64%,EPN2;DAB2IP;TMEM204;ITGB3;HIF1A;MT3;HHEX;ITGA5;PTPN1;VTN
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.34108762434547985,0.8894464634511309,0.6112956810631229,0.9473859597132492,1.0,9/31,22.06%,CD300A;ATM;CD274;GLMN;SDC4;GPNMB;CTLA4;DLG5;ARG1
prerank,integrated stress response signaling (GO:0140467),-0.36788950058445324,-0.8894249510114212,0.6140350877192983,0.8644321758054228,1.0,3/14,15.44%,HSPA5;ATF4;EIF2AK3
prerank,negative regulation of hemostasis (GO:1900047),0.4127680770203588,0.8889561569549901,0.5859519408502772,0.9477817277877496,1.0,3/12,7.11%,TFPI;KNG1;SERPINE1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.39538462274416064,-0.8886922874929946,0.6200873362445415,0.8653454255592229,1.0,2/11,4.48%,PID1;TFRC
prerank,protein localization to kinetochore (GO:0034501),0.39998807245165474,0.88779958182734,0.6245210727969349,0.9496303278387666,1.0,6/14,24.74%,AURKB;IK;CHAMP1;CENPT;MIS12;SPDL1
prerank,lipoxygenase pathway (GO:0019372),0.3970467012920814,0.8876071106074753,0.5912408759124088,0.9493828589192007,1.0,2/14,7.65%,ALOX12;PON3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3317358467004619,0.8875958079528353,0.6064516129032258,0.9487269579904468,1.0,8/37,14.33%,TNPO1;KIF3C;IFT122;WDR19;DYNC2I1;CLUAP1;IFT88;WDR35
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.336505669382879,-0.8867378519127468,0.6323185011709602,0.8689314428683863,1.0,8/18,21.18%,PLCG2;DYSF;DOCK2;SBNO2;LBP;SYK;TYROBP;PYCARD
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.33277429514434814,0.8865308256558048,0.6104928457869634,0.9503749093764476,1.0,14/39,18.63%,TTC7B;PI4KA;SMG1;TMEM150A;PIP4K2C;PIK3CA;ITPKB;PIK3R3;SOCS3;PI4K2B;SOCS4;SOCS7;IP6K3;PI4KB
prerank,pinocytosis (GO:0006907),-0.39448975995478314,-0.8865225710601434,0.6300211416490487,0.8686713022170026,1.0,3/10,9.79%,CARMIL1;PPT1;DOCK2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.3621402045563859,0.8865065268180111,0.616695059625213,0.9497534813852384,1.0,3/26,5.87%,RORA;SULF2;NOX1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4093715708171392,0.8860064418749273,0.5930232558139535,0.950183517180796,1.0,1/12,0.60%,CELSR1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.413773176058061,0.8852806974000119,0.611328125,0.9511081063124749,1.0,2/11,6.04%,STX18;ATL1
prerank,positive regulation of chemokine production (GO:0032722),0.32448253696936646,0.8851191465197692,0.6224328593996841,0.950783413273123,1.0,9/44,13.35%,IL18;TLR3;TLR4;DDX3X;EIF2AK2;IL17RA;MAVS;ADAM17;OAS3
prerank,negative regulation of type I interferon production (GO:0032480),0.3199353625219833,0.8850470934417023,0.6047244094488189,0.9502747827482236,1.0,12/40,21.99%,PCBP2;IKBKE;RNF135;MAVS;DHX58;ACOD1;PPM1B;UFD1;NPLOC4;TAX1BP1;SIRPA;YY1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3397963609390763,0.8841501801380703,0.6065857885615251,0.9515051340149712,1.0,13/31,25.49%,TIMM44;TOMM70;PEX10;PEX14;PEX16;PEX5;TIMM17B;TIMM17A;TIMM21;PEX26;DNAJC15;CHCHD4;GRPEL2
prerank,negative regulation of cell aging (GO:0090344),0.39220144229099685,0.8840714834937392,0.6288288288288288,0.9510267206268598,1.0,5/16,14.53%,SLC30A10;TERT;SIRT1;RBL1;ZKSCAN3
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.3743934682100341,-0.8838793457260088,0.6317991631799164,0.8730796127280528,1.0,6/12,18.37%,ACTN4;EFNA5;CORO1C;DMTN;KANK1;SPRY4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.3743934682100341,-0.8838793457260088,0.6317991631799164,0.8730796127280528,1.0,6/12,18.37%,ACTN4;EFNA5;CORO1C;DMTN;KANK1;SPRY4
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.35622162656561807,0.8833776485339632,0.5989583333333334,0.9519010933920855,1.0,2/22,2.32%,SASH1;SPHK1
prerank,response to tumor necrosis factor (GO:0034612),0.28412439243883036,0.8832297564309899,0.6732394366197183,0.9515477045033085,1.0,12/91,10.18%,GSDME;AFF3;NPNT;SPHK1;CASP3;ZFAND6;GBP3;GBP2;HYAL1;SIRT1;RIPK1;CCL25
prerank,regulation of lysosomal lumen pH (GO:0035751),0.4053187426709973,0.8831979989346169,0.6080305927342257,0.9509423349359499,1.0,4/12,21.21%,LRRK2;CLN6;CCDC115;ATP6AP2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3860875848890105,0.883069674745159,0.6175373134328358,0.9505452399668256,1.0,2/19,1.44%,PICALM;IGF1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.44288751899110124,0.8829785077987221,0.599609375,0.9500671567170987,1.0,1/10,0.65%,ACTN2
prerank,negative regulation of hormone secretion (GO:0046888),-0.38890942555699154,-0.882886455302798,0.6479166666666667,0.8745741048941881,1.0,4/10,33.17%,RAB11FIP1;RAB11FIP5;RAB11FIP3;LIF
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.29415410330018776,-0.8827976608414434,0.6407035175879398,0.8740610284038018,1.0,6/33,17.31%,LEF1;RUNX1;CTNNBIP1;ID2;FES;CD74
prerank,cellular response to calcium ion (GO:0071277),0.30186226143170275,0.8822286533196534,0.6401799100449775,0.9510199325204713,1.0,9/67,9.25%,SYT9;SYT11;SYT12;PRKAA2;ADCY1;BRAF;CPNE3;MEF2A;ITPKB
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.39007646940771407,0.8820693145346381,0.591337099811676,0.9506724841649794,1.0,4/16,17.07%,CPEB3;MOV10;ZFP36L1;PLEKHN1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2924549337991493,0.8817153060117079,0.6443452380952381,0.9507486863405621,1.0,9/69,8.43%,PPARGC1A;PRKN;SLC30A10;RETREG1;SNX6;CPEB4;SOD2;KDM2B;GDNF
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3155082750226492,0.8813044625704194,0.6314152410575428,0.9509772554884891,1.0,7/49,10.39%,GSDME;NUPR1;BID;DDX3X;TP53;DNM1L;BECN1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3976995081805058,0.8810197804199542,0.6021314387211367,0.9502721941398273,1.0,4/15,15.26%,TNRC6B;CPEB3;TNRC6C;ZFP36L1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3976995081805058,0.8810197804199542,0.6021314387211367,0.9502721941398273,1.0,4/15,15.26%,TNRC6B;CPEB3;TNRC6C;ZFP36L1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3467252570912148,0.8808730908965771,0.6086206896551725,0.9499237883721872,1.0,9/29,17.97%,STAT2;SAMHD1;MAVS;YTHDF3;PTPN11;OAS3;USP18;IFNAR2;WNT5A
prerank,phosphorylation (GO:0016310),0.2456429337410157,0.8806653437489879,0.7794285714285715,0.949687372517511,1.0,71/385,15.16%,PRKAG2;WNK4;ROCK2;OXSR1;PRKCZ;FAM20A;PRKAA2;GRK5;SPHK1;PI4KA;PRKAG3;FGFR1;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;PRKCB;GK5;IKBKE;ATM;PRRT1;CAMK1;BRAF;NUAK2;TRIB2;CDC42BPG;SIK1;EIF2AK2;TKFC;GK;TGFBR2;IGFBP3;PIK3CA;RYK;COQ8B;PDPK1;CSNK1A1;PICK1;MKNK1;FER;BRSK1;AURKB;SRPK2;ABL1;DYRK1A;MYLK3;TRIB1;PRKDC;MAPK6;CSNK2A1;PRKCA;HIPK3;PNKP;MAPK10;MAP3K1;FRK;PRKCI;WNK1;BMP2K;MAP2K1;ROS1;COQ8A;GRK3;ACVR2B;STK17B;SPHK2;CERK;ACVR1B;STK4
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3830898968530693,-0.8806018951818355,0.6096033402922756,0.8772895614670227,1.0,6/11,27.82%,CCT8;CCT2;CCT6A;CCT7;MEPCE;DKC1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3830898968530693,-0.8806018951818355,0.6096033402922756,0.8772895614670227,1.0,6/11,27.82%,CCT8;CCT2;CCT6A;CCT7;MEPCE;DKC1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.28498625914211695,-0.8805689994743437,0.6641221374045801,0.8766345310957814,1.0,16/40,32.88%,PID1;SLC25A33;MAPT;PINK1;UBB;RNF122;SOD1;STOML2;PRELID1;PYCR1;PMAIP1;PARK7;SPART;PIP5KL1;SLC4A11;PRDX3
prerank,protein neddylation (GO:0045116),0.40580606912382133,0.8803826217180917,0.5907335907335908,0.9496403683538611,1.0,3/13,16.61%,UBE2M;DCUN1D5;RNF7
prerank,protein polymerization (GO:0051258),0.30573526683925684,0.8800702000290023,0.6439393939393939,0.9496156989096848,1.0,10/56,12.55%,GAS7;PRKN;ARHGAP6;RNF135;DIAPH1;WASL;CATIP;CENPJ;VIL1;TTC17
prerank,regulation of protein binding (GO:0043393),-0.2350416420597733,-0.8798670116591794,0.7635658914728682,0.8774058729872134,1.0,35/114,19.64%,CAV1;ACTB;CLDN5;EPB41;B2M;GSK3B;TIAM1;APP;DISC1;CTNNBIP1;PSEN1;CRK;DACT1;SORL1;BMP2;RALB;TMBIM6;GNL3L;ADD2;PKD1;FKBP1A;MARK2;BMP4;CDKN1A;CARD16;SPPL3;HIPK2;PPP1CA;ZFPM1;MEN1;CTSZ;HIP1R;RAN;LDLRAP1;VTN
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.24870823086900107,-0.879751801297443,0.7604790419161677,0.8769259999959274,1.0,28/72,34.29%,PSMB2;CARD14;MAP3K7;PSMD14;PSMC6;REL;TIRAP;RELB;PSMA4;PSMB9;SKP1;MAP3K14;PSMD11;PSMB10;PSMD2;PSMA2;RELA;PSMB3;PSMB5;PSMA7;PSMF1;PSMD7;MALT1;CARD10;TNFSF15;PSMA5;PSMD4;PSME4
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4185573357487759,0.8795767193209048,0.6070726915520629,0.9499693673172408,1.0,2/11,7.33%,FGFR2;TGFBR2
prerank,skeletal muscle tissue development (GO:0007519),0.33519407221747927,0.8792933462854217,0.6087662337662337,0.9499276552756353,1.0,5/32,8.49%,IGSF8;CSRP3;CFLAR;KLHL41;LEMD2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.373239297166705,-0.8791496514883949,0.6186440677966102,0.8775042198188964,1.0,3/12,20.47%,ANO1;ADCY8;CFTR
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3707265688537486,0.8786783229743407,0.6033519553072626,0.9505735358030518,1.0,6/19,13.82%,CD27;MMP14;PRKDC;ZBTB1;ZMIZ1;AXL
prerank,regulation of phagocytosis (GO:0050764),-0.26524664656458197,-0.8785695742679832,0.720108695652174,0.8780200077857433,1.0,11/53,10.68%,MERTK;SCARB1;GAS6;PTPRC;RAB27A;GATA2;DYSF;CALR;CD47;DOCK2;CYBA
prerank,positive regulation of inflammatory response (GO:0050729),0.2849323802670985,0.8783987825139793,0.6400580551523948,0.950522038446388,1.0,11/86,9.72%,IL18;NAPEPLD;NUPR1;C2CD4B;TLR3;TLR4;IL12B;SERPINE1;GPRC5B;IL17RA;RIPK1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3292566500494706,-0.8783791949895694,0.6502347417840375,0.8776987562809391,1.0,13/23,26.88%,MYO10;CCDC88A;DYNC1I1;KIF5C;MAP6;TUBA1A;CCDC88C;CCDC186;KIF5A;TUBA1B;TUBA1C;F8A1;KIF1A
prerank,embryonic eye morphogenesis (GO:0048048),-0.3827045852353583,-0.878055929939976,0.655982905982906,0.8776629633093076,1.0,6/11,24.12%,MFAP5;FBN2;ALDH1A3;LRP6;TBX2;MFAP2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3487195836146739,0.8777912883070579,0.6156405990016639,0.9511706346983669,1.0,7/26,14.42%,PCBP2;TRIB1;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,smooth muscle contraction (GO:0006939),-0.36448725316536973,-0.8776872165755322,0.6526104417670683,0.8777656323866281,1.0,5/14,10.14%,SLC8A1;EDNRA;SMTN;MYH11;ACTA2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2970711656472068,0.8775275676572606,0.6530324400564175,0.9510778012042218,1.0,15/73,15.33%,DNMT3A;JARID2;TAF1D;BAZ1B;HDAC4;GLMN;MYO1C;TDG;POLR1G;PHF1;PHF2;TBP;KAT2B;SPHK2;MPHOSPH8
prerank,negative regulation of cilium assembly (GO:1902018),-0.3730285691914988,-0.877161405747655,0.6294736842105263,0.8782173523640969,1.0,5/12,23.56%,TBC1D30;LIMK2;MAP4;ODF2L;CCP110
prerank,transferrin transport (GO:0033572),0.3354608509601845,0.8766866804712281,0.6136752136752137,0.9522408246415914,1.0,11/33,18.72%,ATP6V0E1;ATP6V0B;RAB11B;ATP6V1D;ATP6V1E1;CLTC;DNM2;STEAP3;HFE;ATP6V0D1;ARHGAP1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3471467562965028,0.8764095262342929,0.6523235800344234,0.9521775708436547,1.0,7/31,7.92%,SIPA1L1;EPHA4;NGEF;LRRK2;CUX2;CAPRIN2;PTEN
prerank,positive regulation of cellular process (GO:0048522),0.23881194942676157,0.8760679772691509,0.789924973204716,0.9522599201177109,1.0,77/565,12.46%,FGF1;BMP6;COLEC12;EFNB2;LAMC2;IGF1;PRKAA2;CCN2;IL13RA1;FGFR2;ECHDC3;EPHA4;RHOD;PKHD1;GRK5;SPHK1;NUPR1;PHIP;FGFR1;PRODH;TGFBR1;ADRA2A;PDPN;CDCA7L;SLC30A2;DPP4;TNFSF13;CTSH;PPP1R13L;TLR4;TPM1;MEIS1;ATM;DDX3X;P2RX3;NOX1;FLT1;ANKRD17;PDGFRB;IL12B;CACUL1;GAB2;WWTR1;TGFBR2;PTEN;TNFRSF18;GDNF;NRG1;NEUROD4;HDAC4;HYAL1;GLI1;SIRT1;LRP1;RIPK2;HDAC1;ASH2L;CCAR1;HTR1A;HBEGF;FLT3LG;FER;CRKL;TBRG4;SRPK2;MMP14;CDC42;ADAM17;DICER1;NOP2;AXIN2;VEGFD;ITGAV;CSNK2A1;PRKCA;MLXIPL;TGFA
prerank,response to interleukin-1 (GO:0070555),-0.24978208553517167,-0.8758705906515137,0.728125,0.880257320254326,1.0,17/73,21.18%,IL1R1;PTGIS;ANXA1;TNFRSF11A;DAB2IP;APP;IRAK3;CD47;HIF1A;SNCA;CCL13;YTHDC2;CCL19;LGALS9;HAS2;SFRP1;PYCARD
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4155810791538503,0.8758047002923683,0.6269230769230769,0.9521123075565543,1.0,1/11,0.55%,EFNB2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.39717308921895256,0.8755444469319996,0.6171875,0.9519816416190598,1.0,1/13,1.45%,ANAPC15
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3983057752511099,-0.8753588590686974,0.6591375770020534,0.8806328334263809,1.0,6/10,28.97%,CSGALNACT1;XYLT1;B3GAT2;B3GAT3;B3GAT1;CSGALNACT2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.36331730418645874,0.8752734517301948,0.620817843866171,0.9518919772406667,1.0,6/21,7.77%,CD300A;ELF1;PRKCB;GPS2;PTPN22;ELF2
prerank,actin polymerization or depolymerization (GO:0008154),0.31339700045756774,0.8751054284518213,0.6369230769230769,0.9516051681032826,1.0,9/50,12.55%,MICAL3;GAS7;AVIL;ARHGAP6;DIAPH1;WASL;CATIP;VIL1;TTC17
prerank,rRNA 3'-end processing (GO:0031125),0.43155951507453005,0.8750624175894479,0.5988142292490118,0.9510380945418585,1.0,3/10,9.98%,ERI3;EXOSC7;ERI2
prerank,cell-cell junction maintenance (GO:0045217),0.4069711539741435,0.874851394560238,0.6081330868761553,0.9508617928562296,1.0,1/11,2.47%,NLGN2
prerank,cellular response to alcohol (GO:0097306),0.32851617145499695,0.8743831057360745,0.6374807987711214,0.9512155862570875,1.0,4/42,4.94%,ADCY5;ADCY1;GRAMD1B;SMO
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.38511737531920504,0.8743016401191637,0.627151051625239,0.9507359869363333,1.0,4/17,9.79%,IGF1;DOCK5;PDGFRB;DOCK7
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.35190099918299245,-0.8742951838027871,0.6416309012875536,0.882219547964827,1.0,4/15,8.45%,CLASP2;CST3;FAP;TGFB1
prerank,sulfur compound biosynthetic process (GO:0044272),0.2767406906051863,0.8742504107761151,0.6915351506456241,0.9501724204334882,1.0,13/104,10.03%,UST;OGN;CHST15;CHST11;GSTT1;ST3GAL3;FMOD;B4GALT1;DSE;SLC26A1;CHSY1;CTH;GSTA3
prerank,vesicle organization (GO:0016050),-0.27231780667893857,-0.874147007872618,0.7084398976982097,0.8817981100617147,1.0,8/46,8.22%,CAV1;FNBP1L;CD34;CAV2;LAPTM4B;DNM1;SORT1;ALS2CL
prerank,intracellular protein transport (GO:0006886),0.24665616953907762,0.8737653991610252,0.7743413516609393,0.9505459341556535,1.0,62/304,19.97%,RANBP3L;APPL2;WLS;TRAK1;KIF13B;SNX6;SEC31B;TBC1D16;TNPO1;LAMP2;STXBP2;ACD;FUT10;ARFGAP3;VPS26C;IPO13;PICK1;GRTP1;ARL4A;NUP42;RAB43;COPZ2;RANBP3;RAB22A;VPS45;MYO1C;DESI1;CLTC;SNX8;STX5;SGSM2;VIPAS39;SNX15;AP2A1;SEC23IP;RAB29;RAB21;ARFIP2;ARL6;SNF8;SCFD1;TBC1D25;NUP155;CCHCR1;CLIP3;FAM91A1;SGSM3;C2CD5;VPS35;TRAK2;KIF13A;TBC1D14;SEC31A;EVI5;KATNB1;NUP188;AP4M1;TBC1D22B;STX16;TSC2;LTBP2;EVI5L
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3472104033336787,0.8735538136579324,0.6003316749585407,0.9503426333394833,1.0,2/24,5.13%,ACE;TAPBPL
prerank,protein acylation (GO:0043543),0.323425189608596,0.8734643977703401,0.6229508196721312,0.9498835847046432,1.0,10/38,17.92%,SPHK1;NAA80;GLUL;ZDHHC18;ZDHHC1;PORCN;KAT2B;CREBBP;ZDHHC8;ZDHHC23
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.3664725813668531,-0.8734627315237569,0.6601731601731602,0.8825662708253328,1.0,6/13,11.37%,ABHD2;ESR1;PLPP1;AR;GPER1;BMP4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3063035725815982,0.8733293911225235,0.6387596899224807,0.9495108976107738,1.0,10/54,14.70%,TFDP2;ATM;ARID3A;TP53;RBL2;CNOT10;TFDP1;PML;GADD45A;E2F4
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.3518727189054372,0.8732413069545191,0.6313993174061433,0.9490543856079192,1.0,5/25,11.95%,PICALM;RIN3;ATXN2;NEU3;ITGAV
prerank,heterocycle biosynthetic process (GO:0018130),-0.35735672083872005,-0.8731390589650266,0.6548117154811716,0.8824962192284698,1.0,2/14,6.40%,GPHN;GCH1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.42785591254104505,0.8730958541664112,0.6127819548872181,0.9486973851148545,1.0,3/11,17.97%,ITPKB;PPIP5K2;IP6K3
prerank,lymphocyte migration (GO:0072676),-0.2969236127939131,-0.8728442101593948,0.6422018348623854,0.882394085861103,1.0,20/32,46.71%,S1PR1;MSN;RET;CCL13;CCL19;CCL2;MYO1G;CCL11;CCL4;GATA3;CRTAM;CCL8;CCL14;CKLF;CCR6;ADAM8;CCL1;CCL3;TBX21;XCL1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.42031541536078,0.8726936309238706,0.625250501002004,0.9488740704616692,1.0,2/10,9.28%,ATRX;SSBP1
prerank,regulation of protein metabolic process (GO:0051246),0.31736165877255357,0.8726238840962061,0.6460317460317461,0.9483725508840933,1.0,4/44,7.38%,ROCK2;ACE;MAP2K5;ANGPTL8
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3667298746936887,-0.8724325359898347,0.6378947368421053,0.882568614541367,1.0,7/12,28.99%,MAOA;SMS;DDC;AMD1;SLC22A3;OAZ2;ODC1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.40440386413325285,0.872368379220727,0.6097560975609756,0.9482571588430608,1.0,4/13,16.40%,ELOF1;ZMIZ2;ZMIZ1;ARID1B
prerank,mammary gland development (GO:0030879),0.3677365462841179,0.8723304877587655,0.6145833333333334,0.9476852790483355,1.0,4/21,8.46%,WNT4;GLI2;NRG1;APLN
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3635346579156907,-0.8722495151385601,0.6428571428571429,0.8822354987356775,1.0,5/15,10.35%,NGF;NTRK2;SORT1;DDIT4;BCAR1
prerank,proteoglycan biosynthetic process (GO:0030166),0.33716110108850067,0.8717495095776147,0.6359060402684564,0.9483046185551594,1.0,6/31,10.26%,HS3ST3B1;IGF1;CHST11;PXYLP1;GAL3ST4;FOXL1
prerank,intracellular sterol transport (GO:0032366),-0.3693102861716678,-0.8714385821062991,0.6666666666666666,0.8832188924551515,1.0,5/13,21.00%,ABCG1;NPC2;STARD4;RELCH;OSBP
prerank,establishment of protein localization to organelle (GO:0072594),0.2897155449595972,0.8711242210548498,0.6656976744186046,0.9489865528431372,1.0,4/72,3.97%,APPL2;HK2;TNPO1;LAMP2
prerank,DNA-dependent DNA replication (GO:0006261),-0.22135275670171012,-0.8709821758639414,0.7715355805243446,0.8834443542519028,1.0,46/128,29.72%,POLA1;REV3L;PSMB2;PRIM2;POLD3;PSMD14;PSMC6;WRNIP1;PRIMPOL;TEFM;UBB;PSMA4;PSMB9;RPA1;ORC5;ORC2;CDC45;PSMD11;DNA2;PSMB10;PSMD2;RFC4;POLD4;POLD1;RFC2;BLM;RECQL5;PSMA2;UBC;RPS27A;PSMB3;RECQL;MCM6;RFC5;PRIM1;PSMB5;TOPBP1;HELB;PSMA7;CDC7;MGME1;PSMF1;RAD51;CDK2AP1;PSMD7;RPA3
prerank,regulation of calcium ion transport (GO:0051924),0.3040859404240129,0.8704255521283278,0.6409448818897637,0.9498102061036476,1.0,3/54,3.64%,CACNA1D;ANK2;ADRA2A
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.3651231049814655,-0.8704158525240262,0.6172566371681416,0.8839216339155207,1.0,8/14,31.27%,TSEN34;FAM98B;TSEN54;RTCB;CPSF4;TSEN15;CLP1;CPSF1
prerank,exit from mitosis (GO:0010458),-0.3698357124619249,-0.8701552266968127,0.6445783132530121,0.8837331089526338,1.0,5/12,18.56%,CLASP2;EPS8;PPP2R2D;CHMP4B;SPAST
prerank,tRNA aminoacylation (GO:0043039),-0.2920401959411404,-0.8699905084651364,0.6887052341597796,0.8833493564324285,1.0,4/37,12.09%,LARS2;WARS2;GARS1;DARS2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3753439385107098,-0.8699562303720841,0.6337719298245614,0.8826921863994401,1.0,4/12,16.05%,CCN3;NOTCH1;TMEM119;BDNF
prerank,peptidyl-lysine monomethylation (GO:0018026),0.41118375494991805,0.869560415477836,0.6060606060606061,0.9510062829444275,1.0,4/10,18.15%,SETD7;KMT5A;EHMT1;SETD3
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3034742207399478,-0.8693133118658675,0.6618004866180048,0.8833119092503788,1.0,11/27,25.35%,SORL1;ARL5A;ARL1;GCC2;ARL5B;BICD2;RAB6A;TMED10;PAQR3;VPS13C;IFT20
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3437158318393,0.8691778672976066,0.6389351081530782,0.9511500765125837,1.0,7/28,15.81%,KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1;TFIP11
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.28893537620098797,-0.8691671712249299,0.6729857819905213,0.8829294414174798,1.0,8/33,12.99%,ESR1;RUNX1;AR;CALR;DDRGK1;H3-3A;UFM1;AXIN1
prerank,vitamin D metabolic process (GO:0042359),0.3848274114282857,0.8691279569378919,0.6182902584493042,0.9506102017924953,1.0,4/13,22.04%,CYP2R1;GC;PIAS4;CUBN
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.29103209205284863,-0.8688890040972236,0.6648648648648648,0.8827933763161059,1.0,5/32,10.04%,CDK14;CDK17;POLA1;BACH1;ID2
prerank,DNA damage checkpoint signaling (GO:0000077),0.34262311614525864,0.8685421182590825,0.6312056737588653,0.9511637397717828,1.0,14/28,29.23%,ATM;DONSON;HUS1;DOT1L;CEP63;CLSPN;INTS7;NBN;RAD9A;CDC5L;TIPRL;USP28;CHEK1;E2F1
prerank,development of primary male sexual characteristics (GO:0046546),0.32584118888221975,0.8685134515197744,0.6490939044481054,0.9505745728557694,1.0,2/34,1.21%,WNT4;KIT
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.29324817830665506,-0.8682945995030372,0.697841726618705,0.8833063756381273,1.0,11/32,17.55%,NAV3;CLASP2;ARHGEF2;STMN2;FGF13;TUBB4A;SPEF1;SNCA;STMN1;APC;FKBP4
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3074486470703079,-0.8678016868973133,0.6469194312796208,0.8836446219653249,1.0,5/25,10.70%,GHR;STAT3;SOCS2;STAT5B;PKD1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.29700647017894344,-0.8677495170904942,0.639344262295082,0.8830575237252811,1.0,13/24,31.81%,POLD3;UBB;RPA1;RFC4;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;RPA3;RPA2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.4179743981875955,0.8677436857834094,0.5944444444444444,0.9515608237532304,1.0,4/10,17.90%,APOM;BMP1;PRKACB;ZDHHC8
prerank,cellular response to reactive oxygen species (GO:0034614),-0.2562007663260581,-0.8676153993078194,0.7142857142857143,0.8826364189496254,1.0,8/59,6.96%,MAP3K5;PTPRK;CYP1B1;NET1;ANXA1;RPS3;PLEKHA1;RHOB
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.33331640640547056,0.8674032863897717,0.6289517470881864,0.9516169854852011,1.0,5/30,12.05%,LEPROT;FZD5;HUWE1;NPEPPS;CSNK2A2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.39519626076984754,0.8669717742475931,0.6273764258555133,0.9518839142255301,1.0,1/14,0.45%,WNK4
prerank,NAD biosynthetic process (GO:0009435),0.3615024783120353,0.8669095210024553,0.6068840579710145,0.9513470624547415,1.0,9/20,24.36%,PARP10;NMNAT1;SLC5A8;PARP9;QPRT;NMNAT2;PARP16;NMNAT3;NAPRT
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.40041466620322264,0.8665714425780504,0.6053130929791272,0.9513789853660759,1.0,4/12,14.35%,PLK5;TP53;PRKDC;SDE2
prerank,nuclear pore organization (GO:0006999),-0.34972354506871384,-0.8654767143791274,0.6687898089171974,0.8865352781046154,1.0,8/14,39.60%,RTN4;NUP107;NUP93;NUP54;AHCTF1;TMEM170A;NUP205;NUP35
prerank,response to reactive oxygen species (GO:0000302),-0.25847125958329065,-0.8653735637004025,0.7146974063400576,0.8859961785003732,1.0,25/54,32.88%,PTPRK;APOE;RPS3;APOD;CAMKK2;GLRX2;MAPT;HIF1A;GPX1;CAT;ROMO1;SOD1;FYN;PLK3;HYAL2;HMOX1;MAPK8;FOS;MAPK3;JUN;COA8;HP;STK25;NCF1;PRDX3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3457057228437723,0.8652628682848358,0.6301824212271974,0.9534304320256496,1.0,3/25,7.26%,HK2;PGAM2;GCK
prerank,regulation of interleukin-4 production (GO:0032673),-0.32133969787433203,-0.8652200852888768,0.6997742663656885,0.8856020107135449,1.0,8/21,22.11%,LEF1;SLC7A5;HAVCR2;SYK;ZFPM1;PRKCQ;LGALS9;CD86
prerank,N-terminal protein amino acid modification (GO:0031365),0.3960948708803223,0.8652074214911676,0.6322463768115942,0.9528982091873679,1.0,7/14,31.35%,METAP2;NAA16;AANAT;NAA50;NAA15;NAA60;NAA40
prerank,cellular protein catabolic process (GO:0044257),-0.2564523408867117,-0.8650066501820055,0.7213622291021672,0.8853181507259127,1.0,20/59,22.23%,FAP;DAB2IP;CTSC;UBE2G1;SIAH2;CTSB;AP2B1;CAPN2;CTSL;AP2M1;CTSS;VLDLR;CTSO;RSPRY1;HTRA2;CHEK2;CTSZ;UBE2G2;BNIP3;MYLIP
prerank,cGMP metabolic process (GO:0046068),0.4013870692287813,0.8647746942027207,0.6494252873563219,0.9531856135604927,1.0,2/12,6.12%,NPR1;NPR2
prerank,miRNA metabolic process (GO:0010586),0.3571274158540117,0.8646379373838182,0.64376130198915,0.9528459482366402,1.0,5/20,16.39%,TUT4;SND1;DICER1;TENT4B;TUT7
prerank,positive regulation of growth (GO:0045927),-0.25532442316050824,-0.8640414481598415,0.749271137026239,0.8865971156672486,1.0,13/64,14.49%,AKAP6;TGFB2;RFTN1;LGI1;CXCL16;H3-3A;ERBB2;RPS6KA3;SLC25A33;MFSD2A;TAF9B;RPS6KA1;PPM1F
prerank,protein polyubiquitination (GO:0000209),0.2435752184972941,0.863445525056753,0.780373831775701,0.9547692295050892,1.0,62/297,19.14%,RNF152;UBE2E2;SASH1;PRKN;FBXL17;SPSB1;RNF213;NEDD4;IFI27;NHLRC4;RNF135;FBXL19;TRIM56;ANAPC2;UBR2;SMURF2;TTC3;RNF8;FBXW11;HUWE1;TRIP12;RNF217;TNKS2;BTRC;RNF19A;RNF34;HERC6;NPEPPS;UBR5;FBXO22;FBXL12;RNF41;FBXW8;FBXO4;WWP2;FZR1;FBXO10;TRIM62;DDB2;FBXO11;FBXL20;DZIP3;LONRF1;UBE2H;RNF115;RMND5A;AMFR;RNF31;HECTD1;RNF146;RNF19B;UBE2E1;SYVN1;CDC34;FBXW10;RNF20;TAF1;ARIH1;MIB2;NHLRC3;UBE4B;FBXL22
prerank,protein monoubiquitination (GO:0006513),0.32130779115791397,0.8633596831844148,0.6548956661316212,0.9542963372028923,1.0,4/36,7.66%,PRKN;CTR9;MGRN1;HUWE1
prerank,protein complex oligomerization (GO:0051259),0.28682221281712517,0.8631172101335001,0.6915204678362573,0.9541433163590063,1.0,12/85,8.88%,UPB1;ALS2;RNF213;MCU;NACC2;RNF135;ATL1;MICU1;OPA1;TWNK;JMJD6;DNM1L
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.24122379985517137,0.8629590543485421,0.8060879368658399,0.9538463276208279,1.0,75/341,19.43%,RNF43;ASB2;ANAPC15;PRKN;FBXL17;SPSB1;RNF213;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;USP9X;ANAPC2;PTPN23;SPSB4;UBR4;TBL1X;SMURF2;TTC3;RNF8;FBXW11;HUWE1;TRIP12;RNF217;BTRC;TBL1XR1;RNF19A;RNF34;SIRT1;FBXO22;ZSWIM8;AURKB;RNF13;WWP2;CUL4A;UBA6;FZR1;FBXO10;NUB1;PML;FBXO11;UBE2H;RNF115;RMND5A;FAF1;AMFR;VPS37A;ANAPC16;RNF146;BIRC6;MAEA;VPS4A;RNF19B;WDR91;RNF7;UFD1;UBE2E1;KCTD13;SYVN1;CDC34;NPLOC4;SQSTM1;NDFIP1;RNF20;TAF1;ARIH1;KCTD21;NHLRC3;USP33;UBE4B;FBXL22;MIB1;MTA1
prerank,insulin receptor signaling pathway (GO:0008286),0.290863596108224,0.8624576136132178,0.677891654465593,0.9542505723844141,1.0,13/69,11.08%,SORBS1;RHOQ;PHIP;ATP6V0E1;BAIAP2;ATP6V0B;PIK3CA;GRB10;FOXC2;FER;PIK3R3;ATP6V1D;ATP6V1E1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.27388755464530506,-0.8624545519781829,0.7134670487106017,0.8891502619520851,1.0,18/44,22.48%,PTPRJ;LYN;DAB2IP;APOE;SORL1;AIDA;IRAK3;UCHL1;DUSP1;BMP4;SPRY1;DNAJA1;PDCD4;SPRY4;PTPN1;AGT;STK38;PAQR3
prerank,positive regulation of wound healing (GO:0090303),0.32357759151853643,0.8622487335439933,0.6504065040650406,0.9540425165794159,1.0,8/36,11.49%,SMOC2;ADRA2A;RREB1;F2;SERPINE1;FOXC2;HBEGF;MYLK
prerank,histone H3 acetylation (GO:0043966),-0.2767525779217544,-0.8618279674167985,0.7010309278350515,0.8897932846103631,1.0,9/40,19.40%,LEF1;MAP3K7;YEATS2;JADE3;JADE1;MBIP;BRPF3;MEAF6;TAF5
prerank,inner ear morphogenesis (GO:0042472),0.36207126455956873,0.8617350672552476,0.647985989492119,0.9544532427087129,1.0,4/22,8.36%,FGFR2;HOXA1;CHD7;ZIC1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3777625885563734,0.8616028045290465,0.611969111969112,0.9540755214917259,1.0,1/14,1.14%,PPP2R2B
prerank,regulation of interleukin-10 production (GO:0032653),0.31341250925820363,0.8613017444761102,0.6574225122349103,0.9540377010744983,1.0,5/44,6.47%,PRKCZ;TLR4;CD28;TRIB2;IL12B
prerank,nucleocytoplasmic transport (GO:0006913),-0.2769582259766146,-0.8611274897182187,0.7465940054495913,0.890475406284018,1.0,20/40,40.73%,BACH2;XPO1;ANP32A;RBM15B;SNRPF;NXT1;SNRPD3;NPM1;NCBP2;SNRPB;HTATIP2;MALT1;RITA1;SNRPG;GEMIN2;LSG1;NUP205;NCBP1;GEMIN6;HNRNPA1
prerank,nucleotide catabolic process (GO:0009166),0.37555212551739264,0.8610477989454298,0.6153846153846154,0.9539024717938221,1.0,4/16,10.01%,NT5C1B;DERA;SAMHD1;NT5C2
prerank,proteoglycan metabolic process (GO:0006029),0.3450907206222878,0.8605699482411961,0.6429780033840947,0.954253097369417,1.0,7/26,13.29%,IGF1;CHST11;SULF2;GAL3ST4;FOXL1;CNMD;SULF1
prerank,DNA metabolic process (GO:0006259),0.2451922111132843,0.8600876613847668,0.7718446601941747,0.9546071429039852,1.0,70/270,21.91%,TOP2B;POLD2;KMT5C;DNTT;USP3;POLG;ATM;UVRAG;RAD54L;ACD;KMT5B;DNASE1L1;PARP4;SAMHD1;TERT;PDS5A;TCF7L2;SRPK2;RBBP8;PRKDC;MSH3;ZBTB1;HUS1;AXIN2;IGHMBP2;FANCA;RAD50;TOP3A;USP7;PNKP;TDG;POLE2;MCM7;MCM2;ORC3;DDB2;DFFB;POLA2;GADD45A;DOT1L;MGMT;INTS3;LRWD1;POLL;DNASE1L2;SP100;MBD4;CDC34;OGG1;TINF2;NBN;SUMO1;FEN1;RAD51D;SLX4;MMS19;PDS5B;RFC1;XPA;ASF1A;XRCC3;LIG4;RAD9A;ZNF445;EID3;MCM5;TOP1MT;LIG1;ORC6;CBS
prerank,glycogen biosynthetic process (GO:0005978),0.39475039225997444,0.8599458486431719,0.6299810246679317,0.9536206259607,1.0,3/12,14.08%,GYS1;PGM1;PER2
prerank,glucan biosynthetic process (GO:0009250),0.39475039225997444,0.8599458486431719,0.6299810246679317,0.9536206259607,1.0,3/12,14.08%,GYS1;PGM1;PER2
prerank,regulation of interleukin-6 production (GO:0032675),0.27485271049345067,0.8597879177379438,0.7045143638850889,0.9533061152088599,1.0,11/96,10.58%,C1QTNF3;SYT11;TLR3;TLR4;IL17D;ARRB1;AFAP1L2;PTPN22;IL17RA;MAVS;RAB7B
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3609938884512454,-0.8597323149669195,0.6618852459016393,0.8927120361709796,1.0,5/13,34.07%,PIK3AP1;TLR7;IRAK4;PIK3R4;MYD88
prerank,myeloid cell differentiation (GO:0030099),-0.2655055013754195,-0.8597125602732726,0.7470238095238095,0.8920392736451074,1.0,12/47,19.20%,SNRK;RUNX1;ZBTB16;LYN;RPS19;IKZF1;MFHAS1;TIRAP;TAL1;HIPK2;ZFPM1;INHBA
prerank,protein localization to cell surface (GO:0034394),0.3452043305897029,0.8594846201199182,0.6468531468531469,0.9533311132538101,1.0,3/26,7.23%,ANK2;PRRT1;PTPRU
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.41306601603329307,0.8593181033942584,0.6098484848484849,0.9530295070280745,1.0,2/10,7.77%,UBAC2;ERLEC1
prerank,JNK cascade (GO:0007254),-0.27238269769166795,-0.8589599917692461,0.6991869918699187,0.8928704324284542,1.0,14/40,25.00%,MAP3K5;NOD1;MINK1;MAP3K7;TNFRSF19;MAP4K3;UBB;NOD2;MAP3K11;SH2D3C;MAP2K7;UBC;RPS27A;TAB1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.36305696828470324,-0.8586665124826695,0.6423982869379015,0.8927587565355578,1.0,3/13,9.42%,STAT3;IL6ST;JAK1
prerank,response to organic cyclic compound (GO:0014070),0.29720336208173703,0.8585735790860095,0.6640502354788069,0.9539354824295404,1.0,6/52,5.85%,IL18;SPP1;PAQR7;LRRK2;TLR3;TIPARP
prerank,negative regulation of cellular component organization (GO:0051129),0.2872160079593044,0.8583645011960702,0.6884779516358464,0.9537217050360403,1.0,17/74,15.81%,BMP6;PRKCZ;SYT11;RAPGEF3;APOM;DDX3X;WASL;TMC8;CDC42;IMPACT;EPHA3;DNM2;CRYAB;DNAJB2;CARMIL2;LGALS3;TFIP11
prerank,mammary gland epithelium development (GO:0061180),0.39809002316371295,0.8580628053042677,0.6452205882352942,0.9537173152892934,1.0,1/14,1.03%,WNT4
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3766794711931159,0.8579067799077633,0.64,0.9533982008685453,1.0,1/16,1.27%,DDX5
prerank,positive regulation by host of viral transcription (GO:0043923),-0.341245721511249,-0.8578990356568471,0.6872246696035242,0.893606710278646,1.0,1/15,0.47%,LEF1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.38015372266627356,-0.8576030292065528,0.6316872427983539,0.8934589262795345,1.0,5/10,35.64%,NHP2;DKC1;NAF1;RPUSD3;RPUSD2
prerank,kinetochore organization (GO:0051383),-0.35871025248107963,-0.8571095667439027,0.6791666666666667,0.8937623096320046,1.0,8/13,32.23%,CENPE;CENPH;NDC80;CENPA;CENPF;DLGAP5;NUF2;POGZ
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.3854364491725653,0.8570496920037031,0.6039603960396039,0.9545341674433252,1.0,5/13,17.73%,YJU2;SIRT1;DYRK1A;SNAI1;KDM1A
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3469159468332683,0.8568920537453786,0.6498257839721254,0.9542233063664783,1.0,10/25,22.88%,AMPD3;PRPSAP1;AMPD2;APRT;PRPSAP2;MTHFD1;GART;GMPR2;ADSL;GMPS
prerank,regulation of interleukin-12 production (GO:0032655),-0.2667381052983684,-0.8567397404430883,0.7336956521739131,0.8938047079904076,1.0,13/47,21.92%,THBS1;FOXP1;PLCG2;IRAK3;CD47;TIRAP;CMKLR1;LAPTM5;SYK;IRF5;CCL19;LGALS9;MDK
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.3287334480927696,-0.8554913171307071,0.6430205949656751,0.8956775366974427,1.0,6/18,10.85%,NELL1;DAB2IP;DACT1;RDX;HSP90AA1;MSN
prerank,histone H2A ubiquitination (GO:0033522),0.37548450405798944,0.8552183952654488,0.6311926605504588,0.9570744437958648,1.0,5/17,13.59%,UBR2;RNF8;BCOR;KDM2B;DDB2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.34429403904907385,0.85455918587475,0.6696750902527075,0.9577875826579231,1.0,4/25,8.59%,ITPR1;LRRK2;P2RX3;HTT
prerank,axonal transport of mitochondrion (GO:0019896),0.40655989536354376,0.85454485910921,0.6396039603960396,0.9571775611706771,1.0,2/11,7.05%,TRAK1;OPA1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3655105917592229,0.8541333351143063,0.6414762741652021,0.9573738675298099,1.0,6/18,11.57%,COL4A3;FGFR1;FLT1;APLN;PDPK1;ADAM17
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.28230367039459037,0.8540948192269191,0.6964028776978417,0.9568259196331095,1.0,11/80,10.45%,KIF2A;STX18;KIF3C;UVRAG;ARFGAP3;HTT;GOLPH3L;KIF1C;KLC1;PICK1;COPZ2
prerank,synaptic vesicle recycling (GO:0036465),-0.2917082090360663,-0.8538217253337453,0.713216957605985,0.8983225181730904,1.0,4/31,7.30%,NLGN1;SYT1;STON2;AMPH
prerank,cellular response to estrogen stimulus (GO:0071391),-0.3473614654203444,-0.8536901225894308,0.6611570247933884,0.897871891252388,1.0,5/14,21.03%,AR;SERPINB9;NCOA4;ARID5A;SFRP1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.37633856601173715,-0.853618193036864,0.6506276150627615,0.8972968061759619,1.0,3/12,5.51%,PROM1;STAT3;RORB
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.41600931656484275,0.8535690800861726,0.620889748549323,0.957251854837923,1.0,4/10,17.39%,EZR;OPHN1;CDC42;MYO9A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3676018199192843,0.8534017362471321,0.6316725978647687,0.9569803789969131,1.0,3/18,9.34%,PRKN;SOD2;SIRT1
prerank,positive regulation of isotype switching (GO:0045830),0.38296509658116107,0.8528901285280458,0.6298932384341637,0.9573787367585419,1.0,3/15,6.46%,KMT5C;TNFSF13;KMT5B
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3488861583364304,0.8527665587307807,0.6427378964941569,0.9570134261147341,1.0,4/21,12.55%,HK2;DERA;GCK;PGD
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3878514948034886,0.8527177797019879,0.6189591078066915,0.9564764979463863,1.0,4/14,11.35%,EZR;OPHN1;PATJ;CDC42
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.35457240296551984,0.8526650010171085,0.66,0.955945398698785,1.0,4/19,5.69%,CUX1;OBSL1;CUX2;CAPRIN2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.37980802272430303,0.8524795207791601,0.6302186878727635,0.9556967778758927,1.0,4/13,19.08%,NFU1;CISD3;ISCA1;MMS19
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2579826415470142,-0.8522850518062366,0.7065868263473054,0.8993011401277021,1.0,22/54,22.58%,RPL3;RPL26;RPL7;RPL35A;RPLP0;RPL5;RPL14;RPL7A;RPL23A;RPL10A;RPL6;MDN1;MALSU1;NOP53;BRIX1;MRPL20;NHP2;RPL24;RPL11;RSL24D1;NPM1;RRP15
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.3817853941446515,-0.8522753615644006,0.6700819672131147,0.8986092969263281,1.0,3/10,7.03%,CAV1;ENG;ENPP1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3273718374347315,0.852206947340738,0.6722972972972973,0.9556125858322948,1.0,6/33,11.68%,SMAD3;TP53;SMARCA4;TERT;APLN;TEAD1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3116041200396284,-0.8521800451761582,0.6867749419953596,0.8980814088951858,1.0,6/24,13.95%,TRPS1;ACVRL1;ZBTB16;WNT9A;PTHLH;BMPR1B
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.2974582171754762,-0.8518564228948325,0.7086956521739131,0.8980248182393541,1.0,8/25,16.81%,NCKAP5;STMN2;FGF13;TRPV4;MAPT;STMN1;MAP7D3;TPPP
prerank,negative regulation of macroautophagy (GO:0016242),0.34127577121338654,0.8518491277275213,0.645655877342419,0.9557027047143715,1.0,6/26,15.85%,NUPR1;LRRK2;SMG1;PIK3CA;TSC1;SCFD1
prerank,regulation of chemotaxis (GO:0050920),0.3256014787123188,0.8514205652911367,0.6706484641638225,0.955952759028715,1.0,5/30,10.36%,EFNB2;PDGFRB;ADGRA2;CYRIB;ZSWIM8
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.41011950902662786,0.8512506079704613,0.6563106796116505,0.9556875867057486,1.0,3/10,17.02%,PARP14;SOCS3;PIBF1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2706134978205299,0.8511617036089436,0.7014492753623188,0.9552368128381697,1.0,5/93,2.32%,SH3RF2;TPD52L1;SASH1;CCN2;SPHK1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3175555465418581,-0.85072498926425,0.6619047619047619,0.8995386196307463,1.0,12/21,38.60%,RAD51B;ATAD5;NPM1;DTL;MECP2;CCND1;CDC7;CDK1;BRD4;CCNB1;CDC25C;RAB11A
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3256053163273752,0.8505019116378498,0.6603119584055459,0.9559709817642053,1.0,6/29,7.55%,KIT;F2;EPHA8;FLT1;PDGFRB;AMBRA1
prerank,regulation of lipase activity (GO:0060191),-0.359097072986701,-0.8504839515878898,0.6507592190889371,0.8992789343585884,1.0,3/13,13.16%,PCSK5;PCSK6;SNCA
prerank,negative regulation of bone mineralization (GO:0030502),-0.3535047555468298,-0.8500763999294962,0.6551724137931034,0.8993577828377076,1.0,3/13,7.47%,PTK2B;ENPP1;ECM1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.29213404228785556,0.8498310731905788,0.6902927580893683,0.9566774683157045,1.0,12/63,14.70%,TFDP2;ATM;ARID3A;TP53;RBL2;CNOT10;TFDP1;PRKDC;PML;SDE2;GADD45A;E2F4
prerank,chemokine-mediated signaling pathway (GO:0070098),0.308580714786458,0.8494687721323128,0.6929530201342282,0.9568021174604954,1.0,7/42,16.96%,OXSR1;FOXC1;RBM15;CCL25;WNK1;CCL15;CCR2
prerank,membrane fusion (GO:0061025),-0.2852700203867664,-0.8488170805850408,0.7053140096618358,0.9011165174251087,1.0,5/33,9.50%,DNM3;RIMS1;DNM1;DYSF;NSF
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.22244976495171517,-0.8486366343459851,0.8692307692307693,0.900747868370528,1.0,54/125,32.39%,CLASP2;PLK2;DYNC1I1;DYNLL1;XPO1;DYNC1LI2;CEP126;RPS27;SETD2;MAP4;BUB3;CLIP1;STMN1;NUSAP1;CENPE;EFHC2;TBCE;EML1;KIF11;RAN;PPP1CC;NUP107;NEK6;MAD2L1;CENPH;BCCIP;NSL1;NDC80;SUN2;KIF4A;KIF3B;KPNB1;KNTC1;MECP2;TUBG2;DCTN6;CENPA;NUP85;CDCA8;NDEL1;NDE1;RANGAP1;TNKS;CENPF;NUDC;PTPA;STIL;DLGAP5;NUF2;AURKA;CENPI;SPC24;CDC20;BUB1
prerank,coenzyme A metabolic process (GO:0015936),0.38137882050415356,0.8483401530596989,0.6647619047619048,0.9584852405251497,1.0,7/14,27.45%,PANK1;DCAKD;ACLY;CROT;SLC25A16;ACOT7;ACAT1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3072775539873184,0.8482509313602923,0.672787979966611,0.9580245868817586,1.0,5/43,6.37%,IGF1;IL18;BMPR1A;NOX1;PDGFRB
prerank,inositol phosphate catabolic process (GO:0071545),0.4044480184490427,0.8481658884325716,0.6524953789279113,0.95757215261039,1.0,3/12,11.18%,SYNJ2;PTEN;OCRL
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.31670878472197245,0.8475212592044736,0.6661073825503355,0.958243560812175,1.0,9/38,12.65%,ACE;EPHA4;DLG3;SH3BP5;GPRC5B;MVP;NOX4;CASS4;SRCIN1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.35421089793404553,-0.8474301261534317,0.6910229645093946,0.9024355777055626,1.0,2/13,14.20%,MID2;TRIM28
prerank,negative regulation of response to external stimulus (GO:0032102),0.2715878845395027,0.846878791971127,0.7356164383561644,0.9589970687809087,1.0,17/105,14.42%,RORA;C1QTNF3;PPARA;EPHA4;PCBP2;METRNL;GPS2;ENPP3;SERPINE1;PTEN;CDH5;TRIB1;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,vasculature development (GO:0001944),0.3594768583371629,0.846844868731363,0.6466302367941712,0.9584303055466503,1.0,4/16,8.86%,ERRFI1;PDGFRB;PIK3CA;CDH5
prerank,cAMP metabolic process (GO:0046058),0.3939778527323791,0.8468020929705085,0.6518518518518519,0.9578807365610648,1.0,3/13,6.99%,ADCY5;ADCY1;ADCY9
prerank,negative regulation of DNA binding (GO:0043392),-0.29985226802776066,-0.8466514389158392,0.6886543535620053,0.9032553535571444,1.0,3/28,9.18%,LEF1;NFKBIA;HEY2
prerank,mitochondrial fission (GO:0000266),0.36844277191060204,0.8465265085821281,0.6376811594202898,0.9578104799798659,1.0,5/16,13.52%,PRKN;OPA1;MTFR2;DNM1L;DNM2
prerank,tryptophan metabolic process (GO:0006568),0.39824231010671685,0.8454425719587458,0.6530249110320284,0.9594600850818064,1.0,11/11,60.20%,ATP7A;KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.35694558579384567,0.8449990501335439,0.6561954624781849,0.9597329906289015,1.0,4/20,10.00%,FKBP5;NKTR;PPIC;CWC27
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.23614855850862254,-0.8446013415811708,0.8079470198675497,0.9065351683576921,1.0,16/73,20.19%,KITLG;RUNX1;LMO2;PSMB2;GATA2;PSMD14;PSMC6;TCF12;TAL1;METTL3;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;YTHDF2
prerank,protein insertion into membrane (GO:0051205),-0.2758697062476796,-0.8444315048326138,0.7222222222222222,0.9061516747140717,1.0,10/32,29.58%,REEP1;APP;SEC61B;CYB5A;EMD;VAPA;TRAM1;STX1A;HMOX1;WDR83OS
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24328860928663076,0.8441483425400076,0.8072855464159812,0.960833376507584,1.0,69/264,23.34%,SRRM2;DDX5;POLR2A;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;SNIP1;HNRNPA2B1;POLR2D;RBM15;SPEN;NOVA1;GPKOW;CCAR1;CWC27;GTF2F1;SRPK2;HNRNPL;CWC15;IK;USP49;PHF5A;SRSF11;PRCC;HNRNPC;SCAF11;PRPF3;SNRNP40;RBM4;TFIP11;HNRNPM;CPSF3;CWF19L1;FRG1;USP39;ZCRB1;PRPF6;FUS;SRSF1;CSTF1;HNRNPH3;CDC40;PCF11;SRSF10;U2AF1;EFTUD2;SNRPC;SRSF7;SF1;PNN;POLR2G;WBP4;PRPF31;SNRPA1;U2AF2;SF3B2;SF3B1;PPWD1;SF3B5;CPSF7;GCFC2;PQBP1;CDC5L;RNPC3;NUDT21;POLR2F
prerank,microtubule polymerization (GO:0046785),-0.2911478660928226,-0.8437951529583811,0.7102803738317757,0.9066487163572869,1.0,12/29,25.63%,CLASP2;TUBGCP2;FGF13;TRPV4;MAPT;MAP7D3;TPPP;TPX2;TUBG2;NDEL1;NDE1;TPPP3
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.24830879699656117,-0.8426433162972559,0.7818696883852692,0.9082055658761621,1.0,15/56,19.42%,NOD1;ALPK1;SFTPA1;SFTPA2;PLCG2;MAP3K7;CTSB;RPS6KA3;CTSL;CTSS;LBP;UBB;NOD2;TIFA;TLR7
prerank,lipoprotein catabolic process (GO:0042159),-0.36426419084036676,-0.842557048997091,0.6625258799171843,0.9076588145769958,1.0,4/11,13.32%,APOE;CTSD;PPT1;ABHD17B
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3050695819144996,0.8425039067862102,0.6817472698907956,0.9635629492117717,1.0,12/50,17.51%,CCNA2;CCNA1;CCNT2;CCND3;CDK5RAP3;CDC25A;GTPBP4;CCNB2;GADD45A;CCNG1;CCNE1;CNPPD1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.29009961566604214,-0.8424803469673932,0.7119565217391305,0.907086224579085,1.0,5/31,11.05%,TFRC;GPI;PTPRC;EPHB2;HMCES
prerank,negative regulation of potassium ion transport (GO:0043267),0.3909213779513922,0.8422610562978797,0.6405959031657356,0.9634621028879451,1.0,1/13,0.65%,ACTN2
prerank,negative regulation of immune response (GO:0050777),-0.21509859392154287,-0.8417773527545983,0.8608695652173913,0.9077268731613174,1.0,43/154,23.54%,CALCRL;ADCY2;ADCY7;MYH9;GNG2;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;IRAK3;HTR7;PTH1R;TRIM27;CYSLTR1;PRKAR1B;CYSLTR2;PRKAR2B;HAVCR2;HTR4;PTHLH;SAMSN1;RAMP1;IAPP;GNB1;VIPR2;TYRO3;SYK;SIRT2;GPR45;ADCY3;ADCY8;PRKAR2A;GPR176;HRH2;ADCYAP1R1;YES1;MC5R;NPSR1;FYN;LHCGR;RHBDF2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.35937066809593327,-0.8417029220536156,0.6782945736434108,0.9071676296567353,1.0,4/12,14.31%,TASOR;APOBEC1;TRIM28;ATF7IP
prerank,protein-containing complex subunit organization (GO:0043933),-0.22360090875809807,-0.8416957631946981,0.8267148014440433,0.9064685786436333,1.0,27/109,18.45%,SLC2A1;REPS2;RIMS1;IL1RAP;LIN7A;PTK2B;SKAP2;HES1;OCLN;CD2AP;PPP2R1A;ELOB;TUBGCP2;ADD2;CAPZA2;CLDN14;FAS;LPXN;MDN1;DMTN;SHANK1;WASF1;CAPZA1;APC;CD74;TRAF1;FANCC
prerank,axoneme assembly (GO:0035082),-0.28381669578724533,-0.8413855494176148,0.6997578692493946,0.9063753639711211,1.0,17/31,41.98%,DCX;RP1;SPEF1;DNAAF3;LRGUK;CCDC65;RSPH9;CFAP206;SPAG1;FOXJ1;TTLL3;DNAAF2;RSPH1;TTC12;CFAP74;DNAAF1;RSPH4A
prerank,copper ion homeostasis (GO:0055070),-0.32677968638223787,-0.8411355675711923,0.6840909090909091,0.9061218804100307,1.0,6/17,24.62%,APP;ATOX1;SLC31A1;COMMD1;MT2A;CUTC
prerank,RNA 3'-end processing (GO:0031123),0.28515896442941685,0.8410248205167501,0.7029096477794793,0.9653463127764789,1.0,20/69,22.13%,PABPN1;SRSF5;POLDIP3;RPRD2;TUT4;TENT2;SRSF11;SARNP;TENT4B;CPSF3;TUT7;SRSF1;CSTF1;CDC40;PCF11;U2AF1;SRSF7;U2AF2;TUT1;CPSF7
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.26453298796589453,-0.840862196336223,0.7428571428571429,0.9059418807553447,1.0,11/43,16.10%,PTPRJ;SH3KBP1;SH3GL2;ARHGEF7;DAB2IP;DUSP3;PTPN3;SPRY1;SOCS5;ZFYVE28;CBL
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.30209010646356393,-0.8408456944427907,0.674937965260546,0.9052634162920732,1.0,7/25,13.95%,BMPR2;ENG;ACVRL1;NOTCH1;CCN1;BMP4;BMPR1B
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3266132891335253,-0.8406190670145639,0.6769911504424779,0.9049973058356007,1.0,7/17,12.51%,RUNX1;TGFB3;VSIR;TGFB1;CREB3L1;BMP4;VIM
prerank,tryptophan catabolic process (GO:0006569),0.3982423101067169,0.8398803496931606,0.6510791366906474,0.9670524753933954,1.0,11/11,60.20%,AFMID;KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,mitotic spindle assembly (GO:0090307),0.310891430323278,0.8395210507024864,0.68561872909699,0.9671382180363882,1.0,14/42,19.65%,KIF2A;CLASP1;LSM14A;AURKB;MISP;KIFC1;STAG2;SMC3;PIBF1;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.35534793888094207,0.8392002734723236,0.657608695652174,0.9671408865924689,1.0,6/18,17.63%,ANKRD17;DDX60;DHX58;BIRC3;UFD1;NPLOC4
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.3769384194572193,-0.8391257749357246,0.6924731182795699,0.9071907823214966,1.0,1/10,3.67%,RUNX1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.29591377572643773,0.838712647579149,0.7059748427672956,0.9674833480939479,1.0,13/52,17.82%,TUT4;POLR2D;SAMD4A;EXOSC7;CNOT10;PAN3;PNLDC1;DDX6;DCP1A;DIS3;TUT7;NT5C3B;EXOSC3
prerank,protein stabilization (GO:0050821),0.25182740301984424,0.8383781237149374,0.8007662835249042,0.9675385129670805,1.0,12/168,6.58%,ATP1B3;ANK2;PPARGC1A;IGF1;STXBP4;PRKN;EPHA4;AAK1;LAMP2;USP9X;CREBL2;TBL1X
prerank,positive regulation of exosomal secretion (GO:1903543),0.36548883883590844,0.8382589688909511,0.6643835616438356,0.9671250351081426,1.0,7/15,22.43%,SDC4;SMPD3;SNF8;VPS4A;CHMP2A;RAB7A;SDCBP
prerank,membrane protein proteolysis (GO:0033619),0.31201136322898126,0.8376716840774725,0.6981757877280266,0.9676937609499533,1.0,11/37,19.69%,BACE2;DAG1;CTSH;APH1B;ADAM17;MBTPS1;ERAP1;NFKB1;CLPP;NCSTN;AFG3L2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.35076351608910367,0.8376495963864958,0.6818980667838312,0.9671140842390535,1.0,3/20,6.88%,WNT4;SIK1;SLC27A1
prerank,tRNA modification (GO:0006400),0.28647343185249574,0.837600235193469,0.7058823529411765,0.9665833677774427,1.0,12/62,19.97%,TRMT9B;TPRKB;TRMT44;TYW1;METTL6;PUS10;LCMT2;PUSL1;WDR4;DTWD2;DUS2;ADAT2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.33771022420589025,0.8370687438002004,0.666083916083916,0.9670180751497651,1.0,8/22,21.02%,SOX12;TNFRSF18;DUSP10;FANCA;IRF1;CD46;BCL6;CTLA4
prerank,sterol homeostasis (GO:0055092),0.28012421520997893,0.8366816993195687,0.7181688125894135,0.9671758651940678,1.0,4/65,5.03%,RORA;IL18;GRAMD1B;APOM
prerank,nuclear pore complex assembly (GO:0051292),-0.3688266916891304,-0.8365151307608092,0.7111597374179431,0.9115458101513308,1.0,6/10,36.86%,RTN4;NUP107;NUP93;AHCTF1;TMEM170A;NUP205
prerank,response to molecule of bacterial origin (GO:0002237),0.2807817672377068,0.8358782887252559,0.7101449275362319,0.9681644669000947,1.0,14/69,11.59%,CPS1;SMAD6;TLR4;FZD5;PTPN22;SRR;MAPKAPK3;TAB2;FER;CYRIB;LY96;TRIB1;ADAM17;NOCT
prerank,cholesterol homeostasis (GO:0042632),0.28020588279319214,0.8357738848029609,0.7198275862068966,0.9677661992374952,1.0,4/64,5.03%,RORA;IL18;GRAMD1B;APOM
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.31533656203688426,-0.8355701673708994,0.6794582392776524,0.9126842349273551,1.0,5/20,18.09%,HSP90AB1;PROX1;PKD1;CCNY;RGCC
prerank,regulation of sequestering of calcium ion (GO:0051282),0.38233979763014003,0.8354804860358637,0.6705202312138728,0.9677478487784944,1.0,1/12,0.80%,ANK2
prerank,glutathione derivative biosynthetic process (GO:1901687),0.35297172072342065,0.8353272289521128,0.6726618705035972,0.9668025865693813,1.0,2/20,10.03%,GSTT1;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.35297172072342065,0.8353272289521128,0.6726618705035972,0.9668025865693813,1.0,2/20,10.03%,GSTT1;GSTA3
prerank,regulation of lamellipodium assembly (GO:0010591),0.3218718109970542,0.8351466899093212,0.6939102564102564,0.9665065037289065,1.0,7/34,11.35%,AUTS2;AVIL;CAPZB;PIK3CA;HRG;FER;CDC42
prerank,regulation of telomerase activity (GO:0051972),-0.26438304577816946,-0.8348900415282433,0.771117166212534,0.9132521662006098,1.0,20/45,31.43%,PARM1;HSP90AB1;NEK7;HSP90AA1;XRCC5;CTNNB1;TERF1;CCT2;MEN1;PRKCQ;HMBOX1;PTGES3;MAP2K7;KLF4;TNKS;DKC1;NAF1;MAPK3;PIF1;PKIB
prerank,alanine transport (GO:0032328),-0.3731907096000177,-0.8348420372917988,0.681912681912682,0.9126347685809119,1.0,2/10,7.84%,SLC6A6;SLC1A4
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.30539264319189974,0.8346413424409213,0.7089783281733746,0.966922827588967,1.0,10/49,13.90%,PRKCZ;PMEPA1;SMAD6;DDX3X;LDLRAD4;TMC8;CDC42;IMPACT;ANKRD27;CRYAB
prerank,synaptic vesicle transport (GO:0048489),-0.36104400879842696,-0.8345722788340217,0.6982758620689655,0.9124359498875629,1.0,5/11,25.76%,RAB27A;KIF5C;TMEM230;KIF5A;SYNJ1
prerank,positive regulation of protein kinase activity (GO:0045860),0.25373469860638326,0.8345210961477603,0.7881578947368421,0.9665368606548402,1.0,18/148,11.01%,PRKAG2;ACE;EPHA4;ALS2;ADRA2A;DDX3X;CAMK1;IL12B;CACUL1;SLC27A1;DLG3;TGFBR2;GPRC5B;TAB2;NOX4;IRGM;CASS4;JTB
prerank,purine nucleotide metabolic process (GO:0006163),0.3403370206781646,0.8342109519834692,0.6689419795221843,0.9665050793781255,1.0,9/24,20.76%,FHIT;NT5C1B;NT5C2;PRPSAP1;PRPSAP2;MTHFD1;NT5C;GART;ADSL
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2934439760833874,0.8340075336135241,0.7242424242424242,0.9662677246442211,1.0,7/57,9.10%,KIT;IGF1;IL18;PARP14;IL12B;TNFRSF18;PARP9
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3500395970784518,-0.8335111612936686,0.6982758620689655,0.9137812431435476,1.0,4/13,11.37%,TOX;CAMK4;CLPTM1;BMP4
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3381943274102458,0.8333097038168632,0.6766256590509666,0.9670624307988196,1.0,2/24,1.92%,AUTS2;AVIL
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.38545384927228205,0.8327770896120165,0.6541353383458647,0.9674534781823744,1.0,2/13,7.33%,GLI3;TGFBR2
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.28538316544210773,-0.832498053827862,0.7537688442211056,0.9149645744738576,1.0,4/29,8.69%,CXCL12;GAS6;JAM2;CALR
prerank,hippo signaling (GO:0035329),0.3381228138884534,0.8319972778701991,0.676678445229682,0.9684274322487484,1.0,8/26,15.16%,CASP3;TEAD3;WWTR1;TEAD2;AMOTL2;TEAD1;SAV1;STK4
prerank,negative regulation of immune effector process (GO:0002698),0.38901417554615014,0.8316591486926987,0.6588693957115009,0.9684577334789488,1.0,4/13,15.10%,CD300A;ENPP3;FER;LGALS3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.37545785051727787,-0.8316038156120074,0.673036093418259,0.9158998661395013,1.0,2/10,5.96%,DLGAP1;DLGAP2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.327785891175501,-0.8315280877428817,0.6909090909090909,0.9153329986071483,1.0,5/16,14.82%,SCARB1;APOE;GCH1;HIF1A;NUS1
prerank,cellular iron ion homeostasis (GO:0006879),0.28930550810839184,0.831042398290487,0.7488076311605724,0.9690235967007342,1.0,2/55,1.26%,BMP6;CP
prerank,positive regulation of transport (GO:0051050),-0.22776671882568814,-0.8308162970061193,0.8603174603174604,0.9159870293630199,1.0,17/85,14.35%,ACTB;MERTK;GAS6;ACSL3;NEDD4L;GSK3B;ANXA1;APOE;RAB27A;GATA2;CALR;CD47;DOCK2;CYBA;CAPN10;SNCA;CD151
prerank,negative regulation of axonogenesis (GO:0050771),-0.2883410634411753,-0.830778967376561,0.7222222222222222,0.9153511503660039,1.0,13/27,21.40%,RTN4;DCC;DIP2B;ULK1;ULK2;FGF13;LINGO1;SEMA3G;MT3;ARHGDIA;GDI1;RTN4R;MCF2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.3624446859552208,0.8306235462637338,0.6703703703703704,0.9692267374736626,1.0,3/16,8.00%,IGF1;PHIP;IGFBP3
prerank,non-motile cilium assembly (GO:1905515),0.3229569200438203,0.8305536954430104,0.7162162162162162,0.9687407243453408,1.0,9/30,20.98%,CEP250;IFT122;IFT88;BBS10;GORAB;PIBF1;TMEM17;PCM1;FUZ
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.31277354220648107,-0.8303939195470136,0.7205542725173211,0.9153762113846156,1.0,4/18,9.42%,ST18;STAT3;IL6ST;JAK1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3039230549540332,-0.8302112685472475,0.7116704805491991,0.9150231220490828,1.0,6/21,13.74%,PDE4D;XDH;HINT1;PDE2A;NT5E;NT5C1A
prerank,negative regulation of microtubule polymerization (GO:0031115),0.38180033069043917,0.8300678733483197,0.6429906542056075,0.9690723294132093,1.0,4/12,10.70%,EML2;MAP2;CDH5;DYRK1A
prerank,cellular response to mechanical stimulus (GO:0071260),-0.25370264272719556,-0.8299833186374784,0.7652173913043478,0.9147459802716543,1.0,21/46,34.59%,PIEZO2;F11R;PIEZO1;PDE2A;FAS;TMEM150C;CRADD;CASP2;MAP3K14;TLR7;BNIP3;CD40;MAPK8;MAPK3;MAP2K4;AQP1;BCL10;PTGER4;TLR8;MYD88;BAD
prerank,protein import (GO:0017038),0.271388183703963,0.8299163949914429,0.7396870554765291,0.9687463808573649,1.0,26/84,24.39%,APPL2;TNPO1;LAMP2;SAMM50;PEX11B;IPO13;PXMP2;HSPA4;PEX14;ACBD5;PEX19;NUP155;RAB8B;SLC25A17;PEX16;PEX5;NUP188;TSC2;TNPO2;NUP153;SNX33;PEX26;HEATR3;PRICKLE1;PPP1R10;HIKESHI
prerank,actin crosslink formation (GO:0051764),-0.34671424249659716,-0.8297137711242748,0.66,0.9145200416283511,1.0,4/12,14.11%,FLNA;GAS2;EPS8;GAS2L3
prerank,negative regulation of interleukin-10 production (GO:0032693),0.3591359273218261,0.82925500807538,0.6714801444043321,0.9693960342842919,1.0,3/16,10.07%,TRIB2;IL12B;CD274
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.25415999804136596,0.828829661419739,0.7669773635153129,0.9696328259499812,1.0,11/140,6.96%,ADCY5;LPAR1;CCR9;ACKR2;JPH1;LPAR2;BDKRB2;CACNA1C;P2RX3;CACNB3;KNG1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3051600545000567,0.8287587456215062,0.7088186356073212,0.9691561236184045,1.0,6/40,9.69%,DAB2;MAGI2;ARRB1;SERPINE1;WASL;PICK1
prerank,mitochondrion disassembly (GO:0061726),0.31271069232718574,0.8285857263369034,0.7064516129032258,0.9688931744929907,1.0,7/34,13.74%,PRKN;ATG5;WIPI1;AMBRA1;BECN1;ATG7;ATG2A
prerank,neurotrophin signaling pathway (GO:0038179),0.3399648882573534,0.8283083641825747,0.6752767527675276,0.9688515711512933,1.0,3/21,3.52%,FRS2;MAGI2;CASP3
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3195098613316724,0.8277538392993976,0.6909090909090909,0.9693151251733275,1.0,4/32,4.05%,SNCAIP;SYT11;LRRK2;DTNBP1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.2936024050827868,-0.8270964175824047,0.7304147465437788,0.918719778250391,1.0,8/26,20.43%,HECW2;CUL3;CDK5RAP2;DUSP1;LCMT1;CENPE;CDC23;NEK6
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3024177471762242,-0.8269433784125385,0.7077625570776256,0.9175830365867358,1.0,10/21,31.81%,ERCC1;RPA1;GTF2H1;GTF2H4;GTF2H5;ERCC2;DDB1;RPA3;ERCC3;RPA2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3024177471762242,-0.8269433784125385,0.7077625570776256,0.9175830365867358,1.0,10/21,31.81%,ERCC1;RPA1;GTF2H1;GTF2H4;GTF2H5;ERCC2;DDB1;RPA3;ERCC3;RPA2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.25685190108218275,-0.8267238677099783,0.7486187845303868,0.9172927414570818,1.0,29/45,41.95%,STAT3;APP;EGR1;AIM2;USP50;NOD2;PANX1;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;JAK2;TRIM16;P2RX7;CD36;MALT1;TLR8;MYD88;TMEM106A;GBP5;ISL1;CASP8;INAVA;TNF;NLRP12;LPL;GSDMD;IL6
prerank,myotube cell development (GO:0014904),0.4037746032618046,0.8263729899842229,0.6742424242424242,0.9713840406430111,1.0,1/10,1.44%,IGF1
prerank,protein palmitoylation (GO:0018345),-0.28797890030804335,-0.8262484860262423,0.7524752475247525,0.9174686963866092,1.0,6/30,12.48%,ZDHHC9;HHAT;ZDHHC2;SELENOK;GOLGA7;ZDHHC14
prerank,nerve growth factor signaling pathway (GO:0038180),-0.371315740987402,-0.8261403168672578,0.702258726899384,0.9169588509113812,1.0,3/10,16.05%,NGF;RAP1A;BDNF
prerank,thymus development (GO:0048538),-0.3451484375206201,-0.8261084555847245,0.7213114754098361,0.9163080674240122,1.0,3/13,8.27%,TBX1;HES1;SIX1
prerank,positive regulation of macroautophagy (GO:0016239),0.30022572669152287,0.8257908101890017,0.7074721780604134,0.9718711907256911,1.0,10/48,10.49%,PRKAA2;SESN1;SESN2;FYCO1;UVRAG;PIP4K2C;LARP1;HTT;SIRT1;IRGM
prerank,cellular response to cAMP (GO:0071320),0.3211087391702061,0.8254545698841086,0.6895368782161235,0.9719002500877028,1.0,4/30,5.60%,SLC5A5;RAPGEF3;EZR;SLC26A3
prerank,chromatin organization (GO:0006325),0.2547292275419372,0.825242360098613,0.8029891304347826,0.9716795127825577,1.0,34/132,20.78%,JARID2;HDAC8;ATRX;BAZ1B;SETD7;SMARCD3;SMARCA4;SMARCC2;SMARCE1;HDAC4;SIRT1;HDAC1;BAZ1A;ZBTB1;PHF1;CDAN1;HMGN3;SNAI1;KAT2B;MTA2;LRWD1;SETDB2;RB1;EHMT1;TCF7L1;KDM6B;PADI4;SATB2;EZH1;BRWD1;MPND;TAF6L;KDM6A;SMARCD2
prerank,GPI anchor biosynthetic process (GO:0006506),0.3211149523993172,0.8252179415437377,0.6742556917688266,0.971106427624168,1.0,3/30,6.36%,PIGN;PIGW;PIGQ
prerank,regulation of calcium ion import (GO:0090279),-0.3080385556547519,-0.8252115284749327,0.7066974595842956,0.917308834129884,1.0,7/21,26.52%,CXCL12;TRIM27;CTNNB1;SLC30A1;PLN;FYN;CCL2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2907504878501871,-0.8244491467240942,0.7313769751693002,0.9180201684942174,1.0,6/26,14.59%,CAV1;RTN4;MFHAS1;CYBA;TIRAP;LBP
prerank,"base-excision repair, gap-filling (GO:0006287)",0.30616438341271635,0.8243279458338997,0.6944444444444444,0.9721968100842412,1.0,12/35,23.81%,POLD2;POLG;PNKP;TDG;POLL;MBD4;OGG1;FEN1;RFC1;LIG1;ADPRS;SMUG1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3678182915327305,0.823994554554637,0.6691449814126395,0.9722231380596035,1.0,5/14,16.79%,NMNAT1;AK4;AK3;AK8;NMNAT2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3570230937605776,0.8238003732187815,0.6898395721925134,0.9719837822340528,1.0,3/18,6.50%,CD300A;PARP10;TP53
prerank,indolalkylamine catabolic process (GO:0046218),0.3982173121586844,0.8237614704524772,0.663023679417122,0.971433371533819,1.0,10/10,60.20%,KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2764663206931589,0.8237543481005958,0.7397660818713451,0.9708268079734342,1.0,9/72,9.41%,TFDP2;SESN2;ATM;ARID3A;ATRX;TP53;RBL2;CNOT10;TFDP1
prerank,histone H4-K16 acetylation (GO:0043984),0.34714172450662967,0.8230675739190683,0.672566371681416,0.9715436802950363,1.0,7/19,24.56%,KMT2A;KAT7;OGT;KANSL1;KANSL3;MSL3;PHF20
prerank,myeloid cell development (GO:0061515),0.35281465961445624,0.8227479019285554,0.6985559566787004,0.9715422544019748,1.0,1/18,1.21%,KIT
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3579334564680756,0.8226174193160183,0.6536412078152753,0.9711588729792924,1.0,5/17,12.89%,SSC5D;ARRB1;MAP2K5;PTPN22;MAPKBP1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.23885562180837105,-0.8224452943651157,0.8367952522255193,0.9209700093055673,1.0,15/62,18.10%,CXCL12;TPT1;ARHGEF2;PPIA;ACKR3;RTKN2;TMBIM6;CREB3L1;YBX3;ARMC10;PINK1;CLU;DNAJA1;HSPB1;HTRA2
prerank,phospholipid metabolic process (GO:0006644),-0.23870253054448237,-0.8221971488561536,0.8461538461538461,0.9207347009253235,1.0,9/71,10.80%,PLA2G4A;PIP4K2A;PLPP1;MBOAT1;PLPPR1;TNFAIP8L3;PLPPR5;PLPPR4;ENPP2
prerank,regulation of response to oxidative stress (GO:1902882),0.3951969870822519,0.8221737663552958,0.667953667953668,0.9713589165398304,1.0,1/11,1.98%,PRKN
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3263016898039035,0.8212366998419314,0.703125,0.9725550464014645,1.0,4/26,5.97%,OGN;ST3GAL3;FMOD;B4GALT1
prerank,regulation of rRNA processing (GO:2000232),0.3588957636309844,0.8211070688401697,0.6872727272727273,0.9721839318903929,1.0,4/16,18.25%,RIOK2;WDR43;KAT2B;BUD23
prerank,copper ion transport (GO:0006825),-0.353614005954146,-0.8210661405876967,0.6741344195519349,0.922163892358093,1.0,6/11,31.79%,ATOX1;SLC31A1;COX17;CUTC;STEAP4;ATP7B
prerank,negative regulation of autophagosome assembly (GO:1902902),0.37650594575132224,0.8210382972928644,0.6598130841121496,0.9716994769256049,1.0,2/13,3.85%,NUPR1;LRRK2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.29375638771713575,-0.8205536116674411,0.7449664429530202,0.9223593512583963,1.0,7/23,20.71%,GAS6;VSIR;HAVCR2;LAPTM5;NR1H4;INHBA;LGALS9
prerank,Golgi to lysosome transport (GO:0090160),-0.35779602266978683,-0.8205038446383233,0.707983193277311,0.9217484264810182,1.0,3/11,16.54%,SORT1;LAPTM5;EHD3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.34006726986031666,-0.820008862631462,0.6911447084233261,0.9219584754400425,1.0,5/14,24.15%,GAS6;CCDC3;CARD16;RFFL;NLRP2B
prerank,regulation of organelle organization (GO:0033043),0.26611533298357554,0.8198033745659462,0.751412429378531,0.9734612046205351,1.0,17/80,18.58%,SYT11;STX18;PRKN;CPLANE2;EZR;ARMH3;DIAPH1;DNM1L;MAVS;STX5;TBC1D25;CENPV;VPS35;SQSTM1;PAK2;RHOT1;AKAP9
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.35366560360129135,0.8192915846289666,0.6925734024179621,0.9738105131052592,1.0,4/18,9.55%,FRS2;BHLHE41;HDAC4;HDAC1
prerank,superoxide metabolic process (GO:0006801),0.3146338806396755,0.8186889209666645,0.7039586919104991,0.9743361503676101,1.0,6/29,10.41%,ALOX12;SOD3;NOX1;SOD2;SH3PXD2B;NOX4
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.28872780291816824,-0.818631241741047,0.7388392857142857,0.9236735543390083,1.0,12/25,26.21%,CACNB2;AKAP6;CEMIP;TRPC1;GPER1;SNCA;APLNR;NPSR1;THY1;F2R;CXCL10;PLCG1
prerank,ncRNA catabolic process (GO:0034661),0.3144951789900383,0.818483103383081,0.7,0.9741332423399517,1.0,8/28,20.85%,TUT4;EXOSC7;SND1;DIS3;TENT4B;DIS3L;EXOSC3;POP1
prerank,regulation of hemopoiesis (GO:1903706),0.3920905742028509,0.8182400625268565,0.6673076923076923,0.97397851892785,1.0,5/10,16.30%,PRKCB;IL17D;PURB;LGALS3;CREBBP
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.37854338219178596,0.8181266522331169,0.6765249537892791,0.9735814672834163,1.0,4/13,11.57%,FGFR1;APLN;PDPK1;ADAM17
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3837491497229899,0.8175937367938267,0.6876155268022182,0.9739756498572023,1.0,3/12,11.77%,RNF8;LARP7;NELFCD
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3377994622941729,-0.8170990721243337,0.7320675105485233,0.9257521573791373,1.0,8/14,36.50%,ELAVL4;TIRAP;YBX3;HNRNPA0;ELAVL1;MYD88;DAZL;ANGEL2
prerank,response to lipopolysaccharide (GO:0032496),-0.2080859998646668,-0.8168134308539621,0.9201680672268907,0.9255346436452773,1.0,26/138,18.10%,MEF2C;PDE4B;NOS3;SCARB1;TNFRSF11A;DAB2IP;FOXP1;GCH1;TNFRSF1B;IRAK3;ERBIN;RPS6KA3;SBNO2;TIRAP;VIM;NOS1;SNCA;CARD16;LBP;CX3CR1;PELI1;NOD2;CD180;TRIM41;PDCD4;CDC73
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.25751326144250564,-0.8165051521696158,0.7926509186351706,0.9253739550533093,1.0,17/42,26.40%,POLA1;POLD3;WRNIP1;FAAP20;PRIMPOL;UBB;RPA1;RFC4;POLD4;POLD1;RFC2;POLK;DTL;UBC;RPS27A;RFC5;PCLAF
prerank,positive regulation of protein catabolic process (GO:0045732),0.2672747811435667,0.8163991872783969,0.7859154929577464,0.975608280531773,1.0,24/84,17.97%,SH3D19;PRKN;ADRA2A;NEDD4;VGLL4;EZR;APC2;TIPARP;SMURF2;HUWE1;ATG7;RNF41;WWP2;CSNK2A1;FZR1;ASB5;STX5;NKD1;FAF1;NRDC;SNF8;VPS35;GPC3;WNT5A
prerank,regulation of intracellular transport (GO:0032386),0.3052960668517145,0.8162830438331622,0.7180327868852459,0.9752309232613178,1.0,8/38,15.85%,LRRK2;GAS1;MAP2;RAB11B;GRIPAP1;CRYAB;RBM4;SCFD1
prerank,positive regulation of cell cycle (GO:0045787),0.2743721896736839,0.8162217069841152,0.7522123893805309,0.974734898392161,1.0,9/62,12.32%,SMOC2;FGFR2;SPHK1;NUPR1;ANKRD17;CCND3;SRPK2;ADAM17;PRKCA
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.3508728373862481,0.8158461099720701,0.6716981132075471,0.9748185150664035,1.0,2/15,6.70%,UST;DSE
prerank,protein localization to condensed chromosome (GO:1903083),0.3800649375820024,0.8152410464448429,0.7023809523809523,0.975356856222756,1.0,5/12,24.74%,AURKB;IK;CHAMP1;MIS12;SPDL1
prerank,positive regulation of cellular respiration (GO:1901857),0.38278405758134704,0.8149250766504935,0.6598890942698706,0.9753663329043518,1.0,1/11,2.92%,NUPR1
prerank,negative regulation of complement activation (GO:0045916),-0.3683862704679922,-0.8144860541574953,0.69375,0.9283085672027749,1.0,4/10,31.88%,SUSD4;A2M;SERPING1;CR1L
prerank,pre-miRNA processing (GO:0031054),0.3617970536110799,0.814088309459588,0.6706827309236948,0.976288538255822,1.0,7/14,28.23%,TUT4;DICER1;TUT7;AGO1;AGO4;AGO2;ADAR
prerank,regulation of centrosome cycle (GO:0046605),0.33341014533935387,0.8140318959743386,0.703770197486535,0.9757940081292417,1.0,6/21,20.40%,PKHD1;SIRT1;CHMP1A;CHMP4C;XRCC3;CHMP2A
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3889234092279188,0.8134016850918299,0.6815533980582524,0.9758051409677214,1.0,3/10,16.87%,ASCC2;MGMT;ALKBH5
prerank,DNA dealkylation (GO:0035510),0.3889234092279188,0.8134016850918299,0.6815533980582524,0.9758051409677214,1.0,3/10,16.87%,ASCC2;MGMT;ALKBH5
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2455904220237962,-0.8132860371637778,0.8074712643678161,0.9297785767088448,1.0,30/51,41.95%,STAT3;APP;EGR1;AIM2;USP50;NOD2;PANX1;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;TMED10;JAK2;TRIM16;P2RX7;CD36;MALT1;TLR8;MYD88;TMEM106A;GBP5;ISL1;CASP8;INAVA;TNF;NLRP12;LPL;GSDMD;IL6
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2276008170127588,-0.812675765863299,0.8466898954703833,0.9301319558515088,1.0,22/83,24.88%,CDK14;CDK17;USP29;POLA1;PLK2;BACH1;CUL3;E2F3;CDKN1A;ACVR1;KLF11;EIF4E;PIM2;CDC45;NPAT;INHBA;PHF8;CDK18;PLK3;CDKN3;CCNE2;HINFP
prerank,positive regulation of defense response (GO:0031349),0.2622996621653906,0.8120430055722467,0.7625178826895566,0.9777712158854241,1.0,11/89,9.72%,IL18;NAPEPLD;TLR3;TLR4;IFNK;IL12B;SERPINE1;PLSCR1;GPRC5B;IL17RA;RIPK1
prerank,morphogenesis of an epithelium (GO:0002009),-0.28998703931584013,-0.8118776384721891,0.7585421412300684,0.9308734095686365,1.0,10/25,23.24%,ACTB;ACTG1;TBX18;LAMA3;AHI1;SOX8;VCL;LRP6;LHX1;SOX10
prerank,nuclear membrane organization (GO:0071763),-0.3116843961391799,-0.8116383632422964,0.7555066079295154,0.9306007336006219,1.0,5/19,18.56%,GPER1;TMEM43;EMD;CHMP4B;SPAST
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3548208071292752,0.8115141862059299,0.6841121495327103,0.9781754558651059,1.0,5/15,20.24%,EME2;ATF2;HUS1;FANCD2;RAD9A
prerank,regulation of translation (GO:0006417),-0.2014665971025366,-0.8111196468945067,0.949238578680203,0.9308787724253809,1.0,42/173,21.60%,GRM5;PRR16;THBS1;NIBAN1;YBX1;RPL26;APP;RPS3;SYNCRIP;RPL5;CALR;ERBB2;RPS6KA3;FXR1;EIF4ENIF1;RPS4X;DAPK1;VIM;SHFL;MALSU1;EIF3B;RPS6KA1;MTG2;GLE1;EIF1;METTL3;EIF2AK3;BCL3;DHX9;EIF4E;RPL13A;HSPB1;PUM3;RPS27L;EEF2;RBM4B;BTG2;RBM3;EIF4A3;EIF3D;CNOT7;NPM1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.24588534624453084,0.8108523633652326,0.8192934782608695,0.9787943496765977,1.0,17/144,9.99%,SMAD3;TFDP2;LEPROT;BID;RAPGEF3;RUFY3;FZD5;CAMK1;TP53;BCAS3;HUWE1;ZIC1;TFDP1;NPEPPS;UBR5;MAVS;TCF7L2
prerank,sphingoid metabolic process (GO:0046519),0.3825256383354923,0.8106793430634782,0.6994328922495274,0.9785259437669088,1.0,2/12,5.14%,SPHK1;NAAA
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3730097599097665,0.809987588613444,0.6900584795321637,0.9792230795210757,1.0,5/12,19.92%,IDH1;ACO2;SIRT4;IDH2;ACLY
prerank,regulation of lipid kinase activity (GO:0043550),0.3775091354746048,0.8099415981099111,0.684981684981685,0.9786961934503551,1.0,7/11,19.96%,F2;RBL2;RBL1;PIK3R3;RB1;WDR91;WDR81
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3139554327587335,0.8096351592308219,0.725,0.9786687520059509,1.0,4/31,9.41%,TFDP2;BID;TP53;TFDP1
prerank,positive regulation of protein metabolic process (GO:0051247),0.2555649910240821,0.8089606939648813,0.793800539083558,0.9793728835578212,1.0,19/110,12.52%,ROCK2;PRKN;IL18;NEDD4;SLC6A9;IL17D;MAP2K5;APC2;TIPARP;IL12B;SMURF2;LDB1;HUWE1;ATG7;RNF41;WWP2;CSNK2A1;FZR1;ASB5
prerank,regulation of sensory perception of pain (GO:0051930),-0.34977263043887696,-0.808826085030732,0.7278617710583153,0.9341594664289723,1.0,3/11,7.17%,CCN3;MGLL;TMEM100
prerank,protein alkylation (GO:0008213),-0.29310137971596106,-0.8083396750226268,0.7699316628701595,0.9343469478526059,1.0,11/22,35.22%,LCMT1;FAM98B;METTL22;SNRPD3;SNRPB;PRMT8;PRMT1;PRMT3;ETFBKMT;EEF1AKMT2;FAM98A
prerank,L-serine metabolic process (GO:0006563),0.3907080253015497,0.8081548913253881,0.6787762906309751,0.980214451289862,1.0,3/10,21.91%,SRR;PHGDH;CBS
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.2885092792389939,0.8080232225647381,0.7577639751552795,0.9798438399469952,1.0,8/52,11.38%,CELF2;DDX5;MBNL2;RBM15;NOVA1;THRAP3;SAP18;HNRNPL
prerank,purine-containing compound catabolic process (GO:0072523),0.36718609328042545,0.8079778085373278,0.6946983546617916,0.9793259803288149,1.0,3/13,10.01%,DPYD;NT5C1B;NT5C2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.333973382151335,0.8077471339829119,0.7332185886402753,0.9791207332399366,1.0,2/23,4.32%,ALOX12;ACSBG2
prerank,cellular senescence (GO:0090398),-0.29043567900339406,-0.8076017272280861,0.7304785894206549,0.9349341078493146,1.0,6/27,12.53%,TBX3;SMC5;CALR;ECRG4;ID2;CDKN1A
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3134806047348687,0.8074908423644831,0.7065767284991569,0.9789718845173028,1.0,4/28,9.78%,SMAD3;ZIC1;UBR5;MAVS
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.34676959360823456,0.8072854117531865,0.6924460431654677,0.9787575616426126,1.0,3/17,6.47%,IL18;TLR4;IL12B
prerank,translational termination (GO:0006415),0.25587108152660193,0.8063036831515548,0.7948369565217391,0.979983526147812,1.0,29/95,25.76%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;ETF1;GSPT2;MRPS26;MTRF1L;MRPL48;MRPL1;GFM2;MTRF1;MRPL45;MRPS17;CHCHD1;N6AMT1;MRPL14;MRPL32;MRPL23;MRPS34;PTCD3;GSPT1;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.3304111898328029,-0.8062355964521191,0.7118279569892473,0.9365431543069249,1.0,6/14,24.44%,PNPT1;TFAM;SLC25A33;TEFM;TFB1M;FASTKD5
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3010331822584884,0.8061933748275354,0.7411003236245954,0.9795768785213302,1.0,6/38,14.42%,RORA;SIRT1;TLE1;RIPK1;MAPKBP1;PPM1B
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3648994410401302,0.8055603424954576,0.7188679245283018,0.980163320933454,1.0,1/14,1.76%,PPARA
prerank,response to X-ray (GO:0010165),0.3659609602978712,0.8051289673488952,0.6974459724950884,0.9803501049716727,1.0,3/14,8.68%,ATM;NIPBL;XRCC4
prerank,P-body assembly (GO:0033962),0.3790448934230687,0.8048897671034502,0.7019230769230769,0.9801730806815055,1.0,3/12,12.03%,ATXN2;LSM14A;DDX6
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.35141391206571804,0.8048843315493197,0.7197802197802198,0.9795794014146794,1.0,1/17,0.64%,ROCK2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3602973682976156,-0.8048444099438872,0.7211538461538461,0.9381961810710887,1.0,5/10,32.38%,CALM1;CALM3;DRD2;CRHR1;DRD3
prerank,negative regulation of telomere maintenance (GO:0032205),0.34969829959907006,0.8046765720431085,0.6855983772819473,0.9793680075656125,1.0,8/15,26.38%,ATM;TNKS2;RAD50;NBN;SLX4;SMG6;PINX1;RTEL1
prerank,cell junction maintenance (GO:0034331),0.35712931009468846,0.804378970839822,0.7134831460674157,0.9792869499089212,1.0,1/14,2.47%,NLGN2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3560129833454459,-0.8035722487241904,0.7303149606299213,0.938224702038603,1.0,4/10,22.82%,ERCC1;TERF1;DNA2;BLM
prerank,t-circle formation (GO:0090656),-0.3560129833454459,-0.8035722487241904,0.7303149606299213,0.938224702038603,1.0,4/10,22.82%,ERCC1;TERF1;DNA2;BLM
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3560129833454459,-0.8035722487241904,0.7303149606299213,0.938224702038603,1.0,4/10,22.82%,ERCC1;TERF1;DNA2;BLM
prerank,negative regulation of innate immune response (GO:0045824),0.30569692149847427,0.8032121711616168,0.7265238879736409,0.9808816781749297,1.0,9/34,13.93%,STAT2;SAMHD1;FAM3A;YTHDF3;DHX58;NMI;OAS3;ACOD1;USP18
prerank,regulation of myotube differentiation (GO:0010830),0.3285176248014429,0.8030098740948293,0.7160068846815835,0.9806686857414522,1.0,7/24,11.30%,DMPK;SIK1;BHLHE41;HDAC4;HDAC1;FBXO22;MMP14
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.2522320341479305,-0.8029345023330009,0.7937853107344632,0.9385581264409193,1.0,14/47,20.71%,EPHB1;MID1;TGFB2;DAB2IP;PPIA;PHLPP1;FOXO1;RAP2A;FAS;SEMA4C;NOD2;KLHDC10;COPS5;LGALS9
prerank,positive regulation of endocytosis (GO:0045807),0.29246775768017425,0.8029186125639504,0.716323296354992,0.9802259295732418,1.0,2/45,0.68%,DAB2;APPL2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.283444080369686,-0.802766402129338,0.779126213592233,0.9381152798196548,1.0,9/29,23.18%,SMAD7;RPS2;ARRDC4;AXIN1;PINK1;DCUN1D3;BAG5;TRIB3;ARRDC3
prerank,peptidyl-asparagine modification (GO:0018196),0.3067052641037341,0.802683093754156,0.7249134948096886,0.9800574476189878,1.0,6/31,15.71%,ST6GAL1;ASGR1;FUT8;MAGT1;ASGR2;HIF1AN
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.3726525982020001,0.802643340012156,0.6981481481481482,0.9795232421659072,1.0,5/12,22.88%,LHPP;ADSS1;GART;ADSL;GMPS
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.34269790279463574,-0.8026393459169144,0.7245508982035929,0.9376221127631152,1.0,2/11,7.84%,RUNX1;VSIR
prerank,defense response to Gram-negative bacterium (GO:0050829),0.2933848937262197,0.802608651361534,0.7553017944535073,0.9789932447382147,1.0,9/42,17.10%,TLR4;DEFB1;F2;IL12B;SERPINE1;IRGM;CAMP;DMBT1;OPTN
prerank,regulation of neurogenesis (GO:0050767),-0.24144867350268198,-0.8024816230518805,0.8059701492537313,0.9371949686177177,1.0,11/55,12.06%,B2M;NOTCH1;HES1;SERPINF1;SORL1;HEYL;MME;HEY2;NAP1L1;GPER1;CTNNB1
prerank,protein mannosylation (GO:0035268),0.32517584433567953,0.8019725541524426,0.7041742286751361,0.9795591590957299,1.0,5/22,12.41%,TMTC4;LARGE1;DPY19L3;TMTC1;LARGE2
prerank,protein-containing complex assembly (GO:0065003),0.2297051388132214,0.8018652971133199,0.8954171562867215,0.979158044504895,1.0,74/259,22.95%,AFDN;PPARGC1A;PICALM;KMT2A;LAMC1;PLEKHA7;MCU;MITF;CAND2;LRRK2;SAMM50;TP53;TRAPPC9;SH3PXD2B;OPA1;ANO6;SMARCA4;TERT;WDR19;DNM1L;TEAD2;CSNK1A1;WASL;TCF7;TLE1;HDAC1;RIPK1;ASH2L;TCF7L2;VIL1;TEAD1;AXIN2;FANCA;TGFA;KMT2D;PARD3;PML;TLE2;STX5;SEC23IP;F8;PEX14;DNAJB14;SCFD1;CREBBP;TRAPPC5;PPP6R3;TCF7L1;RANBP9;HFE;ZNHIT6;TNFRSF1A;SEC31A;BET1;GOLGA2;YAP1;ITGB1BP1;FOLR1;AFG3L2;PYGO2;TUBGCP4;GPAA1;SEC24C;DBNL;RUVBL1;CD247;CLDN1;SEC24A;EP300;GORASP1;BOK;SNX9;F5;BCL9
prerank,regulation of cytokinesis (GO:0032465),0.26328397838343665,0.8018049319966349,0.8065476190476191,0.9786741387076519,1.0,18/78,17.99%,PKP4;UVRAG;PLK5;CDC14A;MYO19;BECN1;AURKB;CDC14B;CDC42;FLCN;ZFYVE26;BIRC6;VPS4A;CHMP4C;CENPV;KIF13A;MAP9;PKN2
prerank,regulation of pH (GO:0006885),0.3850271159992214,0.8017612496319392,0.7013487475915221,0.9781548184862473,1.0,1/11,2.05%,LACC1
prerank,positive regulation of histone acetylation (GO:0035066),0.33079040903503515,0.801543065279822,0.6924398625429553,0.9779706324418208,1.0,6/23,16.98%,PPARGC1A;ARRB1;BRD7;KAT7;SPHK2;SMAD4
prerank,negative regulation of secretion (GO:0051048),0.38112765198067355,0.8015039226411952,0.69140625,0.977431745065094,1.0,4/10,22.37%,NRG1;SPX;NR1H3;VAMP8
prerank,DNA packaging (GO:0006323),0.35029397288676334,0.8014709083347147,0.7064056939501779,0.9768905719956358,1.0,7/16,27.75%,CHAF1B;TP53;CDAN1;NOC2L;H1-0;M1AP;RBBP4
prerank,cellular response to UV-A (GO:0071492),-0.35058551086268663,-0.8009804423252106,0.7336065573770492,0.939076990133111,1.0,7/11,45.74%,MME;MMP1;MMP3;PPID;MMP2;OPN5;MMP9
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.352017032361202,0.8007833237399659,0.6943942133815552,0.9774942127500187,1.0,3/16,10.93%,WNT4;F2;SUCO
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.3633797852332219,-0.8006888477461707,0.7191235059760956,0.9388608361512523,1.0,4/10,20.04%,PTH1R;SNCA;IRS2;IRS1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.27655425207275464,-0.8005758437499129,0.7677261613691931,0.9383471457067896,1.0,5/29,10.70%,GHR;STAT3;SOCS2;STAT5B;PKD1
prerank,positive regulation of receptor internalization (GO:0002092),0.3184562640298383,0.8004452086746796,0.6958041958041958,0.9775298029795125,1.0,4/22,9.69%,MAGI2;ARRB1;APLN;PICK1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.35954365073371153,0.8003238043699986,0.7065420560747664,0.9771542414559905,1.0,4/15,9.99%,RAPGEF3;CAMK1;TP53;TCF7L2
prerank,regulation of defense response (GO:0031347),-0.22575043077062643,-0.8002302271094787,0.867595818815331,0.9382215530330418,1.0,15/76,13.06%,IL1R1;TMSB4X;SEMA7A;MGLL;ANXA1;FOXP1;APOE;PTGES;AGTR1;PTGS2;PIK3AP1;SBNO2;TIRAP;ACE2;LRP8
prerank,reticulophagy (GO:0061709),-0.34036251098022585,-0.7997583029608777,0.7294589178356713,0.938301563057074,1.0,4/12,9.99%,ULK1;ULK2;DDRGK1;UFM1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.30068023354782636,0.799757692110452,0.7271268057784912,0.977582044011091,1.0,3/36,3.46%,TPD52L1;DEPTOR;TGFBR1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2959889051792026,0.7997210944079672,0.7234726688102894,0.9770559427087318,1.0,6/40,11.47%,ATRX;DONSON;FBH1;FANCM;EME2;MSH3
prerank,spermatid development (GO:0007286),0.30795435363358964,0.7996652842156344,0.7201309328968903,0.9765504438328594,1.0,9/32,25.14%,TOPAZ1;RNF8;MKKS;ACRBP;RFX2;CEP57;NECTIN2;TTC21A;ING2
prerank,defense response to protozoan (GO:0042832),0.3776050874204654,0.7990684679001261,0.7180451127819549,0.9770265280290784,1.0,3/12,13.87%,GBP7;GBP2;GBP6
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3394071634113644,0.7986110771798047,0.7153284671532847,0.9772692528493702,1.0,10/18,30.07%,COX16;SMIM20;COX19;FASTKD3;TIMM21;COA5;SCO1;COX14;PET100;SURF1
prerank,negative regulation of reproductive process (GO:2000242),0.34726158343732305,0.7981821241002921,0.6980108499095841,0.977460700954422,1.0,1/17,1.44%,IGF1
prerank,inositol lipid-mediated signaling (GO:0048017),0.28184478020093445,0.7975405690039771,0.7928348909657321,0.9779863108085936,1.0,9/50,9.26%,IGF1;PI4KA;FGFR1;EZR;PLCD3;PDGFRB;GAB2;PIK3CA;PLCD1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3079879351981948,0.7973848323032955,0.7285464098073555,0.9776567809154957,1.0,3/30,6.29%,ST6GAL1;ASGR1;FUT8
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3420139246060258,-0.7970446232271168,0.735357917570499,0.9421696495640415,1.0,3/12,15.36%,ABCC9;KCNJ8;CACNA1H
prerank,protein heterotetramerization (GO:0051290),-0.33912198239999136,-0.7970042120465993,0.7404426559356136,0.9415354397879437,1.0,3/13,15.27%,GRIN2B;PKD1;GRIN1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.26550411564113613,-0.7970017184985506,0.804177545691906,0.9408404569874873,1.0,9/35,19.95%,STAT3;LYN;STAT5B;HIF1A;TAL1;ZFPM1;INHBA;FAM210B;MAFB
prerank,autophagy of nucleus (GO:0044804),0.3511734056194974,0.7969225911679452,0.7085610200364298,0.9778856636047356,1.0,8/16,26.10%,ATG5;WIPI1;ATG7;ATG2A;ATG2B;ATG12;ATG3;ATG9B
prerank,regulation of DNA binding (GO:0051101),0.2888825542875649,0.7968599203771873,0.753968253968254,0.9774116240779248,1.0,4/44,4.94%,IGF1;PRKN;FOXC1;SMO
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2097243080589933,-0.7966934537620693,0.9288702928870293,0.9406217433982877,1.0,41/121,29.90%,PRR5L;PSMB2;YWHAB;HSPA8;XPO1;PSMD14;PNPT1;ANP32A;PSMC6;FXR1;VIM;UBB;PSMA4;PSMB9;ZC3H14;PABPC1;HSPB1;PSMD11;PSMB10;PSMD2;YTHDF2;DCP2;CNOT7;PSMA2;EXOSC4;UBC;RPS27A;EXOSC1;PSMB3;SET;RBM24;PSMB5;ELAVL1;YWHAZ;YTHDF1;PSMA7;RC3H2;HNRNPD;PSMF1;PSMD7;APEX1
prerank,activation of GTPase activity (GO:0090630),0.26133170272204753,0.7961256049493203,0.8016643550624133,0.9781328642735861,1.0,13/89,11.11%,ARHGAP29;SIPA1L1;ARHGEF16;SYDE2;NGEF;TBC1D16;GMIP;APC2;BCAS3;GRTP1;DOCK7;RALGAPB;MTSS2
prerank,cellular response to gamma radiation (GO:0071480),0.3476544503602509,0.7960781361294091,0.7190388170055453,0.9776090389807611,1.0,6/17,19.10%,ATM;TP53;CRYAB;TLK2;KDM1A;YAP1
prerank,protein deneddylation (GO:0000338),-0.35910057516925237,-0.7960054684144149,0.7595744680851064,0.9410757650346943,1.0,4/10,27.77%,COPS4;COPS6;COPS5;COPS2
prerank,telomere maintenance via telomerase (GO:0007004),-0.2743884018638088,-0.7957585203060057,0.7736720554272517,0.9408137773558022,1.0,9/28,20.20%,HSP90AB1;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;RPA1;ANKRD28;NHP2;PTGES3
prerank,phagolysosome assembly (GO:0001845),0.36558210766250854,0.7952755491510778,0.7057692307692308,0.9784407322533843,1.0,5/12,21.79%,RAB34;PIKFYVE;RAB7B;PLA2G5;RAB7A
prerank,negative regulation of protein binding (GO:0032091),0.2639871322793628,0.7949806949234807,0.7922272047832586,0.978367543035502,1.0,19/71,19.18%,DAB2;IFIT1;IFIT2;LRRK2;MAP2;CAMK1;GTF2F1;AURKB;TMC8;STYX;DNAJB2;EFHB;PEX14;TFIP11;KDM1A;HFE;GOLGA2;USP33;ITGB1BP1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.38152582129602897,0.794966553683733,0.6601941747572816,0.9778048981385287,1.0,3/10,20.36%,RHO;SAG;PDE6B
prerank,positive regulation of ATPase activity (GO:0032781),0.28625551297003937,0.7947710656679061,0.7476635514018691,0.9775440552433194,1.0,7/41,13.95%,ATP1B3;TPM1;PLSCR1;MYL4;SSBP1;MSH3;DNAJB2
prerank,peptidyl-serine modification (GO:0018209),0.2373702043806701,0.7944846820959208,0.863517060367454,0.9774814371699009,1.0,27/166,13.22%,ROCK2;PRKCZ;STK32B;TGFBR1;DMPK;LRRK2;SMG1;PRKCB;IKBKE;ATM;CAMK1;RICTOR;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;MKNK1;BRSK1;SRPK2;DYRK1A;PRKDC;CSNK2A2;CSNK2A1;PRKCA;HIPK3;PRKCI;WNK1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3235046876320169,0.7940748090947615,0.7392086330935251,0.9776318092280424,1.0,4/22,11.53%,FZD5;IL12B;CYRIB;ZBTB1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.3628095683116044,0.7940331588735096,0.7026515151515151,0.9771122479299393,1.0,4/14,15.21%,TGFBR1;PTPN11;RFLNA;ADAMTS7
prerank,histone H4 acetylation (GO:0043967),0.28365230972251976,0.79369708257426,0.7576687116564417,0.9771412260230945,1.0,7/47,13.91%,BRD8;KMT2A;ZZZ3;ATF2;KAT7;BEND3;OGT
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2643851513326087,0.7935412080854273,0.7922848664688428,0.9768014377103446,1.0,16/78,17.75%,CCNA2;NR2F2;CCNA1;CCNT2;PTEN;CCND3;CDK5RAP3;CDC25A;GTPBP4;CCNB2;ADAM17;GADD45A;CCNG1;CCNE1;CNPPD1;HEXIM2
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.27348767062922497,-0.7932791597367541,0.7922705314009661,0.9442113706699419,1.0,8/28,22.80%,NOTCH3;BEND6;GATA2;LFNG;METTL3;DLL4;YTHDF2;TSPAN15
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3029328532506034,0.79316325183175,0.7542662116040956,0.9768856996505534,1.0,8/31,20.17%,CYP21A2;FDXR;DHRS11;MOCOS;SRD5A2;NFS1;LIAS;MOCS1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.32563878720250694,0.7928245469031624,0.7228915662650602,0.9769449208541003,1.0,3/22,8.32%,DDX5;ATM;CDK5RAP3
prerank,amide biosynthetic process (GO:0043604),-0.24623445466118032,-0.7927829261010132,0.8074712643678161,0.9443605397662476,1.0,20/47,29.48%,SGMS1;SGMS2;SPTLC2;DEGS2;PAM;PCSK5;CERS4;ASAH2;SPTSSB;ASAH1;PCSK1;DMD;CLN8;TLCD3B;NANP;SPTLC3;ASS1;SPTLC1;NMRAL1;CERS2
prerank,mitotic DNA replication (GO:1902969),-0.35407945660917695,-0.7924036867241896,0.7334630350194552,0.9442526695015308,1.0,1/10,2.33%,POLA1
prerank,actin filament depolymerization (GO:0030042),-0.34346767616426155,-0.7920126696795139,0.7477477477477478,0.9441945532721877,1.0,4/11,13.37%,GSN;MICAL2;WDR1;CFL1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3343213873610669,0.7915648898951378,0.7319778188539742,0.9785841402170216,1.0,4/21,13.42%,BACE2;DAG1;ADAM17;ERAP1
prerank,ether lipid metabolic process (GO:0046485),-0.3270856210559534,-0.7912022719934334,0.7567567567567568,0.9448310990660196,1.0,5/14,24.50%,AGPS;NCEH1;LIPE;GNPAT;DHRS7B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2727043989038301,-0.7906961173572877,0.7942583732057417,0.9449235554364876,1.0,1/29,0.39%,CADM1
prerank,selective autophagy (GO:0061912),0.27378725658857445,0.7906184837958977,0.7757575757575758,0.9796716477492127,1.0,16/56,19.96%,PRKN;RETREG1;ATM;ATG5;AMBRA1;BECN1;IFT88;ATG2A;ACBD5;TEX264;PEX5;DYNC1LI1;SQSTM1;PCNT;UBA5;WDR81
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.30856466987978287,0.7898425989794302,0.7302405498281787,0.9804950109638161,1.0,5/27,7.55%,KIT;EPHA8;FLT1;PDGFRB;AMBRA1
prerank,nucleus organization (GO:0006997),-0.24235579395431667,-0.789673530454362,0.8186528497409327,0.9458971369002752,1.0,6/47,12.31%,SYNE1;RPS19;BIN1;PITPNB;PDCD6IP;LEMD3
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3251958468849386,0.7896133436952021,0.750445632798574,0.9803239562413217,1.0,3/22,7.94%,APPL2;LRRK2;KDM2B
prerank,negative regulation of organelle assembly (GO:1902116),-0.2624968443058294,-0.7895275770148337,0.8203753351206434,0.9454471136061722,1.0,11/35,19.43%,TBC1D30;LIMK2;FEZ1;CDK5RAP2;TMEM39A;PINK1;FEZ2;TRIM37;CHMP4B;CHMP4A;ODF2L
prerank,bone morphogenesis (GO:0060349),0.35202651275121144,0.7891891065830916,0.710091743119266,0.9805052524448187,1.0,2/14,4.66%,FGFR2;CYP26B1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.35228666870004516,-0.7889788770620516,0.75,0.9456267452918439,1.0,3/10,16.19%,PODXL;PIEZO1;SKAP1
prerank,positive regulation of myelination (GO:0031643),-0.3479802224764528,-0.7889381840395185,0.734020618556701,0.9449918555070562,1.0,2/11,7.20%,TENM4;TNFRSF1B
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.36158905183428036,0.7884913137213408,0.7214022140221402,0.9811561534079044,1.0,3/13,11.77%,RNF8;LARP7;NELFCD
prerank,response to interferon-gamma (GO:0034341),-0.23010520603381981,-0.7882272581818909,0.8918918918918919,0.9454887179282451,1.0,21/67,26.52%,GCH1;AQP4;SYNCRIP;CXCL16;CD47;GBP4;IFITM3;DAPK1;SHFL;SNCA;CD74;CCL13;RPL13A;IRF8;CCL19;LGALS9;IFITM1;IFITM2;CD40;GAPDH;CCL2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.20234214357661845,-0.7881138664022915,0.9552845528455285,0.9449644251608436,1.0,39/132,25.53%,CELF4;HSP90AB1;RPL3;RPL38;RPS19;RPS28;RPLP0;RPS15;RPL5;RPL23A;HSP90AA1;RPS27;XRCC5;SART1;RPS5;RPL6;CLNS1A;MDN1;NOP53;RPSA;DHX9;SNRPF;BRIX1;CDC73;COIL;RPS27L;MRPL20;PTGES3;RPL24;RPL11;SNRPD3;LSM4;RSL24D1;PUF60;ABT1;SRSF6;SNRPB;RRS1;WDR77
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.36023589257229793,0.7879446574371675,0.7130281690140845,0.9815613953039469,1.0,3/15,9.00%,TLR4;IL17D;IL17RA
prerank,endocytic recycling (GO:0032456),0.2811645450020063,0.787607062856422,0.7738853503184714,0.981569041303307,1.0,15/50,18.46%,PTPN23;VPS26C;EIPR1;RAB11B;RAB13;VPS50;ANKRD27;SNX12;MICALL1;SNF8;VPS51;VPS35;VPS35L;CCDC93;CCDC22
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3055043508898855,0.7875358924625516,0.7591973244147158,0.9805160479009801,1.0,5/31,13.79%,POLR2A;POLR2D;GTF2F1;CMTR2;RAMAC
prerank,7-methylguanosine RNA capping (GO:0009452),0.3055043508898855,0.7875358924625516,0.7591973244147158,0.9805160479009801,1.0,5/31,13.79%,POLR2A;POLR2D;GTF2F1;CMTR2;RAMAC
prerank,response to cAMP (GO:0051591),0.29574101480985027,0.7873518484929263,0.7715231788079471,0.9802333474982942,1.0,4/37,5.60%,SLC5A5;RAPGEF3;EZR;SLC26A3
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.3241161365134058,0.7871232824739542,0.7132216014897579,0.9800523284674996,1.0,4/22,7.34%,CD300A;EZR;GPS2;PTPN22
prerank,regulation of intracellular protein transport (GO:0033157),0.2994049128220181,0.78639821824867,0.7408637873754153,0.9806714249777216,1.0,4/32,6.71%,PTPN14;IFI27;RUFY3;BCAS3
prerank,positive regulation of protein import (GO:1904591),0.3034269731307914,0.7857516787485177,0.7658862876254181,0.9811678549416692,1.0,4/30,9.78%,SMAD3;ZIC1;UBR5;MAVS
prerank,telomere organization (GO:0032200),0.2845576738528787,0.7856214138867412,0.7600644122383253,0.9807952005643409,1.0,12/43,18.94%,POLD2;ATM;ACD;TERT;PRKDC;HUS1;RAD50;DOT1L;SP100;TINF2;NBN;RAD51D
prerank,outer dynein arm assembly (GO:0036158),0.3521522822756156,0.7855176060542217,0.7210626185958254,0.980387950846631,1.0,1/15,2.99%,ODAD1
prerank,regulation of fibroblast proliferation (GO:0048145),0.2851919484348423,0.785379588740118,0.7779503105590062,0.9800431893950269,1.0,5/45,6.50%,IGF1;SPHK1;CD300A;PARP10;TP53
prerank,peptidyl-arginine modification (GO:0018195),0.34236213322584896,0.7851365977389629,0.7305605786618445,0.9798853081145665,1.0,4/15,17.45%,ART5;ART4;NDUFAF5;PADI4
prerank,response to UV-A (GO:0070141),-0.324271208457654,-0.7846764441037678,0.7553191489361702,0.9497456624969065,1.0,8/14,45.74%,MME;MMP1;CCND1;MMP3;PPID;MMP2;OPN5;MMP9
prerank,protein K63-linked deubiquitination (GO:0070536),-0.26479596467180977,-0.7838352253944464,0.7774936061381074,0.9503980876238481,1.0,8/31,19.26%,OTUD7A;OTUD7B;USP13;PSMD14;YOD1;USP50;USP8;SPATA2
prerank,cholesterol biosynthetic process (GO:0006695),-0.2621119895364485,-0.7831186246097327,0.8058968058968059,0.9508582535921083,1.0,15/31,27.66%,HMGCS1;IDI1;SC5D;PMVK;LSS;SQLE;DHCR7;DHCR24;CYP51A1;MSMO1;ACAT2;EBP;HMGCR;FDPS;HSD17B7
prerank,bile acid biosynthetic process (GO:0006699),0.3120607214745381,0.7826937025370202,0.7298747763864043,0.9834524728812133,1.0,3/24,5.91%,CYP27A1;AMACR;OSBPL9
prerank,nucleotide-sugar metabolic process (GO:0009225),0.363259579987893,0.7826271001560688,0.7287128712871287,0.9829838653508567,1.0,2/12,6.29%,GMDS;FUT8
prerank,positive regulation of T cell migration (GO:2000406),0.32745532854439297,0.7824631211982559,0.7340619307832422,0.982677324432465,1.0,5/20,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,regulation of chromosome organization (GO:0033044),0.3204037831954138,0.7809841763244842,0.7486818980667839,0.9846080249721123,1.0,8/22,22.90%,HDAC8;SMG1;WAPL;RB1;CENPV;LIG4;YLPM1;SMG6
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2654248401760061,0.7809490007804414,0.8229317851959361,0.9840789297167852,1.0,1/74,0.14%,EPAS1
prerank,dendritic cell migration (GO:0036336),-0.3092540791901097,-0.780496603607948,0.7533039647577092,0.9542380966593398,1.0,4/16,23.09%,EPS8;TRPM2;CCL19;CXCR4
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.27966908454155137,-0.7801005712530812,0.8046511627906977,0.9541981172410907,1.0,13/23,31.92%,SLIT2;MPP1;TIRAP;CD74;DAPK2;CCL19;MDK;THBS4;MOSPD2;JAM3;BST1;C5AR2;RAC2
prerank,peptidyl-tyrosine modification (GO:0018212),0.2753043667873439,0.78009361560806,0.7869362363919129,0.9849242667715072,1.0,11/56,13.10%,KIT;FGFR2;EPHA4;FGFR1;FLT1;PDGFRB;FER;ABL1;DYRK1A;TPST1;EPHA3
prerank,protein prenylation (GO:0018342),0.37557102616220317,0.7799716119786918,0.7401433691756273,0.984550451919923,1.0,4/10,16.77%,RABGGTA;RCE1;FNTB;FNTA
prerank,phagosome maturation (GO:0090382),0.2925328413227825,0.7798570006340874,0.7777777777777778,0.9841656605413422,1.0,7/35,11.08%,ATP6V0E1;RAB34;ATP6V0B;PIKFYVE;RAB43;ATP6V1D;ATP6V1E1
prerank,keratan sulfate metabolic process (GO:0042339),0.29818480489516785,0.7796894976905641,0.7632027257240205,0.9838806251644789,1.0,4/31,5.97%,OGN;ST3GAL3;FMOD;B4GALT1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.1924734837041076,-0.7796585142294938,0.9761904761904762,0.9542010454998154,1.0,62/185,27.70%,HECW2;YWHAE;PSMB2;DYNLL1;PPP2R1A;YWHAG;CUL3;ANLN;PSMD14;TUBA1A;HAUS2;PSMC6;ID2;TUBB4A;CDK5RAP2;HSP90AA1;KCNH5;PKD1;PRKAR2B;BUB3;UBB;HAUS5;PSMA4;PSMB9;CEP78;CENPE;CDC23;SKP1;CETN2;RGCC;PSMD11;SIRT2;PSMB10;TUBA4A;SSNA1;PSMD2;ERCC2;NEK6;MAD2L1;CEP131;PSMA2;CCP110;HMMR;TFAP4;TPX2;UBC;RPS27A;KIF14;KNTC1;NEDD1;HAUS4;CEP135;PSMB3;ACTR1A;NDE1;HAUS6;CEP76;PSMB5;UBE2D1;DDB1;PSMA7;CENPF
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.22850990725577286,0.7796092641653046,0.9108910891089109,0.9834208313759127,1.0,20/208,9.78%,RORA;WLS;LPAR1;PRKN;CFLAR;AKAP13;CXXC5;ZFAND6;PRKCB;IKBKE;ANKRD17;LGALS1;GPRC5B;PDPK1;TAB2;SIRT1;TLE1;RIPK2;RIPK1;MAVS
prerank,dorsal/ventral pattern formation (GO:0009953),-0.29358374980433916,-0.779295709986552,0.7699115044247787,0.9540537202263035,1.0,6/20,13.95%,ACVRL1;DSCAML1;PTCH1;AIDA;ACVR1;BMPR1B
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.21720292889810802,-0.7792704181082124,0.9262820512820513,0.9533939625907466,1.0,30/72,31.81%,POLD3;AQR;ERCC1;ERCC6;POLR2J;UBB;RPA1;COPS4;GTF2H1;COPS6;GTF2H4;GTF2H5;RFC4;COPS5;ERCC2;POLD4;POLD1;RFC2;POLR2C;POLR2L;POLK;UBC;RPS27A;RFC5;DDB1;COPS2;RPA3;ERCC3;XAB2;RPA2
prerank,cellular copper ion homeostasis (GO:0006878),-0.3182803744088305,-0.7784594195538805,0.7668845315904139,0.9539851509445264,1.0,3/14,12.87%,APP;ATOX1;SLC31A1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3146221695000563,-0.778187268213724,0.7554585152838428,0.9536806238540261,1.0,5/15,13.46%,DACT1;SMAD7;FKBP1A;LEMD3;ACVR1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2698739646599614,-0.7781709911667188,0.7875894988066826,0.9530016370865415,1.0,9/29,33.15%,PLA2G4A;LPCAT2;PLA2G12A;PLA2G4E;PLA2G4F;MBOAT7;DBI;PLBD1;PLB1
prerank,DNA biosynthetic process (GO:0071897),-0.3117223841891388,-0.7775854918874345,0.7636761487964989,0.9532001154149397,1.0,4/16,12.01%,POLA1;PPIA;POLD3;WRNIP1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.3310013182860647,0.7773335735251397,0.7256637168141593,0.9867584121461062,1.0,2/19,5.34%,WNT4;F2
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3112781119029767,-0.7771311016166939,0.762114537444934,0.9531789587204776,1.0,5/15,27.99%,ENTPD1;CMPK1;ENTPD2;CMPK2;ENTPD3
prerank,positive regulation of exocytosis (GO:0045921),-0.2565641860635354,-0.7768533897674692,0.8297872340425532,0.9528983761676378,1.0,6/35,13.16%,CADPS;CLASP2;RAB27A;PDCD6IP;RAB27B;SNCA
prerank,RNA transport (GO:0050658),0.26339008478543924,0.775870482612913,0.8320950965824666,0.988682671781425,1.0,21/71,21.33%,NXF2;SRSF5;SIDT2;POLDIP3;HNRNPA2B1;SIDT1;TGFBR2;ATXN2;NXF1;SRSF11;ZFP36L1;SARNP;NUP155;SRSF1;CDC40;NUP188;U2AF1;SRSF7;FMR1;U2AF2;NUP153
prerank,response to UV-B (GO:0010224),-0.33623399227971495,-0.7757720685094461,0.7612903225806451,0.9538688768185675,1.0,6/12,24.36%,MME;MFAP4;CDKN1A;CRIP1;RELA;HYAL2
prerank,protein O-linked mannosylation (GO:0035269),0.3273025865640523,0.7755679640458873,0.7264150943396226,0.9886319106671101,1.0,4/18,12.41%,TMTC4;LARGE1;TMTC1;LARGE2
prerank,negative regulation of inflammatory response (GO:0050728),0.22978821578526523,0.7746514742616972,0.89937106918239,0.9896566140985552,1.0,13/182,9.25%,RORA;C1QTNF3;ADCY5;IGF1;PPARA;ADCY1;METRNL;GPS2;ENPP3;ADCY9;MC2R;CDH5;ADM
prerank,cell cycle G2/M phase transition (GO:0044839),0.23906103002227838,0.774297106342882,0.8851351351351351,0.9896684583901407,1.0,16/130,11.05%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;FBXW11;BTRC;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8;CENPJ
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.258682223313577,-0.773850963914569,0.8353510895883777,0.9560730191332654,1.0,10/33,20.20%,HSP90AB1;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;STN1;RPA1;ANKRD28;NHP2;PTGES3
prerank,autophagy of mitochondrion (GO:0000422),0.28804340164206244,0.7737151336459663,0.7792207792207793,0.9900894823231933,1.0,6/38,10.46%,PRKN;ATG5;WIPI1;AMBRA1;BECN1;ATG7
prerank,protein processing (GO:0016485),0.2436908047426709,0.7736053292066125,0.8644536652835408,0.9896892650530281,1.0,14/102,15.27%,AEBP1;KLK2;SRGN;CTSH;METAP2;RCE1;APH1B;MMP14;ADAM17;PCSK7;OGT;SDE2;PITRM1;ZMPSTE24
prerank,protein targeting (GO:0006605),0.24262152925049377,0.7735924735772196,0.8573388203017832,0.989128306695493,1.0,28/118,19.17%,TRAK1;KIF13B;ZFAND6;LAMP2;RAB3IP;FUT10;TIMM44;PIKFYVE;TOMM70;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MFN2;MICALL1;PITRM1;VPS37A;TIMM10;ARL6;PEX19;PEX16;RABGEF1;TRAK2;ZDHHC23;KATNB1;TIMM17B;AP4M1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2507001765306495,0.7734926528795897,0.8565340909090909,0.988710974527572,1.0,14/94,13.65%,DDX5;ITPR1;FHIT;PRODH;IKBKE;ATM;DDX3X;TP53;ABL1;PRKDC;CUL4A;PPP1R13B;MLLT11;PML
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.26471887750347406,0.7734661702696952,0.8248407643312102,0.9881716659279011,1.0,7/59,10.97%,ROCK2;TLR3;TLR4;TAB2;RIPK2;RIPK1;LY96
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.28333354918542913,-0.7724451877868922,0.8133640552995391,0.9574756358659696,1.0,6/22,18.36%,SLC7A5;TNFRSF1B;LAPTM5;TRIL;NOD2;BTK
prerank,response to nutrient levels (GO:0031667),0.3344874755738095,0.7723524825341588,0.758095238095238,0.9894496728461865,1.0,1/17,1.62%,PRKAA2
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3310922434436324,-0.7722926054785259,0.772,0.956993496632169,1.0,3/11,14.31%,TASOR;TRIM28;ATF7IP
prerank,positive regulation of proteolysis (GO:0045862),0.27112711304957743,0.7721750472682054,0.7919876733436055,0.9891642741316627,1.0,7/55,8.12%,SH3D19;ADRA2A;CTSH;ANGPTL8;FBXW11;CLN6;BTRC
prerank,negative regulation of transmembrane transport (GO:0034763),-0.3416753480064856,-0.7713241382324596,0.7454909819639278,0.9577621662722972,1.0,1/10,2.37%,THBS1
prerank,microtubule anchoring (GO:0034453),0.36112413013551264,0.7710719824974255,0.7115384615384616,0.9903949137593648,1.0,5/12,18.74%,CLASP1;DAG1;PEX14;SAXO2;PCM1
prerank,protein depolymerization (GO:0051261),0.3061953100294794,0.7707249707015906,0.7670068027210885,0.9903966450013766,1.0,2/27,1.82%,MICAL3;KIF2A
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.29464649705331436,0.7704424160114929,0.7754098360655738,0.9903152725361294,1.0,7/35,12.68%,ATM;ACD;HNRNPA2B1;TNKS2;AURKB;FBXO4;PNKP
prerank,protein import into mitochondrial matrix (GO:0030150),0.3271247537201599,0.7701106760908817,0.7481481481481481,0.9903091387416686,1.0,7/18,25.49%,TIMM44;TOMM70;TIMM17B;TIMM17A;TIMM21;DNAJC15;GRPEL2
prerank,protein-DNA complex assembly (GO:0065004),-0.1976455776739868,-0.7695886317620879,0.9734848484848485,0.9596038646845227,1.0,40/116,32.86%,PSMB2;PSMD14;H3-3A;NAP1L1;PSMC6;RAD23B;UBB;SMARCA5;PSMA4;PSMB9;RPA1;ORC5;ORC2;CETN2;PSMD11;GTF2H1;NAP1L4;PSMB10;GTF2H4;PSMD2;GTF2H5;ERCC2;NPM1;PSMA2;UBC;RPS27A;PSMB3;MCM6;PSMB5;DDB1;PSMA7;PSMF1;RAD51;PSMD7;RPA3;ERCC3;RPA2;MCM4;MCM8;PSMA5
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3221765248781258,0.7689777538083745,0.7417677642980935,0.9916367239226584,1.0,4/19,9.78%,ELF1;MAP2K5;PARP9;MAVS
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2614329549966698,0.7687275439158923,0.8220211161387632,0.9914893055957424,1.0,14/63,18.89%,LEPR;TIMP3;NUPR1;PTPN22;CDK5RAP3;TAB2;ATRAID;RGP1;ZKSCAN3;TLK2;MCL1;TBC1D14;EIF4G1;GOLGA2
prerank,regulation of humoral immune response (GO:0002920),-0.24208832898587268,-0.7678925023673995,0.8633879781420765,0.9614783214592854,1.0,15/44,26.26%,SUSD4;C1QB;C4B;PROS1;C1QC;CLU;C3AR1;C1QA;GATA6;VTN;C6;C7;CD81;CFH;C3
prerank,ureteric bud morphogenesis (GO:0060675),-0.30338473739213867,-0.766993010113195,0.7948717948717948,0.962084195176543,1.0,6/16,19.19%,BMP2;SIX1;FGF2;BMP4;PAX2;PAX8
prerank,innate immune response in mucosa (GO:0002227),0.36689661049289857,0.7668821315934246,0.7532228360957642,0.9939899990489854,1.0,2/10,12.19%,DEFB1;CAMP
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3460341035481902,0.766787085642349,0.736283185840708,0.9935584164912856,1.0,2/13,10.25%,IL12B;CYRIB
prerank,positive regulation of organelle assembly (GO:1902117),-0.23977688126770172,-0.7666373106663832,0.8717277486910995,0.9619120708038812,1.0,13/44,23.61%,PIP4K2A;CCDC88A;G3BP2;SH3GLB1;RALB;CNOT2;PDCD6IP;KCTD17;PIP4K2B;LRSAM1;CNOT6L;CCP110;SPAG5
prerank,DNA replication (GO:0006260),0.23894483382463017,0.766407218983098,0.861271676300578,0.9936016638247209,1.0,29/105,21.76%,POLD2;POLG;ATM;REV1;DONSON;RBMS1;RBBP8;BAZ1A;HUS1;IGHMBP2;RAD50;TOP3A;PNKP;KAT7;POLE2;MCM7;MCM2;ORC3;POLA2;POLL;CLSPN;NBN;FEN1;RFC1;RAD9A;MCM9;MCM5;TOP1MT;ORC6
prerank,pseudouridine synthesis (GO:0001522),-0.3202323660410412,-0.7659209400081083,0.7532751091703057,0.9622507209030722,1.0,8/13,38.31%,NHP2;PUS1;PUS7;TRUB1;DKC1;RPUSD2;TRUB2;PUS7L
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37431559213696375,0.7658074599126578,0.7509433962264151,0.9939899798970583,1.0,4/10,17.63%,TKFC;DHX58;UFD1;NPLOC4
prerank,negative regulation of protein processing (GO:0010955),0.3537814995938582,0.7655141879583814,0.7728155339805826,0.9938939443121424,1.0,4/12,12.84%,LRRK2;GAS1;SERPINE1;SNX12
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.23587613864262252,0.7654341609706157,0.8865153538050734,0.9934504936074412,1.0,16/129,11.05%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;FBXW11;BTRC;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8;CENPJ
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.26333541259345533,0.7649114776733564,0.8166409861325116,0.993740988842211,1.0,11/54,19.48%,PRKN;SPHK1;CFLAR;GPS2;RIPK1;ADAM17;RNF31;BIRC3;CLIP3;TNFRSF1A;TAX1BP1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.33175510195826563,-0.7645740132345796,0.797752808988764,0.9634447670308124,1.0,2/12,8.55%,LYN;PTK2
prerank,positive regulation of lipid transport (GO:0032370),0.35520624201858675,0.7643277550294234,0.7458256029684601,0.9941586472532393,1.0,2/12,9.35%,SPP1;LRP1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2827037902790641,0.7641938742762342,0.7802547770700637,0.9937949700233701,1.0,13/37,22.58%,PRKN;RIN3;SIRT5;ATXN2;ITGAV;NCOR1;NFKB1;OPTN;PTX3;ANKRD13D;ANKRD13B;SDCBP;ABCA2
prerank,B cell activation involved in immune response (GO:0002312),0.3451095147398867,0.7641079967951077,0.7495462794918331,0.9933514898945096,1.0,3/13,20.02%,RNF8;EXOSC3;LIG4
prerank,amino sugar metabolic process (GO:0006040),-0.3518122332029953,-0.7636619642815674,0.7865384615384615,0.9639998502684861,1.0,3/10,10.95%,CSGALNACT1;ST3GAL1;GFPT2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3655714803358406,0.7629474761255696,0.7120622568093385,0.9947100645833971,1.0,1/11,1.98%,PRKN
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2567854955578875,0.7627111919697495,0.8253012048192772,0.9945181768419814,1.0,19/68,19.62%,PCCA;SLC19A1;MTHFR;TCN2;ALDH1L1;MCCC1;SLC19A2;FLAD1;TCN1;MTRR;HLCS;THTPA;TPK1;SLC25A19;MTHFD1;MMACHC;MCCC2;FOLR2;AASDHPPT
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3306176929773359,0.762464392100285,0.751412429378531,0.9943718766283475,1.0,5/17,18.07%,ACD;TDG;MBD4;OGG1;TINF2
prerank,regulation of interleukin-8 production (GO:0032677),0.25861835974855085,0.7622734217758811,0.8328313253012049,0.9940807783299282,1.0,11/69,9.78%,TLR3;SSC5D;TLR4;IL17D;ARRB1;MAP2K5;AFAP1L2;SERPINE1;PTPN22;RIPK1;MAVS
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2215484156288361,-0.7618045352800683,0.9298780487804879,0.9659504062719694,1.0,19/65,30.34%,FBXL7;PSMB2;PSMD14;PSMC6;PSMA4;PSMB9;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;FHL1;PSMB5;PSMA7;ZFYVE19;PSMF1;PSMD7;AURKA
prerank,regulation of establishment of planar polarity (GO:0090175),-0.21264289277895654,-0.7614774735932837,0.9183006535947712,0.9656649394949922,1.0,20/88,19.45%,PRICKLE2;DAAM1;PSMB2;ROR2;TIAM1;FZD4;DACT1;PSMD14;AP2B1;PSMC6;VANGL2;AP2M1;SPEF1;SMURF1;PSMA4;PSMB9;PSMD11;ARRB2;PSMB10;PSMD2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3483415181480806,0.761456747463434,0.7287822878228782,0.9947941380164819,1.0,6/13,23.81%,TDG;MBD4;OGG1;NT5C;UPP2;SMUG1
prerank,nuclear transport (GO:0051169),-0.3079815788297833,-0.7614246535104885,0.7892376681614349,0.9650489429487884,1.0,6/16,21.60%,XPO1;ANP32A;RBM15B;NXT1;BANF1;NPM1
prerank,extracellular transport (GO:0006858),0.35233154633446273,0.7610216092658992,0.7469879518072289,0.9949140511442416,1.0,3/13,17.78%,ROPN1L;WWP2;CCDC40
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3617016444754076,0.7607047788931521,0.7706237424547284,0.9937147421931114,1.0,2/11,9.40%,PANK1;DCAKD
prerank,coenzyme A biosynthetic process (GO:0015937),0.3617016444754076,0.7607047788931521,0.7706237424547284,0.9937147421931114,1.0,2/11,9.40%,PANK1;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3617016444754076,0.7607047788931521,0.7706237424547284,0.9937147421931114,1.0,2/11,9.40%,PANK1;DCAKD
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2985221052484592,-0.7603366714054387,0.7939110070257611,0.9658860276704712,1.0,10/18,38.60%,RAD51B;DTL;MECP2;CCND1;CDC7;CDK1;BRD4;CCNB1;CDC25C;RAB11A
prerank,fluid transport (GO:0042044),-0.32459097359375416,-0.7595074608070226,0.7866379310344828,0.9663638968875409,1.0,2/12,7.57%,AQP4;AQP11
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.24774982261943584,0.75949068182395,0.8645533141210374,0.9950989226093414,1.0,24/87,22.92%,NDUFAF4;SAMM50;NDUFAB1;UQCC1;NDUFS1;COX16;NDUFV2;FOXRED1;LYRM7;SDHAF4;SMIM20;NDUFAF5;COX19;TIMMDC1;DMAC2;NDUFS4;TMEM126B;NDUFA2;FASTKD3;NDUFAF7;NDUFS5;TIMM21;NDUFA9;NDUFB2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3435205604443738,0.759316775425797,0.7444029850746269,0.9947890732761797,1.0,3/13,9.10%,PARP10;SLC5A8;PARP9
prerank,membrane lipid metabolic process (GO:0006643),-0.2774895785355085,-0.759247725499694,0.8215962441314554,0.966013982253179,1.0,7/22,19.10%,CYP1B1;ST3GAL6;SERINC1;GAL3ST1;B4GALT4;TECR;SMPDL3B
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.30168028188642804,0.7590999671905908,0.7887563884156729,0.9945698379164268,1.0,2/26,2.32%,SMOC2;SPHK1
prerank,mitochondrial translational termination (GO:0070126),0.24394607017684444,0.7589391120920564,0.8847222222222222,0.9942406087345456,1.0,25/88,25.76%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MTRF1L;MRPL48;MRPL1;GFM2;MTRF1;MRPL45;MRPS17;CHCHD1;MRPL14;MRPL32;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19
prerank,glycolytic process (GO:0006096),0.3004165773285603,0.7579987071024913,0.8009554140127388,0.9951566162272508,1.0,3/28,7.26%,HK2;PGAM2;GCK
prerank,negative regulation of cartilage development (GO:0061037),0.34596687988276725,0.7578871771010427,0.7364485981308411,0.9947684752720197,1.0,3/13,15.21%,TGFBR1;PTPN11;ADAMTS7
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.35479418665288676,0.7575567256582361,0.7588235294117647,0.9947265161827691,1.0,3/11,16.00%,NUPR1;RIPK1;BIRC3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2574631156601708,-0.7563878834879305,0.8520408163265306,0.9692875516596586,1.0,3/33,4.40%,HIP1;BCAR3;CCDC88A
prerank,RNA stabilization (GO:0043489),0.28630264743646,0.7563213440067789,0.7830342577487766,0.9961217357208378,1.0,7/33,11.86%,PHAX;LARP1;GDNF;TENT2;THRAP3;NOCT;AXIN2
prerank,heme biosynthetic process (GO:0006783),-0.2774269174385271,-0.7562233071155868,0.8022727272727272,0.9688001617506566,1.0,1/22,0.78%,ABCG2
prerank,positive regulation of translation (GO:0045727),-0.20629450854495604,-0.7561994281457819,0.9538461538461539,0.9681327027529749,1.0,25/94,21.60%,PRR16;THBS1;NIBAN1;RPL26;RPL5;RPS9;ERBB2;UHMK1;FXR1;EIF5A2;RPS4X;YBX3;VIM;METTL3;BCL3;RCC1L;PKM;DHX9;RPS27L;EEF2;YTHDF2;RBM3;EIF4A3;EIF3D;NPM1
prerank,acute-phase response (GO:0006953),-0.3220617612226344,-0.7553509344699136,0.7756813417190775,0.9685767388963226,1.0,4/12,21.72%,LBP;SIGIRR;IL22;IL6R
prerank,lysosome localization (GO:0032418),0.2787712659390995,0.7547765369961049,0.8,0.9979450683512938,1.0,5/37,14.23%,KIT;RAB34;BLOC1S2;KIF5B;FLCN
prerank,positive regulation of bone resorption (GO:0045780),0.35433163215341373,0.7547472636357799,0.7373737373737373,0.9974125006226111,1.0,2/11,12.32%,SPP1;PRKCA
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3060241842281776,0.7544278346371379,0.7724770642201835,0.9973375036571701,1.0,4/23,11.97%,PKHD1;FBXW11;HTT;MISP
prerank,lymphocyte mediated immunity (GO:0002449),-0.3195548767785924,-0.7543175548102429,0.7849686847599165,0.9693049937242161,1.0,2/12,14.73%,JAG1;BTN3A3
prerank,microtubule anchoring at centrosome (GO:0034454),0.3711667860945921,0.7540594714783985,0.7427466150870407,0.9973540426159616,1.0,3/10,18.74%,NINL;HOOK3;PCM1
prerank,negative regulation of catabolic process (GO:0009895),-0.23433297128428673,-0.7538798081391457,0.9038461538461539,0.9692056378058551,1.0,13/47,22.06%,PDE3B;FMN2;CST3;FLNA;IRAK3;CBFA2T3;PFKFB1;ADGRB1;SIRT2;TIGAR;CYP51A1;MAD2L1;GIT1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3095781249230297,-0.7536423254305932,0.7755555555555556,0.9688060044210464,1.0,3/15,11.37%,PRKCH;SFRP4;BMP4
prerank,response to interferon-alpha (GO:0035455),-0.30329400640771953,-0.7534268660311165,0.8008565310492506,0.9683993459369694,1.0,3/16,11.73%,GAS6;RO60;IFITM3
prerank,regulation of defense response to virus (GO:0050688),0.34292795145201765,0.7532301600280149,0.7454873646209387,0.9980989672738833,1.0,4/14,20.23%,PCBP2;PPM1B;ZMPSTE24;TRAF3
prerank,DNA strand elongation (GO:0022616),0.32035533719336584,0.7531466005683489,0.7566539923954373,0.9976489167101723,1.0,4/18,13.34%,POLD2;TERT;RAD50;MCM7
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3026932829152254,-0.7526885477563668,0.8177966101694916,0.96872463671217,1.0,3/14,12.04%,CARD14;MAP3K7;TIRAP
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.30734987666681685,-0.7526169152027675,0.8016528925619835,0.9681281322513571,1.0,5/14,18.37%,THBS1;FGF2;CREB3L1;SPRY1;SPRY4
prerank,positive regulation of immune system process (GO:0002684),-0.2993119108600851,-0.7525584177147795,0.7902869757174393,0.9675127664887241,1.0,2/16,5.42%,TGFB2;ANXA1
prerank,nuclear envelope organization (GO:0006998),0.31482314782425935,0.7524572895350732,0.7883895131086143,0.9981371979501859,1.0,6/20,18.29%,DMPK;LEMD2;REEP4;VPS4A;NUP155;TOR1AIP1
prerank,transport along microtubule (GO:0010970),-0.3211355599786579,-0.7524384772433618,0.7737068965517241,0.9669861919216842,1.0,2/13,7.28%,APP;DYNC1I1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3101199805513113,-0.7524084052437148,0.7991803278688525,0.9663293616355848,1.0,6/14,25.58%,FLT4;DGKG;VEGFA;MYADM;GPD1L;CD40
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.33523783836765214,-0.7522641469360157,0.7863247863247863,0.9651538824175666,1.0,3/10,12.90%,AP2B1;AP2M1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.33523783836765214,-0.7522641469360157,0.7863247863247863,0.9651538824175666,1.0,3/10,12.90%,AP2B1;AP2M1;VLDLR
prerank,somite development (GO:0061053),0.36013029898630705,0.7522296922185796,0.771255060728745,0.9978966635351075,1.0,2/11,4.94%,LOXL3;SMO
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.33612003260944984,0.7515898248648382,0.7762096774193549,0.9983173709122739,1.0,2/15,9.34%,PRKN;SIRT1
prerank,ATP transport (GO:0015867),0.36495079620651294,0.7515153107914893,0.7581573896353166,0.9978660195894494,1.0,3/10,16.57%,ABCC6;SLC25A42;SLC25A17
prerank,aerobic respiration (GO:0009060),0.3141032042906649,0.7513534588748395,0.7802385008517888,0.9975349730888335,1.0,7/20,22.95%,MTFR2;SIRT3;UQCRC2;ATP5F1D;SDHB;UQCRC1;UQCRH
prerank,I-kappaB phosphorylation (GO:0007252),0.3575367873486106,0.7513135265169532,0.7622950819672131,0.9970261088367457,1.0,2/10,5.16%,TLR3;TLR4
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3239600234385204,0.7508399147862785,0.7407407407407407,0.9966091355668608,1.0,3/15,12.08%,DTNBP1;BLOC1S6;BLOC1S2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3239600234385204,0.7508399147862785,0.7407407407407407,0.9966091355668608,1.0,3/15,12.08%,DTNBP1;BLOC1S6;BLOC1S2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.31108616779672893,0.7505520935695783,0.7811934900542495,0.9964866483857924,1.0,1/23,1.44%,IGF1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.31035226841986585,0.7504666660777917,0.7858407079646018,0.9960445003206453,1.0,4/22,12.87%,CCNT2;ELL;SCAF8;KAT7
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.3393980407925312,-0.7496271767563664,0.7634408602150538,0.9679282107950379,1.0,1/10,0.66%,PRKCH
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.3388970106882406,-0.7494773765063385,0.7848360655737705,0.9674349363555822,1.0,5/10,19.64%,ITGB3;HIF1A;MT3;ITGA5;VTN
prerank,adipose tissue development (GO:0060612),-0.3262833690079429,-0.749357333495541,0.8047337278106509,0.9669144470420507,1.0,5/11,24.99%,SPTLC2;NAMPT;SOX8;PGRMC2;DGAT2
prerank,acute inflammatory response (GO:0002526),0.30577854790238146,0.7491078808458765,0.7849462365591398,0.9975420216642434,1.0,4/23,10.73%,C2CD4B;ANO6;PLSCR1;MYLK3
prerank,response to interferon-beta (GO:0035456),0.3116615940052617,0.7488878479120572,0.7637655417406749,0.9973312427542582,1.0,7/22,17.38%,IKBKE;PLSCR1;IRGM;IRF1;ACOD1;IFNAR2;CDC34
prerank,regulation of steroid biosynthetic process (GO:0050810),0.35406687141941795,0.7488597015850934,0.7649325626204239,0.9967948579918579,1.0,1/11,1.03%,WNT4
prerank,regulation of type I interferon production (GO:0032479),0.24798893939613761,0.7479984834295048,0.8472622478386167,0.9975633760180843,1.0,27/84,24.20%,PCBP2;IKBKE;RNF135;TRIM56;PTPN22;MAVS;PRKDC;DHX58;IRF1;POLR3A;DHX33;ACOD1;NFKB1;STAT6;CREBBP;UFD1;NPLOC4;TAX1BP1;CD14;TRAF3;EP300;PQBP1;POLR2F;POLR3H;POLR3G;ZBP1;DDX41
prerank,regulation of protein localization to centrosome (GO:1904779),0.36222972949329707,0.7474126139990392,0.7485493230174082,0.9978633868835302,1.0,1/10,2.95%,CEP250
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2958715185343008,0.7473826309719199,0.7750439367311072,0.9973435244011339,1.0,1/27,0.97%,LPAR1
prerank,negative regulation of bone remodeling (GO:0046851),-0.32522549616208196,-0.7471598061581808,0.7904564315352697,0.9691228315102189,1.0,7/11,30.81%,UBASH3B;TMEM119;SFRP1;P2RX7;CARTPT;CALCA;TNFAIP3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.28398261815206927,-0.7470394684644556,0.8487584650112867,0.9685943457121795,1.0,7/19,20.71%,PIK3AP1;TIRAP;LBP;TRIL;NR1H4;ITGB2;LGALS9
prerank,establishment of mitotic spindle localization (GO:0040001),0.2928497761681976,0.7469620163969333,0.7982300884955752,0.9973999019621442,1.0,5/28,11.97%,PKHD1;CLASP1;FBXW11;HTT;MISP
prerank,cellular response to pH (GO:0071467),0.3251626211425902,0.7463474793291703,0.7909604519774012,0.9977718189866497,1.0,3/17,11.45%,HYAL1;RAB11B;IMPACT
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.27544503108717516,-0.7463204917364445,0.8148984198645598,0.9681611419917151,1.0,4/22,12.48%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.27544503108717516,-0.7463204917364445,0.8148984198645598,0.9681611419917151,1.0,4/22,12.48%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,regulation of actin nucleation (GO:0051125),0.3392235374443478,0.7461823403383065,0.7934362934362934,0.9974719412301344,1.0,5/12,17.03%,PICK1;VIL1;ARFIP2;WASHC5;CORO1B
prerank,regulation of mast cell activation (GO:0033003),0.3627018305422338,0.7458514410166696,0.7648183556405354,0.9973967975825541,1.0,2/10,7.37%,HAVCR1;PLSCR1
prerank,positive regulation of cytokine production (GO:0001819),0.21268342483829944,0.7457330679386113,0.9597238204833142,0.997000110427033,1.0,36/292,13.29%,RORA;C1QTNF3;ROCK2;PRKCZ;IL18;LACC1;SPHK1;ADRA2A;SULF2;TLR3;TLR4;FZD5;IL17D;NOX1;CD28;IL12B;EIF2AK2;AFAP1L2;SERPINE1;PTPN22;IL17RA;RIPK2;RIPK1;MAVS;CD274;CYRIB;RAB7B;PRKDC;DHX58;ADAM17;GLMN;PTPN11;IRF1;POLR3A;DHX33;SULF1
prerank,sulfur compound catabolic process (GO:0044273),0.2695756470185518,0.7456565599795398,0.8151408450704225,0.99655522004475,1.0,6/38,10.66%,OGN;FMOD;HYAL1;CTH;ARSB;MLYCD
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.2932351844202543,0.7456256222037743,0.8254486133768353,0.9960256020441013,1.0,2/27,2.32%,IGF1;SPHK1
prerank,cellular protein localization (GO:0034613),0.21278606769465927,0.7456213073162068,0.969661610268378,0.9954632761090108,1.0,57/285,18.14%,CELSR1;ANK2;WLS;CSRP3;SNX6;CEP250;SEC31B;TBC1D16;LRRK2;CPLANE2;DUOXA1;STXBP2;PRRT1;ACD;SH3PXD2B;WIPI1;PTPRU;ARFGAP3;NIPBL;CNTNAP1;VPS26C;PICK1;GRTP1;ARL4A;RAB43;COPZ2;RAB22A;NPHP1;AXIN2;VPS45;CLTC;SNX8;STX5;SGSM2;VIPAS39;MFN2;SNX15;AP2A1;SEC23IP;RAB29;RAB21;ARFIP2;ARL6;BBS2;SCFD1;TBC1D25;FAM91A1;SGSM3;CORO1B;RRAGD;MYO7A;VPS35;KIF13A;TBC1D14;WNT5A;SEC31A;EVI5
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.310613183293992,0.7450094071267274,0.791095890410959,0.9958162593280114,1.0,5/23,11.34%,PARP14;PIAS1;PARP9;IRGM;SOCS3
prerank,leukotriene metabolic process (GO:0006691),0.3164457353329051,0.7444844331674636,0.7599309153713298,0.9960204833057849,1.0,2/19,7.72%,ALOX12;ABCC10
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.25699924035080496,0.7440193131759526,0.8414096916299559,0.9961705081062777,1.0,15/59,18.21%,TNRC6A;MITF;TP53;MED12;TNRC6B;PTEN;TCF7L2;MOV10;MED17;TNRC6C;NFKB1;MED23;MED26;MED1;MED8
prerank,mitochondrial genome maintenance (GO:0000002),0.3550454876925784,0.7440141591453473,0.7288135593220338,0.9956115537394088,1.0,4/11,16.03%,OPA1;MEF2A;TOP3A;SLC25A36
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.24131424658582018,0.7439556480840175,0.8909348441926346,0.9951218406783575,1.0,11/84,10.14%,IGF1;SPHK1;IGF2BP1;DDX3X;EIF2AK2;SAMD4A;LARP1;CPEB3;IGF2BP2;CNOT10;LSM14A
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.354528258684363,0.7438185068549447,0.7739463601532567,0.9947442433292841,1.0,5/11,23.64%,UFD1;TOR1A;DERL1;BAG6;RNF5
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.24864539846342643,-0.7435619600313956,0.8871794871794871,0.9710067277620084,1.0,6/32,13.68%,CEPT1;SLC44A5;SLC44A2;MFSD2A;SLC44A1;LPIN3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.27551967987193327,-0.7434838146839684,0.8402625820568927,0.9704137884192086,1.0,7/22,25.02%,ERBB2;ATF4;EIF2AK3;NOL11;UTP15;PHF8;LYAR
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.2555018085752981,0.7433136425028628,0.8221884498480243,0.9949637251338341,1.0,13/55,14.80%,PRKN;F2;PDGFRB;TP53;SIRT5;TGFBR2;PIKFYVE;RIPK1;RNF41;ACOD1;GADD45A;SPHK2;COQ7
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2507739144066097,0.7431327924380047,0.8613569321533924,0.9946649205708725,1.0,12/68,18.66%,POLR2A;TAF1D;PABPN1;TTF2;SCAF8;POLR1G;MTERF2;TBP;TTF1;CPSF3;CSTF1;PCF11
prerank,negative regulation of catalytic activity (GO:0043086),0.3054032237591517,0.74265365503363,0.7852112676056338,0.9948380204145171,1.0,4/24,9.34%,IFIT1;TP53;PARP9;SIRT1
prerank,regulation of mitotic cell cycle (GO:0007346),0.22042057662462228,0.742390668468741,0.944233206590621,0.9946960004764133,1.0,13/171,9.34%,SMAD3;ANAPC15;SMOC2;SPHK1;OBSL1;FOXC1;GAS1;ANAPC2;SIK1;AFAP1L2;BTRC;CDK5RAP3;SIRT1
prerank,mRNA export from nucleus (GO:0006406),0.23378240916775633,0.7422697364101509,0.908835904628331,0.9943061422359691,1.0,24/102,21.33%,NXF2;PABPN1;SMG1;SRSF5;POLDIP3;HNRNPA2B1;POLR2D;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;U2AF2;NUP153
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.21073527240920348,-0.7422182425597776,0.9513677811550152,0.9713623916733837,1.0,18/72,19.26%,LIFR;RUNX1;GAS6;HSP90AB1;PTPRC;IRAK3;IFNGR2;JAK1;HIPK1;IKBKB;RBCK1;ABCE1;SIGIRR;CD74;SYK;TRAF1;PTPN1;SPATA2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2663066326155392,-0.7419294351146599,0.8465227817745803,0.971026642889758,1.0,6/25,19.30%,STAT3;STAT5B;HIF1A;TAL1;INHBA;FAM210B
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.33658570656266684,0.7417702181541647,0.7944954128440367,0.9945100660881442,1.0,4/14,13.56%,ENPP3;AK4;AK3;AK8
prerank,positive regulation of DNA replication (GO:0045740),0.3245559328101859,0.7417073051824343,0.7731568998109641,0.9940383598668736,1.0,4/16,15.14%,GLI2;GLI1;KAT7;FAF1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2601382049317403,-0.7416892236318497,0.8270142180094787,0.9706418863532573,1.0,13/27,29.69%,CD47;CD44;SKAP1;ITGB2;PRKCQ;HAS2;PYCARD;MDK;THY1;RELA;CCL2;NR4A3;RHOA
prerank,bile acid metabolic process (GO:0008206),0.2914904148030728,0.7415632076353166,0.8017699115044248,0.9936896204938334,1.0,3/27,5.91%,CYP27A1;AMACR;OSBPL9
prerank,positive regulation of double-strand break repair (GO:2000781),0.2750536092877342,0.7414898257299469,0.8300751879699249,0.9932438138731915,1.0,10/39,19.08%,ARID2;KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1;MGMT;FUS;MMS19
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3169830314006864,-0.7402427412271552,0.7946611909650924,0.971814577242777,1.0,4/11,10.80%,ARHGEF7;CORO1C;CD44;ENPP2
prerank,positive regulation of viral life cycle (GO:1903902),0.3097043313260811,0.7400746592071035,0.8081705150976909,0.9946989912580874,1.0,6/22,21.07%,LGALS1;KPNA6;AXL;VPS4A;CHMP2A;FMR1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.25319636739476187,-0.7400586226835139,0.8442822384428224,0.9713699116635395,1.0,9/29,28.16%,NSF;COG5;RAB6A;GABARAPL2;COPE;TRAPPC3;COG1;NAPG;COPG2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.32715482242284066,-0.7394770718833018,0.7982646420824295,0.9714368757590679,1.0,3/10,16.59%,PTPRC;IRAK3;SIGIRR
prerank,positive regulation of response to stimulus (GO:0048584),-0.23784168470690406,-0.7394001795271569,0.8986666666666666,0.9708562887365658,1.0,12/40,23.12%,TGFB2;B2M;FXR1;ABI3;HOMER1;ILK;SELENON;DHX9;CDKN2AIP;NSMCE1;NSMCE4A;CGAS
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3255012103323084,-0.739171440312724,0.8024439918533605,0.9704804843157573,1.0,3/11,11.89%,HSPA5;CREB3L1;ATF4
prerank,protein localization to microtubule organizing center (GO:1905508),-0.29308784847005287,-0.7390497209410732,0.8208616780045351,0.9699417093082046,1.0,6/15,31.20%,CEP83;CEP131;SPAG5;NEDD1;STIL;CSNK1D
prerank,mitotic spindle organization (GO:0007052),-0.18542435392379014,-0.7387995432377321,0.9959677419354839,0.9695551446760016,1.0,62/153,32.39%,CLASP2;PLK2;FLNA;DYNC1I1;DYNLL1;XPO1;DYNC1LI2;CEP126;RPS27;MAP4;BUB3;CLIP1;MZT1;STMN1;CENPE;EFHC2;CHEK2;STAG1;SPAST;TBCE;EML1;KIF11;RAN;PPP1CC;NUP107;NEK6;MAD2L1;CENPH;BCCIP;NSL1;NDC80;SUN2;KIF4A;KIF3B;TPX2;KPNB1;KNTC1;MECP2;TUBG2;DCTN6;CENPA;PRC1;NUP85;CDCA8;KIF23;NDEL1;NDE1;RANGAP1;TNKS;CENPF;NUDC;PTPA;STIL;RHOA;DLGAP5;NUF2;AURKA;TOGARAM2;CENPI;SPC24;CDC20;BUB1
prerank,regulation of cell aging (GO:0090342),-0.325983171587295,-0.7385982285268968,0.7937219730941704,0.969128867054102,1.0,4/11,26.99%,PNPT1;NUAK1;NEK6;VASH1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.24350199484001056,0.7383201575922181,0.8746355685131195,0.9966533452060742,1.0,12/76,15.14%,BMP7;PKHD1;PARP10;ARRB1;MAP2K5;CDK5RAP3;SIRT1;USP7;LRRC14;ACOD1;NWD1;FAF1
prerank,regulation of chemokine production (GO:0032642),0.27846117966557515,0.7381605990040035,0.8441127694859039,0.9963239196943653,1.0,4/36,6.57%,IL18;TLR3;TLR4;EIF2AK2
prerank,neurogenesis (GO:0022008),0.27216648842787,0.7380703111231629,0.8298217179902755,0.9959014049556589,1.0,4/43,8.27%,LPAR1;TRAK1;DAGLA;RYK
prerank,protein localization to nucleus (GO:0034504),0.23357429750216815,0.7378574050706612,0.9072305593451568,0.9956526803647225,1.0,3/102,3.53%,BMP7;APPL2;TNPO1
prerank,regulation of complement activation (GO:0030449),-0.23895723717696277,-0.7378273630517437,0.9095890410958904,0.9694161593652623,1.0,17/40,31.88%,SUSD4;C1QB;C4B;PROS1;C1QC;CLU;C3AR1;C1QA;VTN;C6;C7;CD81;CFH;C3;SERPING1;C5AR2;CR1L
prerank,peptidyl-proline modification (GO:0018208),0.30032731359478715,0.7377204302810367,0.7934027777777778,0.9952925333282882,1.0,4/25,10.00%,FKBP5;NKTR;PPIC;CWC27
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2911063514055713,0.7374217990934329,0.8135283363802559,0.9951684724974237,1.0,10/27,24.43%,ZC3H12B;DICER1;ZC3H12C;NYNRIN;CPSF3;POP7;PCF11;POP1;XRN1;LACTB2
prerank,positive regulation of catalytic activity (GO:0043085),0.2744014280394266,0.7373769179589795,0.85,0.9946623881998313,1.0,8/37,11.47%,SLC5A3;NHEJ1;BCAS3;XRCC4;SSBP1;PHACTR4;ABL1;MSH3
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.2957710294620667,-0.737187866523375,0.8286384976525821,0.9695117156920906,1.0,10/16,41.47%,APOE;MYOCD;CLU;CYP51A1;HMGCR;IFNGR1;IL4;ABCA7;TNF;LRPAP1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3091858440136316,0.7371550919184255,0.7931034482758621,0.9944149151019591,1.0,5/18,20.38%,ABL1;PRKDC;ZFP36L1;CCR2;IKZF3
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.33689289566726655,0.7364057605990877,0.7637795275590551,0.9949161127639823,1.0,2/12,12.92%,CLCN2;MBTPS1
prerank,mRNA catabolic process (GO:0006402),0.2643645200718323,0.7361357685565756,0.8470031545741324,0.9947446483593645,1.0,4/44,10.60%,DDX5;TUT4;CNOT10;THRAP3
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.32664050620863133,0.7360879947626443,0.7567049808429118,0.9942619835073634,1.0,6/14,25.36%,SAP18;SFSWAP;SRSF10;SRSF7;U2AF2;SRSF4
prerank,pentose-phosphate shunt (GO:0006098),-0.31426678209648007,-0.7358350161827893,0.7959183673469388,0.9704239995394788,1.0,4/11,21.82%,TKT;TALDO1;RPE;RPIA
prerank,mRNA polyadenylation (GO:0006378),0.29502061505521504,0.7358025074646058,0.8269230769230769,0.9935593555058327,1.0,9/26,21.64%,AHCYL1;TENT2;SCAF8;TENT4B;CPSF3;PAPOLG;GRSF1;PCF11;TUT1
prerank,RNA polyadenylation (GO:0043631),0.29502061505521504,0.7358025074646058,0.8269230769230769,0.9935593555058327,1.0,9/26,21.64%,AHCYL1;TENT2;SCAF8;TENT4B;CPSF3;PAPOLG;GRSF1;PCF11;TUT1
prerank,mitochondrial transport (GO:0006839),-0.22074852929265593,-0.73571145453322,0.8910081743869209,0.969912815848591,1.0,17/53,28.96%,SLC25A13;HSP90AA1;TOMM7;FBXO7;AIP;GDAP1;BCAP31;TOMM22;TIMM8B;TOMM20;STARD3;BNIP3;TIMM13;SPG7;TOMM5;PMAIP1;FIS1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3348185987689749,-0.7351245318533518,0.8224489795918367,0.9693009162205362,1.0,3/10,16.95%,CDC42EP3;CDC42EP2;APC
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3348185987689749,-0.7351245318533518,0.8224489795918367,0.9693009162205362,1.0,3/10,16.95%,CDC42EP3;CDC42EP2;APC
prerank,calcineurin-mediated signaling (GO:0097720),-0.3280101391788188,-0.7346351688464804,0.808,0.9684735203568727,1.0,4/10,15.07%,PPP3R1;NFATC1;PPP3CA;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3280101391788188,-0.7346351688464804,0.808,0.9684735203568727,1.0,4/10,15.07%,PPP3R1;NFATC1;PPP3CA;PPP3CC
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2088411693832526,-0.7330084663416194,0.9483870967741935,0.9697264362328563,1.0,24/70,29.52%,RUNX1;LMO2;PSMB2;GATA2;PSMD14;PSMC6;N4BP2L2;TCF12;TAL1;METTL3;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;YTHDF2;PSMA2;PSMB3;PUS7;TCF3;PSMB5;PSMA7;PSMF1;PSMD7
prerank,negative regulation of JUN kinase activity (GO:0043508),0.35453522472927823,0.7322293063086533,0.7806324110671937,0.9981331646409338,1.0,3/10,12.34%,PTPN22;DUSP10;HIPK3
prerank,regulation of cell cycle process (GO:0010564),-0.1945678178833393,-0.7314786824822798,0.9862542955326461,0.9708991237471505,1.0,44/104,32.59%,CAV2;CALM1;PLK2;CALM2;SH3GLB1;CALM3;GPER1;PRPF40A;CTNNB1;SETD2;TXLNG;ATF5;E4F1;TIPIN;APC;CETN2;KIF11;RAB11FIP4;DCUN1D3;ECT2;BORA;YTHDF2;CUL7;SFRP1;GIT1;TTL;CCDC8;PLK3;CCP110;SPAG5;PRC1;CDKN2B;KLHL13;HMGA2;RPRD1B;MARK4;KIF20A;NUDT16;AURKA;PRMT5;RAB11FIP3;KNSTRN;BUB1;PIK3R4
prerank,regulation of stem cell differentiation (GO:2000736),-0.2007324668582949,-0.7302522127446974,0.9761092150170648,0.9716906582405462,1.0,20/89,20.19%,RUNX1;LMO2;JAG1;NOTCH1;PSMB2;HES1;GATA2;PTN;PSMD14;PSMC6;TCF12;TAL1;NELFB;METTL3;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;YTHDF2
prerank,negative regulation of hippo signaling (GO:0035331),0.33753098834009754,0.7290935264097882,0.783625730994152,1.0,1.0,6/12,21.38%,VGLL4;WWC2;AJUBA;WTIP;MAPK14;DLG5
prerank,ncRNA export from nucleus (GO:0097064),0.27298755372808253,0.7288889536697296,0.8421052631578947,1.0,1.0,19/36,30.67%,PHAX;NUP42;NUP98;NUP43;TSC1;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;NUP160;NOL6;RANBP2;NUP37;SSB;RAE1;NUP133
prerank,iron ion transport (GO:0006826),0.26304229618580116,0.7286948132012815,0.8243670886075949,1.0,1.0,12/47,18.72%,CP;ATP6V0E1;ATP6V0B;RAB11B;ATP6V1D;ATP6V1E1;CLTC;DNM2;STEAP3;HFE;ATP6V0D1;ARHGAP1
prerank,regulation of leukocyte migration (GO:0002685),-0.28893249172335345,-0.7285065945016389,0.8399122807017544,0.973096896038291,1.0,8/16,31.92%,ANXA1;RHOH;VEGFA;CD81;RHOG;HMOX1;BST1;RAC2
prerank,positive regulation of cilium assembly (GO:0045724),-0.28814811249937233,-0.7284766788682544,0.8532110091743119,0.9724466975337089,1.0,7/18,28.89%,CCDC88A;KCTD17;SEPTIN9;CCP110;HAP1;CEP135;MARK4
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.28779439108135774,-0.7283218737366824,0.834070796460177,0.9719457931643743,1.0,2/15,8.48%,PRKCH;AGTR1
prerank,regulation of response to stress (GO:0080134),-0.3236474624304225,-0.7278194160582981,0.8224101479915433,0.9718402687447668,1.0,5/10,36.68%,CORO2B;ADCY8;OPRM1;CRHBP;MLC1
prerank,negative regulation of insulin secretion (GO:0046676),0.31926234579371293,0.7276562739952724,0.7947761194029851,1.0,1.0,4/17,12.56%,PRKN;ADRA2A;MIDN;SIRT4
prerank,cholesterol metabolic process (GO:0008203),-0.2102935143003087,-0.7274771223011044,0.9337349397590361,0.9715395321464378,1.0,27/68,27.66%,PPARD;APOE;ABCG1;SCARF1;HMGCS1;IDI1;SNX17;PMVK;MT3;LSS;SQLE;DHCR7;DHCR24;LDLRAP1;CH25H;CYP51A1;MSMO1;GBA2;STARD3;ACAT2;CLN8;EBP;ABCA1;ABCA5;HMGCR;FDPS;HSD17B7
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.33661363128047694,0.7273180072313276,0.7886792452830189,1.0,1.0,2/14,6.46%,KMT5C;KMT5B
prerank,regulation of immune response (GO:0050776),0.22259617679596969,0.7271688146262796,0.9453551912568307,1.0,1.0,12/135,11.40%,COLEC12;APPL2;CD300A;RNF135;TKFC;PTPN22;PLSCR1;SAMHD1;COL1A2;RSAD2;CXADR;DHX58
prerank,negative regulation of B cell activation (GO:0050869),-0.27147002382392993,-0.7269823090374217,0.8473804100227791,0.9714860066062767,1.0,8/21,21.03%,LYN;TNFRSF21;ID2;SAMSN1;LAPTM5;INHBA;TYROBP;SFRP1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.27386215615263776,0.7262626244750888,0.8578512396694215,1.0,1.0,4/31,9.53%,TLR3;TLR4;IL12B;RIPK2
prerank,DNA modification (GO:0006304),0.30047189891488885,0.7261798204455631,0.8191304347826087,1.0,1.0,8/22,23.98%,ACD;TDG;MBD4;EXOSC3;OGG1;TINF2;SMUG1;PARP3
prerank,negative regulation of histone acetylation (GO:0035067),0.3428303349439773,0.7257386316269697,0.8059701492537313,1.0,1.0,4/11,21.12%,SIRT1;SIN3A;TAF7;NOC2L
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.29574852825557424,0.7256202936348126,0.8162162162162162,1.0,1.0,6/22,18.07%,PPM1E;DUSP10;DUSP2;PPM1B;DUSP18;DUSP4
prerank,nucleoside salvage (GO:0043174),-0.32078052378395283,-0.7252867487957055,0.8333333333333334,0.9728511707329655,1.0,4/10,30.34%,HPRT1;UCK2;UPP1;TK2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2921871981875131,0.7249582302682457,0.8162544169611308,1.0,1.0,5/25,13.62%,BID;FAM162A;TP53;DNM1L;MLLT11
prerank,positive regulation of innate immune response (GO:0045089),0.2868543716690923,0.7246628936945744,0.822742474916388,1.0,1.0,11/30,24.63%,IFNK;PLSCR1;MAVS;NMI;TRIM62;IFI35;WNT5A;PLA2G5;POLR3G;ZBP1;FADD
prerank,spliceosomal snRNP assembly (GO:0000387),-0.23422389781650704,-0.7240726303548505,0.9375,0.973544978027655,1.0,15/38,35.88%,SART1;CLNS1A;SNRPF;COIL;SRSF12;SNRPD3;LSM4;SNRPB;WDR77;PRMT5;SNRPG;LSM2;USP4;PRPF8;GEMIN2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3014747671273621,0.7221588990966622,0.8003731343283582,1.0,1.0,3/20,8.46%,SMOC2;SULF2;APLN
prerank,innate immune response (GO:0045087),0.21180422809785404,0.7217872813177595,0.975,1.0,1.0,28/217,13.65%,COLEC12;IFIT1;IFI27;KRT1;TLR3;TLR4;RNF135;DEFB1;DDX3X;TRIM56;ANKRD17;COLEC11;TKFC;RIPK2;MAVS;FER;IRGM;SRPK2;ZDHHC1;ANKHD1;DHX58;CAMP;NUB1;FRK;AKAP1;TRIM62;POLR3A;PML
prerank,cellular response to glucose stimulus (GO:0071333),0.28165110758398904,0.7211560582023222,0.8347529812606473,1.0,1.0,2/30,2.21%,PRKAA2;ZBTB20
prerank,body fluid secretion (GO:0007589),0.3253004260100023,0.7208793688311058,0.7896613190730838,1.0,1.0,2/15,8.46%,NPR1;APLN
prerank,protein-containing complex disassembly (GO:0032984),-0.21242567123655337,-0.7207858707374154,0.9327956989247311,0.9766020731121049,1.0,10/54,17.20%,CAV1;GSK3B;HSPA8;RPL23;CTNNB1;AXIN1;MAP1LC3A;GABARAPL2;APC;PPP1CA
prerank,polarized epithelial cell differentiation (GO:0030859),0.3365885766907369,0.7205401861116837,0.7835820895522388,1.0,1.0,4/13,17.39%,EZR;OPHN1;CDC42;MYO9A
prerank,positive regulation of monooxygenase activity (GO:0032770),0.28688477870133156,0.7203011044796086,0.8202443280977313,1.0,1.0,4/26,8.43%,NPR3;POR;TERT;GDNF
prerank,positive regulation of RNA splicing (GO:0033120),-0.24710764750009095,-0.7202962814551168,0.8816705336426914,0.9765077091657937,1.0,3/29,4.99%,PIK3R1;CELF4;HNRNPLL
prerank,water transport (GO:0006833),-0.30730750992080325,-0.719546856759476,0.8326180257510729,0.9766961170651199,1.0,2/12,7.57%,AQP4;AQP11
prerank,steroid hormone biosynthetic process (GO:0120178),0.2769524423482216,0.7186679507902346,0.8471986417657046,1.0,1.0,4/29,12.67%,CYP21A2;FDXR;TSPOAP1;SRD5A2
prerank,regulation of protein localization to nucleus (GO:1900180),0.2604116932897868,0.718174974058094,0.8620689655172413,1.0,1.0,9/43,14.23%,SESN2;F2;WWTR1;CDK5RAP3;PARP9;GLUL;KAT7;SIN3A;FLCN
prerank,regulation of immune effector process (GO:0002697),-0.23085152939637923,-0.7175152430844389,0.9234828496042217,0.9782935508756956,1.0,17/41,31.88%,SUSD4;C1QB;C4B;PROS1;C1QC;CLU;C3AR1;C1QA;VTN;C6;C7;CD81;CFH;C3;SERPING1;C5AR2;CR1L
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.23785224662117863,-0.7169024894816416,0.9029850746268657,0.9783162407153623,1.0,4/34,7.96%,SLC7A5;GPI;PTPRC;EPHB2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.29639723143257135,0.7167697268276884,0.8313253012048193,1.0,1.0,5/23,13.57%,MTMR3;SYNJ2;PTEN;OCRL;PIP4P2
prerank,regulation of lymphocyte activation (GO:0051249),0.32142632933643056,0.7162330464410146,0.8077669902912621,1.0,1.0,12/12,67.88%,LAT;IKZF3;PAG1;DCAF15;SIT1;KAT2A;CCL5;CD4;CD19;LCK;CRTAM;THEMIS2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.28263852175861504,-0.7161728148238858,0.8536585365853658,0.9784399984856171,1.0,1/17,0.34%,CTNNA2
prerank,cellular response to ATP (GO:0071318),-0.29410914586232434,-0.7161374363226707,0.865934065934066,0.9778044004946815,1.0,3/14,14.40%,RYR3;P2RY12;P2RY1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2329551586588219,0.7157392501152671,0.9138686131386862,1.0,1.0,20/88,15.75%,IGF2BP1;F2;DDX3X;TM4SF20;EIF2AK2;KNG1;SAMD4A;LARP1;CPEB3;CDK5RAP3;IGF2BP2;CNOT10;LSM14A;DDX6;ATRAID;RGP1;TSC1;NFKB1;PLAT;RBM4
prerank,mRNA stabilization (GO:0048255),-0.22602569699487107,-0.7151877100939957,0.9210526315789473,0.9781917135944227,1.0,10/40,17.72%,YBX1;ELAVL4;SYNCRIP;TAF15;EIF4ENIF1;TIRAP;YBX3;TENT5A;DHX9;PABPC1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2774352498047621,-0.7148985258259842,0.8344370860927153,0.9778152395783275,1.0,9/16,30.51%,GPER1;GRP;CHGA;NECAB2;MRAP2;C3;SLC39A14;PDE6G;PRMT5
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2903925796164335,-0.7147104307016487,0.842436974789916,0.9773596532947548,1.0,3/15,10.92%,SCARB1;LDLR;MFSD2A
prerank,positive regulation of viral transcription (GO:0050434),0.2909862067774746,0.7142800567499273,0.831918505942275,1.0,1.0,5/25,14.70%,POLR2A;POLR2D;GTF2F1;NELFCD;CTDP1
prerank,regulation of secretion (GO:0051046),-0.29800383356215193,-0.7140719182226516,0.8263473053892215,0.9773748636515708,1.0,3/13,8.98%,ACSL3;KCNQ1;MYO6
prerank,response to laminar fluid shear stress (GO:0034616),0.34092341196530085,0.7138972780304522,0.7799227799227799,1.0,1.0,2/10,5.70%,SMAD6;MAP2K5
prerank,positive regulation of chromatin organization (GO:1905269),0.3330245602566451,0.7134669596684118,0.7984189723320159,1.0,1.0,4/12,18.07%,ATRX;ACD;SIN3A;TINF2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24678989334987741,0.7134247198898808,0.9096477794793262,1.0,1.0,9/60,12.68%,SMOC2;ATM;ACD;DSCC1;PDGFRB;TNKS2;AURKB;FBXO4;PNKP
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2354468143047248,0.7134231850736991,0.9154929577464789,1.0,1.0,1/86,0.14%,EPAS1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.19482881923291012,-0.7131699564404655,0.9759450171821306,0.9777249250321685,1.0,31/87,30.34%,FBXL7;PSMB2;DACT1;PSMD14;PSMC6;FAM107A;CDKN1A;JADE1;MYO16;PSMA4;PSMB9;APC;SKP1;RGCC;CDC73;PSMD11;PSMB10;PSMD2;DCUN1D3;PSMA2;CDKN2B;PSMB3;KLF4;FHL1;CCL2;PSMB5;PSMA7;PSMF1;PSMD7;WEE1;AURKA
prerank,eosinophil migration (GO:0072677),-0.295576583053058,-0.7130537580418101,0.8394308943089431,0.9765184085960402,1.0,8/14,45.45%,SCG2;CCL13;CCL2;CCL11;CCL4;CCL8;CCL1;CCL3
prerank,eosinophil chemotaxis (GO:0048245),-0.295576583053058,-0.7130537580418101,0.8394308943089431,0.9765184085960402,1.0,8/14,45.45%,SCG2;CCL13;CCL2;CCL11;CCL4;CCL8;CCL1;CCL3
prerank,maintenance of protein localization in organelle (GO:0072595),0.30241974625539103,0.711876322542259,0.8156996587030717,1.0,1.0,8/19,25.41%,HK2;TAPT1;PML;TAF3;TAF8;HK1;SUPT7L;ARL2
prerank,gastrulation (GO:0007369),-0.2882757968733264,-0.7110529164977868,0.8366445916114791,0.9779480498668807,1.0,5/15,27.13%,TASOR;LHX1;UGDH;LMBRD1;NR4A3
prerank,regulation of response to interferon-gamma (GO:0060330),-0.2874411085052324,-0.7109524086584667,0.8366445916114791,0.9773691145789457,1.0,3/14,9.42%,HSP90AB1;IFNGR2;JAK1
prerank,regulation of mRNA stability (GO:0043488),0.21526830977841988,0.7109395471773845,0.9682337992376112,1.0,1.0,17/145,12.32%,ROCK2;TNPO1;TNFSF13;IGF2BP1;SAMD4A;LARP1;EXOSC7;GDNF;IGF2BP2;CSDC2;YTHDF3;TBRG4;THRAP3;NOCT;AXIN2;DCP1A;PRKCA
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.22291489113411628,-0.7108705946478662,0.9287671232876712,0.9767800703016418,1.0,10/40,19.58%,PGLYRP1;RPL39;GBP4;DROSHA;TIRAP;MPEG1;LBP;RARRES2;PPP1R11;ROMO1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.2913574303187329,0.7108588846182659,0.8230240549828178,1.0,1.0,5/20,15.53%,CTR9;MEIS1;LDB1;ZFP36L1;HOXB8
prerank,replication fork processing (GO:0031297),0.2698207450765577,0.7104339148518509,0.8776508972267537,1.0,1.0,5/38,10.84%,ATRX;SAMHD1;FBH1;FANCM;EME2
prerank,regulation of hippo signaling (GO:0035330),0.3036258159081178,0.7101386326856612,0.8465804066543438,1.0,1.0,7/17,21.38%,VGLL4;WWC2;AJUBA;MOB3B;WTIP;MAPK14;DLG5
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3168797814207137,-0.709706872754416,0.844017094017094,0.9773332590368599,1.0,7/10,41.16%,APC;SIRT2;ECT2;SPAG5;KNSTRN;CCNB1;NEK2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.34406188425373424,0.709466920444998,0.8275193798449613,1.0,1.0,4/10,21.12%,SIRT1;TAF7;KLF15;NOC2L
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2545115444656273,-0.7092514673862584,0.8891402714932126,0.977156724394316,1.0,1/24,0.78%,ABCG2
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.25306574124486647,0.7086504435846444,0.86,1.0,1.0,12/52,19.50%,CXXC1;TLN1;TPP1;WIPI1;EXTL1;CTDSP2;GFPT1;SYVN1;SEC31A;ATP6V0D1;FKBP14;PARP16
prerank,response to gamma radiation (GO:0010332),0.2872684852936947,0.7078591855132619,0.843103448275862,1.0,1.0,8/24,20.02%,ATM;TP53;CRYAB;TLK2;KDM1A;YAP1;FANCD2;LIG4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.28090826426548243,0.7078583532281829,0.8606271777003485,1.0,1.0,2/27,2.00%,PPARA;IL18
prerank,sensory perception (GO:0007600),-0.2204781841084194,-0.7078030375945255,0.9431818181818182,0.9779650172718473,1.0,17/45,28.82%,GNAS;PCDH15;PTGES;MME;SCN9A;GNAL;TMEM150C;CHRNA7;TRPA1;TTC8;PENK;OPRM1;PNOC;CCL2;OPRL1;P2RX7;CDH23
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.2936235938067915,-0.7073207104284763,0.8580931263858093,0.9778056928437554,1.0,3/14,13.17%,ACTR2;WDR48;ERCC6
prerank,phasic smooth muscle contraction (GO:0014821),-0.31770746446300785,-0.7072013747412801,0.8464818763326226,0.9772459026344775,1.0,4/10,21.60%,EDN1;EDN3;EDNRB;DRD2
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.22695297807919634,-0.7068882713925636,0.9264305177111717,0.9768758615817895,1.0,4/42,12.09%,LARS2;WARS2;GARS1;DARS2
prerank,cellular response to ionizing radiation (GO:0071479),0.24840555252641083,0.7064032658929991,0.8845528455284553,1.0,1.0,18/47,24.06%,ATM;TP53;NIPBL;SIRT1;HUS1;CRYAB;GADD45A;TLK2;INTS7;KDM1A;MAPK14;YAP1;LIG4;TANK;RAD9A;FIGNL1;TSPYL5;NUCKS1
prerank,cellular response to acid chemical (GO:0071229),0.2816993350857372,0.7063131736361966,0.8677248677248677,1.0,1.0,7/27,19.10%,CPEB4;SESN2;CPEB3;RPTOR;NSMF;RRAGD;LAMTOR1
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.23930519829801833,-0.7060906540846306,0.9174757281553398,0.9770048687103123,1.0,14/30,27.66%,HMGCS1;IDI1;PMVK;LSS;SQLE;DHCR7;DHCR24;CYP51A1;MSMO1;ACAT2;EBP;HMGCR;FDPS;HSD17B7
prerank,regulation of exit from mitosis (GO:0007096),0.2611456611456889,0.7059100179421102,0.8601626016260162,1.0,1.0,6/38,16.68%,ANAPC15;ANAPC2;CDC14A;CDC14B;ANAPC16;UBE2E1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.24932649719516442,0.7055830991979496,0.8938193343898574,1.0,1.0,16/56,22.92%,NDUFAF4;NDUFAB1;NDUFS1;NDUFV2;FOXRED1;NDUFAF5;TIMMDC1;DMAC2;NDUFS4;TMEM126B;NDUFA2;NDUFAF7;NDUFS5;TIMM21;NDUFA9;NDUFB2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.24932649719516442,0.7055830991979496,0.8938193343898574,1.0,1.0,16/56,22.92%,NDUFAF4;NDUFAB1;NDUFS1;NDUFV2;FOXRED1;NDUFAF5;TIMMDC1;DMAC2;NDUFS4;TMEM126B;NDUFA2;NDUFAF7;NDUFS5;TIMM21;NDUFA9;NDUFB2
prerank,regulation of isotype switching (GO:0045191),0.32200283960904486,0.7055359875206539,0.8131672597864769,1.0,1.0,2/14,6.46%,KMT5C;KMT5B
prerank,protein targeting to mitochondrion (GO:0006626),-0.21778845060215554,-0.7053879386019777,0.9283582089552239,0.9770758530788907,1.0,15/52,22.11%,IMMP2L;AIFM1;HSP90AA1;TOMM7;FBXO7;AIP;TIMM29;GDAP1;BCAP31;TOMM22;TIMM8B;ROMO1;DNLZ;TOMM20;TIMM13
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.20424151881639363,-0.7052823515268795,0.9607250755287009,0.9765159259025651,1.0,39/66,41.95%,STAT3;FOXP1;APP;EGR1;AIM2;CARD16;USP50;CX3CR1;NOD2;PANX1;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;GIT1;NLRP2B;F2R;JAK2;TRIM16;P2RX7;CD36;MALT1;TNFAIP3;CD33;TLR8;MYD88;TMEM106A;GBP5;CPTP;ISL1;CASP8;INAVA;TNF;NLRP12;ZC3H12A;LPL;GSDMD;IL6
prerank,regulation of cellular senescence (GO:2000772),0.28152768205922035,0.7049483538406631,0.867003367003367,1.0,1.0,7/28,14.53%,SLC30A10;HMGA1;TERT;SIRT1;RBL1;RSL1D1;ZKSCAN3
prerank,regulation of cilium assembly (GO:1902017),0.24705196966617798,0.7049108826517084,0.8793893129770992,1.0,1.0,20/62,21.59%,DCDC2;TBC1D16;ATG5;RABEP2;HTT;SDCCAG8;IFT88;TAPT1;TCHP;SGSM3;TBC1D14;TBC1D7;EVI5;YAP1;TBC1D22B;CEP120;EVI5L;TBC1D24;FUZ;USP6NL
prerank,mitotic metaphase plate congression (GO:0007080),0.24394918711297736,0.704444946056946,0.8709150326797386,1.0,1.0,9/51,17.02%,EML4;CHMP1A;BECN1;CHAMP1;KIFC1;VPS4A;CENPC;CHMP4C;PIBF1
prerank,protein polyglutamylation (GO:0018095),0.33278638036296015,0.704166169835564,0.8023255813953488,1.0,1.0,2/11,7.04%,TTLL6;TTLL9
prerank,base-excision repair (GO:0006284),0.24910247337876285,0.7035290811613617,0.8825347758887172,1.0,1.0,14/48,23.81%,POLD2;POLG;HUWE1;PNKP;TDG;POLL;MBD4;OGG1;FEN1;RFC1;XPA;LIG1;ADPRS;SMUG1
prerank,histone mRNA metabolic process (GO:0008334),0.27396072207892075,0.7033735637446786,0.8342541436464088,1.0,1.0,6/27,16.39%,ATM;TUT4;TENT2;TENT4B;CPSF3;TUT7
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23479265223878037,0.7022976470823417,0.9174174174174174,1.0,1.0,6/71,6.32%,PRKN;FBXL17;NGLY1;CTSH;USP9X;CLPX
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3228672158028012,0.7020569023492104,0.8194945848375451,1.0,1.0,3/13,10.95%,NEDD4;NIBAN2;CNMD
prerank,protein kinase B signaling (GO:0043491),0.28864603030652997,0.7014358392364105,0.8556701030927835,1.0,1.0,5/23,15.26%,IGF1;PTEN;PIK3R3;THEM4;ZFP36L1
prerank,positive regulation of histone modification (GO:0031058),0.26877882398506303,0.7013515875263432,0.8512396694214877,1.0,1.0,3/33,7.38%,PPARGC1A;ARRB1;NIPBL
prerank,positive regulation of interleukin-8 production (GO:0032757),0.24845520737826568,0.7007005085198542,0.8918495297805643,1.0,1.0,7/49,9.78%,TLR3;TLR4;IL17D;AFAP1L2;SERPINE1;RIPK1;MAVS
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2965532534159995,-0.6998569555656027,0.8617234468937875,0.9813392118547635,1.0,2/13,7.47%,GRIN2A;PERP
prerank,cytoplasmic microtubule organization (GO:0031122),0.2438200160641929,0.6997212380520835,0.9118086696562033,1.0,1.0,4/54,4.65%,DLG1;HOOK2;CLASP1;EZR
prerank,microtubule-based transport (GO:0099111),0.31597047078949436,0.6993357817062448,0.8155339805825242,1.0,1.0,2/13,8.59%,ROPN1L;HTT
prerank,regulation of melanin biosynthetic process (GO:0048021),0.3369710807579186,0.6991272032891988,0.836852207293666,1.0,1.0,4/10,30.34%,CTNS;ATP7A;RAPGEF2;CDH3
prerank,protein import into peroxisome matrix (GO:0016558),-0.29545175877294455,-0.6988356950320946,0.8438133874239351,0.9816805747539962,1.0,1/12,2.23%,PEX5L
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.23866461187972848,-0.6982055328499911,0.8942065491183879,0.9816227018282295,1.0,7/33,19.30%,STAT3;STAT5B;HIF1A;TAL1;FES;INHBA;FAM210B
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2588937293263206,0.6967172788614976,0.8682432432432432,1.0,1.0,9/36,20.24%,ATM;DONSON;HUS1;DOT1L;CEP63;CLSPN;INTS7;NBN;RAD9A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.3006094444060326,0.6960404255046279,0.8143939393939394,1.0,1.0,6/17,24.74%,AURKB;IK;CHAMP1;RB1;MIS12;SPDL1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.30941816709999254,-0.6959930056509346,0.854389721627409,0.9831127799166075,1.0,1/10,7.44%,SREBF2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2724107681544875,0.6958489403562599,0.8576512455516014,1.0,1.0,8/29,20.27%,ACOT11;MLYCD;ACOT8;THEM4;ACOT12;ACLY;CROT;ACSF2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2724107681544875,0.6958489403562599,0.8576512455516014,1.0,1.0,8/29,20.27%,ACOT11;MLYCD;ACOT8;THEM4;ACOT12;ACLY;CROT;ACSF2
prerank,negative regulation of translational initiation (GO:0045947),0.3230054027386021,0.6955460747218648,0.8298676748582231,1.0,1.0,6/13,29.96%,LARP1;RBM4;FMR1;AGO2;EIF4EBP1;EIF2AK1
prerank,cellular response to light stimulus (GO:0071482),0.2355016038157517,0.69485643829284,0.9147982062780269,1.0,1.0,20/66,23.79%,NEDD4;RHO;TP53;CDC25A;AURKB;ZBTB1;SDE2;CREBBP;SAG;KDM1A;TAF1;PDE6B;FMR1;NOC2L;OPN1SW;YY1;CASP9;EP300;OPN1MW;OPN1MW3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3137529451239136,0.6938800093846865,0.8330058939096268,1.0,1.0,3/13,18.49%,VDAC2;BLOC1S2;RHOT1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.2530629801733152,-0.6923407416081835,0.9045346062052506,0.9859510508202265,1.0,5/24,14.09%,TGFB2;EPHA7;ATF4;CTNNB1;CDK5R1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.18625918184346346,-0.6914957931450093,0.9965034965034965,0.9861451358106433,1.0,17/101,18.10%,MEF2C;PDE4B;LYN;DAB2IP;TNFRSF1B;TGFB1;SBNO2;VIM;CARD16;LBP;MTDH;CX3CR1;NOD2;CD180;TRIM41;PDCD4;CDC73
prerank,regulation of lipid catabolic process (GO:0050994),-0.26773369494644106,-0.6913801087125385,0.8883720930232558,0.9855852986852903,1.0,1/19,2.06%,PDE3B
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.26048533139451663,0.6913757545935024,0.8955223880597015,1.0,1.0,5/35,8.59%,CD300A;PPP4R4;MAGI2;PDGFRB;HTT
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.26347657112162653,-0.6913186418941973,0.8822170900692841,0.9849809482941609,1.0,7/19,21.18%,DDIT4;HIPK1;PHLDA3;BCL3;HIPK2;RPS27L;PYCARD
prerank,regulation of receptor internalization (GO:0002090),0.25701637053750603,0.6907898675057924,0.8852459016393442,1.0,1.0,5/35,9.69%,MAGI2;ARRB1;RIN3;ATXN2;PICK1
prerank,vacuolar acidification (GO:0007035),-0.2550482504993614,-0.69014269845857,0.8918918918918919,0.9854194718360036,1.0,3/21,9.52%,ATP6V0A1;ATP6V0A4;PPT1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.31905432075508305,0.6897415812982178,0.8132075471698114,1.0,1.0,2/12,12.62%,INSIG2;TAPT1
prerank,microtubule depolymerization (GO:0007019),0.29363550303492714,0.6874431195708569,0.8392523364485981,1.0,1.0,1/17,1.82%,KIF2A
prerank,regulation of multicellular organismal development (GO:2000026),0.27707164779206817,0.6867242993503523,0.853309481216458,1.0,1.0,5/25,16.82%,OAS2;NIPBL;TRIP12;TDG;EHMT1
prerank,endoderm development (GO:0007492),0.31167017182041457,0.6866512872902251,0.835820895522388,1.0,1.0,1/13,2.05%,LAMC1
prerank,cellular response to superoxide (GO:0071451),0.3235021426221397,0.6864744462681638,0.8043478260869565,1.0,1.0,2/10,5.88%,SOD3;SOD2
prerank,B cell mediated immunity (GO:0019724),0.3272418554693548,0.6861467541978862,0.8485436893203884,1.0,1.0,1/10,5.66%,CD27
prerank,regulation of axon regeneration (GO:0048679),0.31971308164935713,0.6861287460979895,0.8048780487804879,1.0,1.0,1/12,2.17%,EPHA4
prerank,regulation of B cell differentiation (GO:0045577),0.299691957114447,0.6859418553564507,0.8527724665391969,1.0,1.0,5/17,20.38%,CD27;MMP14;ZFP36L1;INHA;IKZF3
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.22974750183228534,-0.6857288963157017,0.9110070257611241,0.9887812016272858,1.0,6/33,14.08%,PTPRJ;RPS3;CEACAM1;DUSP3;DGKZ;LAPTM5
prerank,regulation of neutrophil migration (GO:1902622),-0.30816205465817625,-0.6856686372827601,0.8541266794625719,0.9881615687098332,1.0,6/10,31.92%,MPP1;RHOH;RHOG;JAM3;BST1;RAC2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.3026386287236446,-0.6854749402663068,0.8620689655172413,0.9876739326022921,1.0,4/11,22.63%,CD44;TAF9B;CD74;TRIAP1
prerank,regulation of histone deacetylation (GO:0031063),-0.2814591236175038,-0.6850206262371404,0.8412371134020619,0.9874483757630151,1.0,1/13,2.27%,CAMK2D
prerank,histone acetylation (GO:0016573),0.2273038024524597,0.6848224120354783,0.9334298118668596,1.0,1.0,21/69,25.13%,BRD8;CPA4;ZZZ3;KAT6B;ATF2;BRD1;KAT14;KAT7;BEND3;KAT2B;CREBBP;SGF29;TAF6L;RUVBL1;EP300;DMAP1;SUPT7L;MSL3;TAF12;PHF20;ING3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.20666685238905122,-0.6846732793398149,0.9545454545454546,0.9870885675716564,1.0,16/51,23.46%,NEK7;GNL3L;XRCC5;CTNNB1;SMG5;TERF1;CCT8;STN1;CCT2;PRKCQ;CCT6A;HMBOX1;CCT7;DCP2;EXOSC10;MAP2K7
prerank,anterograde axonal transport (GO:0008089),0.2544107732550804,0.6842071049606381,0.8994974874371859,1.0,1.0,8/37,15.23%,TRAK1;DTNBP1;KIF1B;KIF1C;BLOC1S6;BLOC1S2;KIF5B;RAB21
prerank,response to UV (GO:0009411),-0.18732554650706593,-0.6834885988896674,0.9791666666666666,0.9875195912804726,1.0,35/95,30.19%,PTPRK;RPL26;MAP4K3;MFAP4;ATF4;ERCC6;SDF4;PRIMPOL;METTL3;UBE2B;BCL3;GPX1;CAT;RHBDD1;MEN1;DCUN1D3;ERCC2;POLD1;NPM1;TRIAP1;N4BP1;POLK;DTL;MAP2K7;RUVBL2;RELA;CCAR2;PCLAF;UBE2A;CCND1;MAPK8;CIRBP;BMF;ERCC3;AQP1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.27869540763610073,0.6830680702655418,0.8621291448516579,1.0,1.0,4/26,9.34%,PRKN;LRRK2;SOD2;SIRT1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.2822795606990568,-0.6829551474401981,0.8967611336032388,0.9873174690197126,1.0,6/14,31.27%,NCBP2;ERN1;CPSF4;CPSF4L;CSTF2T;CPSF1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3102609692069382,0.6827865665279766,0.8380414312617702,1.0,1.0,2/13,7.77%,UBAC2;ERLEC1
prerank,COPII vesicle coating (GO:0048208),-0.20442214347125068,-0.6821301313731393,0.9684813753581661,0.9860564926694917,1.0,18/61,25.51%,GRIA1;CTSC;CUL3;NSF;CNIH1;KLHL12;ANKRD28;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;TRAPPC3;RAB1B
prerank,vesicle coating (GO:0006901),-0.20442214347125068,-0.6821301313731393,0.9684813753581661,0.9860564926694917,1.0,18/61,25.51%,GRIA1;CTSC;CUL3;NSF;CNIH1;KLHL12;ANKRD28;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;TRAPPC3;RAB1B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.20442214347125068,-0.6821301313731393,0.9684813753581661,0.9860564926694917,1.0,18/61,25.51%,GRIA1;CTSC;CUL3;NSF;CNIH1;KLHL12;ANKRD28;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;TRAPPC3;RAB1B
prerank,protein targeting to lysosome (GO:0006622),-0.2590596789155014,-0.6816021870459946,0.9010752688172043,0.9858587545177433,1.0,7/20,16.29%,HSPA8;SORL1;GCC2;LAPTM5;CLU;NCOA4;M6PR
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.3114474820885442,0.680938895512646,0.8349328214971209,1.0,1.0,1/12,1.76%,PPARA
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.208618780004321,-0.6808295688379116,0.955026455026455,0.9858764128257629,1.0,13/48,18.84%,TNFRSF1B;FNIP2;DDIT4;HIPK1;CRIP1;PHLDA3;BCL3;HIPK2;CASP2;HTRA2;CHEK2;BCL2L11;RPS27L
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2345015384599917,-0.6806835270738754,0.9079903147699758,0.9853359410467006,1.0,8/28,26.52%,SH3KBP1;CD47;NOD2;PRKCQ;TYROBP;PYCARD;THY1;CCL2
prerank,determination of left/right symmetry (GO:0007368),0.2522089816699387,0.6803673998880049,0.8907014681892332,1.0,1.0,10/37,21.08%,SMO;MKKS;GALNT11;CCDC39;ARL6;ENKUR;CCDC40;OFD1;CITED2;DAND5
prerank,chromosome condensation (GO:0030261),-0.2238872244997247,-0.6802754517230322,0.9418886198547215,0.9850110372252748,1.0,14/36,27.96%,AIFM1;SMC4;GPER1;NCAPG2;TOP2A;NUSAP1;BANF1;MCPH1;PHF8;NCAPH;TTN;SET;NCAPH2;CSNK2B
prerank,negative regulation of centrosome duplication (GO:0010826),-0.29963749163012077,-0.6799597836158426,0.8634361233480177,0.9846325413658426,1.0,3/11,21.60%,CDK5RAP2;TRIM37;NPM1
prerank,transcription by RNA polymerase III (GO:0006383),-0.2371652277092709,-0.6797531849913598,0.9075,0.9841444372972991,1.0,3/27,10.80%,IVNS1ABP;RO60;GTF3C5
prerank,intracellular pH reduction (GO:0051452),-0.22682751468053022,-0.6795935335014152,0.9436619718309859,0.9836378204534226,1.0,9/33,21.62%,ATP6V0A1;ATP6V0A4;RAB38;CLCN3;RAB39A;GPR89A;GPR89B;ATP6V1F;ATP6V1B2
prerank,fatty acid biosynthetic process (GO:0006633),0.23151035814255416,0.6794902846577371,0.9263622974963182,1.0,1.0,6/63,7.40%,ALOX12;ACSBG2;HACD4;HACD1;SCD5;NDUFAB1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3073575944022499,0.6791797677931759,0.831758034026465,1.0,1.0,1/13,2.89%,NFAT5
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.29592873268973174,-0.6790960884435304,0.8913934426229508,0.983412128623932,1.0,3/11,19.59%,CAMK4;ITGB2;TYROBP
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2886415165152712,0.6786381020592328,0.8448905109489051,1.0,1.0,2/20,7.92%,NR2F2;PTEN
prerank,mitotic cytokinetic process (GO:1902410),0.28458410983181187,0.6784890647148686,0.8535714285714285,1.0,1.0,6/20,21.80%,KLHDC8B;CHMP1A;VPS4A;CHMP4C;CHMP2A;MITD1
prerank,proteasomal protein catabolic process (GO:0010498),0.1979141411637413,0.6784123793936688,0.9900744416873449,1.0,1.0,23/201,11.88%,PRKN;FBXL17;SPSB1;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;SPSB4;TBL1X;SMURF2;FBXW11;HUWE1;ERLEC1;BTRC;TBL1XR1;RNF34;SIRT1;ZSWIM8;RNF41;WWP2;CUL4A
prerank,mitochondrial translational elongation (GO:0070125),0.2181418418569745,0.6780417304109589,0.9556786703601108,1.0,1.0,24/88,26.23%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;MRPL1;GFM2;MRPL45;MRPS17;CHCHD1;MRPL14;MRPL32;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19;TSFM
prerank,regulation of mRNA metabolic process (GO:1903311),0.3204800269905661,0.6780031280053478,0.8442776735459663,1.0,1.0,2/11,10.61%,SLTM;SRPK2
prerank,immunoglobulin mediated immune response (GO:0016064),0.3262612470373889,0.6775988412985597,0.8273092369477911,1.0,1.0,1/10,5.66%,CD27
prerank,organic cation transport (GO:0015695),0.2859252878643035,0.6770720581904449,0.8563829787234043,1.0,1.0,8/20,19.67%,SLC22A18;SLC22A5;RALBP1;SLC25A42;SLC25A29;SLC25A19;SLC25A26;SLC22A4
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.26953217900866555,-0.6770586553888734,0.8969298245614035,0.9845125766081445,1.0,6/16,29.69%,ST3GAL4;ITGB2;MDK;RELA;SELP;RHOA
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.32407079165699576,0.6768474973499177,0.8165680473372781,1.0,1.0,2/10,15.81%,ACD;TFIP11
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.32893027967643773,0.6758876241867275,0.8113948919449901,1.0,1.0,6/10,33.22%,ATP5F1D;ATP5F1C;ATP5MC3;VPS9D1;ATP5MG;ATP5MC2
prerank,protein localization to centrosome (GO:0071539),-0.2626466602520171,-0.6757866066523383,0.8875598086124402,0.984943406423913,1.0,6/17,31.20%,CEP83;CEP131;SPAG5;NEDD1;STIL;CSNK1D
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.20735369408262305,-0.6757462702282148,0.968299711815562,0.9843179512978167,1.0,3/45,6.25%,GRM5;GCNT2;APP
prerank,cochlea morphogenesis (GO:0090103),-0.2982007587977112,-0.6751551623256921,0.8571428571428571,0.9841447694359374,1.0,7/10,34.33%,TBX1;TBX18;PAX2;MYO3B;MYO3A;HPN;TIFAB
prerank,determination of bilateral symmetry (GO:0009855),-0.241744950683846,-0.674343352393846,0.9134615384615384,0.984179708399663,1.0,2/25,5.71%,NOTCH1;TBX1
prerank,regulation of actin filament depolymerization (GO:0030834),0.31723991307072313,0.6743103305836741,0.8427787934186471,1.0,1.0,3/12,11.39%,PLEKHH2;PIK3CA;VIL1
prerank,positive regulation of mRNA processing (GO:0050685),-0.2516389212394271,-0.67326867571588,0.868663594470046,0.98441811076068,1.0,9/21,33.67%,CELF4;CDC73;TRA2A;RBM3;NCBP2;RBMXL1;CIRBP;SF3B4;CELF3
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2317971513411498,-0.6731721034506966,0.9228971962616822,0.9838391671928123,1.0,6/28,17.55%,MAP1B;CLASP2;STMN2;MAPT;STMN1;FKBP4
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2332338645347134,0.6726896928584086,0.9365558912386707,1.0,1.0,22/62,26.79%,POLR2A;TNRC6A;POLR2D;NUP42;AJUBA;NUP98;NUP43;WTIP;NUP155;EIF4G1;NUP188;POLR2G;FMR1;NUP153;AGO1;POLR2F;AAAS;NUP88;AGO2;PUM2;SEC13;POLR2K
prerank,monocyte chemotaxis (GO:0002548),-0.22740861176595834,-0.6723403174351794,0.9382422802850356,0.9838834142303725,1.0,3/32,5.86%,ANXA1;TNFRSF11A;RPS19
prerank,regulation of cellular response to stress (GO:0080135),0.20979023277177036,0.6718403914343705,0.9725274725274725,1.0,1.0,18/115,16.74%,ROCK2;PRKN;NUPR1;SMG1;ATM;SIRT1;NUP42;AJUBA;ABL1;NUP98;NUP43;CRYAB;RSL1D1;AMFR;RPTOR;NUP155;CREBBP;MCL1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2932442240593838,-0.6716987479001264,0.8726114649681529,0.9837555291784523,1.0,8/11,38.78%,TIMM29;TIMM8B;ROMO1;TIMM13;NDUFA13;TIMM10B;AGK;TIMM9
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.26272866086221414,0.671607847829533,0.8894557823129252,1.0,1.0,6/32,12.68%,ATM;ACD;TNKS2;AURKB;FBXO4;PNKP
prerank,regulation of cell size (GO:0008361),0.27066982981747145,0.6713302815815246,0.8677966101694915,1.0,1.0,6/23,15.83%,DEPTOR;EZR;PTEN;RARG;VAV3;RPTOR
prerank,regulation of chromatin binding (GO:0035561),0.3144492640876888,0.67127567278213,0.8383458646616542,1.0,1.0,2/10,11.77%,PARP9;WAPL
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.32073732815667366,0.6712683361164974,0.8389513108614233,1.0,1.0,2/11,15.43%,SIRT1;TAF7
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.21318654759802652,0.6709272982645892,0.9675599435825106,1.0,1.0,24/96,22.90%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;U2AF2;NUP153;FYTTD1;SMG6
prerank,mitotic cell cycle phase transition (GO:0044772),0.19723330245876858,0.6708540834886522,0.9912390488110138,1.0,1.0,45/204,20.83%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;CCNA1;CACUL1;FBXW11;BTRC;CCND3;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8;CENPJ;CUL4A;NASP;DNM2;ALMS1;CTDP1;ACVR1B;CCNG1;CEP63;RB1;CCNE1;USP37;OPTN;CDC34;CEP57;AKAP9;PCM1;CEP164;OFD1;FBXL22;PCNT;TAF2;CHMP2A;UBE2S;DCTN3;CUL5;CCNG2
prerank,toll-like receptor signaling pathway (GO:0002224),0.21704363016267372,0.6707481584878384,0.9571005917159763,1.0,1.0,13/84,16.08%,COLEC12;TLR3;TLR4;MAPKAPK3;TAB2;RIPK2;RIPK1;LY96;NMI;MAP3K1;TLR5;BIRC3;SCARA3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.25760578409355894,-0.6703391994058034,0.8997821350762527,0.9842691343550856,1.0,2/18,8.42%,POLA1;POLD3
prerank,triglyceride catabolic process (GO:0019433),0.28957371535983156,0.6700624429931206,0.8561151079136691,1.0,1.0,1/19,4.38%,CPS1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.30254375150376367,0.6698645292606205,0.8484848484848485,1.0,1.0,2/15,5.82%,RAPGEF3;CAMK1
prerank,mRNA transport (GO:0051028),0.21163511351251832,0.6694231539534525,0.9689265536723164,1.0,1.0,26/101,22.90%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;ZFP36L1;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;FMR1;U2AF2;NUP153;FYTTD1;SMG6
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.18425492992261233,-0.669333419862701,0.9868852459016394,0.9844517488195481,1.0,32/84,34.29%,PSMB2;CUL3;PSMD14;ECRG4;PSMC6;BUB3;UBB;FBXO31;PSMA4;PSMB9;CDC23;PSMD11;PSMB10;PSMD2;MAD2L1;PSMA2;UBC;RPS27A;PSMB3;PSMB5;UBE2D1;PSMA7;PSMF1;PSMD7;AURKA;CDK1;CDC20;PSMA5;UBE2C;PSMD4;ANAPC10;PSME4
prerank,regulation of microtubule nucleation (GO:0010968),0.319277345937482,0.669178591371164,0.834319526627219,1.0,1.0,1/10,2.50%,EML2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.28862414086788973,0.6682559215334903,0.889087656529517,1.0,1.0,4/18,10.62%,POR;SIRT3;GDNF;ABL1
prerank,stress-activated MAPK cascade (GO:0051403),-0.19564564950384528,-0.6678595405158568,0.987012987012987,0.9849733553094286,1.0,17/61,25.00%,MAP3K5;NOD1;MINK1;MAP3K7;TNFRSF19;MAP4K3;IKBKB;UBB;NOD2;SKP1;LGALS9;MAP3K11;SH2D3C;MAP2K7;UBC;RPS27A;TAB1
prerank,regulation of acrosome reaction (GO:0060046),-0.2930584096228499,-0.6675337362312906,0.8547368421052631,0.9845975097727102,1.0,2/10,15.36%,GLRA1;CACNA1H
prerank,RNA modification (GO:0009451),0.23551813543979921,0.6672363689123092,0.9419152276295133,1.0,1.0,9/54,19.97%,TRMT9B;RBM15;JMJD6;NOP2;LCMT2;WDR4;DTWD2;NSUN4;ADAT2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2245641259279034,-0.666854330068084,0.9384615384615385,0.9844541118726605,1.0,8/30,22.64%,CAVIN1;TAF1B;GTF2H1;GTF2H4;GTF2H5;ERCC2;POLR1F;POLR2L
prerank,regulation of B cell apoptotic process (GO:0002902),0.3071767892926863,0.6661477105305246,0.8454198473282443,1.0,1.0,5/12,22.31%,FNIP1;AURKB;BCL6;NOC2L;ORMDL3
prerank,protein hydroxylation (GO:0018126),0.28986668234769947,0.6659518660830235,0.8759124087591241,1.0,1.0,6/15,22.65%,VIPAS39;ASPH;HIF1AN;OGFOD1;P3H4;VPS33B
prerank,regulation of translational initiation (GO:0006446),0.22772772581801334,0.6656387985870572,0.9451851851851852,1.0,1.0,15/63,21.07%,CTIF;MIF4GD;DDX3X;POLR2D;LARP1;YTHDF3;EIF4A2;IMPACT;RBM4;EIF4G1;BOLL;EIF5;POLR2G;RPS6KB2;FMR1
prerank,positive regulation of actin nucleation (GO:0051127),0.3084790432009765,0.6638504782945476,0.8443223443223443,1.0,1.0,1/11,2.14%,FCHSD2
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3051007065488408,0.6635484588354063,0.8541266794625719,1.0,1.0,3/13,9.52%,PRODH;ALDH4A1;GLUL
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.2953087164337179,0.6621399180831852,0.8623188405797102,1.0,1.0,5/14,22.88%,LHPP;ADSS1;GART;ADSL;GMPS
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.310817766282436,0.6602247008870799,0.8467432950191571,1.0,1.0,2/12,7.28%,CYP26B1;DHRS3
prerank,sister chromatid segregation (GO:0000819),0.2526618688148826,0.6599072642616459,0.920774647887324,1.0,1.0,6/31,17.45%,TOP2B;CHAMP1;DSN1;KIFC1;RB1;CENPK
prerank,purine nucleotide biosynthetic process (GO:0006164),0.31107067616220907,0.6595497976014937,0.8547169811320755,1.0,1.0,6/12,20.76%,PRPSAP1;AMPD2;PRPSAP2;MTHFD1;GART;ADSL
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.2568064489967062,-0.6594029654010547,0.9118942731277533,0.9894791926048262,1.0,3/18,18.79%,ANXA1;FAM107A;BCL2L11
prerank,pigment granule transport (GO:0051904),-0.2561542592326791,-0.6593718745039144,0.8794642857142857,0.9881882917585277,1.0,4/18,16.82%,MYO5A;RAB27A;RAB27B;MREG
prerank,melanosome transport (GO:0032402),-0.2561542592326791,-0.6593718745039144,0.8794642857142857,0.9881882917585277,1.0,4/18,16.82%,MYO5A;RAB27A;RAB27B;MREG
prerank,nucleotide-excision repair (GO:0006289),-0.17762073151895008,-0.6591714212118279,0.9924242424242424,0.9876930899350896,1.0,29/101,23.93%,POLA1;POLD3;RAD23B;AQR;ERCC1;ERCC6;POLR2J;UBB;RPA1;COPS4;BRIP1;CETN2;GTF2H1;FANCC;COPS6;GTF2H4;COMMD1;GTF2H5;RFC4;COPS5;ERCC2;POLD4;POLD1;RFC2;POLR2C;POLR2L;POLK;UBC;RPS27A
prerank,oligodendrocyte differentiation (GO:0048709),0.2741851704772701,0.6591002468149474,0.8813868613138686,1.0,1.0,3/19,15.17%,SLC8A3;SOX13;EIF2B1
prerank,positive regulation of lipid storage (GO:0010884),0.2710104177369864,0.6586566853049168,0.8811188811188811,1.0,1.0,4/21,14.87%,IKBKE;OSBPL11;PLIN3;NFKB1
prerank,cytoplasmic translational initiation (GO:0002183),-0.2604169740900742,-0.6582272219923787,0.8993576017130621,0.9877386618086551,1.0,4/17,20.88%,EIF3M;EIF2B3;EIF4A1;EIF3D
prerank,protein modification by small protein removal (GO:0070646),0.18877155327324646,0.6571258347924613,0.9975845410628019,1.0,1.0,62/252,23.65%,SMAD3;PRKN;SENP3;CCNA2;TGFBR1;BABAM2;USP3;CCNA1;USP9X;USP24;TP53;USP11;SMURF2;PTEN;RCE1;CDC25A;RIPK1;BECN1;INO80D;USP34;USP49;UIMC1;DESI2;DESI1;USP12;USP7;BABAM1;DDB2;MBD6;OGT;USP18;KAT2B;BIRC3;USP37;UFD1;CLSPN;SMAD4;ASXL2;USP48;USP1;RHOT1;COPS8;USP33;USP21;USP16;USP35;INO80E;TRAF3;OTUD3;USP5;RUVBL1;YY1;EP300;RNF123;USP20;OTUD4;TOR1A;USPL1;PSMC4;USP9Y;OTUB2;PSMD10
prerank,regulation of T cell mediated immunity (GO:0002709),0.313405703002573,0.6566447074253579,0.8374760994263862,1.0,1.0,3/10,18.04%,ZBTB1;CCR2;AGER
prerank,negative regulation of protein transport (GO:0051224),-0.23128485421760164,-0.6566017022660676,0.9360730593607306,0.9883596361851542,1.0,8/25,23.54%,APOE;NDFIP2;PPM1F;ERP29;PKDCC;CYP51A1;DRD2;RHBDF2
prerank,mitotic sister chromatid segregation (GO:0000070),0.2064421086850473,0.6565921136096481,0.9814814814814815,1.0,1.0,19/98,19.18%,EML4;NIPBL;PDS5A;CHMP1A;BECN1;CSNK2A2;CSNK2A1;DSN1;KIFC1;KMT5A;REC8;NCAPD3;VPS4A;RB1;CHMP4C;PIBF1;CENPK;NCAPD2;PDS5B
prerank,RNA export from nucleus (GO:0006405),0.20782041673045584,0.6556854427346902,0.9758522727272727,1.0,1.0,25/100,22.90%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;U2AF2;NUP153;FYTTD1;XPO5;SMG6
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.2660015985253906,-0.6549968683168476,0.9046653144016227,0.9889021310474094,1.0,6/14,25.37%,ATP2B4;PRKAR1B;PRKAR2B;PRKAR2A;PKIG;ADRB2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.28865907130844914,0.6549444508438625,0.8888888888888888,1.0,1.0,2/15,9.30%,STXBP4;GLI1
prerank,establishment of vesicle localization (GO:0051650),0.2821448722372783,0.6545173636723988,0.903448275862069,1.0,1.0,1/18,1.31%,SYT11
prerank,regulation of centriole replication (GO:0046599),-0.24931068989229976,-0.6540723521729223,0.9160997732426304,0.9889642910282873,1.0,7/18,31.17%,PLK2;CDK5RAP2;TRIM37;NPM1;CEP76;STIL;BRCA1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.29373421525873494,0.6539378178098879,0.8672727272727273,1.0,1.0,4/13,20.51%,PRPF3;PRPF6;SRSF10;PRPF31
prerank,regulation of hormone secretion (GO:0046883),0.292908163830512,0.6535782091646501,0.8670520231213873,1.0,1.0,1/15,2.62%,SNX6
prerank,phosphate ion transmembrane transport (GO:0035435),0.305010695154922,0.6529726221336923,0.8544061302681992,1.0,1.0,5/12,22.63%,SLC20A2;SLC25A11;SLC25A10;SLC37A4;SLC25A3
prerank,regulation of necroptotic process (GO:0060544),-0.24060516560207879,-0.6527818491829311,0.9285714285714286,0.9892394684694801,1.0,9/23,24.31%,ARHGEF2;HSP90AA1;PDCD6IP;MLKL;YBX3;PELI1;SPATA2;FLOT1;STUB1
prerank,pancreas development (GO:0031016),-0.27678525708194823,-0.6515665767210906,0.9041394335511983,0.9894681992641097,1.0,2/12,8.60%,MET;PROX1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2133017158865693,0.6510236278656109,0.9674074074074074,1.0,1.0,24/76,24.86%,SPHK1;LRRK2;PIAS1;FANCI;HUWE1;CDK5RAP3;HDAC4;RIPK2;FBXO4;DCUN1D5;PIAS3;BIRC3;CRY1;TBC1D7;NDFIP1;PIAS4;TANK;GSK3A;DERL1;PRICKLE1;PSMD10;TSPYL5;RCHY1;PHF23
prerank,positive regulation of DNA recombination (GO:0045911),0.2582467959779147,0.6494830702542899,0.895,1.0,1.0,3/27,6.46%,ARID2;KMT5C;KMT5B
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.17733059598890794,-0.648599053599255,0.9964664310954063,0.990943533092241,1.0,16/95,18.68%,MEF2C;PDE4B;DAB2IP;TNFRSF1B;SBNO2;TIRAP;VIM;CARD16;LBP;CX3CR1;NOD2;CD180;TRIM41;PDCD4;CDC73;SIRT2
prerank,modulation by host of symbiont process (GO:0051851),0.24963173205721714,0.6485345911210866,0.9068219633943427,1.0,1.0,10/31,24.06%,NAPEPLD;SMARCA4;HDAC1;TAF11;CTDP1;REST;SP1;EP300;SMARCB1;NUCKS1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2108388025784889,-0.648512443183315,0.9623115577889447,0.9903549915223291,1.0,13/37,24.23%,HSP90AB1;RYBP;RPL5;RPS7;DDRGK1;RPL23;NOP53;HIPK2;PDCL3;RPL11;BAG5;N4BP1;CCAR2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.2988009250400471,0.6479106187423982,0.9005964214711729,1.0,1.0,3/13,12.04%,ABHD14B;SULT2B1;TPST1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.27643224639628666,-0.6478663321560348,0.9061224489795918,0.9901595495538142,1.0,6/12,37.88%,PLK2;WEE1;BUB1;ZWILCH;WEE2;ZW10
prerank,sensory perception of taste (GO:0050909),0.31392145401029625,0.6476601260602032,0.8788426763110307,1.0,1.0,1/10,7.82%,GNAT3
prerank,histone exchange (GO:0043486),0.23981637634044561,0.6472442851311754,0.913322632423756,1.0,1.0,17/37,29.41%,RNF8;SRCAP;NASP;CENPO;CENPC;CENPK;ACTR6;CENPT;ITGB3BP;RUVBL1;DMAP1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,mucosal immune response (GO:0002385),-0.25689272863770074,-0.6470655535722766,0.8970917225950783,0.9900743940250026,1.0,2/15,7.90%,OTUD7B;RPL39
prerank,positive regulation of protein ubiquitination (GO:0031398),0.20948529140493885,0.6468030454748656,0.9706314243759178,1.0,1.0,11/80,11.59%,SPHK1;LRRK2;SPSB4;FANCI;HUWE1;CDK5RAP3;FANCM;RIPK2;FBXO4;MAGEC2;DCUN1D5
prerank,mismatch repair (GO:0006298),0.2529939387708425,0.6466663005441772,0.9145907473309609,1.0,1.0,8/27,21.43%,POLD2;ABL1;MSH3;TDG;MSH4;MCM9;MLH1;LIG1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.27162236934101763,0.6465349397522461,0.9043321299638989,1.0,1.0,5/22,18.39%,ERI3;EXOSC7;ERI2;EXOSC3;WDR12
prerank,neutrophil activation (GO:0042119),-0.27190302859569304,-0.6463669202339053,0.9109730848861284,0.9898933129200843,1.0,3/12,19.59%,SYK;PREX1;TYROBP
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.247522184885504,-0.6457950096199646,0.9359267734553776,0.9896304050450068,1.0,4/20,17.18%,DCC;GSK3B;FAS;CASP2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.21981648139391688,0.6457361783780754,0.9582132564841499,1.0,1.0,14/60,18.21%,TNRC6A;TP53;MED12;TNRC6B;PTEN;TCF7L2;MOV10;MED17;TNRC6C;NFKB1;MED23;MED26;MED1;MED8
prerank,regulation of mitochondrial translation (GO:0070129),-0.2407992383676853,-0.6455403235210824,0.9441964285714286,0.9891405747721239,1.0,12/21,37.60%,MALSU1;MTG2;RCC1L;FASTKD2;NSUN3;RPUSD3;COA3;NGRN;TRMT10C;TRUB2;C1QBP;MTG1
prerank,regulation of trophoblast cell migration (GO:1901163),0.29850254297963313,0.6451859592162039,0.8761904761904762,1.0,1.0,4/14,16.15%,SMURF2;YTHDF3;ACVR1B;NODAL
prerank,positive regulation of leukocyte migration (GO:0002687),-0.22455896034436984,-0.6442574949359872,0.9376558603491272,0.9893723348502458,1.0,7/27,23.71%,ICAM1;PTN;EDN3;VEGFA;IL6R;MDK;THY1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.250506749658823,0.644065255529451,0.9172413793103448,1.0,1.0,6/31,12.23%,PTEN;BTRC;CDC14B;MAGEC2;DCUN1D5;FZR1
prerank,protein targeting to membrane (GO:0006612),0.21439260738685634,0.6438090614644579,0.9745042492917847,1.0,1.0,21/83,17.92%,RAB3IP;PEX11B;PIKFYVE;PXMP2;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MICALL1;PEX14;ACBD5;VPS37A;ARL6;PEX19;RAB8B;SLC25A17;PEX16;RABGEF1;PEX5;ZDHHC23
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.23517283220320645,-0.6434213922598562,0.922566371681416,0.9892817294220061,1.0,4/20,15.24%,YWHAB;MET;SNCA;STMN1
prerank,mitochondrial protein processing (GO:0034982),-0.28113595443913186,-0.6431845537896105,0.8991596638655462,0.988802803931195,1.0,3/11,26.60%,IMMP2L;STOML2;SPG7
prerank,secondary alcohol metabolic process (GO:1902652),0.23633231295967322,0.6431710929923956,0.9355371900826446,1.0,1.0,4/42,9.11%,CYP27A1;IDH1;CLN6;SULT2B1
prerank,cardiolipin metabolic process (GO:0032048),0.2959854241966701,0.6430184551975384,0.8702290076335878,1.0,1.0,5/13,21.28%,SLC27A1;PLA2G6;PLA2G5;HADHA;TAMM41
prerank,T cell homeostasis (GO:0043029),-0.29351969004734785,-0.6427240523257536,0.8916155419222904,0.9884603714089767,1.0,8/10,56.45%,FAS;PMAIP1;FOXP3;RIPK3;NCKAP1L;AKT1;JAK3;PPP2R3C
prerank,regulation of phospholipid metabolic process (GO:1903725),0.30910816101293137,0.6422717515226596,0.851063829787234,1.0,1.0,1/10,2.72%,MTMR3
prerank,negative regulation of receptor internalization (GO:0002091),0.29592342927299886,0.642240387685483,0.871841155234657,1.0,1.0,5/12,22.43%,RIN3;ATXN2;ANKRD13D;ANKRD13B;SDCBP
prerank,positive regulation of calcium ion import (GO:0090280),0.2989880143913662,0.6421527421417227,0.8669275929549902,1.0,1.0,3/12,15.10%,PDGFRB;SPHK2;LGALS3
prerank,regulation of protein kinase A signaling (GO:0010738),0.2701050417588513,0.6396849122982918,0.87569573283859,1.0,1.0,5/20,17.74%,LRRK2;AKAP12;PRKAR1A;AKAP7;ADGRV1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.26888394134544397,0.6392330489087823,0.9128919860627178,1.0,1.0,4/20,13.36%,PTGES3L;MKKS;BBS10;HSPA4
prerank,phagosome acidification (GO:0090383),0.2546115800404083,0.6389339898614933,0.9192982456140351,1.0,1.0,4/26,11.08%,ATP6V0E1;ATP6V0B;ATP6V1D;ATP6V1E1
prerank,response to glucose (GO:0009749),0.22816698503972282,0.638765258200801,0.9341692789968652,1.0,1.0,4/46,9.99%,PRKAA2;ZBTB20;GCK;TCF7L2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.20912761640868086,-0.6385072816039,0.9667519181585678,0.9905734282699769,1.0,8/32,22.64%,CAVIN1;TAF1B;GTF2H1;GTF2H4;GTF2H5;ERCC2;POLR1F;POLR2L
prerank,cellular response to radiation (GO:0071478),0.23231862800609812,0.6384462642957619,0.9490131578947368,1.0,1.0,14/40,23.79%,RHO;TP53;SIRT1;HUS1;GADD45A;INTS7;MAPK14;LIG4;TANK;RAD9A;FIGNL1;OPN1SW;OPN1MW;OPN1MW3
prerank,sulfur amino acid catabolic process (GO:0000098),0.29796248315845286,0.6384334773017496,0.8865384615384615,1.0,1.0,5/10,29.77%,CTH;MTRR;CBS;TST;BLMH
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.24473691728980757,-0.6379813829230483,0.9194630872483222,0.9902558985087615,1.0,3/18,9.22%,ESR1;TGFB1;TMBIM6
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2549311608267081,0.6378992644795415,0.9023972602739726,1.0,1.0,3/24,7.04%,TTLL6;NAA80;TTLL9
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.2445200736180333,0.6376083117599174,0.9269102990033222,1.0,1.0,5/32,12.19%,DEFB1;F2;HRG;FAM3A;CAMP
prerank,natural killer cell activation (GO:0030101),-0.22776252676353706,-0.6372600396697872,0.9410430839002267,0.9900501683225568,1.0,6/23,18.30%,TOX;PTPRC;PBX1;SNX27;PRDX1;NFIL3
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.20246959245804172,0.6368266100428251,0.9848275862068966,1.0,1.0,20/101,15.56%,LARP4B;VGLL4;EZR;ATG10;DDX3X;CD28;POLDIP3;FBXW11;SAMD4A;CLN6;BTRC;CPEB3;YTHDF3;ATG7;PRKDC;PLD1;OGT;ZCCHC4;FAF1;ASPH
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.2958506302131967,0.6367670597816015,0.884313725490196,1.0,1.0,1/13,2.92%,NUPR1
prerank,regulation of protein sumoylation (GO:0033233),0.2832912794523052,0.6363171089757694,0.9028776978417267,1.0,1.0,5/17,18.95%,PIAS1;HDAC4;ZMIZ1;PIAS3;PIAS4
prerank,protein localization to chromatin (GO:0071168),0.2739118273290015,0.6356141776739043,0.9034090909090909,1.0,1.0,6/18,20.38%,NIPBL;LEMD2;WAPL;LRWD1;SGF29;MCM9
prerank,mitotic nuclear division (GO:0140014),0.2155756764322837,0.6352361258059839,0.9667170953101362,1.0,1.0,19/71,20.41%,KIF2A;CLASP1;KLHDC8B;LSM14A;MISP;DSN1;KIFC1;STAG2;CTDP1;SMC3;PIBF1;CENPK;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10;CHMP2A;UBE2S
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.2416438745338369,-0.6350752688894472,0.9213973799126638,0.9908264547824639,1.0,8/19,27.94%,SLC26A2;ENPP1;TPST2;BPNT1;SULT4A1;SLC35B3;PAPSS1;BPNT2
prerank,axonemal dynein complex assembly (GO:0070286),0.2528600336429488,0.634563513543308,0.8983957219251337,1.0,1.0,7/28,22.40%,ODAD1;CCDC39;CCDC40;DNAI4;DNAAF5;CFAP73;DNAL1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2477723026060841,-0.634186150264743,0.9448275862068966,0.9907159673952691,1.0,10/20,33.07%,GATM;GCLM;GAMT;CHAC2;FPGS;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.28710626141030665,-0.6334022972552465,0.9148073022312373,0.9905773152631646,1.0,2/10,11.13%,TSNAX;DROSHA
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.2672009171512188,-0.6332688473448561,0.9096638655462185,0.9900158640572015,1.0,4/12,21.36%,AKR1B1;STARD3NL;CACNA1H;STARD3
prerank,cellular component maintenance (GO:0043954),0.2971135141393841,0.6330704821333558,0.8670520231213873,1.0,1.0,6/12,29.31%,PICK1;ITGA3;CLDN1;IGF1R;PRNP;INSR
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.2513390570395714,0.6327799353587025,0.9436860068259386,1.0,1.0,4/28,10.49%,LACC1;TAB2;RIPK2;IRGM
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.24333845251251385,0.6323319279294741,0.937394247038917,1.0,1.0,17/32,30.67%,NUP42;NUP98;NUP43;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;NUP160;NOL6;RANBP2;NUP37;SSB;RAE1;NUP133
prerank,tRNA export from nucleus (GO:0006409),0.24333845251251385,0.6323319279294741,0.937394247038917,1.0,1.0,17/32,30.67%,NUP42;NUP98;NUP43;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;NUP160;NOL6;RANBP2;NUP37;SSB;RAE1;NUP133
prerank,recombinational repair (GO:0000725),-0.17843606767174353,-0.6319745213929757,0.9907692307692307,0.9901681573054443,1.0,26/77,32.76%,REV3L;SMC5;RAD51B;PSMD14;RPA1;KDM4D;EXD2;RFWD3;MMS22L;NSMCE1;BLM;RECQL5;POLQ;AP5S1;RAD54B;RECQL;PALB2;HUS1B;SWI5;RAD51;MEIOB;RPA3;BRCA1;RPA2;SFR1;MCM8
prerank,receptor recycling (GO:0001881),0.302960977563545,0.6316857626650882,0.8745247148288974,1.0,1.0,3/10,17.36%,ARFGEF2;RAB11B;PHETA1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2059305442719381,0.6313062187666559,0.9885386819484241,1.0,1.0,6/85,8.27%,CELSR1;MAGI2;VANGL1;FZD5;SMURF2;RYK
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21044473773897848,0.6311141742056975,0.969208211143695,1.0,1.0,15/72,19.70%,SPO11;POLD2;DNASE1L1;FBH1;DICER1;CUL4A;DCP1A;RAD50;DDB2;DNASE1L2;OGG1;FEN1;RFC1;XPA;DXO
prerank,cellular response to interferon-beta (GO:0035458),-0.2637233569579016,-0.6305269894897054,0.9350348027842227,0.990427064912572,1.0,6/14,25.52%,PNPT1;AIM2;HTRA2;UBE2G2;IFITM2;NDUFA13
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.17776427185494872,0.6298120348967441,0.9988344988344988,1.0,1.0,51/314,17.63%,ANAPC15;PRKN;FBXL17;SPSB1;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;ANAPC2;SPSB4;TBL1X;UBR2;SMURF2;FBXW11;HUWE1;BTRC;TBL1XR1;FBXO48;RNF34;SIRT1;ECPAS;ZSWIM8;FBXL12;AURKB;FBXO4;WWP2;CUL4A;FZR1;PML;DNAJB2;FBXL20;RMND5A;FAF1;AMFR;ANAPC16;DNAJB14;MAEA;RB1;NEMF;UBR1;UFD1;UBE2E1;KCTD13;ERLIN2;SYVN1;DMAC2;CDC34;DNAJC18;NPLOC4
prerank,negative regulation of T cell proliferation (GO:0042130),0.2511019650753356,0.6292652850129619,0.9224422442244224,1.0,1.0,7/28,22.06%,CD274;GLMN;PRKAR1A;SDC4;GPNMB;DLG5;ARG1
prerank,cellular response to estradiol stimulus (GO:0071392),-0.24138689515251543,-0.629090154824677,0.9433551198257081,0.9906567109387506,1.0,6/18,24.16%,ESR1;GPER1;FAM210B;SFRP1;RUVBL2;NRIP1
prerank,toxin transport (GO:1901998),0.29984109524657343,0.6289299781595523,0.8560460652591171,1.0,1.0,2/10,14.77%,ANTXR2;RAB29
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.24454088161664622,-0.6284819009606157,0.9568034557235421,0.9903575059049547,1.0,5/17,22.09%,PPIA;HSPB1;HTRA2;BAG5;SOD1
prerank,Golgi ribbon formation (GO:0090161),0.28922598805952543,0.6281511296179506,0.8858267716535433,1.0,1.0,5/13,19.50%,MYO18A;VTI1A;OPTN;GOLGA2;STX16
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.22132219771215575,-0.6278422941572931,0.9576470588235294,0.9900903279036654,1.0,8/24,25.00%,NOD1;MAP3K7;UBB;NOD2;AAMP;UBC;RPS27A;TAB1
prerank,negative regulation of protein secretion (GO:0050709),0.23404256700762013,0.6274526713279854,0.9294871794871795,1.0,1.0,5/38,9.32%,PRKN;ADRA2A;IL12B;MIDN;RSAD2
prerank,phospholipid biosynthetic process (GO:0008654),0.23501954140381756,0.6273949135599771,0.9572107765451664,1.0,1.0,4/36,8.48%,AGPAT4;GPAT2;CPNE3;SAMD8
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3088663056705254,0.6270979479420038,0.865234375,1.0,1.0,2/10,16.81%,MTHFR;MTHFD1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2579349442792276,0.6263812164106728,0.9019264448336253,1.0,1.0,2/22,7.92%,NR2F2;PTEN
prerank,dendritic cell chemotaxis (GO:0002407),-0.2581356596091741,-0.6259787600209907,0.9265658747300216,0.9905341895623848,1.0,11/14,54.22%,TRPM2;CCL19;CXCR4;CCR1;PIK3CG;CCR6;CXCR2;HMGB1;CCR7;GPR183;CCL5
prerank,ncRNA metabolic process (GO:0034660),0.2301654413857837,0.6257784873301742,0.9427609427609428,1.0,1.0,8/37,22.33%,MOV10L1;TUT4;DICER1;TENT4B;TUT7;EXD1;ASZ1;XPO5
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.28537629939504644,-0.6248978273228583,0.9138655462184874,0.9905337520531309,1.0,1/10,1.54%,PDE8A
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.26255873444512146,-0.6248443689366056,0.9193899782135077,0.9899169011444127,1.0,5/12,30.34%,DHODH;UCK2;UMPS;UPP1;TK2
prerank,positive regulation of leukocyte activation (GO:0002696),0.27254690734438825,0.6233972922437279,0.9102803738317757,1.0,1.0,2/18,5.16%,HAVCR1;TLR4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.24700479980247392,-0.6220450658918981,0.9436936936936937,0.9909424112318914,1.0,4/17,18.09%,PROX1;PKD1;CCNY;RGCC
prerank,glutamate metabolic process (GO:0006536),0.2637586709649941,0.6213721405585786,0.8957952468007313,1.0,1.0,3/19,9.52%,PRODH;GOT2;GLUL
prerank,termination of RNA polymerase II transcription (GO:0006369),0.23621914450143067,0.6205739921789727,0.9335604770017035,1.0,1.0,8/33,23.34%,PABPN1;TTF2;SCAF8;CPSF3;CSTF1;PCF11;CPSF7;NUDT21
prerank,positive regulation of cellular senescence (GO:2000774),-0.28108442173065484,-0.6205637557157313,0.9150197628458498,0.9911535411935767,1.0,2/10,12.05%,B2M;ABI3
prerank,regulation of lipid storage (GO:0010883),0.2514480302262061,0.6200902142677004,0.9357798165137615,1.0,1.0,4/22,14.87%,IKBKE;SIRT1;ITGAV;NFKB1
prerank,negative regulation of mRNA processing (GO:0050686),0.270666627638186,0.6198622735360095,0.8932584269662921,1.0,1.0,6/15,25.36%,SAP18;SFSWAP;SRSF10;SRSF7;U2AF2;SRSF4
prerank,regulation of lymphocyte proliferation (GO:0050670),0.26908111695128967,0.6196432265523535,0.903921568627451,1.0,1.0,4/16,20.38%,IL12B;PTPN22;LGALS3;IKZF3
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2688371787858962,0.6196299745245808,0.9137931034482759,1.0,1.0,5/17,19.88%,TERT;KAT7;CCNE1;KDM1A;LTBP3
prerank,DNA duplex unwinding (GO:0032508),-0.18849589330236136,-0.6193558339628364,0.9832869080779945,0.991168460334347,1.0,20/50,30.71%,ANXA1;RAD23B;UBB;RPA1;DHX9;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;BLM;RECQL5;UBC;RPS27A;RECQL;MCM6;DDB1;RAD51;ERCC3;PIF1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.28749053510453376,0.6191057334054926,0.8950495049504951,1.0,1.0,3/12,13.81%,NCOR2;TERT;NCOR1
prerank,erythrocyte development (GO:0048821),-0.27718410679799155,-0.617857997780904,0.9254658385093167,0.9913524687713651,1.0,7/10,47.95%,DMTN;LYAR;ALAS1;SH2B3;ABCB10;GATA1;NCKAP1L
prerank,microtubule nucleation (GO:0007020),0.2589023982940042,0.6176054387233314,0.9298245614035088,1.0,1.0,7/20,20.06%,CLASP1;SLAIN2;CENPJ;RANBP9;AKAP9;GOLGA2;TUBGCP4
prerank,aggrephagy (GO:0035973),0.2464793400061515,0.6170258929912005,0.9280701754385965,1.0,1.0,8/27,19.96%,PRKN;ATG5;IFT88;ACBD5;DYNC1LI1;SQSTM1;PCNT;WDR81
prerank,positive regulation of histone deacetylation (GO:0031065),-0.26294566159840416,-0.6167960852232031,0.911578947368421,0.9912995032632289,1.0,3/12,15.93%,PRKD1;VEGFA;APLNR
prerank,DNA replication initiation (GO:0006270),-0.20150355750229296,-0.6165593220662954,0.9685990338164251,0.9907775441725555,1.0,14/37,32.76%,POLA1;PRIM2;RPA1;ORC5;ORC2;CDC45;MCM6;PRIM1;TOPBP1;CDC7;RPA3;RPA2;MCM4;MCM8
prerank,nucleosome assembly (GO:0006334),0.24073985159330738,0.6165571706174283,0.9566724436741768,1.0,1.0,6/31,19.57%,CHAF1B;ATRX;KAT6B;NASP;PADI4;ASF1A
prerank,regulation of nuclear division (GO:0051783),0.2616476147716132,0.6159163765568864,0.9149722735674677,1.0,1.0,1/20,2.45%,OBSL1
prerank,myeloid dendritic cell activation (GO:0001773),-0.26295307525508754,-0.6156513692681825,0.9172113289760349,0.9906279873695464,1.0,2/12,9.79%,CAMK4;DOCK2
prerank,translesion synthesis (GO:0019985),0.22191688521026803,0.6155225994047601,0.9639934533551555,1.0,1.0,9/42,19.36%,POLD2;PARP10;REV1;POLDIP2;ZBTB1;POLE2;UFD1;NPLOC4;RFC1
prerank,glycerophospholipid metabolic process (GO:0006650),0.2031350165910176,0.6154680499077106,0.9791976225854383,1.0,1.0,9/75,10.53%,PIGN;PIGW;PLA1A;PIGQ;PDGFRB;CPNE3;PLA2G6;PLCD1;ABHD12
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2420687395642092,0.614001906761097,0.9398625429553265,1.0,1.0,9/29,27.14%,TEX12;REC8;STAG3;P3H4;FANCD2;SYCE2;BAG6;TRIP13;TERB1
prerank,renal filtration (GO:0097205),-0.2778416292714341,-0.6136948085746664,0.921443736730361,0.9909805407720519,1.0,2/10,8.44%,CD34;MCAM
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2962909684643603,0.6124221414678637,0.8838582677165354,1.0,1.0,3/11,19.57%,ATRX;NASP;ASF1A
prerank,regulation of double-strand break repair (GO:2000779),-0.19455709923212222,-0.6121054388812517,0.9765625,0.9911279069979511,1.0,5/39,14.04%,FMN2;ACTR2;SETD2;TWIST1;TERF2IP
prerank,regulation of myoblast fusion (GO:1901739),0.2935839476565254,0.6108842659201674,0.8766603415559773,1.0,1.0,1/11,3.02%,CFLAR
prerank,cobalamin metabolic process (GO:0009235),0.2606347556589656,0.610565495385108,0.9053571428571429,1.0,1.0,5/17,22.04%,TCN2;TCN1;MTRR;MMACHC;CUBN
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.2975820859472339,0.6098379972441654,0.8923076923076924,1.0,1.0,3/10,14.01%,RNF13;MAP2K1;MAP2K2
prerank,protein deubiquitination (GO:0016579),0.17489564516488268,0.6096091353068133,1.0,1.0,1.0,44/242,19.79%,SMAD3;PRKN;CCNA2;TGFBR1;BABAM2;USP3;CCNA1;USP9X;USP24;TP53;USP11;SMURF2;PTEN;RCE1;CDC25A;RIPK1;BECN1;INO80D;USP34;USP49;UIMC1;DESI2;USP12;USP7;BABAM1;DDB2;MBD6;OGT;USP18;KAT2B;BIRC3;USP37;UFD1;CLSPN;SMAD4;ASXL2;USP48;USP1;RHOT1;USP33;USP21;USP16;USP35;INO80E
prerank,positive regulation of cell aging (GO:0090343),-0.2684342264304393,-0.6094475425635967,0.9204771371769384,0.9918984294613886,1.0,2/11,12.05%,B2M;ABI3
prerank,rRNA catabolic process (GO:0016075),0.2675914850601029,0.6091261297928827,0.9184466019417475,1.0,1.0,4/16,17.82%,EXOSC7;DIS3;DIS3L;EXOSC3
prerank,Golgi inheritance (GO:0048313),0.2880964939960362,0.609077026440932,0.9157088122605364,1.0,1.0,3/11,18.89%,PLK5;STX5;GOLGA2
prerank,protein modification process (GO:0036211),0.20060970365700337,0.6087500720848589,0.9850299401197605,1.0,1.0,19/76,20.99%,MSRA;PARP4;RABGGTA;MANBA;FBXO22;ABL1;UBE2M;ARAF;PRKDC;WWP2;FBXO11;PLAT;PPP4R2;CDC34;PADI4;NTAQ1;GNMT;UBE2S;UBE2I
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.29002768820555047,0.6086126601405416,0.8984674329501916,1.0,1.0,3/12,18.74%,NINL;HOOK3;PCM1
prerank,tRNA transport (GO:0051031),-0.19833369704300968,-0.6085439954950778,0.9722222222222222,0.9916967370234135,1.0,10/35,26.70%,YBX1;NUP210;RAN;NUP107;TOMM20;POM121;NUP93;NUP85;NUP50;NUP54
prerank,mRNA methylation (GO:0080009),-0.24024228886922622,-0.6078476198921707,0.941908713692946,0.9914088025606261,1.0,7/15,37.75%,TRMT61B;METTL3;TRMT6;ZC3H13;CBLL1;TRMT10C;TRMT61A
prerank,gas transport (GO:0015669),-0.27797438924387674,-0.6075266967476616,0.9206008583690987,0.9909265646461622,1.0,2/10,13.76%,CA2;CYGB
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.21818107512200546,-0.6063416996338965,0.9523809523809523,0.9908884654089078,1.0,15/23,38.78%,HSP90AA1;TIMM29;BCL2L11;TOMM22;TIMM8B;ROMO1;TIMM13;NDUFA13;PMAIP1;BMF;TIMM10B;BAD;MAIP1;AGK;TIMM9
prerank,negative regulation of T cell activation (GO:0050868),0.22936756479974704,0.6059407656573038,0.9589490968801314,1.0,1.0,10/35,22.96%,PTPN22;CD274;GLMN;SDC4;LGALS3;GPNMB;LAX1;DLG5;ARG1;RIPOR2
prerank,protein autoprocessing (GO:0016540),-0.2355486999155107,-0.6057037732664072,0.9696312364425163,0.9905744147659353,1.0,10/17,47.77%,CTSL;HTRA2;CASP4;FAM111A;MYRF;TMPRSS2;HJV;PCSK9;OMA1;CASP1
prerank,T cell activation involved in immune response (GO:0002286),-0.25639985448588365,-0.6051224263116607,0.9290322580645162,0.9902417457743957,1.0,3/12,21.92%,ICAM1;CD74;MDK
prerank,histone H4-K5 acetylation (GO:0043981),-0.24072292366614295,-0.6048824076470652,0.94,0.9890932448912554,1.0,4/15,20.11%,JADE3;JADE1;MEAF6;MCRS1
prerank,histone H4-K8 acetylation (GO:0043982),-0.24072292366614295,-0.6048824076470652,0.94,0.9890932448912554,1.0,4/15,20.11%,JADE3;JADE1;MEAF6;MCRS1
prerank,nucleotide biosynthetic process (GO:0009165),0.2580335983931039,0.6042737504734219,0.9383802816901409,1.0,1.0,8/18,22.77%,NMNAT1;PRPSAP1;PRPSAP2;NMNAT2;MTHFD1;GART;ADSL;NMNAT3
prerank,protein import into nucleus (GO:0006606),0.20531626409701864,0.6039460463291572,0.9822222222222222,1.0,1.0,2/66,3.53%,APPL2;TNPO1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.2580036780353888,0.6035526175141955,0.926873857404022,1.0,1.0,2/17,8.88%,MCU;DNM1L
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.1925053160592216,0.6033886883138602,0.9886845827439887,1.0,1.0,19/95,19.22%,CC2D2A;CEP250;CLASP1;NINL;RAB3IP;CEP162;SDCCAG8;CENPJ;NPHP1;ALMS1;CEP63;B9D2;CEP57;AKAP9;TCTN3;PCM1;CEP164;OFD1;PCNT
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.24712550542133965,0.6021454401402482,0.9380378657487092,1.0,1.0,7/25,18.47%,EPHA4;OPHN1;CSNK2A2;CSNK2A1;PML;HFE;TAF1
prerank,DNA double-strand break processing (GO:0000729),0.2605117997562497,0.6021250418216819,0.9365942028985508,1.0,1.0,5/18,19.01%,ATM;RBBP8;RAD50;NBN;SLX4
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.22131232837026366,0.601745070285224,0.9690402476780186,1.0,1.0,17/40,28.60%,SMG1;WDR76;ABL1;KMT5A;MCL1;CRY1;USP1;FMR1;FBXO5;CASP9;BCLAF1;PRKCD;ING2;UBE2V1;FXR2;FEM1B;UBE2N
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2713536362884176,-0.6017396898098561,0.9202453987730062,0.9899670774891945,1.0,3/10,13.10%,HOMER1;SARAF;CD84
prerank,regulation of cellular amide metabolic process (GO:0034248),0.23157729617301295,0.6012798164830148,0.9567307692307693,1.0,1.0,3/32,8.48%,PICALM;ATXN2;SAMD8
prerank,phosphate ion transport (GO:0006817),0.26523229717313734,0.6010232684827983,0.9110320284697508,1.0,1.0,4/16,17.77%,SLC20A2;SLC25A11;SLC25A10;SLC37A4
prerank,regulation of stem cell population maintenance (GO:2000036),0.2538379586935844,0.5993230598159991,0.9325044404973357,1.0,1.0,5/18,20.94%,NCOA3;WDR43;NODAL;TAF6L;REST
prerank,negative regulation of interferon-beta production (GO:0032688),-0.26624388574362323,-0.5964244015426563,0.9307535641547862,0.9917850742454458,1.0,3/10,21.18%,REL;RELB;PYCARD
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.28416893732005977,0.5956750437261777,0.9219330855018587,1.0,1.0,3/12,13.35%,TLR4;MAP2K5;OAS3
prerank,tetrapyrrole metabolic process (GO:0033013),0.2508869122172017,0.5956075304153956,0.9141323792486583,1.0,1.0,5/18,22.04%,TCN2;TCN1;MTRR;MMACHC;CUBN
prerank,RNA catabolic process (GO:0006401),-0.18501613460461486,-0.5950454564417901,0.984,0.9917506587760844,1.0,20/46,34.68%,PNPT1;RNASEH2A;METTL3;RNASEH2B;XRN2;DNA2;YTHDF2;DCP2;MTREX;RNASEH2C;ERN1;HNRNPD;NUDT16;LSM5;LSM2;ZC3H12D;AGO3;RNH1;RNASEH1;PABPC4
prerank,tRNA processing (GO:0008033),0.20478594610321094,0.5937138428332958,0.9805389221556886,1.0,1.0,10/61,21.86%,TRMT9B;TSEN2;RPP21;LCMT2;POP7;WDR4;DTWD2;ADAT2;POP1;KARS1
prerank,regulation of viral transcription (GO:0046782),0.2222607340548688,0.5932783920870132,0.9660194174757282,1.0,1.0,7/39,14.70%,POLR2A;POLR2D;LARP7;GTF2F1;NELFCD;TRIM62;CTDP1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.24788806465914437,0.5920543428923003,0.9350877192982456,1.0,1.0,2/19,8.88%,MCU;DNM1L
prerank,positive regulation of neutrophil migration (GO:1902624),0.2505269676673878,0.5918466195011146,0.9107468123861566,1.0,1.0,2/18,8.88%,MCU;DNM1L
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.24097843384760556,-0.5918246251970336,0.944558521560575,0.9925331313974288,1.0,8/14,40.25%,RPL7;RPL35;NOL9;RPL7L1;RPF2;PES1;NIFK;URB1
prerank,rRNA methylation (GO:0031167),0.2454957511752529,0.5918120971388745,0.951304347826087,1.0,1.0,10/22,29.04%,NOP2;ZCCHC4;BUD23;NSUN4;FDXACB1;MTERF4;METTL5;MRM1;FBLL1;MRM2
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.21805124322020758,-0.59044149975372,0.9694323144104804,0.9925145128199966,1.0,5/20,19.16%,APOE;SREBF2;NR1H4;RAN;LDLRAP1
prerank,cilium movement (GO:0003341),0.21104462194222648,0.589759196408889,0.9707792207792207,1.0,1.0,10/48,22.18%,ODAD1;ROPN1L;CFAP251;CCDC39;CCDC40;DNAI4;GAS8;DNAAF5;CFAP73;RSPH6A
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.22816379787938607,-0.5892515315320831,0.9578713968957872,0.9923999417407512,1.0,6/18,29.50%,MAN1B1;UBB;RNF103;UBC;RPS27A;UGGT2
prerank,regulation of T cell differentiation (GO:0045580),0.2173227988369928,0.5883896316891816,0.9611486486486487,1.0,1.0,6/33,12.10%,TNFRSF18;TCF7;ABL1;ZBTB1;ZMIZ1;FANCA
prerank,centromere complex assembly (GO:0034508),-0.1897681547528122,-0.588050968605783,0.9877750611246944,0.992261876160562,1.0,14/36,32.23%,HJURP;SMARCA5;CENPE;CENPH;NPM1;CENPA;MIS18BP1;CENPF;MIS18A;CENPX;OIP5;DLGAP5;CENPI;POGZ
prerank,double-strand break repair via homologous recombination (GO:0000724),0.18580282255070676,0.5872595004243791,0.9915611814345991,1.0,1.0,22/95,21.99%,RAD54L;NIPBL;SAMHD1;FBH1;FANCM;RBBP8;HUS1;RAD50;NSMCE2;REC8;MCM7;MCM2;ZFYVE26;POLL;NBN;FEN1;RAD51D;SLX4;XRCC3;MCM9;MCM5;YY1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.2896027874035025,0.5871023854402253,0.8987854251012146,1.0,1.0,2/10,13.23%,CD274;PRKAR1A
prerank,response to light stimulus (GO:0009416),-0.17601730202390958,-0.5867925777616743,0.9940119760479041,0.9921685387289533,1.0,22/55,32.24%,MAP4K3;ERCC6;PRIMPOL;UBE2B;CRY2;MEN1;ERCC2;POLD1;DRD2;DTL;MAP2K7;CCAR2;PCLAF;GPR52;TYR;UBE2A;MAPK8;CIRBP;ERCC3;GPR88;TRIM32;USF1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.19737901426295568,-0.5863024815874057,0.9825870646766169,0.9917602847251296,1.0,15/36,29.52%,HSP90AB1;RYBP;AQP11;DDRGK1;NOP53;GABARAPL2;RPL11;BAG5;N4BP1;PSME3IP1;CCAR2;WAC;F8A1;PSMF1;PARK7
prerank,tyrosine metabolic process (GO:0006570),0.2708097928436911,0.5862347221150606,0.9155722326454033,1.0,1.0,11/11,72.94%,FAH;DCT;GSTZ1;TAT;PAH;TH;HGD;IYD;IL4I1;THAP4;TYR
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2363492555683415,0.5856459122088109,0.9426229508196722,1.0,1.0,4/27,13.56%,NUDT13;AK4;CTPS2;AK8
prerank,spindle assembly (GO:0051225),0.20008738517089422,0.5844292994149499,0.9864864864864865,1.0,1.0,18/67,20.06%,KIF2A;CLASP1;LSM14A;MAPRE2;MISP;KIFC1;NCOR1;STAG2;CEP63;GOLGA8B;SMC3;PIBF1;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10;TUBGCP4
prerank,inflammatory response (GO:0006954),0.17078692727318737,0.5842665008539042,1.0,1.0,1.0,17/195,11.07%,KIT;ADCY1;IL18;LOXL3;BDKRB2;TLR4;IL17D;NOX1;AFAP1L2;PARP4;HDAC4;HYAL1;ADM;RIPK2;CCL25;NOX4;NFATC3
prerank,DNA recombination (GO:0006310),0.22132296232538115,0.5838038818118534,0.9688013136288999,1.0,1.0,8/37,20.02%,RAD54L;FBH1;MSH3;IGHMBP2;RAD50;RAD51D;XRCC3;LIG4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.24148774503589052,0.5837677662545033,0.9338983050847458,1.0,1.0,7/22,24.29%,TP53;MED12;MED17;MED1;MED13;PSMC4;MED24
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.2556661328760103,-0.5835716680628326,0.9467849223946785,0.9922700894129797,1.0,7/12,33.07%,GCLM;CHAC2;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,cellular response to UV (GO:0034644),0.19148236904920218,0.5834262198996074,0.9940119760479041,1.0,1.0,20/76,22.23%,NEDD4;TP53;HYAL1;CDC25A;SIRT1;AURKB;IMPACT;ZBTB1;DDB2;SDE2;CREBBP;KDM1A;TAF1;XPA;FMR1;NOC2L;OPN1SW;YY1;CASP9;EP300
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.2771095923980479,0.5823563599468538,0.9186046511627907,1.0,1.0,5/11,27.48%,TP53;SP100;MAD2L2;FOXM1;MUC1
prerank,regulation of microtubule-based movement (GO:0060632),0.2715942320643858,0.5822072326080232,0.9064327485380117,1.0,1.0,1/11,5.20%,MAP2
prerank,import into nucleus (GO:0051170),0.1927411362752092,0.5803854126714832,0.9956772334293948,1.0,1.0,2/73,3.53%,APPL2;TNPO1
prerank,autophagosome organization (GO:1905037),0.20589068556727724,0.580374105961779,0.9707241910631741,1.0,1.0,19/50,27.01%,ATG5;WIPI1;AMBRA1;RAB43;BECN1;ATG7;IRGM;ATG2A;TMEM41B;RAB7A;ATG16L1;UBXN2A;PIK3C3;ATG2B;ULK3;ATG12;ATG3;ATG9B;GABARAPL1
prerank,mitotic chromosome condensation (GO:0007076),0.23126812713725453,0.5794712552366947,0.9614711033274956,1.0,1.0,7/26,18.41%,CHMP1A;CSNK2A2;CSNK2A1;KMT5A;NCAPD3;RB1;NCAPD2
prerank,macrophage differentiation (GO:0030225),-0.2431806782733652,-0.5787585504855335,0.9503239740820735,0.9935580807590177,1.0,3/13,15.38%,BMP4;VEGFA;IL31RA
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.27534345657044024,0.5783781120710032,0.9395711500974658,1.0,1.0,3/10,19.90%,PTPN22;IFI35;NR1H3
prerank,RNA splicing (GO:0008380),0.18777019998713282,0.5781001764191267,0.9971181556195965,1.0,1.0,31/95,25.99%,PPARGC1A;YJU2;NOVA1;LUC7L3;SRPK2;PRPF18;SRSF11;HNRNPC;SCAF11;PRPF3;SNRNP40;USP39;ZCRB1;PRPF6;FUS;HNRNPH3;SRSF10;U2AF1;SRSF7;WBP4;SNRPA1;SF3B2;SF3B1;RNPC3;NRDE2;SRSF4;RP9;LSM6;SF3B3;DHX8;RRAGC
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.28675701510982365,0.5776397353769535,0.9329501915708812,1.0,1.0,2/10,13.22%,MAP2K5;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.28675701510982365,0.5776397353769535,0.9329501915708812,1.0,1.0,2/10,13.22%,MAP2K5;WNK1
prerank,mitochondrial transcription (GO:0006390),-0.26566339993098514,-0.5774131043205367,0.9560439560439561,0.9934675216718986,1.0,4/10,22.42%,TFAM;SLC25A33;TEFM;TFB1M
prerank,protein methylation (GO:0006479),0.21406629361290685,0.57707705828364,0.9655172413793104,1.0,1.0,12/40,23.74%,NSD1;NSD3;ETF1;EHMT2;EHMT1;SETD3;N6AMT1;CAMKMT;EEF1AKMT1;GSPT1;ICMT;PCMT1
prerank,autophagosome assembly (GO:0000045),0.2044511793570224,0.57624325905466,0.9814241486068112,1.0,1.0,20/52,27.01%,ATG5;WIPI1;AMBRA1;RAB43;BECN1;ATG7;IRGM;ATG2A;MFN2;TMEM41B;RAB7A;ATG16L1;UBXN2A;PIK3C3;ATG2B;ATG12;ATG3;ATG9B;TRAPPC8;GABARAPL1
prerank,osteoclast differentiation (GO:0030316),0.2405259196667744,0.5760411415339531,0.9379310344827586,1.0,1.0,2/22,6.71%,OSTM1;GAB2
prerank,protein secretion (GO:0009306),0.20119371146503262,0.5759261608313159,0.9873617693522907,1.0,1.0,9/56,16.86%,WLS;ARFGAP3;RAB13;PORCN;MIA3;MON1A;TANGO2;RAB8B;STEAP3
prerank,regulation of cholesterol transport (GO:0032374),0.2459689024616734,0.5759055293342494,0.9281961471103327,1.0,1.0,10/20,26.86%,LRP1;ARV1;TTC39B;NFKB1;LAMTOR1;NR1H3;ABCA2;NR1H2;YJEFN3;ABCA13
prerank,early endosome to Golgi transport (GO:0034498),-0.25507118172268234,-0.575873236078658,0.9368421052631579,0.9934403282999705,1.0,3/11,19.87%,RAB6A;EHD3;TMED9
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.20510445767473656,0.5754125618460799,0.9713831478537361,1.0,1.0,12/46,24.06%,HK2;TIMM44;TOMM70;MFN2;PITRM1;TIMM10;TIMM17B;TIMM17A;TIMM21;HK1;DNAJC15;CHCHD4
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.22895834442976465,-0.5724259870517366,0.9541284403669725,0.9941172223814821,1.0,2/16,8.90%,PTPRC;CEACAM1
prerank,intracellular protein transmembrane transport (GO:0065002),0.2061056440000479,0.5718488757187538,0.9803921568627451,1.0,1.0,15/42,25.49%,TIMM44;TOMM70;PEX10;PEX14;C2CD5;PEX16;PEX5;TIMM17B;RTN2;TIMM17A;TIMM21;PEX26;DNAJC15;CHCHD4;GRPEL2
prerank,transcription preinitiation complex assembly (GO:0070897),0.2650363474010299,0.5715869032700139,0.9089184060721063,1.0,1.0,6/12,26.03%,TAF11;TBP;TAF7;TAF1;TAF12;BDP1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.2363980678916622,0.5703556582586322,0.9578207381370826,1.0,1.0,9/21,24.19%,PTEN;BTRC;CDC14B;FZR1;GOLGA2;UBE2S;FBXO5;GORASP1;MAD2L2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.1621530061045464,-0.5692015869968494,0.9936305732484076,0.9946595232901299,1.0,15/69,24.31%,HSPA5;DNAJC10;PSMC6;SEC61B;ERLIN1;SGTB;YOD1;MAN1B1;RNF103;RNF121;UBE2G2;UBQLN2;FAM8A1;AUP1;STUB1
prerank,ncRNA 3'-end processing (GO:0043628),0.2599703902247211,0.5691966428982381,0.9404096834264432,1.0,1.0,4/14,17.42%,INTS2;INTS5;INTS7;INTS8
prerank,tRNA methylation (GO:0030488),-0.19104335752491547,-0.5688473493629522,0.9806295399515739,0.9941688965526805,1.0,18/34,44.64%,METTL1;TRMT61B;MTO1;THADA;THUMPD2;METTL2B;METTL2A;TRDMT1;TRMT10C;TRMT5;GTPBP3;TRMT61A;TRMT10A;NSUN6;TRMT13;BCDIN3D;ALKBH8;FTSJ1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.26959874826361435,0.5688071740432682,0.9272727272727272,1.0,1.0,1/11,6.47%,IL12B
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.23648621394224753,-0.5686942891307245,0.9498910675381264,0.9935943262978174,1.0,3/13,17.31%,GAS6;DHX9;CD74
prerank,autophagosome maturation (GO:0097352),0.21658380842159092,0.5682327260846964,0.9638752052545156,1.0,1.0,5/32,16.36%,LAMP2;UVRAG;LIX1L;VIPAS39;SNX14
prerank,mitochondrial translation (GO:0032543),0.17880536424542726,0.5674225288631911,0.9986301369863013,1.0,1.0,27/104,26.77%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MTRF1L;MRPL48;MRPL1;GFM2;MTRF1;MRPL45;MRPS17;CHCHD1;MRPL14;MRPL32;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19;TSFM;MRRF
prerank,regulation of receptor recycling (GO:0001919),-0.22270819143498438,-0.5673798102134815,0.9694117647058823,0.9934209174266033,1.0,4/16,17.18%,ECE1;NSF;SNCA;SCRIB
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.21825113847537936,0.567276067170363,0.9659863945578231,1.0,1.0,10/30,23.60%,FHIT;STYX;USP7;OGT;TLK2;HFE;CAMLG;TRIM39;SDCBP;BAG6
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.232425647337937,-0.5658822725835725,0.9380530973451328,0.9933161006849706,1.0,7/14,36.05%,RPS3;CD81;RELA;CARD11;BCL10;TRAT1;LCK
prerank,error-free translesion synthesis (GO:0070987),-0.20433722012302996,-0.565624718706893,0.9845474613686535,0.9927706296952428,1.0,10/22,31.81%,UBB;RPA1;RFC4;POLD1;RFC2;UBC;RPS27A;RFC5;RPA3;RPA2
prerank,regulation of biosynthetic process (GO:0009889),-0.24762643113003502,-0.564889729383305,0.9513184584178499,0.992414639127572,1.0,2/11,13.16%,SLC25A33;SNCA
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2292006239285208,0.5642101840224752,0.9667221297836939,1.0,1.0,6/28,18.81%,BID;DDX3X;BLOC1S2;DEDD;TNFRSF1A;DELE1
prerank,regulation of glycogen metabolic process (GO:0070873),0.2668453740743408,0.5641975164803282,0.920388349514563,1.0,1.0,1/12,5.82%,PPP1R3B
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.2739380342553043,0.5639257490576157,0.9266409266409267,1.0,1.0,3/10,22.54%,TGFBR2;CD55;ZBTB7B
prerank,glycine transport (GO:0015816),0.2698693457351866,0.5631669358943072,0.9257028112449799,1.0,1.0,1/10,4.87%,SLC6A9
prerank,regulation of cell cycle phase transition (GO:1901987),-0.15333727840782094,-0.562364458141941,1.0,0.9926418340317807,1.0,41/91,39.13%,PSMB2;PSMD14;PSMC6;ATP2B4;CDKN1A;BUB3;PSMA4;PSMB9;CDC23;SKP1;PSMD11;PSMB10;PSMD2;ERCC2;MAD2L1;PSMA2;NEK10;TFAP4;PSMB3;PSMB5;UBE2D1;DDB1;PSMA7;PSMF1;PSMD7;ERCC3;TCIM;CDK1;CDC20;PSMA5;UBE2C;PSMD4;ANAPC10;PSME4;CCNB1;ANAPC1;PSMD3;CDKN1B;GTSE1;FBXW7;PSMC2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.26988005928155845,0.5616825958164006,0.919917864476386,1.0,1.0,2/10,16.39%,TUT4;TUT7
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2592653855813297,0.5599607811530884,0.9401088929219601,1.0,1.0,2/11,15.26%,AHCYL1;ZFP36L1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.2596030800755129,0.5598784232564694,0.9386973180076629,1.0,1.0,2/13,12.25%,KPNA6;RGPD1
prerank,response to acidic pH (GO:0010447),0.2527733264872932,0.5597516681392201,0.947069943289225,1.0,1.0,2/13,11.45%,RAB11B;IMPACT
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.25467057322036957,0.5591838022573414,0.9366852886405959,1.0,1.0,1/14,6.47%,IL12B
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.2418465266489974,-0.5579881584268693,0.9532520325203252,0.9934103214329273,1.0,4/12,26.23%,WRNIP1;TIPIN;BLM;WDR18
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.2558982157416422,0.556766335821959,0.9468864468864469,1.0,1.0,2/14,6.88%,ETNK2;SLC27A1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.24647142970777347,0.5565661690547039,0.933579335793358,1.0,1.0,6/15,27.07%,UFD1;SYVN1;NPLOC4;DERL1;SELENOS;OS9
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.22806683549492476,0.5565540375246314,0.9675090252707581,1.0,1.0,6/24,19.01%,ACD;TNKS2;HNRNPC;TENT4B;TINF2;SLX4
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.23474463092893033,-0.5559614801240523,0.9613034623217923,0.9934428227508343,1.0,5/13,31.27%,NCBP2;CPSF4;CPSF4L;CSTF2T;CPSF1
prerank,transcription by RNA polymerase I (GO:0006360),-0.18062271309166256,-0.5549963938595519,0.9947368421052631,0.993120028218248,1.0,8/34,22.64%,CAVIN1;TAF1B;GTF2H1;GTF2H4;GTF2H5;ERCC2;POLR1F;POLR2L
prerank,positive regulation of immune response (GO:0050778),0.18919717384396828,0.5539942738343601,0.9875968992248062,1.0,1.0,9/64,14.77%,IFNK;IL12B;PLSCR1;HRG;RSAD2;SIRT1;NMI;IFI35;SPHK2
prerank,response to hexose (GO:0009746),-0.19536691377229629,-0.5524815350929512,0.975669099756691,0.993281470456753,1.0,12/25,44.78%,THBS1;EIF2B3;IRS2;EIF2B2;KHK;EIF2B5;ZBED3;SLC2A5;NEUROD1;LPL;SELENOT;HNF4A
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.23622777502607908,0.5520949221249712,0.9602076124567474,1.0,1.0,2/19,7.63%,CHRNA5;RAPSN
prerank,negative regulation of double-strand break repair (GO:2000780),0.2168377861296974,0.5520425001048896,0.9782971619365609,1.0,1.0,10/30,25.91%,TRIP12;FBH1;UBR5;SMCHD1;TFIP11;OGG1;OTUB2;MAD2L2;SHLD2;UBQLN4
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.26524066577882616,0.5511258277808516,0.9438202247191011,1.0,1.0,3/11,17.82%,LARP7;TENT4B;EXOSC3
prerank,regulation of chromosome segregation (GO:0051983),0.24248203690502412,0.5511209344794015,0.9467140319715808,1.0,1.0,3/16,12.06%,AURKB;CSNK2A2;CSNK2A1
prerank,sensory perception of pain (GO:0019233),0.22950463131864882,0.5506644109068163,0.9696428571428571,1.0,1.0,1/21,2.13%,RETREG1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.24278681170206215,-0.5501591465158304,0.9674620390455532,0.993327997072642,1.0,6/11,34.55%,UQCRB;UQCR11;CYCS;UQCC3;UQCR10;CYC1
prerank,C-terminal protein amino acid modification (GO:0018410),0.2597638084444389,0.5493018865891256,0.9300567107750473,1.0,1.0,7/11,26.70%,ATG5;ATG7;FOLH1;ICMT;AGTPBP1;ATG12;GPLD1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.21746212131400774,-0.5460947307305682,0.9629629629629629,0.9938743461195859,1.0,9/16,39.65%,CELF4;TRA2A;RBM3;RBMXL1;CIRBP;SF3B4;CELF3;NCBP1;RBMX
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.24691916640925138,0.5452717324586626,0.9448529411764706,1.0,1.0,2/13,14.77%,GAB2;SPHK2
prerank,cell cycle G1/S phase transition (GO:0044843),-0.15953889831559373,-0.5441172957376722,1.0,0.9938151983508672,1.0,15/61,24.88%,USP29;PLK2;CUL3;E2F3;CDKN1A;ACVR1;EIF4E;PIM2;INHBA;PHF8;MAP3K11;PLK3;CDKN3;CCNE2;HINFP
prerank,regulation of cilium movement (GO:0003352),0.2623187496076831,0.543797290558508,0.9471624266144814,1.0,1.0,10/10,73.78%,CCDC39;CCDC40;DNAH11;ODAD2;DRC1;DNAAF1;CFAP298;CFAP206;CCDC65;CFAP43
prerank,C21-steroid hormone metabolic process (GO:0008207),0.22547570378526088,0.5421173051148542,0.9524647887323944,1.0,1.0,2/20,10.72%,FDXR;TSPOAP1
prerank,positive regulation of telomere capping (GO:1904355),0.2352140046009178,0.5412668844340588,0.9562937062937062,1.0,1.0,3/17,12.68%,TNKS2;AURKB;PNKP
prerank,negative regulation of RNA splicing (GO:0033119),-0.20439292907109408,-0.5407973135319867,0.9647887323943662,0.994149535044293,1.0,7/19,28.18%,TMBIM6;RPS26;RNPS1;SRSF12;RPS13;SRSF6;PTBP2
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.2167969801254999,-0.5389527600316047,0.9740820734341252,0.9940124543385505,1.0,3/16,14.44%,IRAK3;SHFL;GLE1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.23381027360021864,0.5370743149550689,0.9652014652014652,1.0,1.0,2/17,7.30%,SERPINE1;ANO6
prerank,protein localization to phagophore assembly site (GO:0034497),0.2574055870175433,0.5362711571600485,0.9560439560439561,1.0,1.0,2/11,13.99%,WIPI1;MFN2
prerank,dopaminergic neuron differentiation (GO:0071542),-0.20374894822072592,-0.5358401416099389,0.9799107142857143,0.9942112855122438,1.0,7/19,30.02%,CTNNB1;VEGFA;MANF;LRP6;LMX1A;WNT2;LMX1B
prerank,metallo-sulfur cluster assembly (GO:0031163),0.22360244126337278,0.5345720786271444,0.9772296015180265,1.0,1.0,7/22,24.36%,NFU1;CIAO3;ISCA1;NFS1;MMS19;ABCB7;IBA57
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.14853140348563915,-0.5345406046830109,1.0,0.9939208591688632,1.0,14/88,20.29%,FBXL7;PSMB2;FBXL5;PSMD14;FBXL2;PSMC6;FBXO31;PSMA4;PSMB9;SKP1;PSMD11;PSMB10;PSMD2;AMN1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.2516882102336866,0.5334417862353412,0.9392712550607287,1.0,1.0,5/10,29.92%,ZNHIT6;RUVBL1;PIH1D2;PIH1D1;NUFIP1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.2316459399582512,0.5329460248508501,0.9609929078014184,1.0,1.0,3/17,14.56%,AFG1L;COX10;COX8A
prerank,mitotic nuclear membrane organization (GO:0101024),0.1877630617256736,0.5309112635713221,0.9969465648854962,1.0,1.0,14/51,22.03%,LEMD2;CCNB2;NUP98;NUP43;LBR;REEP4;VPS4A;NUP155;CHMP4C;SUMO1;NUP188;CHMP2A;UBE2I;CC2D1B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.1877630617256736,0.5309112635713221,0.9969465648854962,1.0,1.0,14/51,22.03%,LEMD2;CCNB2;NUP98;NUP43;LBR;REEP4;VPS4A;NUP155;CHMP4C;SUMO1;NUP188;CHMP2A;UBE2I;CC2D1B
prerank,neuron fate commitment (GO:0048663),0.2435892771202382,0.5305749279264509,0.9608938547486033,1.0,1.0,1/14,3.46%,TGFBR1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.22635859069580866,-0.529750832787264,0.970276008492569,0.9944548152626287,1.0,5/12,31.17%,CEACAM1;ERLIN1;TRIB3;ACADVL;BRCA1
prerank,negative regulation of cell division (GO:0051782),0.2536427599419538,0.5292046400459596,0.9616858237547893,1.0,1.0,4/11,21.76%,AURKB;VPS4A;CHMP4C;ORC6
prerank,negative regulation of lymphocyte activation (GO:0051250),0.21631412970915348,0.5284255876391187,0.968476357267951,1.0,1.0,5/21,17.61%,PTPN22;LGALS3;PIBF1;GPNMB;LAX1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.23407706916914883,0.528397825291536,0.9587242026266416,1.0,1.0,3/16,13.24%,SCD5;MLYCD;GCDH
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.23536135546794318,-0.5274075882905056,0.9725158562367865,0.9943855721329429,1.0,2/11,10.04%,TGFB1;ID2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.18202128211227148,-0.5271992747546214,0.9872122762148338,0.9938044556444054,1.0,9/29,23.94%,DCP1B;HBS1L;LSM1;DCP2;CNOT7;LSM4;LSM7;EXOSC4;EXOSC1
prerank,tRNA metabolic process (GO:0006399),0.22957610669721623,0.5260829186691566,0.968476357267951,1.0,1.0,9/17,33.70%,RPP21;POP7;POP1;KARS1;THG1L;SSB;DTD2;AARS1;DTD1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.20396213783667472,0.524075454425304,0.9808695652173913,1.0,1.0,5/27,13.88%,TLR4;TAB2;LY96;MAP3K1;TLR5
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.23127158555729993,0.523824048058447,0.9625668449197861,1.0,1.0,16/16,76.90%,FBH1;SMCHD1;MAD2L2;SHLD2;UBQLN4;KLHL15;FANCB;SHLD1;RADX;RMI2;PARPBP;RIF1;HELB;SHLD3;POLQ;CGAS
prerank,amyloid precursor protein catabolic process (GO:0042987),0.23171439772197575,0.5237419054729792,0.9544592030360531,1.0,1.0,3/14,11.57%,APH1B;DYRK1A;ADAM17
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.23629338419838306,-0.5233879048496242,0.9763440860215054,0.9940538249827295,1.0,5/10,31.81%,THOC5;RFWD3;CCAR2;ETAA1;RPA2
prerank,nuclear membrane reassembly (GO:0031468),0.18263886545823288,0.5218925118916644,0.9923780487804879,1.0,1.0,16/54,23.82%,LEMD2;CCNB2;NUP98;NUP43;LBR;REEP4;VPS4A;NUP155;CHMP4C;SUMO1;NUP188;CHMP2A;UBE2I;CC2D1B;IST1;UBXN2A
prerank,regulation of spindle organization (GO:0090224),-0.20303265175119833,-0.5215265063740143,0.9815242494226328,0.9938485236284437,1.0,6/18,33.45%,GNAI1;BORA;TPX2;SENP6;PSRC1;DCTN1
prerank,defense response to tumor cell (GO:0002357),0.25208927982653007,0.5182094952297173,0.9691714836223507,1.0,1.0,3/10,17.54%,PLK5;DLEC1;RBMS3
prerank,peptidyl-proline hydroxylation (GO:0019511),0.24707348606301185,0.5175170279905497,0.9539347408829175,1.0,1.0,4/11,23.78%,P4HA1;OGFOD1;EGLN1;CRTAP
prerank,chromatin remodeling at centromere (GO:0031055),0.1956410548710641,0.5163267259884093,0.9850249584026622,1.0,1.0,14/31,29.41%,NASP;CENPO;CENPC;CENPV;CENPK;CENPT;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.20771550640864556,0.5162667739145366,0.9862542955326461,1.0,1.0,25/25,79.26%,SCAF11;PRPF3;SNRNP40;PRPF6;SRSF10;SF3B1;SRSF4;SF3B3;KHSRP;SMNDC1;PRPF4;DBR1;SRRM1;WDR83;TRA2B;TXNL4A;GEMIN2;PRPF8;DDX23;SLU7;SF3B4;MPHOSPH10;BCAS2;SF3A3;LSM1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.21005060475353782,-0.5158373951761717,0.9764453961456103,0.9944410864661448,1.0,3/15,13.30%,HMGCS1;DIP2A;PMVK
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2189285938579414,0.5157592889180944,0.963302752293578,1.0,1.0,18/18,78.13%,THEM4;PPIF;SLC25A4;SLC25A31;BCL2;MUL1;BCL2L1;SLC25A5;HEBP2;NAIF1;BAK1;TMEM102;BAD;ALKBH7;CAMK2A;PMAIP1;SPG7;BNIP3
prerank,nuclear body organization (GO:0030575),0.23995108091132047,0.5151919102064394,0.9594843462246777,1.0,1.0,5/12,24.42%,SRPK2;PML;DYRK3;USPL1;ZPR1
prerank,Golgi to endosome transport (GO:0006895),0.22574844429464289,0.514980791237646,0.9594594594594594,1.0,1.0,7/16,25.11%,WIPI1;AP2A1;VPS13A;MON2;AP4M1;KLHL20;KIF16B
prerank,defense response to fungus (GO:0050832),0.22474773618345228,0.5141093336713161,0.9610619469026549,1.0,1.0,2/17,9.00%,HRG;FAM3A
prerank,regulation of oxidoreductase activity (GO:0051341),0.23368980610929338,0.5129904417194093,0.9637404580152672,1.0,1.0,3/13,19.94%,ABL1;SIRT4;ATP7A
prerank,negative regulation by host of viral transcription (GO:0043922),0.23880971812417598,0.5119924883688042,0.9528301886792453,1.0,1.0,12/12,76.14%,HDAC1;REST;TARDBP;POU2F3;CCL5;CCL3;PSMC3;CCL4;INPP5K;JUN;HMGA2;TFAP4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.24744387555579866,0.5091898422831008,0.9607843137254902,1.0,1.0,2/10,16.59%,TP53;SP100
prerank,natural killer cell mediated immunity (GO:0002228),0.2229168190437738,0.5064884477506669,0.9651162790697675,1.0,1.0,4/15,22.68%,KIF5B;CEBPG;ULBP1;LYST
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.20094843511861102,-0.5044954044842186,0.9830866807610994,0.9960562476849172,1.0,7/16,34.62%,ATP5F1E;ATP5PF;STOML2;ATP5MF;ATP5PD;ATP5MC1;ATP5F1B
prerank,positive regulation of cell killing (GO:0031343),0.22941916328978046,0.5037786363540644,0.9704724409448819,1.0,1.0,1/13,5.87%,NOX1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.23562429326083512,0.5025977232492373,0.96045197740113,1.0,1.0,1/10,8.31%,CPEB3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.18532382767220076,0.5012857699696092,0.9869281045751634,1.0,1.0,6/37,16.10%,SIDT2;DNASE1L1;EXOSC7;SND1;DFFB;DNASE1L2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.2132109869384,-0.4982357660323624,0.985200845665962,0.9965032316691352,1.0,4/12,28.37%,STK33;CHEK2;TOPBP1;HUS1B
prerank,midbody abscission (GO:0061952),0.21132451059131774,0.4974748537283199,0.9657657657657658,1.0,1.0,5/17,21.80%,CHMP1A;VPS4A;CHMP4C;CHMP2A;MITD1
prerank,negative regulation of transferase activity (GO:0051348),0.19567524743863235,0.49696228062495507,0.9932659932659933,1.0,1.0,4/28,10.89%,NPRL2;TP53;ABL1;EIF4A2
prerank,COPII-coated vesicle budding (GO:0090114),0.16676154753540887,0.49439917397948896,0.9984962406015038,1.0,1.0,20/68,23.59%,SEC31B;TRAPPC9;MIA3;TGFA;STX5;SEC23IP;F8;SCFD1;TRAPPC5;PPP6R3;SEC31A;BET1;GOLGA2;SCAP;FOLR1;SEC24C;SEC24A;GORASP1;F5;SEC16A
prerank,phospholipid homeostasis (GO:0055091),-0.2147563928300818,-0.49150022843415847,0.9744680851063829,0.997006474416896,1.0,3/11,26.81%,ABCG1;RCN3;ABCA1
prerank,aerobic electron transport chain (GO:0019646),0.16780949733626557,0.4913780147072922,0.9984962406015038,1.0,1.0,16/68,22.95%,AFG1L;NDUFAB1;UQCRC2;NDUFS1;NDUFV2;COX10;COX8A;NDUFS4;NDUFA2;UQCRC1;COX15;NDUFS5;NDUFA9;NDUFB2;SDHD;UQCRH
prerank,multivesicular body assembly (GO:0036258),0.18977311980976966,0.4897369417441123,0.993485342019544,1.0,1.0,12/30,28.83%,CHMP1A;VPS37A;SNF8;VPS4A;CHMP4C;CHMP2A;IST1;MVB12A;VTA1;STAM2;CHMP1B;VPS36
prerank,ERAD pathway (GO:0036503),0.15929878744756876,0.4877618192856734,0.9971469329529244,1.0,1.0,30/83,28.98%,PRKN;ERLEC1;ECPAS;DNAJB2;AMFR;DNAJB14;UFD1;ERLIN2;SYVN1;DNAJC18;NPLOC4;UBE4B;UBE2J2;GET4;TOR1A;DERL1;SELENOS;BAG6;RNF5;FBXO17;UBXN4;USP19;TMEM67;ANKZF1;TRIM13;OS9;TMUB2;UBE4A;SGTA;UBXN8
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.18613177175322618,-0.4867367988572139,0.9891774891774892,0.9970739769873447,1.0,5/19,26.06%,AR;MAF1;POLR3F;POLR3C;NAB2
prerank,establishment of protein localization to extracellular region (GO:0035592),0.1811665190673171,0.4862609287184435,1.0,1.0,1.0,10/39,21.44%,ARFGAP3;RAB13;MIA3;MON1A;TANGO2;RAB8B;STEAP3;LTBP2;MIA2;AFM
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.18662833479925778,0.4859005092677473,0.9888,1.0,1.0,10/31,25.85%,EXOSC7;DDX6;DCP1A;DIS3;NT5C3B;EXOSC3;POLR2G;EDC4;LSM6;LSM3
prerank,mitochondrial gene expression (GO:0140053),0.1775814220621154,0.48575047257025433,1.0,1.0,1.0,11/42,23.20%,MRPS6;MRPL2;TWNK;MRPS7;FOXO3;GFM2;MRPS17;MRPL23;MRPS34;PTCD3;POLRMT
prerank,translational elongation (GO:0006414),0.15355644620404754,0.4855404122868401,1.0,1.0,1.0,26/101,26.23%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;NEMF;MRPL1;GFM2;MRPL45;MRPS17;CHCHD1;MRPL14;MRPL32;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;LTN1;MRPL33;MRPS18B;MRPL19;TSFM
prerank,RNA interference (GO:0016246),-0.18972646805482773,-0.4853075534744491,0.9956427015250545,0.9966676248942166,1.0,3/17,16.57%,TSNAX;DROSHA;DHX9
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.16528371799980943,0.4840567888418651,1.0,1.0,1.0,16/69,22.95%,AFG1L;NDUFAB1;UQCRC2;NDUFS1;NDUFV2;COX10;COX8A;NDUFS4;NDUFA2;UQCRC1;COX15;NDUFS5;NDUFA9;NDUFB2;SDHD;UQCRH
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2000905132661689,0.47898073720745227,0.9797794117647058,1.0,1.0,8/20,25.81%,APH1B;ADAM17;MBTPS1;NFKB1;NCSTN;ADAM9;PSEN2;SPPL2A
prerank,regulation of T cell activation (GO:0050863),0.17248703173156296,0.47743442095405114,1.0,1.0,1.0,8/42,17.61%,PTPN22;CYRIB;ABL1;LAT;LGALS3;CCR2;GPNMB;LAX1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.20963503920255563,0.4751218755515407,0.9847328244274809,1.0,1.0,1/18,3.84%,BID
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.22247199543086074,0.47493768678294424,0.9792452830188679,1.0,1.0,1/11,7.97%,SMARCA4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.18610913409414748,0.47464708467567435,0.9967373572593801,1.0,1.0,5/29,11.86%,LARP1;GDNF;THRAP3;NOCT;AXIN2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.1725275146957671,0.4738079288387607,0.9951923076923077,1.0,1.0,16/38,29.41%,ATRX;NASP;CENPO;CENPC;CENPK;CENPT;ASF1A;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;IPO4;CENPN;CENPQ
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.186611848087541,-0.4732727795729942,0.9851694915254238,0.9976855010877917,1.0,7/17,34.62%,ATP5F1E;ATP5PF;STOML2;ATP5MF;ATP5PD;ATP5MC1;ATP5F1B
prerank,regulation of DNA metabolic process (GO:0051052),0.16777350438318633,0.46782018670979897,1.0,1.0,1.0,7/44,18.62%,HDAC8;SMG1;WDR70;KAT7;MPHOSPH8;USP1;NBN
prerank,glutathione metabolic process (GO:0006749),0.17467096664295673,0.46600571745958536,0.9934747145187602,1.0,1.0,7/38,20.01%,GSTT1;CTNS;GSTA3;MMACHC;GSTT2;ETHE1;CNDP2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.19847257976762242,0.4659072098379288,0.9874776386404294,1.0,1.0,9/19,32.33%,CHMP1A;CHMP4C;CHMP2A;EML3;DRG1;CHMP1B;HSPA1A;CEP97;PLK1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.19595000493622194,0.46206726922149227,0.9809160305343512,1.0,1.0,4/16,22.68%,KIF5B;CEBPG;ULBP1;LYST
prerank,regulation of histone modification (GO:0031056),0.21303909342645694,0.46145811869739356,0.9798534798534798,1.0,1.0,2/13,14.23%,MTHFR;FLCN
prerank,DNA replication checkpoint signaling (GO:0000076),-0.18504594121635332,-0.4609914888823166,0.9978448275862069,0.9984912196366543,1.0,5/16,28.37%,TIPIN;CDC45;DNA2;TOPBP1;HUS1B
prerank,cellular response to misfolded protein (GO:0071218),0.19300742102128665,0.4606972326214459,0.9945454545454545,1.0,1.0,7/20,23.64%,DNAJB14;UFD1;DNAJC18;TOR1A;DERL1;BAG6;RNF5
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.20279123537514512,-0.4600425672183596,0.9979123173277662,0.9979773900442498,1.0,6/11,37.47%,CTNNB1;LRP6;LMX1A;WNT2;FZD1;NR4A2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.21189053695661092,0.45906696238239286,0.9813780260707635,1.0,1.0,3/14,20.22%,MPV17L2;RPUSD4;FASTKD3
prerank,DNA geometric change (GO:0032392),-0.163727564303457,-0.45640184119261473,0.993006993006993,0.9977215580281795,1.0,6/24,25.56%,ANXA1;DHX9;DNA2;BLM;RECQL5;RECQL
prerank,double-strand break repair via break-induced replication (GO:0000727),0.21470834920140783,0.4536052867267763,0.984,1.0,1.0,3/12,21.23%,MCM7;MCM2;MCM5
prerank,protein insertion into ER membrane (GO:0045048),0.16988574352122535,0.45294691148369476,1.0,1.0,1.0,9/37,23.60%,TRAM2;EMC2;STX5;EMC1;EMC3;UBE2J2;CAMLG;GET4;BAG6
prerank,regulation of macrophage differentiation (GO:0045649),0.20176649491988674,0.4521377132232409,0.9894179894179894,1.0,1.0,5/15,24.63%,RIPK1;PRKCA;INHA;IL34;FADD
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.21884629164951602,0.45076741966839445,0.9849056603773585,1.0,1.0,3/10,19.75%,IMPACT;HIF1AN;CITED2
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.1867502205195047,0.4498115663348161,0.9878048780487805,1.0,1.0,2/20,11.66%,ATM;IK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.1867502205195047,0.4498115663348161,0.9878048780487805,1.0,1.0,2/20,11.66%,ATM;IK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.1867502205195047,0.4498115663348161,0.9878048780487805,1.0,1.0,2/20,11.66%,ATM;IK
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.17182409670858312,0.44842017763054054,0.9933333333333333,1.0,1.0,13/29,29.41%,NASP;CENPO;CENPC;CENPK;CENPT;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,CENP-A containing chromatin organization (GO:0061641),0.17182409670858312,0.44842017763054054,0.9933333333333333,1.0,1.0,13/29,29.41%,NASP;CENPO;CENPC;CENPK;CENPT;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,macrophage migration (GO:1905517),0.20218197351211015,0.4478090353218064,0.9807692307692307,1.0,1.0,4/13,21.81%,LGALS3;CCR2;CXCL17;P2RX4
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.18819789030648576,-0.44644372306285157,0.9957627118644068,0.9967496810875288,1.0,2/12,17.47%,CUL3;CDC23
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.18819789030648576,-0.44644372306285157,0.9957627118644068,0.9967496810875288,1.0,2/12,17.47%,CUL3;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.18819789030648576,-0.44644372306285157,0.9957627118644068,0.9967496810875288,1.0,2/12,17.47%,CUL3;CDC23
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.18224469570943175,0.4459961597633064,0.987783595113438,1.0,1.0,8/23,27.07%,UFD1;SYVN1;NPLOC4;DERL1;SELENOS;SEC16A;SEC13;OS9
prerank,iron-sulfur cluster assembly (GO:0016226),0.17946059464774883,0.4382600431927034,0.9962825278810409,1.0,1.0,7/24,24.36%,NFU1;CIAO3;ISCA1;NFS1;MMS19;ABCB7;IBA57
prerank,regulation of viral release from host cell (GO:1902186),0.18048895757611694,0.436498066402276,0.9893048128342246,1.0,1.0,7/21,26.35%,TRIM62;PML;VPS4A;CHMP2A;TRIM5;TRIM8;TRIM13
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.1831881171376059,0.4346796060032699,0.992467043314501,1.0,1.0,4/19,19.12%,ROPN1L;CCDC39;CCDC40;OFD1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.16154184745016678,0.43334931672594484,1.0,1.0,1.0,38/38,83.88%,NDUFAB1;NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFA9;NDUFB2;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFAF1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA13;NDUFA7;NDUFA11;NDUFA6;NDUFB5;NDUFB8;NDUFS7;NDUFS6;NDUFB7;NDUFB11
prerank,rRNA modification (GO:0000154),0.17971105527638198,0.43044337059841076,0.9879931389365352,1.0,1.0,21/21,82.05%,ZCCHC4;BUD23;NSUN4;MTERF4;METTL5;FBLL1;MRM2;TSR3;THUMPD1;NOP10;GAR1;TRMT112;FTSJ3;TFB2M;DIMT1;NAT10;NSUN3;DKC1;TFB1M;NHP2;FBL
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.15779135614455408,0.430321690294137,1.0,1.0,1.0,14/42,27.90%,ARID2;FBH1;SMCHD1;PPP4R2;KDM1A;FUS;MMS19;FIGNL1;MAD2L2;SHLD2;UBQLN4;RTEL1;RAD51AP1;CHEK1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.19444228179355605,0.42838705613706246,0.9843444227005871,1.0,1.0,3/12,22.53%,CHAMP1;CENPC;MIS12
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.208118778115926,0.42736220913944495,0.9962121212121212,1.0,1.0,2/10,17.97%,RYK;WNT5A
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.17277104129485332,0.42240871600117325,0.9932203389830508,1.0,1.0,2/21,11.66%,ATM;IK
prerank,multivesicular body organization (GO:0036257),-0.14432644709314285,-0.4197118567935709,1.0,0.9979902499876894,1.0,5/31,18.29%,RAB27A;PDCD6IP;VPS37C;CHMP4B;CHMP4A
prerank,RNA methylation (GO:0001510),0.14427289306438024,0.41966016366818,1.0,1.0,1.0,10/60,18.39%,TRMT44;RBM15;NOP2;WTAP;METTL6;ZCCHC4;LCMT2;VIRMA;BUD23;NSUN4
prerank,aromatic amino acid family catabolic process (GO:0009074),0.1877791482326689,0.4181573620840533,0.9963302752293578,1.0,1.0,14/15,60.20%,FAH;KMO;HAAO;KYAT1;GSTZ1;TAT;KYNU;ACMSD;IDO1;HGD;TDO2;IL4I1;IDO2;AADAT
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.1823803334805824,0.4179977449285427,0.9981412639405205,1.0,1.0,6/17,27.07%,UFD1;SYVN1;NPLOC4;DERL1;SELENOS;OS9
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.17729860255365912,0.41476130754992807,0.9945454545454545,1.0,1.0,4/19,18.07%,ACD;HNRNPC;TENT4B;TINF2
prerank,interstrand cross-link repair (GO:0036297),0.14540132302799094,0.4141576258664503,1.0,1.0,1.0,10/53,20.38%,RNF8;FANCI;FANCM;FANCA;USP1;SLX4;XPA;FANCD2;XRCC3;MCM9
prerank,cranial nerve development (GO:0021545),0.17105487140504938,0.3701492746663083,1.0,1.0,1.0,1/11,7.54%,CHD7
prerank,regulation of mitotic spindle organization (GO:0060236),0.13767210918367542,0.3676785481786242,1.0,1.0,1.0,15/35,32.33%,CHMP1A;CLTC;CHMP4C;MAP9;CHMP2A;EML3;PARP3;DRG1;FSD1;CHMP1B;NUMA1;RAE1;HSPA1A;CEP97;PLK1
prerank,regulation of DNA recombination (GO:0000018),0.13917608628648387,0.36483318798279346,1.0,1.0,1.0,11/32,28.29%,MSH3;RAD50;PPP4R2;KDM1A;FIGNL1;H1-0;SHLD2;RTEL1;RAD51AP1;CHEK1;KPNA1
prerank,regulation of chromatin organization (GO:1902275),0.16349595027312117,0.3564794287319299,0.9964093357271095,1.0,1.0,14/14,83.66%,TLK2;SETD1A;METTL4;TLK1;CDK9;MKI67;ALKBH4;PARG;IGF2;HNRNPU;SSRP1;SETD5;MLLT3;HPF1
prerank,organophosphate catabolic process (GO:0046434),0.16285986614094952,0.3450684941958336,1.0,1.0,1.0,2/11,20.66%,ABHD12;PLBD2
prerank,macrophage chemotaxis (GO:0048246),0.15247002699140036,0.3174334478134196,1.0,1.0,1.0,10/10,84.76%,LGALS3;CXCL17;TAFA4;EDN2;SAA1;CCL5;CCL3;CKLF;CCL2;EDNRB
prerank,regulation of spindle assembly (GO:0090169),0.10885396282820967,0.26964736513816023,1.0,0.9999973189450049,1.0,10/25,32.33%,CHMP1A;CHMP4C;CHMP2A;EML3;DRG1;CHMP1B;NUMA1;HSPA1A;CEP97;PLK1
